data_2kpw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 121.264 0.554 . . . . 53.32 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.73 135.28 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.376 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.47 145.51 51.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.202 -0.454 . . . . 64.32 110.88 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 102' ' ' VAL . 57.2 mt -72.65 99.29 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.595 -0.275 . . . . 73.43 110.629 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -62.09 -56.97 13.53 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.068 0.461 . . . . 74.32 111.271 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -164.87 143.66 6.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 73.5 111.565 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG23 HG12 ' A' ' 100' ' ' VAL . 55.7 mt -102.11 138.89 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.938 -0.393 . . . . 70.53 109.938 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.57 135.56 56.67 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.306 0.484 . . . . 70.14 112.306 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.77 -26.0 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.616 0.598 . . . . 74.3 112.616 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 13.7 t70 -85.01 -25.33 27.76 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.279 0.561 . . . . 62.35 110.326 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.52 30.78 6.38 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.149 -0.478 . . . . 40.04 112.943 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -90.37 -45.54 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.405 0.52 . . . . 74.41 112.405 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.46 161.36 38.24 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.648 0.981 . . . . 74.11 113.648 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -117.41 123.73 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 71.13 109.923 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -103.98 109.95 21.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.423 0.63 . . . . 75.4 112.637 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.8 mp -89.74 156.16 18.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.482 -0.781 . . . . 75.22 110.224 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HG3' HG21 ' A' ' 68' ' ' THR . 81.7 tttt -143.25 110.96 5.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.146 -0.346 . . . . 61.0 111.881 -173.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -87.02 106.12 17.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.026 0.441 . . . . 64.02 111.579 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -109.36 40.84 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.396 0.617 . . . . 72.23 111.406 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HG ' ' HG2' ' A' ' 37' ' ' GLN . 80.7 p -83.33 176.54 9.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.451 0.643 . . . . 73.42 112.591 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.68 -7.45 54.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.766 -0.652 . . . . 65.54 111.933 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -149.4 156.45 42.06 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.841 0.353 . . . . 73.3 111.316 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.1 110.71 1.92 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.97 0.414 . . . . 63.05 111.244 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.407 ' HG2' ' HG ' ' A' ' 33' ' ' SER . 13.9 mm100 -93.37 128.93 40.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.544 0.572 . . . . 60.24 112.544 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.38 119.3 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.415 2.076 . . . . 74.42 112.716 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.2 tpp -62.39 -53.11 59.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.007 0.432 . . . . 74.44 112.041 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.78 -82.13 0.85 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.736 -0.745 . . . . 75.23 112.973 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.97 59.48 0.11 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.732 -0.747 . . . . 52.02 113.65 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -62.27 170.12 2.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.299 0.571 . . . . 74.42 112.245 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.56 114.06 15.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.182 0.515 . . . . 75.4 110.801 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -95.51 113.19 24.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.044 -0.525 . . . . 75.2 111.184 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.677 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 2.1 mp -90.44 109.82 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.749 0.309 . . . . 61.24 110.642 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.01 104.45 16.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.116 0.484 . . . . 75.23 111.559 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 100' ' ' VAL . 24.3 mtpp -92.73 166.14 12.6 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.283 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 49' ' ' GLY . 10.2 tt -164.51 -53.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.384 0.513 . . . . 73.34 112.384 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.428 ' N ' HG21 ' A' ' 48' ' ' ILE . . . -174.43 128.16 1.41 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.175 -0.536 . . . . 51.53 112.337 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.07 -69.24 0.16 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.156 0.582 . . . . 74.2 111.995 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -115.96 -174.04 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.733 0.301 . . . . 75.52 111.294 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.5 p -163.6 157.01 18.93 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.878 0.37 . . . . 71.25 111.722 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.748 HG12 ' HG3' ' A' ' 91' ' ' GLN . 7.3 p -138.38 147.17 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.172 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.586 ' HB3' HG13 ' A' ' 45' ' ' ILE . 89.2 p -112.86 161.75 16.6 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.088 0.471 . . . . 71.33 111.969 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 68.6 t80 -136.46 130.1 32.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.285 -0.416 . . . . 74.45 111.446 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -96.9 144.67 26.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.151 0.5 . . . . 71.34 111.509 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -93.55 179.85 5.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.166 0.507 . . . . 71.01 111.979 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -138.42 155.76 48.19 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.061 -0.518 . . . . 70.14 111.431 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 m -82.38 87.6 6.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.459 -0.337 . . . . 73.15 111.538 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.504 ' NH2' ' HD2' ' A' ' 83' ' ' PRO . 8.9 ptm180 -141.75 7.49 1.88 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.322 0.49 . . . . 71.34 112.322 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -163.9 148.03 10.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.968 0.413 . . . . 72.02 111.643 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.44 131.17 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.224 -0.444 . . . . 41.12 110.86 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.3 106.54 10.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.055 0.455 . . . . 70.13 111.636 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.89 164.74 26.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.173 0.511 . . . . 71.45 111.531 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.4 113.05 3.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.851 0.358 . . . . 61.03 111.11 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.82 8.57 61.88 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.424 -0.417 . . . . 62.04 113.04 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -86.11 122.49 30.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.181 0.515 . . . . 72.44 111.866 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.531 HG21 ' HG3' ' A' ' 30' ' ' LYS . 81.3 p -93.35 150.76 20.23 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.307 -0.406 . . . . 73.34 111.299 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 29' ' ' LEU . 7.7 p -135.87 124.39 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.283 0.563 . . . . 65.21 110.945 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 29.4 m -103.82 127.69 51.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.088 -0.505 . . . . 74.12 111.778 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mm -99.38 99.74 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.776 0.322 . . . . 73.03 111.098 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -83.58 119.77 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.502 -0.317 . . . . 75.33 111.208 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -74.65 82.23 2.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.587 0.588 . . . . 74.54 112.587 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 60.66 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.605 0.965 . . . . 74.14 113.605 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -71.39 90.18 0.95 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.194 0.521 . . . . 42.04 111.269 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -133.03 -39.94 0.94 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.658 0.614 . . . . 64.35 112.658 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.7 -29.74 6.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.193 -0.527 . . . . 51.04 112.589 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 79' ' ' THR . 43.8 t -66.67 159.34 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 122.799 0.44 . . . . 73.13 111.223 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 78' ' ' VAL . 53.8 m -52.26 129.56 28.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.853 0.359 . . . . 74.44 111.834 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.55 111.05 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.315 0.487 . . . . 71.34 112.315 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.482 ' H ' HD12 ' A' ' 87' ' ' ILE . 67.4 m 67.25 71.45 0.43 Allowed Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 113.429 0.9 . . . . 61.3 113.429 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.741 ' HB3' HG21 ' A' ' 84' ' ' THR . 86.2 Cg_exo -51.1 167.16 0.33 Allowed 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.741 2.961 . . . . 70.4 111.788 168.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.504 ' HD2' ' NH2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 13.41 60.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 N-CA-C 122.017 3.814 . . . . 52.43 122.017 38.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 82' ' ' PRO . 9.3 t 153.68 -52.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.885 1.674 . . . . 75.23 109.985 161.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.601 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 17.9 m-20 -136.27 -161.45 1.16 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.474 0.71 . . . . 63.22 109.353 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.1 mt -142.09 144.16 33.41 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.734 -0.604 . . . . 71.0 112.077 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 81' ' ' SER . 1.8 mp -106.55 123.96 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.066 0.46 . . . . 73.04 111.029 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.7 t90 -69.14 91.04 0.49 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.425 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -80.56 20.41 0.72 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.792 0.664 . . . . 72.02 112.792 -175.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.426 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.8 m120 -128.91 -0.06 5.33 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.008 -0.433 . . . . 74.21 112.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.748 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -161.11 127.47 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.74 0.305 . . . . 75.33 110.492 -172.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.6 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 2.8 m-20 -87.34 172.78 9.59 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.982 0.734 . . . . 64.25 112.982 -173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 t -47.27 125.78 8.46 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.103 -0.498 . . . . 64.05 111.419 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -92.7 -30.98 15.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.531 0.567 . . . . 75.32 112.531 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 73.31 102.49 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.768 -0.73 . . . . 72.41 112.072 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.4 t -79.83 28.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.183 0.808 . . . . 60.21 113.183 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.84 -39.48 62.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.87 -0.892 . . . . 55.22 110.87 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -87.63 123.97 33.04 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.487 -0.56 . . . . 73.14 109.487 166.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -52.63 101.63 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.375 0.607 . . . . 73.44 112.536 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 47' ' ' LYS . 7.4 p -71.96 140.38 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.475 -0.784 . . . . 62.51 111.657 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -124.92 117.16 23.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.151 -0.477 . . . . 74.1 110.925 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 17' ' ' ILE . 60.4 t -99.83 123.69 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.111 0.481 . . . . 74.51 112.049 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.677 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 25.1 mm -105.29 116.89 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.037 -0.529 . . . . 70.35 110.95 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.79 107.8 19.81 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.877 0.37 . . . . 53.41 111.847 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.42 139.32 49.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.904 0.383 . . . . 73.34 111.147 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.44 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.3 m120 -63.81 174.53 1.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.297 0.57 . . . . 72.51 112.236 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 m -56.87 -28.02 61.22 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.695 -0.684 . . . . 72.42 112.382 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.53 21.41 14.35 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.934 0.716 . . . . 73.23 112.934 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.88 5.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.949 -0.643 . . . . 43.41 114.552 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.9 pt-20 -53.9 150.47 7.65 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.067 0.433 . . . . 74.35 111.348 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.51 136.11 48.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.129 0.789 . . . . 75.14 113.129 -169.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.28 -55.23 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.131 -0.486 . . . . 63.31 111.722 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.19 170.26 21.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 74.33 112.162 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -152.83 134.54 14.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.891 -0.595 . . . . 71.4 111.149 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -144.92 150.58 37.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.796 0.331 . . . . 74.25 111.428 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.6 p -126.49 -178.84 4.5 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 73.44 111.576 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.5 p -80.01 -176.41 5.49 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.223 0.535 . . . . 72.32 111.649 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.47 0.555 0 CA-C-N 116.112 -0.495 . . . . 73.31 110.954 178.122 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.972 0.415 . . . . 72.54 111.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 29' ' ' LEU . 39.7 t -98.89 109.57 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.057 0.456 . . . . 64.44 111.888 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 52.8 t -107.63 173.18 6.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.42 -0.355 . . . . 74.43 110.663 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 62.4 mt -88.97 119.79 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.951 -0.468 . . . . 63.12 111.766 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.54 -48.43 22.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.85 0.357 . . . . 75.4 110.537 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.47 153.36 28.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.119 0.414 . . . . 71.42 112.119 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG21 HG12 ' A' ' 27' ' ' ILE . 47.0 mt -119.94 126.15 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.427 -0.351 . . . . 71.41 110.193 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.86 143.91 54.4 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.739 0.644 . . . . 70.23 112.739 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.57 -19.15 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.778 -0.646 . . . . 61.54 111.339 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.65 -39.03 92.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.096 0.474 . . . . 70.41 110.409 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.97 23.82 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.911 -0.586 . . . . 63.11 113.371 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -112.53 -63.07 1.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.391 0.885 . . . . 72.23 113.391 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.5 154.02 37.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.725 1.38 . . . . 73.02 114.725 -166.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.449 HD12 HG21 ' A' ' 102' ' ' VAL . 65.6 mt -123.51 110.72 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.166 -0.924 . . . . 73.52 109.381 171.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 36.1 ttm180 -92.06 116.63 29.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.119 0.785 . . . . 75.54 113.119 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 7.7 mp -96.59 179.94 4.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.011 -0.541 . . . . 74.23 111.163 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -165.1 123.14 1.63 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.647 0.26 . . . . 75.21 111.423 -171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.642 ' HB2' HD22 ' A' ' 63' ' ' LEU . 32.6 t30 -74.07 95.37 2.53 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.013 0.435 . . . . 75.44 111.402 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 p -82.32 87.74 6.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.226 0.536 . . . . 74.01 111.317 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.7 p -155.67 175.48 13.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.086 -0.506 . . . . 74.24 111.249 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.71 3.87 37.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.396 0.517 . . . . 51.44 112.396 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.53 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 52.9 tt0 -149.42 153.58 37.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.651 0.263 . . . . 63.25 111.482 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.81 117.25 4.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.904 0.383 . . . . 72.4 110.998 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 24.7 mm-40 -115.7 164.07 18.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 122.311 -0.243 . . . . 71.22 111.477 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.0 144.86 27.54 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.19 1.926 . . . . 74.12 111.152 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.1 tpt -52.42 -56.82 12.46 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.722 0.296 . . . . 74.43 111.651 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.08 148.51 17.79 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.925 -0.655 . . . . 73.0 114.064 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.69 58.88 4.97 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.397 -0.43 . . . . 72.0 112.915 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.79 169.45 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.708 0.29 . . . . 72.54 110.761 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.57 124.3 21.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.261 0.553 . . . . 75.13 111.433 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.558 ' HE2' HG22 ' A' ' 71' ' ' ILE . 55.6 ttp -93.13 108.25 19.88 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.751 -0.659 . . . . 75.12 111.387 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.469 HD11 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -97.18 115.54 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.706 0.288 . . . . 75.21 110.758 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -84.35 97.19 9.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.781 0.324 . . . . 64.43 111.223 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -94.69 131.82 40.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.236 0.541 . . . . 64.33 111.677 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -150.22 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.708 0.765 . . . . 73.01 111.079 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.67 -61.67 0.55 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.036 -0.529 . . . . 64.1 113.562 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -82.57 -66.43 0.89 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.398 -0.472 . . . . 73.31 112.232 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -95.86 173.43 7.45 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.132 0.491 . . . . 65.54 112.185 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -145.37 33.03 1.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.003 -0.544 . . . . 70.34 111.371 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.93 127.72 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.295 0.569 . . . . 74.01 111.998 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 44' ' ' MET . 82.8 p -114.54 177.7 4.55 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.489 0.662 . . . . 63.41 112.772 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.514 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 69.6 t80 -152.99 108.39 3.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.492 -0.776 . . . . 73.42 111.193 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.597 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 4.8 ttmp? -78.83 121.17 24.47 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.803 -0.443 . . . . 72.24 109.803 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.09 124.46 23.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.893 0.701 . . . . 73.44 112.893 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -72.27 85.23 1.07 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.478 0.656 . . . . 71.4 111.454 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.9 t -71.93 72.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.374 0.607 . . . . 53.22 111.217 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 16.4 ptt180 -102.68 5.19 38.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.799 -0.637 . . . . 71.33 112.152 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 51.3 p90 -158.37 165.53 34.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.886 0.374 . . . . 74.35 111.529 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.58 143.35 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.069 0.462 . . . . 62.4 111.792 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.642 HD22 ' HB2' ' A' ' 31' ' ' ASN . 18.9 tp -108.95 124.38 50.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.125 0.488 . . . . 64.23 111.06 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.93 164.89 16.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.639 0.607 . . . . 73.11 112.639 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.82 124.46 24.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.188 -0.46 . . . . 65.31 111.421 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.94 7.34 83.9 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.31 -0.471 . . . . 61.33 113.152 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.47 132.74 45.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.999 0.428 . . . . 75.03 111.585 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.1 p -92.93 99.56 12.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.087 -0.506 . . . . 53.43 111.919 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.11 113.64 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.353 0.596 . . . . 64.34 110.639 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 21.0 m -99.86 131.81 45.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.963 0.411 . . . . 65.34 112.002 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.558 HG22 ' HE2' ' A' ' 44' ' ' MET . 44.2 mm -93.2 99.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.111 -0.495 . . . . 71.11 111.051 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.467 ' HB2' HG13 ' A' ' 87' ' ' ILE . 65.1 m95 -90.1 120.43 31.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.466 -0.334 . . . . 73.4 111.098 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -55.33 153.75 6.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.974 0.361 . . . . 70.0 111.974 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.33 -42.56 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.969 0.729 . . . . 75.32 112.969 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.9 OUTLIER -93.71 43.18 1.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.101 0.477 . . . . 70.22 111.952 -178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.81 -4.38 43.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.793 0.33 . . . . 72.13 111.694 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.02 -49.94 3.85 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.34 -0.457 . . . . 62.13 113.541 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.01 146.39 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 122.646 0.378 . . . . 74.22 111.999 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 81' ' ' SER . 92.3 m -54.63 132.19 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.813 0.339 . . . . 72.44 111.641 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.16 -25.04 20.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.38 0.881 . . . . 62.1 113.38 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.502 ' H ' HG21 ' A' ' 79' ' ' THR . 9.3 t -132.72 82.81 55.11 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 120.859 0.361 . . . . 52.32 110.892 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.513 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 52.7 Cg_exo -53.36 -47.65 26.25 Favored 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 123.372 2.715 . . . . 73.44 115.283 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.513 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 43.0 Cg_endo -103.31 25.77 12.26 Favored 'Cis proline' 0 C--N 1.364 1.391 0 CA-C-N 120.974 1.384 . . . . 70.23 114.501 -0.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.492 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 8.8 t -56.74 -34.28 67.37 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.905 0.383 . . . . 75.43 111.743 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -113.35 173.0 6.62 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.363 -0.381 . . . . 72.01 110.33 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 98.3 mt -122.4 126.36 47.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.368 . . . . 65.33 111.236 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 72' ' ' TRP . 1.7 mp -91.95 124.92 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.479 0.657 . . . . 71.13 112.042 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.514 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 7.9 t90 -74.56 80.44 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.692 -0.685 . . . . 72.4 110.573 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -67.14 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.979 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.473 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.9 m120 -74.11 -12.02 60.48 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -148.52 140.29 23.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.12 0.486 . . . . 72.05 111.697 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 92' ' ' ASN . 0.8 OUTLIER -80.66 -171.48 3.13 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.578 -0.283 . . . . 74.22 110.919 174.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.9 p -73.48 129.53 38.18 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.002 -0.436 . . . . 72.54 110.687 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -90.65 142.29 27.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.258 0.551 . . . . 73.11 112.194 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.03 23.86 24.48 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.095 -0.502 . . . . 62.42 112.654 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.0 p -79.4 127.98 32.78 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.223 0.453 . . . . 61.12 112.223 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.3 -10.15 66.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.431 -0.414 . . . . 71.53 113.33 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.64 156.07 39.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.799 0.333 . . . . 74.53 111.309 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.92 89.18 0.28 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.54 0.686 . . . . 62.12 111.198 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.17 117.56 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.918 -0.583 . . . . 71.1 110.812 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.857 ' HB2' ' HZ2' ' A' ' 101' ' ' LYS . 3.2 ttmp? -103.51 99.1 8.91 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.463 0.649 . . . . 72.15 110.925 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 27' ' ' ILE . 80.0 t -82.09 132.88 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.376 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.46 HG22 ' HE2' ' A' ' 105' ' ' LYS . 38.0 mm -112.42 133.67 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.123 -0.489 . . . . 74.43 111.514 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.408 HD11 HG13 ' A' ' 17' ' ' ILE . 87.5 mt -112.5 110.12 20.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.692 0.282 . . . . 74.32 111.058 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.46 ' HE2' HG22 ' A' ' 103' ' ' ILE . 66.8 mttm -120.36 159.32 25.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 70.22 112.308 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 1.4 m-20 -95.71 -179.27 4.67 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.546 -0.752 . . . . 65.44 111.996 -176.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -61.13 -19.54 61.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.869 -0.605 . . . . 63.14 112.336 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -102.83 17.09 24.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.214 0.45 . . . . 73.41 112.214 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.03 5.36 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.117 -0.563 . . . . 60.33 113.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 15.0 pt-20 -58.68 159.43 6.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.575 0.35 . . . . 61.12 111.162 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 105' ' ' LYS . 35.4 tt0 -121.91 127.43 50.42 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.437 0.532 . . . . 74.14 112.437 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -33.81 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.297 0.481 . . . . 62.42 112.297 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.18 149.73 17.79 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.753 0.649 . . . . 53.42 112.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -146.89 141.29 26.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.67 -0.695 . . . . 74.23 110.19 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 115' ' ' ARG . 31.4 ttt180 -154.67 156.71 36.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.019 -0.426 . . . . 54.32 112.038 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 83.9 p -125.63 170.13 11.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.913 0.387 . . . . 70.13 111.516 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.9 p -72.72 159.22 34.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.222 0.534 . . . . 72.52 111.896 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.306 0.574 . . . . 73.42 111.001 177.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 64.15 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.99 133.03 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.743 0.306 . . . . 73.23 111.201 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.07 159.13 40.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.8 0.333 . . . . 74.34 111.591 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 HD11 ' A' ' 104' ' ' LEU . 71.7 mt -82.29 116.99 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.926 0.393 . . . . 62.32 111.75 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -80.61 -50.23 10.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.019 0.437 . . . . 73.54 111.305 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -161.92 151.91 16.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.202 0.525 . . . . 74.4 111.451 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.759 ' HB ' HG22 ' A' ' 117' ' ' THR . 59.6 mt -115.47 149.22 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.579 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.86 144.51 44.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.067 0.461 . . . . 70.03 112.119 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -32.19 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.18 -0.464 . . . . 72.31 112.027 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.8 -47.3 13.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.98 0.419 . . . . 73.14 110.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.4 23.24 1.4 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.03 -0.532 . . . . 55.23 113.487 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -90.31 -27.89 19.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.453 0.909 . . . . 74.44 113.453 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -151.8 160.31 43.61 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.694 0.998 . . . . 74.45 113.694 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.678 HG21 HG12 ' A' ' 20' ' ' ILE . 70.0 mt -125.98 120.76 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.469 -0.787 . . . . 72.01 110.366 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -93.38 114.38 26.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.845 0.683 . . . . 71.03 112.845 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -100.92 165.21 11.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.268 172.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -151.41 139.59 20.23 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.066 0.46 . . . . 75.32 112.093 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -88.12 145.53 25.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.919 -0.582 . . . . 60.32 110.88 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -119.33 8.24 11.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.462 0.541 . . . . 63.23 112.462 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.424 ' HG ' ' HG2' ' A' ' 37' ' ' GLN . 87.0 p -81.58 155.5 25.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.34 0.59 . . . . 74.24 112.049 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.9 7.65 17.5 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.992 -0.549 . . . . 71.4 111.947 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.8 156.21 42.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.659 0.266 . . . . 72.21 111.498 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.58 106.11 2.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.443 -0.344 . . . . 63.32 111.025 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HG2' ' HG ' ' A' ' 33' ' ' SER . 10.2 mm100 -106.13 144.74 29.56 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.699 -0.228 . . . . 64.1 111.326 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.37 156.03 18.55 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.353 2.035 . . . . 74.21 112.948 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.663 ' HE1' ' HA ' ' A' ' 39' ' ' MET . 4.2 tpt -60.23 -29.24 68.62 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.978 0.418 . . . . 36.98 111.926 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.08 176.86 49.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.373 -0.441 . . . . 73.51 113.559 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 52.63 0.67 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.354 -0.451 . . . . 62.0 112.709 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -98.72 172.36 7.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.554 0.216 . . . . 74.04 110.856 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -137.35 137.3 38.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.316 0.579 . . . . 75.11 111.492 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.405 ' HE1' HG13 ' A' ' 71' ' ' ILE . 55.2 ttp -105.39 122.75 46.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.87 -0.605 . . . . 64.22 111.417 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.2 mp -104.79 124.29 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.888 0.375 . . . . 72.15 111.407 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.651 ' HB2' ' HH2' ' A' ' 88' ' ' TRP . 34.7 ttt180 -90.87 123.16 34.18 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.278 -0.264 . . . . 73.4 111.671 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -116.58 105.53 12.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 64.41 110.831 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.16 -23.43 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.284 0.564 . . . . 73.22 110.789 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -94.8 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.035 -0.529 . . . . 71.32 112.345 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.86 -41.0 11.43 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.691 0.281 . . . . 72.4 111.384 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.3 t -92.72 147.97 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.162 0.506 . . . . 72.1 111.792 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p -140.96 168.88 18.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.082 0.468 . . . . 73.12 111.6 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -162.17 141.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.537 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -115.58 159.72 20.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.539 0.685 . . . . 74.24 112.782 -174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 84.0 t80 -144.44 115.27 7.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.642 -0.708 . . . . 71.03 110.597 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -86.85 140.39 29.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.189 0.519 . . . . 75.21 111.583 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' HE2' HD11 ' A' ' 71' ' ' ILE . 89.2 m-85 -87.56 145.41 26.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 73.51 111.489 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.8 t -121.55 130.1 53.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.949 0.404 . . . . 62.44 111.659 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 67.8 m -73.92 74.68 1.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.162 0.506 . . . . 74.12 111.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -97.76 -2.24 41.56 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.532 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -168.76 172.83 7.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.617 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.06 126.32 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.14 0.495 . . . . 72.42 111.652 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -74.38 119.56 18.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.232 -0.655 . . . . 75.13 109.232 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 66.0 mttm -62.37 158.75 16.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.825 0.676 . . . . 64.12 112.825 -172.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.21 113.88 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.658 -0.701 . . . . 74.43 112.006 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.66 21.4 72.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.463 -0.398 . . . . 45.14 114.029 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -86.35 149.24 25.17 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.148 0.499 . . . . 73.25 111.844 -178.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.1 p -92.45 145.2 24.64 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.178 -0.465 . . . . 75.11 111.557 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 63' ' ' LEU . 7.0 p -134.49 122.29 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.91 0.386 . . . . 62.13 110.391 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -103.1 137.33 41.42 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.253 0.549 . . . . 74.42 112.102 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.442 HD12 ' HB2' ' A' ' 86' ' ' LEU . 43.5 mm -95.4 108.85 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.214 -0.448 . . . . 63.04 110.782 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -97.35 136.22 38.12 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.544 0.212 . . . . 71.12 110.659 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.31 158.11 18.11 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.086 0.402 . . . . 64.14 112.086 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 89' ' ' LYS . . . -47.09 -44.92 21.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.594 0.59 . . . . 73.02 112.594 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 93' ' ' SER . 2.0 m-20 -95.84 74.5 3.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.161 0.505 . . . . 73.42 111.511 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.9 3.15 8.77 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.08 -0.509 . . . . 73.41 111.188 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.62 17.32 64.52 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.309 -0.405 . . . . 74.44 113.651 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.39 171.5 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.152 0.501 . . . . 73.1 112.317 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -82.2 164.4 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.999 -0.546 . . . . 62.02 112.207 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.54 89.89 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.359 -0.382 . . . . 63.42 111.717 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 t 59.83 81.36 0.25 Allowed Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.508 . . . . 52.12 111.342 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.453 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 89.0 Cg_exo -45.23 -51.45 7.75 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.222 2.615 . . . . 65.13 115.365 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 48.6 Cg_endo -100.13 149.35 4.15 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 121.011 1.397 . . . . 70.51 114.008 -1.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 t -171.02 -38.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.259 -0.882 . . . . 44.31 108.892 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -123.21 156.76 34.49 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.838 -1.074 . . . . 72.44 109.308 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' A' ' 71' ' ' ILE . 93.3 mt -104.8 141.65 36.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.026 0.441 . . . . 74.4 111.961 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.5 mp -95.14 121.85 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.313 0.578 . . . . 75.11 111.343 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HH2' ' HB2' ' A' ' 46' ' ' ARG . 4.9 t90 -89.66 84.0 6.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.939 -0.573 . . . . 73.51 110.463 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 48.8 mtmt -74.61 -16.41 60.79 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.187 0.44 . . . . 73.44 112.187 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.541 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 0.9 OUTLIER -65.9 -15.86 63.33 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.79 0.328 . . . . 71.42 111.523 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -148.69 139.01 22.48 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 72.22 111.103 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -72.72 -177.17 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.035 0.445 . . . . 73.45 111.231 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 40.4 t -77.69 142.92 38.51 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.226 -0.297 . . . . 73.15 111.486 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -125.85 157.71 36.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.953 0.406 . . . . 73.14 111.234 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.92 141.75 7.27 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.93 -0.652 . . . . 61.33 112.819 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 t 176.46 -27.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.983 0.364 . . . . 73.21 111.983 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 30.11 20.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.039 -0.6 . . . . 45.24 113.564 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.58 144.08 28.28 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.005 0.402 . . . . 71.12 110.757 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.2 m-20 -64.52 99.32 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.172 0.511 . . . . 74.43 112.15 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.36 127.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.578 . . . . 62.22 111.072 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 19.2 ttpp -104.26 119.53 39.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.188 0.518 . . . . 74.23 111.336 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.1 t -108.71 147.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.132 0.491 . . . . 74.54 112.015 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 mm -116.95 126.49 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.094 -0.503 . . . . 75.42 111.591 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.58 HD11 HG13 ' A' ' 17' ' ' ILE . 66.3 mt -110.58 106.71 16.08 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.702 0.287 . . . . 74.32 111.697 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -120.52 140.82 50.91 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.323 0.583 . . . . 74.21 111.731 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.506 ' OD1' HG11 ' A' ' 112' ' ' VAL . 12.4 m120 -80.77 179.68 7.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.739 -0.664 . . . . 73.12 112.343 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.5 p -54.48 -49.24 70.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.561 -0.745 . . . . 63.01 112.345 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.56 -4.32 22.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.78 0.659 . . . . 71.15 112.78 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.35 -16.75 60.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.047 -0.597 . . . . 70.23 113.468 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.76 143.95 55.62 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.456 -0.438 . . . . 74.31 110.72 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -103.06 130.47 50.21 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.6 0.592 . . . . 74.24 112.6 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.506 HG11 ' OD1' ' A' ' 106' ' ' ASN . 16.0 m -76.7 -45.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.765 -0.198 . . . . 65.11 111.194 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -176.67 133.7 0.21 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.516 0.561 . . . . 64.33 112.516 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.28 141.9 35.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.526 -0.546 . . . . 64.2 109.526 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -155.61 146.91 22.68 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.407 0.521 . . . . 60.23 112.407 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 79.1 p -109.56 169.98 8.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.005 0.431 . . . . 36.98 111.306 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.759 HG22 ' HB ' ' A' ' 20' ' ' ILE . 62.3 p -71.91 164.81 25.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.152 0.501 . . . . 71.42 112.106 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 CA--C 1.536 0.406 0 CA-C-N 116.051 -0.522 . . . . 62.43 110.65 174.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 11.9 m120 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 112.243 0.46 . . . . 71.34 112.243 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.53 97.75 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.209 0.528 . . . . 61.33 110.878 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 p -112.54 158.67 19.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.365 -0.38 . . . . 65.21 111.416 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.697 HG13 HD12 ' A' ' 104' ' ' LEU . 72.2 mt -62.11 135.73 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.734 -0.212 . . . . 44.33 111.037 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 33.0 tt0 -90.56 -69.25 0.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 74.21 110.26 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.85 138.66 22.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.408 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.735 HG23 HG12 ' A' ' 27' ' ' ILE . 56.4 mt -101.53 141.77 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.375 -0.375 . . . . 70.2 110.907 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.0 150.15 35.85 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.368 0.604 . . . . 74.13 112.419 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.37 -31.43 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.302 -0.863 . . . . 62.54 112.569 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.45 -32.15 66.04 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.134 0.492 . . . . 73.12 111.238 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 108.96 34.04 2.66 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.133 -0.485 . . . . 63.05 112.303 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.74 -53.13 3.98 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.416 0.524 . . . . 71.53 112.416 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.39 165.65 35.12 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.834 1.05 . . . . 64.53 113.834 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 20' ' ' ILE . 64.7 mt -129.05 106.44 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.889 -1.05 . . . . 61.53 109.612 172.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -91.66 124.66 35.97 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.85 -0.531 . . . . 72.15 112.343 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 8.0 mp -93.49 -177.28 4.36 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.12 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 61.6 tttp -162.66 119.9 2.0 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.793 0.294 . . . . 73.01 111.793 -174.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.505 ' HB2' HD11 ' A' ' 63' ' ' LEU . 38.5 t30 -90.24 110.43 21.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.609 0.243 . . . . 70.34 111.032 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.6 p -96.65 13.53 27.99 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.369 0.507 . . . . 74.21 112.369 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 29.5 t -79.54 157.6 27.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.288 0.566 . . . . 63.52 112.438 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.61 -13.72 59.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.797 -0.638 . . . . 65.32 110.741 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -115.64 149.26 38.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.191 0.52 . . . . 62.03 111.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.17 108.83 5.56 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.101 -0.5 . . . . 72.21 110.141 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -91.2 119.68 68.68 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.384 0.512 . . . . 53.0 112.384 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.87 136.11 47.45 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.269 1.979 . . . . 65.01 111.844 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.692 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.0 tpt -59.39 -41.53 89.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.21 0.448 . . . . 65.21 112.21 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.27 -67.12 1.21 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.375 -0.441 . . . . 70.34 113.494 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.78 78.52 0.02 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 62.32 112.855 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -98.9 179.96 4.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.73 0.3 . . . . 74.23 111.067 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.42 130.44 11.83 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.522 0.677 . . . . 72.35 111.236 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 54' ' ' SER . 52.2 ttp -99.35 111.39 23.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.808 -0.633 . . . . 55.03 111.416 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.7 mp -89.68 141.6 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.668 0.27 . . . . 75.54 110.631 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -138.17 126.25 22.8 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.939 -0.475 . . . . 73.11 111.621 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -111.97 145.38 39.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 74.34 111.179 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.99 -41.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.062 0.458 . . . . 73.54 111.923 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.15 103.62 0.17 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.146 -0.55 . . . . 63.24 112.369 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 72.47 -36.51 0.36 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.457 0.703 . . . . 64.03 112.616 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -113.84 148.54 36.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.902 0.382 . . . . 73.21 111.457 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.1 p -137.02 143.43 42.73 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.338 -0.392 . . . . 75.2 111.023 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.5 147.38 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 63.24 111.031 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 44' ' ' MET . 97.9 p -131.77 150.32 52.19 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.067 0.461 . . . . 61.12 111.971 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 33.1 t80 -122.6 120.5 33.93 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.36 -0.382 . . . . 73.15 111.297 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.69 129.32 34.85 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.965 0.412 . . . . 73.35 111.649 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.477 ' HB3' ' SD ' ' A' ' 39' ' ' MET . 86.4 m-85 -88.67 122.59 32.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.311 -0.404 . . . . 64.41 111.659 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.9 t -81.91 140.57 33.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.639 0.607 . . . . 72.45 112.639 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 98.9 p -86.05 18.44 3.06 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.17 0.433 . . . . 72.52 112.17 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.469 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 14.4 ptm180 -68.85 -9.8 53.37 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.757 0.651 . . . . 72.01 112.757 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.469 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 48.6 p90 -152.63 168.44 25.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.279 0.562 . . . . 75.2 112.043 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.57 140.71 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.682 -0.69 . . . . 72.12 111.455 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -92.95 100.61 13.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.33 -0.619 . . . . 64.45 109.33 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.61 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 8.4 mtpm? -69.69 163.24 26.08 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.384 0.883 . . . . 75.41 113.384 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.57 122.53 17.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.834 -0.621 . . . . 75.2 111.171 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.34 86.72 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.944 -0.646 . . . . 72.05 113.473 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.603 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -89.37 133.9 34.31 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.462 -0.434 . . . . 75.23 111.041 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.9 p -116.07 100.68 8.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.316 -0.402 . . . . 64.25 111.821 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.67 132.17 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.927 0.394 . . . . 74.14 111.206 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 m -101.2 124.23 46.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.826 0.346 . . . . 71.34 111.694 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 40.7 mm -89.39 96.2 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.91 0.386 . . . . 54.42 110.985 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' TRP . 94.3 m95 -83.05 133.9 35.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.684 0.253 . . . . 75.24 111.684 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 163.3 11.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.038 0.447 . . . . 63.34 111.964 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.35 -21.08 3.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.07 0.767 . . . . 61.24 113.07 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.511 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.8 OUTLIER -86.97 16.47 4.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.106 0.41 . . . . 75.52 112.106 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.94 78.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.051 0.453 . . . . 73.15 111.501 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.36 -26.85 3.34 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.424 -0.417 . . . . 73.31 113.686 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.26 163.57 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.981 0.42 . . . . 74.53 111.98 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -78.13 143.6 37.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.064 0.459 . . . . 75.22 111.662 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.0 78.12 3.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.024 0.44 . . . . 65.42 111.199 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -136.47 95.07 13.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.503 -0.317 . . . . 70.35 111.684 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.427 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 13.4 Cg_exo -72.72 178.17 6.67 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.248 2.632 . . . . 75.54 112.278 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 98.6 Cg_endo -99.9 118.82 1.01 Allowed 'Cis proline' 0 C--N 1.361 1.22 0 N-CA-C 114.544 0.94 . . . . 73.13 114.544 -0.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.553 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.9 t -154.96 -56.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.97 -0.559 . . . . 71.41 109.855 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' HG23 ' A' ' 84' ' ' THR . 21.4 m-20 -141.2 176.85 8.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.779 -0.646 . . . . 65.02 109.703 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 97.0 mt -123.02 124.13 42.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.893 0.378 . . . . 74.24 110.956 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.547 HD11 ' N ' ' A' ' 87' ' ' ILE . 3.2 mp -93.99 111.56 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.167 0.508 . . . . 75.4 111.31 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 4.3 t90 -71.09 77.9 0.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.203 0.525 . . . . 74.43 110.617 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.653 ' HZ3' ' HB3' ' A' ' 89' ' ' LYS . 8.7 mtpm? -76.89 1.8 16.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.022 0.439 . . . . 72.44 111.607 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -93.57 -4.32 51.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.272 -0.422 . . . . 64.33 111.812 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -137.79 148.69 45.75 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.171 0.51 . . . . 75.13 111.457 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -91.44 -174.82 4.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.04 -0.527 . . . . 71.52 110.789 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 98.7 p -64.41 120.43 12.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.141 0.496 . . . . 74.45 111.096 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.505 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.3 p90 -77.73 118.21 19.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.239 0.542 . . . . 72.41 112.062 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.36 102.74 0.16 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.932 -0.576 . . . . 75.33 112.334 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -157.35 26.25 0.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 72.1 111.718 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -54.11 4.35 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.151 -0.547 . . . . 42.42 113.102 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.3 119.19 8.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.479 0.312 . . . . 73.21 111.194 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.04 146.2 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.676 0.621 . . . . 74.22 112.676 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.4 128.47 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.773 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -114.47 142.49 46.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.991 0.424 . . . . 71.14 111.751 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.82 136.91 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 116.192 -0.458 . . . . 71.11 111.996 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.73 122.91 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.024 -0.535 . . . . 74.41 111.432 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.697 HD12 HG13 ' A' ' 17' ' ' ILE . 97.9 mt -89.69 131.28 35.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.231 -0.293 . . . . 70.35 111.095 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.6 mttt -141.09 145.72 36.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.209 0.528 . . . . 53.35 112.052 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -88.31 -173.43 4.2 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.082 0.467 . . . . 74.14 111.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -51.78 -41.96 62.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.742 0.645 . . . . 70.33 112.742 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.99 -0.69 40.66 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.894 0.702 . . . . 75.13 112.894 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.1 0.59 80.51 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.896 -0.669 . . . . 37.44 112.867 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.8 138.6 57.47 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.718 0.407 . . . . 71.21 111.108 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.5 tt0 -83.59 133.15 34.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.174 0.512 . . . . 75.43 111.954 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.71 -50.53 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.964 -0.562 . . . . 71.14 111.162 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.6 163.78 16.9 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.966 -0.561 . . . . 65.23 111.58 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -137.16 136.12 37.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.241 -0.436 . . . . 71.34 111.116 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -160.63 156.25 25.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.118 0.485 . . . . 75.31 111.486 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 54.4 p -142.54 -171.94 3.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.788 0.328 . . . . 60.33 111.221 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 14.8 t -147.23 145.47 29.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.652 0.263 . . . . 73.31 110.571 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.004 0.43 . . . . 72.54 111.831 -176.381 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 . . . . . 0 CA--C 1.542 0.644 0 CA-C-O 121.103 0.478 . . . . 72.22 110.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.42 140.6 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.015 0.436 . . . . 54.0 111.873 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -137.81 164.17 29.59 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.209 -0.45 . . . . 63.31 110.705 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 17' ' ' ILE . 4.1 mp -87.49 119.44 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.22 -0.3 . . . . 72.2 111.28 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.51 -50.52 44.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.785 0.326 . . . . 70.54 111.361 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -171.31 152.79 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 60.33 112.149 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.57 HG23 HG12 ' A' ' 27' ' ' ILE . 65.3 mt -107.49 134.72 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.792 -0.64 . . . . 64.12 110.816 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.0 130.25 41.66 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.032 0.444 . . . . 72.43 111.301 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -70.18 -28.25 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.511 0.56 . . . . 74.31 112.511 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.53 -44.76 56.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.77 0.319 . . . . 74.33 110.835 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 117.02 37.97 0.91 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 116.23 -0.441 . . . . 73.44 113.236 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -104.69 -39.59 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.452 0.538 . . . . 63.51 112.452 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.75 160.46 37.9 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.353 0.871 . . . . 72.14 113.353 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 20' ' ' ILE . 69.7 mt -131.61 122.47 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.611 -0.722 . . . . 71.0 109.781 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -99.72 122.41 42.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.934 0.716 . . . . 73.44 112.934 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 104' ' ' LEU . 7.0 mp -97.3 173.72 7.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.592 -0.731 . . . . 74.33 110.587 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.6 131.6 11.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.936 0.398 . . . . 73.12 111.981 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 63' ' ' LEU . 28.4 t30 -89.87 104.36 16.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.249 -0.432 . . . . 65.45 110.968 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 t -105.72 84.11 2.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 71.45 110.887 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.6 p -136.4 -177.8 4.88 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.722 -0.672 . . . . 64.42 112.164 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.45 -22.53 35.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.909 0.707 . . . . 74.51 112.909 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -146.89 154.56 41.44 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.516 0.561 . . . . 75.12 112.516 -170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -50.36 128.15 19.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.866 -0.606 . . . . 72.41 111.569 175.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.1 mm-40 -121.08 119.68 29.61 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.805 0.336 . . . . 65.21 111.633 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 7.3 Cg_exo -74.8 29.9 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.12 2.547 . . . . 64.32 113.946 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.683 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 1.3 tpt 64.94 -71.18 0.08 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.4 0.518 . . . . 53.14 112.4 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . 96.37 -75.69 0.76 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.134 -0.555 . . . . 64.33 113.247 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.48 83.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.22 -0.514 . . . . 40.31 112.917 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.629 ' HZ3' HG23 ' A' ' 112' ' ' VAL . 9.0 m0 -100.65 174.71 5.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.767 0.318 . . . . 75.54 111.605 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.28 111.32 15.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.799 0.333 . . . . 71.24 111.194 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.404 ' HE1' HG21 ' A' ' 71' ' ' ILE . 59.7 ttp -103.01 121.2 42.07 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.068 -0.395 . . . . 62.33 111.279 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.28 149.64 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.355 -0.384 . . . . 64.04 110.716 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 46' ' ' ARG . 28.4 ttp-105 -135.2 105.54 6.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.944 -0.473 . . . . 74.41 110.878 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 98.3 mttt -88.44 118.91 28.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.481 -0.327 . . . . 71.14 110.666 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 tt -155.07 99.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.934 0.397 . . . . 73.11 111.665 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 58.94 93.66 0.01 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.253 -0.431 . . . . 50.42 114.117 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.9 t70 76.46 -58.75 0.52 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.068 0.766 . . . . 71.21 113.068 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -103.99 163.42 12.38 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.849 0.685 . . . . 71.1 112.849 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.4 p -138.02 105.4 5.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.646 -0.706 . . . . 74.23 110.683 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' A' ' 91' ' ' GLN . 7.1 p -92.28 146.18 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.699 0.285 . . . . 63.42 111.429 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -123.0 159.35 28.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.21 0.528 . . . . 74.35 111.77 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 73.6 t80 -138.93 133.52 31.95 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.114 -0.494 . . . . 64.22 110.813 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -101.18 129.98 47.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.097 0.475 . . . . 72.44 111.715 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.626 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 68.7 m-85 -88.84 172.89 8.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.033 -0.53 . . . . 73.14 111.923 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 t -149.71 153.82 37.56 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.984 0.421 . . . . 75.12 112.111 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 36.9 t -86.3 64.26 8.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.991 0.424 . . . . 63.13 111.919 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.67 HH11 ' HG2' ' A' ' 82' ' ' PRO . 9.6 ptp180 -106.58 -1.53 22.82 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.747 0.308 . . . . 74.22 111.785 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.407 ' HE2' HD23 ' A' ' 63' ' ' LEU . 29.9 p90 -154.98 148.61 25.37 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.681 0.277 . . . . 73.13 111.011 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 47.8 t -97.02 102.37 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 64.11 111.024 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 31' ' ' ASN . 1.1 tm? -80.74 108.82 14.72 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.204 0.526 . . . . 72.35 110.623 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 61.7 mttm -64.36 140.5 58.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.024 -0.534 . . . . 73.31 112.186 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.24 127.19 30.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.253 -0.43 . . . . 61.04 111.306 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.96 -15.37 55.4 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.152 -0.547 . . . . 71.44 112.787 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 1.7 mp0 -95.65 168.08 10.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.885 0.374 . . . . 75.41 110.831 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.8 p -119.25 174.04 6.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.274 0.559 . . . . 74.2 112.183 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.72 127.92 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.976 -0.556 . . . . 44.05 110.448 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.5 m -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.955 0.407 . . . . 72.15 111.96 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 86' ' ' LEU . 29.5 mm -92.54 97.49 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.151 -0.477 . . . . 72.4 110.423 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 88.0 m95 -79.12 168.72 19.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.938 0.399 . . . . 74.33 111.792 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.67 16.63 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.569 -0.287 . . . . 64.21 110.902 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.1 -30.62 37.47 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.108 0.781 . . . . 73.35 113.108 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -97.9 19.63 13.51 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.429 0.529 . . . . 71.3 112.429 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -52.91 -47.83 67.68 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 43.32 112.625 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.93 75.48 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.213 -0.518 . . . . 37.55 112.816 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.91 -164.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.327 0.251 . . . . 64.01 111.106 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.4 m -48.67 130.29 17.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.771 0.319 . . . . 74.44 111.165 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.13 62.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.553 0.945 . . . . 73.12 113.553 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.4 t -159.28 151.91 17.9 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 113.133 0.79 . . . . 74.3 113.133 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.67 ' HG2' HH11 ' A' ' 60' ' ' ARG . 7.1 Cg_endo -48.79 170.84 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 123.919 3.079 . . . . 74.12 111.363 168.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -16.82 -80.51 0.0 OUTLIER 'Cis proline' 0 C--N 1.374 1.896 0 N-CA-C 121.329 3.55 . . . . 74.14 121.329 11.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.2 p -78.62 -83.63 0.09 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.301 1.223 . . . . 62.2 114.301 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 6.3 m-20 -73.78 122.6 22.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.248 0.547 . . . . 75.13 112.458 -171.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 82' ' ' PRO . 12.1 mt -91.09 113.24 25.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.912 -0.585 . . . . 73.45 111.369 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.5 mp -86.08 119.11 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.18 0.514 . . . . 64.41 110.944 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.408 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.1 t90 -69.46 77.9 0.4 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.332 0.587 . . . . 75.44 110.351 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -75.88 27.82 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.324 0.49 . . . . 42.44 112.324 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.1 -1.86 11.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.901 0.381 . . . . 70.51 110.969 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.458 ' OE1' HG13 ' A' ' 53' ' ' VAL . 25.3 tt0 -157.82 146.27 19.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.966 0.413 . . . . 44.11 111.111 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -82.81 -167.62 1.71 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.433 -0.349 . . . . 73.12 110.775 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 t -69.0 145.35 53.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.941 0.401 . . . . 65.42 111.611 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.505 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 49.4 p90 -121.86 -174.46 2.88 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.217 -0.447 . . . . 74.43 110.631 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 137.71 50.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.766 -0.731 . . . . 63.34 113.609 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 98' ' ' GLU . 7.3 t -76.49 -20.91 56.47 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.451 -0.441 . . . . 74.32 111.982 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.62 4.87 60.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.091 -0.576 . . . . 74.42 113.517 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 96' ' ' THR . 9.0 mm-40 -85.69 172.46 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.652 -0.322 . . . . 54.44 111.257 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.05 143.33 55.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.103 0.478 . . . . 52.15 111.995 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.35 132.74 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.284 0.564 . . . . 75.01 111.655 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 114' ' ' GLN . 50.6 tttm -123.35 111.8 16.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.07 -0.514 . . . . 61.31 110.817 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.81 133.09 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.946 0.403 . . . . 72.13 111.39 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.442 HG22 ' HE2' ' A' ' 105' ' ' LYS . 16.3 mm -126.64 136.53 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 111.828 0.307 . . . . 63.12 111.828 -173.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 29' ' ' LEU . 79.4 mt -110.13 107.68 17.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.93 0.395 . . . . 51.25 111.559 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' HG22 ' A' ' 103' ' ' ILE . 67.7 mttm -119.31 167.76 11.57 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.373 0.606 . . . . 71.14 112.061 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.507 ' HB2' ' CG ' ' A' ' 110' ' ' GLU . 12.8 m120 -113.96 -176.65 2.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.987 -0.551 . . . . 74.54 111.681 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 t -58.75 -39.32 80.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.307 0.854 . . . . 74.1 113.307 -173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -73.46 -8.7 57.0 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.552 0.575 . . . . 73.05 112.552 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.75 68.68 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.648 -0.787 . . . . 65.23 112.065 -171.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 106' ' ' ASN . 10.5 pt-20 -68.44 168.59 12.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.658 0.383 . . . . 75.3 110.39 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.71 136.92 48.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.128 -0.358 . . . . 74.5 111.779 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.629 HG23 ' HZ3' ' A' ' 42' ' ' TRP . 29.2 m -96.7 -41.62 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.438 -0.346 . . . . 65.13 111.61 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.79 168.95 13.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 53.25 111.504 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 29.5 pt20 -160.0 163.37 34.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.71 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -161.89 -179.41 7.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.015 0.912 . . . . 54.5 112.793 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.3 p -147.64 -170.99 3.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.821 -1.081 . . . . 73.33 109.892 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 p -78.71 142.45 37.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.894 0.378 . . . . 74.4 110.972 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.383 0.611 . . . . 72.11 111.193 178.051 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.6 m-80 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 120.874 0.368 . . . . 75.23 111.375 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.11 120.27 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.01 0.433 . . . . 74.14 111.361 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -133.62 156.66 47.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.447 -0.342 . . . . 74.21 110.906 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 65.2 mt -71.04 126.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.755 0.312 . . . . 72.41 111.496 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -89.33 -66.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.001 0.429 . . . . 74.43 110.783 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -136.23 130.25 32.81 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.126 0.489 . . . . 70.21 112.085 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 27' ' ' ILE . 62.6 mt -103.91 114.45 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.968 -0.56 . . . . 72.24 110.351 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 17.2 t70 -74.53 139.61 43.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.473 0.654 . . . . 53.22 112.256 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.5 -16.41 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.609 -0.723 . . . . 73.53 110.993 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.07 -14.15 61.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.149 -0.478 . . . . 53.33 111.198 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 99.44 29.22 7.16 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.771 0.669 . . . . 73.1 114.771 168.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.5 mptt -113.3 -54.48 2.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.214 0.82 . . . . 71.34 113.214 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 46.1 p90 -148.04 167.24 25.46 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.106 1.151 . . . . 75.33 114.106 -170.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG21 HG12 ' A' ' 20' ' ' ILE . 69.8 mt -132.63 105.22 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 72.04 109.345 170.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.1 ttm180 -90.8 119.94 31.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.207 0.817 . . . . 75.45 113.207 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HB2' HG11 ' A' ' 69' ' ' VAL . 7.0 mp -93.83 -175.88 3.87 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.712 -0.676 . . . . 75.45 110.333 171.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 35.0 ttpt -157.37 135.16 10.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.996 0.427 . . . . 64.51 112.009 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -108.33 115.23 29.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.039 -0.528 . . . . 64.24 111.403 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -102.19 16.56 25.75 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 72.03 112.116 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 98.3 p -55.24 152.32 8.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.079 0.466 . . . . 63.11 111.707 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -85.14 -0.35 54.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.799 0.333 . . . . 53.3 111.811 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.87 161.04 28.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.395 -0.366 . . . . 72.04 110.269 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.61 111.54 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.725 0.298 . . . . 73.23 111.244 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -104.85 132.07 21.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 N-CA-C 111.893 0.331 . . . . 75.11 111.893 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 62' ' ' VAL . 50.9 Cg_exo -54.69 132.93 54.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.456 2.104 . . . . 43.43 112.19 173.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.68 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.1 tpt -52.45 -72.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.07 0.396 . . . . 74.4 112.07 -175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.64 172.45 45.38 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.711 -0.757 . . . . 62.12 113.085 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.19 89.11 0.41 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.117 -0.563 . . . . 74.51 113.707 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . 41.3 m95 -102.41 156.43 17.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.773 0.321 . . . . 71.24 110.434 171.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.84 115.35 6.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.805 0.336 . . . . 74.31 111.468 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.595 ' HE2' HG23 ' A' ' 71' ' ' ILE . 54.7 ttp -93.99 114.06 26.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.569 -0.287 . . . . 75.0 111.67 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 45' ' ' ILE . 2.8 mp -102.13 106.91 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.894 0.378 . . . . 72.23 110.36 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.708 ' HG3' HG21 ' A' ' 102' ' ' VAL . 50.6 ttt180 -99.11 123.62 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.713 0.292 . . . . 74.42 111.483 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -121.9 116.86 25.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.954 0.407 . . . . 60.51 111.584 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.447 HD11 ' HG1' ' A' ' 96' ' ' THR . 12.1 tt -103.35 -27.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.165 0.507 . . . . 70.25 110.703 175.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.96 -137.31 3.21 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.858 -0.61 . . . . 74.31 112.305 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -71.25 -40.54 70.93 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.03 0.443 . . . . 43.43 111.454 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -79.05 156.5 28.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.189 0.518 . . . . 74.22 112.126 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.3 p -133.69 152.55 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.343 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.9 p -134.96 139.43 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.506 -0.316 . . . . 62.32 111.318 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.0 p -111.53 171.38 7.52 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.233 0.54 . . . . 73.21 112.369 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.436 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 74.6 t80 -160.47 114.21 2.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.863 -0.608 . . . . 74.55 111.252 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.15 127.07 33.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.746 0.307 . . . . 71.32 111.438 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 3.1 m-85 -73.98 121.99 21.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.823 0.344 . . . . 64.23 111.123 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 82' ' ' PRO . 5.2 t -68.84 120.96 15.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.543 0.687 . . . . 71.14 112.213 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -85.89 33.93 0.6 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.113 -0.494 . . . . 63.4 111.925 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.665 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 13.4 ptp180 -78.47 -3.72 44.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.148 0.425 . . . . 75.05 112.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 24.2 p90 -158.54 171.83 19.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.004 0.431 . . . . 75.13 111.362 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 38' ' ' PRO . 34.7 m -92.9 138.74 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.3 -0.409 . . . . 71.04 111.51 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.31 105.7 13.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.137 0.494 . . . . 72.33 109.68 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 7.4 mtpm? -69.14 154.23 42.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.269 0.557 . . . . 63.43 112.446 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.6 57.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.753 -0.658 . . . . 73.33 112.187 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.26 -0.495 . . . . 62.44 113.793 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.615 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.89 132.38 34.71 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.229 -0.571 . . . . 71.42 111.557 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 56.2 p -100.02 83.59 2.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.309 -0.405 . . . . 61.01 111.019 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 29' ' ' LEU . 4.5 p -57.96 106.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.573 0.701 . . . . 61.32 111.372 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 86.4 m -93.06 121.31 34.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 74.05 111.525 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.595 HG23 ' HE2' ' A' ' 44' ' ' MET . 47.8 mm -83.12 106.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.433 -0.348 . . . . 62.42 111.047 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -82.95 144.75 29.79 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.564 0.209 . . . . 75.42 111.564 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.93 157.64 27.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.835 0.35 . . . . 74.45 111.877 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.98 -30.48 25.16 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.439 0.533 . . . . 72.33 112.439 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -81.73 28.66 0.4 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.804 0.335 . . . . 60.44 111.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.62 87.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.176 0.436 . . . . 73.41 112.176 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.84 -37.7 2.5 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.178 -0.534 . . . . 43.2 113.771 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.2 -173.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.152 0.427 . . . . 72.33 112.152 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -51.1 104.92 0.09 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 74.34 111.903 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.82 1.32 35.34 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.671 0.619 . . . . 75.53 112.671 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.4 t -117.2 117.72 36.48 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 120.533 0.206 . . . . 75.21 111.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 54.0 Cg_exo -55.91 178.6 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.527 0 C-N-CA 123.776 2.984 . . . . 63.13 113.414 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 95.4 Cg_endo -76.73 126.19 12.94 Favored 'Cis proline' 0 C--N 1.366 1.459 0 CA-C-N 120.107 1.074 . . . . 71.14 114.813 6.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 82' ' ' PRO . 8.9 t 176.71 -170.94 0.08 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.353 -0.84 . . . . 70.03 109.418 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.476 ' O ' HD13 ' A' ' 87' ' ' ILE . 6.5 m-20 -57.4 108.1 0.51 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.735 -0.469 . . . . 74.02 109.735 171.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 79.6 mt -51.44 109.22 0.32 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.378 0.881 . . . . 72.12 113.378 -169.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 85' ' ' ASP . 3.6 mp -76.25 117.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.193 0.521 . . . . 74.24 110.8 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 6.7 t90 -70.31 134.96 48.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.914 -0.584 . . . . 74.52 110.527 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -127.35 27.99 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.02 0.438 . . . . 73.13 111.769 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.1 m120 -121.45 -26.77 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.361 -0.381 . . . . 74.31 111.522 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -133.32 147.13 51.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.697 0.284 . . . . 74.25 110.874 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -95.51 -171.67 2.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.994 0.426 . . . . 74.42 111.951 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -59.89 127.03 29.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.892 0.377 . . . . 72.43 111.056 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -101.47 118.07 36.2 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.244 0.545 . . . . 75.12 112.457 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -120.93 85.14 0.38 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 72.23 111.893 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.447 ' HG1' HD11 ' A' ' 48' ' ' ILE . 49.6 p -130.56 -39.09 1.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.132 0.419 . . . . 75.33 112.132 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.42 89.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.257 -0.496 . . . . 71.14 112.857 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -96.66 145.75 25.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.97 0.414 . . . . 51.33 111.858 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 6.1 m-20 -64.59 131.1 46.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.402 0.62 . . . . 61.15 112.07 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.599 HG13 HH21 ' A' ' 46' ' ' ARG . 7.5 p -119.09 126.05 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.883 -0.599 . . . . 74.53 111.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.851 ' HE2' HD13 ' A' ' 103' ' ' ILE . 87.3 tttt -90.95 115.99 28.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.797 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 46' ' ' ARG . 46.6 t -104.55 123.76 58.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.907 0.384 . . . . 73.34 111.518 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.851 HD13 ' HE2' ' A' ' 101' ' ' LYS . 50.4 mm -105.92 131.7 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.281 0.474 . . . . 72.21 112.281 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 113' ' ' ALA . 76.4 mt -105.12 112.54 25.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.903 0.382 . . . . 74.25 110.943 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.75 171.59 7.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.17 -0.468 . . . . 73.1 110.931 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.8 -167.4 1.22 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.941 0.401 . . . . 72.34 111.253 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.2 t -56.98 -26.91 60.78 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.446 0.906 . . . . 73.43 113.446 -174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.86 -9.41 31.51 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 122.11 -0.369 . . . . 72.02 111.565 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.42 9.46 55.18 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.294 -0.479 . . . . 75.5 113.672 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.95 124.97 26.05 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.992 0.425 . . . . 74.45 111.88 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.5 107.27 7.52 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.303 -0.408 . . . . 75.21 110.959 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.59 -37.31 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.616 0.599 . . . . 71.21 112.616 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -141.39 122.53 14.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.193 0.442 . . . . 55.13 112.193 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -124.79 141.59 52.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.511 -0.313 . . . . 70.41 111.224 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -161.46 151.76 17.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.716 0.293 . . . . 74.33 111.039 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -140.53 174.67 10.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.168 0.509 . . . . 53.2 111.661 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 38.6 p -70.01 175.49 4.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 73.02 111.209 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.471 0.623 0 O-C-N 122.171 -0.331 . . . . 75.52 111.816 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 m-80 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 112.533 0.568 . . . . 73.43 112.533 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.87 85.76 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.246 0.546 . . . . 72.01 110.164 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.34 147.61 24.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.018 -0.537 . . . . 73.15 111.679 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.804 HG13 ' HG ' ' A' ' 29' ' ' LEU . 3.0 mp -82.24 96.93 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.787 0.327 . . . . 53.51 110.145 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.28 -38.61 88.19 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.926 0.393 . . . . 73.11 111.926 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.42 129.5 14.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.699 0.629 . . . . 71.51 112.699 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.531 HG12 HG21 ' A' ' 27' ' ' ILE . 57.1 mt -116.65 128.82 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.989 -0.551 . . . . 74.4 109.738 172.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.76 114.89 9.29 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.325 0.583 . . . . 74.21 111.351 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' HA3' ' A' ' 97' ' ' GLY . 11.4 p -68.39 -31.12 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 116.123 -0.489 . . . . 74.24 112.041 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 22.8 t70 -57.08 -48.01 79.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.751 0.31 . . . . 75.1 111.132 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 136.23 24.01 0.52 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.311 -0.471 . . . . 74.34 113.985 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -95.57 -63.39 1.16 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.091 0.775 . . . . 74.32 113.091 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -145.29 161.23 40.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.107 1.151 . . . . 74.1 114.107 -168.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.531 HG21 HG12 ' A' ' 20' ' ' ILE . 65.6 mt -116.3 113.81 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.102 -0.953 . . . . 62.51 109.662 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -102.19 112.94 25.81 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.451 0.538 . . . . 74.32 112.451 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.804 ' HG ' HG13 ' A' ' 17' ' ' ILE . 4.8 mp -91.92 154.54 18.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.116 -0.493 . . . . 72.23 111.254 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -150.87 123.29 8.41 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.925 0.393 . . . . 73.02 110.96 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' HB2' HD11 ' A' ' 63' ' ' LEU . 34.1 t30 -83.94 129.49 34.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.784 0.326 . . . . 62.34 111.382 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -109.87 11.24 24.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.25 0.463 . . . . 73.44 112.25 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 94.0 p -80.91 163.44 23.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.454 0.645 . . . . 64.54 112.148 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.06 -18.61 33.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.719 -0.673 . . . . 63.13 111.531 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.54 149.77 46.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.693 0.282 . . . . 73.22 111.288 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -56.69 139.91 48.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.159 0.504 . . . . 64.52 112.209 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -104.02 117.32 59.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.235 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.11 127.73 13.9 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.421 2.08 . . . . 52.45 112.725 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.9 tpp -79.12 -71.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.961 0.41 . . . . 72.25 111.623 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.4 -54.2 2.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.886 -0.673 . . . . 60.02 112.998 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.69 61.77 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.339 -0.458 . . . . 54.22 113.323 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -63.09 153.54 33.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.894 0.378 . . . . 73.53 110.662 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -130.01 116.33 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.206 0.527 . . . . 73.2 111.388 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.545 ' HG3' HG13 ' A' ' 102' ' ' VAL . 47.4 ttp -86.8 109.55 19.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.635 -0.711 . . . . 72.3 111.964 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.8 mp -82.94 89.68 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.102 -0.703 . . . . 71.51 109.102 171.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 101.24 6.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.083 0.468 . . . . 75.21 111.396 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -84.67 -178.86 6.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.317 -0.401 . . . . 72.45 111.016 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -171.2 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.233 0.54 . . . . 74.54 110.547 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.47 -89.24 0.09 OUTLIER Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.96 -0.563 . . . . 55.03 112.702 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.47 -0.09 56.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.025 0.38 . . . . 64.22 112.025 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 t -155.54 164.54 38.52 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.691 0.626 . . . . 74.53 112.691 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -153.15 149.09 27.69 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.658 -0.701 . . . . 72.31 110.739 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.13 134.79 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.874 0.369 . . . . 64.54 111.373 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 m -94.12 111.7 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.11 0.411 . . . . 74.35 112.11 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -103.89 122.82 45.96 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.745 0.307 . . . . 74.14 110.651 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -95.39 116.39 28.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.799 0.333 . . . . 74.32 110.922 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -61.25 121.66 13.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.117 0.484 . . . . 75.22 111.609 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.595 HG22 ' HG2' ' A' ' 60' ' ' ARG . 3.5 t -67.2 132.31 47.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.385 0.612 . . . . 62.32 112.019 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.1 p -73.41 23.72 0.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.236 0.828 . . . . 73.32 113.236 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.595 ' HG2' HG22 ' A' ' 58' ' ' THR . 8.0 ptp180 -73.02 -8.03 53.9 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.12 -0.363 . . . . 72.23 111.841 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.494 ' HE2' HD23 ' A' ' 63' ' ' LEU . 24.8 p90 -145.85 145.07 30.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.173 0.435 . . . . 72.12 112.173 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.45 124.63 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.185 -0.461 . . . . 65.25 109.777 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -74.4 99.39 3.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.192 0.52 . . . . 74.01 111.298 -173.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -66.8 165.26 15.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.475 0.655 . . . . 71.12 112.723 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.77 125.75 25.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.908 -0.587 . . . . 74.05 111.169 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.22 77.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.197 -0.525 . . . . 52.44 113.527 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.554 ' HB3' HD13 ' A' ' 63' ' ' LEU . 8.6 tp-100 -91.7 153.0 19.95 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.107 0.48 . . . . 74.53 111.572 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.4 p -121.9 145.58 47.95 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.248 -0.433 . . . . 63.25 111.951 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.82 137.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.288 -0.414 . . . . 74.55 110.363 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.6 m -118.66 122.44 42.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.162 0.43 . . . . 62.41 112.162 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.2 106.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.69 -0.232 . . . . 72.05 111.208 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 84.6 m95 -91.95 123.13 35.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.572 0.225 . . . . 73.32 111.503 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -79.1 80.54 5.44 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.084 0.772 . . . . 44.32 113.084 -174.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 61.3 -69.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.286 1.217 . . . . 74.41 114.286 173.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -72.86 36.17 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.337 0.866 . . . . 62.23 113.337 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . . . -75.24 -50.61 15.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.305 0.483 . . . . 70.43 112.305 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.62 38.54 20.32 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.165 -0.541 . . . . 74.15 113.054 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.57 173.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.13 0.49 . . . . 65.35 112.186 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.3 m -67.84 94.02 0.43 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 74.35 112.678 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.64 -86.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.264 0.838 . . . . 74.43 113.264 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.4 t -170.46 110.52 0.44 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.211 0.449 . . . . 74.1 112.211 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.631 ' HG2' ' HB2' ' A' ' 85' ' ' ASP . 58.0 Cg_exo -46.21 160.61 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.486 2.79 . . . . 70.41 111.521 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.46 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER 9.03 64.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.903 0 N-CA-C 121.517 3.622 . . . . 74.21 121.517 36.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 85' ' ' ASP . 9.0 t 147.78 -67.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.988 1.715 . . . . 72.35 111.209 161.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.632 ' H ' HG23 ' A' ' 84' ' ' THR . 8.0 m-20 -87.67 173.98 8.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.114 -0.366 . . . . 63.02 110.398 172.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.4 mt -139.96 130.61 25.75 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.751 0.31 . . . . 75.11 111.128 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 87' ' ' ILE . 1.9 mp -87.15 106.01 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.438 0.637 . . . . 72.25 111.136 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.592 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 6.3 t90 -74.24 98.53 3.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.622 -0.717 . . . . 65.21 111.003 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -73.16 -28.54 62.28 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.404 0.52 . . . . 53.31 112.404 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.592 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 10.8 m120 -71.55 -16.96 62.33 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.905 0.706 . . . . 64.2 112.905 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 44.1 tt0 -145.77 139.2 26.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.008 -0.433 . . . . 74.11 111.731 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.619 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -90.21 -174.82 4.32 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.063 0.459 . . . . 70.22 111.089 173.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.2 p -56.27 120.48 7.66 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.423 -0.353 . . . . 70.34 111.864 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.485 ' NE1' ' HA2' ' A' ' 24' ' ' GLY . 33.9 p90 -70.92 -38.74 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.504 0.557 . . . . 75.22 112.504 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 54.3 63.93 4.74 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.314 -0.47 . . . . 62.41 113.763 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 97' ' ' GLY . 1.6 t -167.52 -63.25 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.658 0.614 . . . . 65.24 112.658 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.583 ' H ' HG22 ' A' ' 96' ' ' THR . . . 72.76 10.09 76.0 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.982 -0.628 . . . . 75.03 113.399 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -70.9 78.57 0.63 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.224 0.512 . . . . 72.33 112.072 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.81 31.58 20.86 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.464 -0.789 . . . . 62.14 112.534 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 120.18 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.166 0.507 . . . . 74.21 109.743 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.834 ' HZ3' ' HB2' ' A' ' 101' ' ' LYS . 4.4 ttmp? -119.15 121.45 39.79 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.928 0.714 . . . . 73.24 112.928 -165.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 44' ' ' MET . 98.1 t -86.82 116.54 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.723 -0.671 . . . . 75.0 111.569 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.8 mm -105.27 114.99 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.617 -0.265 . . . . 74.44 110.766 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.59 102.86 15.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.798 0.666 . . . . 65.41 112.798 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.97 154.89 25.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.376 -0.375 . . . . 64.35 110.509 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.515 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 14.2 m120 -99.0 -164.31 1.12 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.844 0.683 . . . . 74.2 112.844 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.1 t -52.98 -51.57 61.11 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.116 1.154 . . . . 51.0 114.116 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -88.28 -61.04 1.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.287 0.565 . . . . 74.32 111.731 -172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.59 27.71 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.785 -0.643 . . . . 74.44 112.697 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 1.2 pm0 -102.69 135.43 44.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.018 0.437 . . . . 55.0 110.681 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.21 132.52 46.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.055 0.391 . . . . 70.4 112.055 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 66.5 t -88.75 -62.08 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.267 -0.424 . . . . 72.41 111.352 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.66 179.16 8.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.168 0.509 . . . . 51.3 111.852 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.68 152.93 49.79 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.937 -0.574 . . . . 75.52 110.757 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 115' ' ' ARG . 1.3 tpm_? -151.31 152.04 32.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.614 0.245 . . . . 74.23 110.892 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.7 p -145.33 170.22 16.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.067 -0.395 . . . . 63.43 111.797 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -67.95 113.96 6.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.542 0.571 . . . . 75.15 112.542 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.127 -0.488 . . . . 53.53 111.102 175.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 32' ' ' THR . 45.3 t30 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.278 0.561 . . . . 74.05 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.432 HG22 ' HE1' ' A' ' 39' ' ' MET . 62.0 t -104.73 125.68 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.548 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 113' ' ' ALA . 53.7 t -135.49 159.87 40.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.923 0.392 . . . . 74.32 111.624 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 104' ' ' LEU . 3.6 mp -87.06 131.35 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.6 -0.273 . . . . 71.04 110.341 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -104.3 -34.27 8.38 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.788 0.292 . . . . 74.31 111.788 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.78 145.01 30.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.102 0.477 . . . . 61.23 111.449 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.36 130.25 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.273 -0.421 . . . . 73.43 110.796 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.34 147.25 40.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.189 0.519 . . . . 75.14 110.888 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG23 ' HA2' ' A' ' 97' ' ' GLY . 13.9 p -105.19 -25.07 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 74.22 111.693 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.429 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 21.2 t70 -64.13 -56.66 13.28 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.064 0.459 . . . . 64.11 111.539 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 144.33 41.89 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.42 -0.419 . . . . 61.04 112.575 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -113.17 -61.97 1.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.733 0.642 . . . . 74.12 112.733 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.95 168.19 26.65 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.107 1.151 . . . . 73.11 114.107 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.3 mt -126.06 131.08 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.906 -1.043 . . . . 72.11 109.371 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -100.76 101.81 12.75 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.483 0.549 . . . . 71.51 112.483 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.8 mp -88.48 156.01 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.33 110.159 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -146.61 127.72 14.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.952 0.406 . . . . 73.23 111.762 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -84.37 110.28 18.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.355 -0.384 . . . . 62.44 110.673 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 14' ' ' ASN . 11.7 t -95.13 9.78 38.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.095 0.474 . . . . 71.24 111.163 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.1 t -82.39 149.85 27.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.059 -0.518 . . . . 73.22 111.391 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.73 43.12 1.01 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.27 -0.423 . . . . 74.31 111.4 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -168.91 154.17 6.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.872 0.368 . . . . 72.24 111.677 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 11.9 m-20 -68.08 104.11 1.69 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.448 -0.342 . . . . 72.52 110.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.95 118.9 66.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.85 0.315 . . . . 75.21 111.85 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.34 117.54 5.03 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.745 2.297 . . . . 70.12 112.51 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.432 ' HE1' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -76.34 77.32 3.1 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.98 0.419 . . . . 71.53 111.5 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.66 -68.96 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.028 -0.606 . . . . 71.34 113.976 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.59 2.89 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.505 -0.379 . . . . 54.34 113.722 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -129.58 140.1 51.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.542 0.337 . . . . 75.14 111.135 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 34.3 tt0 -136.12 125.34 24.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.418 . . . . 74.2 110.733 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.401 ' HE2' ' CZ3' ' A' ' 88' ' ' TRP . 53.5 ttp -102.83 133.86 47.2 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.0 0.429 . . . . 65.15 111.811 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 54' ' ' SER . 32.2 mt -127.17 116.77 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.477 -0.329 . . . . 74.3 110.865 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.578 ' NH2' HG13 ' A' ' 100' ' ' VAL . 67.5 ttt180 -100.84 122.72 43.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.928 0.394 . . . . 73.12 110.947 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -98.2 137.36 37.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.747 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.42 ' HB ' HG23 ' A' ' 100' ' ' VAL . 7.3 tt -130.91 91.72 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.53 0.681 . . . . 72.52 111.485 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.55 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.811 -0.632 . . . . 71.42 113.602 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.88 -64.85 1.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.605 0.362 . . . . 73.13 111.78 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -95.06 178.53 5.52 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.895 0.702 . . . . 71.21 112.895 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -149.27 152.9 36.71 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.176 -0.466 . . . . 63.32 110.968 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -129.57 137.86 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.701 0.286 . . . . 74.42 111.193 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.442 ' CB ' HG12 ' A' ' 45' ' ' ILE . 85.8 p -120.46 161.97 20.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.991 0.737 . . . . 61.42 112.991 -175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -163.57 117.99 1.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.624 -0.716 . . . . 73.2 111.286 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 56.7 tttm -88.1 151.35 22.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.952 0.406 . . . . 73.21 111.488 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -98.21 168.34 10.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.004 0.431 . . . . 74.35 111.718 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -130.37 132.38 45.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.997 0.427 . . . . 62.13 111.752 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.3 t -72.32 86.64 1.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 53.45 112.334 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 82' ' ' PRO . 14.6 ptm180 -131.29 6.05 4.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.903 0.383 . . . . 73.11 111.551 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.502 ' HH ' HG21 ' A' ' 69' ' ' VAL . 27.9 p90 -157.42 155.15 29.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.336 -0.393 . . . . 74.44 110.554 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 31.5 m -114.52 130.33 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.251 0.548 . . . . 63.14 112.049 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.3 mm? -83.45 114.6 21.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.418 -0.355 . . . . 71.24 110.93 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 35.9 mtmm -66.4 168.61 8.66 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.065 0.46 . . . . 73.32 111.866 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.22 107.3 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.352 -0.386 . . . . 65.0 111.47 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.88 6.44 67.27 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.401 -0.428 . . . . 38.33 113.086 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.527 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -79.71 137.13 36.95 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.467 -0.431 . . . . 74.32 111.511 -178.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.1 p -103.53 139.67 38.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.16 0.505 . . . . 70.42 111.718 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.502 HG21 ' HH ' ' A' ' 61' ' ' TYR . 7.4 p -111.35 123.67 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.188 0.518 . . . . 74.34 110.159 173.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.3 m -95.15 102.22 14.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.176 -0.465 . . . . 75.13 111.477 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.18 97.53 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.324 -0.398 . . . . 74.1 111.105 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.533 ' HB2' HG13 ' A' ' 87' ' ' ILE . 93.2 m95 -78.98 160.55 27.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.24 111.623 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.28 165.93 20.98 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.391 -0.368 . . . . 75.1 111.209 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.03 -27.58 45.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.52 25.49 1.68 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.938 0.347 . . . . 74.2 111.938 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.08 64.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.814 0.672 . . . . 73.22 112.814 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.52 75.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.165 -0.541 . . . . 52.24 113.722 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.52 -172.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.556 -0.379 . . . . 72.15 111.017 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.0 m -61.39 101.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.656 -0.498 . . . . 64.32 109.656 171.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.87 42.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.113 0.782 . . . . 73.14 113.113 -168.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.7 m -157.9 139.2 9.69 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 112.275 0.472 . . . . 55.12 112.275 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.549 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 56.0 Cg_exo -44.12 163.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 123.645 2.897 . . . . 62.23 112.162 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 26.9 Cg_exo -11.02 -80.75 0.0 OUTLIER 'Cis proline' 0 C--N 1.375 1.925 0 N-CA-C 121.297 3.537 . . . . 74.45 121.297 17.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.648 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.7 t -106.37 -79.39 0.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.83 1.418 . . . . 64.31 114.83 -165.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.648 ' H ' HG23 ' A' ' 84' ' ' THR . 21.8 m-20 -68.59 129.14 39.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.0 0.741 . . . . 73.42 113.0 -167.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 104.3 16.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.891 -0.595 . . . . 74.13 111.288 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -74.52 121.82 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.781 0.324 . . . . 74.35 110.533 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CZ3' ' HE2' ' A' ' 44' ' ' MET . 3.6 t90 -64.91 77.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.352 0.596 . . . . 72.4 111.078 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.74 22.44 0.59 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.179 -0.464 . . . . 63.52 112.234 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -120.53 11.55 11.36 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.054 0.454 . . . . 75.11 110.939 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -150.48 131.96 14.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.26 -0.427 . . . . 71.21 111.096 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -80.26 178.8 8.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.922 0.391 . . . . 71.31 111.209 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -66.84 116.27 7.53 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.338 -0.226 . . . . 75.33 111.015 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.459 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 43.6 p90 -60.66 -47.15 87.51 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.319 0.488 . . . . 73.05 112.319 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 58.26 11.76 10.37 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.721 0.648 . . . . 71.24 114.721 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -71.0 -31.41 67.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.772 0.656 . . . . 63.43 112.772 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 22' ' ' VAL . . . 69.22 14.22 68.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.981 -0.628 . . . . 63.21 113.037 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -96.58 179.22 5.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.224 0.535 . . . . 54.42 112.071 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.447 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 15.0 p-10 -60.99 -45.32 95.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.769 -0.651 . . . . 70.35 111.599 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.578 HG13 ' NH2' ' A' ' 46' ' ' ARG . 7.4 p 30.73 88.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 72.34 113.28 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.584 ' HD2' ' NE2' ' A' ' 114' ' ' GLN . 34.1 ttpt -86.94 138.53 31.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.077 -0.965 . . . . 75.42 112.846 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 12.4 p -103.63 142.66 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 112.068 0.396 . . . . 74.1 112.068 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mm -122.41 138.59 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.763 0.425 . . . . 74.32 111.579 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.499 ' HG ' HD11 ' A' ' 17' ' ' ILE . 52.4 mt -107.79 121.01 43.85 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.953 0.406 . . . . 74.23 111.769 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 67.8 mttm -115.13 149.0 38.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.087 -0.506 . . . . 62.44 111.167 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.39 -176.92 6.07 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.105 0.479 . . . . 62.53 111.008 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.3 p -55.62 -34.94 65.35 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.144 -0.48 . . . . 64.12 111.001 170.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -72.89 -12.64 61.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.128 -0.487 . . . . 51.55 111.99 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.91 1.58 84.81 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.88 0.712 . . . . 53.01 114.88 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 105' ' ' LYS . 11.9 pt-20 -92.48 178.52 5.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.107 0.953 . . . . 74.13 112.033 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -92.24 133.59 35.67 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.244 0.831 . . . . 54.03 113.244 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.7 t -106.2 -50.23 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.019 -0.537 . . . . 75.13 110.717 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . . . -159.39 162.65 35.82 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.869 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.584 ' NE2' ' HD2' ' A' ' 101' ' ' LYS . 12.6 pt20 -153.17 171.32 18.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.099 -0.501 . . . . 71.51 111.177 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.3 ttm180 -175.6 147.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.859 0.361 . . . . 74.13 111.565 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.1 p -110.95 179.26 4.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.457 0.303 . . . . 62.52 111.002 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 80.7 p -75.48 117.69 17.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.128 0.49 . . . . 63.13 111.601 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.914 0.388 . . . . 73.24 110.623 177.15 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.276 0.473 . . . . 70.12 112.276 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.48 124.48 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.889 0.375 . . . . 75.01 111.216 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -144.95 174.38 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.502 -0.317 . . . . 65.31 110.979 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.32 124.5 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.238 -0.289 . . . . 74.43 111.483 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.77 -53.25 6.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.921 0.391 . . . . 72.22 110.872 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -165.02 137.06 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.23 0.538 . . . . 54.11 111.798 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 27' ' ' ILE . 61.2 mt -104.22 126.15 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.27 -0.423 . . . . 64.35 110.238 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.28 122.47 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.134 0.492 . . . . 73.33 111.87 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.64 -26.12 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.142 -0.481 . . . . 72.15 111.938 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -33.48 73.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.818 0.342 . . . . 64.02 110.586 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.64 30.05 3.92 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 114.126 0.41 . . . . 72.12 114.126 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HZ1' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mtpm? -98.98 -39.94 8.3 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.791 0.663 . . . . 75.41 112.791 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -153.6 158.19 40.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.265 0.839 . . . . 73.33 113.265 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 102' ' ' VAL . 66.0 mt -118.89 107.44 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.44 109.648 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -97.85 117.61 32.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.317 0.58 . . . . 75.01 112.512 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' HB2' HG11 ' A' ' 69' ' ' VAL . 6.5 mp -97.8 -172.68 2.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.011 -0.541 . . . . 71.23 111.501 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 22.9 ttmm -158.05 139.4 13.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.942 0.401 . . . . 72.24 111.719 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -103.21 100.26 10.16 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.451 -0.34 . . . . 71.54 110.253 168.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 t -102.27 98.83 8.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.411 0.624 . . . . 75.22 111.314 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -166.69 -178.46 4.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.312 0.577 . . . . 73.32 111.633 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -109.67 7.04 24.25 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.936 -0.574 . . . . 74.32 110.392 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -135.4 135.03 40.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 75.24 110.816 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.43 134.19 49.8 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.995 0.426 . . . . 61.13 111.853 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -89.0 112.77 52.91 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.391 -0.368 . . . . 72.44 111.213 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.3 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.777 2.318 . . . . 63.31 113.122 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.17 -73.27 0.05 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.104 0.562 . . . . 75.54 111.734 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 -75.48 1.57 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.143 -0.551 . . . . 73.05 113.001 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.67 93.7 0.11 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 74.32 113.403 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -116.44 167.71 10.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.661 0.384 . . . . 75.13 110.712 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -144.42 132.34 21.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.171 0.51 . . . . 74.22 111.34 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.47 ' HE2' HG22 ' A' ' 71' ' ' ILE . 57.6 ttp -103.82 107.78 18.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.848 -0.614 . . . . 60.35 111.428 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG13 ' HG ' ' A' ' 54' ' ' SER . 2.9 mp -95.11 99.94 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.781 0.324 . . . . 71.34 110.845 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.418 HH12 ' NE2' ' A' ' 91' ' ' GLN . 32.9 ttt180 -85.89 102.84 14.08 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.128 -0.357 . . . . 73.11 111.101 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -96.88 117.73 31.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.438 -0.346 . . . . 74.32 111.09 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.16 122.43 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.134 0.493 . . . . 73.13 112.037 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.7 -110.28 2.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.989 -0.551 . . . . 38.46 113.907 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.74 27.4 9.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.973 0.36 . . . . 74.22 111.973 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -153.62 162.35 41.34 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.237 0.541 . . . . 55.25 112.005 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -153.81 114.01 3.93 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.021 -0.536 . . . . 50.44 110.205 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.39 134.87 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.941 0.401 . . . . 70.24 111.809 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.532 ' HG ' HG13 ' A' ' 45' ' ' ILE . 72.2 m -109.16 124.24 50.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.288 -0.415 . . . . 70.35 111.697 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.417 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 70.0 t80 -114.26 108.77 17.39 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.807 0.337 . . . . 74.1 111.686 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.35 109.67 11.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.917 0.389 . . . . 73.35 110.542 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.595 ' HE2' HD12 ' A' ' 71' ' ' ILE . 94.1 m-85 -56.18 135.49 53.19 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.644 0.609 . . . . 64.24 112.644 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -97.27 123.1 40.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.044 -0.525 . . . . 73.55 111.248 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 t -73.56 68.72 1.19 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.118 0.414 . . . . 75.43 112.118 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -87.04 -12.87 46.02 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.987 0.422 . . . . 73.45 111.375 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.46 167.8 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.285 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.76 121.36 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.873 0.368 . . . . 73.45 111.593 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -76.24 87.1 3.07 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.479 0.657 . . . . 72.51 110.166 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 158.33 30.62 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.955 0.724 . . . . 62.22 112.955 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.62 117.89 6.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.612 -0.722 . . . . 75.31 112.841 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.53 -19.75 35.92 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.306 -0.473 . . . . 63.1 114.028 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.44 141.7 38.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.396 0.617 . . . . 75.12 111.747 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.4 p -105.31 98.38 8.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.783 -0.644 . . . . 72.54 111.735 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 29' ' ' LEU . 3.8 p -69.8 117.61 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 64.21 111.693 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 37.0 m -97.55 123.05 41.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.149 0.5 . . . . 74.34 111.921 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.595 HD12 ' HE2' ' A' ' 57' ' ' TYR . 47.8 mm -84.28 102.76 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.318 -0.401 . . . . 60.51 110.928 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.75 118.15 24.26 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.51 -0.314 . . . . 74.31 110.621 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' ASN . . . -71.45 77.46 0.77 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.65 0.611 . . . . 55.34 112.65 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 56.51 -72.82 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.399 0.889 . . . . 74.2 113.399 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 73' ' ' ALA . 65.5 m-20 -87.94 100.71 13.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.908 0.385 . . . . 63.34 111.43 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.47 9.02 0.34 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.546 0.573 . . . . 54.02 112.546 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.65 -35.84 1.83 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.169 -0.539 . . . . 42.13 114.31 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.66 149.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.381 0.511 . . . . 74.42 112.381 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -62.84 175.7 0.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.54 0.57 . . . . 74.2 112.54 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.44 76.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.092 0.775 . . . . 75.2 113.092 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.454 ' O ' ' NH1' ' A' ' 60' ' ' ARG . 69.8 m 65.17 104.17 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.621 0.971 . . . . 73.2 113.621 173.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HB3' HG21 ' A' ' 84' ' ' THR . 67.6 Cg_exo -45.96 169.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 123.747 2.965 . . . . 71.52 112.016 166.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER 10.76 65.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 N-CA-C 121.65 3.673 . . . . 74.0 121.65 38.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.667 HG21 ' HB3' ' A' ' 82' ' ' PRO . 15.3 t 144.74 -59.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.3 1.84 . . . . 71.12 110.812 162.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 84' ' ' THR . 21.3 m-20 -110.76 -168.62 1.33 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.195 0.598 . . . . 61.32 110.296 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -141.78 137.15 31.37 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.945 0.402 . . . . 63.51 111.603 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 81' ' ' SER . 1.6 mp -91.36 123.7 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.699 0.761 . . . . 71.23 111.016 175.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.487 ' CE2' ' HB2' ' A' ' 90' ' ' ASN . 21.7 t90 -92.12 109.74 21.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.324 -0.853 . . . . 72.1 110.999 -176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -93.88 2.07 56.24 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.246 0.832 . . . . 74.55 113.246 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 17.2 m120 -74.01 -40.81 62.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.86 -0.525 . . . . 72.52 111.755 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.418 ' NE2' HH12 ' A' ' 46' ' ' ARG . 39.9 tt0 -148.52 155.88 41.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.605 0.24 . . . . 71.4 110.607 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.611 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 10.7 m120 -91.97 175.96 6.69 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.284 0.564 . . . . 73.44 112.447 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -59.57 125.13 22.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 72.21 111.508 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -104.56 -173.66 2.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.01 0.433 . . . . 73.12 111.664 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.76 95.86 0.14 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.265 -0.493 . . . . 52.01 112.759 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -167.51 160.44 13.1 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.668 -0.313 . . . . 71.05 111.438 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.15 4.1 62.39 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.289 -0.481 . . . . 44.04 113.122 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.76 156.67 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.175 0.512 . . . . 64.31 112.248 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.91 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.777 0.658 . . . . 42.33 112.777 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 117' ' ' THR . 6.5 p -81.04 79.61 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.079 0.942 . . . . 62.51 109.622 167.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.775 ' HZ1' ' HB2' ' A' ' 101' ' ' LYS . 3.9 ttmp? -88.13 105.63 17.63 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.554 -0.748 . . . . 62.02 111.391 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 27' ' ' ILE . 61.7 t -91.05 123.39 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.665 -0.698 . . . . 74.53 111.48 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 21.4 mm -106.57 117.66 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.149 -0.478 . . . . 71.34 110.934 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -91.96 121.72 33.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.838 0.351 . . . . 54.12 111.341 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 93.6 mttt -130.58 168.27 17.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.711 0.291 . . . . 65.41 111.315 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.412 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 20.3 m120 -97.08 175.6 6.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.901 0.381 . . . . 74.41 111.141 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -57.97 -33.2 68.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.775 0.658 . . . . 75.03 112.775 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.91 0.68 17.44 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 72.11 112.436 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.42 33.53 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.152 -0.547 . . . . 38.46 113.336 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 10.9 pt-20 -103.08 127.28 50.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.943 0.401 . . . . 70.52 110.918 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.2 tt0 -76.82 138.93 40.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.978 0.418 . . . . 53.21 111.97 -175.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.45 -61.99 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.256 -0.429 . . . . 44.12 111.326 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.99 162.19 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.7 0.286 . . . . 63.14 111.57 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.36 157.64 42.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.993 0.425 . . . . 73.33 111.834 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -164.31 156.19 16.31 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.201 -0.454 . . . . 75.43 110.977 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.7 p -141.17 -162.37 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.6 0.238 . . . . 75.14 111.3 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.631 HG21 HG13 ' A' ' 100' ' ' VAL . 17.0 p -61.71 94.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.173 0.511 . . . . 63.32 111.89 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.455 0.645 . . . . 74.51 110.846 176.777 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.85 0.357 . . . . 73.31 111.435 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.89 143.68 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.324 -0.398 . . . . 75.44 111.331 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 44.2 t -141.62 173.37 11.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.091 0.472 . . . . 74.05 111.699 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.537 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 61.0 mt -81.51 127.45 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.344 -0.389 . . . . 73.21 111.33 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 37.0 tt0 -81.71 -58.33 3.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.659 -0.497 . . . . 71.44 109.659 171.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 25.2 tt0 173.82 152.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.799 -0.637 . . . . 65.34 111.097 169.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.465 HD12 HG23 ' A' ' 102' ' ' VAL . 23.1 mt -71.89 162.57 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 116.164 -0.471 . . . . 74.3 111.239 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.14 150.36 34.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.229 0.537 . . . . 73.24 111.835 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.07 -33.45 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.849 -0.614 . . . . 63.42 112.268 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.52 -30.58 19.24 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.147 0.498 . . . . 73.22 111.028 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.04 35.75 3.86 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.104 -0.498 . . . . 73.32 112.827 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -96.06 -29.04 14.32 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.709 0.29 . . . . 74.41 111.759 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.09 176.01 12.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.463 0.649 . . . . 74.41 112.286 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -119.89 138.54 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.805 -0.634 . . . . 75.53 109.946 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -119.26 110.21 16.74 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.213 0.53 . . . . 75.43 111.9 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 29' ' ' LEU . 4.6 mp -106.9 175.51 5.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.981 -0.554 . . . . 75.22 110.57 175.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -151.71 138.67 19.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.936 0.398 . . . . 75.3 111.713 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -75.46 84.57 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.562 . . . . 74.53 110.821 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.2 p -78.0 89.03 4.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 61.44 111.094 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.4 p -158.48 -175.77 5.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.305 -0.407 . . . . 71.43 111.161 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.47 -4.52 31.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.334 0.494 . . . . 62.32 112.334 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -156.39 166.68 32.72 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.786 0.327 . . . . 65.31 111.306 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -54.97 117.15 3.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.79 0.293 . . . . 73.53 111.79 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -127.46 112.86 21.11 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 122.618 0.367 . . . . 72.44 110.889 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 58.2 Cg_endo -70.67 136.9 31.65 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.251 1.968 . . . . 62.45 112.921 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 tpt -66.28 -85.59 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 116.452 -0.34 . . . . 75.34 110.706 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.93 -83.09 0.02 OUTLIER Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.362 0.905 . . . . 61.23 115.362 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.48 46.07 3.19 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.605 0.602 . . . . 64.23 114.605 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -120.25 147.27 45.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.457 -0.437 . . . . 73.13 111.124 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -113.77 109.82 19.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.04 -0.527 . . . . 65.34 110.758 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.496 ' HE3' HG22 ' A' ' 71' ' ' ILE . 52.6 ttp -91.34 116.25 28.69 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.236 -0.438 . . . . 74.1 111.717 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.654 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.5 mp -106.26 103.62 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 109.811 -0.44 . . . . 73.12 109.811 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.474 HH12 ' HB ' ' A' ' 48' ' ' ILE . 47.7 ttp85 -89.39 114.1 25.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 73.13 111.628 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -93.44 168.71 10.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.101 -0.499 . . . . 74.44 111.304 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.494 HG21 ' H ' ' A' ' 49' ' ' GLY . 10.8 tt -169.74 -60.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.853 -0.612 . . . . 70.23 111.148 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' H ' HG21 ' A' ' 48' ' ' ILE . . . -159.68 114.87 0.63 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.235 -0.507 . . . . 70.5 112.584 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 67.45 -75.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.213 0.605 . . . . 75.13 111.999 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -93.88 150.86 20.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.196 0.522 . . . . 63.31 112.151 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.6 p -142.06 149.73 40.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.053 0.454 . . . . 72.1 111.444 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.34 146.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.827 0.346 . . . . 74.01 111.654 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -111.91 164.49 13.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.821 0.674 . . . . 73.15 112.821 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -161.36 135.07 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.006 -0.543 . . . . 75.1 111.514 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -91.6 135.12 34.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.566 0.222 . . . . 75.0 110.724 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -67.58 147.02 53.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.044 0.449 . . . . 64.53 111.974 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 t -81.2 126.24 31.27 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.365 0.602 . . . . 65.53 112.226 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.9 m -85.49 82.85 8.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 63.33 110.94 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -135.32 14.04 3.51 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.633 0.605 . . . . 75.34 112.633 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -165.53 158.64 15.94 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.895 0.379 . . . . 71.54 111.913 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 38' ' ' PRO . 61.4 t -104.57 113.92 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.268 -0.423 . . . . 75.1 110.308 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.34 118.56 21.36 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.848 0.356 . . . . 75.42 111.231 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -64.33 152.62 40.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.377 0.608 . . . . 71.55 112.628 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 127.84 33.15 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.046 -0.525 . . . . 70.13 111.851 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.01 -2.05 88.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.149 -0.548 . . . . 72.13 113.41 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.667 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.44 148.97 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.541 -0.388 . . . . 72.53 111.389 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -95.75 157.54 15.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.19 0.519 . . . . 72.34 112.062 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.65 125.21 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.172 0.51 . . . . 73.33 110.191 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -101.61 108.23 19.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.279 -0.419 . . . . 64.23 111.948 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' HE3' ' A' ' 44' ' ' MET . 44.0 mm -91.77 102.63 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.464 -0.335 . . . . 72.14 111.23 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m95 -85.0 170.28 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.0 0.429 . . . . 74.42 111.979 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.82 167.37 11.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.394 -0.366 . . . . 50.24 111.285 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -51.08 -41.72 60.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -93.49 35.52 1.11 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.844 0.354 . . . . 65.21 111.849 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -65.19 -45.94 82.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.486 0.55 . . . . 71.43 112.486 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.1 -38.47 3.17 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.262 -0.494 . . . . 60.24 113.122 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 87' ' ' ILE . 27.0 m -68.17 170.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.085 0.402 . . . . 73.44 112.085 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.0 m -60.46 128.93 39.08 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.497 -0.32 . . . . 71.24 111.413 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.22 -40.17 46.63 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.853 0.686 . . . . 74.54 112.853 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.444 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 22.6 t -146.95 89.38 5.66 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 121.049 0.452 . . . . 64.51 111.345 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.672 ' HB2' ' H ' ' A' ' 84' ' ' THR . 47.1 Cg_exo -59.34 -32.13 96.18 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.772 2.981 . . . . 74.44 117.233 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 28.0 Cg_endo -101.13 37.79 5.59 Favored 'Cis proline' 0 C--N 1.371 1.718 0 CA-C-N 122.437 1.906 . . . . 74.4 114.532 3.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.672 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 74.9 p -62.83 -48.51 78.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.098 0.475 . . . . 65.43 111.219 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 4.8 m-20 -93.29 161.13 14.53 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.087 -0.506 . . . . 63.34 110.943 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' HB2' HD11 ' A' ' 71' ' ' ILE . 90.6 mt -130.02 109.54 10.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.87 0.366 . . . . 62.14 110.631 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.554 HD13 HG21 ' A' ' 78' ' ' VAL . 1.5 mp -85.47 111.18 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.653 0.74 . . . . 74.42 111.637 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.569 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 21.2 t90 -79.68 96.86 6.34 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.309 -0.859 . . . . 73.21 111.19 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 53.4 mtmt -93.35 22.39 5.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.383 0.883 . . . . 71.2 113.383 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.569 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 14.7 m120 -89.92 -8.58 51.48 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.118 0.485 . . . . 75.52 110.799 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -150.91 134.47 16.37 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.025 -0.534 . . . . 75.04 111.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.598 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 15.3 m120 -64.67 -56.06 16.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.467 0.543 . . . . 72.42 112.467 -175.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.9 t -179.09 -178.44 0.52 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.552 0.341 . . . . 65.02 110.793 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -142.22 -82.64 0.2 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 111.634 0.235 . . . . 73.31 111.634 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 35.28 49.06 0.87 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 115.912 1.125 . . . . 43.33 115.912 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -156.37 137.32 13.53 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.862 1.06 . . . . 64.2 113.862 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.15 -97.97 0.78 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.51 0.964 . . . . 72.52 115.51 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -84.92 177.23 8.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.078 0.77 . . . . 75.24 113.078 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 7.4 p-10 -75.27 121.38 22.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.101 -0.954 . . . . 74.13 112.382 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.465 HG22 HH11 ' A' ' 46' ' ' ARG . 7.3 p -81.07 128.59 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.171 0.51 . . . . 75.03 110.955 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -140.15 119.49 12.97 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.34 -0.391 . . . . 65.43 111.443 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG23 HD12 ' A' ' 20' ' ' ILE . 85.0 t -93.81 136.97 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.519 0.563 . . . . 72.12 112.519 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.654 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.0 mm -110.74 132.73 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.772 -0.649 . . . . 53.43 111.012 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.8 mt -113.61 111.3 21.64 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.762 0.653 . . . . 63.13 112.762 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -109.07 161.15 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.386 -0.37 . . . . 71.04 110.765 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.537 ' OD1' HG21 ' A' ' 112' ' ' VAL . 7.4 m120 -114.98 97.69 6.37 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.903 0.334 . . . . 74.3 111.903 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t 47.71 -77.52 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.987 1.106 . . . . 73.34 113.987 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 106' ' ' ASN . 64.6 mt-30 -61.6 -35.46 77.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.77 0.655 . . . . 72.43 112.77 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.59 -24.17 2.32 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.535 -0.84 . . . . 70.51 113.618 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.98 150.03 25.7 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.276 0.538 . . . . 75.42 111.301 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.82 137.53 54.5 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.503 -0.317 . . . . 73.22 111.655 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.537 HG21 ' OD1' ' A' ' 106' ' ' ASN . 94.7 t -98.91 -68.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.179 0.437 . . . . 64.04 112.179 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.27 162.78 33.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.067 0.766 . . . . 75.25 113.067 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -152.46 143.72 23.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.151 -0.931 . . . . 52.33 110.097 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -153.29 142.91 21.86 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.505 0.558 . . . . 61.3 112.505 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 p -111.94 -174.72 2.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.529 -0.76 . . . . 65.14 110.812 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 p -122.6 -178.2 3.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.263 0.554 . . . . 72.34 112.319 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 116.004 -0.543 . . . . 73.03 111.318 179.362 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 121.253 0.549 . . . . 62.53 110.706 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HB ' ' CH2' ' A' ' 42' ' ' TRP . 56.6 t -126.7 139.34 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.059 -0.519 . . . . 70.53 111.402 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -121.26 159.39 26.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.977 0.418 . . . . 61.12 111.208 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.557 HD11 ' HG ' ' A' ' 104' ' ' LEU . 55.2 mt -93.13 127.99 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.311 -0.243 . . . . 54.11 111.316 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.54 -77.02 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.691 0.282 . . . . 74.13 111.095 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -169.29 158.01 7.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.266 -0.424 . . . . 74.44 110.838 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.438 HG12 HG21 ' A' ' 27' ' ' ILE . 48.9 mt -91.69 145.4 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.431 . . . . 71.41 111.495 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.52 143.45 57.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.394 0.516 . . . . 65.52 112.394 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.49 -28.31 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.842 -0.617 . . . . 61.23 112.062 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.09 -31.58 30.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.09 0.471 . . . . 62.43 110.789 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.68 16.55 26.15 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 116.171 -0.468 . . . . 54.12 113.116 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -78.49 -31.25 47.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.347 0.499 . . . . 72.31 112.347 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -157.27 167.05 31.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.861 1.06 . . . . 74.03 113.861 -172.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.438 HG21 HG12 ' A' ' 20' ' ' ILE . 68.1 mt -127.07 110.93 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.934 -1.03 . . . . 72.44 109.343 170.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.3 ttp180 -92.58 117.42 29.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.346 0.593 . . . . 71.01 112.378 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 29' ' ' LEU . 6.5 mp -99.91 158.55 15.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.863 -0.608 . . . . 71.32 110.26 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 65.0 tttm -124.03 116.83 23.47 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.024 -0.422 . . . . 63.43 111.505 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.33 108.14 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.097 0.475 . . . . 73.24 110.411 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -96.52 18.05 14.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.383 0.512 . . . . 73.42 112.383 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.8 p -71.72 161.79 30.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.418 0.628 . . . . 73.21 111.72 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -85.73 -19.4 30.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 72.11 111.168 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -142.03 158.36 43.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.587 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.12 135.78 12.62 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.501 0.556 . . . . 75.43 112.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -134.35 132.46 21.01 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.166 -0.47 . . . . 62.3 111.33 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.46 21.31 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.706 2.271 . . . . 71.11 113.442 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 tpt 63.5 -78.84 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.474 0.71 . . . . 74.05 112.285 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.41 -170.49 18.49 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.3 -0.476 . . . . 52.12 113.732 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.63 1.59 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.309 -0.472 . . . . 70.13 113.384 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.447 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 11.9 m95 -98.46 151.16 20.9 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 122.481 -0.423 . . . . 75.31 111.228 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.64 114.41 24.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.884 0.373 . . . . 52.34 110.001 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.43 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 56.2 ttp -98.33 108.45 21.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.442 -0.344 . . . . 51.03 111.087 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.4 mp -96.8 109.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.584 -0.28 . . . . 75.32 111.444 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -99.46 101.29 12.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.69 0.281 . . . . 74.23 110.931 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 47' ' ' LYS . 7.6 mtpm? -82.04 84.78 6.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.053 0.454 . . . . 72.13 110.987 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -103.39 118.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.021 -0.536 . . . . 74.31 111.248 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.02 46.09 60.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.888 -0.672 . . . . 37.82 111.893 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 73.68 -56.25 0.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.456 0.702 . . . . 74.54 111.953 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -61.61 161.61 9.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.133 0.492 . . . . 75.51 111.795 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 80.5 p -124.0 132.03 53.64 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.26 0.552 . . . . 61.03 112.128 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.4 134.31 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.881 -0.6 . . . . 75.0 109.669 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' MET . 80.8 p -120.18 144.18 47.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.167 0.803 . . . . 72.23 113.167 -170.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -113.83 125.35 53.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.671 -0.695 . . . . 75.02 110.923 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.97 128.59 38.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.024 0.44 . . . . 63.13 111.001 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.447 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 21.0 m-85 -84.42 165.19 18.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.202 0.525 . . . . 72.42 111.694 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -142.96 176.05 9.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.009 -0.541 . . . . 74.5 110.806 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -123.36 105.97 10.28 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.168 0.508 . . . . 71.43 112.008 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 1.9 ptp180 -140.37 17.68 2.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.974 -0.557 . . . . 74.34 110.292 173.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.54 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 47.1 p90 -162.92 172.13 15.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.031 -0.532 . . . . 73.43 111.102 -173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.68 114.63 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.483 -0.326 . . . . 63.35 110.601 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.42 130.03 39.26 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.073 0.463 . . . . 75.02 110.645 -177.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 85.2 mttt -71.76 149.63 45.19 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.23 0.538 . . . . 71.33 112.346 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.47 122.77 14.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.495 . . . . 62.04 112.036 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 0.04 67.49 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.412 -0.423 . . . . 72.2 114.111 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -79.19 148.47 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.173 0.487 . . . . 73.31 111.898 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 65.1 p -92.7 134.56 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.839 0.352 . . . . 75.43 111.644 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.31 112.87 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.413 0.625 . . . . 62.35 111.004 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 85.3 m -91.36 123.95 35.18 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 65.12 112.047 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.544 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.5 mm -90.14 99.24 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.822 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.561 ' HB2' HG13 ' A' ' 87' ' ' ILE . 85.6 m95 -84.49 161.79 20.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.975 0.417 . . . . 75.12 111.966 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . . . -87.27 167.84 13.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.906 0.384 . . . . 51.41 111.96 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.2 -60.78 2.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.543 0.572 . . . . 62.54 112.543 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -91.08 41.57 1.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.103 0.477 . . . . 71.15 111.877 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.27 60.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.81 0.338 . . . . 64.22 111.664 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.17 -44.22 2.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.319 -0.467 . . . . 74.24 113.627 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.27 171.03 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.459 0.541 . . . . 71.14 112.459 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.8 m -53.87 130.24 36.5 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.784 0.326 . . . . 75.45 111.336 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.528 ' HB1' ' HD3' ' A' ' 89' ' ' LYS . . . -78.27 10.28 3.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.413 0.894 . . . . 75.14 113.413 -173.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 t -152.73 133.07 7.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 112.407 0.521 . . . . 73.23 112.407 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.624 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 66.8 Cg_exo -54.33 -178.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.906 3.071 . . . . 65.52 113.0 172.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.594 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 89.6 Cg_endo -93.85 101.67 0.22 Allowed 'Cis proline' 0 C--N 1.366 1.49 0 N-CA-C 115.536 1.322 . . . . 74.32 115.536 5.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 83' ' ' PRO . 2.1 p -158.13 -60.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.509 0.724 . . . . 74.42 109.56 171.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 8.1 m-20 -122.1 -168.87 1.79 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.304 -0.862 . . . . 74.24 109.75 172.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' HD13 ' A' ' 71' ' ' ILE . 78.4 mt -127.08 108.7 11.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.048 0.452 . . . . 70.25 110.885 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -95.96 108.66 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.318 0.58 . . . . 62.01 111.436 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.462 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 10.9 t90 -74.35 84.06 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.548 0.69 . . . . 65.55 110.617 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.709 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 9.7 mtmp? -73.1 4.07 4.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.695 0.628 . . . . 73.54 112.695 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.462 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 16.1 m120 -92.43 -13.35 30.14 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.508 0.559 . . . . 72.54 112.508 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -151.44 159.13 44.35 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.002 0.43 . . . . 54.24 111.327 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 52.4 m-80 -109.83 -169.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.565 0.579 . . . . 75.45 112.565 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.5 m -60.03 156.47 14.77 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.372 0.879 . . . . 70.34 113.372 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -127.46 160.2 32.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.2 -0.909 . . . . 73.03 111.116 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.42 48.68 0.36 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.985 -0.626 . . . . 62.02 112.865 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.4 t -65.65 -22.81 66.68 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.722 0.638 . . . . 73.43 112.722 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.29 3.43 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.074 -0.584 . . . . 71.22 113.238 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -82.41 170.22 15.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.145 0.498 . . . . 65.23 111.849 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.11 164.19 26.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.884 -0.598 . . . . 73.42 111.781 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.5 p -144.66 140.33 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.96 0.41 . . . . 71.42 111.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.7 ttpt -107.38 128.87 54.86 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.942 0.401 . . . . 63.31 111.314 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.5 HG13 HD12 ' A' ' 17' ' ' ILE . 4.0 p -114.01 136.87 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.325 0.583 . . . . 70.05 111.886 -178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.38 142.49 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.917 -0.583 . . . . 72.31 111.599 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.557 ' HG ' HD11 ' A' ' 17' ' ' ILE . 38.9 mt -122.95 107.76 12.19 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.054 0.39 . . . . 70.1 112.054 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -114.12 136.56 52.8 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.296 0.57 . . . . 51.02 111.337 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.53 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 9.4 m120 -93.57 108.05 19.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.823 -0.626 . . . . 73.45 112.489 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.3 t 59.92 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.297 0.851 . . . . 73.34 113.297 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.93 -71.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.444 0.64 . . . . 75.24 111.654 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.58 -22.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.455 -0.793 . . . . 73.4 111.732 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 9.2 pt-20 -44.28 133.25 5.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.344 0.658 . . . . 73.22 111.349 171.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.7 128.8 53.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.898 0.38 . . . . 75.21 111.844 -172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 106' ' ' ASN . 17.9 m -85.57 -35.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 112.066 0.395 . . . . 72.12 112.066 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.59 154.01 1.94 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.429 0.633 . . . . 72.1 112.621 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -139.59 130.15 25.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.565 -0.743 . . . . 74.31 110.102 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -141.5 148.33 39.24 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.481 0.549 . . . . 70.14 112.481 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.9 p -106.99 169.8 8.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.241 -0.436 . . . . 52.44 111.407 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.1 p -78.51 134.22 37.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.032 0.382 . . . . 73.34 112.032 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.945 0.403 . . . . 74.13 111.475 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.908 0.336 . . . . 72.3 111.908 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.0 t -84.62 102.84 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.899 0.38 . . . . 73.42 111.528 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.8 t -121.41 149.82 42.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.818 0.342 . . . . 65.1 111.404 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.633 HG13 HD11 ' A' ' 104' ' ' LEU . 61.3 mt -62.37 132.19 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 112.301 0.482 . . . . 75.51 112.301 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -84.47 -62.39 1.57 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.408 0.623 . . . . 74.11 110.206 173.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -149.45 136.68 19.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.614 . . . . 72.33 110.748 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.76 HG21 HG12 ' A' ' 27' ' ' ILE . 40.9 mt -94.5 146.69 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.945 -0.391 . . . . 75.43 109.945 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.18 129.87 41.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.141 0.496 . . . . 73.15 112.069 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.52 -23.54 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.902 -0.59 . . . . 71.34 111.59 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.37 -32.3 54.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.162 0.506 . . . . 74.12 110.775 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 102.08 41.9 2.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.073 -0.512 . . . . 73.12 114.32 173.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -129.36 -6.58 4.77 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.975 1.102 . . . . 74.1 113.975 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.74 163.19 24.17 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.573 0.953 . . . . 73.24 113.573 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.76 HG12 HG21 ' A' ' 20' ' ' ILE . 56.0 mt -134.54 115.5 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.366 -0.834 . . . . 71.22 110.337 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -94.88 110.34 22.23 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.686 -0.634 . . . . 75.53 112.172 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 5.8 mp -94.09 145.3 24.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.063 -0.517 . . . . 63.44 110.636 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -125.65 125.5 43.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.839 0.352 . . . . 71.34 111.11 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.09 127.54 32.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.719 0.295 . . . . 71.43 110.906 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.7 p -93.24 -15.99 25.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.313 0.486 . . . . 74.35 112.313 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.0 p -69.92 134.61 48.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.002 0.429 . . . . 72.32 111.114 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.62 25.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.118 0.485 . . . . 52.52 111.424 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.74 143.74 27.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.16 -0.473 . . . . 71.44 110.872 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.84 104.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.722 0.409 . . . . 74.02 111.859 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.04 135.08 20.03 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 111.756 0.28 . . . . 64.21 111.756 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.95 48.07 2.54 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.701 2.267 . . . . 62.43 112.907 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.678 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 1.9 tpt 67.23 -69.4 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.422 0.689 . . . . 74.1 112.059 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.1 4.01 61.53 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.136 -0.554 . . . . 63.12 113.458 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.87 101.11 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.197 -0.525 . . . . 70.33 113.345 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.454 ' CD1' ' HE3' ' A' ' 39' ' ' MET . 22.6 m95 -121.16 175.88 5.88 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.599 -0.354 . . . . 74.33 111.419 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -145.36 123.11 11.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.421 . . . . 74.32 111.387 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.575 ' HE1' HG22 ' A' ' 71' ' ' ILE . 52.6 ttp -99.96 117.31 33.98 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.119 -0.491 . . . . 73.15 111.329 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.775 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.2 mp -104.45 105.49 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.036 0.446 . . . . 73.2 111.036 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.651 HH11 ' HZ3' ' A' ' 88' ' ' TRP . 61.0 ttt180 -82.29 109.02 16.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.499 -0.318 . . . . 74.42 111.398 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -117.03 141.73 47.88 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.876 0.369 . . . . 75.41 111.108 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 100' ' ' VAL . 13.3 tt -166.1 -46.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 111.785 0.291 . . . . 73.52 111.785 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.26 21.29 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.174 -0.536 . . . . 42.51 113.093 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.23 8.56 5.76 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.536 -0.391 . . . . 74.32 111.922 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -149.32 166.06 30.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.862 0.363 . . . . 72.43 111.202 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.0 p -128.26 164.39 22.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.961 0.41 . . . . 75.01 111.252 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.45 132.69 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.543 -0.299 . . . . 73.04 110.954 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.5 m -104.87 162.05 13.66 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.27 0.557 . . . . 65.14 112.481 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 72.3 t80 -142.87 118.96 10.71 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.956 -0.566 . . . . 74.22 110.645 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -91.67 123.38 35.02 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.834 0.35 . . . . 70.23 110.54 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -74.56 177.07 6.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.539 0.94 . . . . 71.13 113.539 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 HG21 ' CE2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -125.71 165.87 17.82 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.522 -0.763 . . . . 71.33 112.09 -177.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 t -106.4 10.4 31.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.216 -0.447 . . . . 55.14 111.855 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.58 -35.43 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.208 0.448 . . . . 74.23 112.208 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.468 ' CE2' HG21 ' A' ' 58' ' ' THR . 17.5 p90 -101.19 149.15 24.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.109 0.481 . . . . 75.12 111.566 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.46 126.11 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.084 0.469 . . . . 70.22 111.496 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.56 96.34 6.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 62.54 110.941 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.41 168.61 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.196 0.522 . . . . 63.33 111.954 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.76 107.24 0.58 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.137 -0.483 . . . . 61.3 111.602 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 2.67 83.23 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.44 -0.41 . . . . 74.44 113.592 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -54.49 120.96 7.38 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.845 0.683 . . . . 72.24 112.845 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -94.39 112.92 24.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.04 -0.527 . . . . 73.22 110.975 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.38 128.5 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.02 0.438 . . . . 75.24 110.726 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.7 m -106.97 118.59 37.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.189 0.519 . . . . 75.33 112.1 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.575 HG22 ' HE1' ' A' ' 44' ' ' MET . 33.7 mm -86.36 104.8 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 65.14 110.644 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 63.3 m95 -87.53 159.19 18.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.953 0.406 . . . . 75.33 111.26 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.07 175.85 8.77 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.913 0.387 . . . . 70.34 111.374 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -22.6 19.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.315 0.487 . . . . 70.1 112.315 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.44 29.6 3.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.685 0.278 . . . . 74.11 111.477 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.77 -62.19 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.07 0.767 . . . . 73.2 113.07 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.63 -37.72 3.48 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.079 -0.51 . . . . 73.54 112.351 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 87' ' ' ILE . 30.4 m -76.55 166.61 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.84 0.353 . . . . 73.13 111.707 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -67.13 170.12 7.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.553 0.575 . . . . 75.55 112.553 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.77 92.2 2.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.834 0.679 . . . . 61.23 112.834 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.541 ' H ' HD12 ' A' ' 87' ' ' ILE . 71.2 m 59.96 94.54 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.33 0.863 . . . . 65.45 113.33 172.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 78.5 Cg_exo -52.77 -41.34 70.54 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.542 2.828 . . . . 62.02 116.228 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.588 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.4 Cg_endo -98.2 135.97 3.24 Favored 'Cis proline' 0 C--N 1.366 1.477 0 CA-C-N 121.394 1.533 . . . . 71.42 114.639 -1.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.3 t -163.8 -48.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.933 -0.766 . . . . 75.22 108.933 170.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 8.1 m-20 -86.25 115.11 23.59 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.98 -0.748 . . . . 62.12 108.98 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -92.59 112.11 23.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.921 0.391 . . . . 50.23 111.659 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.563 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.5 mp -81.93 96.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.578 0.704 . . . . 61.23 110.636 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HZ3' HH11 ' A' ' 46' ' ' ARG . 28.8 t90 -71.44 86.28 0.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.68 -0.691 . . . . 74.33 111.066 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.17 7.26 9.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.888 0.699 . . . . 72.32 112.888 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 14.6 m120 -70.06 -27.3 64.52 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.841 0.311 . . . . 72.24 111.841 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -159.44 156.92 29.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.861 0.362 . . . . 75.43 111.397 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -170.31 0.97 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.136 0.791 . . . . 70.2 113.136 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.4 m -67.41 -173.01 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.823 -0.626 . . . . 75.52 112.58 -173.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.465 ' HB3' ' NH2' ' A' ' 46' ' ' ARG . 49.3 p90 -141.69 147.0 36.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.06 0.457 . . . . 75.33 111.49 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.66 43.5 0.06 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.357 -0.449 . . . . 75.41 112.594 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.5 t -83.41 18.65 1.75 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.49 0.552 . . . . 74.22 112.49 -176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.61 -37.59 3.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.971 -0.633 . . . . 37.91 113.115 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.41 151.63 23.38 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.357 0.599 . . . . 73.34 112.015 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.35 130.34 41.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.33 -0.85 . . . . 71.03 112.226 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 48' ' ' ILE . 7.3 p -75.85 108.83 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.386 0.612 . . . . 55.13 110.811 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -90.19 103.13 15.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.491 0.662 . . . . 75.31 110.859 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG22 HD12 ' A' ' 27' ' ' ILE . 61.1 t -88.87 126.77 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.575 -0.739 . . . . 75.22 112.019 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.775 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 46.7 mm -97.71 132.18 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.536 -0.756 . . . . 74.05 111.461 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.633 HD11 HG13 ' A' ' 17' ' ' ILE . 80.8 mt -111.63 108.24 17.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.236 0.541 . . . . 72.23 111.689 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.85 161.2 16.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.971 -0.559 . . . . 72.51 111.294 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 108' ' ' GLN . 13.9 m120 -86.58 177.32 7.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.003 0.43 . . . . 72.51 111.364 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.5 t -74.45 28.96 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.004 0.431 . . . . 65.31 111.82 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 106' ' ' ASN . 46.8 mt-30 -127.01 -39.48 1.94 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.126 0.489 . . . . 75.4 111.374 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.43 -32.93 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.914 -0.474 . . . . 64.25 111.914 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.86 161.32 28.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 74.22 111.73 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -122.46 138.76 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.261 -0.427 . . . . 75.15 112.057 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.17 -32.39 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 113.667 0.988 . . . . 74.01 113.667 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.81 41.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.879 0.696 . . . . 63.0 112.879 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.86 135.93 3.47 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.702 -0.681 . . . . 55.34 110.894 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -164.32 165.25 21.93 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.17 -0.331 . . . . 75.11 111.23 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.1 p -129.41 -173.15 2.93 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.884 0.698 . . . . 71.35 112.884 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.2 p -81.14 127.99 33.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.998 -0.546 . . . . 61.4 112.404 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 116.096 -0.502 . . . . 63.2 110.399 174.072 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.866 0.365 . . . . 70.45 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -107.23 104.7 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.434 -0.348 . . . . 75.42 110.731 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.8 p -119.36 156.28 30.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.786 0.327 . . . . 72.51 111.69 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.694 HG13 HD11 ' A' ' 104' ' ' LEU . 67.2 mt -76.08 122.86 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.748 0.309 . . . . 73.22 111.083 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.11 -35.26 23.8 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.993 0.425 . . . . 71.14 110.882 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -167.66 145.48 4.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.997 0.427 . . . . 70.22 111.716 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.568 HG12 HG21 ' A' ' 27' ' ' ILE . 47.9 mt -113.19 131.92 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.588 -0.278 . . . . 71.01 110.258 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.55 126.64 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.963 0.411 . . . . 61.2 111.803 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.9 p -82.93 23.03 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.574 0.702 . . . . 73.23 112.013 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -121.28 -53.08 2.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.048 0.451 . . . . 74.13 110.112 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.44 13.33 0.57 Allowed Glycine 0 CA--C 1.524 0.64 0 CA-C-N 116.026 -0.534 . . . . 60.43 113.834 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -76.07 -52.94 9.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.596 0.591 . . . . 73.21 112.596 -176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.35 158.99 39.56 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.472 0.915 . . . . 74.54 113.472 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.568 HG21 HG12 ' A' ' 20' ' ' ILE . 59.9 mt -114.33 121.85 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.153 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -94.41 107.76 19.71 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.391 0.515 . . . . 75.03 112.391 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.603 ' HB2' HG11 ' A' ' 69' ' ' VAL . 7.1 mp -100.99 169.4 8.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.851 0.357 . . . . 75.1 111.118 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.68 128.49 7.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.983 0.364 . . . . 62.33 111.983 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -91.72 112.4 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.348 -0.387 . . . . 71.41 110.754 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -100.95 19.0 18.16 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.16 0.505 . . . . 74.13 111.954 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.0 t -78.27 -176.84 4.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.065 -0.397 . . . . 64.03 111.646 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.58 -39.19 20.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.053 0.76 . . . . 74.45 113.053 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 57.9 tt0 -130.5 170.63 13.97 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.822 0.344 . . . . 64.54 111.591 -171.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.4 m-20 -52.16 104.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.827 0.451 . . . . 54.03 111.623 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.14 136.85 26.79 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.106 0.409 . . . . 74.33 112.106 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.08 113.24 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.715 2.277 . . . . 74.14 112.647 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.699 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.4 tpt -69.56 -28.71 66.22 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.989 0.423 . . . . 72.2 111.674 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.28 76.55 0.76 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.387 -0.435 . . . . 64.42 113.576 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.07 12.63 0.03 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.476 -0.393 . . . . 55.41 113.156 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -124.89 162.07 25.2 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.696 0.398 . . . . 75.41 110.803 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -145.49 135.37 23.59 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.029 0.442 . . . . 73.15 111.371 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.441 ' HE2' HG22 ' A' ' 71' ' ' ILE . 57.0 ttp -101.69 120.51 40.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.988 -0.551 . . . . 74.22 111.619 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.4 mp -109.05 118.18 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.647 0.26 . . . . 71.54 110.576 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' NH1' HE22 ' A' ' 91' ' ' GLN . 43.8 ttt-85 -90.49 129.77 36.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.066 -0.396 . . . . 54.34 111.938 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 29.0 mtpp -129.29 147.84 51.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.288 0.566 . . . . 74.33 111.843 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' HG22 ' A' ' 100' ' ' VAL . 9.6 tt -167.78 -40.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.568 -0.742 . . . . 71.52 110.193 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.66 -153.94 6.31 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.803 -0.635 . . . . 75.12 111.864 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 71.73 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.284 0.564 . . . . 73.34 111.724 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -174.99 163.89 3.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.67 . . . . 74.54 110.985 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.2 p -163.07 101.51 0.98 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.039 0.447 . . . . 74.45 111.302 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.17 144.13 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.26 -0.427 . . . . 75.21 111.37 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.7 m -109.04 158.72 17.46 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.253 0.549 . . . . 53.33 112.329 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -149.0 109.12 4.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.983 -0.553 . . . . 73.11 111.204 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -75.8 131.85 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.888 0.375 . . . . 72.1 111.273 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 52.4 m-85 -78.75 121.76 25.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.878 0.37 . . . . 75.23 110.762 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -79.13 158.04 27.82 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.369 0.507 . . . . 63.22 112.369 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.664 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 20.7 t -104.29 23.68 12.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.238 -0.437 . . . . 61.14 111.541 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 81' ' ' SER . 13.5 ptm180 -58.01 -29.67 65.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.867 0.365 . . . . 74.32 111.618 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -143.18 156.29 44.73 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 71.23 109.997 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.46 139.8 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.457 -0.338 . . . . 73.42 111.563 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -84.35 104.3 14.26 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.925 0.393 . . . . 72.14 111.038 -175.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 63.6 mttm -65.92 168.82 7.5 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.527 0.936 . . . . 65.42 113.527 -174.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 129.37 37.63 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.541 -0.754 . . . . 74.44 111.123 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.03 9.15 79.81 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.948 -0.644 . . . . 72.11 112.763 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -81.06 117.95 22.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.944 0.402 . . . . 62.24 111.305 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.0 p -86.1 96.31 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.011 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' A' ' 29' ' ' LEU . 6.6 p -79.62 119.04 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.538 0.685 . . . . 74.11 110.988 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 20.2 m -100.0 110.07 22.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 71.31 111.655 -175.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.441 HG22 ' HE2' ' A' ' 44' ' ' MET . 49.6 mm -74.12 95.58 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.878 0.371 . . . . 72.33 110.629 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -79.89 128.27 33.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.41 -0.359 . . . . 75.34 110.949 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.51 162.5 6.28 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.284 -0.26 . . . . 55.02 111.559 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -50.29 -26.02 4.36 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.993 0.738 . . . . 72.14 112.993 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 92' ' ' ASN . 74.8 m-20 -90.8 28.28 1.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.925 0.393 . . . . 74.54 111.566 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.03 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.694 0.627 . . . . 74.22 112.694 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.1 2.3 82.45 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.095 -0.574 . . . . 63.55 113.243 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.78 -178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.155 0.502 . . . . 65.25 111.619 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 m -75.26 139.85 42.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.264 -0.426 . . . . 74.35 111.288 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.25 79.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.212 0.53 . . . . 73.42 111.574 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.554 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 8.5 t 66.08 89.87 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 115.484 -0.78 . . . . 54.43 111.729 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.709 ' HD2' HG21 ' A' ' 84' ' ' THR . 41.0 Cg_exo -60.97 -30.23 89.5 Favored 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 124.112 3.208 . . . . 72.21 118.084 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.622 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 33.3 Cg_endo -97.97 -179.43 6.05 Favored 'Cis proline' 0 C--N 1.367 1.532 0 CA-C-N 122.249 1.839 . . . . 72.51 115.284 6.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.709 HG21 ' HD2' ' A' ' 82' ' ' PRO . 2.9 t 177.01 -44.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.682 -1.599 . . . . 73.52 108.724 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 70' ' ' THR . 18.2 m-20 -140.06 -171.9 3.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.014 -0.994 . . . . 65.41 110.157 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 88.9 mt -123.02 132.33 54.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.936 0.398 . . . . 72.53 111.278 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.44 ' N ' HD13 ' A' ' 87' ' ' ILE . 1.8 mp -95.68 125.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.25 0.547 . . . . 64.33 111.396 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.506 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 16.2 t90 -80.33 90.42 5.58 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.754 -0.657 . . . . 73.1 111.033 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -80.16 -5.2 55.62 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.506 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 15.1 m120 -82.31 -14.45 55.33 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.543 0.572 . . . . 71.01 112.543 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.512 HE22 ' NH1' ' A' ' 46' ' ' ARG . 46.7 tt0 -154.27 143.05 20.94 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.254 0.55 . . . . 74.21 111.528 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 15.6 m120 -75.11 172.28 12.65 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.021 175.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.8 p -71.79 114.36 9.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.582 0.23 . . . . 74.33 110.568 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -59.32 -29.84 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.131 0.419 . . . . 64.41 112.131 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 48.03 39.41 18.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 114.733 0.653 . . . . 62.41 114.733 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -133.85 12.4 4.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.158 0.504 . . . . 75.22 110.941 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.18 -112.58 4.94 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.982 -0.628 . . . . 52.24 112.759 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 66.41 163.13 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.914 0.709 . . . . 74.33 112.914 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.455 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 11.1 p-10 -95.9 87.8 4.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.639 0.733 . . . . 64.53 110.711 176.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 48' ' ' ILE . 7.6 p -96.25 135.38 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.059 -0.519 . . . . 74.14 111.299 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.0 ttpt -115.31 124.26 50.85 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.094 0.473 . . . . 65.14 111.199 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 27' ' ' ILE . 87.6 t -98.9 136.39 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.035 -0.53 . . . . 72.53 112.075 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.9 mm -103.2 121.31 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.821 -0.627 . . . . 62.11 111.286 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.694 HD11 HG13 ' A' ' 17' ' ' ILE . 80.7 mt -97.5 121.77 39.78 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.352 -0.218 . . . . 72.13 111.083 175.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.557 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.9 mttt -129.36 159.24 36.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.031 0.443 . . . . 72.45 111.457 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -93.21 163.77 13.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 54.54 110.938 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -57.3 -29.75 64.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.306 0.484 . . . . 63.01 112.306 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -74.75 -19.26 60.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.69 0.626 . . . . 75.32 112.69 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 135.28 -46.89 1.01 Allowed Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.663 1.025 . . . . 64.3 115.663 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.91 169.48 17.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.596 0.698 . . . . 73.11 112.746 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 36.5 tt0 -94.7 146.97 23.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.713 -0.676 . . . . 74.21 112.181 -173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.9 -59.6 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.949 -0.569 . . . . 62.12 110.806 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.59 159.73 14.48 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 64.14 111.563 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.27 152.03 45.17 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.64 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -156.11 144.87 20.26 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.781 -0.19 . . . . 71.32 111.362 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 87.2 p -114.64 175.35 5.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 62.13 112.377 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 33.0 p -77.17 -174.59 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.936 -0.575 . . . . 73.3 111.18 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 116.546 -0.297 . . . . 74.03 111.252 178.557 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.504 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 13.8 m120 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 111.963 0.357 . . . . 73.24 111.963 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -102.7 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.961 0.41 . . . . 75.12 110.221 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.25 151.0 25.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.076 0.465 . . . . 73.03 112.016 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD12 ' HG ' ' A' ' 104' ' ' LEU . 56.4 mt -77.28 115.4 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.264 -0.426 . . . . 71.24 110.619 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -84.19 -42.34 16.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.722 0.296 . . . . 73.44 111.522 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.1 148.61 27.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.23 112.037 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.66 123.35 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.908 -0.587 . . . . 65.22 110.265 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.17 140.05 40.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.487 0.661 . . . . 71.03 112.462 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -97.1 -20.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.716 -0.674 . . . . 74.11 111.142 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -68.02 -34.62 76.83 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.15 0.5 . . . . 62.2 110.381 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 104.03 44.53 1.61 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.345 0.498 . . . . 44.35 114.345 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -128.3 -26.08 2.86 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.373 0.879 . . . . 75.43 113.373 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -156.08 152.46 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.884 1.068 . . . . 75.15 113.884 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -127.06 118.55 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.748 . . . . 75.21 109.537 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 28' ' ' ARG . 37.8 ttp180 -101.61 110.3 22.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.689 0.626 . . . . 71.32 112.689 -171.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.9 mp -97.92 169.47 9.62 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.89 -0.596 . . . . 74.25 110.439 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -149.99 140.84 22.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.148 0.499 . . . . 65.22 111.843 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.486 ' HB3' HD11 ' A' ' 63' ' ' LEU . 37.5 t30 -100.27 126.9 46.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.259 -0.428 . . . . 71.54 111.079 177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.2 t -113.16 10.97 18.7 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.806 0.336 . . . . 72.44 111.597 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 32.2 m -65.94 146.23 54.97 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.327 -0.233 . . . . 55.32 111.186 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.88 -19.21 62.65 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.415 0.524 . . . . 62.25 112.415 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 42.7 tt0 -123.06 166.06 15.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.81 0.338 . . . . 72.33 111.167 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.489 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.7 m-20 -55.09 130.84 43.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.763 0.425 . . . . 75.44 111.84 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.41 113.32 40.95 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 112.459 0.54 . . . . 71.44 112.459 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.54 125.44 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.748 2.299 . . . . 74.02 111.211 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 tpp -58.07 -20.88 42.89 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.777 0.658 . . . . 53.14 112.777 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.06 -90.19 0.08 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.249 -0.501 . . . . 70.12 113.518 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.08 59.66 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.047 -0.597 . . . . 65.33 113.577 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -76.43 168.8 19.42 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.475 -0.426 . . . . 73.55 110.912 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.33 113.82 26.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.099 0.476 . . . . 72.54 111.606 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.4 ttp -92.28 125.54 36.99 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.147 -0.479 . . . . 70.53 111.213 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.7 mt -117.21 109.11 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.783 0.325 . . . . 73.44 111.371 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -90.21 107.69 19.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.812 0.339 . . . . 72.01 111.141 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 37.3 mttm -95.83 129.32 43.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.811 0.339 . . . . 74.24 111.217 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.411 HD12 ' HG1' ' A' ' 96' ' ' THR . 11.6 tt -134.67 100.82 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.445 0.641 . . . . 51.32 110.901 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.83 -103.98 1.31 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.1 -0.571 . . . . 74.02 112.419 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -102.74 -32.12 9.99 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.035 0.383 . . . . 74.15 112.035 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -92.91 168.69 10.99 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.3 0.572 . . . . 64.22 112.39 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 92.5 p -155.1 150.75 27.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.959 -0.564 . . . . 64.12 111.415 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.401 HG12 ' OE1' ' A' ' 91' ' ' GLN . 7.5 p -134.61 140.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.443 -0.344 . . . . 72.43 110.874 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.4 p -108.3 158.01 17.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.409 0.623 . . . . 73.2 112.584 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -154.56 115.27 3.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.735 -0.666 . . . . 75.51 111.069 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -86.33 133.82 33.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.921 0.391 . . . . 75.01 110.867 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.79 -177.86 2.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.195 0.521 . . . . 70.13 111.851 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -148.36 142.95 26.5 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.084 -0.507 . . . . 72.34 110.982 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -95.43 82.45 3.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.049 0.452 . . . . 73.53 111.983 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.36 6.25 10.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 71.21 111.209 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.6 ' HH ' HG21 ' A' ' 69' ' ' VAL . 26.0 p90 -153.01 152.26 31.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 74.34 110.362 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 36' ' ' ASP . 11.7 t -115.47 116.92 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.825 0.345 . . . . 72.41 110.733 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -93.0 123.83 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.488 -0.324 . . . . 60.0 111.07 -173.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -80.97 -169.82 2.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.753 0.649 . . . . 75.12 112.753 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.68 144.3 31.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.67 0.619 . . . . 71.05 112.67 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.2 12.32 62.94 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.953 -0.567 . . . . 39.05 114.038 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.32 144.41 37.52 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.446 -0.443 . . . . 72.4 110.938 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -99.73 143.59 29.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.963 0.411 . . . . 70.44 112.011 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.6 HG21 ' HH ' ' A' ' 61' ' ' TYR . 5.7 p -114.77 123.96 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.121 172.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 86.6 m -101.74 126.72 48.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.472 . . . . 74.54 112.008 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.7 mm -92.01 103.1 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.43 . . . . 74.32 110.253 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.413 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -85.58 135.12 33.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.3 -0.409 . . . . 65.02 111.607 -177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 153.23 40.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.657 0.265 . . . . 71.03 111.533 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.735 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -53.88 -34.32 59.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.736 0.643 . . . . 73.31 112.736 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.405 HD22 ' HB3' ' A' ' 92' ' ' ASN . 77.2 m-20 -82.37 6.73 16.13 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.651 0.612 . . . . 61.13 112.651 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.68 77.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.974 0.361 . . . . 70.15 111.974 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.56 2.02 90.57 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.152 -0.547 . . . . 64.04 114.2 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.0 171.79 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 122.389 -0.477 . . . . 75.03 111.823 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.591 HG21 ' H ' ' A' ' 81' ' ' SER . 85.6 m -69.26 126.61 30.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 74.4 111.701 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -64.99 -15.25 62.08 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.177 0.806 . . . . 73.0 113.177 -176.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.591 ' H ' HG21 ' A' ' 79' ' ' THR . 23.2 t -149.25 86.53 5.55 Favored Pre-proline 0 N--CA 1.474 0.745 0 O-C-N 122.154 -0.341 . . . . 65.15 111.743 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.551 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 53.9 Cg_exo -53.65 -44.8 45.94 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 122.984 2.456 . . . . 73.53 115.399 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.551 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 69.7 Cg_endo -99.97 132.9 2.21 Favored 'Cis proline' 0 C--N 1.369 1.649 0 CA-C-N 121.161 1.45 . . . . 75.21 114.095 -1.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 82' ' ' PRO . 5.1 t -174.72 -47.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.96 -0.563 . . . . 74.0 110.241 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' THR . 17.3 m-20 -89.98 164.55 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.513 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 92.1 mt -126.47 133.85 51.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.035 0.445 . . . . 73.44 111.412 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 80' ' ' ALA . 1.6 mp -94.28 114.9 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.995 0.426 . . . . 61.31 111.281 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.473 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 4.5 t90 -66.96 93.46 0.27 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.055 -0.52 . . . . 75.35 110.691 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.628 ' HZ1' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -78.51 -28.04 46.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.106 0.41 . . . . 74.31 112.106 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.473 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 15.9 m120 -63.32 -20.31 65.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.287 0.477 . . . . 63.33 112.287 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 47.5 tt0 -132.63 127.18 34.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.864 0.364 . . . . 64.23 110.817 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.735 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 16.1 m120 -67.19 -51.81 48.95 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.349 . . . . 72.15 111.205 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 t -175.21 -179.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 61.23 111.577 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.534 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 38.5 p90 -153.48 -178.81 7.24 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.116 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.18 55.17 0.02 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.394 -0.908 . . . . 70.33 113.166 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.411 ' HG1' HD12 ' A' ' 48' ' ' ILE . 71.8 p -79.83 -40.9 27.47 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.145 0.498 . . . . 73.11 111.513 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.82 -23.25 19.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.063 -0.517 . . . . 52.54 112.789 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.51 179.35 5.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.257 0.551 . . . . 64.14 112.073 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.4 124.41 23.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.741 -0.663 . . . . 73.51 112.22 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.97 135.64 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.134 0.492 . . . . 75.01 111.072 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.614 ' HZ3' ' HB3' ' A' ' 101' ' ' LYS . 7.7 ttpm? -122.96 136.68 54.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.087 -0.506 . . . . 55.13 111.718 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.18 123.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.198 0.523 . . . . 72.4 111.246 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.433 HD13 ' HE2' ' A' ' 101' ' ' LYS . 48.8 mm -102.95 135.34 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.831 -0.622 . . . . 65.2 111.93 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HG ' HD12 ' A' ' 17' ' ' ILE . 68.6 mt -111.45 105.75 14.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 54.23 110.797 173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.69 130.62 54.91 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.16 0.505 . . . . 65.23 111.423 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.94 156.11 39.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.609 . . . . 73.54 111.66 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -57.5 -16.43 9.75 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.173 0.805 . . . . 75.13 113.173 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -101.08 12.81 36.95 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.449 0.537 . . . . 73.42 112.449 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.35 -23.81 33.96 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.888 0.715 . . . . 52.32 114.888 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -76.77 174.8 10.06 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.462 0.631 . . . . 72.31 111.905 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.87 142.4 50.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.519 -0.31 . . . . 70.22 111.282 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.84 -32.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 113.323 0.86 . . . . 75.33 113.323 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.98 152.53 47.75 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.636 0.606 . . . . 74.23 112.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.65 46.88 0.49 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.313 0.577 . . . . 73.14 111.276 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -75.54 151.1 37.98 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.183 0.516 . . . . 71.4 111.958 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.2 p -116.55 173.35 6.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.387 -0.369 . . . . 72.11 110.903 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.5 p -80.56 169.2 17.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.054 0.454 . . . . 75.32 111.508 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 116.109 -0.496 . . . . 65.45 110.705 177.6 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 75.2 111.902 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.93 114.17 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.41 . . . . 72.13 110.759 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.67 150.71 20.36 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.23 0.538 . . . . 73.31 112.243 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.39 110.15 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 62.22 110.163 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -77.22 -68.13 0.64 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.937 0.347 . . . . 64.32 111.937 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -155.92 150.49 25.97 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.287 0.565 . . . . 62.31 111.848 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.647 HD13 HH12 ' A' ' 46' ' ' ARG . 63.4 mt -108.86 137.1 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.065 -0.516 . . . . 72.32 110.864 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 11.0 t70 -70.19 147.22 50.1 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.392 0.615 . . . . 73.14 111.939 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.95 -16.87 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.643 -0.708 . . . . 70.21 111.488 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.5 -26.71 60.17 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 52.02 110.705 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.93 41.15 3.38 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.928 -0.578 . . . . 74.23 113.128 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 -37.75 2.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.356 0.872 . . . . 72.42 113.356 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 51.3 p90 -155.46 171.78 19.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.186 1.18 . . . . 74.02 114.186 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 20' ' ' ILE . 60.2 mt -136.68 143.9 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.221 -0.9 . . . . 70.34 109.265 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.65 115.04 22.02 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.576 -0.703 . . . . 74.45 112.401 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.2 mp -104.58 170.42 7.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.876 -0.602 . . . . 75.32 110.521 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.84 127.76 17.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.019 0.377 . . . . 62.14 112.019 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -90.38 131.52 36.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 64.22 110.742 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.4 p -117.5 11.23 13.78 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.31 0.485 . . . . 74.55 112.31 -176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.7 p -72.78 155.86 39.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.181 0.437 . . . . 64.34 112.181 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.99 -28.24 68.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.116 0.484 . . . . 70.02 112.209 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -124.58 139.0 54.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.077 -0.51 . . . . 70.1 110.411 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.27 126.35 22.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.792 0.329 . . . . 73.53 111.708 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -91.1 120.93 68.45 Favored Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 54.14 111.934 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.23 107.74 0.34 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.343 2.029 . . . . 73.52 112.432 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.675 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 1.5 tpt -78.99 91.49 4.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.777 0.323 . . . . 72.42 111.147 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.04 -51.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.89 -0.671 . . . . 74.32 113.802 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.39 50.72 3.53 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.114 -0.565 . . . . 72.31 113.619 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -140.92 141.15 34.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.014 0.526 . . . . 73.42 110.592 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 38.0 tt0 -124.32 126.9 46.8 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.171 0.51 . . . . 72.42 110.836 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.533 ' HE2' HG22 ' A' ' 71' ' ' ILE . 30.9 ttp -102.04 116.06 31.87 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.653 -0.703 . . . . 74.43 111.384 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.712 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.4 mt -100.41 161.46 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.476 -0.329 . . . . 74.31 110.615 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.647 HH12 HD13 ' A' ' 20' ' ' ILE . 46.7 ttt85 -158.87 137.07 10.63 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.817 -0.552 . . . . 74.44 111.344 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 100' ' ' VAL . 94.4 mttt -123.88 147.55 47.56 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.515 0.561 . . . . 72.2 112.515 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 tt -139.91 109.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.519 -0.764 . . . . 53.31 110.286 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.13 -78.17 0.68 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.008 -0.615 . . . . 37.48 112.847 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -136.94 -43.78 0.58 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.951 0.405 . . . . 74.14 111.502 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -68.01 137.78 55.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.182 0.515 . . . . 71.43 112.343 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.9 p -118.97 153.08 35.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.229 0.538 . . . . 73.44 112.044 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.11 151.55 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 115.743 -0.662 . . . . 75.42 110.288 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -134.99 165.97 24.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.1 0.476 . . . . 71.23 112.046 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -157.03 113.93 3.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 74.21 111.109 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 22.2 ttpp -84.01 133.85 34.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.858 0.361 . . . . 70.32 110.8 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -69.37 158.02 35.9 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.909 0.385 . . . . 74.52 110.973 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -120.33 129.55 54.03 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.158 0.504 . . . . 71.23 111.487 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.7 t -76.93 85.96 3.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.084 0.469 . . . . 74.21 112.05 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.543 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 9.8 ptp180 -119.54 4.85 11.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.399 . . . . 71.44 110.902 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.543 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 8.3 p90 -170.79 173.96 5.08 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.127 0.489 . . . . 70.35 110.69 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.48 129.02 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.208 -0.451 . . . . 64.01 110.75 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.32 105.71 1.51 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.561 -0.533 . . . . 72.22 109.561 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -54.55 136.05 45.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.71 0.633 . . . . 63.1 112.71 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.86 128.92 39.13 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.726 -0.67 . . . . 75.11 111.508 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.35 32.76 72.13 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.091 -0.576 . . . . 53.43 113.392 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -127.71 149.49 50.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.154 0.502 . . . . 72.04 111.814 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.4 p -96.4 135.53 38.13 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.104 -0.498 . . . . 61.3 111.754 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.6 134.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.397 -0.365 . . . . 73.11 110.828 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 26.6 m -104.56 118.62 37.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.267 0.556 . . . . 74.12 111.951 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.533 HG22 ' HE2' ' A' ' 44' ' ' MET . 44.4 mm -89.18 102.1 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.158 -0.474 . . . . 44.1 110.859 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -84.29 125.8 32.59 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.631 -0.259 . . . . 74.14 111.467 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -177.49 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.014 0.435 . . . . 62.43 111.751 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 -16.97 16.96 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.138 0.422 . . . . 71.3 112.138 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -93.11 19.17 8.24 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.538 -0.301 . . . . 64.14 111.204 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 78' ' ' VAL . . . -46.54 -61.74 1.68 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.504 0.927 . . . . 75.13 113.504 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.17 21.48 78.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.799 -0.715 . . . . 62.14 112.792 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 76' ' ' ALA . 30.2 m -127.54 -173.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.561 0.344 . . . . 73.22 110.863 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 p -60.69 123.47 17.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.088 0.471 . . . . 70.1 111.302 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 9.36 3.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.348 0.499 . . . . 64.21 112.348 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -134.46 119.04 13.95 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.174 0.435 . . . . 72.33 112.174 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.641 ' HG3' ' O ' ' A' ' 85' ' ' ASP . 36.8 Cg_exo -54.88 138.18 76.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.773 2.316 . . . . 64.11 110.101 168.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 5.3 Cg_exo 0.29 103.57 0.0 OUTLIER 'Cis proline' 0 C--N 1.363 1.329 0 N-CA-C 121.498 3.615 . . . . 64.23 121.498 25.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 85' ' ' ASP . 12.6 t 51.28 -67.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 117.062 2.245 . . . . 75.34 117.062 162.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 50.5 m-20 -68.21 -178.47 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.758 -0.589 . . . . 74.24 112.132 -171.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 29.3 mt -146.22 142.85 28.8 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.016 -0.427 . . . . 62.21 111.419 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.8 mp -103.57 116.41 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 112.033 0.383 . . . . 54.44 112.033 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.461 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.5 t90 -74.22 82.9 1.84 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.53 0.681 . . . . 74.41 109.792 173.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -77.13 17.48 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.874 -0.603 . . . . 74.04 112.414 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.461 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.1 m120 -127.39 12.16 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.378 0.511 . . . . 43.24 112.378 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -148.64 145.64 27.84 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.205 -0.31 . . . . 64.35 111.533 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -100.64 -137.16 0.32 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 111.686 0.254 . . . . 71.22 111.686 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 96.8 p -75.93 -2.3 29.67 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.821 1.045 . . . . 74.43 113.821 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.0 p90 45.39 22.24 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.154 1.168 . . . . 74.21 114.154 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.98 -156.67 15.84 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.295 -0.478 . . . . 63.32 113.597 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 t -127.05 -31.3 2.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.103 0.478 . . . . 73.34 111.515 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.81 48.45 0.21 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.808 -0.517 . . . . 75.43 111.808 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.01 162.84 14.54 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.618 -0.342 . . . . 74.4 111.191 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -78.39 43.97 0.49 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.54 0.686 . . . . 51.22 111.215 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.6 p -66.31 136.3 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 115.534 -0.757 . . . . 71.42 111.487 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -130.1 150.32 51.42 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.003 0.372 . . . . 70.51 112.003 -171.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.84 155.71 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.859 0.689 . . . . 75.33 112.859 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.712 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 19.7 mm -126.52 134.73 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.819 0.848 . . . . 74.45 111.068 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.77 112.84 22.61 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.722 0.296 . . . . 73.11 111.487 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.34 155.92 34.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.74 0.305 . . . . 65.45 111.169 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.11 177.98 6.0 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.221 0.534 . . . . 75.13 111.677 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.8 p -57.79 -20.92 38.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.039 -0.528 . . . . 70.23 112.027 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.01 -4.61 58.86 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.258 0.466 . . . . 55.21 112.258 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.89 -19.46 45.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.296 -0.478 . . . . 63.32 113.954 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.09 152.68 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.328 -0.513 . . . . 74.1 111.759 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -99.55 128.91 45.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.098 -0.501 . . . . 63.52 112.269 -171.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -84.97 -54.7 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.885 0.374 . . . . 74.2 111.32 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.83 167.36 30.64 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.395 0.617 . . . . 74.45 112.483 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.06 153.82 30.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.501 -0.772 . . . . 55.13 110.896 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -160.26 152.52 20.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.74 0.305 . . . . 73.11 111.502 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -115.02 178.89 4.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.068 0.461 . . . . 74.13 111.942 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 p -77.76 149.72 34.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.14 0.495 . . . . 75.33 111.255 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 70.22 111.241 -178.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 121.115 0.483 . . . . 70.44 110.69 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.75 149.74 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.063 -0.517 . . . . 71.13 110.581 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 p -134.96 145.54 48.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.833 0.349 . . . . 73.22 111.903 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.13 96.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.978 0.418 . . . . 75.42 110.554 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.57 -53.2 59.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 64.41 111.563 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -157.97 146.59 19.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.054 0.454 . . . . 71.14 111.566 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.616 HG21 HG12 ' A' ' 27' ' ' ILE . 30.7 mt -114.58 122.32 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.465 -0.569 . . . . 72.22 109.465 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.59 133.32 36.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.022 0.749 . . . . 70.55 113.022 -171.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.61 -21.76 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.655 -0.702 . . . . 73.42 112.453 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.69 -24.08 23.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.898 0.38 . . . . 73.33 110.939 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.73 26.22 9.27 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.272 -0.422 . . . . 65.21 113.508 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.718 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 8.5 mtpm? -95.02 -28.08 15.3 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.088 0.773 . . . . 72.2 113.088 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.58 174.45 11.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.93 0.715 . . . . 75.45 112.93 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.616 HG12 HG21 ' A' ' 20' ' ' ILE . 52.3 mt -127.81 149.65 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.461 -0.79 . . . . 61.14 109.357 173.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -130.76 116.3 17.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.332 0.587 . . . . 63.42 112.071 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.2 mp -109.1 154.24 22.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.795 -0.639 . . . . 74.45 110.288 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HZ1' ' HB3' ' A' ' 30' ' ' LYS . 6.9 ttpm? -124.2 124.28 42.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 65.53 111.523 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -74.83 97.29 3.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.7 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -79.6 -2.15 41.21 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.912 0.387 . . . . 72.32 111.391 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -75.37 118.08 17.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.43 -0.35 . . . . 71.34 110.536 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 39.1 mt-10 -81.79 61.24 5.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 71.3 111.227 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -170.11 159.26 7.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.968 -0.56 . . . . 71.52 110.463 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.38 101.4 0.95 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.759 0.314 . . . . 62.21 110.655 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.8 mm100 -105.07 123.74 38.83 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 112.402 0.519 . . . . 63.13 112.402 -174.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 13.3 Cg_exo -71.28 135.29 26.58 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.589 2.193 . . . . 75.33 111.91 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.65 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.2 tpt -65.45 -19.04 65.77 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.958 0.408 . . . . 53.15 111.943 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -109.13 2.68 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.209 -0.519 . . . . 73.21 113.312 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.82 60.07 0.2 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.264 -0.493 . . . . 45.12 112.592 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.8 m0 -79.92 -178.12 6.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.952 0.406 . . . . 74.22 111.321 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.63 119.52 11.92 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.198 0.523 . . . . 74.02 111.101 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.605 ' HE1' HG21 ' A' ' 71' ' ' ILE . 50.8 ttp -97.7 118.14 33.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.192 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.473 HG12 ' HB3' ' A' ' 54' ' ' SER . 59.7 mt -103.17 132.87 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.555 -0.293 . . . . 71.14 111.177 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.4 ttm-85 -113.51 130.88 56.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.859 0.361 . . . . 62.14 111.909 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -120.52 133.4 55.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.874 0.368 . . . . 74.12 110.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 100' ' ' VAL . 11.9 tt -159.17 -42.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.004 0.372 . . . . 73.13 112.004 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.65 93.87 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.955 -0.64 . . . . 64.41 113.449 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.65 25.44 14.37 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.438 0.533 . . . . 74.13 112.438 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -146.92 144.51 29.29 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.201 0.524 . . . . 75.51 112.386 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -121.79 32.7 5.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.999 -0.546 . . . . 71.33 110.394 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.22 123.54 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.837 -0.62 . . . . 73.32 112.145 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.473 ' HB3' HG12 ' A' ' 45' ' ' ILE . 60.3 p -118.6 163.88 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.118 0.485 . . . . 70.14 111.98 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 62.9 t80 -137.51 111.35 8.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.956 -0.566 . . . . 65.32 111.901 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -72.33 116.8 13.2 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.033 -0.531 . . . . 75.4 111.077 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.484 ' HE2' ' HB2' ' A' ' 44' ' ' MET . 55.4 m-85 -72.13 162.62 29.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.242 0.544 . . . . 71.32 112.32 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -128.7 133.96 48.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.988 -0.551 . . . . 75.12 111.574 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.495 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 14.8 t -86.46 34.62 0.64 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.431 -0.35 . . . . 62.42 111.338 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 2.5 ptm180 -59.03 -22.67 61.08 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.242 0.46 . . . . 52.23 112.242 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 44.4 p90 -143.09 149.84 38.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.021 0.439 . . . . 75.23 110.96 175.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.81 114.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.413 -0.358 . . . . 71.22 110.576 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.61 136.05 52.41 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.114 0.483 . . . . 71.41 112.273 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -72.85 160.22 32.5 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 74.32 112.157 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 34' ' ' GLU . . . -70.59 130.36 41.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.038 -0.528 . . . . 55.35 111.981 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.05 73.81 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.082 -0.58 . . . . 62.34 113.551 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -83.52 135.55 34.6 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.97 0.414 . . . . 71.45 111.859 -177.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -96.13 109.35 21.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.007 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.12 133.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.315 0.578 . . . . 73.2 111.651 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 55.8 m -105.33 111.64 24.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 64.54 111.441 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.605 HG21 ' HE1' ' A' ' 44' ' ' MET . 49.4 mm -80.33 100.28 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.086 0.47 . . . . 55.31 110.415 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.457 ' HB2' HG13 ' A' ' 87' ' ' ILE . 72.7 m95 -77.47 166.64 22.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.16 -0.473 . . . . 70.2 111.318 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.67 178.12 4.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.572 -0.285 . . . . 72.05 110.73 174.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.78 16.46 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.023 0.439 . . . . 50.31 112.023 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -89.34 19.7 4.26 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.866 0.321 . . . . 70.51 111.866 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.5 70.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.005 0.743 . . . . 73.15 113.005 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -41.53 2.76 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.911 -0.662 . . . . 73.22 112.865 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.24 -179.6 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.244 0.545 . . . . 73.51 111.959 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.9 p -76.54 161.02 28.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.109 0.481 . . . . 73.21 111.521 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.89 2.18 9.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.808 0.67 . . . . 75.33 112.808 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -144.44 87.89 7.47 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 122.2 -0.313 . . . . 54.1 111.774 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.579 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 50.8 Cg_exo -55.8 -42.46 67.0 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 123.159 2.572 . . . . 73.32 115.582 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.579 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 41.6 Cg_endo -99.68 19.72 23.35 Favored 'Cis proline' 0 C--N 1.37 1.683 0 CA-C-N 121.509 1.575 . . . . 74.14 113.905 1.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.539 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 44.5 p -59.28 -48.73 80.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.012 0.434 . . . . 75.42 112.104 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 70' ' ' THR . 12.9 m-20 -98.58 179.27 4.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.068 -0.514 . . . . 70.21 111.833 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.94 129.11 45.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 63.3 110.974 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.2 mp -96.59 109.21 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.749 0.309 . . . . 73.2 111.162 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 7.6 t90 -74.55 86.62 2.09 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.256 0.55 . . . . 64.21 110.422 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -71.59 -20.21 62.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.419 0.526 . . . . 71.03 112.419 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 10.0 m120 -68.01 -13.57 62.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.365 0.505 . . . . 72.22 112.365 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -143.29 142.88 31.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.158 0.504 . . . . 75.31 112.172 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.82 -172.65 3.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.211 -0.45 . . . . 64.23 112.003 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.1 p -60.32 127.48 32.0 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 72.31 111.013 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -102.81 2.1 35.03 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.58 0.956 . . . . 75.23 113.58 -169.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 96' ' ' THR . . . 84.06 -44.55 3.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.875 -0.679 . . . . 71.13 114.171 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 95' ' ' GLY . 2.6 m 76.73 -32.86 0.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.705 1.002 . . . . 72.44 113.705 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.15 -23.33 24.48 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.261 0.864 . . . . 62.5 115.261 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.37 17.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.055 0.761 . . . . 73.52 113.055 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 t70 59.12 73.29 0.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.502 0.668 . . . . 74.22 110.308 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 48' ' ' ILE . 6.1 p -81.2 120.62 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.557 -175.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.97 122.18 38.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.113 0.482 . . . . 74.23 111.768 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.12 131.73 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.891 -0.595 . . . . 73.42 111.304 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.9 mm -111.99 120.39 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.368 -0.378 . . . . 75.32 111.395 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -102.95 109.76 21.42 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.382 -0.199 . . . . 71.42 111.412 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.64 141.16 52.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.375 0.607 . . . . 74.24 112.162 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -77.27 172.93 12.51 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.653 -0.703 . . . . 70.35 111.237 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.4 m -57.75 -21.76 43.01 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 111.985 0.365 . . . . 62.44 111.985 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.72 -7.54 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.574 0.583 . . . . 70.22 112.574 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 -17.22 57.81 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.957 -0.639 . . . . 52.11 113.334 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.78 164.15 22.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 60.03 111.306 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -104.35 142.29 34.83 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.086 0.772 . . . . 75.31 113.086 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.74 -51.91 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.708 -0.678 . . . . 75.12 110.14 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -172.6 163.92 5.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.498 -0.773 . . . . 37.49 111.137 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -144.1 145.2 31.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.857 0.36 . . . . 70.34 110.922 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -150.97 143.57 24.37 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.783 0.325 . . . . 72.42 111.811 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.6 p -108.0 178.66 4.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.501 -0.318 . . . . 73.43 110.935 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.517 HG22 ' HB ' ' A' ' 20' ' ' ILE . 30.0 p -99.86 120.87 40.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.684 -0.487 . . . . 63.13 109.684 171.278 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.438 HD22 ' NE2' ' A' ' 37' ' ' GLN . 8.3 p30 . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.159 0.429 . . . . 75.2 112.159 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -90.28 94.87 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.166 0.508 . . . . 71.44 110.384 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.62 153.09 18.01 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.908 0.385 . . . . 71.34 112.032 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.43 HG22 ' HD2' ' A' ' 115' ' ' ARG . 59.2 mt -65.22 125.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.496 -0.32 . . . . 65.3 110.854 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.07 -52.62 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.186 0.517 . . . . 71.34 111.046 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.1 158.34 36.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.32 111.309 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 HG22 ' A' ' 27' ' ' ILE . 59.7 mt -126.66 143.92 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.752 -0.462 . . . . 71.34 109.752 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.74 137.73 56.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.912 0.387 . . . . 70.41 111.345 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.411 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.3 p -65.19 -36.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.258 0.466 . . . . 75.24 112.258 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -81.54 -70.37 0.54 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.016 0.436 . . . . 75.22 110.461 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.42 38.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.385 -0.912 . . . . 74.4 114.784 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -89.09 -50.52 6.11 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.48 0.64 . . . . 65.14 112.457 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.0 162.86 35.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.515 0.932 . . . . 60.52 113.515 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.703 HG22 HG12 ' A' ' 20' ' ' ILE . 65.7 mt -119.93 137.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.511 -0.768 . . . . 72.21 109.88 173.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.88 116.61 28.28 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.249 0.547 . . . . 71.35 112.269 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.1 mp -106.28 149.56 26.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.155 -0.475 . . . . 44.12 110.705 177.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB2' HG21 ' A' ' 68' ' ' THR . 82.9 tttt -123.88 131.8 53.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.905 0.383 . . . . 72.51 111.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -85.94 112.0 20.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.725 0.298 . . . . 72.02 110.564 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -98.63 14.54 28.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.834 0.35 . . . . 72.22 111.848 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 t -87.74 -177.57 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.012 0.434 . . . . 61.43 111.369 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.1 -19.9 16.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.153 0.501 . . . . 71.24 111.632 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -101.56 155.95 17.78 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.187 -0.46 . . . . 61.23 112.11 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 5.0 m-20 -64.66 91.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.164 -0.471 . . . . 62.05 110.165 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.438 ' NE2' HD22 ' A' ' 14' ' ' ASN . 16.0 mm100 -76.56 116.77 59.42 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 112.82 0.674 . . . . 73.45 112.82 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.83 144.09 63.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.171 1.914 . . . . 73.1 112.143 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.787 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -51.78 -26.79 10.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.005 0.431 . . . . 62.11 111.671 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.1 -100.35 0.45 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 114.448 0.539 . . . . 73.32 114.448 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 57' ' ' TYR . . . 172.27 55.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.549 0 N-CA-C 112.098 -0.401 . . . . 64.24 112.098 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -89.43 152.93 21.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.147 0.499 . . . . 74.32 112.102 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -97.39 118.75 34.55 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.909 -0.587 . . . . 73.14 111.372 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.572 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 55.8 ttp -98.99 104.75 16.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.188 -0.46 . . . . 63.13 110.794 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.8 mt -90.96 116.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.327 -0.397 . . . . 74.22 111.095 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HE ' HG22 ' A' ' 100' ' ' VAL . 59.0 ttt180 -116.98 137.3 52.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.694 0.283 . . . . 73.32 111.513 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 50' ' ' ASP . 85.1 tttt -133.53 116.98 16.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.138 0.494 . . . . 73.14 110.811 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -113.09 119.56 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.108 -0.496 . . . . 71.12 110.937 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.22 -78.78 0.22 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.926 -0.654 . . . . 51.13 111.893 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 34.3 t70 -149.75 -15.33 0.27 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 111.801 0.297 . . . . 60.21 111.801 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -80.33 143.63 33.43 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.983 -0.448 . . . . 74.12 111.044 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.2 p -123.98 149.49 45.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.514 0.673 . . . . 72.32 112.68 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.75 145.23 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.49 -0.777 . . . . 72.3 110.33 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.3 p -128.08 127.68 43.55 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.089 0.471 . . . . 74.22 111.734 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -119.94 137.2 54.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.397 -0.365 . . . . 74.04 111.311 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -99.97 131.4 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.029 0.442 . . . . 40.02 111.668 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.576 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 60.6 m-85 -86.05 94.82 9.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.368 -0.378 . . . . 72.01 111.771 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -71.92 137.8 47.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.157 0.503 . . . . 74.42 112.247 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.787 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 79.5 p -72.25 91.22 1.29 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.304 0.483 . . . . 73.33 112.304 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 14.4 ptm180 -109.08 -16.82 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.692 0.282 . . . . 71.13 111.666 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.474 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 46.9 p90 -158.15 -177.71 6.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.642 0.258 . . . . 61.51 111.051 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.13 159.35 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.399 0.619 . . . . 72.43 112.102 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 tp -124.19 113.87 18.89 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.08 -0.509 . . . . 73.23 110.047 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 39.0 tttp -75.29 169.15 18.61 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.605 0.594 . . . . 63.32 112.605 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.71 127.46 20.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.781 0.66 . . . . 64.22 112.781 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.61 -18.2 9.28 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.173 -0.467 . . . . 38.21 114.014 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -72.41 138.51 47.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.176 0.512 . . . . 71.13 111.674 -176.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 30' ' ' LYS . 59.9 p -105.47 132.51 51.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.197 -0.456 . . . . 74.32 112.052 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.8 140.93 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.91 0.386 . . . . 61.42 111.41 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.2 m -109.8 122.39 47.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 63.43 111.473 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 mm -105.61 102.35 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.399 -0.364 . . . . 70.24 111.255 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -82.94 125.92 31.93 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.821 0.304 . . . . 75.14 111.821 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.19 81.46 2.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.197 0.443 . . . . 65.41 112.197 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . . . 64.83 -67.14 0.12 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.844 1.053 . . . . 71.34 113.844 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -71.39 75.58 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.113 0.412 . . . . 64.23 112.113 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.84 -48.82 3.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 72.02 111.697 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.48 -35.69 3.3 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.444 -0.407 . . . . 72.51 113.19 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.75 -173.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.144 0.424 . . . . 74.3 112.144 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -52.83 121.97 8.29 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.186 -0.461 . . . . 70.31 111.836 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.69 91.05 0.29 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.617 0.969 . . . . 65.54 113.617 -173.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 87' ' ' ILE . 33.8 t 72.84 87.09 0.1 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 114.151 1.167 . . . . 71.34 114.151 168.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.654 ' HB2' ' N ' ' A' ' 84' ' ' THR . 81.8 Cg_exo -50.67 -176.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.576 2.582 0 C-N-CA 123.563 2.842 . . . . 64.4 112.259 163.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 14.82 47.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.44 0 N-CA-C 122.185 3.879 . . . . 72.15 122.185 44.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.654 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 7.3 t 157.67 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.598 1.159 . . . . 70.13 111.628 160.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 1.5 m-20 -105.72 158.33 16.8 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.805 0.336 . . . . 74.31 111.203 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.404 HD13 ' SD ' ' A' ' 39' ' ' MET . 76.5 mt -126.25 139.6 53.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.844 0.354 . . . . 72.32 111.493 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 81' ' ' SER . 1.8 mp -105.39 116.17 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.081 0.467 . . . . 75.51 111.061 176.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.587 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 7.9 t90 -74.69 105.85 5.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.146 -0.479 . . . . 73.43 110.421 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.24 -5.15 58.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.805 0.669 . . . . 62.42 112.805 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.587 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 20.1 m120 -91.35 -42.95 10.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.588 0.588 . . . . 71.34 112.588 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -120.52 143.54 48.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.82 0.343 . . . . 72.23 111.398 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 16.5 m120 -93.52 177.21 6.1 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.057 0.455 . . . . 72.42 111.395 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.7 p -60.46 113.24 2.31 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.123 0.487 . . . . 71.25 111.153 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -76.24 -32.96 59.17 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.76 0.652 . . . . 75.3 112.76 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.98 50.54 21.11 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.292 0.477 . . . . 43.32 114.292 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.7 p -97.52 -44.78 6.68 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.724 0.639 . . . . 62.14 112.724 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 80.17 -33.73 2.21 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.898 -0.668 . . . . 54.21 112.676 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.75 148.15 47.61 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.799 0.333 . . . . 74.15 111.109 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 4.6 p-10 -64.43 126.41 27.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.341 0.867 . . . . 71.43 113.341 -173.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG22 ' HE ' ' A' ' 46' ' ' ARG . 7.7 p -124.92 141.71 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.794 -0.639 . . . . 73.2 110.938 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -109.55 134.88 51.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.919 0.39 . . . . 74.22 111.726 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 144.86 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.15 0.5 . . . . 74.33 111.768 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.76 141.46 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 116.186 -0.461 . . . . 74.01 111.347 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 76.5 mt -114.05 120.46 40.64 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.928 0.394 . . . . 74.31 111.568 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 95.5 mttt -123.05 146.74 47.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.462 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.587 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 16.8 m120 -76.53 153.33 35.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.036 -0.357 . . . . 61.25 110.036 169.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.8 t -67.94 8.37 0.41 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.277 0.843 . . . . 74.03 113.277 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.14 3.91 52.9 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.101 -0.374 . . . . 74.21 111.247 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 36.72 17.27 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.06 -0.591 . . . . 44.54 112.846 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.1 pt-20 -125.39 126.78 45.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.032 0.444 . . . . 75.25 111.501 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 33.8 tt0 -91.47 129.39 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.891 -0.595 . . . . 73.22 111.433 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.44 -64.16 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.285 0.476 . . . . 73.22 112.285 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . . . -101.74 145.4 29.19 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.451 0.537 . . . . 71.51 112.451 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.65 139.96 26.98 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.263 -0.426 . . . . 53.42 110.981 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.43 ' HD2' HG22 ' A' ' 17' ' ' ILE . 47.7 ttm-85 -166.13 136.81 3.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.249 0.547 . . . . 72.32 112.282 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.7 p -111.32 154.54 24.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.756 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.547 HG22 ' HB ' ' A' ' 20' ' ' ILE . 66.5 p -62.45 107.07 0.85 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.025 0.441 . . . . 73.52 111.648 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.423 0.63 . . . . 63.53 111.71 178.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.145 0.497 . . . . 63.11 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.74 128.64 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.425 . . . . 43.41 111.176 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 p -133.71 155.34 49.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.791 0.329 . . . . 51.5 111.445 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.785 HG13 HD11 ' A' ' 104' ' ' LEU . 73.7 mt -62.68 120.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 112.276 0.473 . . . . 72.44 112.276 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 40.6 tt0 -68.38 -55.51 11.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.252 -0.431 . . . . 71.24 109.981 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 23.6 tt0 178.52 160.46 0.6 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.665 -0.698 . . . . 75.22 110.502 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG23 HG12 ' A' ' 27' ' ' ILE . 57.6 mt -95.39 153.6 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.439 -0.346 . . . . 60.41 111.412 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.64 147.71 36.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.124 0.487 . . . . 64.54 111.587 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.35 -28.01 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.113 -0.494 . . . . 74.1 111.993 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.77 -34.54 13.16 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.886 0.374 . . . . 73.23 110.876 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.01 10.86 8.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.192 -0.458 . . . . 71.03 113.426 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.36 -27.74 64.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.223 0.823 . . . . 71.31 113.223 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -158.94 159.65 35.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.972 0.73 . . . . 74.33 112.972 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.472 HG12 HG23 ' A' ' 20' ' ' ILE . 63.8 mt -125.24 117.19 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.695 -0.684 . . . . 63.42 110.722 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -98.55 132.85 43.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 73.04 112.267 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD12 ' HE3' ' A' ' 44' ' ' MET . 6.6 mp -109.65 134.68 51.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.355 -0.384 . . . . 62.12 111.304 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.495 ' HA ' HG23 ' A' ' 68' ' ' THR . 24.3 ttmm -103.37 136.08 43.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.882 0.372 . . . . 72.41 111.494 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.95 107.43 15.55 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.424 -0.353 . . . . 74.14 110.833 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.6 p -95.9 17.14 15.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.161 0.505 . . . . 71.35 111.808 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -70.29 159.32 34.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.1 0.476 . . . . 70.2 111.869 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.23 -26.35 58.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.222 -0.444 . . . . 52.43 111.717 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 44.6 tt0 -138.9 166.74 23.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.761 0.315 . . . . 75.42 110.936 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 6.1 m-20 -68.14 117.04 9.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.532 -0.304 . . . . 73.21 111.224 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -133.68 144.16 50.78 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 111.61 0.226 . . . . 72.4 111.61 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 36.4 Cg_exo -60.95 147.5 95.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.677 2.251 . . . . 75.14 112.615 174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.1 tpt -54.82 -50.59 68.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.072 0.463 . . . . 52.42 112.174 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.17 -122.1 5.83 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.02 -0.609 . . . . 65.32 113.293 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 108.87 1.14 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.377 -0.439 . . . . 65.42 113.142 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -135.08 164.87 26.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.641 0.376 . . . . 75.41 110.515 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -150.25 117.02 5.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.125 0.488 . . . . 74.12 111.374 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.456 ' HE1' ' OH ' ' A' ' 57' ' ' TYR . 38.1 ttm -91.81 117.4 29.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.245 -0.434 . . . . 73.32 111.721 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.59 102.65 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.859 0.361 . . . . 73.14 110.549 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -90.37 120.41 31.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.747 0.308 . . . . 72.23 111.414 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.27 113.86 27.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.409 -0.359 . . . . 53.13 111.035 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.468 ' HB ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.54 137.98 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.572 -0.285 . . . . 74.43 110.86 -176.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' N ' HD12 ' A' ' 48' ' ' ILE . . . 55.35 36.46 63.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.191 -0.528 . . . . 62.41 113.438 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.18 -4.29 1.59 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.829 0.852 . . . . 74.35 113.028 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -103.68 173.45 6.3 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.685 -0.634 . . . . 71.23 111.057 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -139.34 150.46 45.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.34 0.59 . . . . 60.31 112.105 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.58 130.36 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.636 -0.711 . . . . 74.3 110.354 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' MET . 94.0 p -105.43 148.72 26.84 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.328 0.585 . . . . 70.44 112.183 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -128.73 112.08 13.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.945 -0.57 . . . . 75.31 110.476 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.26 125.75 33.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.99 0.424 . . . . 75.33 111.651 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.456 ' OH ' ' HE1' ' A' ' 44' ' ' MET . 54.0 m-85 -85.9 168.9 13.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.509 0.671 . . . . 71.14 112.391 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -140.05 157.99 44.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.678 -0.692 . . . . 72.01 111.797 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.7 p -87.62 23.23 2.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.205 -0.452 . . . . 63.12 111.923 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -69.53 -2.18 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.624 0.602 . . . . 73.12 112.624 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.467 ' HH ' HG21 ' A' ' 69' ' ' VAL . 4.2 p90 -151.29 156.94 41.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.172 0.51 . . . . 72.33 111.7 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 83.2 t -103.6 124.77 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.16 -0.473 . . . . 65.34 111.659 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.12 109.85 18.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.008 0.432 . . . . 64.42 111.328 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.75 144.5 32.11 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.372 -0.376 . . . . 64.42 111.145 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.22 119.53 4.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.909 0.385 . . . . 74.13 111.798 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.16 -41.49 2.5 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.184 -0.532 . . . . 64.24 113.218 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.54 140.25 58.54 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.314 -0.521 . . . . 51.5 111.187 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 30' ' ' LYS . 70.1 p -111.49 153.72 25.78 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.726 0.639 . . . . 71.04 112.726 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG21 ' HH ' ' A' ' 61' ' ' TYR . 5.9 p -114.57 123.24 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.968 -0.56 . . . . 75.4 110.566 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m -94.13 124.61 38.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.186 0.517 . . . . 72.42 111.516 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.429 HD12 ' HE2' ' A' ' 57' ' ' TYR . 41.6 mm -86.21 99.67 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.048 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -84.38 -178.45 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 74.41 110.971 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.37 170.48 7.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.715 -0.221 . . . . 55.33 110.95 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 92' ' ' ASN . . . -51.62 -33.19 32.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.194 0.442 . . . . 73.52 112.194 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.07 32.48 2.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.455 -0.339 . . . . 62.22 111.563 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.16 -48.55 44.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.913 0.708 . . . . 74.31 112.913 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.17 -33.66 6.23 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.13 -0.557 . . . . 64.4 112.277 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.33 -171.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 122.555 0.342 . . . . 72.14 110.843 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.3 p -69.97 147.33 50.29 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.98 -0.45 . . . . 65.55 111.369 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.91 2.65 3.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.642 0.608 . . . . 53.03 112.642 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -169.68 86.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.073 0.549 . . . . 73.41 110.345 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HB2' ' N ' ' A' ' 84' ' ' THR . 53.5 Cg_exo -53.0 -46.95 30.3 Favored 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.262 2.641 . . . . 74.53 115.972 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.538 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.7 Cg_endo -101.73 21.86 17.36 Favored 'Cis proline' 0 C--N 1.363 1.322 0 CA-C-N 121.307 1.503 . . . . 72.11 114.664 2.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.548 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 10.2 t -55.74 -41.44 73.91 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.443 0.535 . . . . 63.32 112.443 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -97.37 164.35 12.5 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.117 0.484 . . . . 72.54 111.29 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.04 126.24 51.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.071 0.462 . . . . 72.23 111.378 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.0 mp -91.84 127.38 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 73.12 110.938 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -69.6 79.35 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.175 0.512 . . . . 70.44 110.183 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -58.29 -22.19 51.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.856 0.687 . . . . 73.14 112.856 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.6 -23.7 58.77 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.706 0.632 . . . . 61.15 112.706 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -146.2 150.06 35.11 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.129 0.788 . . . . 74.31 113.129 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -75.3 -172.22 1.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.628 -0.715 . . . . 71.12 110.616 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -74.98 142.3 43.9 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.864 -0.523 . . . . 61.4 111.214 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -120.47 101.32 7.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.64 0.733 . . . . 74.14 111.821 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.22 135.74 12.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.163 -0.472 . . . . 75.22 112.059 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -170.95 -42.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.863 0.69 . . . . 73.44 112.863 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.51 -15.72 62.68 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.007 -0.616 . . . . 64.23 113.024 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -56.89 131.94 51.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.74 0.305 . . . . 71.15 111.236 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.504 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.7 m-20 -60.95 114.5 3.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.295 0.569 . . . . 62.34 112.033 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 48' ' ' ILE . 3.8 p -106.05 136.81 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.727 -0.67 . . . . 72.12 111.41 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -115.85 132.44 56.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.232 0.539 . . . . 74.32 110.524 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.3 141.49 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.309 0.576 . . . . 62.12 112.446 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.1 mm -107.47 140.67 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 60.13 111.618 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.785 HD11 HG13 ' A' ' 17' ' ' ILE . 76.1 mt -110.26 114.89 28.72 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.756 0.312 . . . . 72.13 111.694 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -106.16 140.29 39.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.956 0.408 . . . . 73.52 111.421 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 112' ' ' VAL . 10.6 m120 -87.16 -171.2 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.271 -0.422 . . . . 70.3 111.086 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.9 t -57.91 -36.75 72.9 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.185 0.439 . . . . 52.51 112.185 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -81.72 3.02 27.16 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.116 0.413 . . . . 51.13 112.116 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.61 -1.26 78.46 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.174 -0.536 . . . . 64.1 113.039 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.49 151.25 47.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.884 0.474 . . . . 70.11 111.223 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -101.79 119.27 38.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.881 0.372 . . . . 73.41 111.662 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.402 HG12 ' OD1' ' A' ' 106' ' ' ASN . 18.8 m -106.41 -18.71 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.347 0.499 . . . . 52.15 112.347 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 104' ' ' LEU . . . -155.04 142.75 19.85 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.575 0.583 . . . . 73.11 112.575 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.62 122.03 11.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.466 -0.788 . . . . 65.12 109.842 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -144.5 156.74 44.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.979 0.419 . . . . 73.02 112.076 -171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.7 p -133.28 175.36 9.47 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.962 0.411 . . . . 61.42 111.607 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 45.8 p -79.17 -176.38 5.1 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.991 0.424 . . . . 65.32 111.391 173.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 120.888 0.375 . . . . 73.31 111.015 177.624 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 121.13 0.49 . . . . 74.41 110.515 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.2 145.22 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.996 -0.547 . . . . 53.35 111.087 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.3 p -132.76 154.66 50.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.989 0.423 . . . . 74.51 111.634 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.63 111.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.321 -0.399 . . . . 55.25 110.796 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.83 -56.33 4.35 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.44 111.835 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.58 123.77 6.38 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.231 0.538 . . . . 74.24 112.39 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.608 HG21 HG12 ' A' ' 27' ' ' ILE . 72.2 mt -89.16 140.33 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.878 -0.601 . . . . 71.13 110.624 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.5 143.07 40.67 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.104 0.478 . . . . 73.11 111.472 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -85.82 -25.86 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.562 0.578 . . . . 73.11 112.562 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.83 -21.13 41.06 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.182 0.515 . . . . 71.0 111.009 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 103.45 20.21 11.3 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.796 -0.638 . . . . 55.01 113.256 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -79.72 -48.58 13.41 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.396 0.517 . . . . 74.32 112.396 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -160.81 173.25 15.65 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.489 0.922 . . . . 63.43 113.489 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.608 HG12 HG21 ' A' ' 20' ' ' ILE . 57.0 mt -133.85 121.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.469 -0.787 . . . . 64.5 109.794 170.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -101.4 123.58 45.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.744 -0.597 . . . . 63.35 112.19 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.7 mp -110.72 172.45 6.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.021 -0.536 . . . . 63.23 110.941 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.707 ' HB3' ' HZ2' ' A' ' 30' ' ' LYS . 7.1 ttpm? -150.61 138.14 19.68 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.007 0.432 . . . . 72.25 111.998 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -78.73 114.52 17.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.919 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -102.76 12.81 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.919 0.39 . . . . 74.14 111.876 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 t -77.57 164.55 25.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.06 0.457 . . . . 60.42 111.426 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -85.91 5.98 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.2 0.444 . . . . 74.53 112.2 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 60.3 tt0 -146.43 159.9 42.79 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.686 0.279 . . . . 73.35 111.354 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -63.85 115.29 4.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.817 0.341 . . . . 71.22 110.409 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 17.2 mm-40 -105.71 146.19 32.34 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.333 0.494 . . . . 73.51 112.333 -172.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 9.2 Cg_exo -72.8 103.22 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.644 2.23 . . . . 54.2 112.486 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.651 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.6 tpt -59.88 -28.46 67.57 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 71.33 111.501 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.18 5.04 15.58 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 114.539 0.576 . . . . 73.12 114.539 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.29 8.78 69.62 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.92 -0.657 . . . . 42.13 113.127 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -119.03 170.89 8.66 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.599 0.592 . . . . 74.53 112.599 -176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -152.42 130.38 11.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.33 110.845 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 47.7 ttp -96.82 116.62 29.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 73.15 111.418 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 60.0 mt -105.4 113.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.809 0.338 . . . . 71.33 111.011 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' HE ' ' HZ3' ' A' ' 88' ' ' TRP . 54.2 ttm-85 -98.88 118.15 34.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.246 0.461 . . . . 70.51 112.246 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -95.39 106.17 18.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.973 -0.38 . . . . 63.35 109.973 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.405 ' HA ' HG23 ' A' ' 100' ' ' VAL . 10.6 tt -116.62 107.23 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.531 0.681 . . . . 72.1 112.699 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.6 -93.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.658 -0.701 . . . . 53.04 114.079 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -107.54 -17.42 14.11 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.287 0.477 . . . . 72.23 112.287 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.8 t -128.21 -172.67 2.75 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.044 0.45 . . . . 73.21 112.093 -175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 p -154.15 146.6 24.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.115 0.483 . . . . 74.24 111.693 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' HH2' ' A' ' 88' ' ' TRP . 7.7 p -153.52 145.29 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.06 -0.518 . . . . 64.45 110.404 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.6 p -120.74 168.36 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.296 0.85 . . . . 50.43 113.296 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 29.7 t80 -139.91 110.81 6.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.246 -0.888 . . . . 74.24 110.944 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -79.75 124.27 28.45 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.683 0.278 . . . . 64.54 110.327 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -68.53 105.83 2.36 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.967 0.413 . . . . 73.42 111.619 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t -71.36 121.98 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.231 0.538 . . . . 62.42 111.226 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.784 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 32.9 t -83.1 82.49 8.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.132 0.491 . . . . 74.52 112.247 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.785 ' HD2' ' HG2' ' A' ' 82' ' ' PRO . 11.6 ptp180 -104.6 4.19 32.53 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.829 0.347 . . . . 72.42 111.233 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.439 ' HE1' HD22 ' A' ' 86' ' ' LEU . 29.8 p90 -163.4 167.33 21.79 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 75.45 110.695 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.55 150.14 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.947 0.404 . . . . 74.21 111.804 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 39' ' ' MET . 39.3 tp -101.96 102.14 12.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.165 0.507 . . . . 71.15 110.604 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -62.53 162.62 10.09 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.843 0.682 . . . . 75.45 112.843 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.58 122.02 15.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.112 -0.494 . . . . 62.34 111.444 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.92 20.42 76.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.211 -0.518 . . . . 74.01 113.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -96.45 132.94 41.49 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.94 0.4 . . . . 75.11 111.99 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 30' ' ' LYS . 74.4 p -93.63 145.86 24.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.771 175.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.09 146.14 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.67 0.388 . . . . 62.3 111.29 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.88 129.8 53.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.958 0.355 . . . . 62.42 111.958 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.91 103.69 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.649 0.261 . . . . 75.24 110.944 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.45 166.69 18.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.579 -0.282 . . . . 64.13 111.432 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.05 94.31 4.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.815 0.672 . . . . 70.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 47.47 -82.57 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.232 1.197 . . . . 74.21 114.232 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -77.46 36.24 0.19 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.544 0.572 . . . . 73.15 112.544 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.08 -11.77 59.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.771 0.319 . . . . 73.24 111.552 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.24 -42.4 2.56 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.331 -0.462 . . . . 54.52 113.52 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.2 m -55.42 158.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.765 0.654 . . . . 63.25 112.765 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.8 p -68.21 136.45 53.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.083 -0.508 . . . . 74.41 111.597 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -83.0 39.01 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.144 0.424 . . . . 74.42 112.144 -176.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.2 m -130.24 102.95 16.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 112.563 0.579 . . . . 72.43 112.563 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.785 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 28.4 Cg_exo -44.5 -164.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.397 0 C-N-CA 124.532 3.488 . . . . 70.23 114.238 168.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 2.4 Cg_endo -84.51 1.42 61.15 Favored 'Cis proline' 0 C--N 1.371 1.714 0 CA-C-N 120.982 1.386 . . . . 64.35 114.153 11.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.0 p -67.15 -71.63 0.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.487 0.551 . . . . 64.24 112.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 5.4 m-20 -121.51 169.38 10.72 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.097 0.475 . . . . 75.13 112.216 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.439 HD22 ' HE1' ' A' ' 61' ' ' TYR . 81.8 mt -115.82 134.69 54.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.375 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 80' ' ' ALA . 2.5 mp -109.14 114.32 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.949 0.404 . . . . 72.21 111.245 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.544 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 15.9 t90 -84.52 110.33 18.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.981 0.42 . . . . 73.33 110.766 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -84.3 -11.48 56.32 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.645 0.98 . . . . 72.14 113.645 -171.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.97 -54.52 9.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.313 0.486 . . . . 73.3 112.313 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 64.7 tt0 -85.95 123.78 31.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.815 0.341 . . . . 62.2 111.735 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 19.1 m120 -83.17 52.98 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.852 0.316 . . . . 53.15 111.852 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.2 t 66.6 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.323 0.582 . . . . 45.1 112.2 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.534 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 42.3 p90 -106.23 171.78 7.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.484 -0.326 . . . . 74.32 111.117 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.01 105.72 0.28 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.555 -0.831 . . . . 42.04 113.234 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 t -151.68 -50.17 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.329 0.492 . . . . 72.24 112.329 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.55 -29.34 2.38 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.167 -0.54 . . . . 61.44 112.426 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -71.16 144.87 50.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.628 0.251 . . . . 71.11 111.037 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 23.1 m-20 -75.72 104.3 6.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.693 0.627 . . . . 74.43 112.693 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 48' ' ' ILE . 4.3 p -81.53 127.11 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.744 -0.662 . . . . 74.34 110.896 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 36.8 ttpt -97.79 115.84 28.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.331 0.586 . . . . 73.53 111.905 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 135.36 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.904 -0.589 . . . . 75.44 111.462 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 114' ' ' GLN . 27.6 mm -116.52 141.91 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 116.111 -0.495 . . . . 74.11 111.488 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.505 HD11 ' HB1' ' A' ' 113' ' ' ALA . 76.6 mt -115.35 118.22 32.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.953 0.406 . . . . 63.44 111.79 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 111' ' ' GLU . 57.9 mttp -125.32 160.22 29.83 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.313 -0.403 . . . . 73.05 110.951 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 17.1 m120 -99.18 -178.65 3.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 73.45 111.826 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -50.63 -43.36 56.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.16 0.8 . . . . 74.12 113.16 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.47 1.48 13.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.411 0.522 . . . . 73.42 112.411 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.44 84.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.235 -0.507 . . . . 52.5 113.094 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 7.3 pt-20 -78.76 137.94 37.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.922 0.391 . . . . 64.24 111.059 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.405 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 38.8 tt0 -102.0 137.12 40.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.853 0.316 . . . . 73.31 111.853 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 113' ' ' ALA . 27.1 m -127.89 -47.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 113.008 0.744 . . . . 71.31 113.008 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 104' ' ' LEU . . . -132.19 156.19 46.88 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.169 0.433 . . . . 73.34 112.169 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.453 ' HB2' HD11 ' A' ' 103' ' ' ILE . 3.3 pt20 -175.4 150.18 1.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.331 -0.395 . . . . 64.31 111.408 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 116' ' ' SER . 35.7 ttp180 -173.52 159.32 3.61 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.897 0.379 . . . . 55.02 111.52 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.3 p -86.71 -169.35 2.59 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.135 0.493 . . . . 62.42 111.029 172.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 31.7 p -87.85 -167.91 2.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.976 0.417 . . . . 63.24 111.51 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.064 0.459 . . . . 74.31 111.377 -179.524 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 32' ' ' THR . 17.2 m-80 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.657 0.614 . . . . 73.12 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.88 130.76 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 75.55 112.031 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -129.15 177.37 7.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.132 -0.485 . . . . 62.01 110.637 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.88 127.55 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 122.007 -0.433 . . . . 72.52 110.721 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.71 -51.45 3.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.37 0.508 . . . . 61.52 112.37 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -147.86 138.1 22.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.075 0.464 . . . . 71.21 112.062 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.77 HG12 HG21 ' A' ' 27' ' ' ILE . 53.3 mt -132.9 139.93 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.256 -0.429 . . . . 70.1 111.054 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -85.59 126.22 33.72 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.03 0.443 . . . . 63.33 110.925 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.36 -26.4 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.241 0.46 . . . . 75.01 112.241 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.12 -37.1 80.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.872 0.368 . . . . 70.24 111.688 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 119.58 57.86 0.25 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.262 -0.494 . . . . 71.25 113.472 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -129.81 -57.49 1.11 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.49 0.552 . . . . 74.35 112.49 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.76 161.8 38.35 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.477 0.917 . . . . 75.12 113.477 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.77 HG21 HG12 ' A' ' 20' ' ' ILE . 63.6 mt -128.49 160.92 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 114.873 -1.058 . . . . 72.14 108.634 173.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 28' ' ' ARG . 38.2 ttp-105 -147.2 122.1 10.0 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.251 -0.906 . . . . 70.45 112.554 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.8 mp -97.08 172.68 7.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.742 -0.663 . . . . 74.42 110.507 175.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HG3' HG21 ' A' ' 68' ' ' THR . 74.4 tttt -142.59 121.06 12.43 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.834 0.349 . . . . 74.45 111.213 -175.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -82.01 86.27 6.59 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.238 0.542 . . . . 70.43 111.272 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 14' ' ' ASN . 71.8 p -83.65 87.72 7.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.227 -0.442 . . . . 63.23 110.293 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HG ' ' HG2' ' A' ' 37' ' ' GLN . 46.5 t -131.46 164.19 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.108 0.781 . . . . 61.5 113.108 -168.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -81.14 -26.62 35.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.945 -1.025 . . . . 72.13 110.647 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -140.35 162.4 35.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.644 -0.707 . . . . 74.5 110.488 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -68.98 109.82 4.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.862 0.363 . . . . 65.23 110.182 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HG2' ' HG ' ' A' ' 33' ' ' SER . 14.2 mm100 -103.02 138.6 19.59 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.682 0.623 . . . . 72.42 112.682 -170.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 84.3 Cg_endo -75.94 46.51 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.87 2.38 . . . . 75.24 113.348 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.417 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 6.4 tpt 63.11 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.87 0.468 . . . . 75.35 112.179 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.48 172.55 23.92 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.491 -0.385 . . . . 74.2 113.467 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.91 78.88 1.64 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.984 -0.627 . . . . 61.22 113.386 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -99.38 142.45 30.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.661 -0.317 . . . . 73.25 111.597 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -115.57 115.14 25.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.345 . . . . 73.22 110.478 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.48 ' HE2' ' CZ3' ' A' ' 88' ' ' TRP . 44.9 ttp -99.44 105.91 17.9 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.89 0.33 . . . . 74.31 111.89 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.632 HG13 ' HB3' ' A' ' 54' ' ' SER . 3.5 mp -91.08 118.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.56 -0.291 . . . . 74.34 111.313 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.453 ' HB2' ' CH2' ' A' ' 88' ' ' TRP . 55.0 ttp180 -94.35 93.79 7.91 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.06 0.457 . . . . 74.23 111.209 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.4 84.42 5.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.484 0.659 . . . . 61.34 111.456 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 96' ' ' THR . 16.5 tt -78.8 -14.57 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.606 -0.724 . . . . 71.3 110.787 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.03 -152.84 10.2 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.583 -0.735 . . . . 62.32 111.828 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.13 82.35 5.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.381 0.61 . . . . 73.32 109.963 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -167.18 -179.3 4.5 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.501 -0.772 . . . . 73.0 110.76 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.3 p -142.13 105.93 4.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.046 0.451 . . . . 74.45 111.605 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' NE2' ' A' ' 91' ' ' GLN . 7.1 p -138.2 137.68 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.221 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB3' HG13 ' A' ' 45' ' ' ILE . 81.2 p -145.94 161.27 40.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.01 0.744 . . . . 75.11 113.01 -174.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -126.77 126.64 43.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.181 -0.918 . . . . 74.55 109.785 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.15 141.21 28.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.055 0.455 . . . . 75.14 111.577 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -83.81 -178.6 7.05 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.995 -0.548 . . . . 72.44 111.631 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -144.35 149.76 36.69 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.161 0.43 . . . . 71.1 112.161 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 t -91.91 16.25 11.39 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.114 -0.494 . . . . 73.21 111.762 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.8 2.18 7.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.777 0.658 . . . . 72.34 112.777 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -148.6 164.5 34.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 74.55 111.328 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 61.4 t -112.77 119.16 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.907 0.384 . . . . 72.14 111.315 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.92 116.79 29.16 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.965 0.412 . . . . 64.43 110.19 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -58.44 153.58 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.687 0.625 . . . . 74.21 112.687 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.51 133.16 46.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.17 -0.468 . . . . 73.33 111.415 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.43 18.35 79.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.165 -0.54 . . . . 72.11 113.074 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.88 147.13 37.67 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.668 -0.313 . . . . 61.5 110.778 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 30' ' ' LYS . 43.1 p -95.8 171.4 8.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.354 0.597 . . . . 71.41 112.119 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.02 122.76 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.038 -0.528 . . . . 64.13 110.656 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.5 m -94.85 124.57 38.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.493 0.553 . . . . 73.11 112.493 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 86' ' ' LEU . 31.0 mm -94.88 136.38 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.83 -0.623 . . . . 54.11 110.492 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -117.24 179.36 4.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.907 0.384 . . . . 75.35 111.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -84.36 156.37 21.89 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.654 -0.248 . . . . 64.4 111.42 176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.67 -46.0 1.77 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.368 0.877 . . . . 70.03 113.368 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -129.28 74.39 1.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.129 0.49 . . . . 65.11 110.599 174.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.02 -3.48 54.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 52.3 112.105 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -41.68 2.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.367 -0.444 . . . . 75.41 113.086 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.05 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.034 0.445 . . . . 74.03 112.009 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.3 p -63.35 139.56 58.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 54.22 112.031 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.47 70.29 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.833 0.679 . . . . 62.23 112.833 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.1 p -139.57 98.68 7.94 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.999 0.428 . . . . 64.11 111.703 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.566 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 74.9 Cg_exo -52.79 -43.03 59.23 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.003 2.469 . . . . 72.52 115.324 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.566 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 77.4 Cg_endo -99.27 109.91 0.41 Allowed 'Cis proline' 0 C--N 1.368 1.597 0 CA-C-N 121.301 1.5 . . . . 74.1 113.738 -2.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.438 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 53.1 p -139.08 -66.0 0.48 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.258 0.623 . . . . 74.22 109.505 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.11 130.82 41.14 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.836 -0.62 . . . . 74.23 109.739 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.476 ' HB2' HD12 ' A' ' 71' ' ' ILE . 87.7 mt -100.26 108.38 20.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.15 0.5 . . . . 61.52 111.918 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 73' ' ' ALA . 1.7 mp -77.04 131.1 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.004 0.431 . . . . 73.21 111.183 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.48 ' CZ3' ' HE2' ' A' ' 44' ' ' MET . 2.0 t90 -70.91 77.06 0.64 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.437 0.636 . . . . 75.55 110.214 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 7.6 mtpm? -68.57 -2.11 8.21 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.07 0.767 . . . . 75.01 113.07 -175.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.96 -12.78 20.34 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.487 0.551 . . . . 70.12 112.487 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.467 ' NE2' HG23 ' A' ' 53' ' ' VAL . 36.1 tt0 -164.54 143.32 7.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.041 0.448 . . . . 73.15 111.363 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -75.24 -164.22 0.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.724 0.773 . . . . 74.34 112.971 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -62.37 178.38 0.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.92 -1.037 . . . . 73.22 112.797 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.558 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.1 p90 -141.8 167.76 21.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.715 -0.675 . . . . 75.14 110.443 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.15 66.35 0.02 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.552 -0.832 . . . . 54.02 113.702 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.531 HG23 HD13 ' A' ' 48' ' ' ILE . 47.0 p -78.78 -65.93 0.93 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.964 0.412 . . . . 61.3 111.445 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.03 -32.22 1.69 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.169 -0.468 . . . . 74.45 113.094 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.43 -63.38 1.09 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.477 0.547 . . . . 73.34 112.477 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -177.43 158.77 1.46 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.715 0.293 . . . . 62.32 110.686 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.31 89.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.846 0.831 . . . . 70.43 110.351 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HE2' HD12 ' A' ' 103' ' ' ILE . 87.6 tttt -91.31 126.61 36.45 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.641 -0.709 . . . . 74.13 111.783 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.6 t -118.74 136.56 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.041 0.448 . . . . 72.41 111.657 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.406 HD12 ' HE2' ' A' ' 101' ' ' LYS . 45.7 mm -122.34 138.88 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.054 -0.521 . . . . 54.11 111.039 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 113' ' ' ALA . 78.4 mt -110.63 113.99 27.03 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.253 0.464 . . . . 74.5 112.253 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HZ1' ' HB2' ' A' ' 111' ' ' GLU . 67.9 mttm -108.16 156.18 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.097 0.475 . . . . 62.22 110.623 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.7 m120 -99.21 179.07 4.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.051 0.453 . . . . 74.04 111.68 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.7 t -46.96 -40.68 14.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.42 0.896 . . . . 73.05 113.42 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.83 14.77 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.666 0.617 . . . . 70.01 112.666 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.55 -21.56 10.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.334 -0.46 . . . . 64.03 112.881 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 10.7 pt-20 -52.6 125.38 16.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.259 0.624 . . . . 62.55 111.937 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.413 ' HB2' ' HZ1' ' A' ' 105' ' ' LYS . 33.7 tt0 -95.88 136.81 35.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.796 -0.638 . . . . 74.15 111.436 -174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG21 ' H ' ' A' ' 113' ' ' ALA . 12.7 m -125.08 -60.83 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.104 0.779 . . . . 75.34 113.104 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.474 ' H ' HG21 ' A' ' 112' ' ' VAL . . . -105.07 154.45 20.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.38 0.511 . . . . 75.05 112.38 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.73 154.96 33.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.989 -0.551 . . . . 72.33 111.287 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.9 ttm180 -166.58 123.86 1.32 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.366 0.876 . . . . 64.42 113.366 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -105.18 129.85 53.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.688 -0.856 . . . . 73.12 108.688 164.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.2 p -68.45 -94.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.903 0.705 . . . . 73.31 112.903 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.296 0.569 . . . . 72.5 111.301 -178.147 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.587 0.708 . . . . 72.43 109.896 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.27 90.93 1.46 Allowed Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.866 -0.606 . . . . 64.33 114.537 -171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -100.41 18.33 19.25 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.96 0.409 . . . . 64.32 111.252 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.11 148.5 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.268 -0.423 . . . . 73.11 110.672 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -85.75 157.82 20.18 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.944 0.402 . . . . 74.21 111.686 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -106.02 163.59 12.65 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.692 0.282 . . . . 73.34 111.428 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -166.43 116.88 0.96 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.783 0.325 . . . . 63.23 110.612 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -83.68 111.78 19.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.844 0.354 . . . . 75.3 111.823 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.3 m -156.05 146.68 21.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.255 -0.429 . . . . 45.01 110.788 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -82.21 84.63 7.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.604 0.24 . . . . 73.24 111.358 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -74.75 73.5 2.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.595 0.712 . . . . 73.43 110.734 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 8.9 t -162.73 170.98 17.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.497 -0.774 . . . . 70.03 111.285 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 168.26 41.0 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.596 -0.812 . . . . 72.33 113.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 67.27 9.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.264 0.554 . . . . 53.32 110.085 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.73 135.28 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.376 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.47 145.51 51.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.202 -0.454 . . . . 64.32 110.88 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 102' ' ' VAL . 57.2 mt -72.65 99.29 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.595 -0.275 . . . . 73.43 110.629 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -62.09 -56.97 13.53 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.068 0.461 . . . . 74.32 111.271 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -164.87 143.66 6.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 73.5 111.565 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG23 HG12 ' A' ' 100' ' ' VAL . 55.7 mt -102.11 138.89 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.938 -0.393 . . . . 70.53 109.938 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.57 135.56 56.67 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.306 0.484 . . . . 70.14 112.306 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.77 -26.0 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.616 0.598 . . . . 74.3 112.616 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 13.7 t70 -85.01 -25.33 27.76 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.279 0.561 . . . . 62.35 110.326 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.52 30.78 6.38 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.149 -0.478 . . . . 40.04 112.943 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -90.37 -45.54 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.405 0.52 . . . . 74.41 112.405 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.46 161.36 38.24 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.648 0.981 . . . . 74.11 113.648 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -117.41 123.73 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 71.13 109.923 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -103.98 109.95 21.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.423 0.63 . . . . 75.4 112.637 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.8 mp -89.74 156.16 18.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.482 -0.781 . . . . 75.22 110.224 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HG3' HG21 ' A' ' 68' ' ' THR . 81.7 tttt -143.25 110.96 5.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.146 -0.346 . . . . 61.0 111.881 -173.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -87.02 106.12 17.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.026 0.441 . . . . 64.02 111.579 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -109.36 40.84 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.396 0.617 . . . . 72.23 111.406 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HG ' ' HG2' ' A' ' 37' ' ' GLN . 80.7 p -83.33 176.54 9.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.451 0.643 . . . . 73.42 112.591 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.68 -7.45 54.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.766 -0.652 . . . . 65.54 111.933 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -149.4 156.45 42.06 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.841 0.353 . . . . 73.3 111.316 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.1 110.71 1.92 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.97 0.414 . . . . 63.05 111.244 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.407 ' HG2' ' HG ' ' A' ' 33' ' ' SER . 13.9 mm100 -93.37 128.93 40.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.544 0.572 . . . . 60.24 112.544 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.38 119.3 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.415 2.076 . . . . 74.42 112.716 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.2 tpp -62.39 -53.11 59.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.007 0.432 . . . . 74.44 112.041 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.78 -82.13 0.85 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.736 -0.745 . . . . 75.23 112.973 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.97 59.48 0.11 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.732 -0.747 . . . . 52.02 113.65 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.435 ' HE1' ' HA ' ' A' ' 12' ' ' THR . 11.4 m0 -62.27 170.12 2.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.299 0.571 . . . . 74.42 112.245 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.56 114.06 15.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.182 0.515 . . . . 75.4 110.801 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -95.51 113.19 24.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.044 -0.525 . . . . 75.2 111.184 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.677 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 2.1 mp -90.44 109.82 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.749 0.309 . . . . 61.24 110.642 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.01 104.45 16.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.116 0.484 . . . . 75.23 111.559 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 100' ' ' VAL . 24.3 mtpp -92.73 166.14 12.6 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.283 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 49' ' ' GLY . 10.2 tt -164.51 -53.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.384 0.513 . . . . 73.34 112.384 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.428 ' N ' HG21 ' A' ' 48' ' ' ILE . . . -174.43 128.16 1.41 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.175 -0.536 . . . . 51.53 112.337 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.07 -69.24 0.16 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.156 0.582 . . . . 74.2 111.995 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -115.96 -174.04 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.733 0.301 . . . . 75.52 111.294 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.5 p -163.6 157.01 18.93 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.878 0.37 . . . . 71.25 111.722 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.748 HG12 ' HG3' ' A' ' 91' ' ' GLN . 7.3 p -138.38 147.17 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.172 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.586 ' HB3' HG13 ' A' ' 45' ' ' ILE . 89.2 p -112.86 161.75 16.6 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.088 0.471 . . . . 71.33 111.969 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 68.6 t80 -136.46 130.1 32.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.285 -0.416 . . . . 74.45 111.446 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -96.9 144.67 26.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.151 0.5 . . . . 71.34 111.509 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -93.55 179.85 5.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.166 0.507 . . . . 71.01 111.979 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -138.42 155.76 48.19 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.061 -0.518 . . . . 70.14 111.431 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 m -82.38 87.6 6.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.459 -0.337 . . . . 73.15 111.538 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.504 ' NH2' ' HD2' ' A' ' 83' ' ' PRO . 8.9 ptm180 -141.75 7.49 1.88 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.322 0.49 . . . . 71.34 112.322 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -163.9 148.03 10.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.968 0.413 . . . . 72.02 111.643 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.44 131.17 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.224 -0.444 . . . . 41.12 110.86 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.3 106.54 10.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.055 0.455 . . . . 70.13 111.636 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.89 164.74 26.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.173 0.511 . . . . 71.45 111.531 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.4 113.05 3.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.851 0.358 . . . . 61.03 111.11 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.82 8.57 61.88 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.424 -0.417 . . . . 62.04 113.04 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -86.11 122.49 30.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.181 0.515 . . . . 72.44 111.866 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.531 HG21 ' HG3' ' A' ' 30' ' ' LYS . 81.3 p -93.35 150.76 20.23 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.307 -0.406 . . . . 73.34 111.299 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 29' ' ' LEU . 7.7 p -135.87 124.39 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.283 0.563 . . . . 65.21 110.945 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 29.4 m -103.82 127.69 51.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.088 -0.505 . . . . 74.12 111.778 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mm -99.38 99.74 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.776 0.322 . . . . 73.03 111.098 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -83.58 119.77 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.502 -0.317 . . . . 75.33 111.208 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -74.65 82.23 2.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.587 0.588 . . . . 74.54 112.587 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 60.66 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.605 0.965 . . . . 74.14 113.605 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -71.39 90.18 0.95 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.194 0.521 . . . . 42.04 111.269 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -133.03 -39.94 0.94 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.658 0.614 . . . . 64.35 112.658 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.7 -29.74 6.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.193 -0.527 . . . . 51.04 112.589 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 79' ' ' THR . 43.8 t -66.67 159.34 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 122.799 0.44 . . . . 73.13 111.223 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 78' ' ' VAL . 53.8 m -52.26 129.56 28.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.853 0.359 . . . . 74.44 111.834 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.55 111.05 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.315 0.487 . . . . 71.34 112.315 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.482 ' H ' HD12 ' A' ' 87' ' ' ILE . 67.4 m 67.25 71.45 0.43 Allowed Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 113.429 0.9 . . . . 61.3 113.429 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.741 ' HB3' HG21 ' A' ' 84' ' ' THR . 86.2 Cg_exo -51.1 167.16 0.33 Allowed 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.741 2.961 . . . . 70.4 111.788 168.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.504 ' HD2' ' NH2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 13.41 60.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 N-CA-C 122.017 3.814 . . . . 52.43 122.017 38.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 82' ' ' PRO . 9.3 t 153.68 -52.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.885 1.674 . . . . 75.23 109.985 161.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.601 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 17.9 m-20 -136.27 -161.45 1.16 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.474 0.71 . . . . 63.22 109.353 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.1 mt -142.09 144.16 33.41 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.734 -0.604 . . . . 71.0 112.077 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 81' ' ' SER . 1.8 mp -106.55 123.96 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.066 0.46 . . . . 73.04 111.029 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.7 t90 -69.14 91.04 0.49 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.425 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -80.56 20.41 0.72 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.792 0.664 . . . . 72.02 112.792 -175.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.426 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.8 m120 -128.91 -0.06 5.33 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.008 -0.433 . . . . 74.21 112.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.748 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -161.11 127.47 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.74 0.305 . . . . 75.33 110.492 -172.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.6 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 2.8 m-20 -87.34 172.78 9.59 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.982 0.734 . . . . 64.25 112.982 -173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 t -47.27 125.78 8.46 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.103 -0.498 . . . . 64.05 111.419 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -92.7 -30.98 15.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.531 0.567 . . . . 75.32 112.531 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 73.31 102.49 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.768 -0.73 . . . . 72.41 112.072 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.4 t -79.83 28.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.183 0.808 . . . . 60.21 113.183 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.84 -39.48 62.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.87 -0.892 . . . . 55.22 110.87 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -87.63 123.97 33.04 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.487 -0.56 . . . . 73.14 109.487 166.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -52.63 101.63 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.375 0.607 . . . . 73.44 112.536 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 47' ' ' LYS . 7.4 p -71.96 140.38 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.475 -0.784 . . . . 62.51 111.657 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -124.92 117.16 23.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.151 -0.477 . . . . 74.1 110.925 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 17' ' ' ILE . 60.4 t -99.83 123.69 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.111 0.481 . . . . 74.51 112.049 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.677 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 25.1 mm -105.29 116.89 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.037 -0.529 . . . . 70.35 110.95 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.79 107.8 19.81 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.877 0.37 . . . . 53.41 111.847 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.42 139.32 49.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.904 0.383 . . . . 73.34 111.147 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.3 m120 -63.81 174.53 1.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.297 0.57 . . . . 72.51 112.236 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 m -56.87 -28.02 61.22 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.695 -0.684 . . . . 72.42 112.382 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.53 21.41 14.35 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.934 0.716 . . . . 73.23 112.934 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.88 5.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.949 -0.643 . . . . 43.41 114.552 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.9 pt-20 -53.9 150.47 7.65 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.067 0.433 . . . . 74.35 111.348 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.51 136.11 48.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.129 0.789 . . . . 75.14 113.129 -169.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.28 -55.23 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.131 -0.486 . . . . 63.31 111.722 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.19 170.26 21.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 74.33 112.162 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -152.83 134.54 14.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.891 -0.595 . . . . 71.4 111.149 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -144.92 150.58 37.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.796 0.331 . . . . 74.25 111.428 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.6 p -126.49 -178.84 4.5 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 73.44 111.576 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.5 p -80.01 -176.41 5.49 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.223 0.535 . . . . 72.32 111.649 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.67 134.11 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.112 -0.495 . . . . 73.31 110.954 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -64.19 91.65 0.07 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.025 0.441 . . . . 75.31 111.728 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -141.08 151.97 44.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.927 0.394 . . . . 72.13 111.167 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -69.25 170.7 9.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.236 -0.438 . . . . 62.54 111.512 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.252 1.23 0 CA-C-N 116.398 -0.364 . . . . 72.11 111.898 -178.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.57 0.224 . . . . 53.31 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.4 99.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.105 -0.569 . . . . 41.22 112.893 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -62.68 -9.35 8.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.893 0.701 . . . . 74.13 112.893 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -57.63 119.98 7.53 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.934 0.397 . . . . 71.23 110.887 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -97.44 128.51 44.28 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.511 0.56 . . . . 72.4 112.511 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -78.67 114.99 18.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.989 -0.551 . . . . 74.33 111.237 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -98.97 134.14 42.24 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.582 0.23 . . . . 71.43 111.486 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -57.52 90.68 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.293 0.568 . . . . 73.03 111.458 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.5 p -126.72 -169.68 2.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.275 -0.421 . . . . 75.25 111.672 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -96.74 123.37 40.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.429 . . . . 61.1 111.283 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.506 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 26.3 mmt -83.26 112.59 20.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.065 0.46 . . . . 72.12 110.965 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 p -90.03 10.22 24.99 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.976 0.732 . . . . 72.03 112.976 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.77 88.55 0.46 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.226 -0.511 . . . . 72.55 113.545 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -68.16 81.0 0.23 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.972 0.415 . . . . 72.54 111.466 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 29' ' ' LEU . 39.7 t -98.89 109.57 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.057 0.456 . . . . 64.44 111.888 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 52.8 t -107.63 173.18 6.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.42 -0.355 . . . . 74.43 110.663 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 62.4 mt -88.97 119.79 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.951 -0.468 . . . . 63.12 111.766 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.54 -48.43 22.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.85 0.357 . . . . 75.4 110.537 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.47 153.36 28.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.119 0.414 . . . . 71.42 112.119 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG21 HG12 ' A' ' 27' ' ' ILE . 47.0 mt -119.94 126.15 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.427 -0.351 . . . . 71.41 110.193 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.86 143.91 54.4 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.739 0.644 . . . . 70.23 112.739 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.57 -19.15 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.778 -0.646 . . . . 61.54 111.339 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.65 -39.03 92.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.096 0.474 . . . . 70.41 110.409 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.97 23.82 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.911 -0.586 . . . . 63.11 113.371 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -112.53 -63.07 1.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.391 0.885 . . . . 72.23 113.391 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.5 154.02 37.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.725 1.38 . . . . 73.02 114.725 -166.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.449 HD12 HG21 ' A' ' 102' ' ' VAL . 65.6 mt -123.51 110.72 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.166 -0.924 . . . . 73.52 109.381 171.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 36.1 ttm180 -92.06 116.63 29.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.119 0.785 . . . . 75.54 113.119 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 7.7 mp -96.59 179.94 4.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.011 -0.541 . . . . 74.23 111.163 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -165.1 123.14 1.63 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.647 0.26 . . . . 75.21 111.423 -171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.642 ' HB2' HD22 ' A' ' 63' ' ' LEU . 32.6 t30 -74.07 95.37 2.53 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.013 0.435 . . . . 75.44 111.402 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 p -82.32 87.74 6.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.226 0.536 . . . . 74.01 111.317 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.7 p -155.67 175.48 13.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.086 -0.506 . . . . 74.24 111.249 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.71 3.87 37.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.396 0.517 . . . . 51.44 112.396 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.53 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 52.9 tt0 -149.42 153.58 37.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.651 0.263 . . . . 63.25 111.482 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.81 117.25 4.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.904 0.383 . . . . 72.4 110.998 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 24.7 mm-40 -115.7 164.07 18.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 122.311 -0.243 . . . . 71.22 111.477 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.0 144.86 27.54 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.19 1.926 . . . . 74.12 111.152 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.1 tpt -52.42 -56.82 12.46 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.722 0.296 . . . . 74.43 111.651 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.506 ' HA2' ' HG3' ' A' ' 11' ' ' MET . . . 105.08 148.51 17.79 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.925 -0.655 . . . . 73.0 114.064 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.69 58.88 4.97 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.397 -0.43 . . . . 72.0 112.915 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.79 169.45 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.708 0.29 . . . . 72.54 110.761 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.57 124.3 21.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.261 0.553 . . . . 75.13 111.433 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.558 ' HE2' HG22 ' A' ' 71' ' ' ILE . 55.6 ttp -93.13 108.25 19.88 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.751 -0.659 . . . . 75.12 111.387 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD11 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -97.18 115.54 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.706 0.288 . . . . 75.21 110.758 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -84.35 97.19 9.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.781 0.324 . . . . 64.43 111.223 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -94.69 131.82 40.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.236 0.541 . . . . 64.33 111.677 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -150.22 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.708 0.765 . . . . 73.01 111.079 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.67 -61.67 0.55 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.036 -0.529 . . . . 64.1 113.562 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -82.57 -66.43 0.89 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.398 -0.472 . . . . 73.31 112.232 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -95.86 173.43 7.45 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.132 0.491 . . . . 65.54 112.185 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -145.37 33.03 1.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.003 -0.544 . . . . 70.34 111.371 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.93 127.72 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.295 0.569 . . . . 74.01 111.998 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 44' ' ' MET . 82.8 p -114.54 177.7 4.55 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.489 0.662 . . . . 63.41 112.772 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.514 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 69.6 t80 -152.99 108.39 3.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.492 -0.776 . . . . 73.42 111.193 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.597 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 4.8 ttmp? -78.83 121.17 24.47 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.803 -0.443 . . . . 72.24 109.803 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.09 124.46 23.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.893 0.701 . . . . 73.44 112.893 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -72.27 85.23 1.07 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.478 0.656 . . . . 71.4 111.454 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.9 t -71.93 72.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.374 0.607 . . . . 53.22 111.217 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 16.4 ptt180 -102.68 5.19 38.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.799 -0.637 . . . . 71.33 112.152 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 51.3 p90 -158.37 165.53 34.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.886 0.374 . . . . 74.35 111.529 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.58 143.35 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.069 0.462 . . . . 62.4 111.792 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.642 HD22 ' HB2' ' A' ' 31' ' ' ASN . 18.9 tp -108.95 124.38 50.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.125 0.488 . . . . 64.23 111.06 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.93 164.89 16.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.639 0.607 . . . . 73.11 112.639 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.82 124.46 24.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.188 -0.46 . . . . 65.31 111.421 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.94 7.34 83.9 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.31 -0.471 . . . . 61.33 113.152 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.47 132.74 45.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.999 0.428 . . . . 75.03 111.585 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.1 p -92.93 99.56 12.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.087 -0.506 . . . . 53.43 111.919 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.11 113.64 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.353 0.596 . . . . 64.34 110.639 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 21.0 m -99.86 131.81 45.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.963 0.411 . . . . 65.34 112.002 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.558 HG22 ' HE2' ' A' ' 44' ' ' MET . 44.2 mm -93.2 99.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.111 -0.495 . . . . 71.11 111.051 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.467 ' HB2' HG13 ' A' ' 87' ' ' ILE . 65.1 m95 -90.1 120.43 31.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.466 -0.334 . . . . 73.4 111.098 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -55.33 153.75 6.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.974 0.361 . . . . 70.0 111.974 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.33 -42.56 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.969 0.729 . . . . 75.32 112.969 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.9 OUTLIER -93.71 43.18 1.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.101 0.477 . . . . 70.22 111.952 -178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.81 -4.38 43.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.793 0.33 . . . . 72.13 111.694 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.02 -49.94 3.85 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.34 -0.457 . . . . 62.13 113.541 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.01 146.39 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 122.646 0.378 . . . . 74.22 111.999 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 81' ' ' SER . 92.3 m -54.63 132.19 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.813 0.339 . . . . 72.44 111.641 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.16 -25.04 20.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.38 0.881 . . . . 62.1 113.38 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.502 ' H ' HG21 ' A' ' 79' ' ' THR . 9.3 t -132.72 82.81 55.11 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 120.859 0.361 . . . . 52.32 110.892 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.513 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 52.7 Cg_exo -53.36 -47.65 26.25 Favored 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 123.372 2.715 . . . . 73.44 115.283 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.513 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 43.0 Cg_endo -103.31 25.77 12.26 Favored 'Cis proline' 0 C--N 1.364 1.391 0 CA-C-N 120.974 1.384 . . . . 70.23 114.501 -0.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.492 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 8.8 t -56.74 -34.28 67.37 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.905 0.383 . . . . 75.43 111.743 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -113.35 173.0 6.62 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.363 -0.381 . . . . 72.01 110.33 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 98.3 mt -122.4 126.36 47.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.368 . . . . 65.33 111.236 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 72' ' ' TRP . 1.7 mp -91.95 124.92 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.479 0.657 . . . . 71.13 112.042 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.514 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 7.9 t90 -74.56 80.44 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.692 -0.685 . . . . 72.4 110.573 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -67.14 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.979 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.473 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.9 m120 -74.11 -12.02 60.48 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -148.52 140.29 23.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.12 0.486 . . . . 72.05 111.697 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 92' ' ' ASN . 0.8 OUTLIER -80.66 -171.48 3.13 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.578 -0.283 . . . . 74.22 110.919 174.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.9 p -73.48 129.53 38.18 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.002 -0.436 . . . . 72.54 110.687 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -90.65 142.29 27.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.258 0.551 . . . . 73.11 112.194 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.03 23.86 24.48 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.095 -0.502 . . . . 62.42 112.654 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.0 p -79.4 127.98 32.78 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.223 0.453 . . . . 61.12 112.223 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.3 -10.15 66.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.431 -0.414 . . . . 71.53 113.33 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.64 156.07 39.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.799 0.333 . . . . 74.53 111.309 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.92 89.18 0.28 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.54 0.686 . . . . 62.12 111.198 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.17 117.56 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.918 -0.583 . . . . 71.1 110.812 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.857 ' HB2' ' HZ2' ' A' ' 101' ' ' LYS . 3.2 ttmp? -103.51 99.1 8.91 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.463 0.649 . . . . 72.15 110.925 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 27' ' ' ILE . 80.0 t -82.09 132.88 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.376 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.46 HG22 ' HE2' ' A' ' 105' ' ' LYS . 38.0 mm -112.42 133.67 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.123 -0.489 . . . . 74.43 111.514 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.408 HD11 HG13 ' A' ' 17' ' ' ILE . 87.5 mt -112.5 110.12 20.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.692 0.282 . . . . 74.32 111.058 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.46 ' HE2' HG22 ' A' ' 103' ' ' ILE . 66.8 mttm -120.36 159.32 25.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 70.22 112.308 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 1.4 m-20 -95.71 -179.27 4.67 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.546 -0.752 . . . . 65.44 111.996 -176.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -61.13 -19.54 61.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.869 -0.605 . . . . 63.14 112.336 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -102.83 17.09 24.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.214 0.45 . . . . 73.41 112.214 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.03 5.36 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.117 -0.563 . . . . 60.33 113.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 15.0 pt-20 -58.68 159.43 6.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.575 0.35 . . . . 61.12 111.162 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 105' ' ' LYS . 35.4 tt0 -121.91 127.43 50.42 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.437 0.532 . . . . 74.14 112.437 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -33.81 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.297 0.481 . . . . 62.42 112.297 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.18 149.73 17.79 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.753 0.649 . . . . 53.42 112.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -146.89 141.29 26.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.67 -0.695 . . . . 74.23 110.19 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 115' ' ' ARG . 31.4 ttt180 -154.67 156.71 36.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.019 -0.426 . . . . 54.32 112.038 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 83.9 p -125.63 170.13 11.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.913 0.387 . . . . 70.13 111.516 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.9 p -72.72 159.22 34.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.222 0.534 . . . . 72.52 111.896 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -76.8 89.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.306 0.574 . . . . 73.42 111.001 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -69.83 -25.25 63.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.959 -0.564 . . . . 75.33 111.407 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.692 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 0.5 OUTLIER -101.9 96.38 7.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 60.12 111.34 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.0 p -80.61 154.56 27.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.485 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.253 1.289 0 CA-C-N 116.302 -0.408 . . . . 72.35 112.033 -179.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.378 0.132 . . . . 72.54 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.11 77.95 0.06 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.399 -0.905 . . . . 51.43 114.394 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -146.85 101.65 3.46 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.236 -0.567 . . . . 74.44 110.95 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -97.87 14.16 28.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.86 0.689 . . . . 70.13 112.86 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.9 t60 62.26 21.18 12.31 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.395 0.517 . . . . 72.43 112.395 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.26 -174.17 5.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.886 -0.509 . . . . 61.53 112.029 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.4 t60 74.87 26.46 1.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.488 0.715 . . . . 73.4 111.847 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -64.2 148.66 49.56 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.99 -0.55 . . . . 72.24 111.519 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 t -63.44 177.15 0.71 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.51 0.559 . . . . 73.25 112.51 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -111.56 142.92 43.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.507 . . . . 75.21 111.787 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.544 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 25.7 mmt -84.77 108.99 17.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.237 -0.438 . . . . 64.12 111.963 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 t -76.83 -31.53 56.95 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.501 0.556 . . . . 45.14 112.501 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.52 -169.53 17.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.98 -0.629 . . . . 62.54 113.818 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.85 108.73 2.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 64.15 110.757 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.99 133.03 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.743 0.306 . . . . 73.23 111.201 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.07 159.13 40.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.8 0.333 . . . . 74.34 111.591 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 HD11 ' A' ' 104' ' ' LEU . 71.7 mt -82.29 116.99 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.926 0.393 . . . . 62.32 111.75 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -80.61 -50.23 10.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.019 0.437 . . . . 73.54 111.305 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -161.92 151.91 16.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.202 0.525 . . . . 74.4 111.451 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.759 ' HB ' HG22 ' A' ' 117' ' ' THR . 59.6 mt -115.47 149.22 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.579 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.86 144.51 44.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.067 0.461 . . . . 70.03 112.119 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -32.19 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.18 -0.464 . . . . 72.31 112.027 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.8 -47.3 13.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.98 0.419 . . . . 73.14 110.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.4 23.24 1.4 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.03 -0.532 . . . . 55.23 113.487 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -90.31 -27.89 19.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.453 0.909 . . . . 74.44 113.453 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -151.8 160.31 43.61 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.694 0.998 . . . . 74.45 113.694 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.678 HG21 HG12 ' A' ' 20' ' ' ILE . 70.0 mt -125.98 120.76 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.469 -0.787 . . . . 72.01 110.366 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -93.38 114.38 26.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.845 0.683 . . . . 71.03 112.845 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -100.92 165.21 11.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.268 172.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -151.41 139.59 20.23 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.066 0.46 . . . . 75.32 112.093 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -88.12 145.53 25.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.919 -0.582 . . . . 60.32 110.88 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -119.33 8.24 11.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.462 0.541 . . . . 63.23 112.462 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.424 ' HG ' ' HG2' ' A' ' 37' ' ' GLN . 87.0 p -81.58 155.5 25.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.34 0.59 . . . . 74.24 112.049 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.9 7.65 17.5 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.992 -0.549 . . . . 71.4 111.947 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.8 156.21 42.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.659 0.266 . . . . 72.21 111.498 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.58 106.11 2.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.443 -0.344 . . . . 63.32 111.025 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' HB3' ' A' ' 11' ' ' MET . 10.2 mm100 -106.13 144.74 29.56 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.699 -0.228 . . . . 64.1 111.326 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.37 156.03 18.55 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.353 2.035 . . . . 74.21 112.948 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.663 ' HE1' ' HA ' ' A' ' 39' ' ' MET . 4.2 tpt -60.23 -29.24 68.62 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.978 0.418 . . . . 36.98 111.926 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.08 176.86 49.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.373 -0.441 . . . . 73.51 113.559 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 52.63 0.67 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.354 -0.451 . . . . 62.0 112.709 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -98.72 172.36 7.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.554 0.216 . . . . 74.04 110.856 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -137.35 137.3 38.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.316 0.579 . . . . 75.11 111.492 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.405 ' HE1' HG13 ' A' ' 71' ' ' ILE . 55.2 ttp -105.39 122.75 46.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.87 -0.605 . . . . 64.22 111.417 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.2 mp -104.79 124.29 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.888 0.375 . . . . 72.15 111.407 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.651 ' HB2' ' HH2' ' A' ' 88' ' ' TRP . 34.7 ttt180 -90.87 123.16 34.18 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.278 -0.264 . . . . 73.4 111.671 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -116.58 105.53 12.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 64.41 110.831 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.16 -23.43 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.284 0.564 . . . . 73.22 110.789 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -94.8 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.035 -0.529 . . . . 71.32 112.345 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.86 -41.0 11.43 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.691 0.281 . . . . 72.4 111.384 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.3 t -92.72 147.97 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.162 0.506 . . . . 72.1 111.792 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p -140.96 168.88 18.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.082 0.468 . . . . 73.12 111.6 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -162.17 141.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.537 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -115.58 159.72 20.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.539 0.685 . . . . 74.24 112.782 -174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 84.0 t80 -144.44 115.27 7.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.642 -0.708 . . . . 71.03 110.597 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -86.85 140.39 29.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.189 0.519 . . . . 75.21 111.583 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' HE2' HD11 ' A' ' 71' ' ' ILE . 89.2 m-85 -87.56 145.41 26.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 73.51 111.489 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.8 t -121.55 130.1 53.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.949 0.404 . . . . 62.44 111.659 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 67.8 m -73.92 74.68 1.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.162 0.506 . . . . 74.12 111.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -97.76 -2.24 41.56 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.532 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -168.76 172.83 7.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.617 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.06 126.32 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.14 0.495 . . . . 72.42 111.652 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -74.38 119.56 18.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.232 -0.655 . . . . 75.13 109.232 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 66.0 mttm -62.37 158.75 16.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.825 0.676 . . . . 64.12 112.825 -172.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.21 113.88 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.658 -0.701 . . . . 74.43 112.006 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.66 21.4 72.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.463 -0.398 . . . . 45.14 114.029 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -86.35 149.24 25.17 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.148 0.499 . . . . 73.25 111.844 -178.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.1 p -92.45 145.2 24.64 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.178 -0.465 . . . . 75.11 111.557 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 63' ' ' LEU . 7.0 p -134.49 122.29 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.91 0.386 . . . . 62.13 110.391 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -103.1 137.33 41.42 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.253 0.549 . . . . 74.42 112.102 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.442 HD12 ' HB2' ' A' ' 86' ' ' LEU . 43.5 mm -95.4 108.85 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.214 -0.448 . . . . 63.04 110.782 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -97.35 136.22 38.12 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.544 0.212 . . . . 71.12 110.659 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.31 158.11 18.11 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.086 0.402 . . . . 64.14 112.086 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 89' ' ' LYS . . . -47.09 -44.92 21.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.594 0.59 . . . . 73.02 112.594 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 93' ' ' SER . 2.0 m-20 -95.84 74.5 3.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.161 0.505 . . . . 73.42 111.511 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.9 3.15 8.77 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.08 -0.509 . . . . 73.41 111.188 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.62 17.32 64.52 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.309 -0.405 . . . . 74.44 113.651 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.39 171.5 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.152 0.501 . . . . 73.1 112.317 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -82.2 164.4 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.999 -0.546 . . . . 62.02 112.207 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.54 89.89 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.359 -0.382 . . . . 63.42 111.717 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 t 59.83 81.36 0.25 Allowed Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.508 . . . . 52.12 111.342 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.453 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 89.0 Cg_exo -45.23 -51.45 7.75 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.222 2.615 . . . . 65.13 115.365 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 48.6 Cg_endo -100.13 149.35 4.15 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 121.011 1.397 . . . . 70.51 114.008 -1.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 t -171.02 -38.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.259 -0.882 . . . . 44.31 108.892 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -123.21 156.76 34.49 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.838 -1.074 . . . . 72.44 109.308 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' A' ' 71' ' ' ILE . 93.3 mt -104.8 141.65 36.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.026 0.441 . . . . 74.4 111.961 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.5 mp -95.14 121.85 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.313 0.578 . . . . 75.11 111.343 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HH2' ' HB2' ' A' ' 46' ' ' ARG . 4.9 t90 -89.66 84.0 6.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.939 -0.573 . . . . 73.51 110.463 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 48.8 mtmt -74.61 -16.41 60.79 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.187 0.44 . . . . 73.44 112.187 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.541 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 0.9 OUTLIER -65.9 -15.86 63.33 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.79 0.328 . . . . 71.42 111.523 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -148.69 139.01 22.48 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 72.22 111.103 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -72.72 -177.17 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.035 0.445 . . . . 73.45 111.231 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 40.4 t -77.69 142.92 38.51 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.226 -0.297 . . . . 73.15 111.486 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -125.85 157.71 36.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.953 0.406 . . . . 73.14 111.234 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.92 141.75 7.27 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.93 -0.652 . . . . 61.33 112.819 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 t 176.46 -27.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.983 0.364 . . . . 73.21 111.983 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 30.11 20.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.039 -0.6 . . . . 45.24 113.564 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.58 144.08 28.28 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.005 0.402 . . . . 71.12 110.757 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.2 m-20 -64.52 99.32 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.172 0.511 . . . . 74.43 112.15 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.36 127.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.578 . . . . 62.22 111.072 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 19.2 ttpp -104.26 119.53 39.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.188 0.518 . . . . 74.23 111.336 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.1 t -108.71 147.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.132 0.491 . . . . 74.54 112.015 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 mm -116.95 126.49 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.094 -0.503 . . . . 75.42 111.591 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.58 HD11 HG13 ' A' ' 17' ' ' ILE . 66.3 mt -110.58 106.71 16.08 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.702 0.287 . . . . 74.32 111.697 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -120.52 140.82 50.91 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.323 0.583 . . . . 74.21 111.731 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.506 ' OD1' HG11 ' A' ' 112' ' ' VAL . 12.4 m120 -80.77 179.68 7.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.739 -0.664 . . . . 73.12 112.343 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.5 p -54.48 -49.24 70.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.561 -0.745 . . . . 63.01 112.345 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.56 -4.32 22.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.78 0.659 . . . . 71.15 112.78 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.35 -16.75 60.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.047 -0.597 . . . . 70.23 113.468 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.76 143.95 55.62 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.456 -0.438 . . . . 74.31 110.72 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -103.06 130.47 50.21 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.6 0.592 . . . . 74.24 112.6 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.506 HG11 ' OD1' ' A' ' 106' ' ' ASN . 16.0 m -76.7 -45.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.765 -0.198 . . . . 65.11 111.194 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -176.67 133.7 0.21 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.516 0.561 . . . . 64.33 112.516 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.28 141.9 35.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.526 -0.546 . . . . 64.2 109.526 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -155.61 146.91 22.68 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.407 0.521 . . . . 60.23 112.407 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 79.1 p -109.56 169.98 8.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.005 0.431 . . . . 36.98 111.306 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.759 HG22 ' HB ' ' A' ' 20' ' ' ILE . 62.3 p -71.91 164.81 25.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.152 0.501 . . . . 71.42 112.106 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.09 117.12 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.051 -0.522 . . . . 62.43 110.65 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -82.16 114.67 20.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.918 0.39 . . . . 75.4 111.538 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 mttp -80.45 108.3 13.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.286 -0.415 . . . . 65.24 110.806 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.5 p -76.74 106.5 8.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.925 0.393 . . . . 61.53 111.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.253 1.268 0 N-CA-C 112.187 0.44 . . . . 75.32 112.187 -178.597 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.513 0.197 . . . . 61.14 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.45 146.14 48.29 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.185 -0.531 . . . . 72.43 113.39 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -127.69 22.34 6.38 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.373 0.508 . . . . 73.44 112.373 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -130.51 109.6 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.835 0.35 . . . . 72.3 111.179 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -87.35 -63.3 1.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.92 0.391 . . . . 73.04 111.662 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -107.14 120.46 42.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.265 0.555 . . . . 75.11 111.367 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -134.87 111.36 9.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.664 -0.698 . . . . 65.43 110.497 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -137.73 156.49 47.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.672 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -47.14 125.39 7.69 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.823 0.344 . . . . 63.1 111.593 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.79 137.22 56.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.922 1.082 . . . . 75.43 113.922 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.2 mmt -144.84 157.63 44.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.721 -1.127 . . . . 75.11 109.613 170.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -67.12 -43.82 81.47 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.193 0.442 . . . . 42.22 112.193 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.62 81.35 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.163 -0.542 . . . . 73.01 112.515 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 11.9 m120 -76.84 47.69 0.53 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.243 0.46 . . . . 71.34 112.243 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.53 97.75 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.209 0.528 . . . . 61.33 110.878 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 p -112.54 158.67 19.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.365 -0.38 . . . . 65.21 111.416 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.697 HG13 HD12 ' A' ' 104' ' ' LEU . 72.2 mt -62.11 135.73 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.734 -0.212 . . . . 44.33 111.037 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 33.0 tt0 -90.56 -69.25 0.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 74.21 110.26 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.85 138.66 22.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.408 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.735 HG23 HG12 ' A' ' 27' ' ' ILE . 56.4 mt -101.53 141.77 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.375 -0.375 . . . . 70.2 110.907 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.0 150.15 35.85 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.368 0.604 . . . . 74.13 112.419 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 119' ' ' PHE . 7.4 p -89.37 -31.43 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.302 -0.863 . . . . 62.54 112.569 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.45 -32.15 66.04 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.134 0.492 . . . . 73.12 111.238 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 108.96 34.04 2.66 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.133 -0.485 . . . . 63.05 112.303 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.74 -53.13 3.98 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.416 0.524 . . . . 71.53 112.416 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.39 165.65 35.12 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.834 1.05 . . . . 64.53 113.834 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 20' ' ' ILE . 64.7 mt -129.05 106.44 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.889 -1.05 . . . . 61.53 109.612 172.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -91.66 124.66 35.97 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.85 -0.531 . . . . 72.15 112.343 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 8.0 mp -93.49 -177.28 4.36 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.12 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 61.6 tttp -162.66 119.9 2.0 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.793 0.294 . . . . 73.01 111.793 -174.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.505 ' HB2' HD11 ' A' ' 63' ' ' LEU . 38.5 t30 -90.24 110.43 21.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.609 0.243 . . . . 70.34 111.032 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.6 p -96.65 13.53 27.99 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.369 0.507 . . . . 74.21 112.369 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 29.5 t -79.54 157.6 27.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.288 0.566 . . . . 63.52 112.438 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.61 -13.72 59.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.797 -0.638 . . . . 65.32 110.741 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -115.64 149.26 38.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.191 0.52 . . . . 62.03 111.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.17 108.83 5.56 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.101 -0.5 . . . . 72.21 110.141 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -91.2 119.68 68.68 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.384 0.512 . . . . 53.0 112.384 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.87 136.11 47.45 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.269 1.979 . . . . 65.01 111.844 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.692 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.0 tpt -59.39 -41.53 89.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.21 0.448 . . . . 65.21 112.21 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.27 -67.12 1.21 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.375 -0.441 . . . . 70.34 113.494 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.78 78.52 0.02 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 62.32 112.855 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -98.9 179.96 4.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.73 0.3 . . . . 74.23 111.067 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.42 130.44 11.83 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.522 0.677 . . . . 72.35 111.236 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 54' ' ' SER . 52.2 ttp -99.35 111.39 23.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.808 -0.633 . . . . 55.03 111.416 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.7 mp -89.68 141.6 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.668 0.27 . . . . 75.54 110.631 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -138.17 126.25 22.8 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.939 -0.475 . . . . 73.11 111.621 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -111.97 145.38 39.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 74.34 111.179 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.99 -41.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.062 0.458 . . . . 73.54 111.923 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.15 103.62 0.17 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.146 -0.55 . . . . 63.24 112.369 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 72.47 -36.51 0.36 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.457 0.703 . . . . 64.03 112.616 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -113.84 148.54 36.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.902 0.382 . . . . 73.21 111.457 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.1 p -137.02 143.43 42.73 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.338 -0.392 . . . . 75.2 111.023 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.5 147.38 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 63.24 111.031 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 44' ' ' MET . 97.9 p -131.77 150.32 52.19 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.067 0.461 . . . . 61.12 111.971 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 33.1 t80 -122.6 120.5 33.93 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.36 -0.382 . . . . 73.15 111.297 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.69 129.32 34.85 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.965 0.412 . . . . 73.35 111.649 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.477 ' HB3' ' SD ' ' A' ' 39' ' ' MET . 86.4 m-85 -88.67 122.59 32.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.311 -0.404 . . . . 64.41 111.659 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.9 t -81.91 140.57 33.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.639 0.607 . . . . 72.45 112.639 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 98.9 p -86.05 18.44 3.06 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.17 0.433 . . . . 72.52 112.17 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.469 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 14.4 ptm180 -68.85 -9.8 53.37 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.757 0.651 . . . . 72.01 112.757 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.469 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 48.6 p90 -152.63 168.44 25.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.279 0.562 . . . . 75.2 112.043 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.57 140.71 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.682 -0.69 . . . . 72.12 111.455 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -92.95 100.61 13.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.33 -0.619 . . . . 64.45 109.33 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.61 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 8.4 mtpm? -69.69 163.24 26.08 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.384 0.883 . . . . 75.41 113.384 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.57 122.53 17.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.834 -0.621 . . . . 75.2 111.171 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.34 86.72 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.944 -0.646 . . . . 72.05 113.473 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.603 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -89.37 133.9 34.31 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.462 -0.434 . . . . 75.23 111.041 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.9 p -116.07 100.68 8.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.316 -0.402 . . . . 64.25 111.821 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.67 132.17 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.927 0.394 . . . . 74.14 111.206 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 m -101.2 124.23 46.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.826 0.346 . . . . 71.34 111.694 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 40.7 mm -89.39 96.2 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.91 0.386 . . . . 54.42 110.985 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' TRP . 94.3 m95 -83.05 133.9 35.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.684 0.253 . . . . 75.24 111.684 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 163.3 11.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.038 0.447 . . . . 63.34 111.964 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.35 -21.08 3.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.07 0.767 . . . . 61.24 113.07 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.511 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.8 OUTLIER -86.97 16.47 4.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.106 0.41 . . . . 75.52 112.106 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.94 78.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.051 0.453 . . . . 73.15 111.501 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.36 -26.85 3.34 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.424 -0.417 . . . . 73.31 113.686 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.26 163.57 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.981 0.42 . . . . 74.53 111.98 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -78.13 143.6 37.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.064 0.459 . . . . 75.22 111.662 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.0 78.12 3.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.024 0.44 . . . . 65.42 111.199 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -136.47 95.07 13.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.503 -0.317 . . . . 70.35 111.684 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.427 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 13.4 Cg_exo -72.72 178.17 6.67 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.248 2.632 . . . . 75.54 112.278 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 98.6 Cg_endo -99.9 118.82 1.01 Allowed 'Cis proline' 0 C--N 1.361 1.22 0 N-CA-C 114.544 0.94 . . . . 73.13 114.544 -0.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.553 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.9 t -154.96 -56.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.97 -0.559 . . . . 71.41 109.855 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' HG23 ' A' ' 84' ' ' THR . 21.4 m-20 -141.2 176.85 8.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.779 -0.646 . . . . 65.02 109.703 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 97.0 mt -123.02 124.13 42.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.893 0.378 . . . . 74.24 110.956 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.547 HD11 ' N ' ' A' ' 87' ' ' ILE . 3.2 mp -93.99 111.56 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.167 0.508 . . . . 75.4 111.31 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 4.3 t90 -71.09 77.9 0.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.203 0.525 . . . . 74.43 110.617 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.653 ' HZ3' ' HB3' ' A' ' 89' ' ' LYS . 8.7 mtpm? -76.89 1.8 16.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.022 0.439 . . . . 72.44 111.607 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -93.57 -4.32 51.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.272 -0.422 . . . . 64.33 111.812 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -137.79 148.69 45.75 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.171 0.51 . . . . 75.13 111.457 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -91.44 -174.82 4.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.04 -0.527 . . . . 71.52 110.789 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 98.7 p -64.41 120.43 12.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.141 0.496 . . . . 74.45 111.096 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.505 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.3 p90 -77.73 118.21 19.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.239 0.542 . . . . 72.41 112.062 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.36 102.74 0.16 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.932 -0.576 . . . . 75.33 112.334 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -157.35 26.25 0.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 72.1 111.718 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -54.11 4.35 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.151 -0.547 . . . . 42.42 113.102 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.3 119.19 8.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.479 0.312 . . . . 73.21 111.194 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.04 146.2 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.676 0.621 . . . . 74.22 112.676 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.412 HG13 ' HE1' ' A' ' 119' ' ' PHE . 7.4 p -126.4 128.47 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.773 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -114.47 142.49 46.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.991 0.424 . . . . 71.14 111.751 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.82 136.91 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 116.192 -0.458 . . . . 71.11 111.996 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.73 122.91 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.024 -0.535 . . . . 74.41 111.432 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.697 HD12 HG13 ' A' ' 17' ' ' ILE . 97.9 mt -89.69 131.28 35.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.231 -0.293 . . . . 70.35 111.095 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.6 mttt -141.09 145.72 36.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.209 0.528 . . . . 53.35 112.052 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -88.31 -173.43 4.2 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.082 0.467 . . . . 74.14 111.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -51.78 -41.96 62.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.742 0.645 . . . . 70.33 112.742 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.99 -0.69 40.66 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.894 0.702 . . . . 75.13 112.894 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.1 0.59 80.51 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.896 -0.669 . . . . 37.44 112.867 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.8 138.6 57.47 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.718 0.407 . . . . 71.21 111.108 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.5 tt0 -83.59 133.15 34.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.174 0.512 . . . . 75.43 111.954 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.71 -50.53 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.964 -0.562 . . . . 71.14 111.162 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.6 163.78 16.9 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.966 -0.561 . . . . 65.23 111.58 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -137.16 136.12 37.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.241 -0.436 . . . . 71.34 111.116 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -160.63 156.25 25.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.118 0.485 . . . . 75.31 111.486 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 54.4 p -142.54 -171.94 3.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.788 0.328 . . . . 60.33 111.221 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 14.8 t -147.23 145.47 29.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.652 0.263 . . . . 73.31 110.571 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 102.16 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.004 0.43 . . . . 72.54 111.831 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.597 ' HA ' HG22 ' A' ' 22' ' ' VAL . 22.2 p90 -96.14 102.14 13.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.497 0.665 . . . . 72.24 110.842 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -134.72 160.85 36.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.418 0.628 . . . . 70.02 112.52 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.6 p -126.98 121.46 31.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.554 -0.748 . . . . 73.13 110.525 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.036 -0.983 . . . . 74.53 112.634 -174.656 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.626 0.25 . . . . 74.35 111.065 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.42 75.91 0.43 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.539 -0.363 . . . . 62.54 113.089 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -65.09 -53.33 47.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.916 0.389 . . . . 74.42 111.495 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -91.95 -25.89 18.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.119 0.485 . . . . 74.21 110.577 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.14 -20.58 66.53 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.796 -0.638 . . . . 73.14 110.884 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.8 135.34 52.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.242 0.544 . . . . 72.03 111.055 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -151.94 95.79 2.13 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.935 -0.575 . . . . 64.12 110.949 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -146.74 121.83 10.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.757 -0.656 . . . . 74.04 111.037 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 37.7 p -90.03 -179.69 5.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.555 -0.293 . . . . 54.43 111.52 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' SER . 75.8 m-70 68.9 33.09 3.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.153 0.502 . . . . 74.41 112.102 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 90.4 mmm -82.45 92.78 7.1 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.021 0.438 . . . . 73.15 110.468 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -91.38 32.19 1.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.408 0.521 . . . . 75.13 112.408 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' HA2' ' HG3' ' A' ' 37' ' ' GLN . . . -60.41 91.21 0.05 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.412 0.525 . . . . 62.1 114.412 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -107.43 96.37 6.36 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.103 0.478 . . . . 72.22 110.428 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.42 140.6 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.015 0.436 . . . . 54.0 111.873 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -137.81 164.17 29.59 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.209 -0.45 . . . . 63.31 110.705 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 17' ' ' ILE . 4.1 mp -87.49 119.44 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.22 -0.3 . . . . 72.2 111.28 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.51 -50.52 44.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.785 0.326 . . . . 70.54 111.361 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -171.31 152.79 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 60.33 112.149 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.57 HG23 HG12 ' A' ' 27' ' ' ILE . 65.3 mt -107.49 134.72 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.792 -0.64 . . . . 64.12 110.816 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.0 130.25 41.66 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.032 0.444 . . . . 72.43 111.301 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -70.18 -28.25 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.511 0.56 . . . . 74.31 112.511 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.53 -44.76 56.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.77 0.319 . . . . 74.33 110.835 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 117.02 37.97 0.91 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 116.23 -0.441 . . . . 73.44 113.236 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -104.69 -39.59 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.452 0.538 . . . . 63.51 112.452 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.75 160.46 37.9 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.353 0.871 . . . . 72.14 113.353 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 20' ' ' ILE . 69.7 mt -131.61 122.47 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.611 -0.722 . . . . 71.0 109.781 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -99.72 122.41 42.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.934 0.716 . . . . 73.44 112.934 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 104' ' ' LEU . 7.0 mp -97.3 173.72 7.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.592 -0.731 . . . . 74.33 110.587 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.6 131.6 11.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.936 0.398 . . . . 73.12 111.981 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 63' ' ' LEU . 28.4 t30 -89.87 104.36 16.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.249 -0.432 . . . . 65.45 110.968 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 t -105.72 84.11 2.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 71.45 110.887 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.6 p -136.4 -177.8 4.88 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.722 -0.672 . . . . 64.42 112.164 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.45 -22.53 35.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.909 0.707 . . . . 74.51 112.909 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -146.89 154.56 41.44 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.516 0.561 . . . . 75.12 112.516 -170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -50.36 128.15 19.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.866 -0.606 . . . . 72.41 111.569 175.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.466 ' HG3' ' HA2' ' A' ' 13' ' ' GLY . 30.1 mm-40 -121.08 119.68 29.61 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.805 0.336 . . . . 65.21 111.633 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 7.3 Cg_exo -74.8 29.9 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.12 2.547 . . . . 64.32 113.946 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.683 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 1.3 tpt 64.94 -71.18 0.08 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.4 0.518 . . . . 53.14 112.4 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . 96.37 -75.69 0.76 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.134 -0.555 . . . . 64.33 113.247 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.48 83.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.22 -0.514 . . . . 40.31 112.917 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.629 ' HZ3' HG23 ' A' ' 112' ' ' VAL . 9.0 m0 -100.65 174.71 5.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.767 0.318 . . . . 75.54 111.605 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.28 111.32 15.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.799 0.333 . . . . 71.24 111.194 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.404 ' HE1' HG21 ' A' ' 71' ' ' ILE . 59.7 ttp -103.01 121.2 42.07 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.068 -0.395 . . . . 62.33 111.279 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.28 149.64 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.355 -0.384 . . . . 64.04 110.716 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 46' ' ' ARG . 28.4 ttp-105 -135.2 105.54 6.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.944 -0.473 . . . . 74.41 110.878 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 98.3 mttt -88.44 118.91 28.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.481 -0.327 . . . . 71.14 110.666 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 tt -155.07 99.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.934 0.397 . . . . 73.11 111.665 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 58.94 93.66 0.01 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.253 -0.431 . . . . 50.42 114.117 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.9 t70 76.46 -58.75 0.52 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.068 0.766 . . . . 71.21 113.068 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -103.99 163.42 12.38 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.849 0.685 . . . . 71.1 112.849 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.4 p -138.02 105.4 5.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.646 -0.706 . . . . 74.23 110.683 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' A' ' 91' ' ' GLN . 7.1 p -92.28 146.18 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.699 0.285 . . . . 63.42 111.429 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -123.0 159.35 28.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.21 0.528 . . . . 74.35 111.77 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 73.6 t80 -138.93 133.52 31.95 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.114 -0.494 . . . . 64.22 110.813 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -101.18 129.98 47.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.097 0.475 . . . . 72.44 111.715 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.626 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 68.7 m-85 -88.84 172.89 8.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.033 -0.53 . . . . 73.14 111.923 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 t -149.71 153.82 37.56 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.984 0.421 . . . . 75.12 112.111 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 36.9 t -86.3 64.26 8.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.991 0.424 . . . . 63.13 111.919 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.67 HH11 ' HG2' ' A' ' 82' ' ' PRO . 9.6 ptp180 -106.58 -1.53 22.82 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.747 0.308 . . . . 74.22 111.785 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.407 ' HE2' HD23 ' A' ' 63' ' ' LEU . 29.9 p90 -154.98 148.61 25.37 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.681 0.277 . . . . 73.13 111.011 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 47.8 t -97.02 102.37 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 64.11 111.024 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 31' ' ' ASN . 1.1 tm? -80.74 108.82 14.72 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.204 0.526 . . . . 72.35 110.623 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 61.7 mttm -64.36 140.5 58.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.024 -0.534 . . . . 73.31 112.186 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.24 127.19 30.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.253 -0.43 . . . . 61.04 111.306 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.96 -15.37 55.4 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.152 -0.547 . . . . 71.44 112.787 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 1.7 mp0 -95.65 168.08 10.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.885 0.374 . . . . 75.41 110.831 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.8 p -119.25 174.04 6.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.274 0.559 . . . . 74.2 112.183 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.72 127.92 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.976 -0.556 . . . . 44.05 110.448 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.5 m -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.955 0.407 . . . . 72.15 111.96 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 86' ' ' LEU . 29.5 mm -92.54 97.49 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.151 -0.477 . . . . 72.4 110.423 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 88.0 m95 -79.12 168.72 19.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.938 0.399 . . . . 74.33 111.792 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.67 16.63 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.569 -0.287 . . . . 64.21 110.902 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.1 -30.62 37.47 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.108 0.781 . . . . 73.35 113.108 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -97.9 19.63 13.51 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.429 0.529 . . . . 71.3 112.429 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -52.91 -47.83 67.68 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 43.32 112.625 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.93 75.48 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.213 -0.518 . . . . 37.55 112.816 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.91 -164.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.327 0.251 . . . . 64.01 111.106 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.4 m -48.67 130.29 17.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.771 0.319 . . . . 74.44 111.165 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.13 62.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.553 0.945 . . . . 73.12 113.553 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.4 t -159.28 151.91 17.9 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 113.133 0.79 . . . . 74.3 113.133 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.67 ' HG2' HH11 ' A' ' 60' ' ' ARG . 7.1 Cg_endo -48.79 170.84 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 123.919 3.079 . . . . 74.12 111.363 168.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -16.82 -80.51 0.0 OUTLIER 'Cis proline' 0 C--N 1.374 1.896 0 N-CA-C 121.329 3.55 . . . . 74.14 121.329 11.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.2 p -78.62 -83.63 0.09 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.301 1.223 . . . . 62.2 114.301 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 6.3 m-20 -73.78 122.6 22.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.248 0.547 . . . . 75.13 112.458 -171.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 82' ' ' PRO . 12.1 mt -91.09 113.24 25.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.912 -0.585 . . . . 73.45 111.369 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.5 mp -86.08 119.11 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.18 0.514 . . . . 64.41 110.944 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.408 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.1 t90 -69.46 77.9 0.4 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.332 0.587 . . . . 75.44 110.351 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -75.88 27.82 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.324 0.49 . . . . 42.44 112.324 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.1 -1.86 11.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.901 0.381 . . . . 70.51 110.969 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.458 ' OE1' HG13 ' A' ' 53' ' ' VAL . 25.3 tt0 -157.82 146.27 19.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.966 0.413 . . . . 44.11 111.111 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -82.81 -167.62 1.71 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.433 -0.349 . . . . 73.12 110.775 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 t -69.0 145.35 53.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.941 0.401 . . . . 65.42 111.611 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.505 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 49.4 p90 -121.86 -174.46 2.88 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.217 -0.447 . . . . 74.43 110.631 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 137.71 50.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.766 -0.731 . . . . 63.34 113.609 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 98' ' ' GLU . 7.3 t -76.49 -20.91 56.47 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.451 -0.441 . . . . 74.32 111.982 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.62 4.87 60.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.091 -0.576 . . . . 74.42 113.517 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 96' ' ' THR . 9.0 mm-40 -85.69 172.46 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.652 -0.322 . . . . 54.44 111.257 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.05 143.33 55.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.103 0.478 . . . . 52.15 111.995 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.35 132.74 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.284 0.564 . . . . 75.01 111.655 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 114' ' ' GLN . 50.6 tttm -123.35 111.8 16.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.07 -0.514 . . . . 61.31 110.817 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.81 133.09 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.946 0.403 . . . . 72.13 111.39 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.442 HG22 ' HE2' ' A' ' 105' ' ' LYS . 16.3 mm -126.64 136.53 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 111.828 0.307 . . . . 63.12 111.828 -173.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 29' ' ' LEU . 79.4 mt -110.13 107.68 17.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.93 0.395 . . . . 51.25 111.559 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' HG22 ' A' ' 103' ' ' ILE . 67.7 mttm -119.31 167.76 11.57 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.373 0.606 . . . . 71.14 112.061 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.507 ' HB2' ' CG ' ' A' ' 110' ' ' GLU . 12.8 m120 -113.96 -176.65 2.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.987 -0.551 . . . . 74.54 111.681 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 t -58.75 -39.32 80.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.307 0.854 . . . . 74.1 113.307 -173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -73.46 -8.7 57.0 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.552 0.575 . . . . 73.05 112.552 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.75 68.68 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.648 -0.787 . . . . 65.23 112.065 -171.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 106' ' ' ASN . 10.5 pt-20 -68.44 168.59 12.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.658 0.383 . . . . 75.3 110.39 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.71 136.92 48.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.128 -0.358 . . . . 74.5 111.779 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.629 HG23 ' HZ3' ' A' ' 42' ' ' TRP . 29.2 m -96.7 -41.62 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.438 -0.346 . . . . 65.13 111.61 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.79 168.95 13.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 53.25 111.504 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 29.5 pt20 -160.0 163.37 34.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.71 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -161.89 -179.41 7.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.015 0.912 . . . . 54.5 112.793 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.3 p -147.64 -170.99 3.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.821 -1.081 . . . . 73.33 109.892 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 p -78.71 142.45 37.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.894 0.378 . . . . 74.4 110.972 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p -78.57 101.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.383 0.611 . . . . 72.11 111.193 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -99.14 104.22 16.18 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.54 112.093 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -84.66 124.11 31.11 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.347 -0.388 . . . . 74.21 110.665 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.9 m -70.64 85.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 73.33 111.586 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.254 1.315 0 CA-C-O 118.976 -0.535 . . . . 73.21 111.65 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.559 0.219 . . . . 63.32 110.429 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.02 -107.72 1.04 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.13 -0.557 . . . . 60.05 112.75 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -144.66 39.7 1.27 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.326 0.584 . . . . 72.11 110.584 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -99.6 4.83 45.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.47 0.544 . . . . 73.12 112.47 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -72.07 97.87 1.99 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.119 0.485 . . . . 71.0 111.195 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -125.88 26.29 6.64 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 71.23 112.155 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -66.0 99.43 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.992 0.425 . . . . 74.32 111.4 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -98.25 114.2 26.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.533 -0.303 . . . . 74.51 110.792 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 t -113.53 81.98 1.6 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.089 0.471 . . . . 74.54 111.501 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -132.06 119.6 21.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.493 -0.321 . . . . 74.42 111.435 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 mmt 61.58 108.88 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.419 0.628 . . . . 64.22 112.389 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -94.26 36.51 1.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.2 0.445 . . . . 71.41 112.2 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.0 61.96 2.55 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.172 -0.537 . . . . 75.41 112.902 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.6 m-80 -94.63 -32.91 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.874 0.368 . . . . 75.23 111.375 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.11 120.27 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.01 0.433 . . . . 74.14 111.361 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -133.62 156.66 47.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.447 -0.342 . . . . 74.21 110.906 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 65.2 mt -71.04 126.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.755 0.312 . . . . 72.41 111.496 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -89.33 -66.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.001 0.429 . . . . 74.43 110.783 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -136.23 130.25 32.81 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.126 0.489 . . . . 70.21 112.085 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 27' ' ' ILE . 62.6 mt -103.91 114.45 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.968 -0.56 . . . . 72.24 110.351 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 17.2 t70 -74.53 139.61 43.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.473 0.654 . . . . 53.22 112.256 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.5 -16.41 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.609 -0.723 . . . . 73.53 110.993 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.07 -14.15 61.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.149 -0.478 . . . . 53.33 111.198 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 99.44 29.22 7.16 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.771 0.669 . . . . 73.1 114.771 168.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.5 mptt -113.3 -54.48 2.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.214 0.82 . . . . 71.34 113.214 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 46.1 p90 -148.04 167.24 25.46 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.106 1.151 . . . . 75.33 114.106 -170.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG21 HG12 ' A' ' 20' ' ' ILE . 69.8 mt -132.63 105.22 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 72.04 109.345 170.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.1 ttm180 -90.8 119.94 31.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.207 0.817 . . . . 75.45 113.207 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HB2' HG11 ' A' ' 69' ' ' VAL . 7.0 mp -93.83 -175.88 3.87 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.712 -0.676 . . . . 75.45 110.333 171.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 35.0 ttpt -157.37 135.16 10.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.996 0.427 . . . . 64.51 112.009 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -108.33 115.23 29.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.039 -0.528 . . . . 64.24 111.403 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -102.19 16.56 25.75 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 72.03 112.116 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 98.3 p -55.24 152.32 8.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.079 0.466 . . . . 63.11 111.707 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -85.14 -0.35 54.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.799 0.333 . . . . 53.3 111.811 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.87 161.04 28.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.395 -0.366 . . . . 72.04 110.269 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.61 111.54 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.725 0.298 . . . . 73.23 111.244 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -104.85 132.07 21.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 N-CA-C 111.893 0.331 . . . . 75.11 111.893 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 62' ' ' VAL . 50.9 Cg_exo -54.69 132.93 54.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.456 2.104 . . . . 43.43 112.19 173.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.68 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.1 tpt -52.45 -72.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.07 0.396 . . . . 74.4 112.07 -175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.64 172.45 45.38 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.711 -0.757 . . . . 62.12 113.085 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.19 89.11 0.41 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.117 -0.563 . . . . 74.51 113.707 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . 41.3 m95 -102.41 156.43 17.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.773 0.321 . . . . 71.24 110.434 171.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.84 115.35 6.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.805 0.336 . . . . 74.31 111.468 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.595 ' HE2' HG23 ' A' ' 71' ' ' ILE . 54.7 ttp -93.99 114.06 26.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.569 -0.287 . . . . 75.0 111.67 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 45' ' ' ILE . 2.8 mp -102.13 106.91 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.894 0.378 . . . . 72.23 110.36 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.708 ' HG3' HG21 ' A' ' 102' ' ' VAL . 50.6 ttt180 -99.11 123.62 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.713 0.292 . . . . 74.42 111.483 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -121.9 116.86 25.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.954 0.407 . . . . 60.51 111.584 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.447 HD11 ' HG1' ' A' ' 96' ' ' THR . 12.1 tt -103.35 -27.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.165 0.507 . . . . 70.25 110.703 175.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.96 -137.31 3.21 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.858 -0.61 . . . . 74.31 112.305 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -71.25 -40.54 70.93 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.03 0.443 . . . . 43.43 111.454 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -79.05 156.5 28.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.189 0.518 . . . . 74.22 112.126 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.3 p -133.69 152.55 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.343 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.9 p -134.96 139.43 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.506 -0.316 . . . . 62.32 111.318 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.0 p -111.53 171.38 7.52 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.233 0.54 . . . . 73.21 112.369 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.436 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 74.6 t80 -160.47 114.21 2.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.863 -0.608 . . . . 74.55 111.252 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.15 127.07 33.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.746 0.307 . . . . 71.32 111.438 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 3.1 m-85 -73.98 121.99 21.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.823 0.344 . . . . 64.23 111.123 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 82' ' ' PRO . 5.2 t -68.84 120.96 15.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.543 0.687 . . . . 71.14 112.213 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -85.89 33.93 0.6 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.113 -0.494 . . . . 63.4 111.925 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.665 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 13.4 ptp180 -78.47 -3.72 44.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.148 0.425 . . . . 75.05 112.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 24.2 p90 -158.54 171.83 19.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.004 0.431 . . . . 75.13 111.362 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 38' ' ' PRO . 34.7 m -92.9 138.74 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.3 -0.409 . . . . 71.04 111.51 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.31 105.7 13.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.137 0.494 . . . . 72.33 109.68 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 7.4 mtpm? -69.14 154.23 42.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.269 0.557 . . . . 63.43 112.446 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.6 57.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.753 -0.658 . . . . 73.33 112.187 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.26 -0.495 . . . . 62.44 113.793 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.615 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.89 132.38 34.71 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.229 -0.571 . . . . 71.42 111.557 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 56.2 p -100.02 83.59 2.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.309 -0.405 . . . . 61.01 111.019 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 29' ' ' LEU . 4.5 p -57.96 106.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.573 0.701 . . . . 61.32 111.372 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 86.4 m -93.06 121.31 34.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 74.05 111.525 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.595 HG23 ' HE2' ' A' ' 44' ' ' MET . 47.8 mm -83.12 106.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.433 -0.348 . . . . 62.42 111.047 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -82.95 144.75 29.79 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.564 0.209 . . . . 75.42 111.564 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.93 157.64 27.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.835 0.35 . . . . 74.45 111.877 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.98 -30.48 25.16 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.439 0.533 . . . . 72.33 112.439 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -81.73 28.66 0.4 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.804 0.335 . . . . 60.44 111.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.62 87.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.176 0.436 . . . . 73.41 112.176 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.84 -37.7 2.5 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.178 -0.534 . . . . 43.2 113.771 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.2 -173.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.152 0.427 . . . . 72.33 112.152 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -51.1 104.92 0.09 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 74.34 111.903 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.82 1.32 35.34 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.671 0.619 . . . . 75.53 112.671 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.4 t -117.2 117.72 36.48 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 120.533 0.206 . . . . 75.21 111.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 54.0 Cg_exo -55.91 178.6 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.527 0 C-N-CA 123.776 2.984 . . . . 63.13 113.414 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 95.4 Cg_endo -76.73 126.19 12.94 Favored 'Cis proline' 0 C--N 1.366 1.459 0 CA-C-N 120.107 1.074 . . . . 71.14 114.813 6.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 82' ' ' PRO . 8.9 t 176.71 -170.94 0.08 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.353 -0.84 . . . . 70.03 109.418 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.476 ' O ' HD13 ' A' ' 87' ' ' ILE . 6.5 m-20 -57.4 108.1 0.51 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.735 -0.469 . . . . 74.02 109.735 171.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 79.6 mt -51.44 109.22 0.32 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.378 0.881 . . . . 72.12 113.378 -169.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 85' ' ' ASP . 3.6 mp -76.25 117.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.193 0.521 . . . . 74.24 110.8 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 6.7 t90 -70.31 134.96 48.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.914 -0.584 . . . . 74.52 110.527 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -127.35 27.99 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.02 0.438 . . . . 73.13 111.769 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.1 m120 -121.45 -26.77 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.361 -0.381 . . . . 74.31 111.522 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -133.32 147.13 51.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.697 0.284 . . . . 74.25 110.874 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -95.51 -171.67 2.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.994 0.426 . . . . 74.42 111.951 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -59.89 127.03 29.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.892 0.377 . . . . 72.43 111.056 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -101.47 118.07 36.2 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.244 0.545 . . . . 75.12 112.457 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -120.93 85.14 0.38 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 72.23 111.893 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.447 ' HG1' HD11 ' A' ' 48' ' ' ILE . 49.6 p -130.56 -39.09 1.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.132 0.419 . . . . 75.33 112.132 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.42 89.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.257 -0.496 . . . . 71.14 112.857 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -96.66 145.75 25.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.97 0.414 . . . . 51.33 111.858 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 6.1 m-20 -64.59 131.1 46.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.402 0.62 . . . . 61.15 112.07 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.599 HG13 HH21 ' A' ' 46' ' ' ARG . 7.5 p -119.09 126.05 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.883 -0.599 . . . . 74.53 111.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.851 ' HE2' HD13 ' A' ' 103' ' ' ILE . 87.3 tttt -90.95 115.99 28.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.797 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 46' ' ' ARG . 46.6 t -104.55 123.76 58.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.907 0.384 . . . . 73.34 111.518 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.851 HD13 ' HE2' ' A' ' 101' ' ' LYS . 50.4 mm -105.92 131.7 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.281 0.474 . . . . 72.21 112.281 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 113' ' ' ALA . 76.4 mt -105.12 112.54 25.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.903 0.382 . . . . 74.25 110.943 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.75 171.59 7.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.17 -0.468 . . . . 73.1 110.931 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.8 -167.4 1.22 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.941 0.401 . . . . 72.34 111.253 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.2 t -56.98 -26.91 60.78 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.446 0.906 . . . . 73.43 113.446 -174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.86 -9.41 31.51 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 122.11 -0.369 . . . . 72.02 111.565 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.42 9.46 55.18 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.294 -0.479 . . . . 75.5 113.672 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.95 124.97 26.05 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.992 0.425 . . . . 74.45 111.88 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.5 107.27 7.52 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.303 -0.408 . . . . 75.21 110.959 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.59 -37.31 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.616 0.599 . . . . 71.21 112.616 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -141.39 122.53 14.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.193 0.442 . . . . 55.13 112.193 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -124.79 141.59 52.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.511 -0.313 . . . . 70.41 111.224 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -161.46 151.76 17.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.716 0.293 . . . . 74.33 111.039 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -140.53 174.67 10.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.168 0.509 . . . . 53.2 111.661 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 38.6 p -70.01 175.49 4.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 73.02 111.209 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 t -126.79 79.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.171 -0.331 . . . . 75.52 111.816 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 28.56 75.98 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.395 1.078 . . . . 74.54 113.79 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.99 122.62 45.77 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.026 0.441 . . . . 60.21 111.473 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -79.04 98.88 6.65 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.434 0.635 . . . . 74.15 111.854 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.501 -0.761 . . . . 72.14 111.924 179.234 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.779 0.323 . . . . 55.12 111.393 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.21 133.64 0.28 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.458 -0.401 . . . . 52.34 113.422 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -55.8 123.22 13.49 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.881 0.372 . . . . 71.41 111.983 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -153.44 165.97 34.13 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.082 0.468 . . . . 75.42 111.351 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -106.48 151.43 24.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.165 172.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -65.27 93.71 0.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.52 0.676 . . . . 74.52 112.011 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -126.81 117.48 22.71 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.284 -0.871 . . . . 74.43 110.364 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -144.99 137.76 26.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.011 0.434 . . . . 71.23 112.063 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 t -165.45 151.09 9.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.909 -0.587 . . . . 55.1 110.675 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -90.68 93.19 9.15 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.303 0.573 . . . . 73.42 111.943 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 mmt -97.8 125.65 42.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.849 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.9 t -58.19 -48.02 81.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.95 0.722 . . . . 75.31 112.95 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.56 89.08 0.15 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.113 -0.565 . . . . 72.04 113.547 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 m-80 -123.7 22.74 8.96 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.128 -0.631 . . . . 73.43 112.533 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.87 85.76 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.246 0.546 . . . . 72.01 110.164 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.34 147.61 24.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.018 -0.537 . . . . 73.15 111.679 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.804 HG13 ' HG ' ' A' ' 29' ' ' LEU . 3.0 mp -82.24 96.93 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.787 0.327 . . . . 53.51 110.145 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.28 -38.61 88.19 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.926 0.393 . . . . 73.11 111.926 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.42 129.5 14.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.699 0.629 . . . . 71.51 112.699 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.531 HG12 HG21 ' A' ' 27' ' ' ILE . 57.1 mt -116.65 128.82 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.989 -0.551 . . . . 74.4 109.738 172.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.76 114.89 9.29 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.325 0.583 . . . . 74.21 111.351 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' HA3' ' A' ' 97' ' ' GLY . 11.4 p -68.39 -31.12 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 116.123 -0.489 . . . . 74.24 112.041 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 22.8 t70 -57.08 -48.01 79.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.751 0.31 . . . . 75.1 111.132 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 136.23 24.01 0.52 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.311 -0.471 . . . . 74.34 113.985 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -95.57 -63.39 1.16 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.091 0.775 . . . . 74.32 113.091 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -145.29 161.23 40.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.107 1.151 . . . . 74.1 114.107 -168.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.531 HG21 HG12 ' A' ' 20' ' ' ILE . 65.6 mt -116.3 113.81 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.102 -0.953 . . . . 62.51 109.662 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -102.19 112.94 25.81 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.451 0.538 . . . . 74.32 112.451 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.804 ' HG ' HG13 ' A' ' 17' ' ' ILE . 4.8 mp -91.92 154.54 18.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.116 -0.493 . . . . 72.23 111.254 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -150.87 123.29 8.41 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.925 0.393 . . . . 73.02 110.96 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' HB2' HD11 ' A' ' 63' ' ' LEU . 34.1 t30 -83.94 129.49 34.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.784 0.326 . . . . 62.34 111.382 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -109.87 11.24 24.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.25 0.463 . . . . 73.44 112.25 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 94.0 p -80.91 163.44 23.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.454 0.645 . . . . 64.54 112.148 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.06 -18.61 33.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.719 -0.673 . . . . 63.13 111.531 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.54 149.77 46.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.693 0.282 . . . . 73.22 111.288 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -56.69 139.91 48.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.159 0.504 . . . . 64.52 112.209 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -104.02 117.32 59.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.235 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.11 127.73 13.9 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.421 2.08 . . . . 52.45 112.725 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.9 tpp -79.12 -71.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.961 0.41 . . . . 72.25 111.623 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.4 -54.2 2.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.886 -0.673 . . . . 60.02 112.998 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.69 61.77 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.339 -0.458 . . . . 54.22 113.323 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -63.09 153.54 33.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.894 0.378 . . . . 73.53 110.662 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -130.01 116.33 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.206 0.527 . . . . 73.2 111.388 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.545 ' HG3' HG13 ' A' ' 102' ' ' VAL . 47.4 ttp -86.8 109.55 19.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.635 -0.711 . . . . 72.3 111.964 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.8 mp -82.94 89.68 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.102 -0.703 . . . . 71.51 109.102 171.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 101.24 6.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.083 0.468 . . . . 75.21 111.396 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -84.67 -178.86 6.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.317 -0.401 . . . . 72.45 111.016 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -171.2 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.233 0.54 . . . . 74.54 110.547 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.47 -89.24 0.09 OUTLIER Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.96 -0.563 . . . . 55.03 112.702 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.47 -0.09 56.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.025 0.38 . . . . 64.22 112.025 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 t -155.54 164.54 38.52 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.691 0.626 . . . . 74.53 112.691 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -153.15 149.09 27.69 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.658 -0.701 . . . . 72.31 110.739 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.13 134.79 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.874 0.369 . . . . 64.54 111.373 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 m -94.12 111.7 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.11 0.411 . . . . 74.35 112.11 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -103.89 122.82 45.96 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.745 0.307 . . . . 74.14 110.651 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -95.39 116.39 28.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.799 0.333 . . . . 74.32 110.922 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -61.25 121.66 13.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.117 0.484 . . . . 75.22 111.609 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.595 HG22 ' HG2' ' A' ' 60' ' ' ARG . 3.5 t -67.2 132.31 47.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.385 0.612 . . . . 62.32 112.019 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.1 p -73.41 23.72 0.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.236 0.828 . . . . 73.32 113.236 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.595 ' HG2' HG22 ' A' ' 58' ' ' THR . 8.0 ptp180 -73.02 -8.03 53.9 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.12 -0.363 . . . . 72.23 111.841 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.494 ' HE2' HD23 ' A' ' 63' ' ' LEU . 24.8 p90 -145.85 145.07 30.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.173 0.435 . . . . 72.12 112.173 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.45 124.63 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.185 -0.461 . . . . 65.25 109.777 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -74.4 99.39 3.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.192 0.52 . . . . 74.01 111.298 -173.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -66.8 165.26 15.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.475 0.655 . . . . 71.12 112.723 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.77 125.75 25.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.908 -0.587 . . . . 74.05 111.169 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.22 77.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.197 -0.525 . . . . 52.44 113.527 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.554 ' HB3' HD13 ' A' ' 63' ' ' LEU . 8.6 tp-100 -91.7 153.0 19.95 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.107 0.48 . . . . 74.53 111.572 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.4 p -121.9 145.58 47.95 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.248 -0.433 . . . . 63.25 111.951 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.82 137.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.288 -0.414 . . . . 74.55 110.363 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.6 m -118.66 122.44 42.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.162 0.43 . . . . 62.41 112.162 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.2 106.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.69 -0.232 . . . . 72.05 111.208 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 84.6 m95 -91.95 123.13 35.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.572 0.225 . . . . 73.32 111.503 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -79.1 80.54 5.44 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.084 0.772 . . . . 44.32 113.084 -174.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 61.3 -69.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.286 1.217 . . . . 74.41 114.286 173.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -72.86 36.17 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.337 0.866 . . . . 62.23 113.337 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . . . -75.24 -50.61 15.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.305 0.483 . . . . 70.43 112.305 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.62 38.54 20.32 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.165 -0.541 . . . . 74.15 113.054 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.57 173.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.13 0.49 . . . . 65.35 112.186 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.3 m -67.84 94.02 0.43 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 74.35 112.678 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.64 -86.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.264 0.838 . . . . 74.43 113.264 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.4 t -170.46 110.52 0.44 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.211 0.449 . . . . 74.1 112.211 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.631 ' HG2' ' HB2' ' A' ' 85' ' ' ASP . 58.0 Cg_exo -46.21 160.61 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.486 2.79 . . . . 70.41 111.521 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.46 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER 9.03 64.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.903 0 N-CA-C 121.517 3.622 . . . . 74.21 121.517 36.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 85' ' ' ASP . 9.0 t 147.78 -67.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.988 1.715 . . . . 72.35 111.209 161.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.632 ' H ' HG23 ' A' ' 84' ' ' THR . 8.0 m-20 -87.67 173.98 8.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.114 -0.366 . . . . 63.02 110.398 172.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.4 mt -139.96 130.61 25.75 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.751 0.31 . . . . 75.11 111.128 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 87' ' ' ILE . 1.9 mp -87.15 106.01 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.438 0.637 . . . . 72.25 111.136 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.592 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 6.3 t90 -74.24 98.53 3.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.622 -0.717 . . . . 65.21 111.003 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -73.16 -28.54 62.28 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.404 0.52 . . . . 53.31 112.404 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.592 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 10.8 m120 -71.55 -16.96 62.33 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.905 0.706 . . . . 64.2 112.905 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 44.1 tt0 -145.77 139.2 26.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.008 -0.433 . . . . 74.11 111.731 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.619 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -90.21 -174.82 4.32 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.063 0.459 . . . . 70.22 111.089 173.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.2 p -56.27 120.48 7.66 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.423 -0.353 . . . . 70.34 111.864 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.485 ' NE1' ' HA2' ' A' ' 24' ' ' GLY . 33.9 p90 -70.92 -38.74 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.504 0.557 . . . . 75.22 112.504 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 54.3 63.93 4.74 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.314 -0.47 . . . . 62.41 113.763 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 97' ' ' GLY . 1.6 t -167.52 -63.25 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.658 0.614 . . . . 65.24 112.658 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.583 ' H ' HG22 ' A' ' 96' ' ' THR . . . 72.76 10.09 76.0 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.982 -0.628 . . . . 75.03 113.399 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -70.9 78.57 0.63 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.224 0.512 . . . . 72.33 112.072 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.81 31.58 20.86 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.464 -0.789 . . . . 62.14 112.534 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 120.18 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.166 0.507 . . . . 74.21 109.743 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.834 ' HZ3' ' HB2' ' A' ' 101' ' ' LYS . 4.4 ttmp? -119.15 121.45 39.79 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.928 0.714 . . . . 73.24 112.928 -165.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 44' ' ' MET . 98.1 t -86.82 116.54 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.723 -0.671 . . . . 75.0 111.569 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.8 mm -105.27 114.99 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.617 -0.265 . . . . 74.44 110.766 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.59 102.86 15.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.798 0.666 . . . . 65.41 112.798 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.97 154.89 25.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.376 -0.375 . . . . 64.35 110.509 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.515 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 14.2 m120 -99.0 -164.31 1.12 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.844 0.683 . . . . 74.2 112.844 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.1 t -52.98 -51.57 61.11 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.116 1.154 . . . . 51.0 114.116 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -88.28 -61.04 1.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.287 0.565 . . . . 74.32 111.731 -172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.59 27.71 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.785 -0.643 . . . . 74.44 112.697 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 1.2 pm0 -102.69 135.43 44.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.018 0.437 . . . . 55.0 110.681 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.21 132.52 46.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.055 0.391 . . . . 70.4 112.055 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 66.5 t -88.75 -62.08 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.267 -0.424 . . . . 72.41 111.352 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.66 179.16 8.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.168 0.509 . . . . 51.3 111.852 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.68 152.93 49.79 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.937 -0.574 . . . . 75.52 110.757 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 115' ' ' ARG . 1.3 tpm_? -151.31 152.04 32.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.614 0.245 . . . . 74.23 110.892 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.7 p -145.33 170.22 16.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.067 -0.395 . . . . 63.43 111.797 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -67.95 113.96 6.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.542 0.571 . . . . 75.15 112.542 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 132.21 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.127 -0.488 . . . . 53.53 111.102 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.77 84.81 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.29 0.567 . . . . 61.33 111.524 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.89 -21.79 37.23 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.949 -0.568 . . . . 64.31 111.021 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.0 m 66.4 98.37 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.748 -0.66 . . . . 51.53 111.261 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.25 1.107 0 C-N-CA 123.421 0.688 . . . . 64.35 112.676 -179.296 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.802 0.334 . . . . 73.34 111.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.28 -178.29 53.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.161 -0.542 . . . . 55.14 113.493 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -135.58 161.18 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.519 -0.4 . . . . 75.51 111.132 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.48 103.91 4.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.365 -0.379 . . . . 63.14 111.294 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -144.42 130.43 19.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.145 0.497 . . . . 72.11 111.254 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -92.66 117.74 30.3 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 73.14 111.849 -175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -148.44 120.51 8.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.093 0.473 . . . . 72.31 111.331 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -125.4 116.95 22.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.214 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -130.56 167.98 17.82 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 71.43 111.79 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.08 -10.42 36.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.033 0.444 . . . . 74.42 111.036 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 91.2 mmm -76.21 118.08 18.56 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.16 -0.473 . . . . 71.5 111.601 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.4 p -85.03 -64.1 1.21 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 54.15 111.294 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.05 108.34 2.38 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.263 -0.494 . . . . 74.15 113.227 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 32' ' ' THR . 45.3 t30 -77.73 103.91 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.278 0.561 . . . . 74.05 111.178 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.432 HG22 ' HE1' ' A' ' 39' ' ' MET . 62.0 t -104.73 125.68 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.548 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 113' ' ' ALA . 53.7 t -135.49 159.87 40.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.923 0.392 . . . . 74.32 111.624 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 104' ' ' LEU . 3.6 mp -87.06 131.35 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.6 -0.273 . . . . 71.04 110.341 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -104.3 -34.27 8.38 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.788 0.292 . . . . 74.31 111.788 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.78 145.01 30.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.102 0.477 . . . . 61.23 111.449 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.36 130.25 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.273 -0.421 . . . . 73.43 110.796 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.34 147.25 40.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.189 0.519 . . . . 75.14 110.888 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG23 ' HA2' ' A' ' 97' ' ' GLY . 13.9 p -105.19 -25.07 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 74.22 111.693 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 21.2 t70 -64.13 -56.66 13.28 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.064 0.459 . . . . 64.11 111.539 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 144.33 41.89 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.42 -0.419 . . . . 61.04 112.575 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -113.17 -61.97 1.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.733 0.642 . . . . 74.12 112.733 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.95 168.19 26.65 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.107 1.151 . . . . 73.11 114.107 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.3 mt -126.06 131.08 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.906 -1.043 . . . . 72.11 109.371 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -100.76 101.81 12.75 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.483 0.549 . . . . 71.51 112.483 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.8 mp -88.48 156.01 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.33 110.159 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -146.61 127.72 14.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.952 0.406 . . . . 73.23 111.762 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -84.37 110.28 18.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.355 -0.384 . . . . 62.44 110.673 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 14' ' ' ASN . 11.7 t -95.13 9.78 38.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.095 0.474 . . . . 71.24 111.163 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.1 t -82.39 149.85 27.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.059 -0.518 . . . . 73.22 111.391 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.73 43.12 1.01 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.27 -0.423 . . . . 74.31 111.4 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -168.91 154.17 6.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.872 0.368 . . . . 72.24 111.677 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 11.9 m-20 -68.08 104.11 1.69 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.448 -0.342 . . . . 72.52 110.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.95 118.9 66.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.85 0.315 . . . . 75.21 111.85 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.34 117.54 5.03 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.745 2.297 . . . . 70.12 112.51 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.432 ' HE1' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -76.34 77.32 3.1 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.98 0.419 . . . . 71.53 111.5 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.66 -68.96 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.028 -0.606 . . . . 71.34 113.976 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.59 2.89 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.505 -0.379 . . . . 54.34 113.722 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -129.58 140.1 51.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.542 0.337 . . . . 75.14 111.135 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 34.3 tt0 -136.12 125.34 24.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.418 . . . . 74.2 110.733 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.401 ' HE2' ' CZ3' ' A' ' 88' ' ' TRP . 53.5 ttp -102.83 133.86 47.2 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.0 0.429 . . . . 65.15 111.811 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 54' ' ' SER . 32.2 mt -127.17 116.77 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.477 -0.329 . . . . 74.3 110.865 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.578 ' NH2' HG13 ' A' ' 100' ' ' VAL . 67.5 ttt180 -100.84 122.72 43.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.928 0.394 . . . . 73.12 110.947 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -98.2 137.36 37.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.747 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.42 ' HB ' HG23 ' A' ' 100' ' ' VAL . 7.3 tt -130.91 91.72 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.53 0.681 . . . . 72.52 111.485 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.55 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.811 -0.632 . . . . 71.42 113.602 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.88 -64.85 1.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.605 0.362 . . . . 73.13 111.78 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -95.06 178.53 5.52 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.895 0.702 . . . . 71.21 112.895 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -149.27 152.9 36.71 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.176 -0.466 . . . . 63.32 110.968 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -129.57 137.86 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.701 0.286 . . . . 74.42 111.193 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.442 ' CB ' HG12 ' A' ' 45' ' ' ILE . 85.8 p -120.46 161.97 20.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.991 0.737 . . . . 61.42 112.991 -175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -163.57 117.99 1.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.624 -0.716 . . . . 73.2 111.286 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 56.7 tttm -88.1 151.35 22.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.952 0.406 . . . . 73.21 111.488 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -98.21 168.34 10.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.004 0.431 . . . . 74.35 111.718 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -130.37 132.38 45.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.997 0.427 . . . . 62.13 111.752 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.3 t -72.32 86.64 1.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 53.45 112.334 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 82' ' ' PRO . 14.6 ptm180 -131.29 6.05 4.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.903 0.383 . . . . 73.11 111.551 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.502 ' HH ' HG21 ' A' ' 69' ' ' VAL . 27.9 p90 -157.42 155.15 29.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.336 -0.393 . . . . 74.44 110.554 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 31.5 m -114.52 130.33 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.251 0.548 . . . . 63.14 112.049 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.3 mm? -83.45 114.6 21.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.418 -0.355 . . . . 71.24 110.93 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 35.9 mtmm -66.4 168.61 8.66 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.065 0.46 . . . . 73.32 111.866 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.22 107.3 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.352 -0.386 . . . . 65.0 111.47 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.88 6.44 67.27 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.401 -0.428 . . . . 38.33 113.086 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.527 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -79.71 137.13 36.95 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.467 -0.431 . . . . 74.32 111.511 -178.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.1 p -103.53 139.67 38.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.16 0.505 . . . . 70.42 111.718 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.502 HG21 ' HH ' ' A' ' 61' ' ' TYR . 7.4 p -111.35 123.67 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.188 0.518 . . . . 74.34 110.159 173.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.3 m -95.15 102.22 14.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.176 -0.465 . . . . 75.13 111.477 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.18 97.53 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.324 -0.398 . . . . 74.1 111.105 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.533 ' HB2' HG13 ' A' ' 87' ' ' ILE . 93.2 m95 -78.98 160.55 27.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.24 111.623 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.28 165.93 20.98 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.391 -0.368 . . . . 75.1 111.209 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.03 -27.58 45.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.52 25.49 1.68 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.938 0.347 . . . . 74.2 111.938 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.08 64.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.814 0.672 . . . . 73.22 112.814 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.52 75.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.165 -0.541 . . . . 52.24 113.722 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.52 -172.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.556 -0.379 . . . . 72.15 111.017 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.0 m -61.39 101.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.656 -0.498 . . . . 64.32 109.656 171.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.87 42.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.113 0.782 . . . . 73.14 113.113 -168.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.7 m -157.9 139.2 9.69 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 112.275 0.472 . . . . 55.12 112.275 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 56.0 Cg_exo -44.12 163.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 123.645 2.897 . . . . 62.23 112.162 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 26.9 Cg_exo -11.02 -80.75 0.0 OUTLIER 'Cis proline' 0 C--N 1.375 1.925 0 N-CA-C 121.297 3.537 . . . . 74.45 121.297 17.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.648 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.7 t -106.37 -79.39 0.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.83 1.418 . . . . 64.31 114.83 -165.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.648 ' H ' HG23 ' A' ' 84' ' ' THR . 21.8 m-20 -68.59 129.14 39.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.0 0.741 . . . . 73.42 113.0 -167.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 104.3 16.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.891 -0.595 . . . . 74.13 111.288 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -74.52 121.82 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.781 0.324 . . . . 74.35 110.533 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CZ3' ' HE2' ' A' ' 44' ' ' MET . 3.6 t90 -64.91 77.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.352 0.596 . . . . 72.4 111.078 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.74 22.44 0.59 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.179 -0.464 . . . . 63.52 112.234 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -120.53 11.55 11.36 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.054 0.454 . . . . 75.11 110.939 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -150.48 131.96 14.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.26 -0.427 . . . . 71.21 111.096 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -80.26 178.8 8.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.922 0.391 . . . . 71.31 111.209 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -66.84 116.27 7.53 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.338 -0.226 . . . . 75.33 111.015 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.459 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 43.6 p90 -60.66 -47.15 87.51 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.319 0.488 . . . . 73.05 112.319 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 58.26 11.76 10.37 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.721 0.648 . . . . 71.24 114.721 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -71.0 -31.41 67.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.772 0.656 . . . . 63.43 112.772 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 22' ' ' VAL . . . 69.22 14.22 68.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.981 -0.628 . . . . 63.21 113.037 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -96.58 179.22 5.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.224 0.535 . . . . 54.42 112.071 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 15.0 p-10 -60.99 -45.32 95.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.769 -0.651 . . . . 70.35 111.599 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.578 HG13 ' NH2' ' A' ' 46' ' ' ARG . 7.4 p 30.73 88.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 72.34 113.28 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.584 ' HD2' ' NE2' ' A' ' 114' ' ' GLN . 34.1 ttpt -86.94 138.53 31.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.077 -0.965 . . . . 75.42 112.846 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 12.4 p -103.63 142.66 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 112.068 0.396 . . . . 74.1 112.068 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mm -122.41 138.59 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.763 0.425 . . . . 74.32 111.579 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.499 ' HG ' HD11 ' A' ' 17' ' ' ILE . 52.4 mt -107.79 121.01 43.85 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.953 0.406 . . . . 74.23 111.769 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 67.8 mttm -115.13 149.0 38.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.087 -0.506 . . . . 62.44 111.167 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.39 -176.92 6.07 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.105 0.479 . . . . 62.53 111.008 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.3 p -55.62 -34.94 65.35 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.144 -0.48 . . . . 64.12 111.001 170.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -72.89 -12.64 61.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.128 -0.487 . . . . 51.55 111.99 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.91 1.58 84.81 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.88 0.712 . . . . 53.01 114.88 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 105' ' ' LYS . 11.9 pt-20 -92.48 178.52 5.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.107 0.953 . . . . 74.13 112.033 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -92.24 133.59 35.67 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.244 0.831 . . . . 54.03 113.244 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.7 t -106.2 -50.23 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.019 -0.537 . . . . 75.13 110.717 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . . . -159.39 162.65 35.82 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.869 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.584 ' NE2' ' HD2' ' A' ' 101' ' ' LYS . 12.6 pt20 -153.17 171.32 18.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.099 -0.501 . . . . 71.51 111.177 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.3 ttm180 -175.6 147.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.859 0.361 . . . . 74.13 111.565 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.1 p -110.95 179.26 4.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.457 0.303 . . . . 62.52 111.002 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 80.7 p -75.48 117.69 17.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.128 0.49 . . . . 63.13 111.601 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -85.95 111.89 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.914 0.388 . . . . 73.24 110.623 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.77 70.72 2.57 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.498 0.666 . . . . 74.44 111.949 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -87.17 -38.92 15.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.845 -0.616 . . . . 71.3 111.013 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.8 m 57.85 102.33 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.542 0.571 . . . . 72.25 112.542 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.255 1.371 0 CA-C-N 116.15 -0.477 . . . . 74.4 111.932 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.643 ' SD ' ' NE2' ' A' ' 3' ' ' HIS . 20.9 ptp . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 111.732 0.271 . . . . 73.22 111.732 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.23 1.49 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.029 -0.605 . . . . 72.52 113.796 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.643 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 33.8 m170 -84.46 88.4 7.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.037 0.446 . . . . 73.22 110.95 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -94.14 125.14 38.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.957 0.408 . . . . 75.03 111.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -131.13 93.67 3.43 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.174 0.511 . . . . 73.35 111.97 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -138.74 102.51 4.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.386 -0.37 . . . . 74.51 110.891 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -99.58 -3.85 32.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.764 0.653 . . . . 73.0 112.764 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -76.29 105.3 7.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.169 0.509 . . . . 72.53 110.282 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 m -90.13 97.2 11.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.614 0.598 . . . . 43.22 112.614 -171.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -134.94 89.35 2.52 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.2 0.524 . . . . 72.55 110.098 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.5 mmt -88.11 155.36 19.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.765 -0.652 . . . . 63.52 111.924 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 t -141.52 113.98 8.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.092 -0.503 . . . . 71.43 111.626 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.3 101.32 2.75 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.226 -0.512 . . . . 72.32 112.653 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -100.32 9.12 43.16 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.276 0.473 . . . . 70.12 112.276 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.48 124.48 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.889 0.375 . . . . 75.01 111.216 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -144.95 174.38 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.502 -0.317 . . . . 65.31 110.979 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.32 124.5 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.238 -0.289 . . . . 74.43 111.483 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.77 -53.25 6.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.921 0.391 . . . . 72.22 110.872 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -165.02 137.06 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.23 0.538 . . . . 54.11 111.798 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 27' ' ' ILE . 61.2 mt -104.22 126.15 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.27 -0.423 . . . . 64.35 110.238 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.28 122.47 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.134 0.492 . . . . 73.33 111.87 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.64 -26.12 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.142 -0.481 . . . . 72.15 111.938 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -33.48 73.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.818 0.342 . . . . 64.02 110.586 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.64 30.05 3.92 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 114.126 0.41 . . . . 72.12 114.126 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HZ1' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mtpm? -98.98 -39.94 8.3 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.791 0.663 . . . . 75.41 112.791 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -153.6 158.19 40.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.265 0.839 . . . . 73.33 113.265 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 102' ' ' VAL . 66.0 mt -118.89 107.44 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.44 109.648 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -97.85 117.61 32.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.317 0.58 . . . . 75.01 112.512 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' HB2' HG11 ' A' ' 69' ' ' VAL . 6.5 mp -97.8 -172.68 2.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.011 -0.541 . . . . 71.23 111.501 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 22.9 ttmm -158.05 139.4 13.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.942 0.401 . . . . 72.24 111.719 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -103.21 100.26 10.16 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.451 -0.34 . . . . 71.54 110.253 168.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 t -102.27 98.83 8.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.411 0.624 . . . . 75.22 111.314 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -166.69 -178.46 4.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.312 0.577 . . . . 73.32 111.633 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -109.67 7.04 24.25 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.936 -0.574 . . . . 74.32 110.392 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -135.4 135.03 40.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 75.24 110.816 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.43 134.19 49.8 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.995 0.426 . . . . 61.13 111.853 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -89.0 112.77 52.91 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.391 -0.368 . . . . 72.44 111.213 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.3 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.777 2.318 . . . . 63.31 113.122 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.17 -73.27 0.05 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.104 0.562 . . . . 75.54 111.734 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 -75.48 1.57 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.143 -0.551 . . . . 73.05 113.001 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.67 93.7 0.11 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 74.32 113.403 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -116.44 167.71 10.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.661 0.384 . . . . 75.13 110.712 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -144.42 132.34 21.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.171 0.51 . . . . 74.22 111.34 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.47 ' HE2' HG22 ' A' ' 71' ' ' ILE . 57.6 ttp -103.82 107.78 18.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.848 -0.614 . . . . 60.35 111.428 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG13 ' HG ' ' A' ' 54' ' ' SER . 2.9 mp -95.11 99.94 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.781 0.324 . . . . 71.34 110.845 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.418 HH12 ' NE2' ' A' ' 91' ' ' GLN . 32.9 ttt180 -85.89 102.84 14.08 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.128 -0.357 . . . . 73.11 111.101 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -96.88 117.73 31.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.438 -0.346 . . . . 74.32 111.09 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.16 122.43 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.134 0.493 . . . . 73.13 112.037 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.7 -110.28 2.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.989 -0.551 . . . . 38.46 113.907 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.74 27.4 9.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.973 0.36 . . . . 74.22 111.973 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -153.62 162.35 41.34 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.237 0.541 . . . . 55.25 112.005 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -153.81 114.01 3.93 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.021 -0.536 . . . . 50.44 110.205 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.39 134.87 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.941 0.401 . . . . 70.24 111.809 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.532 ' HG ' HG13 ' A' ' 45' ' ' ILE . 72.2 m -109.16 124.24 50.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.288 -0.415 . . . . 70.35 111.697 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.417 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 70.0 t80 -114.26 108.77 17.39 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.807 0.337 . . . . 74.1 111.686 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.35 109.67 11.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.917 0.389 . . . . 73.35 110.542 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.595 ' HE2' HD12 ' A' ' 71' ' ' ILE . 94.1 m-85 -56.18 135.49 53.19 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.644 0.609 . . . . 64.24 112.644 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -97.27 123.1 40.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.044 -0.525 . . . . 73.55 111.248 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 t -73.56 68.72 1.19 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.118 0.414 . . . . 75.43 112.118 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -87.04 -12.87 46.02 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.987 0.422 . . . . 73.45 111.375 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.46 167.8 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.285 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.76 121.36 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.873 0.368 . . . . 73.45 111.593 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -76.24 87.1 3.07 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.479 0.657 . . . . 72.51 110.166 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 158.33 30.62 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.955 0.724 . . . . 62.22 112.955 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.62 117.89 6.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.612 -0.722 . . . . 75.31 112.841 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.53 -19.75 35.92 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.306 -0.473 . . . . 63.1 114.028 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.44 141.7 38.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.396 0.617 . . . . 75.12 111.747 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.4 p -105.31 98.38 8.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.783 -0.644 . . . . 72.54 111.735 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 29' ' ' LEU . 3.8 p -69.8 117.61 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 64.21 111.693 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 37.0 m -97.55 123.05 41.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.149 0.5 . . . . 74.34 111.921 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.595 HD12 ' HE2' ' A' ' 57' ' ' TYR . 47.8 mm -84.28 102.76 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.318 -0.401 . . . . 60.51 110.928 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.75 118.15 24.26 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.51 -0.314 . . . . 74.31 110.621 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' ASN . . . -71.45 77.46 0.77 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.65 0.611 . . . . 55.34 112.65 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 56.51 -72.82 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.399 0.889 . . . . 74.2 113.399 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 73' ' ' ALA . 65.5 m-20 -87.94 100.71 13.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.908 0.385 . . . . 63.34 111.43 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.47 9.02 0.34 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.546 0.573 . . . . 54.02 112.546 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.65 -35.84 1.83 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.169 -0.539 . . . . 42.13 114.31 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.66 149.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.381 0.511 . . . . 74.42 112.381 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -62.84 175.7 0.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.54 0.57 . . . . 74.2 112.54 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.44 76.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.092 0.775 . . . . 75.2 113.092 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.454 ' O ' ' NH1' ' A' ' 60' ' ' ARG . 69.8 m 65.17 104.17 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.621 0.971 . . . . 73.2 113.621 173.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HB3' HG21 ' A' ' 84' ' ' THR . 67.6 Cg_exo -45.96 169.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 123.747 2.965 . . . . 71.52 112.016 166.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER 10.76 65.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 N-CA-C 121.65 3.673 . . . . 74.0 121.65 38.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.667 HG21 ' HB3' ' A' ' 82' ' ' PRO . 15.3 t 144.74 -59.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.3 1.84 . . . . 71.12 110.812 162.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 84' ' ' THR . 21.3 m-20 -110.76 -168.62 1.33 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.195 0.598 . . . . 61.32 110.296 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -141.78 137.15 31.37 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.945 0.402 . . . . 63.51 111.603 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 81' ' ' SER . 1.6 mp -91.36 123.7 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.699 0.761 . . . . 71.23 111.016 175.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.487 ' CE2' ' HB2' ' A' ' 90' ' ' ASN . 21.7 t90 -92.12 109.74 21.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.324 -0.853 . . . . 72.1 110.999 -176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -93.88 2.07 56.24 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.246 0.832 . . . . 74.55 113.246 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 17.2 m120 -74.01 -40.81 62.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.86 -0.525 . . . . 72.52 111.755 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.418 ' NE2' HH12 ' A' ' 46' ' ' ARG . 39.9 tt0 -148.52 155.88 41.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.605 0.24 . . . . 71.4 110.607 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.611 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 10.7 m120 -91.97 175.96 6.69 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.284 0.564 . . . . 73.44 112.447 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -59.57 125.13 22.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 72.21 111.508 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -104.56 -173.66 2.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.01 0.433 . . . . 73.12 111.664 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.76 95.86 0.14 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.265 -0.493 . . . . 52.01 112.759 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -167.51 160.44 13.1 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.668 -0.313 . . . . 71.05 111.438 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.15 4.1 62.39 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.289 -0.481 . . . . 44.04 113.122 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.76 156.67 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.175 0.512 . . . . 64.31 112.248 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.91 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.777 0.658 . . . . 42.33 112.777 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 117' ' ' THR . 6.5 p -81.04 79.61 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.079 0.942 . . . . 62.51 109.622 167.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.775 ' HZ1' ' HB2' ' A' ' 101' ' ' LYS . 3.9 ttmp? -88.13 105.63 17.63 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.554 -0.748 . . . . 62.02 111.391 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 27' ' ' ILE . 61.7 t -91.05 123.39 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.665 -0.698 . . . . 74.53 111.48 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 21.4 mm -106.57 117.66 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.149 -0.478 . . . . 71.34 110.934 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -91.96 121.72 33.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.838 0.351 . . . . 54.12 111.341 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 93.6 mttt -130.58 168.27 17.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.711 0.291 . . . . 65.41 111.315 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.412 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 20.3 m120 -97.08 175.6 6.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.901 0.381 . . . . 74.41 111.141 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -57.97 -33.2 68.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.775 0.658 . . . . 75.03 112.775 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.91 0.68 17.44 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 72.11 112.436 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.42 33.53 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.152 -0.547 . . . . 38.46 113.336 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 10.9 pt-20 -103.08 127.28 50.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.943 0.401 . . . . 70.52 110.918 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.2 tt0 -76.82 138.93 40.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.978 0.418 . . . . 53.21 111.97 -175.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.45 -61.99 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.256 -0.429 . . . . 44.12 111.326 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.99 162.19 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.7 0.286 . . . . 63.14 111.57 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.36 157.64 42.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.993 0.425 . . . . 73.33 111.834 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -164.31 156.19 16.31 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.201 -0.454 . . . . 75.43 110.977 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.7 p -141.17 -162.37 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.6 0.238 . . . . 75.14 111.3 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.631 HG21 HG13 ' A' ' 100' ' ' VAL . 17.0 p -61.71 94.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.173 0.511 . . . . 63.32 111.89 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.37 86.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.455 0.645 . . . . 74.51 110.846 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -78.38 26.0 0.23 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.897 -0.592 . . . . 75.25 112.39 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -140.48 133.28 29.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.147 -0.346 . . . . 61.14 110.559 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -94.46 128.26 40.92 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.209 0.528 . . . . 74.34 111.336 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.041 0.385 . . . . 74.25 112.041 -176.051 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.12 0.486 . . . . 73.14 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.9 158.61 10.16 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.032 -0.531 . . . . 41.2 112.784 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -136.62 21.83 3.12 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.72 0.637 . . . . 75.24 112.72 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -104.56 95.89 6.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.767 0.317 . . . . 74.2 111.405 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -108.94 -14.73 14.51 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.355 0.502 . . . . 73.21 112.355 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -75.74 82.97 2.71 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.145 0.498 . . . . 71.45 111.876 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -128.67 112.02 13.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.206 -0.452 . . . . 75.14 111.28 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.564 ' NE2' ' SD ' ' A' ' 11' ' ' MET . 56.5 p-80 -132.29 112.91 12.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.981 0.419 . . . . 73.34 110.304 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 p -82.91 58.83 4.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.187 0.518 . . . . 72.51 112.221 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -151.44 83.17 1.3 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.085 -0.507 . . . . 74.12 110.129 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.564 ' SD ' ' NE2' ' A' ' 8' ' ' HIS . 94.3 mmm -140.05 152.5 46.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 74.33 112.32 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 t -128.14 170.21 13.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.758 -0.655 . . . . 73.5 111.167 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 129.07 10.52 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 114.306 0.482 . . . . 44.51 114.306 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -114.43 -57.7 2.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.85 0.357 . . . . 73.31 111.435 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.89 143.68 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.324 -0.398 . . . . 75.44 111.331 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 44.2 t -141.62 173.37 11.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.091 0.472 . . . . 74.05 111.699 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.537 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 61.0 mt -81.51 127.45 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.344 -0.389 . . . . 73.21 111.33 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 37.0 tt0 -81.71 -58.33 3.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.659 -0.497 . . . . 71.44 109.659 171.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 25.2 tt0 173.82 152.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.799 -0.637 . . . . 65.34 111.097 169.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.465 HD12 HG23 ' A' ' 102' ' ' VAL . 23.1 mt -71.89 162.57 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 116.164 -0.471 . . . . 74.3 111.239 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.14 150.36 34.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.229 0.537 . . . . 73.24 111.835 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.07 -33.45 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.849 -0.614 . . . . 63.42 112.268 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.52 -30.58 19.24 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.147 0.498 . . . . 73.22 111.028 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.04 35.75 3.86 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.104 -0.498 . . . . 73.32 112.827 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -96.06 -29.04 14.32 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.709 0.29 . . . . 74.41 111.759 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.09 176.01 12.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.463 0.649 . . . . 74.41 112.286 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -119.89 138.54 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.805 -0.634 . . . . 75.53 109.946 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -119.26 110.21 16.74 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.213 0.53 . . . . 75.43 111.9 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 29' ' ' LEU . 4.6 mp -106.9 175.51 5.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.981 -0.554 . . . . 75.22 110.57 175.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -151.71 138.67 19.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.936 0.398 . . . . 75.3 111.713 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -75.46 84.57 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.562 . . . . 74.53 110.821 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.2 p -78.0 89.03 4.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 61.44 111.094 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.4 p -158.48 -175.77 5.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.305 -0.407 . . . . 71.43 111.161 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.47 -4.52 31.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.334 0.494 . . . . 62.32 112.334 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -156.39 166.68 32.72 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.786 0.327 . . . . 65.31 111.306 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -54.97 117.15 3.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.79 0.293 . . . . 73.53 111.79 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -127.46 112.86 21.11 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 122.618 0.367 . . . . 72.44 110.889 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 58.2 Cg_endo -70.67 136.9 31.65 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.251 1.968 . . . . 62.45 112.921 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 tpt -66.28 -85.59 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 116.452 -0.34 . . . . 75.34 110.706 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.93 -83.09 0.02 OUTLIER Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.362 0.905 . . . . 61.23 115.362 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.48 46.07 3.19 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.605 0.602 . . . . 64.23 114.605 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -120.25 147.27 45.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.457 -0.437 . . . . 73.13 111.124 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -113.77 109.82 19.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.04 -0.527 . . . . 65.34 110.758 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.496 ' HE3' HG22 ' A' ' 71' ' ' ILE . 52.6 ttp -91.34 116.25 28.69 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.236 -0.438 . . . . 74.1 111.717 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.654 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.5 mp -106.26 103.62 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 109.811 -0.44 . . . . 73.12 109.811 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.474 HH12 ' HB ' ' A' ' 48' ' ' ILE . 47.7 ttp85 -89.39 114.1 25.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 73.13 111.628 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -93.44 168.71 10.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.101 -0.499 . . . . 74.44 111.304 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.494 HG21 ' H ' ' A' ' 49' ' ' GLY . 10.8 tt -169.74 -60.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.853 -0.612 . . . . 70.23 111.148 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' H ' HG21 ' A' ' 48' ' ' ILE . . . -159.68 114.87 0.63 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.235 -0.507 . . . . 70.5 112.584 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 67.45 -75.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.213 0.605 . . . . 75.13 111.999 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -93.88 150.86 20.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.196 0.522 . . . . 63.31 112.151 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.6 p -142.06 149.73 40.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.053 0.454 . . . . 72.1 111.444 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.34 146.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.827 0.346 . . . . 74.01 111.654 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -111.91 164.49 13.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.821 0.674 . . . . 73.15 112.821 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -161.36 135.07 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.006 -0.543 . . . . 75.1 111.514 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -91.6 135.12 34.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.566 0.222 . . . . 75.0 110.724 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -67.58 147.02 53.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.044 0.449 . . . . 64.53 111.974 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 t -81.2 126.24 31.27 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.365 0.602 . . . . 65.53 112.226 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.9 m -85.49 82.85 8.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 63.33 110.94 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -135.32 14.04 3.51 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.633 0.605 . . . . 75.34 112.633 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -165.53 158.64 15.94 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.895 0.379 . . . . 71.54 111.913 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 38' ' ' PRO . 61.4 t -104.57 113.92 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.268 -0.423 . . . . 75.1 110.308 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.34 118.56 21.36 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.848 0.356 . . . . 75.42 111.231 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -64.33 152.62 40.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.377 0.608 . . . . 71.55 112.628 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 127.84 33.15 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.046 -0.525 . . . . 70.13 111.851 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.01 -2.05 88.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.149 -0.548 . . . . 72.13 113.41 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.667 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.44 148.97 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.541 -0.388 . . . . 72.53 111.389 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -95.75 157.54 15.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.19 0.519 . . . . 72.34 112.062 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.65 125.21 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.172 0.51 . . . . 73.33 110.191 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -101.61 108.23 19.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.279 -0.419 . . . . 64.23 111.948 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' HE3' ' A' ' 44' ' ' MET . 44.0 mm -91.77 102.63 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.464 -0.335 . . . . 72.14 111.23 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m95 -85.0 170.28 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.0 0.429 . . . . 74.42 111.979 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.82 167.37 11.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.394 -0.366 . . . . 50.24 111.285 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -51.08 -41.72 60.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -93.49 35.52 1.11 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.844 0.354 . . . . 65.21 111.849 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -65.19 -45.94 82.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.486 0.55 . . . . 71.43 112.486 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.1 -38.47 3.17 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.262 -0.494 . . . . 60.24 113.122 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 87' ' ' ILE . 27.0 m -68.17 170.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.085 0.402 . . . . 73.44 112.085 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.0 m -60.46 128.93 39.08 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.497 -0.32 . . . . 71.24 111.413 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.22 -40.17 46.63 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.853 0.686 . . . . 74.54 112.853 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.444 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 22.6 t -146.95 89.38 5.66 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 121.049 0.452 . . . . 64.51 111.345 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.672 ' HB2' ' H ' ' A' ' 84' ' ' THR . 47.1 Cg_exo -59.34 -32.13 96.18 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.772 2.981 . . . . 74.44 117.233 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 28.0 Cg_endo -101.13 37.79 5.59 Favored 'Cis proline' 0 C--N 1.371 1.718 0 CA-C-N 122.437 1.906 . . . . 74.4 114.532 3.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.672 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 74.9 p -62.83 -48.51 78.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.098 0.475 . . . . 65.43 111.219 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 4.8 m-20 -93.29 161.13 14.53 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.087 -0.506 . . . . 63.34 110.943 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' HB2' HD11 ' A' ' 71' ' ' ILE . 90.6 mt -130.02 109.54 10.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.87 0.366 . . . . 62.14 110.631 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.554 HD13 HG21 ' A' ' 78' ' ' VAL . 1.5 mp -85.47 111.18 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.653 0.74 . . . . 74.42 111.637 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.569 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 21.2 t90 -79.68 96.86 6.34 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.309 -0.859 . . . . 73.21 111.19 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 53.4 mtmt -93.35 22.39 5.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.383 0.883 . . . . 71.2 113.383 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.569 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 14.7 m120 -89.92 -8.58 51.48 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.118 0.485 . . . . 75.52 110.799 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -150.91 134.47 16.37 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.025 -0.534 . . . . 75.04 111.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.598 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 15.3 m120 -64.67 -56.06 16.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.467 0.543 . . . . 72.42 112.467 -175.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.9 t -179.09 -178.44 0.52 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.552 0.341 . . . . 65.02 110.793 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -142.22 -82.64 0.2 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 111.634 0.235 . . . . 73.31 111.634 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 35.28 49.06 0.87 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 115.912 1.125 . . . . 43.33 115.912 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -156.37 137.32 13.53 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.862 1.06 . . . . 64.2 113.862 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.15 -97.97 0.78 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.51 0.964 . . . . 72.52 115.51 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -84.92 177.23 8.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.078 0.77 . . . . 75.24 113.078 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 7.4 p-10 -75.27 121.38 22.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.101 -0.954 . . . . 74.13 112.382 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.465 HG22 HH11 ' A' ' 46' ' ' ARG . 7.3 p -81.07 128.59 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.171 0.51 . . . . 75.03 110.955 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -140.15 119.49 12.97 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.34 -0.391 . . . . 65.43 111.443 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG23 HD12 ' A' ' 20' ' ' ILE . 85.0 t -93.81 136.97 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.519 0.563 . . . . 72.12 112.519 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.654 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.0 mm -110.74 132.73 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.772 -0.649 . . . . 53.43 111.012 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.8 mt -113.61 111.3 21.64 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.762 0.653 . . . . 63.13 112.762 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -109.07 161.15 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.386 -0.37 . . . . 71.04 110.765 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.537 ' OD1' HG21 ' A' ' 112' ' ' VAL . 7.4 m120 -114.98 97.69 6.37 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.903 0.334 . . . . 74.3 111.903 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t 47.71 -77.52 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.987 1.106 . . . . 73.34 113.987 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 106' ' ' ASN . 64.6 mt-30 -61.6 -35.46 77.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.77 0.655 . . . . 72.43 112.77 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.59 -24.17 2.32 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.535 -0.84 . . . . 70.51 113.618 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.98 150.03 25.7 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.276 0.538 . . . . 75.42 111.301 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.82 137.53 54.5 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.503 -0.317 . . . . 73.22 111.655 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.537 HG21 ' OD1' ' A' ' 106' ' ' ASN . 94.7 t -98.91 -68.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.179 0.437 . . . . 64.04 112.179 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.27 162.78 33.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.067 0.766 . . . . 75.25 113.067 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -152.46 143.72 23.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.151 -0.931 . . . . 52.33 110.097 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -153.29 142.91 21.86 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.505 0.558 . . . . 61.3 112.505 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 p -111.94 -174.72 2.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.529 -0.76 . . . . 65.14 110.812 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 p -122.6 -178.2 3.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.263 0.554 . . . . 72.34 112.319 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.38 148.23 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.004 -0.543 . . . . 73.03 111.318 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -77.98 126.85 31.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.387 0.514 . . . . 74.04 112.387 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -108.3 133.61 52.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.406 0.283 . . . . 64.22 110.888 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.7 m -76.97 83.69 3.5 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.134 0.492 . . . . 74.43 111.287 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.625 -0.703 . . . . 73.25 112.005 -177.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.005 0.431 . . . . 74.21 111.652 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.28 49.01 0.05 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.429 -0.415 . . . . 72.53 112.745 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -102.36 96.71 7.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.866 0.365 . . . . 73.45 111.353 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -144.26 175.01 10.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.188 0.518 . . . . 74.42 112.278 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.48 116.92 15.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.091 -0.504 . . . . 74.45 110.755 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -64.54 107.83 1.5 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.856 0.687 . . . . 74.53 112.856 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -145.28 137.33 25.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.27 -0.423 . . . . 75.11 109.901 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -140.62 142.53 35.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.668 0.247 . . . . 64.41 111.668 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.0 p -178.3 112.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.493 -0.321 . . . . 72.24 111.757 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -75.63 90.66 2.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.093 0.473 . . . . 72.32 110.644 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.504 ' HG3' ' HD2' ' A' ' 38' ' ' PRO . 25.4 mmt -99.83 147.27 25.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.149 -0.478 . . . . 74.05 111.628 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 t -71.9 -37.21 70.14 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.092 -0.504 . . . . 63.01 111.785 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.62 68.9 1.47 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.013 -0.613 . . . . 72.22 113.081 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.68 7.79 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.253 -0.557 . . . . 62.53 110.706 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HB ' ' CH2' ' A' ' 42' ' ' TRP . 56.6 t -126.7 139.34 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.059 -0.519 . . . . 70.53 111.402 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -121.26 159.39 26.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.977 0.418 . . . . 61.12 111.208 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.557 HD11 ' HG ' ' A' ' 104' ' ' LEU . 55.2 mt -93.13 127.99 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.311 -0.243 . . . . 54.11 111.316 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.54 -77.02 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.691 0.282 . . . . 74.13 111.095 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -169.29 158.01 7.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.266 -0.424 . . . . 74.44 110.838 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.438 HG12 HG21 ' A' ' 27' ' ' ILE . 48.9 mt -91.69 145.4 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.431 . . . . 71.41 111.495 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.52 143.45 57.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.394 0.516 . . . . 65.52 112.394 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.49 -28.31 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.842 -0.617 . . . . 61.23 112.062 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.09 -31.58 30.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.09 0.471 . . . . 62.43 110.789 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.68 16.55 26.15 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 116.171 -0.468 . . . . 54.12 113.116 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -78.49 -31.25 47.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.347 0.499 . . . . 72.31 112.347 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -157.27 167.05 31.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.861 1.06 . . . . 74.03 113.861 -172.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.438 HG21 HG12 ' A' ' 20' ' ' ILE . 68.1 mt -127.07 110.93 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.934 -1.03 . . . . 72.44 109.343 170.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.3 ttp180 -92.58 117.42 29.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.346 0.593 . . . . 71.01 112.378 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 29' ' ' LEU . 6.5 mp -99.91 158.55 15.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.863 -0.608 . . . . 71.32 110.26 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 65.0 tttm -124.03 116.83 23.47 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.024 -0.422 . . . . 63.43 111.505 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.33 108.14 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.097 0.475 . . . . 73.24 110.411 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -96.52 18.05 14.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.383 0.512 . . . . 73.42 112.383 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.8 p -71.72 161.79 30.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.418 0.628 . . . . 73.21 111.72 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -85.73 -19.4 30.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 72.11 111.168 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -142.03 158.36 43.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.587 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.12 135.78 12.62 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.501 0.556 . . . . 75.43 112.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -134.35 132.46 21.01 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.166 -0.47 . . . . 62.3 111.33 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 11' ' ' MET . 73.3 Cg_endo -73.46 21.31 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.706 2.271 . . . . 71.11 113.442 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 tpt 63.5 -78.84 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.474 0.71 . . . . 74.05 112.285 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.41 -170.49 18.49 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.3 -0.476 . . . . 52.12 113.732 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.63 1.59 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.309 -0.472 . . . . 70.13 113.384 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.447 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 11.9 m95 -98.46 151.16 20.9 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 122.481 -0.423 . . . . 75.31 111.228 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.64 114.41 24.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.884 0.373 . . . . 52.34 110.001 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.43 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 56.2 ttp -98.33 108.45 21.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.442 -0.344 . . . . 51.03 111.087 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.4 mp -96.8 109.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.584 -0.28 . . . . 75.32 111.444 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -99.46 101.29 12.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.69 0.281 . . . . 74.23 110.931 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 47' ' ' LYS . 7.6 mtpm? -82.04 84.78 6.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.053 0.454 . . . . 72.13 110.987 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -103.39 118.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.021 -0.536 . . . . 74.31 111.248 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.02 46.09 60.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.888 -0.672 . . . . 37.82 111.893 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 73.68 -56.25 0.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.456 0.702 . . . . 74.54 111.953 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -61.61 161.61 9.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.133 0.492 . . . . 75.51 111.795 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 80.5 p -124.0 132.03 53.64 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.26 0.552 . . . . 61.03 112.128 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.4 134.31 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.881 -0.6 . . . . 75.0 109.669 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' MET . 80.8 p -120.18 144.18 47.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.167 0.803 . . . . 72.23 113.167 -170.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -113.83 125.35 53.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.671 -0.695 . . . . 75.02 110.923 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.97 128.59 38.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.024 0.44 . . . . 63.13 111.001 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.447 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 21.0 m-85 -84.42 165.19 18.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.202 0.525 . . . . 72.42 111.694 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -142.96 176.05 9.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.009 -0.541 . . . . 74.5 110.806 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -123.36 105.97 10.28 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.168 0.508 . . . . 71.43 112.008 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 1.9 ptp180 -140.37 17.68 2.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.974 -0.557 . . . . 74.34 110.292 173.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.54 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 47.1 p90 -162.92 172.13 15.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.031 -0.532 . . . . 73.43 111.102 -173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.68 114.63 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.483 -0.326 . . . . 63.35 110.601 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.42 130.03 39.26 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.073 0.463 . . . . 75.02 110.645 -177.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 85.2 mttt -71.76 149.63 45.19 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.23 0.538 . . . . 71.33 112.346 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.47 122.77 14.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.495 . . . . 62.04 112.036 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 0.04 67.49 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.412 -0.423 . . . . 72.2 114.111 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -79.19 148.47 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.173 0.487 . . . . 73.31 111.898 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 65.1 p -92.7 134.56 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.839 0.352 . . . . 75.43 111.644 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.31 112.87 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.413 0.625 . . . . 62.35 111.004 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 85.3 m -91.36 123.95 35.18 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 65.12 112.047 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.544 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.5 mm -90.14 99.24 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.822 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.561 ' HB2' HG13 ' A' ' 87' ' ' ILE . 85.6 m95 -84.49 161.79 20.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.975 0.417 . . . . 75.12 111.966 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . . . -87.27 167.84 13.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.906 0.384 . . . . 51.41 111.96 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.2 -60.78 2.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.543 0.572 . . . . 62.54 112.543 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -91.08 41.57 1.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.103 0.477 . . . . 71.15 111.877 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.27 60.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.81 0.338 . . . . 64.22 111.664 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.17 -44.22 2.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.319 -0.467 . . . . 74.24 113.627 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.27 171.03 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.459 0.541 . . . . 71.14 112.459 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.8 m -53.87 130.24 36.5 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.784 0.326 . . . . 75.45 111.336 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.528 ' HB1' ' HD3' ' A' ' 89' ' ' LYS . . . -78.27 10.28 3.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.413 0.894 . . . . 75.14 113.413 -173.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 t -152.73 133.07 7.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 112.407 0.521 . . . . 73.23 112.407 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.624 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 66.8 Cg_exo -54.33 -178.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.906 3.071 . . . . 65.52 113.0 172.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.594 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 89.6 Cg_endo -93.85 101.67 0.22 Allowed 'Cis proline' 0 C--N 1.366 1.49 0 N-CA-C 115.536 1.322 . . . . 74.32 115.536 5.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 83' ' ' PRO . 2.1 p -158.13 -60.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.509 0.724 . . . . 74.42 109.56 171.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 8.1 m-20 -122.1 -168.87 1.79 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.304 -0.862 . . . . 74.24 109.75 172.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' HD13 ' A' ' 71' ' ' ILE . 78.4 mt -127.08 108.7 11.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.048 0.452 . . . . 70.25 110.885 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -95.96 108.66 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.318 0.58 . . . . 62.01 111.436 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.462 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 10.9 t90 -74.35 84.06 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.548 0.69 . . . . 65.55 110.617 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.709 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 9.7 mtmp? -73.1 4.07 4.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.695 0.628 . . . . 73.54 112.695 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.462 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 16.1 m120 -92.43 -13.35 30.14 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.508 0.559 . . . . 72.54 112.508 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -151.44 159.13 44.35 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.002 0.43 . . . . 54.24 111.327 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 52.4 m-80 -109.83 -169.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.565 0.579 . . . . 75.45 112.565 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.5 m -60.03 156.47 14.77 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.372 0.879 . . . . 70.34 113.372 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -127.46 160.2 32.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.2 -0.909 . . . . 73.03 111.116 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.42 48.68 0.36 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.985 -0.626 . . . . 62.02 112.865 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.4 t -65.65 -22.81 66.68 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.722 0.638 . . . . 73.43 112.722 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.29 3.43 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.074 -0.584 . . . . 71.22 113.238 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -82.41 170.22 15.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.145 0.498 . . . . 65.23 111.849 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.11 164.19 26.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.884 -0.598 . . . . 73.42 111.781 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.5 p -144.66 140.33 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.96 0.41 . . . . 71.42 111.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.7 ttpt -107.38 128.87 54.86 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.942 0.401 . . . . 63.31 111.314 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.5 HG13 HD12 ' A' ' 17' ' ' ILE . 4.0 p -114.01 136.87 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.325 0.583 . . . . 70.05 111.886 -178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.38 142.49 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.917 -0.583 . . . . 72.31 111.599 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.557 ' HG ' HD11 ' A' ' 17' ' ' ILE . 38.9 mt -122.95 107.76 12.19 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.054 0.39 . . . . 70.1 112.054 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -114.12 136.56 52.8 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.296 0.57 . . . . 51.02 111.337 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.53 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 9.4 m120 -93.57 108.05 19.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.823 -0.626 . . . . 73.45 112.489 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.3 t 59.92 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.297 0.851 . . . . 73.34 113.297 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.93 -71.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.444 0.64 . . . . 75.24 111.654 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.58 -22.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.455 -0.793 . . . . 73.4 111.732 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 9.2 pt-20 -44.28 133.25 5.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.344 0.658 . . . . 73.22 111.349 171.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.7 128.8 53.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.898 0.38 . . . . 75.21 111.844 -172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 106' ' ' ASN . 17.9 m -85.57 -35.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 112.066 0.395 . . . . 72.12 112.066 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.59 154.01 1.94 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.429 0.633 . . . . 72.1 112.621 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -139.59 130.15 25.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.565 -0.743 . . . . 74.31 110.102 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -141.5 148.33 39.24 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.481 0.549 . . . . 70.14 112.481 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.9 p -106.99 169.8 8.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.241 -0.436 . . . . 52.44 111.407 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.1 p -78.51 134.22 37.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.032 0.382 . . . . 73.34 112.032 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.21 135.93 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.945 0.403 . . . . 74.13 111.475 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -70.69 86.58 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.028 0.442 . . . . 73.43 111.529 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.462 ' HZ2' ' C ' ' A' ' 122' ' ' THR . 59.5 tttm -96.18 107.58 19.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 75.21 110.423 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -86.91 -15.3 39.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.97 0.414 . . . . 75.14 112.07 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.462 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 34.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.777 -0.63 . . . . 72.23 110.881 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' SD ' ' OG1' ' A' ' 58' ' ' THR . 26.6 ptm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.603 0.239 . . . . 71.03 111.453 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.58 116.43 8.69 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.324 -0.465 . . . . 74.44 113.449 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -137.64 164.98 27.48 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.439 -0.448 . . . . 72.3 111.508 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -66.75 91.78 0.2 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.23 -0.441 . . . . 53.15 111.016 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -82.33 128.29 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.009 0.433 . . . . 72.22 111.106 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -106.09 175.3 5.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.258 -0.428 . . . . 73.43 111.122 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -108.34 141.73 39.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.444 0.164 . . . . 71.22 110.951 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.4 m80 68.91 11.69 8.41 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.098 0.559 . . . . 71.11 111.708 -172.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -80.3 92.85 5.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.935 0.398 . . . . 63.34 111.583 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -143.12 123.3 13.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.89 0.376 . . . . 63.34 111.712 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 mmt -129.88 144.36 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.457 -0.338 . . . . 71.44 110.798 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.4 p -73.9 -74.35 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.28 0.474 . . . . 72.12 112.28 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.3 101.82 0.2 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.98 -0.629 . . . . 53.25 113.109 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -102.94 -43.17 5.6 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.598 -0.354 . . . . 72.3 111.908 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.0 t -84.62 102.84 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.899 0.38 . . . . 73.42 111.528 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.8 t -121.41 149.82 42.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.818 0.342 . . . . 65.1 111.404 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.633 HG13 HD11 ' A' ' 104' ' ' LEU . 61.3 mt -62.37 132.19 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 112.301 0.482 . . . . 75.51 112.301 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -84.47 -62.39 1.57 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.408 0.623 . . . . 74.11 110.206 173.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -149.45 136.68 19.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.614 . . . . 72.33 110.748 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.76 HG21 HG12 ' A' ' 27' ' ' ILE . 40.9 mt -94.5 146.69 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.945 -0.391 . . . . 75.43 109.945 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.18 129.87 41.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.141 0.496 . . . . 73.15 112.069 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.52 -23.54 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.902 -0.59 . . . . 71.34 111.59 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.37 -32.3 54.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.162 0.506 . . . . 74.12 110.775 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 102.08 41.9 2.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.073 -0.512 . . . . 73.12 114.32 173.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -129.36 -6.58 4.77 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.975 1.102 . . . . 74.1 113.975 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.74 163.19 24.17 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.573 0.953 . . . . 73.24 113.573 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.76 HG12 HG21 ' A' ' 20' ' ' ILE . 56.0 mt -134.54 115.5 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.366 -0.834 . . . . 71.22 110.337 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -94.88 110.34 22.23 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.686 -0.634 . . . . 75.53 112.172 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 5.8 mp -94.09 145.3 24.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.063 -0.517 . . . . 63.44 110.636 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -125.65 125.5 43.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.839 0.352 . . . . 71.34 111.11 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.09 127.54 32.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.719 0.295 . . . . 71.43 110.906 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.7 p -93.24 -15.99 25.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.313 0.486 . . . . 74.35 112.313 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.0 p -69.92 134.61 48.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.002 0.429 . . . . 72.32 111.114 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.62 25.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.118 0.485 . . . . 52.52 111.424 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.74 143.74 27.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.16 -0.473 . . . . 71.44 110.872 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.84 104.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.722 0.409 . . . . 74.02 111.859 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.04 135.08 20.03 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 111.756 0.28 . . . . 64.21 111.756 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.95 48.07 2.54 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.701 2.267 . . . . 62.43 112.907 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.678 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 1.9 tpt 67.23 -69.4 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.422 0.689 . . . . 74.1 112.059 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.1 4.01 61.53 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.136 -0.554 . . . . 63.12 113.458 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.87 101.11 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.197 -0.525 . . . . 70.33 113.345 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.454 ' CD1' ' HE3' ' A' ' 39' ' ' MET . 22.6 m95 -121.16 175.88 5.88 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.599 -0.354 . . . . 74.33 111.419 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -145.36 123.11 11.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.421 . . . . 74.32 111.387 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.575 ' HE1' HG22 ' A' ' 71' ' ' ILE . 52.6 ttp -99.96 117.31 33.98 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.119 -0.491 . . . . 73.15 111.329 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.775 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.2 mp -104.45 105.49 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.036 0.446 . . . . 73.2 111.036 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.651 HH11 ' HZ3' ' A' ' 88' ' ' TRP . 61.0 ttt180 -82.29 109.02 16.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.499 -0.318 . . . . 74.42 111.398 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -117.03 141.73 47.88 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.876 0.369 . . . . 75.41 111.108 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 100' ' ' VAL . 13.3 tt -166.1 -46.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 111.785 0.291 . . . . 73.52 111.785 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.26 21.29 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.174 -0.536 . . . . 42.51 113.093 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.23 8.56 5.76 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.536 -0.391 . . . . 74.32 111.922 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -149.32 166.06 30.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.862 0.363 . . . . 72.43 111.202 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.0 p -128.26 164.39 22.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.961 0.41 . . . . 75.01 111.252 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.45 132.69 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.543 -0.299 . . . . 73.04 110.954 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.5 m -104.87 162.05 13.66 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.27 0.557 . . . . 65.14 112.481 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 72.3 t80 -142.87 118.96 10.71 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.956 -0.566 . . . . 74.22 110.645 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -91.67 123.38 35.02 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.834 0.35 . . . . 70.23 110.54 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -74.56 177.07 6.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.539 0.94 . . . . 71.13 113.539 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 HG21 ' CE2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -125.71 165.87 17.82 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.522 -0.763 . . . . 71.33 112.09 -177.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 t -106.4 10.4 31.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.216 -0.447 . . . . 55.14 111.855 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.58 -35.43 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.208 0.448 . . . . 74.23 112.208 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.468 ' CE2' HG21 ' A' ' 58' ' ' THR . 17.5 p90 -101.19 149.15 24.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.109 0.481 . . . . 75.12 111.566 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.46 126.11 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.084 0.469 . . . . 70.22 111.496 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.56 96.34 6.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 62.54 110.941 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.41 168.61 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.196 0.522 . . . . 63.33 111.954 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.76 107.24 0.58 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.137 -0.483 . . . . 61.3 111.602 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 2.67 83.23 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.44 -0.41 . . . . 74.44 113.592 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -54.49 120.96 7.38 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.845 0.683 . . . . 72.24 112.845 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -94.39 112.92 24.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.04 -0.527 . . . . 73.22 110.975 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.38 128.5 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.02 0.438 . . . . 75.24 110.726 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.7 m -106.97 118.59 37.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.189 0.519 . . . . 75.33 112.1 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.575 HG22 ' HE1' ' A' ' 44' ' ' MET . 33.7 mm -86.36 104.8 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 65.14 110.644 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 63.3 m95 -87.53 159.19 18.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.953 0.406 . . . . 75.33 111.26 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.07 175.85 8.77 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.913 0.387 . . . . 70.34 111.374 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -22.6 19.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.315 0.487 . . . . 70.1 112.315 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.44 29.6 3.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.685 0.278 . . . . 74.11 111.477 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.77 -62.19 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.07 0.767 . . . . 73.2 113.07 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.63 -37.72 3.48 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.079 -0.51 . . . . 73.54 112.351 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 87' ' ' ILE . 30.4 m -76.55 166.61 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.84 0.353 . . . . 73.13 111.707 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -67.13 170.12 7.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.553 0.575 . . . . 75.55 112.553 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.77 92.2 2.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.834 0.679 . . . . 61.23 112.834 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.541 ' H ' HD12 ' A' ' 87' ' ' ILE . 71.2 m 59.96 94.54 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.33 0.863 . . . . 65.45 113.33 172.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 78.5 Cg_exo -52.77 -41.34 70.54 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.542 2.828 . . . . 62.02 116.228 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.588 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.4 Cg_endo -98.2 135.97 3.24 Favored 'Cis proline' 0 C--N 1.366 1.477 0 CA-C-N 121.394 1.533 . . . . 71.42 114.639 -1.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 85' ' ' ASP . 6.3 t -163.8 -48.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.933 -0.766 . . . . 75.22 108.933 170.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 8.1 m-20 -86.25 115.11 23.59 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.98 -0.748 . . . . 62.12 108.98 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -92.59 112.11 23.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.921 0.391 . . . . 50.23 111.659 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.563 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.5 mp -81.93 96.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.578 0.704 . . . . 61.23 110.636 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HZ3' HH11 ' A' ' 46' ' ' ARG . 28.8 t90 -71.44 86.28 0.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.68 -0.691 . . . . 74.33 111.066 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.17 7.26 9.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.888 0.699 . . . . 72.32 112.888 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 14.6 m120 -70.06 -27.3 64.52 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.841 0.311 . . . . 72.24 111.841 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -159.44 156.92 29.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.861 0.362 . . . . 75.43 111.397 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -170.31 0.97 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.136 0.791 . . . . 70.2 113.136 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.4 m -67.41 -173.01 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.823 -0.626 . . . . 75.52 112.58 -173.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.465 ' HB3' ' NH2' ' A' ' 46' ' ' ARG . 49.3 p90 -141.69 147.0 36.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.06 0.457 . . . . 75.33 111.49 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.66 43.5 0.06 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.357 -0.449 . . . . 75.41 112.594 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.5 t -83.41 18.65 1.75 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.49 0.552 . . . . 74.22 112.49 -176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.61 -37.59 3.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.971 -0.633 . . . . 37.91 113.115 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.41 151.63 23.38 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.357 0.599 . . . . 73.34 112.015 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.35 130.34 41.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.33 -0.85 . . . . 71.03 112.226 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 48' ' ' ILE . 7.3 p -75.85 108.83 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.386 0.612 . . . . 55.13 110.811 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -90.19 103.13 15.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.491 0.662 . . . . 75.31 110.859 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG22 HD12 ' A' ' 27' ' ' ILE . 61.1 t -88.87 126.77 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.575 -0.739 . . . . 75.22 112.019 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.775 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 46.7 mm -97.71 132.18 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.536 -0.756 . . . . 74.05 111.461 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.633 HD11 HG13 ' A' ' 17' ' ' ILE . 80.8 mt -111.63 108.24 17.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.236 0.541 . . . . 72.23 111.689 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.85 161.2 16.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.971 -0.559 . . . . 72.51 111.294 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 108' ' ' GLN . 13.9 m120 -86.58 177.32 7.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.003 0.43 . . . . 72.51 111.364 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.5 t -74.45 28.96 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.004 0.431 . . . . 65.31 111.82 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 106' ' ' ASN . 46.8 mt-30 -127.01 -39.48 1.94 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.126 0.489 . . . . 75.4 111.374 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.43 -32.93 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.914 -0.474 . . . . 64.25 111.914 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.86 161.32 28.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 74.22 111.73 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -122.46 138.76 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.261 -0.427 . . . . 75.15 112.057 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.17 -32.39 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 113.667 0.988 . . . . 74.01 113.667 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.81 41.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.879 0.696 . . . . 63.0 112.879 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.86 135.93 3.47 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.702 -0.681 . . . . 55.34 110.894 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -164.32 165.25 21.93 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.17 -0.331 . . . . 75.11 111.23 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.1 p -129.41 -173.15 2.93 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.884 0.698 . . . . 71.35 112.884 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.2 p -81.14 127.99 33.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.998 -0.546 . . . . 61.4 112.404 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.66 103.15 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.096 -0.502 . . . . 63.2 110.399 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -67.63 105.73 1.97 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.002 0.43 . . . . 73.11 111.435 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -80.36 105.7 11.82 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 74.55 111.519 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.7 m -73.39 108.65 6.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.019 -0.537 . . . . 71.03 111.511 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.697 -0.668 . . . . 63.25 111.585 179.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.654 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 120.669 0.271 . . . . 64.34 111.076 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.34 72.97 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.52 0.568 . . . . 64.33 114.52 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -84.19 87.79 7.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.467 0.633 . . . . 73.05 111.775 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -172.72 107.32 0.17 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.073 0.463 . . . . 75.42 111.762 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -136.97 149.5 47.58 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.522 -0.308 . . . . 74.4 110.889 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -138.0 159.4 42.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.156 0.503 . . . . 71.11 112.095 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -123.3 108.73 13.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.405 0.521 . . . . 72.11 112.405 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -70.57 110.83 5.65 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.859 0.361 . . . . 65.15 110.374 171.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -98.64 163.83 12.49 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.376 0.51 . . . . 51.54 112.376 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -133.47 86.24 2.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.03 0.443 . . . . 74.21 111.428 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.8 mmm -138.77 109.64 6.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.072 -0.513 . . . . 74.03 110.014 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 -40.67 94.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.356 0.502 . . . . 60.03 112.356 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.22 -176.0 34.95 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.828 -0.701 . . . . 74.53 112.736 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -140.54 94.41 2.73 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.265 -0.55 . . . . 70.45 111.242 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -107.23 104.7 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.434 -0.348 . . . . 75.42 110.731 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.8 p -119.36 156.28 30.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.786 0.327 . . . . 72.51 111.69 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.694 HG13 HD11 ' A' ' 104' ' ' LEU . 67.2 mt -76.08 122.86 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.748 0.309 . . . . 73.22 111.083 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.11 -35.26 23.8 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.993 0.425 . . . . 71.14 110.882 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -167.66 145.48 4.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.997 0.427 . . . . 70.22 111.716 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.568 HG12 HG21 ' A' ' 27' ' ' ILE . 47.9 mt -113.19 131.92 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.588 -0.278 . . . . 71.01 110.258 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.55 126.64 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.963 0.411 . . . . 61.2 111.803 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.9 p -82.93 23.03 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.574 0.702 . . . . 73.23 112.013 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -121.28 -53.08 2.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.048 0.451 . . . . 74.13 110.112 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.44 13.33 0.57 Allowed Glycine 0 CA--C 1.524 0.64 0 CA-C-N 116.026 -0.534 . . . . 60.43 113.834 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -76.07 -52.94 9.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.596 0.591 . . . . 73.21 112.596 -176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.35 158.99 39.56 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.472 0.915 . . . . 74.54 113.472 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.568 HG21 HG12 ' A' ' 20' ' ' ILE . 59.9 mt -114.33 121.85 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.153 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -94.41 107.76 19.71 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.391 0.515 . . . . 75.03 112.391 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.603 ' HB2' HG11 ' A' ' 69' ' ' VAL . 7.1 mp -100.99 169.4 8.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.851 0.357 . . . . 75.1 111.118 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.68 128.49 7.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.983 0.364 . . . . 62.33 111.983 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -91.72 112.4 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.348 -0.387 . . . . 71.41 110.754 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -100.95 19.0 18.16 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.16 0.505 . . . . 74.13 111.954 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.0 t -78.27 -176.84 4.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.065 -0.397 . . . . 64.03 111.646 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.58 -39.19 20.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.053 0.76 . . . . 74.45 113.053 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 57.9 tt0 -130.5 170.63 13.97 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.822 0.344 . . . . 64.54 111.591 -171.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.4 m-20 -52.16 104.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.827 0.451 . . . . 54.03 111.623 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.14 136.85 26.79 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.106 0.409 . . . . 74.33 112.106 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.08 113.24 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.715 2.277 . . . . 74.14 112.647 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.699 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.4 tpt -69.56 -28.71 66.22 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.989 0.423 . . . . 72.2 111.674 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.28 76.55 0.76 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.387 -0.435 . . . . 64.42 113.576 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.07 12.63 0.03 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.476 -0.393 . . . . 55.41 113.156 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -124.89 162.07 25.2 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.696 0.398 . . . . 75.41 110.803 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -145.49 135.37 23.59 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.029 0.442 . . . . 73.15 111.371 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.441 ' HE2' HG22 ' A' ' 71' ' ' ILE . 57.0 ttp -101.69 120.51 40.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.988 -0.551 . . . . 74.22 111.619 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.4 mp -109.05 118.18 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.647 0.26 . . . . 71.54 110.576 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' NH1' HE22 ' A' ' 91' ' ' GLN . 43.8 ttt-85 -90.49 129.77 36.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.066 -0.396 . . . . 54.34 111.938 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 29.0 mtpp -129.29 147.84 51.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.288 0.566 . . . . 74.33 111.843 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' HG22 ' A' ' 100' ' ' VAL . 9.6 tt -167.78 -40.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.568 -0.742 . . . . 71.52 110.193 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.66 -153.94 6.31 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.803 -0.635 . . . . 75.12 111.864 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 71.73 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.284 0.564 . . . . 73.34 111.724 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -174.99 163.89 3.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.67 . . . . 74.54 110.985 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.2 p -163.07 101.51 0.98 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.039 0.447 . . . . 74.45 111.302 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.17 144.13 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.26 -0.427 . . . . 75.21 111.37 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.7 m -109.04 158.72 17.46 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.253 0.549 . . . . 53.33 112.329 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -149.0 109.12 4.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.983 -0.553 . . . . 73.11 111.204 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -75.8 131.85 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.888 0.375 . . . . 72.1 111.273 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 52.4 m-85 -78.75 121.76 25.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.878 0.37 . . . . 75.23 110.762 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -79.13 158.04 27.82 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.369 0.507 . . . . 63.22 112.369 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.664 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 20.7 t -104.29 23.68 12.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.238 -0.437 . . . . 61.14 111.541 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 81' ' ' SER . 13.5 ptm180 -58.01 -29.67 65.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.867 0.365 . . . . 74.32 111.618 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -143.18 156.29 44.73 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 71.23 109.997 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.46 139.8 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.457 -0.338 . . . . 73.42 111.563 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -84.35 104.3 14.26 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.925 0.393 . . . . 72.14 111.038 -175.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 63.6 mttm -65.92 168.82 7.5 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.527 0.936 . . . . 65.42 113.527 -174.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 129.37 37.63 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.541 -0.754 . . . . 74.44 111.123 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.03 9.15 79.81 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.948 -0.644 . . . . 72.11 112.763 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -81.06 117.95 22.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.944 0.402 . . . . 62.24 111.305 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.0 p -86.1 96.31 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.011 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' A' ' 29' ' ' LEU . 6.6 p -79.62 119.04 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.538 0.685 . . . . 74.11 110.988 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 20.2 m -100.0 110.07 22.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 71.31 111.655 -175.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.441 HG22 ' HE2' ' A' ' 44' ' ' MET . 49.6 mm -74.12 95.58 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.878 0.371 . . . . 72.33 110.629 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -79.89 128.27 33.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.41 -0.359 . . . . 75.34 110.949 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.51 162.5 6.28 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.284 -0.26 . . . . 55.02 111.559 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -50.29 -26.02 4.36 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.993 0.738 . . . . 72.14 112.993 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 92' ' ' ASN . 74.8 m-20 -90.8 28.28 1.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.925 0.393 . . . . 74.54 111.566 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.03 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.694 0.627 . . . . 74.22 112.694 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.1 2.3 82.45 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.095 -0.574 . . . . 63.55 113.243 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.78 -178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.155 0.502 . . . . 65.25 111.619 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 m -75.26 139.85 42.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.264 -0.426 . . . . 74.35 111.288 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.25 79.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.212 0.53 . . . . 73.42 111.574 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.554 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 8.5 t 66.08 89.87 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 115.484 -0.78 . . . . 54.43 111.729 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.709 ' HD2' HG21 ' A' ' 84' ' ' THR . 41.0 Cg_exo -60.97 -30.23 89.5 Favored 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 124.112 3.208 . . . . 72.21 118.084 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.622 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 33.3 Cg_endo -97.97 -179.43 6.05 Favored 'Cis proline' 0 C--N 1.367 1.532 0 CA-C-N 122.249 1.839 . . . . 72.51 115.284 6.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.709 HG21 ' HD2' ' A' ' 82' ' ' PRO . 2.9 t 177.01 -44.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.682 -1.599 . . . . 73.52 108.724 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 70' ' ' THR . 18.2 m-20 -140.06 -171.9 3.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.014 -0.994 . . . . 65.41 110.157 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 88.9 mt -123.02 132.33 54.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.936 0.398 . . . . 72.53 111.278 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.44 ' N ' HD13 ' A' ' 87' ' ' ILE . 1.8 mp -95.68 125.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.25 0.547 . . . . 64.33 111.396 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.506 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 16.2 t90 -80.33 90.42 5.58 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.754 -0.657 . . . . 73.1 111.033 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -80.16 -5.2 55.62 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 15.1 m120 -82.31 -14.45 55.33 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.543 0.572 . . . . 71.01 112.543 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.512 HE22 ' NH1' ' A' ' 46' ' ' ARG . 46.7 tt0 -154.27 143.05 20.94 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.254 0.55 . . . . 74.21 111.528 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 15.6 m120 -75.11 172.28 12.65 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.021 175.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.8 p -71.79 114.36 9.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.582 0.23 . . . . 74.33 110.568 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -59.32 -29.84 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.131 0.419 . . . . 64.41 112.131 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 48.03 39.41 18.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 114.733 0.653 . . . . 62.41 114.733 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -133.85 12.4 4.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.158 0.504 . . . . 75.22 110.941 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.18 -112.58 4.94 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.982 -0.628 . . . . 52.24 112.759 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 66.41 163.13 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.914 0.709 . . . . 74.33 112.914 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.455 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 11.1 p-10 -95.9 87.8 4.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.639 0.733 . . . . 64.53 110.711 176.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 48' ' ' ILE . 7.6 p -96.25 135.38 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.059 -0.519 . . . . 74.14 111.299 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.0 ttpt -115.31 124.26 50.85 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.094 0.473 . . . . 65.14 111.199 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 27' ' ' ILE . 87.6 t -98.9 136.39 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.035 -0.53 . . . . 72.53 112.075 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.9 mm -103.2 121.31 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.821 -0.627 . . . . 62.11 111.286 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.694 HD11 HG13 ' A' ' 17' ' ' ILE . 80.7 mt -97.5 121.77 39.78 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.352 -0.218 . . . . 72.13 111.083 175.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.557 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.9 mttt -129.36 159.24 36.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.031 0.443 . . . . 72.45 111.457 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -93.21 163.77 13.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 54.54 110.938 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -57.3 -29.75 64.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.306 0.484 . . . . 63.01 112.306 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -74.75 -19.26 60.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.69 0.626 . . . . 75.32 112.69 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 135.28 -46.89 1.01 Allowed Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.663 1.025 . . . . 64.3 115.663 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.91 169.48 17.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.596 0.698 . . . . 73.11 112.746 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 36.5 tt0 -94.7 146.97 23.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.713 -0.676 . . . . 74.21 112.181 -173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.9 -59.6 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.949 -0.569 . . . . 62.12 110.806 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.59 159.73 14.48 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 64.14 111.563 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.27 152.03 45.17 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.64 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -156.11 144.87 20.26 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.781 -0.19 . . . . 71.32 111.362 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 87.2 p -114.64 175.35 5.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 62.13 112.377 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 33.0 p -77.17 -174.59 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.936 -0.575 . . . . 73.3 111.18 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.23 113.26 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.546 -0.297 . . . . 74.03 111.252 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -61.35 98.15 0.08 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.85 0.357 . . . . 74.43 110.853 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.28 103.67 6.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.282 -0.417 . . . . 74.23 111.803 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.6 m -117.04 92.45 3.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.09 0.471 . . . . 63.12 110.467 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.656 -0.688 . . . . 73.32 111.921 -177.586 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtm . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.605 -0.146 . . . . 75.11 110.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 47.89 36.46 14.09 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.369 0.508 . . . . 75.33 114.369 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -60.03 -41.9 93.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.993 0.425 . . . . 74.02 110.934 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -59.92 124.06 19.0 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.981 -0.554 . . . . 74.33 111.474 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -88.55 164.98 15.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.427 -0.352 . . . . 75.25 111.589 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.64 85.56 0.11 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.133 0.492 . . . . 75.54 111.29 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -86.99 128.4 35.08 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.108 0.781 . . . . 61.24 113.108 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -130.22 131.23 45.46 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.644 -0.707 . . . . 73.3 109.881 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m -99.05 88.06 3.86 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.075 0.398 . . . . 71.01 112.075 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -144.98 109.18 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.772 0.32 . . . . 71.01 110.842 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.6 mmt -94.42 106.67 18.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.757 0.313 . . . . 65.14 111.392 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.4 p -112.57 97.22 6.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.095 0.474 . . . . 62.42 111.781 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.9 61.76 4.5 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.455 -0.402 . . . . 64.12 113.212 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.504 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 13.8 m120 -100.03 23.42 9.9 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.514 -0.404 . . . . 73.24 111.963 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -102.7 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.961 0.41 . . . . 75.12 110.221 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.25 151.0 25.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.076 0.465 . . . . 73.03 112.016 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD12 ' HG ' ' A' ' 104' ' ' LEU . 56.4 mt -77.28 115.4 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.264 -0.426 . . . . 71.24 110.619 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -84.19 -42.34 16.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.722 0.296 . . . . 73.44 111.522 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.1 148.61 27.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.23 112.037 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.66 123.35 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.908 -0.587 . . . . 65.22 110.265 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.17 140.05 40.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.487 0.661 . . . . 71.03 112.462 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -97.1 -20.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.716 -0.674 . . . . 74.11 111.142 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -68.02 -34.62 76.83 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.15 0.5 . . . . 62.2 110.381 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 104.03 44.53 1.61 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.345 0.498 . . . . 44.35 114.345 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -128.3 -26.08 2.86 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.373 0.879 . . . . 75.43 113.373 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -156.08 152.46 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.884 1.068 . . . . 75.15 113.884 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -127.06 118.55 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.748 . . . . 75.21 109.537 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 28' ' ' ARG . 37.8 ttp180 -101.61 110.3 22.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.689 0.626 . . . . 71.32 112.689 -171.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.9 mp -97.92 169.47 9.62 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.89 -0.596 . . . . 74.25 110.439 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -149.99 140.84 22.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.148 0.499 . . . . 65.22 111.843 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.486 ' HB3' HD11 ' A' ' 63' ' ' LEU . 37.5 t30 -100.27 126.9 46.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.259 -0.428 . . . . 71.54 111.079 177.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.2 t -113.16 10.97 18.7 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.806 0.336 . . . . 72.44 111.597 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 32.2 m -65.94 146.23 54.97 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.327 -0.233 . . . . 55.32 111.186 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.88 -19.21 62.65 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.415 0.524 . . . . 62.25 112.415 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 42.7 tt0 -123.06 166.06 15.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.81 0.338 . . . . 72.33 111.167 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.489 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.7 m-20 -55.09 130.84 43.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.763 0.425 . . . . 75.44 111.84 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.41 113.32 40.95 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 112.459 0.54 . . . . 71.44 112.459 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.54 125.44 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.748 2.299 . . . . 74.02 111.211 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 tpp -58.07 -20.88 42.89 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.777 0.658 . . . . 53.14 112.777 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.06 -90.19 0.08 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.249 -0.501 . . . . 70.12 113.518 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.08 59.66 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.047 -0.597 . . . . 65.33 113.577 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -76.43 168.8 19.42 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.475 -0.426 . . . . 73.55 110.912 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.33 113.82 26.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.099 0.476 . . . . 72.54 111.606 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.4 ttp -92.28 125.54 36.99 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.147 -0.479 . . . . 70.53 111.213 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.7 mt -117.21 109.11 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.783 0.325 . . . . 73.44 111.371 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -90.21 107.69 19.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.812 0.339 . . . . 72.01 111.141 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 37.3 mttm -95.83 129.32 43.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.811 0.339 . . . . 74.24 111.217 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.411 HD12 ' HG1' ' A' ' 96' ' ' THR . 11.6 tt -134.67 100.82 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.445 0.641 . . . . 51.32 110.901 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.83 -103.98 1.31 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.1 -0.571 . . . . 74.02 112.419 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -102.74 -32.12 9.99 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.035 0.383 . . . . 74.15 112.035 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -92.91 168.69 10.99 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.3 0.572 . . . . 64.22 112.39 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 92.5 p -155.1 150.75 27.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.959 -0.564 . . . . 64.12 111.415 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.401 HG12 ' OE1' ' A' ' 91' ' ' GLN . 7.5 p -134.61 140.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.443 -0.344 . . . . 72.43 110.874 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.4 p -108.3 158.01 17.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.409 0.623 . . . . 73.2 112.584 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -154.56 115.27 3.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.735 -0.666 . . . . 75.51 111.069 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -86.33 133.82 33.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.921 0.391 . . . . 75.01 110.867 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.79 -177.86 2.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.195 0.521 . . . . 70.13 111.851 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -148.36 142.95 26.5 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.084 -0.507 . . . . 72.34 110.982 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -95.43 82.45 3.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.049 0.452 . . . . 73.53 111.983 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.36 6.25 10.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 71.21 111.209 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.6 ' HH ' HG21 ' A' ' 69' ' ' VAL . 26.0 p90 -153.01 152.26 31.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 74.34 110.362 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 36' ' ' ASP . 11.7 t -115.47 116.92 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.825 0.345 . . . . 72.41 110.733 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -93.0 123.83 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.488 -0.324 . . . . 60.0 111.07 -173.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -80.97 -169.82 2.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.753 0.649 . . . . 75.12 112.753 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.68 144.3 31.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.67 0.619 . . . . 71.05 112.67 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.2 12.32 62.94 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.953 -0.567 . . . . 39.05 114.038 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.32 144.41 37.52 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.446 -0.443 . . . . 72.4 110.938 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -99.73 143.59 29.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.963 0.411 . . . . 70.44 112.011 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.6 HG21 ' HH ' ' A' ' 61' ' ' TYR . 5.7 p -114.77 123.96 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.121 172.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 86.6 m -101.74 126.72 48.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.472 . . . . 74.54 112.008 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.7 mm -92.01 103.1 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.43 . . . . 74.32 110.253 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.413 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -85.58 135.12 33.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.3 -0.409 . . . . 65.02 111.607 -177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 153.23 40.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.657 0.265 . . . . 71.03 111.533 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.735 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -53.88 -34.32 59.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.736 0.643 . . . . 73.31 112.736 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.405 HD22 ' HB3' ' A' ' 92' ' ' ASN . 77.2 m-20 -82.37 6.73 16.13 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.651 0.612 . . . . 61.13 112.651 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.68 77.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.974 0.361 . . . . 70.15 111.974 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.56 2.02 90.57 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.152 -0.547 . . . . 64.04 114.2 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.0 171.79 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 122.389 -0.477 . . . . 75.03 111.823 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.591 HG21 ' H ' ' A' ' 81' ' ' SER . 85.6 m -69.26 126.61 30.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 74.4 111.701 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -64.99 -15.25 62.08 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.177 0.806 . . . . 73.0 113.177 -176.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.591 ' H ' HG21 ' A' ' 79' ' ' THR . 23.2 t -149.25 86.53 5.55 Favored Pre-proline 0 N--CA 1.474 0.745 0 O-C-N 122.154 -0.341 . . . . 65.15 111.743 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.551 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 53.9 Cg_exo -53.65 -44.8 45.94 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 122.984 2.456 . . . . 73.53 115.399 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.551 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 69.7 Cg_endo -99.97 132.9 2.21 Favored 'Cis proline' 0 C--N 1.369 1.649 0 CA-C-N 121.161 1.45 . . . . 75.21 114.095 -1.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 82' ' ' PRO . 5.1 t -174.72 -47.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.96 -0.563 . . . . 74.0 110.241 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' THR . 17.3 m-20 -89.98 164.55 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.513 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 92.1 mt -126.47 133.85 51.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.035 0.445 . . . . 73.44 111.412 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 80' ' ' ALA . 1.6 mp -94.28 114.9 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.995 0.426 . . . . 61.31 111.281 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.473 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 4.5 t90 -66.96 93.46 0.27 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.055 -0.52 . . . . 75.35 110.691 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.628 ' HZ1' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -78.51 -28.04 46.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.106 0.41 . . . . 74.31 112.106 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.473 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 15.9 m120 -63.32 -20.31 65.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.287 0.477 . . . . 63.33 112.287 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 47.5 tt0 -132.63 127.18 34.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.864 0.364 . . . . 64.23 110.817 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.735 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 16.1 m120 -67.19 -51.81 48.95 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.349 . . . . 72.15 111.205 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 t -175.21 -179.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 61.23 111.577 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.534 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 38.5 p90 -153.48 -178.81 7.24 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.116 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.18 55.17 0.02 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.394 -0.908 . . . . 70.33 113.166 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.411 ' HG1' HD12 ' A' ' 48' ' ' ILE . 71.8 p -79.83 -40.9 27.47 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.145 0.498 . . . . 73.11 111.513 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.82 -23.25 19.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.063 -0.517 . . . . 52.54 112.789 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.51 179.35 5.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.257 0.551 . . . . 64.14 112.073 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.4 124.41 23.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.741 -0.663 . . . . 73.51 112.22 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.97 135.64 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.134 0.492 . . . . 75.01 111.072 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.614 ' HZ3' ' HB3' ' A' ' 101' ' ' LYS . 7.7 ttpm? -122.96 136.68 54.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.087 -0.506 . . . . 55.13 111.718 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.18 123.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.198 0.523 . . . . 72.4 111.246 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.433 HD13 ' HE2' ' A' ' 101' ' ' LYS . 48.8 mm -102.95 135.34 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.831 -0.622 . . . . 65.2 111.93 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HG ' HD12 ' A' ' 17' ' ' ILE . 68.6 mt -111.45 105.75 14.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 54.23 110.797 173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.69 130.62 54.91 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.16 0.505 . . . . 65.23 111.423 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.94 156.11 39.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.609 . . . . 73.54 111.66 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -57.5 -16.43 9.75 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.173 0.805 . . . . 75.13 113.173 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -101.08 12.81 36.95 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.449 0.537 . . . . 73.42 112.449 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.35 -23.81 33.96 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.888 0.715 . . . . 52.32 114.888 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -76.77 174.8 10.06 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.462 0.631 . . . . 72.31 111.905 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.87 142.4 50.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.519 -0.31 . . . . 70.22 111.282 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.84 -32.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 113.323 0.86 . . . . 75.33 113.323 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.98 152.53 47.75 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.636 0.606 . . . . 74.23 112.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.65 46.88 0.49 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.313 0.577 . . . . 73.14 111.276 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -75.54 151.1 37.98 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.183 0.516 . . . . 71.4 111.958 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.2 p -116.55 173.35 6.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.387 -0.369 . . . . 72.11 110.903 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.5 p -80.56 169.2 17.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.054 0.454 . . . . 75.32 111.508 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.39 130.46 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.109 -0.496 . . . . 65.45 110.705 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -125.99 113.46 17.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.399 0.618 . . . . 74.54 111.822 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -143.9 27.12 1.49 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.564 -0.744 . . . . 73.43 110.608 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.1 p 47.68 67.71 0.78 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.293 0.568 . . . . 75.42 111.166 -172.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.485 -0.769 . . . . 72.51 112.46 -172.51 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.807 0.337 . . . . 74.23 111.71 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.61 -129.07 2.7 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.216 -0.447 . . . . 64.42 112.243 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -77.63 122.47 25.36 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.904 0.383 . . . . 73.42 111.266 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -70.33 -35.78 73.83 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.815 0.302 . . . . 72.34 111.815 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 t60 60.72 43.71 12.04 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.196 0.522 . . . . 74.31 112.125 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -118.0 116.02 26.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.176 0.512 . . . . 73.25 111.722 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -140.53 102.83 4.41 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.077 -0.511 . . . . 74.41 109.912 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -85.73 18.24 2.98 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.554 0.946 . . . . 71.42 113.554 -168.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -62.72 130.71 46.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.149 0.5 . . . . 64.41 112.157 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -93.84 11.56 28.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.25 -0.432 . . . . 75.02 111.621 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 96.1 mmm -70.09 110.18 4.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.028 0.442 . . . . 74.24 111.49 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -67.02 156.63 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 70.15 112.093 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.97 76.33 1.42 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.004 -0.617 . . . . 63.24 113.49 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -79.91 54.5 1.89 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 75.2 111.902 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.93 114.17 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.41 . . . . 72.13 110.759 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.67 150.71 20.36 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.23 0.538 . . . . 73.31 112.243 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.39 110.15 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 62.22 110.163 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -77.22 -68.13 0.64 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.937 0.347 . . . . 64.32 111.937 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -155.92 150.49 25.97 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.287 0.565 . . . . 62.31 111.848 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.647 HD13 HH12 ' A' ' 46' ' ' ARG . 63.4 mt -108.86 137.1 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.065 -0.516 . . . . 72.32 110.864 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 11.0 t70 -70.19 147.22 50.1 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.392 0.615 . . . . 73.14 111.939 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.95 -16.87 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.643 -0.708 . . . . 70.21 111.488 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.5 -26.71 60.17 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 52.02 110.705 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.93 41.15 3.38 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.928 -0.578 . . . . 74.23 113.128 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 -37.75 2.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.356 0.872 . . . . 72.42 113.356 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 51.3 p90 -155.46 171.78 19.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.186 1.18 . . . . 74.02 114.186 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 20' ' ' ILE . 60.2 mt -136.68 143.9 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.221 -0.9 . . . . 70.34 109.265 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.65 115.04 22.02 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.576 -0.703 . . . . 74.45 112.401 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.2 mp -104.58 170.42 7.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.876 -0.602 . . . . 75.32 110.521 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.84 127.76 17.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.019 0.377 . . . . 62.14 112.019 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -90.38 131.52 36.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 64.22 110.742 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.4 p -117.5 11.23 13.78 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.31 0.485 . . . . 74.55 112.31 -176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.7 p -72.78 155.86 39.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.181 0.437 . . . . 64.34 112.181 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.99 -28.24 68.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.116 0.484 . . . . 70.02 112.209 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -124.58 139.0 54.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.077 -0.51 . . . . 70.1 110.411 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.27 126.35 22.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.792 0.329 . . . . 73.53 111.708 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -91.1 120.93 68.45 Favored Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 54.14 111.934 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.23 107.74 0.34 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.343 2.029 . . . . 73.52 112.432 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.675 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 1.5 tpt -78.99 91.49 4.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.777 0.323 . . . . 72.42 111.147 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.04 -51.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.89 -0.671 . . . . 74.32 113.802 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.39 50.72 3.53 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.114 -0.565 . . . . 72.31 113.619 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -140.92 141.15 34.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.014 0.526 . . . . 73.42 110.592 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 38.0 tt0 -124.32 126.9 46.8 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.171 0.51 . . . . 72.42 110.836 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.533 ' HE2' HG22 ' A' ' 71' ' ' ILE . 30.9 ttp -102.04 116.06 31.87 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.653 -0.703 . . . . 74.43 111.384 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.712 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.4 mt -100.41 161.46 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.476 -0.329 . . . . 74.31 110.615 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.647 HH12 HD13 ' A' ' 20' ' ' ILE . 46.7 ttt85 -158.87 137.07 10.63 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.817 -0.552 . . . . 74.44 111.344 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 100' ' ' VAL . 94.4 mttt -123.88 147.55 47.56 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.515 0.561 . . . . 72.2 112.515 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 tt -139.91 109.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.519 -0.764 . . . . 53.31 110.286 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.13 -78.17 0.68 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.008 -0.615 . . . . 37.48 112.847 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -136.94 -43.78 0.58 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.951 0.405 . . . . 74.14 111.502 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -68.01 137.78 55.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.182 0.515 . . . . 71.43 112.343 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.9 p -118.97 153.08 35.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.229 0.538 . . . . 73.44 112.044 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.11 151.55 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 115.743 -0.662 . . . . 75.42 110.288 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -134.99 165.97 24.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.1 0.476 . . . . 71.23 112.046 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -157.03 113.93 3.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 74.21 111.109 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 22.2 ttpp -84.01 133.85 34.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.858 0.361 . . . . 70.32 110.8 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -69.37 158.02 35.9 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.909 0.385 . . . . 74.52 110.973 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -120.33 129.55 54.03 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.158 0.504 . . . . 71.23 111.487 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.7 t -76.93 85.96 3.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.084 0.469 . . . . 74.21 112.05 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.543 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 9.8 ptp180 -119.54 4.85 11.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.399 . . . . 71.44 110.902 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.543 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 8.3 p90 -170.79 173.96 5.08 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.127 0.489 . . . . 70.35 110.69 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.48 129.02 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.208 -0.451 . . . . 64.01 110.75 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.32 105.71 1.51 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.561 -0.533 . . . . 72.22 109.561 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -54.55 136.05 45.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.71 0.633 . . . . 63.1 112.71 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.86 128.92 39.13 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.726 -0.67 . . . . 75.11 111.508 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.35 32.76 72.13 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.091 -0.576 . . . . 53.43 113.392 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -127.71 149.49 50.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.154 0.502 . . . . 72.04 111.814 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.4 p -96.4 135.53 38.13 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.104 -0.498 . . . . 61.3 111.754 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.6 134.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.397 -0.365 . . . . 73.11 110.828 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 26.6 m -104.56 118.62 37.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.267 0.556 . . . . 74.12 111.951 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.533 HG22 ' HE2' ' A' ' 44' ' ' MET . 44.4 mm -89.18 102.1 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.158 -0.474 . . . . 44.1 110.859 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -84.29 125.8 32.59 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.631 -0.259 . . . . 74.14 111.467 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -177.49 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.014 0.435 . . . . 62.43 111.751 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 -16.97 16.96 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.138 0.422 . . . . 71.3 112.138 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -93.11 19.17 8.24 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.538 -0.301 . . . . 64.14 111.204 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 78' ' ' VAL . . . -46.54 -61.74 1.68 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.504 0.927 . . . . 75.13 113.504 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.17 21.48 78.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.799 -0.715 . . . . 62.14 112.792 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 76' ' ' ALA . 30.2 m -127.54 -173.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.561 0.344 . . . . 73.22 110.863 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 p -60.69 123.47 17.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.088 0.471 . . . . 70.1 111.302 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 9.36 3.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.348 0.499 . . . . 64.21 112.348 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -134.46 119.04 13.95 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.174 0.435 . . . . 72.33 112.174 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.641 ' HG3' ' O ' ' A' ' 85' ' ' ASP . 36.8 Cg_exo -54.88 138.18 76.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.773 2.316 . . . . 64.11 110.101 168.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 5.3 Cg_exo 0.29 103.57 0.0 OUTLIER 'Cis proline' 0 C--N 1.363 1.329 0 N-CA-C 121.498 3.615 . . . . 64.23 121.498 25.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 85' ' ' ASP . 12.6 t 51.28 -67.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 117.062 2.245 . . . . 75.34 117.062 162.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 50.5 m-20 -68.21 -178.47 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.758 -0.589 . . . . 74.24 112.132 -171.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 29.3 mt -146.22 142.85 28.8 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.016 -0.427 . . . . 62.21 111.419 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.8 mp -103.57 116.41 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 112.033 0.383 . . . . 54.44 112.033 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.461 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.5 t90 -74.22 82.9 1.84 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.53 0.681 . . . . 74.41 109.792 173.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -77.13 17.48 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.874 -0.603 . . . . 74.04 112.414 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.461 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.1 m120 -127.39 12.16 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.378 0.511 . . . . 43.24 112.378 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -148.64 145.64 27.84 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.205 -0.31 . . . . 64.35 111.533 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -100.64 -137.16 0.32 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 111.686 0.254 . . . . 71.22 111.686 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 96.8 p -75.93 -2.3 29.67 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.821 1.045 . . . . 74.43 113.821 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.0 p90 45.39 22.24 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.154 1.168 . . . . 74.21 114.154 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.98 -156.67 15.84 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.295 -0.478 . . . . 63.32 113.597 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 t -127.05 -31.3 2.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.103 0.478 . . . . 73.34 111.515 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.81 48.45 0.21 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.808 -0.517 . . . . 75.43 111.808 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.01 162.84 14.54 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.618 -0.342 . . . . 74.4 111.191 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -78.39 43.97 0.49 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.54 0.686 . . . . 51.22 111.215 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.6 p -66.31 136.3 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 115.534 -0.757 . . . . 71.42 111.487 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -130.1 150.32 51.42 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.003 0.372 . . . . 70.51 112.003 -171.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.84 155.71 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.859 0.689 . . . . 75.33 112.859 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.712 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 19.7 mm -126.52 134.73 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.819 0.848 . . . . 74.45 111.068 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.77 112.84 22.61 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.722 0.296 . . . . 73.11 111.487 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.34 155.92 34.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.74 0.305 . . . . 65.45 111.169 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.11 177.98 6.0 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.221 0.534 . . . . 75.13 111.677 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.8 p -57.79 -20.92 38.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.039 -0.528 . . . . 70.23 112.027 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.01 -4.61 58.86 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.258 0.466 . . . . 55.21 112.258 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.89 -19.46 45.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.296 -0.478 . . . . 63.32 113.954 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.09 152.68 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.328 -0.513 . . . . 74.1 111.759 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -99.55 128.91 45.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.098 -0.501 . . . . 63.52 112.269 -171.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -84.97 -54.7 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.885 0.374 . . . . 74.2 111.32 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.83 167.36 30.64 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.395 0.617 . . . . 74.45 112.483 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.06 153.82 30.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.501 -0.772 . . . . 55.13 110.896 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -160.26 152.52 20.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.74 0.305 . . . . 73.11 111.502 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -115.02 178.89 4.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.068 0.461 . . . . 74.13 111.942 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 p -77.76 149.72 34.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.14 0.495 . . . . 75.33 111.255 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.11 143.33 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 70.22 111.241 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.97 100.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.865 0.364 . . . . 53.31 110.907 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 10.3 mmpt? -114.73 145.41 42.11 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.405 0.622 . . . . 71.4 112.064 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.6 t -140.22 31.82 1.94 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.54 -0.755 . . . . 65.14 110.179 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.758 -0.655 . . . . 71.44 112.348 -177.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.745 0.307 . . . . 63.53 111.704 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.68 -175.22 52.02 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.318 -0.467 . . . . 70.43 113.779 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -88.58 21.76 2.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.908 0.385 . . . . 73.41 111.391 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -70.34 66.63 0.31 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.353 0.661 . . . . 72.51 111.5 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -116.77 104.33 11.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 74.4 112.08 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -146.19 -174.19 4.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.553 0.341 . . . . 75.32 110.619 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -79.57 123.57 27.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.108 0.48 . . . . 75.22 111.526 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -85.75 167.17 15.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.18 -0.464 . . . . 64.1 111.342 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.0 m -124.65 138.59 54.29 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.906 0.384 . . . . 64.53 111.69 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -90.5 116.27 28.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.027 0.442 . . . . 72.2 111.92 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mmt -123.43 141.59 51.84 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.246 -0.434 . . . . 42.31 111.105 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -81.56 -52.14 7.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.144 0.497 . . . . 62.5 110.802 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.06 100.19 2.22 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.883 -0.599 . . . . 65.3 113.286 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.62 96.93 10.91 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.322 -0.516 . . . . 70.44 110.69 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.75 149.74 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.063 -0.517 . . . . 71.13 110.581 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 p -134.96 145.54 48.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.833 0.349 . . . . 73.22 111.903 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.13 96.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.978 0.418 . . . . 75.42 110.554 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.57 -53.2 59.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 64.41 111.563 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -157.97 146.59 19.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.054 0.454 . . . . 71.14 111.566 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.616 HG21 HG12 ' A' ' 27' ' ' ILE . 30.7 mt -114.58 122.32 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.465 -0.569 . . . . 72.22 109.465 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.59 133.32 36.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.022 0.749 . . . . 70.55 113.022 -171.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.61 -21.76 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.655 -0.702 . . . . 73.42 112.453 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.69 -24.08 23.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.898 0.38 . . . . 73.33 110.939 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.73 26.22 9.27 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.272 -0.422 . . . . 65.21 113.508 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.718 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 8.5 mtpm? -95.02 -28.08 15.3 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.088 0.773 . . . . 72.2 113.088 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.58 174.45 11.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.93 0.715 . . . . 75.45 112.93 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.616 HG12 HG21 ' A' ' 20' ' ' ILE . 52.3 mt -127.81 149.65 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.461 -0.79 . . . . 61.14 109.357 173.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -130.76 116.3 17.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.332 0.587 . . . . 63.42 112.071 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.2 mp -109.1 154.24 22.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.795 -0.639 . . . . 74.45 110.288 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HZ1' ' HB3' ' A' ' 30' ' ' LYS . 6.9 ttpm? -124.2 124.28 42.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 65.53 111.523 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -74.83 97.29 3.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.7 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -79.6 -2.15 41.21 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.912 0.387 . . . . 72.32 111.391 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -75.37 118.08 17.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.43 -0.35 . . . . 71.34 110.536 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 39.1 mt-10 -81.79 61.24 5.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 71.3 111.227 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -170.11 159.26 7.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.968 -0.56 . . . . 71.52 110.463 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.38 101.4 0.95 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.759 0.314 . . . . 62.21 110.655 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.8 mm100 -105.07 123.74 38.83 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 112.402 0.519 . . . . 63.13 112.402 -174.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 13.3 Cg_exo -71.28 135.29 26.58 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.589 2.193 . . . . 75.33 111.91 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.65 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.2 tpt -65.45 -19.04 65.77 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.958 0.408 . . . . 53.15 111.943 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -109.13 2.68 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.209 -0.519 . . . . 73.21 113.312 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.82 60.07 0.2 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.264 -0.493 . . . . 45.12 112.592 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.8 m0 -79.92 -178.12 6.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.952 0.406 . . . . 74.22 111.321 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.63 119.52 11.92 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.198 0.523 . . . . 74.02 111.101 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.605 ' HE1' HG21 ' A' ' 71' ' ' ILE . 50.8 ttp -97.7 118.14 33.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.192 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.473 HG12 ' HB3' ' A' ' 54' ' ' SER . 59.7 mt -103.17 132.87 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.555 -0.293 . . . . 71.14 111.177 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.4 ttm-85 -113.51 130.88 56.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.859 0.361 . . . . 62.14 111.909 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -120.52 133.4 55.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.874 0.368 . . . . 74.12 110.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 100' ' ' VAL . 11.9 tt -159.17 -42.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.004 0.372 . . . . 73.13 112.004 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.65 93.87 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.955 -0.64 . . . . 64.41 113.449 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.65 25.44 14.37 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.438 0.533 . . . . 74.13 112.438 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -146.92 144.51 29.29 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.201 0.524 . . . . 75.51 112.386 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -121.79 32.7 5.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.999 -0.546 . . . . 71.33 110.394 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.22 123.54 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.837 -0.62 . . . . 73.32 112.145 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.473 ' HB3' HG12 ' A' ' 45' ' ' ILE . 60.3 p -118.6 163.88 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.118 0.485 . . . . 70.14 111.98 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 62.9 t80 -137.51 111.35 8.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.956 -0.566 . . . . 65.32 111.901 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -72.33 116.8 13.2 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.033 -0.531 . . . . 75.4 111.077 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.484 ' HE2' ' HB2' ' A' ' 44' ' ' MET . 55.4 m-85 -72.13 162.62 29.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.242 0.544 . . . . 71.32 112.32 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -128.7 133.96 48.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.988 -0.551 . . . . 75.12 111.574 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.495 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 14.8 t -86.46 34.62 0.64 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.431 -0.35 . . . . 62.42 111.338 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 2.5 ptm180 -59.03 -22.67 61.08 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.242 0.46 . . . . 52.23 112.242 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 44.4 p90 -143.09 149.84 38.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.021 0.439 . . . . 75.23 110.96 175.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.81 114.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.413 -0.358 . . . . 71.22 110.576 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.61 136.05 52.41 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.114 0.483 . . . . 71.41 112.273 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -72.85 160.22 32.5 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 74.32 112.157 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 34' ' ' GLU . . . -70.59 130.36 41.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.038 -0.528 . . . . 55.35 111.981 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.05 73.81 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.082 -0.58 . . . . 62.34 113.551 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -83.52 135.55 34.6 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.97 0.414 . . . . 71.45 111.859 -177.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -96.13 109.35 21.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.007 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.12 133.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.315 0.578 . . . . 73.2 111.651 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 55.8 m -105.33 111.64 24.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 64.54 111.441 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.605 HG21 ' HE1' ' A' ' 44' ' ' MET . 49.4 mm -80.33 100.28 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.086 0.47 . . . . 55.31 110.415 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.457 ' HB2' HG13 ' A' ' 87' ' ' ILE . 72.7 m95 -77.47 166.64 22.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.16 -0.473 . . . . 70.2 111.318 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.67 178.12 4.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.572 -0.285 . . . . 72.05 110.73 174.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.78 16.46 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.023 0.439 . . . . 50.31 112.023 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -89.34 19.7 4.26 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.866 0.321 . . . . 70.51 111.866 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.5 70.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.005 0.743 . . . . 73.15 113.005 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -41.53 2.76 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.911 -0.662 . . . . 73.22 112.865 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.24 -179.6 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.244 0.545 . . . . 73.51 111.959 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.9 p -76.54 161.02 28.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.109 0.481 . . . . 73.21 111.521 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.89 2.18 9.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.808 0.67 . . . . 75.33 112.808 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -144.44 87.89 7.47 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 122.2 -0.313 . . . . 54.1 111.774 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.579 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 50.8 Cg_exo -55.8 -42.46 67.0 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 123.159 2.572 . . . . 73.32 115.582 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.579 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 41.6 Cg_endo -99.68 19.72 23.35 Favored 'Cis proline' 0 C--N 1.37 1.683 0 CA-C-N 121.509 1.575 . . . . 74.14 113.905 1.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.539 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 44.5 p -59.28 -48.73 80.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.012 0.434 . . . . 75.42 112.104 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 70' ' ' THR . 12.9 m-20 -98.58 179.27 4.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.068 -0.514 . . . . 70.21 111.833 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.94 129.11 45.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 63.3 110.974 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.2 mp -96.59 109.21 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.749 0.309 . . . . 73.2 111.162 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 7.6 t90 -74.55 86.62 2.09 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.256 0.55 . . . . 64.21 110.422 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -71.59 -20.21 62.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.419 0.526 . . . . 71.03 112.419 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 10.0 m120 -68.01 -13.57 62.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.365 0.505 . . . . 72.22 112.365 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -143.29 142.88 31.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.158 0.504 . . . . 75.31 112.172 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.82 -172.65 3.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.211 -0.45 . . . . 64.23 112.003 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.1 p -60.32 127.48 32.0 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 72.31 111.013 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -102.81 2.1 35.03 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.58 0.956 . . . . 75.23 113.58 -169.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 96' ' ' THR . . . 84.06 -44.55 3.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.875 -0.679 . . . . 71.13 114.171 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 95' ' ' GLY . 2.6 m 76.73 -32.86 0.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.705 1.002 . . . . 72.44 113.705 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.15 -23.33 24.48 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.261 0.864 . . . . 62.5 115.261 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.37 17.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.055 0.761 . . . . 73.52 113.055 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 t70 59.12 73.29 0.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.502 0.668 . . . . 74.22 110.308 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 48' ' ' ILE . 6.1 p -81.2 120.62 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.557 -175.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.97 122.18 38.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.113 0.482 . . . . 74.23 111.768 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.12 131.73 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.891 -0.595 . . . . 73.42 111.304 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.9 mm -111.99 120.39 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.368 -0.378 . . . . 75.32 111.395 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -102.95 109.76 21.42 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.382 -0.199 . . . . 71.42 111.412 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.64 141.16 52.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.375 0.607 . . . . 74.24 112.162 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -77.27 172.93 12.51 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.653 -0.703 . . . . 70.35 111.237 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.4 m -57.75 -21.76 43.01 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 111.985 0.365 . . . . 62.44 111.985 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.72 -7.54 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.574 0.583 . . . . 70.22 112.574 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 -17.22 57.81 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.957 -0.639 . . . . 52.11 113.334 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.78 164.15 22.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 60.03 111.306 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -104.35 142.29 34.83 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.086 0.772 . . . . 75.31 113.086 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.74 -51.91 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.708 -0.678 . . . . 75.12 110.14 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -172.6 163.92 5.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.498 -0.773 . . . . 37.49 111.137 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -144.1 145.2 31.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.857 0.36 . . . . 70.34 110.922 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -150.97 143.57 24.37 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.783 0.325 . . . . 72.42 111.811 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.6 p -108.0 178.66 4.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.501 -0.318 . . . . 73.43 110.935 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.517 HG22 ' HB ' ' A' ' 20' ' ' ILE . 30.0 p -99.86 120.87 40.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.76 95.51 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.684 -0.487 . . . . 63.13 109.684 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -57.72 112.61 1.51 Allowed 'General case' 0 CA--C 1.543 0.712 0 CA-C-O 121.454 0.645 . . . . 63.22 112.223 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.15 158.73 20.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.785 -0.643 . . . . 75.01 111.846 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.5 m -137.56 94.8 2.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.69 -0.686 . . . . 71.55 110.02 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.252 1.213 0 N-CA-C 112.366 0.506 . . . . 64.23 112.366 -175.788 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.86 0.362 . . . . 62.41 111.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.19 146.94 21.52 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.125 -0.559 . . . . 64.3 112.842 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -95.62 143.89 26.52 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.079 0.466 . . . . 74.44 111.537 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -130.64 124.79 32.44 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.198 -0.456 . . . . 71.34 110.932 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -68.68 122.99 19.69 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.87 0.367 . . . . 71.32 111.72 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 7' ' ' HIS . 12.6 t60 -132.28 164.77 25.69 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 110.126 -0.324 . . . . 71.45 110.126 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 9.6 m170 68.99 31.39 4.17 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.11 0.481 . . . . 71.04 111.133 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -79.19 73.02 5.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.076 0.465 . . . . 74.42 110.891 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -96.66 178.86 5.18 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.23 0.456 . . . . 64.12 112.23 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -141.66 122.2 14.17 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.243 -0.435 . . . . 72.42 111.285 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.434 ' HB3' HE22 ' A' ' 37' ' ' GLN . 19.4 mmt -133.21 120.41 21.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.997 0.427 . . . . 73.25 111.718 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -96.45 -157.88 0.62 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.231 -0.44 . . . . 72.22 111.018 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.72 78.1 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 C-N-CA 121.329 -0.462 . . . . 53.03 113.46 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.438 HD22 ' NE2' ' A' ' 37' ' ' GLN . 8.3 p30 -97.13 3.55 51.59 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.159 0.429 . . . . 75.2 112.159 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -90.28 94.87 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.166 0.508 . . . . 71.44 110.384 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.62 153.09 18.01 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.908 0.385 . . . . 71.34 112.032 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.43 HG22 ' HD2' ' A' ' 115' ' ' ARG . 59.2 mt -65.22 125.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.496 -0.32 . . . . 65.3 110.854 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.07 -52.62 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.186 0.517 . . . . 71.34 111.046 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.1 158.34 36.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.32 111.309 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 HG22 ' A' ' 27' ' ' ILE . 59.7 mt -126.66 143.92 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.752 -0.462 . . . . 71.34 109.752 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.74 137.73 56.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.912 0.387 . . . . 70.41 111.345 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.411 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.3 p -65.19 -36.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.258 0.466 . . . . 75.24 112.258 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -81.54 -70.37 0.54 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.016 0.436 . . . . 75.22 110.461 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.42 38.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.385 -0.912 . . . . 74.4 114.784 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -89.09 -50.52 6.11 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.48 0.64 . . . . 65.14 112.457 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.0 162.86 35.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.515 0.932 . . . . 60.52 113.515 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.703 HG22 HG12 ' A' ' 20' ' ' ILE . 65.7 mt -119.93 137.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.511 -0.768 . . . . 72.21 109.88 173.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.88 116.61 28.28 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.249 0.547 . . . . 71.35 112.269 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.1 mp -106.28 149.56 26.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.155 -0.475 . . . . 44.12 110.705 177.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB2' HG21 ' A' ' 68' ' ' THR . 82.9 tttt -123.88 131.8 53.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.905 0.383 . . . . 72.51 111.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -85.94 112.0 20.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.725 0.298 . . . . 72.02 110.564 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -98.63 14.54 28.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.834 0.35 . . . . 72.22 111.848 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 t -87.74 -177.57 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.012 0.434 . . . . 61.43 111.369 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.1 -19.9 16.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.153 0.501 . . . . 71.24 111.632 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -101.56 155.95 17.78 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.187 -0.46 . . . . 61.23 112.11 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 5.0 m-20 -64.66 91.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.164 -0.471 . . . . 62.05 110.165 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.438 ' NE2' HD22 ' A' ' 14' ' ' ASN . 16.0 mm100 -76.56 116.77 59.42 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 112.82 0.674 . . . . 73.45 112.82 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.83 144.09 63.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.171 1.914 . . . . 73.1 112.143 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.787 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -51.78 -26.79 10.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.005 0.431 . . . . 62.11 111.671 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.1 -100.35 0.45 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 114.448 0.539 . . . . 73.32 114.448 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 57' ' ' TYR . . . 172.27 55.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.549 0 N-CA-C 112.098 -0.401 . . . . 64.24 112.098 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -89.43 152.93 21.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.147 0.499 . . . . 74.32 112.102 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -97.39 118.75 34.55 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.909 -0.587 . . . . 73.14 111.372 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.572 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 55.8 ttp -98.99 104.75 16.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.188 -0.46 . . . . 63.13 110.794 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.8 mt -90.96 116.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.327 -0.397 . . . . 74.22 111.095 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HE ' HG22 ' A' ' 100' ' ' VAL . 59.0 ttt180 -116.98 137.3 52.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.694 0.283 . . . . 73.32 111.513 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 50' ' ' ASP . 85.1 tttt -133.53 116.98 16.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.138 0.494 . . . . 73.14 110.811 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -113.09 119.56 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.108 -0.496 . . . . 71.12 110.937 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.22 -78.78 0.22 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.926 -0.654 . . . . 51.13 111.893 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 34.3 t70 -149.75 -15.33 0.27 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 111.801 0.297 . . . . 60.21 111.801 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -80.33 143.63 33.43 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.983 -0.448 . . . . 74.12 111.044 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.2 p -123.98 149.49 45.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.514 0.673 . . . . 72.32 112.68 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.75 145.23 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.49 -0.777 . . . . 72.3 110.33 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.3 p -128.08 127.68 43.55 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.089 0.471 . . . . 74.22 111.734 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -119.94 137.2 54.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.397 -0.365 . . . . 74.04 111.311 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -99.97 131.4 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.029 0.442 . . . . 40.02 111.668 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.576 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 60.6 m-85 -86.05 94.82 9.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.368 -0.378 . . . . 72.01 111.771 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -71.92 137.8 47.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.157 0.503 . . . . 74.42 112.247 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.787 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 79.5 p -72.25 91.22 1.29 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.304 0.483 . . . . 73.33 112.304 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 14.4 ptm180 -109.08 -16.82 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.692 0.282 . . . . 71.13 111.666 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.474 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 46.9 p90 -158.15 -177.71 6.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.642 0.258 . . . . 61.51 111.051 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.13 159.35 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.399 0.619 . . . . 72.43 112.102 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 tp -124.19 113.87 18.89 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.08 -0.509 . . . . 73.23 110.047 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 39.0 tttp -75.29 169.15 18.61 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.605 0.594 . . . . 63.32 112.605 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.71 127.46 20.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.781 0.66 . . . . 64.22 112.781 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.61 -18.2 9.28 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.173 -0.467 . . . . 38.21 114.014 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -72.41 138.51 47.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.176 0.512 . . . . 71.13 111.674 -176.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 30' ' ' LYS . 59.9 p -105.47 132.51 51.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.197 -0.456 . . . . 74.32 112.052 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.8 140.93 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.91 0.386 . . . . 61.42 111.41 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.2 m -109.8 122.39 47.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 63.43 111.473 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 mm -105.61 102.35 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.399 -0.364 . . . . 70.24 111.255 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -82.94 125.92 31.93 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.821 0.304 . . . . 75.14 111.821 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.19 81.46 2.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.197 0.443 . . . . 65.41 112.197 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . . . 64.83 -67.14 0.12 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.844 1.053 . . . . 71.34 113.844 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -71.39 75.58 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.113 0.412 . . . . 64.23 112.113 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.84 -48.82 3.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 72.02 111.697 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.48 -35.69 3.3 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.444 -0.407 . . . . 72.51 113.19 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.75 -173.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.144 0.424 . . . . 74.3 112.144 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -52.83 121.97 8.29 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.186 -0.461 . . . . 70.31 111.836 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.69 91.05 0.29 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.617 0.969 . . . . 65.54 113.617 -173.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 87' ' ' ILE . 33.8 t 72.84 87.09 0.1 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 114.151 1.167 . . . . 71.34 114.151 168.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.654 ' HB2' ' N ' ' A' ' 84' ' ' THR . 81.8 Cg_exo -50.67 -176.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.576 2.582 0 C-N-CA 123.563 2.842 . . . . 64.4 112.259 163.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 14.82 47.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.44 0 N-CA-C 122.185 3.879 . . . . 72.15 122.185 44.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.654 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 7.3 t 157.67 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.598 1.159 . . . . 70.13 111.628 160.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 1.5 m-20 -105.72 158.33 16.8 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.805 0.336 . . . . 74.31 111.203 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 HD13 ' SD ' ' A' ' 39' ' ' MET . 76.5 mt -126.25 139.6 53.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.844 0.354 . . . . 72.32 111.493 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 81' ' ' SER . 1.8 mp -105.39 116.17 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.081 0.467 . . . . 75.51 111.061 176.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.587 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 7.9 t90 -74.69 105.85 5.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.146 -0.479 . . . . 73.43 110.421 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.24 -5.15 58.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.805 0.669 . . . . 62.42 112.805 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.587 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 20.1 m120 -91.35 -42.95 10.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.588 0.588 . . . . 71.34 112.588 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -120.52 143.54 48.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.82 0.343 . . . . 72.23 111.398 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 16.5 m120 -93.52 177.21 6.1 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.057 0.455 . . . . 72.42 111.395 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.7 p -60.46 113.24 2.31 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.123 0.487 . . . . 71.25 111.153 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -76.24 -32.96 59.17 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.76 0.652 . . . . 75.3 112.76 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.98 50.54 21.11 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.292 0.477 . . . . 43.32 114.292 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.7 p -97.52 -44.78 6.68 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.724 0.639 . . . . 62.14 112.724 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 80.17 -33.73 2.21 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.898 -0.668 . . . . 54.21 112.676 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.75 148.15 47.61 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.799 0.333 . . . . 74.15 111.109 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 4.6 p-10 -64.43 126.41 27.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.341 0.867 . . . . 71.43 113.341 -173.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG22 ' HE ' ' A' ' 46' ' ' ARG . 7.7 p -124.92 141.71 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.794 -0.639 . . . . 73.2 110.938 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -109.55 134.88 51.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.919 0.39 . . . . 74.22 111.726 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 144.86 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.15 0.5 . . . . 74.33 111.768 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.76 141.46 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 116.186 -0.461 . . . . 74.01 111.347 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 76.5 mt -114.05 120.46 40.64 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.928 0.394 . . . . 74.31 111.568 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 95.5 mttt -123.05 146.74 47.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.462 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 16.8 m120 -76.53 153.33 35.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.036 -0.357 . . . . 61.25 110.036 169.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.8 t -67.94 8.37 0.41 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.277 0.843 . . . . 74.03 113.277 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.14 3.91 52.9 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.101 -0.374 . . . . 74.21 111.247 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 36.72 17.27 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.06 -0.591 . . . . 44.54 112.846 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.1 pt-20 -125.39 126.78 45.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.032 0.444 . . . . 75.25 111.501 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 33.8 tt0 -91.47 129.39 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.891 -0.595 . . . . 73.22 111.433 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.44 -64.16 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.285 0.476 . . . . 73.22 112.285 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . . . -101.74 145.4 29.19 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.451 0.537 . . . . 71.51 112.451 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.65 139.96 26.98 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.263 -0.426 . . . . 53.42 110.981 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' HD2' HG22 ' A' ' 17' ' ' ILE . 47.7 ttm-85 -166.13 136.81 3.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.249 0.547 . . . . 72.32 112.282 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.7 p -111.32 154.54 24.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.756 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.547 HG22 ' HB ' ' A' ' 20' ' ' ILE . 66.5 p -62.45 107.07 0.85 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.025 0.441 . . . . 73.52 111.648 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.29 96.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.423 0.63 . . . . 63.53 111.71 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -67.96 135.43 52.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.154 0.502 . . . . 73.42 111.01 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -121.5 136.04 54.98 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.447 0.536 . . . . 70.43 112.447 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 95.52 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.077 -0.51 . . . . 72.32 110.499 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.998 -0.525 . . . . 74.5 111.533 -178.185 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.836 0.351 . . . . 61.13 111.335 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.86 45.98 0.1 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.062 -0.589 . . . . 72.33 113.366 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -96.86 95.38 7.82 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.373 -0.486 . . . . 75.12 110.569 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -77.47 134.25 38.4 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.282 0.563 . . . . 74.43 111.846 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -124.61 133.89 53.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.885 -0.598 . . . . 63.33 110.391 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -101.86 -78.78 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.184 -0.323 . . . . 75.11 111.218 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -170.69 164.67 8.15 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.81 0.338 . . . . 72.23 111.193 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -105.01 149.53 25.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.525 -0.307 . . . . 74.21 110.614 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 t -149.58 168.68 22.88 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.878 0.37 . . . . 64.23 111.427 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -106.13 134.2 49.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 71.13 111.658 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.575 ' HE2' ' HA ' ' A' ' 11' ' ' MET . 28.5 mmt -87.27 108.3 18.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.235 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.1 p -91.07 3.23 55.3 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.784 0.326 . . . . 74.15 111.655 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.16 82.35 0.89 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.319 -0.401 . . . . 65.11 113.325 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.48 94.41 9.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.145 0.497 . . . . 63.11 111.237 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.74 128.64 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.425 . . . . 43.41 111.176 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 p -133.71 155.34 49.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.791 0.329 . . . . 51.5 111.445 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.785 HG13 HD11 ' A' ' 104' ' ' LEU . 73.7 mt -62.68 120.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 112.276 0.473 . . . . 72.44 112.276 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 40.6 tt0 -68.38 -55.51 11.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.252 -0.431 . . . . 71.24 109.981 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 23.6 tt0 178.52 160.46 0.6 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.665 -0.698 . . . . 75.22 110.502 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG23 HG12 ' A' ' 27' ' ' ILE . 57.6 mt -95.39 153.6 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.439 -0.346 . . . . 60.41 111.412 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.64 147.71 36.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.124 0.487 . . . . 64.54 111.587 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.35 -28.01 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.113 -0.494 . . . . 74.1 111.993 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.77 -34.54 13.16 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.886 0.374 . . . . 73.23 110.876 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.01 10.86 8.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.192 -0.458 . . . . 71.03 113.426 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.36 -27.74 64.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.223 0.823 . . . . 71.31 113.223 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -158.94 159.65 35.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.972 0.73 . . . . 74.33 112.972 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG12 HG23 ' A' ' 20' ' ' ILE . 63.8 mt -125.24 117.19 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.695 -0.684 . . . . 63.42 110.722 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -98.55 132.85 43.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 73.04 112.267 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD12 ' HE3' ' A' ' 44' ' ' MET . 6.6 mp -109.65 134.68 51.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.355 -0.384 . . . . 62.12 111.304 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' HA ' HG23 ' A' ' 68' ' ' THR . 24.3 ttmm -103.37 136.08 43.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.882 0.372 . . . . 72.41 111.494 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.95 107.43 15.55 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.424 -0.353 . . . . 74.14 110.833 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.6 p -95.9 17.14 15.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.161 0.505 . . . . 71.35 111.808 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -70.29 159.32 34.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.1 0.476 . . . . 70.2 111.869 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.23 -26.35 58.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.222 -0.444 . . . . 52.43 111.717 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 44.6 tt0 -138.9 166.74 23.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.761 0.315 . . . . 75.42 110.936 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 6.1 m-20 -68.14 117.04 9.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.532 -0.304 . . . . 73.21 111.224 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -133.68 144.16 50.78 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 111.61 0.226 . . . . 72.4 111.61 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 36.4 Cg_exo -60.95 147.5 95.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.677 2.251 . . . . 75.14 112.615 174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.1 tpt -54.82 -50.59 68.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.072 0.463 . . . . 52.42 112.174 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.17 -122.1 5.83 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.02 -0.609 . . . . 65.32 113.293 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 108.87 1.14 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.377 -0.439 . . . . 65.42 113.142 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -135.08 164.87 26.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.641 0.376 . . . . 75.41 110.515 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -150.25 117.02 5.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.125 0.488 . . . . 74.12 111.374 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.456 ' HE1' ' OH ' ' A' ' 57' ' ' TYR . 38.1 ttm -91.81 117.4 29.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.245 -0.434 . . . . 73.32 111.721 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.59 102.65 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.859 0.361 . . . . 73.14 110.549 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -90.37 120.41 31.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.747 0.308 . . . . 72.23 111.414 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.27 113.86 27.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.409 -0.359 . . . . 53.13 111.035 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.468 ' HB ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.54 137.98 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.572 -0.285 . . . . 74.43 110.86 -176.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' N ' HD12 ' A' ' 48' ' ' ILE . . . 55.35 36.46 63.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.191 -0.528 . . . . 62.41 113.438 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.18 -4.29 1.59 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.829 0.852 . . . . 74.35 113.028 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -103.68 173.45 6.3 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.685 -0.634 . . . . 71.23 111.057 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -139.34 150.46 45.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.34 0.59 . . . . 60.31 112.105 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.58 130.36 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.636 -0.711 . . . . 74.3 110.354 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' MET . 94.0 p -105.43 148.72 26.84 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.328 0.585 . . . . 70.44 112.183 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -128.73 112.08 13.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.945 -0.57 . . . . 75.31 110.476 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.26 125.75 33.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.99 0.424 . . . . 75.33 111.651 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.456 ' OH ' ' HE1' ' A' ' 44' ' ' MET . 54.0 m-85 -85.9 168.9 13.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.509 0.671 . . . . 71.14 112.391 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -140.05 157.99 44.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.678 -0.692 . . . . 72.01 111.797 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.7 p -87.62 23.23 2.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.205 -0.452 . . . . 63.12 111.923 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -69.53 -2.18 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.624 0.602 . . . . 73.12 112.624 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.467 ' HH ' HG21 ' A' ' 69' ' ' VAL . 4.2 p90 -151.29 156.94 41.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.172 0.51 . . . . 72.33 111.7 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 83.2 t -103.6 124.77 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.16 -0.473 . . . . 65.34 111.659 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.12 109.85 18.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.008 0.432 . . . . 64.42 111.328 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.75 144.5 32.11 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.372 -0.376 . . . . 64.42 111.145 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.22 119.53 4.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.909 0.385 . . . . 74.13 111.798 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.16 -41.49 2.5 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.184 -0.532 . . . . 64.24 113.218 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.54 140.25 58.54 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.314 -0.521 . . . . 51.5 111.187 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 30' ' ' LYS . 70.1 p -111.49 153.72 25.78 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.726 0.639 . . . . 71.04 112.726 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG21 ' HH ' ' A' ' 61' ' ' TYR . 5.9 p -114.57 123.24 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.968 -0.56 . . . . 75.4 110.566 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m -94.13 124.61 38.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.186 0.517 . . . . 72.42 111.516 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.429 HD12 ' HE2' ' A' ' 57' ' ' TYR . 41.6 mm -86.21 99.67 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.048 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -84.38 -178.45 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 74.41 110.971 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.37 170.48 7.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.715 -0.221 . . . . 55.33 110.95 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 92' ' ' ASN . . . -51.62 -33.19 32.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.194 0.442 . . . . 73.52 112.194 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.07 32.48 2.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.455 -0.339 . . . . 62.22 111.563 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.16 -48.55 44.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.913 0.708 . . . . 74.31 112.913 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.17 -33.66 6.23 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.13 -0.557 . . . . 64.4 112.277 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.33 -171.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 122.555 0.342 . . . . 72.14 110.843 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.3 p -69.97 147.33 50.29 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.98 -0.45 . . . . 65.55 111.369 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.91 2.65 3.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.642 0.608 . . . . 53.03 112.642 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -169.68 86.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.073 0.549 . . . . 73.41 110.345 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HB2' ' N ' ' A' ' 84' ' ' THR . 53.5 Cg_exo -53.0 -46.95 30.3 Favored 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.262 2.641 . . . . 74.53 115.972 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.538 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.7 Cg_endo -101.73 21.86 17.36 Favored 'Cis proline' 0 C--N 1.363 1.322 0 CA-C-N 121.307 1.503 . . . . 72.11 114.664 2.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.548 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 10.2 t -55.74 -41.44 73.91 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.443 0.535 . . . . 63.32 112.443 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -97.37 164.35 12.5 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.117 0.484 . . . . 72.54 111.29 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.04 126.24 51.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.071 0.462 . . . . 72.23 111.378 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 87' ' ' ILE . 2.0 mp -91.84 127.38 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 73.12 110.938 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -69.6 79.35 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.175 0.512 . . . . 70.44 110.183 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -58.29 -22.19 51.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.856 0.687 . . . . 73.14 112.856 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.6 -23.7 58.77 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.706 0.632 . . . . 61.15 112.706 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -146.2 150.06 35.11 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.129 0.788 . . . . 74.31 113.129 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -75.3 -172.22 1.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.628 -0.715 . . . . 71.12 110.616 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -74.98 142.3 43.9 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.864 -0.523 . . . . 61.4 111.214 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -120.47 101.32 7.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.64 0.733 . . . . 74.14 111.821 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.22 135.74 12.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.163 -0.472 . . . . 75.22 112.059 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -170.95 -42.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.863 0.69 . . . . 73.44 112.863 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.51 -15.72 62.68 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.007 -0.616 . . . . 64.23 113.024 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -56.89 131.94 51.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.74 0.305 . . . . 71.15 111.236 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.504 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.7 m-20 -60.95 114.5 3.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.295 0.569 . . . . 62.34 112.033 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 48' ' ' ILE . 3.8 p -106.05 136.81 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.727 -0.67 . . . . 72.12 111.41 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -115.85 132.44 56.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.232 0.539 . . . . 74.32 110.524 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.3 141.49 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.309 0.576 . . . . 62.12 112.446 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.1 mm -107.47 140.67 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 60.13 111.618 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.785 HD11 HG13 ' A' ' 17' ' ' ILE . 76.1 mt -110.26 114.89 28.72 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.756 0.312 . . . . 72.13 111.694 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -106.16 140.29 39.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.956 0.408 . . . . 73.52 111.421 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 112' ' ' VAL . 10.6 m120 -87.16 -171.2 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.271 -0.422 . . . . 70.3 111.086 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.9 t -57.91 -36.75 72.9 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.185 0.439 . . . . 52.51 112.185 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -81.72 3.02 27.16 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.116 0.413 . . . . 51.13 112.116 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.61 -1.26 78.46 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.174 -0.536 . . . . 64.1 113.039 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.49 151.25 47.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.884 0.474 . . . . 70.11 111.223 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -101.79 119.27 38.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.881 0.372 . . . . 73.41 111.662 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.402 HG12 ' OD1' ' A' ' 106' ' ' ASN . 18.8 m -106.41 -18.71 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.347 0.499 . . . . 52.15 112.347 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 104' ' ' LEU . . . -155.04 142.75 19.85 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.575 0.583 . . . . 73.11 112.575 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.62 122.03 11.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.466 -0.788 . . . . 65.12 109.842 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -144.5 156.74 44.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.979 0.419 . . . . 73.02 112.076 -171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.7 p -133.28 175.36 9.47 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.962 0.411 . . . . 61.42 111.607 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 45.8 p -79.17 -176.38 5.1 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.991 0.424 . . . . 65.32 111.391 173.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.36 129.88 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.888 0.375 . . . . 73.31 111.015 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -59.71 95.59 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 72.53 112.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -126.67 150.63 48.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.051 -0.522 . . . . 61.42 111.176 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 86.5 m -121.5 92.62 3.79 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 64.12 110.703 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.843 -0.598 . . . . 73.11 111.801 -178.151 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.718 0.294 . . . . 72.04 111.383 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.71 -64.58 2.22 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.202 -0.523 . . . . 73.31 113.219 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.58 132.41 38.3 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.794 0.331 . . . . 74.1 111.224 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -149.73 -178.07 6.25 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.061 0.458 . . . . 55.21 111.893 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -115.09 177.26 4.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.956 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -155.32 157.91 37.92 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.689 -0.232 . . . . 72.12 110.429 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -71.05 161.71 30.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.657 0.614 . . . . 74.53 112.657 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -147.86 109.19 4.32 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.82 -0.627 . . . . 74.14 110.989 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 m -117.3 156.88 27.04 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.95 0.405 . . . . 70.43 111.51 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -125.56 178.61 5.55 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.132 0.491 . . . . 75.14 111.538 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -125.17 129.45 50.16 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.298 -0.41 . . . . 71.42 110.866 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -71.63 -23.65 61.73 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.332 0.493 . . . . 72.25 112.332 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.97 142.52 13.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.141 -0.552 . . . . 61.11 112.843 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -131.98 91.78 3.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.13 0.49 . . . . 74.41 110.515 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.2 145.22 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.996 -0.547 . . . . 53.35 111.087 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.3 p -132.76 154.66 50.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.989 0.423 . . . . 74.51 111.634 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.63 111.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.321 -0.399 . . . . 55.25 110.796 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.83 -56.33 4.35 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.44 111.835 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.58 123.77 6.38 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.231 0.538 . . . . 74.24 112.39 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.608 HG21 HG12 ' A' ' 27' ' ' ILE . 72.2 mt -89.16 140.33 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.878 -0.601 . . . . 71.13 110.624 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.5 143.07 40.67 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.104 0.478 . . . . 73.11 111.472 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -85.82 -25.86 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.562 0.578 . . . . 73.11 112.562 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.83 -21.13 41.06 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.182 0.515 . . . . 71.0 111.009 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 103.45 20.21 11.3 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.796 -0.638 . . . . 55.01 113.256 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -79.72 -48.58 13.41 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.396 0.517 . . . . 74.32 112.396 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -160.81 173.25 15.65 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.489 0.922 . . . . 63.43 113.489 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.608 HG12 HG21 ' A' ' 20' ' ' ILE . 57.0 mt -133.85 121.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.469 -0.787 . . . . 64.5 109.794 170.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -101.4 123.58 45.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.744 -0.597 . . . . 63.35 112.19 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 29' ' ' LEU . 5.7 mp -110.72 172.45 6.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.021 -0.536 . . . . 63.23 110.941 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.707 ' HB3' ' HZ2' ' A' ' 30' ' ' LYS . 7.1 ttpm? -150.61 138.14 19.68 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.007 0.432 . . . . 72.25 111.998 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -78.73 114.52 17.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.919 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -102.76 12.81 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.919 0.39 . . . . 74.14 111.876 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 t -77.57 164.55 25.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.06 0.457 . . . . 60.42 111.426 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -85.91 5.98 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.2 0.444 . . . . 74.53 112.2 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 60.3 tt0 -146.43 159.9 42.79 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.686 0.279 . . . . 73.35 111.354 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -63.85 115.29 4.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.817 0.341 . . . . 71.22 110.409 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 17.2 mm-40 -105.71 146.19 32.34 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.333 0.494 . . . . 73.51 112.333 -172.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 9.2 Cg_exo -72.8 103.22 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.644 2.23 . . . . 54.2 112.486 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.651 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 3.6 tpt -59.88 -28.46 67.57 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 71.33 111.501 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.18 5.04 15.58 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 114.539 0.576 . . . . 73.12 114.539 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.29 8.78 69.62 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.92 -0.657 . . . . 42.13 113.127 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -119.03 170.89 8.66 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.599 0.592 . . . . 74.53 112.599 -176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -152.42 130.38 11.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.33 110.845 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 47.7 ttp -96.82 116.62 29.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 73.15 111.418 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 60.0 mt -105.4 113.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.809 0.338 . . . . 71.33 111.011 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' HE ' ' HZ3' ' A' ' 88' ' ' TRP . 54.2 ttm-85 -98.88 118.15 34.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.246 0.461 . . . . 70.51 112.246 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -95.39 106.17 18.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.973 -0.38 . . . . 63.35 109.973 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.405 ' HA ' HG23 ' A' ' 100' ' ' VAL . 10.6 tt -116.62 107.23 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.531 0.681 . . . . 72.1 112.699 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.6 -93.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.658 -0.701 . . . . 53.04 114.079 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -107.54 -17.42 14.11 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.287 0.477 . . . . 72.23 112.287 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.8 t -128.21 -172.67 2.75 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.044 0.45 . . . . 73.21 112.093 -175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 p -154.15 146.6 24.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.115 0.483 . . . . 74.24 111.693 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' HH2' ' A' ' 88' ' ' TRP . 7.7 p -153.52 145.29 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.06 -0.518 . . . . 64.45 110.404 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.6 p -120.74 168.36 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.296 0.85 . . . . 50.43 113.296 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 29.7 t80 -139.91 110.81 6.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.246 -0.888 . . . . 74.24 110.944 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -79.75 124.27 28.45 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.683 0.278 . . . . 64.54 110.327 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -68.53 105.83 2.36 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.967 0.413 . . . . 73.42 111.619 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t -71.36 121.98 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.231 0.538 . . . . 62.42 111.226 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.784 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 32.9 t -83.1 82.49 8.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.132 0.491 . . . . 74.52 112.247 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.785 ' HD2' ' HG2' ' A' ' 82' ' ' PRO . 11.6 ptp180 -104.6 4.19 32.53 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.829 0.347 . . . . 72.42 111.233 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.439 ' HE1' HD22 ' A' ' 86' ' ' LEU . 29.8 p90 -163.4 167.33 21.79 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 75.45 110.695 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.55 150.14 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.947 0.404 . . . . 74.21 111.804 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 39' ' ' MET . 39.3 tp -101.96 102.14 12.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.165 0.507 . . . . 71.15 110.604 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -62.53 162.62 10.09 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.843 0.682 . . . . 75.45 112.843 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.58 122.02 15.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.112 -0.494 . . . . 62.34 111.444 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.92 20.42 76.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.211 -0.518 . . . . 74.01 113.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -96.45 132.94 41.49 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.94 0.4 . . . . 75.11 111.99 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 30' ' ' LYS . 74.4 p -93.63 145.86 24.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.771 175.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.09 146.14 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.67 0.388 . . . . 62.3 111.29 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.88 129.8 53.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.958 0.355 . . . . 62.42 111.958 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.91 103.69 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.649 0.261 . . . . 75.24 110.944 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.45 166.69 18.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.579 -0.282 . . . . 64.13 111.432 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.05 94.31 4.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.815 0.672 . . . . 70.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . 47.47 -82.57 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.232 1.197 . . . . 74.21 114.232 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -77.46 36.24 0.19 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.544 0.572 . . . . 73.15 112.544 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.08 -11.77 59.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.771 0.319 . . . . 73.24 111.552 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.24 -42.4 2.56 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.331 -0.462 . . . . 54.52 113.52 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.2 m -55.42 158.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.765 0.654 . . . . 63.25 112.765 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.8 p -68.21 136.45 53.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.083 -0.508 . . . . 74.41 111.597 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -83.0 39.01 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.144 0.424 . . . . 74.42 112.144 -176.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.2 m -130.24 102.95 16.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 112.563 0.579 . . . . 72.43 112.563 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.785 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 28.4 Cg_exo -44.5 -164.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.397 0 C-N-CA 124.532 3.488 . . . . 70.23 114.238 168.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 2.4 Cg_endo -84.51 1.42 61.15 Favored 'Cis proline' 0 C--N 1.371 1.714 0 CA-C-N 120.982 1.386 . . . . 64.35 114.153 11.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.0 p -67.15 -71.63 0.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.487 0.551 . . . . 64.24 112.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 5.4 m-20 -121.51 169.38 10.72 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.097 0.475 . . . . 75.13 112.216 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.439 HD22 ' HE1' ' A' ' 61' ' ' TYR . 81.8 mt -115.82 134.69 54.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.375 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 80' ' ' ALA . 2.5 mp -109.14 114.32 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.949 0.404 . . . . 72.21 111.245 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.544 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 15.9 t90 -84.52 110.33 18.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.981 0.42 . . . . 73.33 110.766 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -84.3 -11.48 56.32 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.645 0.98 . . . . 72.14 113.645 -171.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.97 -54.52 9.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.313 0.486 . . . . 73.3 112.313 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 64.7 tt0 -85.95 123.78 31.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.815 0.341 . . . . 62.2 111.735 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HA ' ' HB1' ' A' ' 74' ' ' ALA . 19.1 m120 -83.17 52.98 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.852 0.316 . . . . 53.15 111.852 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.2 t 66.6 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.323 0.582 . . . . 45.1 112.2 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.534 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 42.3 p90 -106.23 171.78 7.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.484 -0.326 . . . . 74.32 111.117 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.01 105.72 0.28 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.555 -0.831 . . . . 42.04 113.234 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 t -151.68 -50.17 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.329 0.492 . . . . 72.24 112.329 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.55 -29.34 2.38 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.167 -0.54 . . . . 61.44 112.426 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -71.16 144.87 50.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.628 0.251 . . . . 71.11 111.037 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 23.1 m-20 -75.72 104.3 6.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.693 0.627 . . . . 74.43 112.693 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 48' ' ' ILE . 4.3 p -81.53 127.11 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.744 -0.662 . . . . 74.34 110.896 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 36.8 ttpt -97.79 115.84 28.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.331 0.586 . . . . 73.53 111.905 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 135.36 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.904 -0.589 . . . . 75.44 111.462 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 114' ' ' GLN . 27.6 mm -116.52 141.91 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 116.111 -0.495 . . . . 74.11 111.488 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.505 HD11 ' HB1' ' A' ' 113' ' ' ALA . 76.6 mt -115.35 118.22 32.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.953 0.406 . . . . 63.44 111.79 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 111' ' ' GLU . 57.9 mttp -125.32 160.22 29.83 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.313 -0.403 . . . . 73.05 110.951 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 17.1 m120 -99.18 -178.65 3.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 73.45 111.826 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -50.63 -43.36 56.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.16 0.8 . . . . 74.12 113.16 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.47 1.48 13.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.411 0.522 . . . . 73.42 112.411 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.44 84.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.235 -0.507 . . . . 52.5 113.094 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 7.3 pt-20 -78.76 137.94 37.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.922 0.391 . . . . 64.24 111.059 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.405 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 38.8 tt0 -102.0 137.12 40.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.853 0.316 . . . . 73.31 111.853 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 113' ' ' ALA . 27.1 m -127.89 -47.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 113.008 0.744 . . . . 71.31 113.008 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 104' ' ' LEU . . . -132.19 156.19 46.88 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.169 0.433 . . . . 73.34 112.169 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.453 ' HB2' HD11 ' A' ' 103' ' ' ILE . 3.3 pt20 -175.4 150.18 1.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.331 -0.395 . . . . 64.31 111.408 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 116' ' ' SER . 35.7 ttp180 -173.52 159.32 3.61 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.897 0.379 . . . . 55.02 111.52 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.3 p -86.71 -169.35 2.59 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.135 0.493 . . . . 62.42 111.029 172.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 31.7 p -87.85 -167.91 2.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.976 0.417 . . . . 63.24 111.51 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.29 109.13 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.064 0.459 . . . . 74.31 111.377 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -79.17 21.78 0.44 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.515 0.561 . . . . 62.41 112.515 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -58.02 98.74 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.142 0.496 . . . . 51.31 112.123 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 32.9 m -90.5 142.45 27.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.093 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.201 -0.904 . . . . 64.45 112.418 -176.615 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptt? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.106 0.479 . . . . 71.12 111.181 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.03 114.57 2.56 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-N 116.143 -0.48 . . . . 63.31 112.134 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -92.41 -57.43 2.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.0 0.429 . . . . 75.14 112.057 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -102.66 110.94 23.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.714 0.292 . . . . 72.23 111.154 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -148.33 87.11 1.57 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.268 0.556 . . . . 72.52 111.833 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -147.24 144.87 29.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.227 -0.442 . . . . 73.25 110.968 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -80.67 97.12 7.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.35 0.595 . . . . 74.3 110.212 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -87.03 9.62 19.07 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.26 0.837 . . . . 71.11 113.26 -171.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -63.07 125.98 25.83 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.84 0.352 . . . . 63.24 111.0 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -101.73 133.51 46.34 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.949 0.404 . . . . 73.44 111.702 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.624 ' SD ' ' NE2' ' A' ' 37' ' ' GLN . 21.9 mmt -70.54 114.6 8.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.852 0.358 . . . . 64.24 110.741 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -65.06 -17.53 64.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.095 0.776 . . . . 71.43 113.095 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.72 94.49 1.24 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.087 -0.577 . . . . 55.02 112.273 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 32' ' ' THR . 17.2 m-80 -115.8 8.17 14.77 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.657 0.614 . . . . 73.12 112.657 -172.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.88 130.76 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 75.55 112.031 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -129.15 177.37 7.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.132 -0.485 . . . . 62.01 110.637 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.88 127.55 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 122.007 -0.433 . . . . 72.52 110.721 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.71 -51.45 3.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.37 0.508 . . . . 61.52 112.37 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -147.86 138.1 22.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.075 0.464 . . . . 71.21 112.062 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.77 HG12 HG21 ' A' ' 27' ' ' ILE . 53.3 mt -132.9 139.93 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.256 -0.429 . . . . 70.1 111.054 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -85.59 126.22 33.72 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.03 0.443 . . . . 63.33 110.925 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.36 -26.4 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.241 0.46 . . . . 75.01 112.241 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.12 -37.1 80.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.872 0.368 . . . . 70.24 111.688 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 119.58 57.86 0.25 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.262 -0.494 . . . . 71.25 113.472 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -129.81 -57.49 1.11 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.49 0.552 . . . . 74.35 112.49 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.76 161.8 38.35 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.477 0.917 . . . . 75.12 113.477 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.77 HG21 HG12 ' A' ' 20' ' ' ILE . 63.6 mt -128.49 160.92 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 114.873 -1.058 . . . . 72.14 108.634 173.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 28' ' ' ARG . 38.2 ttp-105 -147.2 122.1 10.0 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.251 -0.906 . . . . 70.45 112.554 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.8 mp -97.08 172.68 7.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.742 -0.663 . . . . 74.42 110.507 175.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HG3' HG21 ' A' ' 68' ' ' THR . 74.4 tttt -142.59 121.06 12.43 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.834 0.349 . . . . 74.45 111.213 -175.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -82.01 86.27 6.59 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.238 0.542 . . . . 70.43 111.272 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 14' ' ' ASN . 71.8 p -83.65 87.72 7.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.227 -0.442 . . . . 63.23 110.293 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HG ' ' HG2' ' A' ' 37' ' ' GLN . 46.5 t -131.46 164.19 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.108 0.781 . . . . 61.5 113.108 -168.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -81.14 -26.62 35.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.945 -1.025 . . . . 72.13 110.647 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -140.35 162.4 35.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.644 -0.707 . . . . 74.5 110.488 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -68.98 109.82 4.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.862 0.363 . . . . 65.23 110.182 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.624 ' NE2' ' SD ' ' A' ' 11' ' ' MET . 14.2 mm100 -103.02 138.6 19.59 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.682 0.623 . . . . 72.42 112.682 -170.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 84.3 Cg_endo -75.94 46.51 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.87 2.38 . . . . 75.24 113.348 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.417 ' HA ' ' HE2' ' A' ' 39' ' ' MET . 6.4 tpt 63.11 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.87 0.468 . . . . 75.35 112.179 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.48 172.55 23.92 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.491 -0.385 . . . . 74.2 113.467 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.91 78.88 1.64 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.984 -0.627 . . . . 61.22 113.386 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -99.38 142.45 30.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.661 -0.317 . . . . 73.25 111.597 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -115.57 115.14 25.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.345 . . . . 73.22 110.478 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.48 ' HE2' ' CZ3' ' A' ' 88' ' ' TRP . 44.9 ttp -99.44 105.91 17.9 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.89 0.33 . . . . 74.31 111.89 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.632 HG13 ' HB3' ' A' ' 54' ' ' SER . 3.5 mp -91.08 118.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.56 -0.291 . . . . 74.34 111.313 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.453 ' HB2' ' CH2' ' A' ' 88' ' ' TRP . 55.0 ttp180 -94.35 93.79 7.91 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.06 0.457 . . . . 74.23 111.209 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.4 84.42 5.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.484 0.659 . . . . 61.34 111.456 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 96' ' ' THR . 16.5 tt -78.8 -14.57 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.606 -0.724 . . . . 71.3 110.787 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.03 -152.84 10.2 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.583 -0.735 . . . . 62.32 111.828 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.13 82.35 5.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.381 0.61 . . . . 73.32 109.963 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -167.18 -179.3 4.5 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.501 -0.772 . . . . 73.0 110.76 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.3 p -142.13 105.93 4.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.046 0.451 . . . . 74.45 111.605 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' NE2' ' A' ' 91' ' ' GLN . 7.1 p -138.2 137.68 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.221 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB3' HG13 ' A' ' 45' ' ' ILE . 81.2 p -145.94 161.27 40.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.01 0.744 . . . . 75.11 113.01 -174.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -126.77 126.64 43.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.181 -0.918 . . . . 74.55 109.785 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.15 141.21 28.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.055 0.455 . . . . 75.14 111.577 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -83.81 -178.6 7.05 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.995 -0.548 . . . . 72.44 111.631 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -144.35 149.76 36.69 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.161 0.43 . . . . 71.1 112.161 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 t -91.91 16.25 11.39 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.114 -0.494 . . . . 73.21 111.762 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.8 2.18 7.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.777 0.658 . . . . 72.34 112.777 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -148.6 164.5 34.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 74.55 111.328 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 61.4 t -112.77 119.16 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.907 0.384 . . . . 72.14 111.315 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.92 116.79 29.16 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.965 0.412 . . . . 64.43 110.19 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -58.44 153.58 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.687 0.625 . . . . 74.21 112.687 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.51 133.16 46.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.17 -0.468 . . . . 73.33 111.415 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.43 18.35 79.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.165 -0.54 . . . . 72.11 113.074 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.88 147.13 37.67 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.668 -0.313 . . . . 61.5 110.778 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 30' ' ' LYS . 43.1 p -95.8 171.4 8.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.354 0.597 . . . . 71.41 112.119 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.02 122.76 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.038 -0.528 . . . . 64.13 110.656 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.5 m -94.85 124.57 38.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.493 0.553 . . . . 73.11 112.493 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 86' ' ' LEU . 31.0 mm -94.88 136.38 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.83 -0.623 . . . . 54.11 110.492 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -117.24 179.36 4.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.907 0.384 . . . . 75.35 111.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -84.36 156.37 21.89 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.654 -0.248 . . . . 64.4 111.42 176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.67 -46.0 1.77 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.368 0.877 . . . . 70.03 113.368 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -129.28 74.39 1.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.129 0.49 . . . . 65.11 110.599 174.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.02 -3.48 54.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 52.3 112.105 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -41.68 2.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.367 -0.444 . . . . 75.41 113.086 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.05 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.034 0.445 . . . . 74.03 112.009 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.3 p -63.35 139.56 58.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 54.22 112.031 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.47 70.29 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.833 0.679 . . . . 62.23 112.833 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.1 p -139.57 98.68 7.94 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.999 0.428 . . . . 64.11 111.703 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.566 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 74.9 Cg_exo -52.79 -43.03 59.23 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.003 2.469 . . . . 72.52 115.324 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.566 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 77.4 Cg_endo -99.27 109.91 0.41 Allowed 'Cis proline' 0 C--N 1.368 1.597 0 CA-C-N 121.301 1.5 . . . . 74.1 113.738 -2.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.438 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 53.1 p -139.08 -66.0 0.48 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.258 0.623 . . . . 74.22 109.505 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.11 130.82 41.14 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.836 -0.62 . . . . 74.23 109.739 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.476 ' HB2' HD12 ' A' ' 71' ' ' ILE . 87.7 mt -100.26 108.38 20.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.15 0.5 . . . . 61.52 111.918 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 73' ' ' ALA . 1.7 mp -77.04 131.1 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.004 0.431 . . . . 73.21 111.183 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.48 ' CZ3' ' HE2' ' A' ' 44' ' ' MET . 2.0 t90 -70.91 77.06 0.64 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.437 0.636 . . . . 75.55 110.214 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 7.6 mtpm? -68.57 -2.11 8.21 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.07 0.767 . . . . 75.01 113.07 -175.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.96 -12.78 20.34 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.487 0.551 . . . . 70.12 112.487 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.467 ' NE2' HG23 ' A' ' 53' ' ' VAL . 36.1 tt0 -164.54 143.32 7.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.041 0.448 . . . . 73.15 111.363 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -75.24 -164.22 0.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.724 0.773 . . . . 74.34 112.971 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -62.37 178.38 0.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.92 -1.037 . . . . 73.22 112.797 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.558 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.1 p90 -141.8 167.76 21.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.715 -0.675 . . . . 75.14 110.443 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.15 66.35 0.02 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.552 -0.832 . . . . 54.02 113.702 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.531 HG23 HD13 ' A' ' 48' ' ' ILE . 47.0 p -78.78 -65.93 0.93 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.964 0.412 . . . . 61.3 111.445 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.03 -32.22 1.69 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.169 -0.468 . . . . 74.45 113.094 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.43 -63.38 1.09 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.477 0.547 . . . . 73.34 112.477 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -177.43 158.77 1.46 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.715 0.293 . . . . 62.32 110.686 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.31 89.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.846 0.831 . . . . 70.43 110.351 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HE2' HD12 ' A' ' 103' ' ' ILE . 87.6 tttt -91.31 126.61 36.45 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.641 -0.709 . . . . 74.13 111.783 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.6 t -118.74 136.56 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.041 0.448 . . . . 72.41 111.657 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.406 HD12 ' HE2' ' A' ' 101' ' ' LYS . 45.7 mm -122.34 138.88 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.054 -0.521 . . . . 54.11 111.039 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 113' ' ' ALA . 78.4 mt -110.63 113.99 27.03 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.253 0.464 . . . . 74.5 112.253 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HZ1' ' HB2' ' A' ' 111' ' ' GLU . 67.9 mttm -108.16 156.18 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.097 0.475 . . . . 62.22 110.623 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.7 m120 -99.21 179.07 4.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.051 0.453 . . . . 74.04 111.68 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.7 t -46.96 -40.68 14.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.42 0.896 . . . . 73.05 113.42 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.83 14.77 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.666 0.617 . . . . 70.01 112.666 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.55 -21.56 10.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.334 -0.46 . . . . 64.03 112.881 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 10.7 pt-20 -52.6 125.38 16.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.259 0.624 . . . . 62.55 111.937 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.413 ' HB2' ' HZ1' ' A' ' 105' ' ' LYS . 33.7 tt0 -95.88 136.81 35.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.796 -0.638 . . . . 74.15 111.436 -174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG21 ' H ' ' A' ' 113' ' ' ALA . 12.7 m -125.08 -60.83 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.104 0.779 . . . . 75.34 113.104 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.474 ' H ' HG21 ' A' ' 112' ' ' VAL . . . -105.07 154.45 20.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.38 0.511 . . . . 75.05 112.38 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.73 154.96 33.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.989 -0.551 . . . . 72.33 111.287 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.9 ttm180 -166.58 123.86 1.32 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.366 0.876 . . . . 64.42 113.366 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -105.18 129.85 53.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.688 -0.856 . . . . 73.12 108.688 164.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.2 p -68.45 -94.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.903 0.705 . . . . 73.31 112.903 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.47 130.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.296 0.569 . . . . 72.5 111.301 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -87.38 29.62 0.85 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.179 -0.464 . . . . 70.12 111.85 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -74.87 -5.23 42.51 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.029 0.442 . . . . 70.51 111.907 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.0 t -63.46 0.09 0.79 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.929 0.714 . . . . 73.05 112.929 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.3 p . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.632 -0.699 . . . . 61.31 112.064 177.458 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 30.5 t-20 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 121.264 0.554 . . . . 53.32 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 9.0 p -98.73 135.28 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.854 -0.612 . . . . 74.200000000000003 111.376 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.47 145.51 51.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.202 -0.454 . . . . 64.319999999999993 110.88 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' A' ' 102' ' ' VAL . 57.2 mt -72.65 99.29 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.595 -0.275 . . . . 73.430000000000007 110.629 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -62.09 -56.97 13.53 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.068 0.461 . . . . 74.319999999999993 111.271 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -164.87 143.66 6.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 73.5 111.565 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.443 HG21 HG11 ' A' ' 100' ' ' VAL . 55.7 mt -102.11 138.89 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.938 -0.393 . . . . 63.140000000000001 109.938 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.57 135.56 56.67 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.306 0.484 . . . . 70.140000000000001 112.306 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.77 -26.0 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.616 0.598 . . . . 74.299999999999997 112.616 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 13.7 t70 -85.01 -25.33 27.76 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.279 0.561 . . . . 62.350000000000001 110.326 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.52 30.78 6.38 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.149 -0.478 . . . . 40.039999999999999 112.943 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -90.37 -45.54 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.405 0.52 . . . . 74.409999999999997 112.405 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.46 161.36 38.24 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.648 0.981 . . . . 74.109999999999999 113.648 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -117.41 123.73 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 71.129999999999995 109.923 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -103.98 109.95 21.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.423 0.63 . . . . 75.400000000000006 112.637 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 mp -89.74 156.16 18.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.482 -0.781 . . . . 75.219999999999999 110.224 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 68' ' ' THR . 81.7 tttt -143.25 110.96 5.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.146 -0.346 . . . . 61.0 111.881 -173.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 9.4 t30 -87.02 106.12 17.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.026 0.441 . . . . 64.019999999999996 111.579 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -109.36 40.84 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.396 0.617 . . . . 72.230000000000004 111.406 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 80.7 p -83.33 176.54 9.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.451 0.643 . . . . 62.299999999999997 112.591 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.68 -7.45 54.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.766 -0.652 . . . . 65.540000000000006 111.933 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -149.4 156.45 42.06 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.841 0.353 . . . . 73.299999999999997 111.316 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.1 110.71 1.92 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.97 0.414 . . . . 63.049999999999997 111.244 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -93.37 128.93 40.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.544 0.572 . . . . 60.240000000000002 112.544 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.38 119.3 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.415 2.076 . . . . 74.420000000000002 112.716 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.2 tpp -62.39 -53.11 59.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.007 0.432 . . . . 74.439999999999998 112.041 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.78 -82.13 0.85 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.736 -0.745 . . . . 75.230000000000004 112.973 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.97 59.48 0.11 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.732 -0.747 . . . . 52.020000000000003 113.65 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -62.27 170.12 2.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.299 0.571 . . . . 74.420000000000002 112.245 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.56 114.06 15.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.182 0.515 . . . . 75.400000000000006 110.801 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -95.51 113.19 24.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.044 -0.525 . . . . 75.200000000000003 111.184 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 2.1 mp -90.44 109.82 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.749 0.309 . . . . 42.310000000000002 110.642 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.01 104.45 16.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.116 0.484 . . . . 75.230000000000004 111.559 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 100' ' ' VAL . 24.3 mtpp -92.73 166.14 12.6 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.324 -0.398 . . . . 74.329999999999998 110.283 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 49' ' ' GLY . 10.2 tt -164.51 -53.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.384 0.513 . . . . 64.140000000000001 112.384 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 48' ' ' ILE . . . -174.43 128.16 1.41 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.175 -0.536 . . . . 51.530000000000001 112.337 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.07 -69.24 0.16 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.156 0.582 . . . . 74.200000000000003 111.995 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -115.96 -174.04 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.733 0.301 . . . . 62.32 111.294 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.5 p -163.6 157.01 18.93 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.878 0.37 . . . . 70.230000000000004 111.722 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.782 HG11 ' HG3' ' A' ' 91' ' ' GLN . 7.3 p -138.38 147.17 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.402 -0.363 . . . . 54.130000000000003 111.172 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.619 ' HB3' HG13 ' A' ' 45' ' ' ILE . 89.2 p -112.86 161.75 16.6 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.088 0.471 . . . . 71.329999999999998 111.969 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.48 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 68.6 t80 -136.46 130.1 32.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.285 -0.416 . . . . 74.25 111.446 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -96.9 144.67 26.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.151 0.5 . . . . 71.340000000000003 111.509 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -93.55 179.85 5.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.166 0.507 . . . . 71.010000000000005 111.979 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -138.42 155.76 48.19 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.061 -0.518 . . . . 70.140000000000001 111.431 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 m -82.38 87.6 6.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.459 -0.337 . . . . 73.150000000000006 111.538 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 83' ' ' PRO . 8.9 ptm180 -141.75 7.49 1.88 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.322 0.49 . . . . 71.340000000000003 112.322 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -163.9 148.03 10.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.968 0.413 . . . . 62.549999999999997 111.643 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.44 131.17 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.224 -0.444 . . . . 33.009999999999998 110.86 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.3 106.54 10.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.055 0.455 . . . . 70.129999999999995 111.636 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.89 164.74 26.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.173 0.511 . . . . 63.240000000000002 111.531 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.4 113.05 3.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.851 0.358 . . . . 61.030000000000001 111.11 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.82 8.57 61.88 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.424 -0.417 . . . . 62.039999999999999 113.04 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -86.11 122.49 30.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.181 0.515 . . . . 72.439999999999998 111.866 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 30' ' ' LYS . 81.3 p -93.35 150.76 20.23 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.307 -0.406 . . . . 73.340000000000003 111.299 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 29' ' ' LEU . 7.7 p -135.87 124.39 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.283 0.563 . . . . 65.209999999999994 110.945 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 29.4 m -103.82 127.69 51.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.088 -0.505 . . . . 72.400000000000006 111.778 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mm -99.38 99.74 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.776 0.322 . . . . 73.030000000000001 111.098 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 80.1 m95 -83.58 119.77 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.502 -0.317 . . . . 62.530000000000001 111.208 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -74.65 82.23 2.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.587 0.588 . . . . 74.540000000000006 112.587 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 60.66 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.605 0.965 . . . . 74.140000000000001 113.605 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -71.39 90.18 0.95 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.194 0.521 . . . . 42.039999999999999 111.269 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -133.03 -39.94 0.94 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.658 0.614 . . . . 61.109999999999999 112.658 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.7 -29.74 6.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.193 -0.527 . . . . 51.039999999999999 112.589 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 79' ' ' THR . 43.8 t -66.67 159.34 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 122.799 0.44 . . . . 73.129999999999995 111.223 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 78' ' ' VAL . 53.8 m -52.26 129.56 28.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.853 0.359 . . . . 74.439999999999998 111.834 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.55 111.05 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.315 0.487 . . . . 71.340000000000003 112.315 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.514 ' H ' HD13 ' A' ' 87' ' ' ILE . 67.4 m 67.25 71.45 0.43 Allowed Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 113.429 0.9 . . . . 61.299999999999997 113.429 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.823 ' HB3' HG22 ' A' ' 84' ' ' THR . 86.2 Cg_exo -51.1 167.16 0.33 Allowed 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.741 2.961 . . . . 70.400000000000006 111.788 168.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD2' ' NH2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 13.41 60.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 N-CA-C 122.017 3.814 . . . . 52.43 122.017 38.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.823 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.3 t 153.68 -52.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.885 1.674 . . . . 74.349999999999994 109.985 161.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.66 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 17.9 m-20 -136.27 -161.45 1.16 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.474 0.71 . . . . 63.219999999999999 109.353 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.1 mt -142.09 144.16 33.41 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.734 -0.604 . . . . 50.0 112.077 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 81' ' ' SER . 1.8 mp -106.55 123.96 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.066 0.46 . . . . 72.030000000000001 111.029 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 73' ' ' ALA . 3.7 t90 -69.14 91.04 0.49 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 110.425 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -80.56 20.41 0.72 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.792 0.664 . . . . 72.019999999999996 112.792 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 83.5 m-20 -128.91 -0.06 5.33 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.008 -0.433 . . . . 74.209999999999994 112.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.782 ' HG3' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -161.11 127.47 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.74 0.305 . . . . 75.329999999999998 110.492 -172.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.678 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 2.8 m-20 -87.34 172.78 9.59 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.982 0.734 . . . . 64.25 112.982 -173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 t -47.27 125.78 8.46 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.103 -0.498 . . . . 64.049999999999997 111.419 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CD1' HD12 ' A' ' 48' ' ' ILE . 48.6 p90 -92.7 -30.98 15.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.531 0.567 . . . . 75.319999999999993 112.531 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 73.31 102.49 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.768 -0.73 . . . . 72.409999999999997 112.072 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.4 t -79.83 28.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.183 0.808 . . . . 60.210000000000001 113.183 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.84 -39.48 62.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.87 -0.892 . . . . 55.219999999999999 110.87 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -87.63 123.97 33.04 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.487 -0.56 . . . . 73.140000000000001 109.487 166.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -52.63 101.63 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.375 0.607 . . . . 73.439999999999998 112.536 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 20' ' ' ILE . 7.4 p -71.96 140.38 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.475 -0.784 . . . . 62.509999999999998 111.657 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -124.92 117.16 23.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.151 -0.477 . . . . 64.120000000000005 110.925 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 17' ' ' ILE . 60.4 t -99.83 123.69 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.111 0.481 . . . . 74.510000000000005 112.049 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 25.1 mm -105.29 116.89 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.037 -0.529 . . . . 70.349999999999994 110.95 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.79 107.8 19.81 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.877 0.37 . . . . 53.409999999999997 111.847 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.42 139.32 49.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 111.147 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.3 m120 -63.81 174.53 1.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.297 0.57 . . . . 72.510000000000005 112.236 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 m -56.87 -28.02 61.22 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.695 -0.684 . . . . 72.420000000000002 112.382 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.53 21.41 14.35 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.934 0.716 . . . . 73.230000000000004 112.934 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.88 5.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.949 -0.643 . . . . 43.409999999999997 114.552 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.9 pt-20 -53.9 150.47 7.65 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.067 0.433 . . . . 74.349999999999994 111.348 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.51 136.11 48.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.129 0.789 . . . . 75.129999999999995 113.129 -169.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.28 -55.23 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.131 -0.486 . . . . 63.310000000000002 111.722 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.19 170.26 21.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 74.329999999999998 112.162 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -152.83 134.54 14.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.891 -0.595 . . . . 71.400000000000006 111.149 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -144.92 150.58 37.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.796 0.331 . . . . 74.25 111.428 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.6 p -126.49 -178.84 4.5 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 111.576 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.5 p -80.01 -176.41 5.49 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.223 0.535 . . . . 32.310000000000002 111.649 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.47 0.555 0 CA-C-N 116.112 -0.495 . . . . 71.299999999999997 110.954 178.122 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.972 0.415 . . . . 72.540000000000006 111.466 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 29' ' ' LEU . 39.7 t -98.89 109.57 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.057 0.456 . . . . 64.439999999999998 111.888 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 52.8 t -107.63 173.18 6.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.42 -0.355 . . . . 63.140000000000001 110.663 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 62.4 mt -88.97 119.79 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.951 -0.468 . . . . 63.119999999999997 111.766 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.54 -48.43 22.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.85 0.357 . . . . 75.400000000000006 110.537 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.47 153.36 28.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.119 0.414 . . . . 71.420000000000002 112.119 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.452 HG23 HG12 ' A' ' 27' ' ' ILE . 47.0 mt -119.94 126.15 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.427 -0.351 . . . . 71.409999999999997 110.193 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.86 143.91 54.4 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.739 0.644 . . . . 64.5 112.739 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.57 -19.15 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.778 -0.646 . . . . 61.539999999999999 111.339 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.65 -39.03 92.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.096 0.474 . . . . 70.409999999999997 110.409 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.97 23.82 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.911 -0.586 . . . . 63.109999999999999 113.371 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -112.53 -63.07 1.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.391 0.885 . . . . 72.230000000000004 113.391 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.5 154.02 37.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.725 1.38 . . . . 60.229999999999997 114.725 -166.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 102' ' ' VAL . 65.6 mt -123.51 110.72 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.166 -0.924 . . . . 73.519999999999996 109.381 171.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 36.1 ttm180 -92.06 116.63 29.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.119 0.785 . . . . 75.540000000000006 113.119 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 7.7 mp -96.59 179.94 4.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.011 -0.541 . . . . 74.230000000000004 111.163 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -165.1 123.14 1.63 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.647 0.26 . . . . 75.209999999999994 111.423 -171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . 32.6 t30 -74.07 95.37 2.53 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.013 0.435 . . . . 75.439999999999998 111.402 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 p -82.32 87.74 6.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.226 0.536 . . . . 74.010000000000005 111.317 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.7 p -155.67 175.48 13.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.086 -0.506 . . . . 62.130000000000003 111.249 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.71 3.87 37.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.396 0.517 . . . . 51.439999999999998 112.396 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 52.9 tt0 -149.42 153.58 37.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.651 0.263 . . . . 63.25 111.482 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.81 117.25 4.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.904 0.383 . . . . 72.400000000000006 110.998 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 13.0 mm100 -115.7 164.07 18.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 122.311 -0.243 . . . . 71.219999999999999 111.477 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.0 144.86 27.54 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.19 1.926 . . . . 74.120000000000005 111.152 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.1 tpt -52.42 -56.82 12.46 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.722 0.296 . . . . 74.430000000000007 111.651 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.08 148.51 17.79 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.925 -0.655 . . . . 73.0 114.064 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.69 58.88 4.97 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.397 -0.43 . . . . 72.0 112.915 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.79 169.45 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.708 0.29 . . . . 72.540000000000006 110.761 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.57 124.3 21.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.261 0.553 . . . . 75.129999999999995 111.433 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' SER . 55.6 ttp -93.13 108.25 19.88 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.751 -0.659 . . . . 72.319999999999993 111.387 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.4 mp -97.18 115.54 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.706 0.288 . . . . 73.230000000000004 110.758 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -84.35 97.19 9.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.781 0.324 . . . . 64.430000000000007 111.223 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -94.69 131.82 40.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.236 0.541 . . . . 62.530000000000001 111.677 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 48' ' ' ILE . 15.2 tt -150.22 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.708 0.765 . . . . 73.010000000000005 111.079 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.67 -61.67 0.55 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.036 -0.529 . . . . 64.099999999999994 113.562 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -82.57 -66.43 0.89 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.398 -0.472 . . . . 73.310000000000002 112.232 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -95.86 173.43 7.45 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.132 0.491 . . . . 65.540000000000006 112.185 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -145.37 33.03 1.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.003 -0.544 . . . . 70.340000000000003 111.371 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.93 127.72 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.295 0.569 . . . . 70.230000000000004 111.998 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' MET . 82.8 p -114.54 177.7 4.55 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.489 0.662 . . . . 63.409999999999997 112.772 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.518 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 69.6 t80 -152.99 108.39 3.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.492 -0.776 . . . . 64.310000000000002 111.193 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -78.83 121.17 24.47 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.803 -0.443 . . . . 63.340000000000003 109.803 173.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.09 124.46 23.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.893 0.701 . . . . 73.319999999999993 112.893 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -72.27 85.23 1.07 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.478 0.656 . . . . 53.32 111.454 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.9 t -71.93 72.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.374 0.607 . . . . 52.509999999999998 111.217 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 16.4 ptt180 -102.68 5.19 38.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.799 -0.637 . . . . 71.329999999999998 112.152 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 51.3 p90 -158.37 165.53 34.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.886 0.374 . . . . 74.349999999999994 111.529 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.58 143.35 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.069 0.462 . . . . 53.130000000000003 111.792 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 31' ' ' ASN . 18.9 tp -108.95 124.38 50.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.125 0.488 . . . . 64.230000000000004 111.06 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.93 164.89 16.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.639 0.607 . . . . 73.109999999999999 112.639 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.82 124.46 24.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.188 -0.46 . . . . 64.230000000000004 111.421 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.94 7.34 83.9 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.31 -0.471 . . . . 61.329999999999998 113.152 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -71.47 132.74 45.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.999 0.428 . . . . 75.030000000000001 111.585 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.1 p -92.93 99.56 12.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.087 -0.506 . . . . 52.32 111.919 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.11 113.64 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.353 0.596 . . . . 64.340000000000003 110.639 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 21.0 m -99.86 131.81 45.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.963 0.411 . . . . 53.450000000000003 112.002 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.2 mm -93.2 99.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.111 -0.495 . . . . 71.109999999999999 111.051 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 87' ' ' ILE . 65.1 m95 -90.1 120.43 31.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.466 -0.334 . . . . 71.200000000000003 111.098 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -55.33 153.75 6.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.974 0.361 . . . . 70.0 111.974 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.33 -42.56 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.969 0.729 . . . . 75.319999999999993 112.969 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.445 ' HB2' ' H ' ' A' ' 93' ' ' SER . 6.4 m-20 -93.71 43.18 1.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.101 0.477 . . . . 70.219999999999999 111.952 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.81 -4.38 43.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.793 0.33 . . . . 72.129999999999995 111.694 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.02 -49.94 3.85 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.34 -0.457 . . . . 62.130000000000003 113.541 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.01 146.39 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 122.646 0.378 . . . . 74.219999999999999 111.999 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 81' ' ' SER . 92.3 m -54.63 132.19 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.813 0.339 . . . . 72.439999999999998 111.641 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.16 -25.04 20.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.38 0.881 . . . . 62.100000000000001 113.38 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.555 ' H ' HG22 ' A' ' 79' ' ' THR . 9.3 t -132.72 82.81 55.11 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 120.859 0.361 . . . . 52.32 110.892 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 52.7 Cg_exo -53.36 -47.65 26.25 Favored 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 123.372 2.715 . . . . 73.439999999999998 115.283 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 43.0 Cg_endo -103.31 25.77 12.26 Favored 'Cis proline' 0 C--N 1.364 1.391 0 CA-C-N 120.974 1.384 . . . . 70.230000000000004 114.501 -0.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.498 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 8.8 t -56.74 -34.28 67.37 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.905 0.383 . . . . 73.439999999999998 111.743 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -113.35 173.0 6.62 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.363 -0.381 . . . . 72.010000000000005 110.33 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 98.3 mt -122.4 126.36 47.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.368 . . . . 65.329999999999998 111.236 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 72' ' ' TRP . 1.7 mp -91.95 124.92 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.479 0.657 . . . . 71.129999999999995 112.042 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.518 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 7.9 t90 -74.56 80.44 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.692 -0.685 . . . . 72.400000000000006 110.573 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -67.14 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.24 -0.436 . . . . 72.340000000000003 111.979 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.479 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.9 m120 -74.11 -12.02 60.48 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.879 0.326 . . . . 73.239999999999995 111.879 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -148.52 140.29 23.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.12 0.486 . . . . 64.540000000000006 111.697 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.66 -171.48 3.13 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.578 -0.283 . . . . 74.219999999999999 110.919 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 75' ' ' ASN . 94.9 p -73.48 129.53 38.18 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.002 -0.436 . . . . 72.540000000000006 110.687 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -90.65 142.29 27.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.258 0.551 . . . . 73.109999999999999 112.194 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.03 23.86 24.48 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.095 -0.502 . . . . 62.420000000000002 112.654 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.0 p -79.4 127.98 32.78 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.223 0.453 . . . . 61.119999999999997 112.223 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.3 -10.15 66.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.431 -0.414 . . . . 71.530000000000001 113.33 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.64 156.07 39.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.799 0.333 . . . . 74.530000000000001 111.309 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 7.6 p-10 -67.92 89.18 0.28 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.54 0.686 . . . . 62.119999999999997 111.198 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.17 117.56 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.918 -0.583 . . . . 71.099999999999994 110.812 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 3.2 ttmp? -103.51 99.1 8.91 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.463 0.649 . . . . 72.150000000000006 110.925 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 27' ' ' ILE . 80.0 t -82.09 132.88 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.376 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' A' ' 105' ' ' LYS . 38.0 mm -112.42 133.67 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 111.514 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 HG13 ' A' ' 17' ' ' ILE . 87.5 mt -112.5 110.12 20.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.058 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 103' ' ' ILE . 66.8 mttm -120.36 159.32 25.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 70.219999999999999 112.308 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 1.4 m-20 -95.71 -179.27 4.67 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.546 -0.752 . . . . 65.439999999999998 111.996 -176.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -61.13 -19.54 61.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.869 -0.605 . . . . 63.140000000000001 112.336 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -102.83 17.09 24.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.214 0.45 . . . . 73.409999999999997 112.214 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.03 5.36 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.117 -0.563 . . . . 60.329999999999998 113.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 15.0 pt-20 -58.68 159.43 6.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.575 0.35 . . . . 61.119999999999997 111.162 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 105' ' ' LYS . 35.4 tt0 -121.91 127.43 50.42 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.437 0.532 . . . . 74.140000000000001 112.437 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -33.81 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.297 0.481 . . . . 54.200000000000003 112.297 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.18 149.73 17.79 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.753 0.649 . . . . 44.0 112.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -146.89 141.29 26.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.67 -0.695 . . . . 74.230000000000004 110.19 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 115' ' ' ARG . 31.4 ttt180 -154.67 156.71 36.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.019 -0.426 . . . . 54.32 112.038 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 83.9 p -125.63 170.13 11.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.913 0.387 . . . . 64.540000000000006 111.516 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 39.9 p -72.72 159.22 34.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.222 0.534 . . . . 44.240000000000002 111.896 176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.306 0.574 . . . . 73.420000000000002 111.001 177.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 64.150000000000006 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 29' ' ' LEU . 57.4 t -127.99 133.03 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.743 0.306 . . . . 73.230000000000004 111.201 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.07 159.13 40.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.8 0.333 . . . . 51.130000000000003 111.591 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.611 HG13 HD11 ' A' ' 104' ' ' LEU . 71.7 mt -82.29 116.99 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.926 0.393 . . . . 62.32 111.75 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -80.61 -50.23 10.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.019 0.437 . . . . 73.540000000000006 111.305 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -161.92 151.91 16.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.202 0.525 . . . . 52.520000000000003 111.451 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 117' ' ' THR . 59.6 mt -115.47 149.22 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.579 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.86 144.51 44.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.067 0.461 . . . . 70.030000000000001 112.119 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -32.19 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.18 -0.464 . . . . 44.350000000000001 112.027 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.8 -47.3 13.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.98 0.419 . . . . 73.140000000000001 110.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.4 23.24 1.4 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.03 -0.532 . . . . 55.229999999999997 113.487 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -90.31 -27.89 19.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.453 0.909 . . . . 74.439999999999998 113.453 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -151.8 160.31 43.61 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.694 0.998 . . . . 74.450000000000003 113.694 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.685 HG23 HG12 ' A' ' 20' ' ' ILE . 70.0 mt -125.98 120.76 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.469 -0.787 . . . . 72.010000000000005 110.366 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -93.38 114.38 26.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.845 0.683 . . . . 71.030000000000001 112.845 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -100.92 165.21 11.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.268 172.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -151.41 139.59 20.23 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.066 0.46 . . . . 75.319999999999993 112.093 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 29.7 t30 -88.12 145.53 25.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.919 -0.582 . . . . 60.32 110.88 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -119.33 8.24 11.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.462 0.541 . . . . 63.229999999999997 112.462 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.0 p -81.58 155.5 25.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.34 0.59 . . . . 63.340000000000003 112.049 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.9 7.65 17.5 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.992 -0.549 . . . . 71.400000000000006 111.947 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.8 156.21 42.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.659 0.266 . . . . 72.209999999999994 111.498 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.58 106.11 2.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.443 -0.344 . . . . 63.32 111.025 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -106.13 144.74 29.56 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.699 -0.228 . . . . 64.099999999999994 111.326 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.37 156.03 18.55 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.353 2.035 . . . . 74.209999999999994 112.948 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.589 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 4.2 tpt -60.23 -29.24 68.62 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.978 0.418 . . . . 34.009999999999998 111.926 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.08 176.86 49.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.373 -0.441 . . . . 73.510000000000005 113.559 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 52.63 0.67 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.354 -0.451 . . . . 62.0 112.709 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -98.72 172.36 7.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.554 0.216 . . . . 64.030000000000001 110.856 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 43.5 tt0 -137.35 137.3 38.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.316 0.579 . . . . 75.109999999999999 111.492 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.2 ttp -105.39 122.75 46.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.87 -0.605 . . . . 64.219999999999999 111.417 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.2 mp -104.79 124.29 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.888 0.375 . . . . 70.310000000000002 111.407 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.667 ' HB2' ' HH2' ' A' ' 88' ' ' TRP . 34.7 ttt180 -90.87 123.16 34.18 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.278 -0.264 . . . . 73.400000000000006 111.671 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -116.58 105.53 12.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 64.409999999999997 110.831 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.16 -23.43 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.284 0.564 . . . . 71.019999999999996 110.789 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -94.8 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.035 -0.529 . . . . 71.319999999999993 112.345 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.86 -41.0 11.43 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.691 0.281 . . . . 72.400000000000006 111.384 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.3 t -92.72 147.97 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.162 0.506 . . . . 72.099999999999994 111.792 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p -140.96 168.88 18.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.082 0.468 . . . . 73.120000000000005 111.6 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -162.17 141.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.245 -0.434 . . . . 45.43 110.537 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -115.58 159.72 20.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.539 0.685 . . . . 61.130000000000003 112.782 -174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 84.0 t80 -144.44 115.27 7.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.642 -0.708 . . . . 71.030000000000001 110.597 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 87.3 tttt -86.85 140.39 29.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.189 0.519 . . . . 75.209999999999994 111.583 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.431 ' HE2' HD11 ' A' ' 71' ' ' ILE . 89.2 m-85 -87.56 145.41 26.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 73.510000000000005 111.489 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.8 t -121.55 130.1 53.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.949 0.404 . . . . 62.439999999999998 111.659 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 67.8 m -73.92 74.68 1.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.162 0.506 . . . . 65.200000000000003 111.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -97.76 -2.24 41.56 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.915 -0.584 . . . . 61.43 111.532 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -168.76 172.83 7.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.112 -0.494 . . . . 75.219999999999999 110.617 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.06 126.32 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.14 0.495 . . . . 72.420000000000002 111.652 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -74.38 119.56 18.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.232 -0.655 . . . . 75.129999999999995 109.232 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 66.0 mttm -62.37 158.75 16.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.825 0.676 . . . . 50.420000000000002 112.825 -172.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.21 113.88 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.658 -0.701 . . . . 74.430000000000007 112.006 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . 67.66 21.4 72.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.463 -0.398 . . . . 45.140000000000001 114.029 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.6 tp60 -86.35 149.24 25.17 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.148 0.499 . . . . 73.25 111.844 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.1 p -92.45 145.2 24.64 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.178 -0.465 . . . . 75.109999999999999 111.557 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' HD21 ' A' ' 63' ' ' LEU . 7.0 p -134.49 122.29 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.91 0.386 . . . . 62.130000000000003 110.391 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -103.1 137.33 41.42 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.253 0.549 . . . . 74.420000000000002 112.102 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 86' ' ' LEU . 43.5 mm -95.4 108.85 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.214 -0.448 . . . . 63.039999999999999 110.782 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -97.35 136.22 38.12 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.544 0.212 . . . . 71.120000000000005 110.659 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.31 158.11 18.11 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.086 0.402 . . . . 64.140000000000001 112.086 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 89' ' ' LYS . . . -47.09 -44.92 21.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.594 0.59 . . . . 73.019999999999996 112.594 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 93' ' ' SER . 2.0 m-20 -95.84 74.5 3.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.161 0.505 . . . . 73.420000000000002 111.511 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.9 3.15 8.77 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.08 -0.509 . . . . 72.329999999999998 111.188 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.62 17.32 64.52 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.309 -0.405 . . . . 74.439999999999998 113.651 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.39 171.5 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.152 0.501 . . . . 73.099999999999994 112.317 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -82.2 164.4 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.999 -0.546 . . . . 62.020000000000003 112.207 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.54 89.89 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.359 -0.382 . . . . 63.420000000000002 111.717 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 t 59.83 81.36 0.25 Allowed Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.508 . . . . 45.119999999999997 111.342 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 89.0 Cg_exo -45.23 -51.45 7.75 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.222 2.615 . . . . 65.129999999999995 115.365 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 48.6 Cg_endo -100.13 149.35 4.15 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 121.011 1.397 . . . . 70.510000000000005 114.008 -1.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 t -171.02 -38.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.259 -0.882 . . . . 31.210000000000001 108.892 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -123.21 156.76 34.49 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.838 -1.074 . . . . 72.439999999999998 109.308 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 71' ' ' ILE . 93.3 mt -104.8 141.65 36.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.026 0.441 . . . . 74.400000000000006 111.961 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.5 mp -95.14 121.85 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.313 0.578 . . . . 75.109999999999999 111.343 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.667 ' HH2' ' HB2' ' A' ' 46' ' ' ARG . 4.9 t90 -89.66 84.0 6.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.939 -0.573 . . . . 73.510000000000005 110.463 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 48.8 mtmt -74.61 -16.41 60.79 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.187 0.44 . . . . 73.439999999999998 112.187 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.567 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 0.9 OUTLIER -65.9 -15.86 63.33 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.79 0.328 . . . . 71.420000000000002 111.523 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -148.69 139.01 22.48 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 72.219999999999999 111.103 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.9 m120 -72.72 -177.17 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.035 0.445 . . . . 73.450000000000003 111.231 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 40.4 t -77.69 142.92 38.51 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.226 -0.297 . . . . 73.150000000000006 111.486 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -125.85 157.71 36.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.953 0.406 . . . . 73.140000000000001 111.234 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.92 141.75 7.27 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.93 -0.652 . . . . 61.329999999999998 112.819 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 t 176.46 -27.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.983 0.364 . . . . 63.240000000000002 111.983 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 30.11 20.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.039 -0.6 . . . . 45.240000000000002 113.564 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.58 144.08 28.28 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.005 0.402 . . . . 71.120000000000005 110.757 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.2 m-20 -64.52 99.32 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.172 0.511 . . . . 74.0 112.15 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.36 127.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.578 . . . . 62.219999999999999 111.072 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 19.2 ttpp -104.26 119.53 39.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.336 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.1 t -108.71 147.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.132 0.491 . . . . 74.019999999999996 112.015 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 mm -116.95 126.49 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.094 -0.503 . . . . 75.420000000000002 111.591 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 HG13 ' A' ' 17' ' ' ILE . 66.3 mt -110.58 106.71 16.08 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.702 0.287 . . . . 74.319999999999993 111.697 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -120.52 140.82 50.91 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.323 0.583 . . . . 74.209999999999994 111.731 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.517 ' OD1' HG13 ' A' ' 112' ' ' VAL . 12.4 m120 -80.77 179.68 7.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.739 -0.664 . . . . 73.120000000000005 112.343 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.5 p -54.48 -49.24 70.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.561 -0.745 . . . . 53.5 112.345 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.56 -4.32 22.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.78 0.659 . . . . 71.150000000000006 112.78 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.35 -16.75 60.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.047 -0.597 . . . . 70.230000000000004 113.468 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.76 143.95 55.62 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.456 -0.438 . . . . 74.310000000000002 110.72 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -103.06 130.47 50.21 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.6 0.592 . . . . 74.239999999999995 112.6 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 106' ' ' ASN . 16.0 m -76.7 -45.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.765 -0.198 . . . . 65.109999999999999 111.194 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -176.67 133.7 0.21 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.516 0.561 . . . . 64.329999999999998 112.516 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.28 141.9 35.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.526 -0.546 . . . . 63.420000000000002 109.526 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -155.61 146.91 22.68 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.407 0.521 . . . . 60.229999999999997 112.407 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 79.1 p -109.56 169.98 8.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.005 0.431 . . . . 24.0 111.306 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.782 HG22 ' HB ' ' A' ' 20' ' ' ILE . 62.3 p -71.91 164.81 25.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.152 0.501 . . . . 71.420000000000002 112.106 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 CA--C 1.536 0.406 0 CA-C-N 116.051 -0.522 . . . . 62.43 110.65 174.853 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 11.9 m120 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 112.243 0.46 . . . . 52.229999999999997 112.243 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.53 97.75 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.209 0.528 . . . . 61.329999999999998 110.878 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 p -112.54 158.67 19.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.365 -0.38 . . . . 65.209999999999994 111.416 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.737 HG13 HD11 ' A' ' 104' ' ' LEU . 72.2 mt -62.11 135.73 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.734 -0.212 . . . . 43.140000000000001 111.037 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 33.0 tt0 -90.56 -69.25 0.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 74.209999999999994 110.26 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.85 138.66 22.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 111.408 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.755 HG23 HG12 ' A' ' 27' ' ' ILE . 56.4 mt -101.53 141.77 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.375 -0.375 . . . . 70.200000000000003 110.907 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.0 150.15 35.85 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.368 0.604 . . . . 74.129999999999995 112.419 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.37 -31.43 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.302 -0.863 . . . . 62.539999999999999 112.569 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.45 -32.15 66.04 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.134 0.492 . . . . 73.120000000000005 111.238 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 108.96 34.04 2.66 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.133 -0.485 . . . . 63.049999999999997 112.303 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.74 -53.13 3.98 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.416 0.524 . . . . 71.530000000000001 112.416 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.39 165.65 35.12 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.834 1.05 . . . . 64.319999999999993 113.834 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.755 HG12 HG23 ' A' ' 20' ' ' ILE . 64.7 mt -129.05 106.44 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.889 -1.05 . . . . 61.530000000000001 109.612 172.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -91.66 124.66 35.97 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.85 -0.531 . . . . 72.150000000000006 112.343 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 8.0 mp -93.49 -177.28 4.36 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.21 -0.45 . . . . 74.200000000000003 111.12 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 61.6 tttp -162.66 119.9 2.0 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.793 0.294 . . . . 73.010000000000005 111.793 -174.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' HB2' HD12 ' A' ' 63' ' ' LEU . 38.5 t30 -90.24 110.43 21.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.609 0.243 . . . . 70.340000000000003 111.032 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.6 p -96.65 13.53 27.99 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.369 0.507 . . . . 74.209999999999994 112.369 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 29.5 t -79.54 157.6 27.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.288 0.566 . . . . 63.43 112.438 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.61 -13.72 59.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.797 -0.638 . . . . 65.319999999999993 110.741 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -115.64 149.26 38.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.191 0.52 . . . . 62.030000000000001 111.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.17 108.83 5.56 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.101 -0.5 . . . . 72.209999999999994 110.141 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -91.2 119.68 68.68 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.384 0.512 . . . . 53.0 112.384 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.87 136.11 47.45 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.269 1.979 . . . . 65.010000000000005 111.844 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 3.0 tpt -59.39 -41.53 89.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.21 0.448 . . . . 65.209999999999994 112.21 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.27 -67.12 1.21 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.375 -0.441 . . . . 70.340000000000003 113.494 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.78 78.52 0.02 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 62.32 112.855 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -98.9 179.96 4.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.73 0.3 . . . . 74.230000000000004 111.067 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.42 130.44 11.83 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.522 0.677 . . . . 64.329999999999998 111.236 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' SER . 52.2 ttp -99.35 111.39 23.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.808 -0.633 . . . . 55.030000000000001 111.416 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.7 mp -89.68 141.6 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.668 0.27 . . . . 75.540000000000006 110.631 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -138.17 126.25 22.8 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.939 -0.475 . . . . 73.109999999999999 111.621 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -111.97 145.38 39.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 74.340000000000003 111.179 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.99 -41.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.062 0.458 . . . . 73.540000000000006 111.923 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.15 103.62 0.17 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.146 -0.55 . . . . 63.240000000000002 112.369 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 72.47 -36.51 0.36 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.457 0.703 . . . . 64.030000000000001 112.616 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -113.84 148.54 36.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.902 0.382 . . . . 73.209999999999994 111.457 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.1 p -137.02 143.43 42.73 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.338 -0.392 . . . . 75.200000000000003 111.023 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.5 147.38 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 63.240000000000002 111.031 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' MET . 97.9 p -131.77 150.32 52.19 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.067 0.461 . . . . 61.119999999999997 111.971 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 33.1 t80 -122.6 120.5 33.93 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.36 -0.382 . . . . 73.150000000000006 111.297 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.69 129.32 34.85 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.965 0.412 . . . . 73.349999999999994 111.649 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HB3' ' SD ' ' A' ' 39' ' ' MET . 86.4 m-85 -88.67 122.59 32.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.311 -0.404 . . . . 55.210000000000001 111.659 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.9 t -81.91 140.57 33.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.639 0.607 . . . . 71.209999999999994 112.639 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 98.9 p -86.05 18.44 3.06 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.17 0.433 . . . . 72.519999999999996 112.17 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 14.4 ptm180 -68.85 -9.8 53.37 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.757 0.651 . . . . 72.010000000000005 112.757 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.49 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 48.6 p90 -152.63 168.44 25.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.279 0.562 . . . . 75.200000000000003 112.043 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.57 140.71 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.682 -0.69 . . . . 72.120000000000005 111.455 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -92.95 100.61 13.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.33 -0.619 . . . . 64.450000000000003 109.33 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 8.4 mtpm? -69.69 163.24 26.08 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.384 0.883 . . . . 75.409999999999997 113.384 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.57 122.53 17.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.834 -0.621 . . . . 75.200000000000003 111.171 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.34 86.72 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.944 -0.646 . . . . 72.049999999999997 113.473 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' HB3' HD13 ' A' ' 63' ' ' LEU . 7.6 tp60 -89.37 133.9 34.31 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.462 -0.434 . . . . 63.549999999999997 111.041 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.9 p -116.07 100.68 8.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.316 -0.402 . . . . 63.210000000000001 111.821 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.67 132.17 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.927 0.394 . . . . 63.409999999999997 111.206 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 m -101.2 124.23 46.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.826 0.346 . . . . 65.530000000000001 111.694 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 40.7 mm -89.39 96.2 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.91 0.386 . . . . 54.420000000000002 110.985 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' TRP . 94.3 m95 -83.05 133.9 35.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.684 0.253 . . . . 71.409999999999997 111.684 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 163.3 11.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.038 0.447 . . . . 34.420000000000002 111.964 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.35 -21.08 3.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.07 0.767 . . . . 61.240000000000002 113.07 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.97 16.47 4.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.106 0.41 . . . . 75.519999999999996 112.106 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.94 78.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.051 0.453 . . . . 73.150000000000006 111.501 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.36 -26.85 3.34 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.424 -0.417 . . . . 73.310000000000002 113.686 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.26 163.57 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.981 0.42 . . . . 74.530000000000001 111.98 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -78.13 143.6 37.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.064 0.459 . . . . 75.219999999999999 111.662 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.0 78.12 3.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.024 0.44 . . . . 63.409999999999997 111.199 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -136.47 95.07 13.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.503 -0.317 . . . . 70.349999999999994 111.684 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 13.4 Cg_exo -72.72 178.17 6.67 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.248 2.632 . . . . 75.540000000000006 112.278 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 98.6 Cg_endo -99.9 118.82 1.01 Allowed 'Cis proline' 0 C--N 1.361 1.22 0 N-CA-C 114.544 0.94 . . . . 73.129999999999995 114.544 -0.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.9 t -154.96 -56.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.97 -0.559 . . . . 70.010000000000005 109.855 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 84' ' ' THR . 21.4 m-20 -141.2 176.85 8.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.779 -0.646 . . . . 65.019999999999996 109.703 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 97.0 mt -123.02 124.13 42.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.893 0.378 . . . . 74.239999999999995 110.956 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 87' ' ' ILE . 3.2 mp -93.99 111.56 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.167 0.508 . . . . 75.400000000000006 111.31 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.443 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 4.3 t90 -71.09 77.9 0.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.203 0.525 . . . . 74.430000000000007 110.617 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.89 1.8 16.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.022 0.439 . . . . 72.439999999999998 111.607 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.443 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 15.2 m120 -93.57 -4.32 51.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.272 -0.422 . . . . 64.329999999999998 111.812 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -137.79 148.69 45.75 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.171 0.51 . . . . 75.129999999999995 111.457 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -91.44 -174.82 4.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.04 -0.527 . . . . 71.519999999999996 110.789 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 98.7 p -64.41 120.43 12.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.141 0.496 . . . . 54.329999999999998 111.096 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.3 p90 -77.73 118.21 19.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.239 0.542 . . . . 72.340000000000003 112.062 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.36 102.74 0.16 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.932 -0.576 . . . . 75.329999999999998 112.334 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -157.35 26.25 0.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 65.230000000000004 111.718 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -54.11 4.35 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.151 -0.547 . . . . 42.420000000000002 113.102 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.3 119.19 8.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.479 0.312 . . . . 73.209999999999994 111.194 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.04 146.2 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.676 0.621 . . . . 74.219999999999999 112.676 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.4 128.47 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.786 -0.643 . . . . 73.519999999999996 111.773 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 116' ' ' SER . 80.7 tttt -114.47 142.49 46.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.991 0.424 . . . . 71.140000000000001 111.751 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.82 136.91 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.996 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.73 122.91 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.024 -0.535 . . . . 74.409999999999997 111.432 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 17' ' ' ILE . 97.9 mt -89.69 131.28 35.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.231 -0.293 . . . . 70.349999999999994 111.095 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.6 mttt -141.09 145.72 36.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.209 0.528 . . . . 53.350000000000001 112.052 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' HG3' ' A' ' 110' ' ' GLU . 10.6 m120 -88.31 -173.43 4.2 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.082 0.467 . . . . 74.140000000000001 111.674 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -51.78 -41.96 62.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.742 0.645 . . . . 61.130000000000003 112.742 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.99 -0.69 40.66 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.894 0.702 . . . . 75.129999999999995 112.894 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.1 0.59 80.51 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.896 -0.669 . . . . 22.219999999999999 112.867 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' OD1' ' A' ' 106' ' ' ASN . 13.8 pt-20 -66.8 138.6 57.47 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.718 0.407 . . . . 71.209999999999994 111.108 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.5 tt0 -83.59 133.15 34.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.174 0.512 . . . . 75.430000000000007 111.954 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.71 -50.53 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.964 -0.562 . . . . 71.140000000000001 111.162 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.6 163.78 16.9 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.966 -0.561 . . . . 65.230000000000004 111.58 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -137.16 136.12 37.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.241 -0.436 . . . . 71.340000000000003 111.116 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -160.63 156.25 25.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.118 0.485 . . . . 75.310000000000002 111.486 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 54.4 p -142.54 -171.94 3.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.788 0.328 . . . . 60.329999999999998 111.221 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 14.8 t -147.23 145.47 29.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.652 0.263 . . . . 62.009999999999998 110.571 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.004 0.43 . . . . 71.420000000000002 111.831 -176.381 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 . . . . . 0 CA--C 1.542 0.644 0 CA-C-O 121.103 0.478 . . . . 72.219999999999999 110.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.42 140.6 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.015 0.436 . . . . 52.509999999999998 111.873 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -137.81 164.17 29.59 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.209 -0.45 . . . . 62.020000000000003 110.705 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.1 mp -87.49 119.44 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.22 -0.3 . . . . 72.200000000000003 111.28 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.51 -50.52 44.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.785 0.326 . . . . 70.540000000000006 111.361 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -171.31 152.79 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 60.329999999999998 112.149 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 27' ' ' ILE . 65.3 mt -107.49 134.72 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.792 -0.64 . . . . 64.120000000000005 110.816 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.0 130.25 41.66 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.032 0.444 . . . . 65.209999999999994 111.301 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -70.18 -28.25 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.511 0.56 . . . . 74.310000000000002 112.511 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.53 -44.76 56.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 110.835 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 117.02 37.97 0.91 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 116.23 -0.441 . . . . 73.439999999999998 113.236 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -104.69 -39.59 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.452 0.538 . . . . 63.509999999999998 112.452 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.75 160.46 37.9 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.353 0.871 . . . . 72.140000000000001 113.353 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 20' ' ' ILE . 69.7 mt -131.61 122.47 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.611 -0.722 . . . . 71.0 109.781 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -99.72 122.41 42.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.934 0.716 . . . . 73.439999999999998 112.934 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 104' ' ' LEU . 7.0 mp -97.3 173.72 7.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.592 -0.731 . . . . 74.329999999999998 110.587 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.6 131.6 11.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.936 0.398 . . . . 73.120000000000005 111.981 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HB3' HD12 ' A' ' 63' ' ' LEU . 28.4 t30 -89.87 104.36 16.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.249 -0.432 . . . . 65.450000000000003 110.968 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 t -105.72 84.11 2.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 71.450000000000003 110.887 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.6 p -136.4 -177.8 4.88 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.722 -0.672 . . . . 64.420000000000002 112.164 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.45 -22.53 35.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.909 0.707 . . . . 74.510000000000005 112.909 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -146.89 154.56 41.44 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.516 0.561 . . . . 75.120000000000005 112.516 -170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -50.36 128.15 19.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.866 -0.606 . . . . 72.409999999999997 111.569 175.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.1 mm-40 -121.08 119.68 29.61 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.805 0.336 . . . . 53.509999999999998 111.633 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 7.3 Cg_exo -74.8 29.9 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.12 2.547 . . . . 64.319999999999993 113.946 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.3 tpt 64.94 -71.18 0.08 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.4 0.518 . . . . 53.140000000000001 112.4 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . 96.37 -75.69 0.76 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.134 -0.555 . . . . 64.329999999999998 113.247 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.48 83.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.22 -0.514 . . . . 40.310000000000002 112.917 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.685 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 9.0 m0 -100.65 174.71 5.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.767 0.318 . . . . 75.540000000000006 111.605 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.28 111.32 15.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.799 0.333 . . . . 71.239999999999995 111.194 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.7 ttp -103.01 121.2 42.07 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.068 -0.395 . . . . 62.329999999999998 111.279 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.28 149.64 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.355 -0.384 . . . . 64.040000000000006 110.716 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 46' ' ' ARG . 28.4 ttp-105 -135.2 105.54 6.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.944 -0.473 . . . . 43.119999999999997 110.878 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 98.3 mttt -88.44 118.91 28.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.481 -0.327 . . . . 71.140000000000001 110.666 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 tt -155.07 99.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.934 0.397 . . . . 73.109999999999999 111.665 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 58.94 93.66 0.01 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.253 -0.431 . . . . 50.420000000000002 114.117 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.9 t70 76.46 -58.75 0.52 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.068 0.766 . . . . 71.209999999999994 113.068 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -103.99 163.42 12.38 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.849 0.685 . . . . 63.340000000000003 112.849 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.4 p -138.02 105.4 5.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.646 -0.706 . . . . 74.230000000000004 110.683 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.1 p -92.28 146.18 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.699 0.285 . . . . 63.420000000000002 111.429 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -123.0 159.35 28.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.21 0.528 . . . . 74.349999999999994 111.77 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 73.6 t80 -138.93 133.52 31.95 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.114 -0.494 . . . . 64.219999999999999 110.813 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -101.18 129.98 47.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.097 0.475 . . . . 72.439999999999998 111.715 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.685 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 68.7 m-85 -88.84 172.89 8.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.033 -0.53 . . . . 72.340000000000003 111.923 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 t -149.71 153.82 37.56 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.984 0.421 . . . . 75.120000000000005 112.111 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 36.9 t -86.3 64.26 8.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.991 0.424 . . . . 53.530000000000001 111.919 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.683 HH11 ' HG2' ' A' ' 82' ' ' PRO . 9.6 ptp180 -106.58 -1.53 22.82 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.747 0.308 . . . . 74.219999999999999 111.785 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HD23 ' A' ' 63' ' ' LEU . 29.9 p90 -154.98 148.61 25.37 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.681 0.277 . . . . 73.129999999999995 111.011 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 47.8 t -97.02 102.37 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 64.109999999999999 111.024 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 31' ' ' ASN . 1.1 tm? -80.74 108.82 14.72 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.204 0.526 . . . . 72.349999999999994 110.623 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 61.7 mttm -64.36 140.5 58.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.024 -0.534 . . . . 73.310000000000002 112.186 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.24 127.19 30.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.253 -0.43 . . . . 61.039999999999999 111.306 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.96 -15.37 55.4 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.152 -0.547 . . . . 71.439999999999998 112.787 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -95.65 168.08 10.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.885 0.374 . . . . 75.409999999999997 110.831 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.8 p -119.25 174.04 6.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.274 0.559 . . . . 74.200000000000003 112.183 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.72 127.92 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.976 -0.556 . . . . 44.049999999999997 110.448 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.5 m -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.955 0.407 . . . . 72.150000000000006 111.96 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 86' ' ' LEU . 29.5 mm -92.54 97.49 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.151 -0.477 . . . . 72.400000000000006 110.423 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 88.0 m95 -79.12 168.72 19.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.938 0.399 . . . . 74.329999999999998 111.792 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.67 16.63 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.569 -0.287 . . . . 64.209999999999994 110.902 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.1 -30.62 37.47 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.108 0.781 . . . . 73.349999999999994 113.108 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -97.9 19.63 13.51 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.429 0.529 . . . . 55.549999999999997 112.429 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -52.91 -47.83 67.68 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 43.32 112.625 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.93 75.48 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.213 -0.518 . . . . 33.549999999999997 112.816 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.91 -164.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.327 0.251 . . . . 64.010000000000005 111.106 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.4 m -48.67 130.29 17.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.771 0.319 . . . . 74.439999999999998 111.165 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.13 62.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.553 0.945 . . . . 73.120000000000005 113.553 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.4 t -159.28 151.91 17.9 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 113.133 0.79 . . . . 74.299999999999997 113.133 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.685 ' HG3' HD23 ' A' ' 86' ' ' LEU . 7.1 Cg_endo -48.79 170.84 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 123.919 3.079 . . . . 74.120000000000005 111.363 168.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -16.82 -80.51 0.0 OUTLIER 'Cis proline' 0 C--N 1.374 1.896 0 N-CA-C 121.329 3.55 . . . . 74.140000000000001 121.329 11.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.2 p -78.62 -83.63 0.09 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.301 1.223 . . . . 62.200000000000003 114.301 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 6.3 m-20 -73.78 122.6 22.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.248 0.547 . . . . 73.230000000000004 112.458 -171.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.685 HD23 ' HG3' ' A' ' 82' ' ' PRO . 12.1 mt -91.09 113.24 25.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.912 -0.585 . . . . 73.450000000000003 111.369 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.5 mp -86.08 119.11 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.18 0.514 . . . . 60.140000000000001 110.944 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.421 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.1 t90 -69.46 77.9 0.4 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.332 0.587 . . . . 75.439999999999998 110.351 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -75.88 27.82 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.324 0.49 . . . . 42.439999999999998 112.324 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -118.1 -1.86 11.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.901 0.381 . . . . 70.510000000000005 110.969 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.455 ' OE1' HG11 ' A' ' 53' ' ' VAL . 25.3 tt0 -157.82 146.27 19.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.966 0.413 . . . . 44.109999999999999 111.111 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -82.81 -167.62 1.71 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.433 -0.349 . . . . 73.120000000000005 110.775 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 t -69.0 145.35 53.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.941 0.401 . . . . 65.420000000000002 111.611 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.512 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 49.4 p90 -121.86 -174.46 2.88 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.217 -0.447 . . . . 64.200000000000003 110.631 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 137.71 50.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.766 -0.731 . . . . 63.340000000000003 113.609 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 98' ' ' GLU . 7.3 t -76.49 -20.91 56.47 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.451 -0.441 . . . . 74.319999999999993 111.982 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.62 4.87 60.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.091 -0.576 . . . . 74.420000000000002 113.517 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.606 ' H ' HG23 ' A' ' 96' ' ' THR . 9.0 mm-40 -85.69 172.46 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.652 -0.322 . . . . 54.439999999999998 111.257 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.05 143.33 55.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.103 0.478 . . . . 52.149999999999999 111.995 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.35 132.74 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.284 0.564 . . . . 75.010000000000005 111.655 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 114' ' ' GLN . 50.6 tttm -123.35 111.8 16.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.07 -0.514 . . . . 61.310000000000002 110.817 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.81 133.09 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.946 0.403 . . . . 72.129999999999995 111.39 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.463 HG21 ' HE2' ' A' ' 105' ' ' LYS . 16.3 mm -126.64 136.53 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 111.828 0.307 . . . . 63.119999999999997 111.828 -173.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 29' ' ' LEU . 79.4 mt -110.13 107.68 17.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.93 0.395 . . . . 51.25 111.559 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' A' ' 103' ' ' ILE . 67.7 mttm -119.31 167.76 11.57 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.373 0.606 . . . . 71.140000000000001 112.061 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HB2' ' CG ' ' A' ' 110' ' ' GLU . 12.8 m120 -113.96 -176.65 2.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.987 -0.551 . . . . 74.540000000000006 111.681 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 t -58.75 -39.32 80.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.307 0.854 . . . . 62.219999999999999 113.307 -173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -73.46 -8.7 57.0 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.552 0.575 . . . . 73.049999999999997 112.552 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.75 68.68 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.648 -0.787 . . . . 65.230000000000004 112.065 -171.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.513 ' CG ' ' HB2' ' A' ' 106' ' ' ASN . 10.5 pt-20 -68.44 168.59 12.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.658 0.383 . . . . 75.299999999999997 110.39 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.71 136.92 48.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.128 -0.358 . . . . 74.5 111.779 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.648 HG21 ' HZ3' ' A' ' 42' ' ' TRP . 29.2 m -96.7 -41.62 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.438 -0.346 . . . . 53.130000000000003 111.61 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.79 168.95 13.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 40.329999999999998 111.504 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 29.5 pt20 -160.0 163.37 34.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.238 -0.437 . . . . 73.239999999999995 110.71 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -161.89 -179.41 7.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.015 0.912 . . . . 54.5 112.793 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.3 p -147.64 -170.99 3.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.821 -1.081 . . . . 73.329999999999998 109.892 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 p -78.71 142.45 37.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.894 0.378 . . . . 74.400000000000006 110.972 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.383 0.611 . . . . 72.109999999999999 111.193 178.051 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.6 m-80 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 120.874 0.368 . . . . 75.230000000000004 111.375 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.11 120.27 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.01 0.433 . . . . 73.239999999999995 111.361 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -133.62 156.66 47.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.447 -0.342 . . . . 74.209999999999994 110.906 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 65.2 mt -71.04 126.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.755 0.312 . . . . 64.219999999999999 111.496 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -89.33 -66.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.001 0.429 . . . . 74.430000000000007 110.783 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -136.23 130.25 32.81 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.126 0.489 . . . . 70.209999999999994 112.085 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG23 ' A' ' 27' ' ' ILE . 62.6 mt -103.91 114.45 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.968 -0.56 . . . . 72.239999999999995 110.351 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 17.2 t70 -74.53 139.61 43.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.473 0.654 . . . . 53.219999999999999 112.256 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.5 -16.41 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.609 -0.723 . . . . 73.530000000000001 110.993 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.07 -14.15 61.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.149 -0.478 . . . . 32.420000000000002 111.198 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 99.44 29.22 7.16 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.771 0.669 . . . . 73.099999999999994 114.771 168.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 11.5 mptt -113.3 -54.48 2.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.214 0.82 . . . . 71.340000000000003 113.214 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 46.1 p90 -148.04 167.24 25.46 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.106 1.151 . . . . 75.329999999999998 114.106 -170.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.466 HG23 HG12 ' A' ' 20' ' ' ILE . 69.8 mt -132.63 105.22 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 72.040000000000006 109.345 170.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.1 ttm180 -90.8 119.94 31.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.207 0.817 . . . . 75.450000000000003 113.207 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.0 mp -93.83 -175.88 3.87 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.712 -0.676 . . . . 75.450000000000003 110.333 171.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 35.0 ttpt -157.37 135.16 10.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.996 0.427 . . . . 64.510000000000005 112.009 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -108.33 115.23 29.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.039 -0.528 . . . . 64.239999999999995 111.403 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -102.19 16.56 25.75 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 64.420000000000002 112.116 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 98.3 p -55.24 152.32 8.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.079 0.466 . . . . 63.109999999999999 111.707 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -85.14 -0.35 54.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.799 0.333 . . . . 53.299999999999997 111.811 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.87 161.04 28.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.395 -0.366 . . . . 72.040000000000006 110.269 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.61 111.54 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.725 0.298 . . . . 73.230000000000004 111.244 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -104.85 132.07 21.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 N-CA-C 111.893 0.331 . . . . 75.109999999999999 111.893 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.69 132.93 54.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.456 2.104 . . . . 43.43 112.19 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 tpt -52.45 -72.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.07 0.396 . . . . 74.400000000000006 112.07 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.64 172.45 45.38 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.711 -0.757 . . . . 62.119999999999997 113.085 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.19 89.11 0.41 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.117 -0.563 . . . . 74.510000000000005 113.707 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . 41.3 m95 -102.41 156.43 17.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.773 0.321 . . . . 71.239999999999995 110.434 171.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.84 115.35 6.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.805 0.336 . . . . 74.310000000000002 111.468 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' SER . 54.7 ttp -93.99 114.06 26.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.569 -0.287 . . . . 75.0 111.67 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.8 mp -102.13 106.91 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.894 0.378 . . . . 72.230000000000004 110.36 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HG3' HG22 ' A' ' 102' ' ' VAL . 50.6 ttt180 -99.11 123.62 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.713 0.292 . . . . 74.420000000000002 111.483 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -121.9 116.86 25.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.954 0.407 . . . . 60.509999999999998 111.584 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 tt -103.35 -27.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.165 0.507 . . . . 70.25 110.703 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.96 -137.31 3.21 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 112.305 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -71.25 -40.54 70.93 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.03 0.443 . . . . 43.43 111.454 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -79.05 156.5 28.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.189 0.518 . . . . 51.140000000000001 112.126 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.3 p -133.69 152.55 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.128 -0.487 . . . . 73.040000000000006 111.343 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.9 p -134.96 139.43 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.506 -0.316 . . . . 62.32 111.318 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' MET . 84.0 p -111.53 171.38 7.52 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.233 0.54 . . . . 73.209999999999994 112.369 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.435 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 74.6 t80 -160.47 114.21 2.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.863 -0.608 . . . . 74.549999999999997 111.252 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.15 127.07 33.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.746 0.307 . . . . 71.319999999999993 111.438 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 3.1 m-85 -73.98 121.99 21.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.823 0.344 . . . . 64.230000000000004 111.123 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.53 HG21 ' HG2' ' A' ' 82' ' ' PRO . 5.2 t -68.84 120.96 15.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.543 0.687 . . . . 71.140000000000001 112.213 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -85.89 33.93 0.6 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.113 -0.494 . . . . 63.399999999999999 111.925 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.662 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 13.4 ptp180 -78.47 -3.72 44.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.148 0.425 . . . . 75.049999999999997 112.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.538 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 24.2 p90 -158.54 171.83 19.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.004 0.431 . . . . 71.049999999999997 111.362 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -92.9 138.74 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.3 -0.409 . . . . 63.340000000000003 111.51 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.31 105.7 13.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.137 0.494 . . . . 72.329999999999998 109.68 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 7.4 mtpm? -69.14 154.23 42.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.269 0.557 . . . . 63.43 112.446 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.6 57.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.753 -0.658 . . . . 73.329999999999998 112.187 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.26 -0.495 . . . . 62.439999999999998 113.793 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.89 132.38 34.71 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.229 -0.571 . . . . 71.420000000000002 111.557 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 56.2 p -100.02 83.59 2.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.309 -0.405 . . . . 61.009999999999998 111.019 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 29' ' ' LEU . 4.5 p -57.96 106.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.573 0.701 . . . . 61.219999999999999 111.372 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 86.4 m -93.06 121.31 34.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 74.049999999999997 111.525 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 47.8 mm -83.12 106.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.433 -0.348 . . . . 62.420000000000002 111.047 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -82.95 144.75 29.79 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.564 0.209 . . . . 73.409999999999997 111.564 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.93 157.64 27.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.835 0.35 . . . . 74.450000000000003 111.877 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.98 -30.48 25.16 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.439 0.533 . . . . 62.109999999999999 112.439 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -81.73 28.66 0.4 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.804 0.335 . . . . 60.439999999999998 111.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.62 87.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.176 0.436 . . . . 73.409999999999997 112.176 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.84 -37.7 2.5 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.178 -0.534 . . . . 43.200000000000003 113.771 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.2 -173.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.152 0.427 . . . . 65.510000000000005 112.152 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -51.1 104.92 0.09 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.099999999999994 111.903 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.82 1.32 35.34 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.671 0.619 . . . . 62.310000000000002 112.671 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.4 t -117.2 117.72 36.48 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 120.533 0.206 . . . . 75.209999999999994 111.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.662 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 54.0 Cg_exo -55.91 178.6 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.527 0 C-N-CA 123.776 2.984 . . . . 63.130000000000003 113.414 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 95.4 Cg_endo -76.73 126.19 12.94 Favored 'Cis proline' 0 C--N 1.366 1.459 0 CA-C-N 120.107 1.074 . . . . 71.140000000000001 114.813 6.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 82' ' ' PRO . 8.9 t 176.71 -170.94 0.08 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.353 -0.84 . . . . 70.030000000000001 109.418 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 87' ' ' ILE . 6.5 m-20 -57.4 108.1 0.51 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.735 -0.469 . . . . 74.019999999999996 109.735 171.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 79.6 mt -51.44 109.22 0.32 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.378 0.881 . . . . 72.120000000000005 113.378 -169.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 85' ' ' ASP . 3.6 mp -76.25 117.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.193 0.521 . . . . 64.200000000000003 110.8 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 6.7 t90 -70.31 134.96 48.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.914 -0.584 . . . . 74.519999999999996 110.527 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -127.35 27.99 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.02 0.438 . . . . 73.129999999999995 111.769 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.426 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 13.5 m-80 -121.45 -26.77 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.361 -0.381 . . . . 74.310000000000002 111.522 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -133.32 147.13 51.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.697 0.284 . . . . 54.43 110.874 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -95.51 -171.67 2.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.994 0.426 . . . . 74.420000000000002 111.951 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -59.89 127.03 29.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.892 0.377 . . . . 72.430000000000007 111.056 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -101.47 118.07 36.2 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.244 0.545 . . . . 75.120000000000005 112.457 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -120.93 85.14 0.38 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 111.893 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 p -130.56 -39.09 1.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.132 0.419 . . . . 74.219999999999999 112.132 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.42 89.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.257 -0.496 . . . . 71.140000000000001 112.857 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -96.66 145.75 25.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.97 0.414 . . . . 51.229999999999997 111.858 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 6.1 m-20 -64.59 131.1 46.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.402 0.62 . . . . 61.149999999999999 112.07 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 46' ' ' ARG . 7.5 p -119.09 126.05 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.883 -0.599 . . . . 74.530000000000001 111.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.875 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.3 tttt -90.95 115.99 28.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.189 -0.46 . . . . 70.299999999999997 110.797 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 46' ' ' ARG . 46.6 t -104.55 123.76 58.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.907 0.384 . . . . 73.340000000000003 111.518 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.875 HD11 ' HE2' ' A' ' 101' ' ' LYS . 50.4 mm -105.92 131.7 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.281 0.474 . . . . 72.209999999999994 112.281 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.4 mt -105.12 112.54 25.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.903 0.382 . . . . 74.25 110.943 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.75 171.59 7.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.931 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.8 -167.4 1.22 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.941 0.401 . . . . 72.340000000000003 111.253 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.2 t -56.98 -26.91 60.78 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.446 0.906 . . . . 73.430000000000007 113.446 -174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.86 -9.41 31.51 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 122.11 -0.369 . . . . 72.019999999999996 111.565 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.42 9.46 55.18 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.294 -0.479 . . . . 75.5 113.672 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.95 124.97 26.05 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.992 0.425 . . . . 74.450000000000003 111.88 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.5 107.27 7.52 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 110.959 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.59 -37.31 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.616 0.599 . . . . 71.209999999999994 112.616 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -141.39 122.53 14.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.193 0.442 . . . . 55.130000000000003 112.193 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -124.79 141.59 52.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.511 -0.313 . . . . 70.409999999999997 111.224 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -161.46 151.76 17.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.716 0.293 . . . . 74.329999999999998 111.039 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -140.53 174.67 10.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.168 0.509 . . . . 51.520000000000003 111.661 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 38.6 p -70.01 175.49 4.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 73.019999999999996 111.209 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.471 0.623 0 O-C-N 122.171 -0.331 . . . . 75.519999999999996 111.816 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 m-80 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 112.533 0.568 . . . . 73.430000000000007 112.533 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.87 85.76 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.246 0.546 . . . . 72.010000000000005 110.164 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.34 147.61 24.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.018 -0.537 . . . . 73.150000000000006 111.679 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.814 HG13 ' HG ' ' A' ' 29' ' ' LEU . 3.0 mp -82.24 96.93 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.787 0.327 . . . . 53.509999999999998 110.145 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.28 -38.61 88.19 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.926 0.393 . . . . 73.109999999999999 111.926 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.42 129.5 14.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.699 0.629 . . . . 63.219999999999999 112.699 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.543 HG12 HG23 ' A' ' 27' ' ' ILE . 57.1 mt -116.65 128.82 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.989 -0.551 . . . . 74.400000000000006 109.738 172.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.76 114.89 9.29 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.325 0.583 . . . . 74.209999999999994 111.351 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' HA3' ' A' ' 97' ' ' GLY . 11.4 p -68.39 -31.12 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 116.123 -0.489 . . . . 72.510000000000005 112.041 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 22.8 t70 -57.08 -48.01 79.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.751 0.31 . . . . 75.099999999999994 111.132 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 136.23 24.01 0.52 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.311 -0.471 . . . . 74.340000000000003 113.985 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -95.57 -63.39 1.16 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.091 0.775 . . . . 74.319999999999993 113.091 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -145.29 161.23 40.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.107 1.151 . . . . 74.099999999999994 114.107 -168.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 20' ' ' ILE . 65.6 mt -116.3 113.81 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.102 -0.953 . . . . 62.509999999999998 109.662 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -102.19 112.94 25.81 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.451 0.538 . . . . 74.319999999999993 112.451 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 17' ' ' ILE . 4.8 mp -91.92 154.54 18.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.116 -0.493 . . . . 72.230000000000004 111.254 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -150.87 123.29 8.41 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.925 0.393 . . . . 73.019999999999996 110.96 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.502 ' HB2' HD12 ' A' ' 63' ' ' LEU . 34.1 t30 -83.94 129.49 34.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.784 0.326 . . . . 62.340000000000003 111.382 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -109.87 11.24 24.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.25 0.463 . . . . 73.439999999999998 112.25 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 94.0 p -80.91 163.44 23.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.454 0.645 . . . . 64.540000000000006 112.148 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.06 -18.61 33.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.719 -0.673 . . . . 63.130000000000003 111.531 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.54 149.77 46.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.693 0.282 . . . . 73.219999999999999 111.288 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -56.69 139.91 48.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.159 0.504 . . . . 64.519999999999996 112.209 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -104.02 117.32 59.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.065 -0.516 . . . . 71.109999999999999 111.235 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.11 127.73 13.9 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.421 2.08 . . . . 52.450000000000003 112.725 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.9 tpp -79.12 -71.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.961 0.41 . . . . 72.25 111.623 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.4 -54.2 2.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.886 -0.673 . . . . 60.020000000000003 112.998 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.69 61.77 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.339 -0.458 . . . . 54.219999999999999 113.323 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -63.09 153.54 33.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.894 0.378 . . . . 73.530000000000001 110.662 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -130.01 116.33 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.206 0.527 . . . . 73.200000000000003 111.388 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 102' ' ' VAL . 47.4 ttp -86.8 109.55 19.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.635 -0.711 . . . . 72.299999999999997 111.964 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.8 mp -82.94 89.68 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.102 -0.703 . . . . 71.510000000000005 109.102 171.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 101.24 6.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.083 0.468 . . . . 75.209999999999994 111.396 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 101' ' ' LYS . 68.3 mttm -84.67 -178.86 6.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.317 -0.401 . . . . 72.450000000000003 111.016 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -171.2 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.233 0.54 . . . . 74.540000000000006 110.547 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.47 -89.24 0.09 OUTLIER Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.96 -0.563 . . . . 55.030000000000001 112.702 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.47 -0.09 56.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.025 0.38 . . . . 64.219999999999999 112.025 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 t -155.54 164.54 38.52 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.691 0.626 . . . . 74.530000000000001 112.691 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -153.15 149.09 27.69 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.658 -0.701 . . . . 72.310000000000002 110.739 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.13 134.79 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.874 0.369 . . . . 64.540000000000006 111.373 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 m -94.12 111.7 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.11 0.411 . . . . 74.349999999999994 112.11 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -103.89 122.82 45.96 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.745 0.307 . . . . 74.140000000000001 110.651 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -95.39 116.39 28.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.799 0.333 . . . . 74.319999999999993 110.922 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -61.25 121.66 13.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.117 0.484 . . . . 71.299999999999997 111.609 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 60' ' ' ARG . 3.5 t -67.2 132.31 47.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.385 0.612 . . . . 62.32 112.019 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.1 p -73.41 23.72 0.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.236 0.828 . . . . 73.319999999999993 113.236 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' A' ' 58' ' ' THR . 8.0 ptp180 -73.02 -8.03 53.9 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.12 -0.363 . . . . 72.230000000000004 111.841 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HE2' HD23 ' A' ' 63' ' ' LEU . 24.8 p90 -145.85 145.07 30.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.173 0.435 . . . . 63.219999999999999 112.173 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.45 124.63 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.185 -0.461 . . . . 65.25 109.777 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -74.4 99.39 3.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.192 0.52 . . . . 74.010000000000005 111.298 -173.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -66.8 165.26 15.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.475 0.655 . . . . 52.340000000000003 112.723 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.77 125.75 25.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.908 -0.587 . . . . 74.049999999999997 111.169 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.22 77.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.197 -0.525 . . . . 52.439999999999998 113.527 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.544 ' HB3' HD13 ' A' ' 63' ' ' LEU . 60.0 tp60 -91.7 153.0 19.95 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.107 0.48 . . . . 74.530000000000001 111.572 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.4 p -121.9 145.58 47.95 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.248 -0.433 . . . . 63.25 111.951 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.82 137.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.288 -0.414 . . . . 71.430000000000007 110.363 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.6 m -118.66 122.44 42.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.162 0.43 . . . . 62.409999999999997 112.162 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 86' ' ' LEU . 41.4 mm -95.2 106.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.69 -0.232 . . . . 72.049999999999997 111.208 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.737 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 84.6 m95 -91.95 123.13 35.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.572 0.225 . . . . 71.230000000000004 111.503 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -79.1 80.54 5.44 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.084 0.772 . . . . 44.32 113.084 -174.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 61.3 -69.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.286 1.217 . . . . 74.409999999999997 114.286 173.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -72.86 36.17 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.337 0.866 . . . . 62.229999999999997 113.337 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -75.24 -50.61 15.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.305 0.483 . . . . 70.430000000000007 112.305 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.62 38.54 20.32 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.165 -0.541 . . . . 74.150000000000006 113.054 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.57 173.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.13 0.49 . . . . 61.130000000000003 112.186 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.3 m -67.84 94.02 0.43 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 74.349999999999994 112.678 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.64 -86.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.264 0.838 . . . . 74.430000000000007 113.264 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.4 t -170.46 110.52 0.44 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.211 0.449 . . . . 74.099999999999994 112.211 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 84' ' ' THR . 58.0 Cg_exo -46.21 160.61 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.486 2.79 . . . . 70.409999999999997 111.521 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER 9.03 64.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.903 0 N-CA-C 121.517 3.622 . . . . 74.209999999999994 121.517 36.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.644 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.0 t 147.78 -67.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.988 1.715 . . . . 72.349999999999994 111.209 161.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' H ' HG23 ' A' ' 84' ' ' THR . 8.0 m-20 -87.67 173.98 8.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.114 -0.366 . . . . 63.020000000000003 110.398 172.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.4 mt -139.96 130.61 25.75 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.751 0.31 . . . . 75.109999999999999 111.128 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.9 mp -87.15 106.01 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.438 0.637 . . . . 72.25 111.136 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.614 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 6.3 t90 -74.24 98.53 3.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.622 -0.717 . . . . 61.409999999999997 111.003 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -73.16 -28.54 62.28 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.404 0.52 . . . . 53.310000000000002 112.404 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.614 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 10.8 m120 -71.55 -16.96 62.33 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.905 0.706 . . . . 64.200000000000003 112.905 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 44.1 tt0 -145.77 139.2 26.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.008 -0.433 . . . . 73.129999999999995 111.731 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.704 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 2.6 m-20 -90.21 -174.82 4.32 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.063 0.459 . . . . 70.219999999999999 111.089 173.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.2 p -56.27 120.48 7.66 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.423 -0.353 . . . . 70.340000000000003 111.864 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.496 ' NE1' ' HA2' ' A' ' 24' ' ' GLY . 33.9 p90 -70.92 -38.74 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.504 0.557 . . . . 75.219999999999999 112.504 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 54.3 63.93 4.74 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.314 -0.47 . . . . 62.409999999999997 113.763 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.596 HG23 ' H ' ' A' ' 97' ' ' GLY . 1.6 t -167.52 -63.25 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.658 0.614 . . . . 65.239999999999995 112.658 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.596 ' H ' HG23 ' A' ' 96' ' ' THR . . . 72.76 10.09 76.0 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.982 -0.628 . . . . 75.030000000000001 113.399 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -70.9 78.57 0.63 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.224 0.512 . . . . 72.329999999999998 112.072 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.81 31.58 20.86 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.464 -0.789 . . . . 62.140000000000001 112.534 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 120.18 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.166 0.507 . . . . 74.209999999999994 109.743 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.4 ttmp? -119.15 121.45 39.79 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.928 0.714 . . . . 73.239999999999995 112.928 -165.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 44' ' ' MET . 98.1 t -86.82 116.54 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.723 -0.671 . . . . 75.0 111.569 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.8 mm -105.27 114.99 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.617 -0.265 . . . . 70.430000000000007 110.766 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.59 102.86 15.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.798 0.666 . . . . 65.409999999999997 112.798 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.97 154.89 25.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.376 -0.375 . . . . 64.349999999999994 110.509 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 14.2 m120 -99.0 -164.31 1.12 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.844 0.683 . . . . 51.420000000000002 112.844 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.1 t -52.98 -51.57 61.11 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.116 1.154 . . . . 45.399999999999999 114.116 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -88.28 -61.04 1.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.287 0.565 . . . . 74.319999999999993 111.731 -172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.59 27.71 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.785 -0.643 . . . . 74.439999999999998 112.697 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 1.2 pm0 -102.69 135.43 44.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.018 0.437 . . . . 55.0 110.681 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.21 132.52 46.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.055 0.391 . . . . 70.400000000000006 112.055 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 66.5 t -88.75 -62.08 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 111.352 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.66 179.16 8.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.168 0.509 . . . . 40.350000000000001 111.852 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.68 152.93 49.79 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.937 -0.574 . . . . 75.519999999999996 110.757 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.59 ' HA ' ' HE ' ' A' ' 115' ' ' ARG . 1.3 tpm_? -151.31 152.04 32.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.614 0.245 . . . . 74.230000000000004 110.892 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.7 p -145.33 170.22 16.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.067 -0.395 . . . . 63.43 111.797 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -67.95 113.96 6.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.542 0.571 . . . . 75.150000000000006 112.542 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.127 -0.488 . . . . 53.530000000000001 111.102 175.707 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 32' ' ' THR . 45.3 t30 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.278 0.561 . . . . 74.049999999999997 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.73 125.68 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.054 -0.521 . . . . 75.409999999999997 110.548 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB1' ' A' ' 113' ' ' ALA . 53.7 t -135.49 159.87 40.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.923 0.392 . . . . 74.319999999999993 111.624 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.6 mp -87.06 131.35 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.6 -0.273 . . . . 63.450000000000003 110.341 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -104.3 -34.27 8.38 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.788 0.292 . . . . 74.310000000000002 111.788 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.78 145.01 30.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.102 0.477 . . . . 52.43 111.449 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.36 130.25 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.273 -0.421 . . . . 73.430000000000007 110.796 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.34 147.25 40.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.189 0.519 . . . . 75.140000000000001 110.888 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 97' ' ' GLY . 13.9 p -105.19 -25.07 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 74.219999999999999 111.693 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 21.2 t70 -64.13 -56.66 13.28 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.064 0.459 . . . . 64.109999999999999 111.539 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 144.33 41.89 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.42 -0.419 . . . . 61.039999999999999 112.575 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -113.17 -61.97 1.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.733 0.642 . . . . 74.120000000000005 112.733 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.95 168.19 26.65 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.107 1.151 . . . . 64.319999999999993 114.107 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.3 mt -126.06 131.08 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.906 -1.043 . . . . 72.109999999999999 109.371 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -100.76 101.81 12.75 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.483 0.549 . . . . 71.510000000000005 112.483 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -88.48 156.01 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.329999999999998 110.159 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -146.61 127.72 14.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.952 0.406 . . . . 73.230000000000004 111.762 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -84.37 110.28 18.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.355 -0.384 . . . . 62.439999999999998 110.673 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 14' ' ' ASN . 11.7 t -95.13 9.78 38.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.095 0.474 . . . . 71.239999999999995 111.163 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.1 t -82.39 149.85 27.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.059 -0.518 . . . . 72.450000000000003 111.391 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.73 43.12 1.01 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.27 -0.423 . . . . 74.310000000000002 111.4 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -168.91 154.17 6.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.872 0.368 . . . . 72.239999999999995 111.677 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 11.9 m-20 -68.08 104.11 1.69 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.448 -0.342 . . . . 72.519999999999996 110.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.95 118.9 66.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.85 0.315 . . . . 75.209999999999994 111.85 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.34 117.54 5.03 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.745 2.297 . . . . 70.120000000000005 112.51 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.34 77.32 3.1 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.98 0.419 . . . . 71.530000000000001 111.5 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.66 -68.96 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.028 -0.606 . . . . 71.340000000000003 113.976 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.59 2.89 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.505 -0.379 . . . . 54.340000000000003 113.722 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -129.58 140.1 51.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.542 0.337 . . . . 73.519999999999996 111.135 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 34.3 tt0 -136.12 125.34 24.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.418 . . . . 74.200000000000003 110.733 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -102.83 133.86 47.2 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.0 0.429 . . . . 65.150000000000006 111.811 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 54' ' ' SER . 32.2 mt -127.17 116.77 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.477 -0.329 . . . . 74.299999999999997 110.865 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.588 ' NH2' HG13 ' A' ' 100' ' ' VAL . 67.5 ttt180 -100.84 122.72 43.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.928 0.394 . . . . 73.120000000000005 110.947 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -98.2 137.36 37.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 111.747 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 100' ' ' VAL . 7.3 tt -130.91 91.72 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.53 0.681 . . . . 72.519999999999996 111.485 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.55 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.811 -0.632 . . . . 71.420000000000002 113.602 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.88 -64.85 1.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.605 0.362 . . . . 73.129999999999995 111.78 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -95.06 178.53 5.52 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.895 0.702 . . . . 71.209999999999994 112.895 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -149.27 152.9 36.71 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.176 -0.466 . . . . 63.32 110.968 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.475 HG11 ' NE2' ' A' ' 91' ' ' GLN . 7.9 p -129.57 137.86 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.701 0.286 . . . . 74.400000000000006 111.193 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.464 ' HB3' HG12 ' A' ' 45' ' ' ILE . 85.8 p -120.46 161.97 20.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.991 0.737 . . . . 61.420000000000002 112.991 -175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -163.57 117.99 1.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.624 -0.716 . . . . 73.200000000000003 111.286 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 56.7 tttm -88.1 151.35 22.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.952 0.406 . . . . 73.209999999999994 111.488 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -98.21 168.34 10.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.004 0.431 . . . . 74.349999999999994 111.718 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -130.37 132.38 45.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.997 0.427 . . . . 54.119999999999997 111.752 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.3 t -72.32 86.64 1.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 53.450000000000003 112.334 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 82' ' ' PRO . 14.6 ptm180 -131.29 6.05 4.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.903 0.383 . . . . 73.109999999999999 111.551 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.42 155.15 29.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.336 -0.393 . . . . 64.450000000000003 110.554 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 31.5 m -114.52 130.33 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.251 0.548 . . . . 63.140000000000001 112.049 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.3 mm? -83.45 114.6 21.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.418 -0.355 . . . . 71.239999999999995 110.93 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 35.9 mtmm -66.4 168.61 8.66 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.065 0.46 . . . . 52.020000000000003 111.866 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.22 107.3 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.352 -0.386 . . . . 65.0 111.47 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.88 6.44 67.27 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.401 -0.428 . . . . 30.219999999999999 113.086 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.5 tp60 -79.71 137.13 36.95 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.467 -0.431 . . . . 74.319999999999993 111.511 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.1 p -103.53 139.67 38.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.16 0.505 . . . . 70.420000000000002 111.718 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.35 123.67 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 110.159 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.3 m -95.15 102.22 14.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.176 -0.465 . . . . 62.530000000000001 111.477 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.18 97.53 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.324 -0.398 . . . . 74.099999999999994 111.105 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB2' HG13 ' A' ' 87' ' ' ILE . 93.2 m95 -78.98 160.55 27.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.239999999999995 111.623 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.28 165.93 20.98 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.391 -0.368 . . . . 75.099999999999994 111.209 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.03 -27.58 45.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.521 0.563 . . . . 74.329999999999998 112.521 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.52 25.49 1.68 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.938 0.347 . . . . 74.200000000000003 111.938 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.08 64.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.814 0.672 . . . . 73.219999999999999 112.814 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.52 75.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.165 -0.541 . . . . 52.240000000000002 113.722 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.52 -172.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.556 -0.379 . . . . 72.150000000000006 111.017 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.0 m -61.39 101.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.656 -0.498 . . . . 64.319999999999993 109.656 171.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.87 42.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.113 0.782 . . . . 65.439999999999998 113.113 -168.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.7 m -157.9 139.2 9.69 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 112.275 0.472 . . . . 41.109999999999999 112.275 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 56.0 Cg_exo -44.12 163.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 123.645 2.897 . . . . 62.229999999999997 112.162 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 26.9 Cg_exo -11.02 -80.75 0.0 OUTLIER 'Cis proline' 0 C--N 1.375 1.925 0 N-CA-C 121.297 3.537 . . . . 63.140000000000001 121.297 17.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.7 t -106.37 -79.39 0.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.83 1.418 . . . . 64.310000000000002 114.83 -165.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.659 ' H ' HG23 ' A' ' 84' ' ' THR . 21.8 m-20 -68.59 129.14 39.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.0 0.741 . . . . 63.100000000000001 113.0 -167.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 104.3 16.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.891 -0.595 . . . . 74.129999999999995 111.288 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -74.52 121.82 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.781 0.324 . . . . 74.349999999999994 110.533 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.412 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.6 t90 -64.91 77.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.352 0.596 . . . . 72.200000000000003 111.078 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.74 22.44 0.59 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.179 -0.464 . . . . 63.520000000000003 112.234 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 18.4 m120 -120.53 11.55 11.36 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.054 0.454 . . . . 75.109999999999999 110.939 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.475 ' NE2' HG11 ' A' ' 53' ' ' VAL . 54.0 tt0 -150.48 131.96 14.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.26 -0.427 . . . . 71.209999999999994 111.096 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -80.26 178.8 8.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.922 0.391 . . . . 61.409999999999997 111.209 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -66.84 116.27 7.53 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.338 -0.226 . . . . 75.329999999999998 111.015 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.469 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 43.6 p90 -60.66 -47.15 87.51 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.319 0.488 . . . . 73.049999999999997 112.319 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 58.26 11.76 10.37 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.721 0.648 . . . . 71.239999999999995 114.721 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -71.0 -31.41 67.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.772 0.656 . . . . 63.43 112.772 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 22' ' ' VAL . . . 69.22 14.22 68.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.981 -0.628 . . . . 63.210000000000001 113.037 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -96.58 179.22 5.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.224 0.535 . . . . 54.420000000000002 112.071 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 15.0 p-10 -60.99 -45.32 95.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.769 -0.651 . . . . 70.349999999999994 111.599 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG13 ' NH2' ' A' ' 46' ' ' ARG . 7.4 p 30.73 88.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 72.340000000000003 113.28 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HD2' ' OE1' ' A' ' 114' ' ' GLN . 34.1 ttpt -86.94 138.53 31.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.077 -0.965 . . . . 75.420000000000002 112.846 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 12.4 p -103.63 142.66 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 112.068 0.396 . . . . 74.099999999999994 112.068 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mm -122.41 138.59 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.763 0.425 . . . . 61.119999999999997 111.579 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 17' ' ' ILE . 52.4 mt -107.79 121.01 43.85 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.953 0.406 . . . . 74.230000000000004 111.769 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 67.8 mttm -115.13 149.0 38.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.087 -0.506 . . . . 62.030000000000001 111.167 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.39 -176.92 6.07 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.105 0.479 . . . . 52.43 111.008 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.3 p -55.62 -34.94 65.35 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.144 -0.48 . . . . 64.120000000000005 111.001 170.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -72.89 -12.64 61.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.128 -0.487 . . . . 51.549999999999997 111.99 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.91 1.58 84.81 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.88 0.712 . . . . 53.009999999999998 114.88 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 105' ' ' LYS . 11.9 pt-20 -92.48 178.52 5.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.107 0.953 . . . . 74.129999999999995 112.033 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -92.24 133.59 35.67 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.244 0.831 . . . . 54.030000000000001 113.244 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.7 t -106.2 -50.23 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.019 -0.537 . . . . 75.129999999999995 110.717 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HB1' ' SG ' ' A' ' 16' ' ' CYS . . . -159.39 162.65 35.82 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.869 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 101' ' ' LYS . 8.0 pt20 -153.17 171.32 18.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.099 -0.501 . . . . 71.510000000000005 111.177 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.3 ttm180 -175.6 147.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.859 0.361 . . . . 74.129999999999995 111.565 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.1 p -110.95 179.26 4.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.457 0.303 . . . . 62.520000000000003 111.002 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 80.7 p -75.48 117.69 17.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.128 0.49 . . . . 63.130000000000003 111.601 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.914 0.388 . . . . 73.239999999999995 110.623 177.15 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.276 0.473 . . . . 70.120000000000005 112.276 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.48 124.48 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.889 0.375 . . . . 75.010000000000005 111.216 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -144.95 174.38 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.502 -0.317 . . . . 65.310000000000002 110.979 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.32 124.5 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.238 -0.289 . . . . 73.510000000000005 111.483 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.77 -53.25 6.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.921 0.391 . . . . 72.219999999999999 110.872 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -165.02 137.06 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.23 0.538 . . . . 54.109999999999999 111.798 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 27' ' ' ILE . 61.2 mt -104.22 126.15 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.27 -0.423 . . . . 64.349999999999994 110.238 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.28 122.47 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.134 0.492 . . . . 73.329999999999998 111.87 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.64 -26.12 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.142 -0.481 . . . . 72.150000000000006 111.938 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -33.48 73.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.818 0.342 . . . . 64.019999999999996 110.586 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.64 30.05 3.92 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 114.126 0.41 . . . . 72.120000000000005 114.126 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 6.8 mtpm? -98.98 -39.94 8.3 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.791 0.663 . . . . 75.409999999999997 112.791 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -153.6 158.19 40.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.265 0.839 . . . . 73.329999999999998 113.265 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 102' ' ' VAL . 66.0 mt -118.89 107.44 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.439999999999998 109.648 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 35.6 ttt85 -97.85 117.61 32.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.317 0.58 . . . . 75.010000000000005 112.512 -171.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.553 ' HB2' HG13 ' A' ' 69' ' ' VAL . 6.5 mp -97.8 -172.68 2.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.011 -0.541 . . . . 63.119999999999997 111.501 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 22.9 ttmm -158.05 139.4 13.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.942 0.401 . . . . 72.239999999999995 111.719 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -103.21 100.26 10.16 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.451 -0.34 . . . . 71.540000000000006 110.253 168.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 5.0 t -102.27 98.83 8.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.411 0.624 . . . . 71.109999999999999 111.314 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -166.69 -178.46 4.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 111.633 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -109.67 7.04 24.25 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.936 -0.574 . . . . 74.319999999999993 110.392 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -135.4 135.03 40.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 74.549999999999997 110.816 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.43 134.19 49.8 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.995 0.426 . . . . 61.130000000000003 111.853 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 27.3 mm-40 -89.0 112.77 52.91 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.391 -0.368 . . . . 72.439999999999998 111.213 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 2.7 Cg_exo -76.3 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.777 2.318 . . . . 32.439999999999998 113.122 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.17 -73.27 0.05 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.104 0.562 . . . . 75.540000000000006 111.734 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 -75.48 1.57 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.143 -0.551 . . . . 73.049999999999997 113.001 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.67 93.7 0.11 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 74.319999999999993 113.403 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -116.44 167.71 10.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.661 0.384 . . . . 72.209999999999994 110.712 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -144.42 132.34 21.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.171 0.51 . . . . 74.219999999999999 111.34 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.6 ttp -103.82 107.78 18.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.848 -0.614 . . . . 60.350000000000001 111.428 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.9 mp -95.11 99.94 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.781 0.324 . . . . 71.340000000000003 110.845 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.438 HH12 ' NE2' ' A' ' 91' ' ' GLN . 32.9 ttt180 -85.89 102.84 14.08 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.128 -0.357 . . . . 73.109999999999999 111.101 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -96.88 117.73 31.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.438 -0.346 . . . . 74.319999999999993 111.09 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.16 122.43 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.134 0.493 . . . . 73.129999999999995 112.037 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.7 -110.28 2.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.989 -0.551 . . . . 33.329999999999998 113.907 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.74 27.4 9.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.973 0.36 . . . . 71.349999999999994 111.973 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -153.62 162.35 41.34 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.237 0.541 . . . . 55.25 112.005 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -153.81 114.01 3.93 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.021 -0.536 . . . . 50.439999999999998 110.205 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.39 134.87 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.941 0.401 . . . . 65.129999999999995 111.809 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.2 m -109.16 124.24 50.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.288 -0.415 . . . . 70.349999999999994 111.697 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.459 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 70.0 t80 -114.26 108.77 17.39 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.807 0.337 . . . . 74.099999999999994 111.686 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.35 109.67 11.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.917 0.389 . . . . 73.349999999999994 110.542 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 94.1 m-85 -56.18 135.49 53.19 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.644 0.609 . . . . 54.420000000000002 112.644 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -97.27 123.1 40.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.044 -0.525 . . . . 64.200000000000003 111.248 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 t -73.56 68.72 1.19 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.118 0.414 . . . . 75.430000000000007 112.118 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -87.04 -12.87 46.02 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.987 0.422 . . . . 73.450000000000003 111.375 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.46 167.8 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.509 -0.314 . . . . 73.420000000000002 110.285 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.76 121.36 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.873 0.368 . . . . 73.450000000000003 111.593 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -76.24 87.1 3.07 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.479 0.657 . . . . 62.030000000000001 110.166 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 158.33 30.62 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.955 0.724 . . . . 62.219999999999999 112.955 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.62 117.89 6.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.612 -0.722 . . . . 75.310000000000002 112.841 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.53 -19.75 35.92 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.306 -0.473 . . . . 63.100000000000001 114.028 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.44 141.7 38.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.396 0.617 . . . . 75.120000000000005 111.747 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.4 p -105.31 98.38 8.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.783 -0.644 . . . . 72.540000000000006 111.735 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 29' ' ' LEU . 3.8 p -69.8 117.61 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 64.209999999999994 111.693 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 37.0 m -97.55 123.05 41.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.149 0.5 . . . . 62.119999999999997 111.921 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 57' ' ' TYR . 47.8 mm -84.28 102.76 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.318 -0.401 . . . . 60.509999999999998 110.928 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.75 118.15 24.26 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.51 -0.314 . . . . 74.310000000000002 110.621 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' ASN . . . -71.45 77.46 0.77 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.65 0.611 . . . . 55.340000000000003 112.65 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 56.51 -72.82 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.399 0.889 . . . . 74.200000000000003 113.399 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 73' ' ' ALA . 65.5 m-20 -87.94 100.71 13.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.908 0.385 . . . . 63.340000000000003 111.43 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.47 9.02 0.34 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.546 0.573 . . . . 54.020000000000003 112.546 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.65 -35.84 1.83 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.169 -0.539 . . . . 42.130000000000003 114.31 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.66 149.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.381 0.511 . . . . 74.420000000000002 112.381 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -62.84 175.7 0.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.54 0.57 . . . . 62.420000000000002 112.54 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.44 76.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.092 0.775 . . . . 75.200000000000003 113.092 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.491 ' HA ' HD13 ' A' ' 87' ' ' ILE . 69.8 m 65.17 104.17 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.621 0.971 . . . . 73.200000000000003 113.621 173.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HB3' HG22 ' A' ' 84' ' ' THR . 67.6 Cg_exo -45.96 169.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 123.747 2.965 . . . . 51.229999999999997 112.016 166.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER 10.76 65.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 N-CA-C 121.65 3.673 . . . . 74.0 121.65 38.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 82' ' ' PRO . 15.3 t 144.74 -59.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.3 1.84 . . . . 71.120000000000005 110.812 162.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' H ' ' CB ' ' A' ' 82' ' ' PRO . 21.3 m-20 -110.76 -168.62 1.33 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.195 0.598 . . . . 61.32 110.296 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -141.78 137.15 31.37 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.945 0.402 . . . . 63.509999999999998 111.603 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 81' ' ' SER . 1.6 mp -91.36 123.7 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.699 0.761 . . . . 71.230000000000004 111.016 175.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.496 ' CE2' ' HB2' ' A' ' 90' ' ' ASN . 21.7 t90 -92.12 109.74 21.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.324 -0.853 . . . . 65.099999999999994 110.999 -176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -93.88 2.07 56.24 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.246 0.832 . . . . 74.549999999999997 113.246 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 17.2 m120 -74.01 -40.81 62.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.86 -0.525 . . . . 72.519999999999996 111.755 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' NE2' HH12 ' A' ' 46' ' ' ARG . 39.9 tt0 -148.52 155.88 41.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.605 0.24 . . . . 71.400000000000006 110.607 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.675 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.7 m120 -91.97 175.96 6.69 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 112.447 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -59.57 125.13 22.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 72.209999999999994 111.508 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -104.56 -173.66 2.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.01 0.433 . . . . 73.019999999999996 111.664 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.76 95.86 0.14 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.265 -0.493 . . . . 52.009999999999998 112.759 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -167.51 160.44 13.1 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.668 -0.313 . . . . 63.420000000000002 111.438 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.15 4.1 62.39 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.289 -0.481 . . . . 44.039999999999999 113.122 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.76 156.67 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.175 0.512 . . . . 64.310000000000002 112.248 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.91 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.777 0.658 . . . . 42.329999999999998 112.777 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 117' ' ' THR . 6.5 p -81.04 79.61 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.079 0.942 . . . . 62.509999999999998 109.622 167.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 3.9 ttmp? -88.13 105.63 17.63 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.554 -0.748 . . . . 62.020000000000003 111.391 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 27' ' ' ILE . 61.7 t -91.05 123.39 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.665 -0.698 . . . . 74.530000000000001 111.48 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 21.4 mm -106.57 117.66 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.149 -0.478 . . . . 61.329999999999998 110.934 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -91.96 121.72 33.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.838 0.351 . . . . 54.119999999999997 111.341 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 93.6 mttt -130.58 168.27 17.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.711 0.291 . . . . 65.409999999999997 111.315 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 20.3 m120 -97.08 175.6 6.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.901 0.381 . . . . 74.409999999999997 111.141 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -57.97 -33.2 68.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.775 0.658 . . . . 75.030000000000001 112.775 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.91 0.68 17.44 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 72.109999999999999 112.436 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.42 33.53 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.152 -0.547 . . . . 30.0 113.336 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 10.9 pt-20 -103.08 127.28 50.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.943 0.401 . . . . 61.43 110.918 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.2 tt0 -76.82 138.93 40.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.978 0.418 . . . . 52.0 111.97 -175.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.45 -61.99 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.256 -0.429 . . . . 44.119999999999997 111.326 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.99 162.19 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.7 0.286 . . . . 62.450000000000003 111.57 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.36 157.64 42.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.993 0.425 . . . . 73.329999999999998 111.834 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -164.31 156.19 16.31 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.977 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.7 p -141.17 -162.37 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.6 0.238 . . . . 75.140000000000001 111.3 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.647 HG23 HG12 ' A' ' 100' ' ' VAL . 17.0 p -61.71 94.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.173 0.511 . . . . 63.32 111.89 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.455 0.645 . . . . 74.510000000000005 110.846 176.777 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.85 0.357 . . . . 73.310000000000002 111.435 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.89 143.68 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.324 -0.398 . . . . 55.409999999999997 111.331 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 44.2 t -141.62 173.37 11.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.091 0.472 . . . . 74.049999999999997 111.699 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.537 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 61.0 mt -81.51 127.45 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.344 -0.389 . . . . 73.209999999999994 111.33 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 37.0 tt0 -81.71 -58.33 3.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.659 -0.497 . . . . 71.439999999999998 109.659 171.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 25.2 tt0 173.82 152.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.799 -0.637 . . . . 65.340000000000003 111.097 169.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 102' ' ' VAL . 23.1 mt -71.89 162.57 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 116.164 -0.471 . . . . 74.299999999999997 111.239 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 20' ' ' ILE . 19.0 t70 -61.14 150.36 34.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.229 0.537 . . . . 73.239999999999995 111.835 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.07 -33.45 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.849 -0.614 . . . . 63.420000000000002 112.268 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.52 -30.58 19.24 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.147 0.498 . . . . 73.219999999999999 111.028 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.04 35.75 3.86 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 112.827 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -96.06 -29.04 14.32 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.709 0.29 . . . . 74.409999999999997 111.759 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.09 176.01 12.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.463 0.649 . . . . 74.409999999999997 112.286 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -119.89 138.54 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.805 -0.634 . . . . 75.530000000000001 109.946 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 28' ' ' ARG . 10.3 ttp180 -119.26 110.21 16.74 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 111.9 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.6 mp -106.9 175.51 5.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.981 -0.554 . . . . 75.219999999999999 110.57 175.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.3 ttmt -151.71 138.67 19.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.936 0.398 . . . . 75.299999999999997 111.713 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -75.46 84.57 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.562 . . . . 63.310000000000002 110.821 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.2 p -78.0 89.03 4.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 61.439999999999998 111.094 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.4 p -158.48 -175.77 5.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.305 -0.407 . . . . 71.430000000000007 111.161 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.47 -4.52 31.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.334 0.494 . . . . 62.32 112.334 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -156.39 166.68 32.72 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.786 0.327 . . . . 65.310000000000002 111.306 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -54.97 117.15 3.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.79 0.293 . . . . 73.530000000000001 111.79 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -127.46 112.86 21.11 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 122.618 0.367 . . . . 72.439999999999998 110.889 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 58.2 Cg_endo -70.67 136.9 31.65 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.251 1.968 . . . . 62.450000000000003 112.921 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 tpt -66.28 -85.59 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 116.452 -0.34 . . . . 75.340000000000003 110.706 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.93 -83.09 0.02 OUTLIER Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.362 0.905 . . . . 61.229999999999997 115.362 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.48 46.07 3.19 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.605 0.602 . . . . 64.230000000000004 114.605 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -120.25 147.27 45.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.457 -0.437 . . . . 73.129999999999995 111.124 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -113.77 109.82 19.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.04 -0.527 . . . . 65.340000000000003 110.758 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -91.34 116.25 28.69 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.236 -0.438 . . . . 73.219999999999999 111.717 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.5 mp -106.26 103.62 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 109.811 -0.44 . . . . 73.120000000000005 109.811 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.503 HH12 ' HB ' ' A' ' 48' ' ' ILE . 47.7 ttp85 -89.39 114.1 25.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 73.129999999999995 111.628 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -93.44 168.71 10.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.101 -0.499 . . . . 74.319999999999993 111.304 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 49' ' ' GLY . 10.8 tt -169.74 -60.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.853 -0.612 . . . . 70.230000000000004 111.148 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -159.68 114.87 0.63 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.235 -0.507 . . . . 70.5 112.584 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 67.45 -75.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.213 0.605 . . . . 75.129999999999995 111.999 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -93.88 150.86 20.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.196 0.522 . . . . 63.240000000000002 112.151 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.6 p -142.06 149.73 40.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.053 0.454 . . . . 72.099999999999994 111.444 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.34 146.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.827 0.346 . . . . 74.010000000000005 111.654 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.417 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.5 p -111.91 164.49 13.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.821 0.674 . . . . 61.100000000000001 112.821 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -161.36 135.07 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.006 -0.543 . . . . 75.010000000000005 111.514 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -91.6 135.12 34.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.566 0.222 . . . . 75.0 110.724 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -67.58 147.02 53.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.044 0.449 . . . . 64.530000000000001 111.974 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 t -81.2 126.24 31.27 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.365 0.602 . . . . 63.109999999999999 112.226 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.9 m -85.49 82.85 8.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 110.94 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -135.32 14.04 3.51 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.633 0.605 . . . . 75.340000000000003 112.633 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -165.53 158.64 15.94 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.895 0.379 . . . . 53.32 111.913 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 38' ' ' PRO . 61.4 t -104.57 113.92 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.268 -0.423 . . . . 75.099999999999994 110.308 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.34 118.56 21.36 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.848 0.356 . . . . 75.420000000000002 111.231 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -64.33 152.62 40.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.377 0.608 . . . . 71.549999999999997 112.628 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 127.84 33.15 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.046 -0.525 . . . . 70.129999999999995 111.851 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.01 -2.05 88.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.149 -0.548 . . . . 72.129999999999995 113.41 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -88.44 148.97 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.541 -0.388 . . . . 72.530000000000001 111.389 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 71.3 p -95.75 157.54 15.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.19 0.519 . . . . 72.340000000000003 112.062 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.65 125.21 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.172 0.51 . . . . 73.329999999999998 110.191 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -101.61 108.23 19.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.279 -0.419 . . . . 64.230000000000004 111.948 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 86' ' ' LEU . 44.0 mm -91.77 102.63 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.464 -0.335 . . . . 63.200000000000003 111.23 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m95 -85.0 170.28 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.0 0.429 . . . . 73.510000000000005 111.979 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.82 167.37 11.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.394 -0.366 . . . . 50.240000000000002 111.285 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -51.08 -41.72 60.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.340000000000003 112.677 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -93.49 35.52 1.11 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.844 0.354 . . . . 65.209999999999994 111.849 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -65.19 -45.94 82.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.486 0.55 . . . . 42.299999999999997 112.486 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.1 -38.47 3.17 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.262 -0.494 . . . . 60.240000000000002 113.122 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 87' ' ' ILE . 27.0 m -68.17 170.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.085 0.402 . . . . 72.219999999999999 112.085 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.0 m -60.46 128.93 39.08 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.497 -0.32 . . . . 51.039999999999999 111.413 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.22 -40.17 46.63 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.853 0.686 . . . . 74.540000000000006 112.853 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -146.95 89.38 5.66 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 121.049 0.452 . . . . 64.510000000000005 111.345 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.712 ' HB2' ' H ' ' A' ' 84' ' ' THR . 47.1 Cg_exo -59.34 -32.13 96.18 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.772 2.981 . . . . 71.430000000000007 117.233 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.659 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 28.0 Cg_endo -101.13 37.79 5.59 Favored 'Cis proline' 0 C--N 1.371 1.718 0 CA-C-N 122.437 1.906 . . . . 74.400000000000006 114.532 3.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.712 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 74.9 p -62.83 -48.51 78.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.098 0.475 . . . . 63.439999999999998 111.219 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 4.8 m-20 -93.29 161.13 14.53 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.087 -0.506 . . . . 63.340000000000003 110.943 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.6 mt -130.02 109.54 10.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.87 0.366 . . . . 62.140000000000001 110.631 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 78' ' ' VAL . 1.5 mp -85.47 111.18 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.653 0.74 . . . . 74.420000000000002 111.637 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.572 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 21.2 t90 -79.68 96.86 6.34 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.309 -0.859 . . . . 73.209999999999994 111.19 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 53.4 mtmt -93.35 22.39 5.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.383 0.883 . . . . 71.200000000000003 113.383 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 14.7 m120 -89.92 -8.58 51.48 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.118 0.485 . . . . 75.519999999999996 110.799 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -150.91 134.47 16.37 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.025 -0.534 . . . . 75.040000000000006 111.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.3 m120 -64.67 -56.06 16.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.467 0.543 . . . . 72.420000000000002 112.467 -175.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.9 t -179.09 -178.44 0.52 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.552 0.341 . . . . 65.019999999999996 110.793 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -142.22 -82.64 0.2 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 111.634 0.235 . . . . 73.310000000000002 111.634 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 35.28 49.06 0.87 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 115.912 1.125 . . . . 43.329999999999998 115.912 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -156.37 137.32 13.53 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.862 1.06 . . . . 64.200000000000003 113.862 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.15 -97.97 0.78 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.51 0.964 . . . . 72.519999999999996 115.51 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -84.92 177.23 8.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.078 0.77 . . . . 75.239999999999995 113.078 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 7.4 p-10 -75.27 121.38 22.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.101 -0.954 . . . . 74.129999999999995 112.382 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 HH11 ' A' ' 46' ' ' ARG . 7.3 p -81.07 128.59 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.171 0.51 . . . . 75.030000000000001 110.955 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -140.15 119.49 12.97 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.34 -0.391 . . . . 65.430000000000007 111.443 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 20' ' ' ILE . 85.0 t -93.81 136.97 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.519 0.563 . . . . 72.120000000000005 112.519 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.0 mm -110.74 132.73 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.772 -0.649 . . . . 53.210000000000001 111.012 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.8 mt -113.61 111.3 21.64 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.762 0.653 . . . . 60.149999999999999 112.762 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -109.07 161.15 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.386 -0.37 . . . . 71.040000000000006 110.765 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 112' ' ' VAL . 7.4 m120 -114.98 97.69 6.37 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.903 0.334 . . . . 74.299999999999997 111.903 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t 47.71 -77.52 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 106' ' ' ASN . 64.6 mt-30 -61.6 -35.46 77.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.77 0.655 . . . . 72.430000000000007 112.77 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.59 -24.17 2.32 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.535 -0.84 . . . . 70.510000000000005 113.618 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.98 150.03 25.7 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.276 0.538 . . . . 75.420000000000002 111.301 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.82 137.53 54.5 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.503 -0.317 . . . . 73.219999999999999 111.655 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.545 HG23 ' OD1' ' A' ' 106' ' ' ASN . 94.7 t -98.91 -68.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.179 0.437 . . . . 64.040000000000006 112.179 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.27 162.78 33.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.067 0.766 . . . . 75.25 113.067 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -152.46 143.72 23.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.151 -0.931 . . . . 52.329999999999998 110.097 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -153.29 142.91 21.86 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.505 0.558 . . . . 61.299999999999997 112.505 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 p -111.94 -174.72 2.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.529 -0.76 . . . . 65.140000000000001 110.812 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 p -122.6 -178.2 3.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.263 0.554 . . . . 71.239999999999995 112.319 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 116.004 -0.543 . . . . 73.030000000000001 111.318 179.362 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 121.253 0.549 . . . . 62.530000000000001 110.706 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.419 ' HB ' ' CH2' ' A' ' 42' ' ' TRP . 56.6 t -126.7 139.34 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.059 -0.519 . . . . 63.329999999999998 111.402 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -121.26 159.39 26.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.977 0.418 . . . . 61.119999999999997 111.208 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.572 HD11 ' HG ' ' A' ' 104' ' ' LEU . 55.2 mt -93.13 127.99 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.311 -0.243 . . . . 54.109999999999999 111.316 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.54 -77.02 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.691 0.282 . . . . 74.129999999999995 111.095 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -169.29 158.01 7.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.266 -0.424 . . . . 74.439999999999998 110.838 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 27' ' ' ILE . 48.9 mt -91.69 145.4 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.431 . . . . 71.409999999999997 111.495 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.52 143.45 57.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.394 0.516 . . . . 65.519999999999996 112.394 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.49 -28.31 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.842 -0.617 . . . . 61.229999999999997 112.062 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.09 -31.58 30.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.09 0.471 . . . . 62.43 110.789 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.68 16.55 26.15 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 116.171 -0.468 . . . . 54.119999999999997 113.116 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -78.49 -31.25 47.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.347 0.499 . . . . 72.310000000000002 112.347 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -157.27 167.05 31.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.861 1.06 . . . . 74.030000000000001 113.861 -172.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG23 HG12 ' A' ' 20' ' ' ILE . 68.1 mt -127.07 110.93 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.934 -1.03 . . . . 72.439999999999998 109.343 170.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.3 ttp180 -92.58 117.42 29.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.346 0.593 . . . . 70.5 112.378 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.5 mp -99.91 158.55 15.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.863 -0.608 . . . . 71.150000000000006 110.26 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 65.0 tttm -124.03 116.83 23.47 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.024 -0.422 . . . . 63.43 111.505 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.33 108.14 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.097 0.475 . . . . 73.239999999999995 110.411 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -96.52 18.05 14.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.383 0.512 . . . . 73.420000000000002 112.383 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.8 p -71.72 161.79 30.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.418 0.628 . . . . 73.209999999999994 111.72 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -85.73 -19.4 30.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 72.109999999999999 111.168 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -142.03 158.36 43.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.895 -0.593 . . . . 63.219999999999999 110.587 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.12 135.78 12.62 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.501 0.556 . . . . 75.430000000000007 112.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -134.35 132.46 21.01 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.166 -0.47 . . . . 62.299999999999997 111.33 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.46 21.31 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.706 2.271 . . . . 71.109999999999999 113.442 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 tpt 63.5 -78.84 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.474 0.71 . . . . 71.400000000000006 112.285 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.41 -170.49 18.49 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.3 -0.476 . . . . 52.119999999999997 113.732 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.63 1.59 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.309 -0.472 . . . . 70.129999999999995 113.384 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.534 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 11.9 m95 -98.46 151.16 20.9 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 122.481 -0.423 . . . . 75.310000000000002 111.228 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.64 114.41 24.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.884 0.373 . . . . 52.340000000000003 110.001 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.454 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 56.2 ttp -98.33 108.45 21.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.442 -0.344 . . . . 51.030000000000001 111.087 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.4 mp -96.8 109.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.584 -0.28 . . . . 75.319999999999993 111.444 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -99.46 101.29 12.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.69 0.281 . . . . 74.230000000000004 110.931 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 7.6 mtpm? -82.04 84.78 6.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.053 0.454 . . . . 72.129999999999995 110.987 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -103.39 118.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.021 -0.536 . . . . 74.310000000000002 111.248 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 69.02 46.09 60.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.888 -0.672 . . . . 34.119999999999997 111.893 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.8 t70 73.68 -56.25 0.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.456 0.702 . . . . 74.540000000000006 111.953 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -61.61 161.61 9.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.133 0.492 . . . . 75.510000000000005 111.795 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 80.5 p -124.0 132.03 53.64 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.26 0.552 . . . . 61.030000000000001 112.128 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.4 134.31 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.881 -0.6 . . . . 75.0 109.669 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.8 p -120.18 144.18 47.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.167 0.803 . . . . 64.329999999999998 113.167 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -113.83 125.35 53.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.671 -0.695 . . . . 75.019999999999996 110.923 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.97 128.59 38.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.024 0.44 . . . . 63.130000000000003 111.001 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.534 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 21.0 m-85 -84.42 165.19 18.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.202 0.525 . . . . 72.420000000000002 111.694 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -142.96 176.05 9.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.009 -0.541 . . . . 74.5 110.806 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -123.36 105.97 10.28 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.168 0.508 . . . . 71.430000000000007 112.008 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 1.9 ptp180 -140.37 17.68 2.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.974 -0.557 . . . . 74.340000000000003 110.292 173.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 47.1 p90 -162.92 172.13 15.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 111.102 -173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.68 114.63 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.483 -0.326 . . . . 63.350000000000001 110.601 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.45 HD23 ' HE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.42 130.03 39.26 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.073 0.463 . . . . 75.019999999999996 110.645 -177.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 85.2 mttt -71.76 149.63 45.19 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.23 0.538 . . . . 71.329999999999998 112.346 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.47 122.77 14.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.495 . . . . 53.020000000000003 112.036 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 0.04 67.49 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.412 -0.423 . . . . 72.200000000000003 114.111 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.1 tp60 -79.19 148.47 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.173 0.487 . . . . 73.310000000000002 111.898 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 65.1 p -92.7 134.56 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.839 0.352 . . . . 75.430000000000007 111.644 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.31 112.87 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.413 0.625 . . . . 62.350000000000001 111.004 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 85.3 m -91.36 123.95 35.18 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 65.120000000000005 112.047 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.5 mm -90.14 99.24 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.261 -0.427 . . . . 74.140000000000001 110.822 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HB2' HG13 ' A' ' 87' ' ' ILE . 85.6 m95 -84.49 161.79 20.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.975 0.417 . . . . 64.129999999999995 111.966 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -87.27 167.84 13.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.906 0.384 . . . . 51.409999999999997 111.96 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.2 -60.78 2.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.543 0.572 . . . . 62.539999999999999 112.543 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -91.08 41.57 1.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.103 0.477 . . . . 71.150000000000006 111.877 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.27 60.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.81 0.338 . . . . 55.009999999999998 111.664 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.17 -44.22 2.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.319 -0.467 . . . . 74.239999999999995 113.627 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.27 171.03 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.459 0.541 . . . . 71.140000000000001 112.459 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 81' ' ' SER . 57.8 m -53.87 130.24 36.5 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.784 0.326 . . . . 75.450000000000003 111.336 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' HD3' ' A' ' 89' ' ' LYS . . . -78.27 10.28 3.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.413 0.894 . . . . 75.140000000000001 113.413 -173.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.449 ' H ' HG22 ' A' ' 79' ' ' THR . 22.9 t -152.73 133.07 7.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 112.407 0.521 . . . . 73.230000000000004 112.407 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 66.8 Cg_exo -54.33 -178.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.906 3.071 . . . . 54.399999999999999 113.0 172.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 89.6 Cg_endo -93.85 101.67 0.22 Allowed 'Cis proline' 0 C--N 1.366 1.49 0 N-CA-C 115.536 1.322 . . . . 74.319999999999993 115.536 5.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.1 p -158.13 -60.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.509 0.724 . . . . 53.329999999999998 109.56 171.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 8.1 m-20 -122.1 -168.87 1.79 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.304 -0.862 . . . . 74.239999999999995 109.75 172.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.553 ' HB2' HD13 ' A' ' 71' ' ' ILE . 78.4 mt -127.08 108.7 11.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.048 0.452 . . . . 70.25 110.885 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -95.96 108.66 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.318 0.58 . . . . 62.009999999999998 111.436 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.466 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 10.9 t90 -74.35 84.06 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.548 0.69 . . . . 63.520000000000003 110.617 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HD3' ' HB1' ' A' ' 80' ' ' ALA . 9.7 mtmp? -73.1 4.07 4.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.695 0.628 . . . . 73.540000000000006 112.695 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.466 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 16.1 m120 -92.43 -13.35 30.14 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.508 0.559 . . . . 72.540000000000006 112.508 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -151.44 159.13 44.35 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.002 0.43 . . . . 54.240000000000002 111.327 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 52.4 m-80 -109.83 -169.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.565 0.579 . . . . 75.450000000000003 112.565 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.5 m -60.03 156.47 14.77 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.372 0.879 . . . . 70.340000000000003 113.372 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -127.46 160.2 32.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.2 -0.909 . . . . 73.030000000000001 111.116 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.42 48.68 0.36 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.985 -0.626 . . . . 62.020000000000003 112.865 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.4 t -65.65 -22.81 66.68 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.722 0.638 . . . . 73.430000000000007 112.722 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.29 3.43 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.074 -0.584 . . . . 71.219999999999999 113.238 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -82.41 170.22 15.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.145 0.498 . . . . 65.230000000000004 111.849 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.11 164.19 26.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.884 -0.598 . . . . 73.420000000000002 111.781 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.5 p -144.66 140.33 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.96 0.41 . . . . 64.010000000000005 111.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.7 ttpt -107.38 128.87 54.86 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.942 0.401 . . . . 63.310000000000002 111.314 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 17' ' ' ILE . 4.0 p -114.01 136.87 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.325 0.583 . . . . 70.049999999999997 111.886 -178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.38 142.49 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.917 -0.583 . . . . 64.219999999999999 111.599 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 17' ' ' ILE . 38.9 mt -122.95 107.76 12.19 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.054 0.39 . . . . 52.229999999999997 112.054 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -114.12 136.56 52.8 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.296 0.57 . . . . 51.020000000000003 111.337 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 9.4 m120 -93.57 108.05 19.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.823 -0.626 . . . . 73.450000000000003 112.489 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.3 t 59.92 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.297 0.851 . . . . 73.129999999999995 113.297 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.93 -71.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.444 0.64 . . . . 75.239999999999995 111.654 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.58 -22.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.455 -0.793 . . . . 73.400000000000006 111.732 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 9.2 pt-20 -44.28 133.25 5.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.344 0.658 . . . . 73.219999999999999 111.349 171.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.7 128.8 53.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.844 -172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.48 HG13 ' OD1' ' A' ' 106' ' ' ASN . 17.9 m -85.57 -35.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 112.066 0.395 . . . . 72.120000000000005 112.066 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.59 154.01 1.94 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.429 0.633 . . . . 72.099999999999994 112.621 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -139.59 130.15 25.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.565 -0.743 . . . . 74.310000000000002 110.102 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 115' ' ' ARG . 4.0 ttt85 -141.5 148.33 39.24 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.481 0.549 . . . . 51.109999999999999 112.481 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.9 p -106.99 169.8 8.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.241 -0.436 . . . . 44.049999999999997 111.407 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.1 p -78.51 134.22 37.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.032 0.382 . . . . 73.340000000000003 112.032 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.945 0.403 . . . . 74.129999999999995 111.475 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.908 0.336 . . . . 72.299999999999997 111.908 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.0 t -84.62 102.84 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.899 0.38 . . . . 73.420000000000002 111.528 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.8 t -121.41 149.82 42.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.818 0.342 . . . . 65.099999999999994 111.404 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 104' ' ' LEU . 61.3 mt -62.37 132.19 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 112.301 0.482 . . . . 75.510000000000005 112.301 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -84.47 -62.39 1.57 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.408 0.623 . . . . 74.109999999999999 110.206 173.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -149.45 136.68 19.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.614 . . . . 72.329999999999998 110.748 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 27' ' ' ILE . 40.9 mt -94.5 146.69 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.945 -0.391 . . . . 75.430000000000007 109.945 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.18 129.87 41.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.141 0.496 . . . . 73.150000000000006 112.069 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.52 -23.54 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.902 -0.59 . . . . 71.150000000000006 111.59 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.37 -32.3 54.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.162 0.506 . . . . 74.120000000000005 110.775 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 102.08 41.9 2.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.073 -0.512 . . . . 73.120000000000005 114.32 173.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -129.36 -6.58 4.77 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.975 1.102 . . . . 71.120000000000005 113.975 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.74 163.19 24.17 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.573 0.953 . . . . 72.409999999999997 113.573 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 20' ' ' ILE . 56.0 mt -134.54 115.5 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.366 -0.834 . . . . 71.219999999999999 110.337 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -94.88 110.34 22.23 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.686 -0.634 . . . . 75.530000000000001 112.172 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 5.8 mp -94.09 145.3 24.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.063 -0.517 . . . . 63.439999999999998 110.636 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -125.65 125.5 43.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.839 0.352 . . . . 71.340000000000003 111.11 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.09 127.54 32.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.719 0.295 . . . . 71.430000000000007 110.906 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.7 p -93.24 -15.99 25.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.313 0.486 . . . . 74.349999999999994 112.313 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.0 p -69.92 134.61 48.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.002 0.429 . . . . 72.319999999999993 111.114 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.62 25.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.118 0.485 . . . . 41.25 111.424 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -147.74 143.74 27.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.16 -0.473 . . . . 71.439999999999998 110.872 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.84 104.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.722 0.409 . . . . 74.019999999999996 111.859 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.04 135.08 20.03 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 111.756 0.28 . . . . 64.209999999999994 111.756 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.95 48.07 2.54 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.701 2.267 . . . . 62.43 112.907 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 tpt 67.23 -69.4 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.422 0.689 . . . . 72.310000000000002 112.059 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.1 4.01 61.53 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.136 -0.554 . . . . 63.119999999999997 113.458 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.87 101.11 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.197 -0.525 . . . . 70.329999999999998 113.345 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -121.16 175.88 5.88 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.599 -0.354 . . . . 74.329999999999998 111.419 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -145.36 123.11 11.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.421 . . . . 74.319999999999993 111.387 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -99.96 117.31 33.98 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.119 -0.491 . . . . 73.150000000000006 111.329 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.2 mp -104.45 105.49 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.036 0.446 . . . . 73.200000000000003 111.036 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.666 HH11 ' HZ3' ' A' ' 88' ' ' TRP . 61.0 ttt180 -82.29 109.02 16.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.499 -0.318 . . . . 74.420000000000002 111.398 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -117.03 141.73 47.88 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.876 0.369 . . . . 75.409999999999997 111.108 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 100' ' ' VAL . 13.3 tt -166.1 -46.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 111.785 0.291 . . . . 73.519999999999996 111.785 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.26 21.29 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.174 -0.536 . . . . 42.509999999999998 113.093 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.23 8.56 5.76 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.536 -0.391 . . . . 74.319999999999993 111.922 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -149.32 166.06 30.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.862 0.363 . . . . 52.509999999999998 111.202 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.0 p -128.26 164.39 22.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.961 0.41 . . . . 74.150000000000006 111.252 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.45 132.69 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.543 -0.299 . . . . 44.140000000000001 110.954 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.413 ' OG ' HG13 ' A' ' 45' ' ' ILE . 69.5 m -104.87 162.05 13.66 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.27 0.557 . . . . 65.140000000000001 112.481 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.402 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 72.3 t80 -142.87 118.96 10.71 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.956 -0.566 . . . . 74.219999999999999 110.645 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -91.67 123.38 35.02 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.834 0.35 . . . . 70.230000000000004 110.54 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -74.56 177.07 6.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.539 0.94 . . . . 64.030000000000001 113.539 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.473 HG23 ' CE2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -125.71 165.87 17.82 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.522 -0.763 . . . . 71.329999999999998 112.09 -177.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 t -106.4 10.4 31.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.216 -0.447 . . . . 54.409999999999997 111.855 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.58 -35.43 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.208 0.448 . . . . 74.230000000000004 112.208 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.473 ' CE2' HG23 ' A' ' 58' ' ' THR . 17.5 p90 -101.19 149.15 24.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.109 0.481 . . . . 72.430000000000007 111.566 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.46 126.11 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.084 0.469 . . . . 70.219999999999999 111.496 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.5 mm? -80.56 96.34 6.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 51.32 110.941 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.41 168.61 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.196 0.522 . . . . 63.329999999999998 111.954 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.76 107.24 0.58 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.137 -0.483 . . . . 61.299999999999997 111.602 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 2.67 83.23 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.44 -0.41 . . . . 74.439999999999998 113.592 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -54.49 120.96 7.38 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.845 0.683 . . . . 72.239999999999995 112.845 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -94.39 112.92 24.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.04 -0.527 . . . . 63.329999999999998 110.975 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.38 128.5 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.02 0.438 . . . . 75.239999999999995 110.726 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.7 m -106.97 118.59 37.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.189 0.519 . . . . 52.210000000000001 112.1 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.36 104.8 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 65.140000000000001 110.644 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 63.3 m95 -87.53 159.19 18.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.953 0.406 . . . . 74.340000000000003 111.26 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.07 175.85 8.77 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.913 0.387 . . . . 70.340000000000003 111.374 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -22.6 19.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.315 0.487 . . . . 60.119999999999997 112.315 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -99.44 29.6 3.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.685 0.278 . . . . 74.109999999999999 111.477 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.77 -62.19 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.07 0.767 . . . . 73.200000000000003 113.07 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.63 -37.72 3.48 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.079 -0.51 . . . . 73.540000000000006 112.351 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 HD11 ' A' ' 87' ' ' ILE . 30.4 m -76.55 166.61 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.84 0.353 . . . . 73.129999999999995 111.707 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -67.13 170.12 7.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.553 0.575 . . . . 55.409999999999997 112.553 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.77 92.2 2.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.834 0.679 . . . . 61.229999999999997 112.834 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.579 ' H ' HD13 ' A' ' 87' ' ' ILE . 71.2 m 59.96 94.54 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.33 0.863 . . . . 65.450000000000003 113.33 172.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.602 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 78.5 Cg_exo -52.77 -41.34 70.54 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.542 2.828 . . . . 62.020000000000003 116.228 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.602 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.4 Cg_endo -98.2 135.97 3.24 Favored 'Cis proline' 0 C--N 1.366 1.477 0 CA-C-N 121.394 1.533 . . . . 71.420000000000002 114.639 -1.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 t -163.8 -48.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.933 -0.766 . . . . 75.219999999999999 108.933 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 8.1 m-20 -86.25 115.11 23.59 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.98 -0.748 . . . . 62.119999999999997 108.98 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -92.59 112.11 23.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.921 0.391 . . . . 50.229999999999997 111.659 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 81' ' ' SER . 2.5 mp -81.93 96.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.578 0.704 . . . . 61.229999999999997 110.636 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.666 ' HZ3' HH11 ' A' ' 46' ' ' ARG . 28.8 t90 -71.44 86.28 0.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.68 -0.691 . . . . 73.120000000000005 111.066 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.17 7.26 9.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.888 0.699 . . . . 72.319999999999993 112.888 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 14.6 m120 -70.06 -27.3 64.52 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.841 0.311 . . . . 72.239999999999995 111.841 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -159.44 156.92 29.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.861 0.362 . . . . 75.430000000000007 111.397 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -170.31 0.97 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.136 0.791 . . . . 70.200000000000003 113.136 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.4 m -67.41 -173.01 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.823 -0.626 . . . . 75.519999999999996 112.58 -173.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.473 ' HB3' ' NH2' ' A' ' 46' ' ' ARG . 49.3 p90 -141.69 147.0 36.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.06 0.457 . . . . 75.329999999999998 111.49 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.66 43.5 0.06 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.357 -0.449 . . . . 75.409999999999997 112.594 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.406 HG22 HD11 ' A' ' 48' ' ' ILE . 14.5 t -83.41 18.65 1.75 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.49 0.552 . . . . 74.219999999999999 112.49 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.61 -37.59 3.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.971 -0.633 . . . . 34.520000000000003 113.115 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.41 151.63 23.38 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.357 0.599 . . . . 71.450000000000003 112.015 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.35 130.34 41.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.33 -0.85 . . . . 71.030000000000001 112.226 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 48' ' ' ILE . 7.3 p -75.85 108.83 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.386 0.612 . . . . 55.130000000000003 110.811 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -90.19 103.13 15.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.491 0.662 . . . . 75.310000000000002 110.859 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.524 HG21 HD13 ' A' ' 27' ' ' ILE . 61.1 t -88.87 126.77 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.575 -0.739 . . . . 75.219999999999999 112.019 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 46.7 mm -97.71 132.18 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.536 -0.756 . . . . 74.049999999999997 111.461 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.663 HD11 HG13 ' A' ' 17' ' ' ILE . 80.8 mt -111.63 108.24 17.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.236 0.541 . . . . 72.230000000000004 111.689 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.85 161.2 16.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.971 -0.559 . . . . 60.030000000000001 111.294 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.58 177.32 7.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.003 0.43 . . . . 72.510000000000005 111.364 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.5 t -74.45 28.96 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.004 0.431 . . . . 54.539999999999999 111.82 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.01 -39.48 1.94 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.126 0.489 . . . . 75.400000000000006 111.374 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.43 -32.93 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.914 -0.474 . . . . 64.25 111.914 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.86 161.32 28.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 74.219999999999999 111.73 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -122.46 138.76 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.261 -0.427 . . . . 75.150000000000006 112.057 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.17 -32.39 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 113.667 0.988 . . . . 74.010000000000005 113.667 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.81 41.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.879 0.696 . . . . 63.0 112.879 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.86 135.93 3.47 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.702 -0.681 . . . . 55.340000000000003 110.894 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -164.32 165.25 21.93 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.17 -0.331 . . . . 75.109999999999999 111.23 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.1 p -129.41 -173.15 2.93 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.884 0.698 . . . . 71.349999999999994 112.884 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.2 p -81.14 127.99 33.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.998 -0.546 . . . . 61.399999999999999 112.404 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 116.096 -0.502 . . . . 63.200000000000003 110.399 174.072 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.866 0.365 . . . . 70.450000000000003 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -107.23 104.7 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.434 -0.348 . . . . 75.420000000000002 110.731 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.8 p -119.36 156.28 30.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.786 0.327 . . . . 72.510000000000005 111.69 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 104' ' ' LEU . 67.2 mt -76.08 122.86 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.748 0.309 . . . . 73.219999999999999 111.083 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.11 -35.26 23.8 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.993 0.425 . . . . 71.140000000000001 110.882 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -167.66 145.48 4.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.997 0.427 . . . . 70.219999999999999 111.716 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 27' ' ' ILE . 47.9 mt -113.19 131.92 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.588 -0.278 . . . . 61.140000000000001 110.258 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.55 126.64 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.963 0.411 . . . . 61.200000000000003 111.803 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 7.9 p -82.93 23.03 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.574 0.702 . . . . 73.230000000000004 112.013 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -121.28 -53.08 2.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.048 0.451 . . . . 74.019999999999996 110.112 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.44 13.33 0.57 Allowed Glycine 0 CA--C 1.524 0.64 0 CA-C-N 116.026 -0.534 . . . . 60.43 113.834 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -76.07 -52.94 9.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.596 0.591 . . . . 73.209999999999994 112.596 -176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.35 158.99 39.56 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.472 0.915 . . . . 74.540000000000006 113.472 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 20' ' ' ILE . 59.9 mt -114.33 121.85 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 74.439999999999998 110.153 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -94.41 107.76 19.71 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.391 0.515 . . . . 63.310000000000002 112.391 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.1 mp -100.99 169.4 8.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.851 0.357 . . . . 75.099999999999994 111.118 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.68 128.49 7.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.983 0.364 . . . . 62.329999999999998 111.983 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -91.72 112.4 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.348 -0.387 . . . . 71.409999999999997 110.754 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -100.95 19.0 18.16 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.16 0.505 . . . . 65.439999999999998 111.954 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.0 t -78.27 -176.84 4.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.065 -0.397 . . . . 64.030000000000001 111.646 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.58 -39.19 20.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.053 0.76 . . . . 74.450000000000003 113.053 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 57.9 tt0 -130.5 170.63 13.97 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.822 0.344 . . . . 64.540000000000006 111.591 -171.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.4 m-20 -52.16 104.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.827 0.451 . . . . 54.030000000000001 111.623 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 15.7 mm100 -91.14 136.85 26.79 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.106 0.409 . . . . 74.329999999999998 112.106 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 39.7 Cg_exo -62.08 113.24 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.715 2.277 . . . . 72.519999999999996 112.647 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.59 ' HG3' ' HB3' ' A' ' 57' ' ' TYR . 3.4 tpt -69.56 -28.71 66.22 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.989 0.423 . . . . 72.200000000000003 111.674 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.675 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.28 76.55 0.76 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.387 -0.435 . . . . 64.420000000000002 113.576 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.07 12.63 0.03 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.476 -0.393 . . . . 55.409999999999997 113.156 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.41 ' CZ3' HG21 ' A' ' 112' ' ' VAL . 30.2 m95 -124.89 162.07 25.2 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.696 0.398 . . . . 75.409999999999997 110.803 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -145.49 135.37 23.59 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.029 0.442 . . . . 73.150000000000006 111.371 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.0 ttp -101.69 120.51 40.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.988 -0.551 . . . . 74.219999999999999 111.619 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.4 mp -109.05 118.18 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.647 0.26 . . . . 71.540000000000006 110.576 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.546 ' NH1' HE22 ' A' ' 91' ' ' GLN . 43.8 ttt-85 -90.49 129.77 36.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.066 -0.396 . . . . 54.340000000000003 111.938 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 29.0 mtpp -129.29 147.84 51.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.288 0.566 . . . . 74.329999999999998 111.843 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' HG23 ' A' ' 100' ' ' VAL . 9.6 tt -167.78 -40.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.568 -0.742 . . . . 71.519999999999996 110.193 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.66 -153.94 6.31 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.803 -0.635 . . . . 75.120000000000005 111.864 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 71.73 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.284 0.564 . . . . 73.340000000000003 111.724 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -174.99 163.89 3.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.67 . . . . 74.540000000000006 110.985 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.2 p -163.07 101.51 0.98 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.039 0.447 . . . . 70.430000000000007 111.302 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.17 144.13 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.26 -0.427 . . . . 64.040000000000006 111.37 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.7 m -109.04 158.72 17.46 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.253 0.549 . . . . 53.329999999999998 112.329 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -149.0 109.12 4.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.983 -0.553 . . . . 73.109999999999999 111.204 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -75.8 131.85 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.888 0.375 . . . . 72.099999999999994 111.273 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 52.4 m-85 -78.75 121.76 25.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 110.762 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -79.13 158.04 27.82 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.369 0.507 . . . . 63.219999999999999 112.369 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.675 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 20.7 t -104.29 23.68 12.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.238 -0.437 . . . . 61.140000000000001 111.541 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 81' ' ' SER . 13.5 ptm180 -58.01 -29.67 65.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.867 0.365 . . . . 74.319999999999993 111.618 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -143.18 156.29 44.73 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 71.230000000000004 109.997 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.46 139.8 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.457 -0.338 . . . . 73.420000000000002 111.563 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -84.35 104.3 14.26 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.925 0.393 . . . . 70.409999999999997 111.038 -175.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 63.6 mttm -65.92 168.82 7.5 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.527 0.936 . . . . 65.420000000000002 113.527 -174.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 129.37 37.63 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.541 -0.754 . . . . 73.319999999999993 111.123 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.03 9.15 79.81 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.948 -0.644 . . . . 72.109999999999999 112.763 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.06 117.95 22.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.944 0.402 . . . . 62.229999999999997 111.305 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.0 p -86.1 96.31 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.362 -0.381 . . . . 73.230000000000004 111.011 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' A' ' 29' ' ' LEU . 6.6 p -79.62 119.04 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.538 0.685 . . . . 71.420000000000002 110.988 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 20.2 m -100.0 110.07 22.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 71.310000000000002 111.655 -175.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 49.6 mm -74.12 95.58 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 110.629 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 87.4 m95 -79.89 128.27 33.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.41 -0.359 . . . . 75.340000000000003 110.949 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.51 162.5 6.28 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.284 -0.26 . . . . 55.020000000000003 111.559 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -50.29 -26.02 4.36 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.993 0.738 . . . . 72.140000000000001 112.993 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 92' ' ' ASN . 74.8 m-20 -90.8 28.28 1.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.925 0.393 . . . . 74.540000000000006 111.566 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -59.71 -36.03 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.694 0.627 . . . . 52.219999999999999 112.694 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.1 2.3 82.45 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.095 -0.574 . . . . 63.549999999999997 113.243 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.78 -178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.155 0.502 . . . . 55.009999999999998 111.619 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 m -75.26 139.85 42.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.264 -0.426 . . . . 52.219999999999999 111.288 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.25 79.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.212 0.53 . . . . 73.420000000000002 111.574 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.533 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 8.5 t 66.08 89.87 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 115.484 -0.78 . . . . 54.43 111.729 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 84' ' ' THR . 41.0 Cg_exo -60.97 -30.23 89.5 Favored 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 124.112 3.208 . . . . 72.209999999999994 118.084 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.687 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 33.3 Cg_endo -97.97 -179.43 6.05 Favored 'Cis proline' 0 C--N 1.367 1.532 0 CA-C-N 122.249 1.839 . . . . 72.510000000000005 115.284 6.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.716 HG22 ' HD2' ' A' ' 82' ' ' PRO . 2.9 t 177.01 -44.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.682 -1.599 . . . . 72.329999999999998 108.724 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 70' ' ' THR . 18.2 m-20 -140.06 -171.9 3.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.014 -0.994 . . . . 65.409999999999997 110.157 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 88.9 mt -123.02 132.33 54.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.936 0.398 . . . . 72.530000000000001 111.278 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.8 mp -95.68 125.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.25 0.547 . . . . 64.329999999999998 111.396 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.512 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 16.2 t90 -80.33 90.42 5.58 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.754 -0.657 . . . . 73.099999999999994 111.033 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -80.16 -5.2 55.62 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.424 0.527 . . . . 75.310000000000002 112.424 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 15.1 m120 -82.31 -14.45 55.33 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.543 0.572 . . . . 71.010000000000005 112.543 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.546 HE22 ' NH1' ' A' ' 46' ' ' ARG . 46.7 tt0 -154.27 143.05 20.94 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.254 0.55 . . . . 74.209999999999994 111.528 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.6 m120 -75.11 172.28 12.65 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.111 -0.495 . . . . 74.540000000000006 111.021 175.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.8 p -71.79 114.36 9.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.582 0.23 . . . . 74.329999999999998 110.568 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -59.32 -29.84 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.131 0.419 . . . . 64.409999999999997 112.131 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 48.03 39.41 18.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 114.733 0.653 . . . . 62.409999999999997 114.733 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -133.85 12.4 4.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.158 0.504 . . . . 72.219999999999999 110.941 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 67.18 -112.58 4.94 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.982 -0.628 . . . . 52.240000000000002 112.759 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 66.41 163.13 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.914 0.709 . . . . 74.329999999999998 112.914 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 11.1 p-10 -95.9 87.8 4.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.639 0.733 . . . . 64.530000000000001 110.711 176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 48' ' ' ILE . 7.6 p -96.25 135.38 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.059 -0.519 . . . . 71.439999999999998 111.299 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -115.31 124.26 50.85 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.094 0.473 . . . . 65.140000000000001 111.199 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 27' ' ' ILE . 87.6 t -98.9 136.39 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.035 -0.53 . . . . 72.530000000000001 112.075 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 43.9 mm -103.2 121.31 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.821 -0.627 . . . . 62.109999999999999 111.286 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.746 HD11 HG13 ' A' ' 17' ' ' ILE . 80.7 mt -97.5 121.77 39.78 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.352 -0.218 . . . . 72.129999999999995 111.083 175.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.9 mttt -129.36 159.24 36.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.031 0.443 . . . . 72.450000000000003 111.457 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -93.21 163.77 13.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 54.539999999999999 110.938 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -57.3 -29.75 64.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.306 0.484 . . . . 62.549999999999997 112.306 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -74.75 -19.26 60.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.69 0.626 . . . . 75.319999999999993 112.69 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 135.28 -46.89 1.01 Allowed Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.663 1.025 . . . . 64.299999999999997 115.663 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.91 169.48 17.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.596 0.698 . . . . 73.109999999999999 112.746 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 36.5 tt0 -94.7 146.97 23.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.713 -0.676 . . . . 74.209999999999994 112.181 -173.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.41 HG21 ' CZ3' ' A' ' 42' ' ' TRP . 46.6 t -97.9 -59.6 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.949 -0.569 . . . . 62.119999999999997 110.806 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.59 159.73 14.48 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 64.140000000000001 111.563 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.27 152.03 45.17 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.64 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 115' ' ' ARG . 18.6 ttt180 -156.11 144.87 20.26 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.781 -0.19 . . . . 71.319999999999993 111.362 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.2 p -114.64 175.35 5.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 62.130000000000003 112.377 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 33.0 p -77.17 -174.59 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.936 -0.575 . . . . 71.530000000000001 111.18 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 116.546 -0.297 . . . . 74.030000000000001 111.252 178.557 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 77.5 m-20 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 111.963 0.357 . . . . 73.239999999999995 111.963 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -102.7 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.961 0.41 . . . . 73.219999999999999 110.221 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.25 151.0 25.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.076 0.465 . . . . 73.030000000000001 112.016 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 104' ' ' LEU . 56.4 mt -77.28 115.4 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.264 -0.426 . . . . 71.239999999999995 110.619 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -84.19 -42.34 16.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.722 0.296 . . . . 73.439999999999998 111.522 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.1 148.61 27.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.230000000000004 112.037 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.66 123.35 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.908 -0.587 . . . . 62.340000000000003 110.265 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.17 140.05 40.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.487 0.661 . . . . 51.5 112.462 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -97.1 -20.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.716 -0.674 . . . . 70.140000000000001 111.142 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -68.02 -34.62 76.83 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.15 0.5 . . . . 62.200000000000003 110.381 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 104.03 44.53 1.61 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.345 0.498 . . . . 44.350000000000001 114.345 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -128.3 -26.08 2.86 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.373 0.879 . . . . 75.430000000000007 113.373 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' HB2' ' CG2' ' A' ' 70' ' ' THR . 49.2 p90 -156.08 152.46 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.884 1.068 . . . . 75.150000000000006 113.884 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -127.06 118.55 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.748 . . . . 75.209999999999994 109.537 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 28' ' ' ARG . 37.8 ttp180 -101.61 110.3 22.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.689 0.626 . . . . 71.319999999999993 112.689 -171.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.9 mp -97.92 169.47 9.62 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.89 -0.596 . . . . 74.25 110.439 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -149.99 140.84 22.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.148 0.499 . . . . 65.219999999999999 111.843 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' HB3' HD12 ' A' ' 63' ' ' LEU . 37.5 t30 -100.27 126.9 46.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.259 -0.428 . . . . 71.540000000000006 111.079 177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.2 t -113.16 10.97 18.7 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.806 0.336 . . . . 64.400000000000006 111.597 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 32.2 m -65.94 146.23 54.97 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.327 -0.233 . . . . 55.32 111.186 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.88 -19.21 62.65 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.415 0.524 . . . . 62.25 112.415 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 42.7 tt0 -123.06 166.06 15.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.81 0.338 . . . . 72.329999999999998 111.167 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.7 m-20 -55.09 130.84 43.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.763 0.425 . . . . 75.439999999999998 111.84 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.41 113.32 40.95 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 112.459 0.54 . . . . 71.439999999999998 112.459 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.54 125.44 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.748 2.299 . . . . 74.019999999999996 111.211 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 tpp -58.07 -20.88 42.89 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.777 0.658 . . . . 53.140000000000001 112.777 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.06 -90.19 0.08 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.249 -0.501 . . . . 70.120000000000005 113.518 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.08 59.66 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.047 -0.597 . . . . 65.329999999999998 113.577 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -76.43 168.8 19.42 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.475 -0.426 . . . . 73.549999999999997 110.912 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.33 113.82 26.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.099 0.476 . . . . 72.540000000000006 111.606 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.4 ttp -92.28 125.54 36.99 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.147 -0.479 . . . . 70.530000000000001 111.213 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.7 mt -117.21 109.11 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.783 0.325 . . . . 73.439999999999998 111.371 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -90.21 107.69 19.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.812 0.339 . . . . 72.010000000000005 111.141 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 37.3 mttm -95.83 129.32 43.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.811 0.339 . . . . 74.239999999999995 111.217 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.6 tt -134.67 100.82 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.445 0.641 . . . . 51.32 110.901 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.83 -103.98 1.31 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.1 -0.571 . . . . 74.019999999999996 112.419 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -102.74 -32.12 9.99 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.035 0.383 . . . . 74.150000000000006 112.035 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -92.91 168.69 10.99 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.3 0.572 . . . . 64.219999999999999 112.39 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.51 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 92.5 p -155.1 150.75 27.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.959 -0.564 . . . . 64.120000000000005 111.415 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.5 p -134.61 140.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.443 -0.344 . . . . 72.430000000000007 110.874 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.4 p -108.3 158.01 17.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.409 0.623 . . . . 73.200000000000003 112.584 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -154.56 115.27 3.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.735 -0.666 . . . . 75.510000000000005 111.069 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -86.33 133.82 33.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.921 0.391 . . . . 75.010000000000005 110.867 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.79 -177.86 2.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.195 0.521 . . . . 70.129999999999995 111.851 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -148.36 142.95 26.5 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.084 -0.507 . . . . 72.340000000000003 110.982 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -95.43 82.45 3.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.049 0.452 . . . . 73.530000000000001 111.983 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.36 6.25 10.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 71.209999999999994 111.209 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.01 152.26 31.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 74.340000000000003 110.362 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 36' ' ' ASP . 11.7 t -115.47 116.92 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.825 0.345 . . . . 71.049999999999997 110.733 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -93.0 123.83 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.488 -0.324 . . . . 43.420000000000002 111.07 -173.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -80.97 -169.82 2.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.753 0.649 . . . . 75.120000000000005 112.753 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' SER . . . -81.68 144.3 31.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.67 0.619 . . . . 71.049999999999997 112.67 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.2 12.32 62.94 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.953 -0.567 . . . . 31.300000000000001 114.038 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -109.32 144.41 37.52 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.446 -0.443 . . . . 72.400000000000006 110.938 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -99.73 143.59 29.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.963 0.411 . . . . 63.340000000000003 112.011 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.77 123.96 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.208 -0.451 . . . . 72.25 110.121 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 86.6 m -101.74 126.72 48.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.472 . . . . 74.540000000000006 112.008 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.7 mm -92.01 103.1 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.43 . . . . 74.319999999999993 110.253 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.429 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -85.58 135.12 33.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.3 -0.409 . . . . 65.019999999999996 111.607 -177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 153.23 40.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.657 0.265 . . . . 71.030000000000001 111.533 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -53.88 -34.32 59.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.736 0.643 . . . . 73.310000000000002 112.736 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.419 HD21 ' HB3' ' A' ' 92' ' ' ASN . 77.2 m-20 -82.37 6.73 16.13 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.651 0.612 . . . . 61.130000000000003 112.651 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.68 77.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.974 0.361 . . . . 64.450000000000003 111.974 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.56 2.02 90.57 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.152 -0.547 . . . . 64.040000000000006 114.2 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.0 171.79 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 122.389 -0.477 . . . . 75.030000000000001 111.823 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 ' H ' ' A' ' 81' ' ' SER . 85.6 m -69.26 126.61 30.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 74.120000000000005 111.701 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -64.99 -15.25 62.08 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.177 0.806 . . . . 73.0 113.177 -176.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.659 ' H ' HG22 ' A' ' 79' ' ' THR . 23.2 t -149.25 86.53 5.55 Favored Pre-proline 0 N--CA 1.474 0.745 0 O-C-N 122.154 -0.341 . . . . 65.150000000000006 111.743 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 84' ' ' THR . 53.9 Cg_exo -53.65 -44.8 45.94 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 122.984 2.456 . . . . 73.530000000000001 115.399 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 69.7 Cg_endo -99.97 132.9 2.21 Favored 'Cis proline' 0 C--N 1.369 1.649 0 CA-C-N 121.161 1.45 . . . . 75.209999999999994 114.095 -1.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.569 HG22 ' HB2' ' A' ' 82' ' ' PRO . 5.1 t -174.72 -47.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.96 -0.563 . . . . 74.0 110.241 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' THR . 17.3 m-20 -89.98 164.55 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.513 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 92.1 mt -126.47 133.85 51.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.035 0.445 . . . . 73.439999999999998 111.412 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 80' ' ' ALA . 1.6 mp -94.28 114.9 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.995 0.426 . . . . 61.310000000000002 111.281 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.509 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 4.5 t90 -66.96 93.46 0.27 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.055 -0.52 . . . . 73.439999999999998 110.691 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -78.51 -28.04 46.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.106 0.41 . . . . 74.310000000000002 112.106 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 15.9 m120 -63.32 -20.31 65.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.287 0.477 . . . . 63.329999999999998 112.287 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 47.5 tt0 -132.63 127.18 34.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.864 0.364 . . . . 64.230000000000004 110.817 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.1 m120 -67.19 -51.81 48.95 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.349 . . . . 72.150000000000006 111.205 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 t -175.21 -179.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 61.229999999999997 111.577 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.547 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 38.5 p90 -153.48 -178.81 7.24 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.131 -0.486 . . . . 73.120000000000005 110.116 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.18 55.17 0.02 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.394 -0.908 . . . . 70.329999999999998 113.166 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -79.83 -40.9 27.47 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.145 0.498 . . . . 73.109999999999999 111.513 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.82 -23.25 19.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.063 -0.517 . . . . 52.539999999999999 112.789 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.51 179.35 5.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.257 0.551 . . . . 64.140000000000001 112.073 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.4 124.41 23.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.741 -0.663 . . . . 72.030000000000001 112.22 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.97 135.64 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.134 0.492 . . . . 75.010000000000005 111.072 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 103' ' ' ILE . 7.7 ttpm? -122.96 136.68 54.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.087 -0.506 . . . . 50.229999999999997 111.718 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.18 123.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.198 0.523 . . . . 72.400000000000006 111.246 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 101' ' ' LYS . 48.8 mm -102.95 135.34 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.831 -0.622 . . . . 65.200000000000003 111.93 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 17' ' ' ILE . 68.6 mt -111.45 105.75 14.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 54.229999999999997 110.797 173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 103' ' ' ILE . 68.3 mttm -107.69 130.62 54.91 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.16 0.505 . . . . 65.230000000000004 111.423 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.94 156.11 39.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.609 . . . . 73.540000000000006 111.66 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -57.5 -16.43 9.75 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.173 0.805 . . . . 75.129999999999995 113.173 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -101.08 12.81 36.95 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.449 0.537 . . . . 73.420000000000002 112.449 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.35 -23.81 33.96 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.888 0.715 . . . . 52.32 114.888 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -76.77 174.8 10.06 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.462 0.631 . . . . 72.310000000000002 111.905 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.87 142.4 50.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.519 -0.31 . . . . 70.219999999999999 111.282 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.84 -32.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 113.323 0.86 . . . . 75.329999999999998 113.323 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.98 152.53 47.75 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.636 0.606 . . . . 74.230000000000004 112.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.65 46.88 0.49 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.313 0.577 . . . . 73.140000000000001 111.276 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -75.54 151.1 37.98 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.183 0.516 . . . . 71.400000000000006 111.958 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.2 p -116.55 173.35 6.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.387 -0.369 . . . . 64.030000000000001 110.903 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.5 p -80.56 169.2 17.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.054 0.454 . . . . 75.319999999999993 111.508 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 116.109 -0.496 . . . . 64.219999999999999 110.705 177.6 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 73.120000000000005 111.902 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.93 114.17 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.41 . . . . 71.409999999999997 110.759 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.67 150.71 20.36 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.23 0.538 . . . . 73.140000000000001 112.243 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.39 110.15 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 62.219999999999999 110.163 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -77.22 -68.13 0.64 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.937 0.347 . . . . 64.319999999999993 111.937 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -155.92 150.49 25.97 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.287 0.565 . . . . 62.310000000000002 111.848 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.665 HD13 HH12 ' A' ' 46' ' ' ARG . 63.4 mt -108.86 137.1 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.065 -0.516 . . . . 72.319999999999993 110.864 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 11.0 t70 -70.19 147.22 50.1 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.392 0.615 . . . . 73.140000000000001 111.939 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.95 -16.87 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.643 -0.708 . . . . 70.209999999999994 111.488 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.5 -26.71 60.17 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 52.020000000000003 110.705 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.93 41.15 3.38 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.928 -0.578 . . . . 74.230000000000004 113.128 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 -37.75 2.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.356 0.872 . . . . 72.420000000000002 113.356 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.596 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 51.3 p90 -155.46 171.78 19.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.186 1.18 . . . . 74.019999999999996 114.186 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 20' ' ' ILE . 60.2 mt -136.68 143.9 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.221 -0.9 . . . . 70.340000000000003 109.265 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.65 115.04 22.02 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.576 -0.703 . . . . 74.450000000000003 112.401 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -104.58 170.42 7.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.876 -0.602 . . . . 61.329999999999998 110.521 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.84 127.76 17.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.019 0.377 . . . . 60.119999999999997 112.019 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -90.38 131.52 36.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 64.219999999999999 110.742 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.4 p -117.5 11.23 13.78 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.31 0.485 . . . . 74.549999999999997 112.31 -176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.7 p -72.78 155.86 39.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.181 0.437 . . . . 64.340000000000003 112.181 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.99 -28.24 68.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.116 0.484 . . . . 64.230000000000004 112.209 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -124.58 139.0 54.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.077 -0.51 . . . . 70.099999999999994 110.411 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.27 126.35 22.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.792 0.329 . . . . 73.530000000000001 111.708 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -91.1 120.93 68.45 Favored Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 54.140000000000001 111.934 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.23 107.74 0.34 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.343 2.029 . . . . 73.519999999999996 112.432 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 tpt -78.99 91.49 4.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.777 0.323 . . . . 72.420000000000002 111.147 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.04 -51.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.89 -0.671 . . . . 74.319999999999993 113.802 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.39 50.72 3.53 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.114 -0.565 . . . . 72.310000000000002 113.619 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -140.92 141.15 34.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.014 0.526 . . . . 73.420000000000002 110.592 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 38.0 tt0 -124.32 126.9 46.8 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.171 0.51 . . . . 72.420000000000002 110.836 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HE1' HG21 ' A' ' 71' ' ' ILE . 30.9 ttp -102.04 116.06 31.87 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.653 -0.703 . . . . 74.430000000000007 111.384 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.4 mt -100.41 161.46 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.476 -0.329 . . . . 64.310000000000002 110.615 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.665 HH12 HD13 ' A' ' 20' ' ' ILE . 46.7 ttt85 -158.87 137.07 10.63 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.817 -0.552 . . . . 74.439999999999998 111.344 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 100' ' ' VAL . 94.4 mttt -123.88 147.55 47.56 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.515 0.561 . . . . 72.200000000000003 112.515 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 tt -139.91 109.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.519 -0.764 . . . . 53.310000000000002 110.286 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.13 -78.17 0.68 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.008 -0.615 . . . . 34.130000000000003 112.847 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -136.94 -43.78 0.58 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.951 0.405 . . . . 74.140000000000001 111.502 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -68.01 137.78 55.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.182 0.515 . . . . 71.430000000000007 112.343 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.9 p -118.97 153.08 35.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.229 0.538 . . . . 62.140000000000001 112.044 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.11 151.55 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 115.743 -0.662 . . . . 75.420000000000002 110.288 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -134.99 165.97 24.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.1 0.476 . . . . 71.230000000000004 112.046 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -157.03 113.93 3.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 74.209999999999994 111.109 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 22.2 ttpp -84.01 133.85 34.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.858 0.361 . . . . 70.319999999999993 110.8 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -69.37 158.02 35.9 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.909 0.385 . . . . 71.540000000000006 110.973 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -120.33 129.55 54.03 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.158 0.504 . . . . 71.230000000000004 111.487 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.7 t -76.93 85.96 3.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.084 0.469 . . . . 74.209999999999994 112.05 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 9.8 ptp180 -119.54 4.85 11.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.399 . . . . 71.439999999999998 110.902 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 8.3 p90 -170.79 173.96 5.08 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.127 0.489 . . . . 70.349999999999994 110.69 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.48 129.02 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.208 -0.451 . . . . 62.409999999999997 110.75 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.32 105.71 1.51 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.561 -0.533 . . . . 63.229999999999997 109.561 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -54.55 136.05 45.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.71 0.633 . . . . 63.100000000000001 112.71 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.86 128.92 39.13 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.726 -0.67 . . . . 72.099999999999994 111.508 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.35 32.76 72.13 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.091 -0.576 . . . . 53.43 113.392 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -127.71 149.49 50.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.154 0.502 . . . . 72.040000000000006 111.814 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.4 p -96.4 135.53 38.13 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.104 -0.498 . . . . 61.299999999999997 111.754 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.6 134.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.397 -0.365 . . . . 73.109999999999999 110.828 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 m -104.56 118.62 37.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.267 0.556 . . . . 74.120000000000005 111.951 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.706 HG21 ' HE1' ' A' ' 44' ' ' MET . 44.4 mm -89.18 102.1 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.158 -0.474 . . . . 44.100000000000001 110.859 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -84.29 125.8 32.59 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.631 -0.259 . . . . 74.140000000000001 111.467 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -177.49 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.014 0.435 . . . . 62.43 111.751 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 -16.97 16.96 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.138 0.422 . . . . 71.299999999999997 112.138 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -93.11 19.17 8.24 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.538 -0.301 . . . . 52.439999999999998 111.204 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.662 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -46.54 -61.74 1.68 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.504 0.927 . . . . 75.129999999999995 113.504 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.17 21.48 78.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.799 -0.715 . . . . 62.140000000000001 112.792 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.662 HG22 ' HB1' ' A' ' 76' ' ' ALA . 30.2 m -127.54 -173.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.561 0.344 . . . . 73.219999999999999 110.863 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 p -60.69 123.47 17.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.088 0.471 . . . . 70.099999999999994 111.302 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 9.36 3.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.348 0.499 . . . . 64.209999999999994 112.348 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -134.46 119.04 13.95 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.174 0.435 . . . . 72.329999999999998 112.174 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.653 ' HG3' ' O ' ' A' ' 85' ' ' ASP . 36.8 Cg_exo -54.88 138.18 76.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.773 2.316 . . . . 64.109999999999999 110.101 168.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 5.3 Cg_exo 0.29 103.57 0.0 OUTLIER 'Cis proline' 0 C--N 1.363 1.329 0 N-CA-C 121.498 3.615 . . . . 61.299999999999997 121.498 25.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' ASP . 12.6 t 51.28 -67.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 117.062 2.245 . . . . 75.340000000000003 117.062 162.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 50.5 m-20 -68.21 -178.47 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.758 -0.589 . . . . 74.239999999999995 112.132 -171.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 29.3 mt -146.22 142.85 28.8 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.016 -0.427 . . . . 50.200000000000003 111.419 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.8 mp -103.57 116.41 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 112.033 0.383 . . . . 54.439999999999998 112.033 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.529 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.5 t90 -74.22 82.9 1.84 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.53 0.681 . . . . 74.409999999999997 109.792 173.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -77.13 17.48 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.874 -0.603 . . . . 74.040000000000006 112.414 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.529 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 78.6 m-20 -127.39 12.16 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.378 0.511 . . . . 43.240000000000002 112.378 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -148.64 145.64 27.84 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.205 -0.31 . . . . 64.349999999999994 111.533 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -100.64 -137.16 0.32 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 111.686 0.254 . . . . 71.219999999999999 111.686 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 96.8 p -75.93 -2.3 29.67 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.821 1.045 . . . . 72.310000000000002 113.821 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.0 p90 45.39 22.24 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.154 1.168 . . . . 74.209999999999994 114.154 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.98 -156.67 15.84 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.295 -0.478 . . . . 63.32 113.597 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 t -127.05 -31.3 2.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.103 0.478 . . . . 73.340000000000003 111.515 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.81 48.45 0.21 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.808 -0.517 . . . . 75.430000000000007 111.808 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.01 162.84 14.54 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.618 -0.342 . . . . 74.400000000000006 111.191 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -78.39 43.97 0.49 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.54 0.686 . . . . 51.219999999999999 111.215 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.6 p -66.31 136.3 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 115.534 -0.757 . . . . 71.420000000000002 111.487 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -130.1 150.32 51.42 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.003 0.372 . . . . 70.510000000000005 112.003 -171.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.84 155.71 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.859 0.689 . . . . 75.329999999999998 112.859 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 19.7 mm -126.52 134.73 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.819 0.848 . . . . 74.450000000000003 111.068 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.77 112.84 22.61 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.722 0.296 . . . . 73.109999999999999 111.487 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.34 155.92 34.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.74 0.305 . . . . 65.450000000000003 111.169 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.11 177.98 6.0 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.221 0.534 . . . . 75.129999999999995 111.677 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.8 p -57.79 -20.92 38.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.039 -0.528 . . . . 70.230000000000004 112.027 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.01 -4.61 58.86 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.258 0.466 . . . . 55.210000000000001 112.258 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.89 -19.46 45.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.296 -0.478 . . . . 63.32 113.954 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.09 152.68 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.328 -0.513 . . . . 73.340000000000003 111.759 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -99.55 128.91 45.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.098 -0.501 . . . . 62.310000000000002 112.269 -171.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -84.97 -54.7 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.885 0.374 . . . . 74.200000000000003 111.32 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.83 167.36 30.64 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.395 0.617 . . . . 74.450000000000003 112.483 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.06 153.82 30.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.501 -0.772 . . . . 55.130000000000003 110.896 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -160.26 152.52 20.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.74 0.305 . . . . 73.109999999999999 111.502 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -115.02 178.89 4.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.068 0.461 . . . . 74.129999999999995 111.942 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 p -77.76 149.72 34.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.14 0.495 . . . . 75.329999999999998 111.255 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 70.219999999999999 111.241 -178.632 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 121.115 0.483 . . . . 70.439999999999998 110.69 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.75 149.74 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.063 -0.517 . . . . 71.129999999999995 110.581 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 p -134.96 145.54 48.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.833 0.349 . . . . 73.219999999999999 111.903 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.13 96.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.978 0.418 . . . . 75.420000000000002 110.554 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.57 -53.2 59.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 64.409999999999997 111.563 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -157.97 146.59 19.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.054 0.454 . . . . 61.200000000000003 111.566 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 HG12 ' A' ' 27' ' ' ILE . 30.7 mt -114.58 122.32 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.465 -0.569 . . . . 62.299999999999997 109.465 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.59 133.32 36.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.022 0.749 . . . . 70.549999999999997 113.022 -171.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.61 -21.76 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.655 -0.702 . . . . 73.420000000000002 112.453 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.69 -24.08 23.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 110.939 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.73 26.22 9.27 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.272 -0.422 . . . . 65.209999999999994 113.508 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 8.5 mtpm? -95.02 -28.08 15.3 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.088 0.773 . . . . 72.200000000000003 113.088 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.58 174.45 11.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.93 0.715 . . . . 75.450000000000003 112.93 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.627 HG12 HG23 ' A' ' 20' ' ' ILE . 52.3 mt -127.81 149.65 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.461 -0.79 . . . . 61.140000000000001 109.357 173.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -130.76 116.3 17.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.332 0.587 . . . . 63.420000000000002 112.071 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -109.1 154.24 22.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.795 -0.639 . . . . 74.450000000000003 110.288 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -124.2 124.28 42.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 65.530000000000001 111.523 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -74.83 97.29 3.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.7 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -79.6 -2.15 41.21 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.912 0.387 . . . . 61.310000000000002 111.391 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -75.37 118.08 17.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.43 -0.35 . . . . 55.43 110.536 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.79 61.24 5.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 71.299999999999997 111.227 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -170.11 159.26 7.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.968 -0.56 . . . . 71.519999999999996 110.463 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.38 101.4 0.95 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.759 0.314 . . . . 62.210000000000001 110.655 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.8 mm100 -105.07 123.74 38.83 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 112.402 0.519 . . . . 63.130000000000003 112.402 -174.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 13.3 Cg_exo -71.28 135.29 26.58 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.589 2.193 . . . . 75.329999999999998 111.91 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 3.2 tpt -65.45 -19.04 65.77 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.958 0.408 . . . . 45.109999999999999 111.943 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -109.13 2.68 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.209 -0.519 . . . . 73.209999999999994 113.312 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.82 60.07 0.2 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.264 -0.493 . . . . 45.119999999999997 112.592 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.8 m0 -79.92 -178.12 6.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.952 0.406 . . . . 64.230000000000004 111.321 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.63 119.52 11.92 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.198 0.523 . . . . 74.019999999999996 111.101 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.503 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 50.8 ttp -97.7 118.14 33.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 111.192 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' SER . 59.7 mt -103.17 132.87 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.555 -0.293 . . . . 71.140000000000001 111.177 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD2' HE22 ' A' ' 91' ' ' GLN . 51.4 ttm-85 -113.51 130.88 56.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.859 0.361 . . . . 62.140000000000001 111.909 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -120.52 133.4 55.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.874 0.368 . . . . 74.120000000000005 110.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 100' ' ' VAL . 11.9 tt -159.17 -42.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.004 0.372 . . . . 53.140000000000001 112.004 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.65 93.87 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.955 -0.64 . . . . 64.409999999999997 113.449 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.65 25.44 14.37 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.438 0.533 . . . . 74.129999999999995 112.438 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -146.92 144.51 29.29 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.201 0.524 . . . . 75.510000000000005 112.386 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -121.79 32.7 5.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.999 -0.546 . . . . 71.329999999999998 110.394 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.22 123.54 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.837 -0.62 . . . . 62.509999999999998 112.145 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.505 ' HB3' HG12 ' A' ' 45' ' ' ILE . 60.3 p -118.6 163.88 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.118 0.485 . . . . 30.329999999999998 111.98 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 62.9 t80 -137.51 111.35 8.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.956 -0.566 . . . . 63.140000000000001 111.901 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -72.33 116.8 13.2 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.033 -0.531 . . . . 75.400000000000006 111.077 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HE2' ' HB2' ' A' ' 44' ' ' MET . 55.4 m-85 -72.13 162.62 29.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.242 0.544 . . . . 71.319999999999993 112.32 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -128.7 133.96 48.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.988 -0.551 . . . . 75.109999999999999 111.574 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 14.8 t -86.46 34.62 0.64 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.431 -0.35 . . . . 62.420000000000002 111.338 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.653 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 2.5 ptm180 -59.03 -22.67 61.08 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.242 0.46 . . . . 45.119999999999997 112.242 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.653 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 44.4 p90 -143.09 149.84 38.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.021 0.439 . . . . 72.409999999999997 110.96 175.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.81 114.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.413 -0.358 . . . . 71.219999999999999 110.576 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.61 136.05 52.41 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.114 0.483 . . . . 71.409999999999997 112.273 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -72.85 160.22 32.5 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 74.319999999999993 112.157 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.59 130.36 41.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.038 -0.528 . . . . 55.350000000000001 111.981 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.05 73.81 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.082 -0.58 . . . . 62.340000000000003 113.551 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -83.52 135.55 34.6 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.97 0.414 . . . . 71.450000000000003 111.859 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -96.13 109.35 21.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.007 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.12 133.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.315 0.578 . . . . 73.200000000000003 111.651 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 55.8 m -105.33 111.64 24.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 52.439999999999998 111.441 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.33 100.28 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.086 0.47 . . . . 55.310000000000002 110.415 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 72.7 m95 -77.47 166.64 22.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.16 -0.473 . . . . 64.120000000000005 111.318 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.67 178.12 4.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.572 -0.285 . . . . 60.310000000000002 110.73 174.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.78 16.46 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.023 0.439 . . . . 50.310000000000002 112.023 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -89.34 19.7 4.26 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.866 0.321 . . . . 70.299999999999997 111.866 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -58.04 -34.5 70.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.005 0.743 . . . . 73.150000000000006 113.005 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -41.53 2.76 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.911 -0.662 . . . . 73.219999999999999 112.865 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.24 -179.6 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.244 0.545 . . . . 73.510000000000005 111.959 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.9 p -76.54 161.02 28.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.109 0.481 . . . . 55.109999999999999 111.521 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.89 2.18 9.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.808 0.67 . . . . 75.329999999999998 112.808 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -144.44 87.89 7.47 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 122.2 -0.313 . . . . 54.100000000000001 111.774 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.594 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 50.8 Cg_exo -55.8 -42.46 67.0 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 123.159 2.572 . . . . 73.319999999999993 115.582 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.594 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 41.6 Cg_endo -99.68 19.72 23.35 Favored 'Cis proline' 0 C--N 1.37 1.683 0 CA-C-N 121.509 1.575 . . . . 74.140000000000001 113.905 1.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.534 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 44.5 p -59.28 -48.73 80.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.012 0.434 . . . . 75.420000000000002 112.104 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 70' ' ' THR . 12.9 m-20 -98.58 179.27 4.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.068 -0.514 . . . . 70.209999999999994 111.833 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.94 129.11 45.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 63.229999999999997 110.974 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.2 mp -96.59 109.21 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.749 0.309 . . . . 73.200000000000003 111.162 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 7.6 t90 -74.55 86.62 2.09 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.256 0.55 . . . . 63.039999999999999 110.422 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -71.59 -20.21 62.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.419 0.526 . . . . 71.030000000000001 112.419 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 10.0 m120 -68.01 -13.57 62.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.365 0.505 . . . . 72.219999999999999 112.365 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.419 HE22 ' HD2' ' A' ' 46' ' ' ARG . 63.6 tt0 -143.29 142.88 31.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.158 0.504 . . . . 75.310000000000002 112.172 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.82 -172.65 3.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 112.003 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.1 p -60.32 127.48 32.0 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 72.310000000000002 111.013 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -102.81 2.1 35.03 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.58 0.956 . . . . 64.010000000000005 113.58 -169.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 96' ' ' THR . . . 84.06 -44.55 3.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.875 -0.679 . . . . 71.129999999999995 114.171 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 95' ' ' GLY . 2.6 m 76.73 -32.86 0.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.705 1.002 . . . . 72.439999999999998 113.705 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.15 -23.33 24.48 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.261 0.864 . . . . 62.5 115.261 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.37 17.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.055 0.761 . . . . 73.519999999999996 113.055 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 t70 59.12 73.29 0.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.502 0.668 . . . . 74.219999999999999 110.308 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 48' ' ' ILE . 6.1 p -81.2 120.62 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.557 -175.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.97 122.18 38.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.113 0.482 . . . . 74.230000000000004 111.768 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.12 131.73 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.891 -0.595 . . . . 72.530000000000001 111.304 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.9 mm -111.99 120.39 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.368 -0.378 . . . . 75.319999999999993 111.395 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -102.95 109.76 21.42 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.382 -0.199 . . . . 71.420000000000002 111.412 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.64 141.16 52.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.375 0.607 . . . . 74.239999999999995 112.162 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -77.27 172.93 12.51 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.653 -0.703 . . . . 70.349999999999994 111.237 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.4 m -57.75 -21.76 43.01 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 111.985 0.365 . . . . 54.119999999999997 111.985 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.72 -7.54 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.574 0.583 . . . . 70.219999999999999 112.574 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 -17.22 57.81 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.957 -0.639 . . . . 52.109999999999999 113.334 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.78 164.15 22.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 60.030000000000001 111.306 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -104.35 142.29 34.83 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.086 0.772 . . . . 75.310000000000002 113.086 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.74 -51.91 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.708 -0.678 . . . . 75.120000000000005 110.14 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -172.6 163.92 5.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.498 -0.773 . . . . 32.119999999999997 111.137 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.1 145.2 31.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.857 0.36 . . . . 70.340000000000003 110.922 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -150.97 143.57 24.37 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.783 0.325 . . . . 72.420000000000002 111.811 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.6 p -108.0 178.66 4.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.501 -0.318 . . . . 73.430000000000007 110.935 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.53 HG22 ' HB ' ' A' ' 20' ' ' ILE . 30.0 p -99.86 120.87 40.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.344 0.868 . . . . 75.409999999999997 113.344 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.684 -0.487 . . . . 63.130000000000003 109.684 171.278 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.159 0.429 . . . . 75.200000000000003 112.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -90.28 94.87 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.166 0.508 . . . . 71.439999999999998 110.384 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.62 153.09 18.01 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.908 0.385 . . . . 71.340000000000003 112.032 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.437 HG22 ' HD2' ' A' ' 115' ' ' ARG . 59.2 mt -65.22 125.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.496 -0.32 . . . . 53.039999999999999 110.854 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.07 -52.62 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.186 0.517 . . . . 71.340000000000003 111.046 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.1 158.34 36.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.319999999999993 111.309 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 27' ' ' ILE . 59.7 mt -126.66 143.92 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.752 -0.462 . . . . 71.340000000000003 109.752 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.74 137.73 56.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.912 0.387 . . . . 70.409999999999997 111.345 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.3 p -65.19 -36.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.258 0.466 . . . . 75.239999999999995 112.258 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -81.54 -70.37 0.54 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.016 0.436 . . . . 75.030000000000001 110.461 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.42 38.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.385 -0.912 . . . . 74.400000000000006 114.784 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -89.09 -50.52 6.11 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.48 0.64 . . . . 65.140000000000001 112.457 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.0 162.86 35.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.515 0.932 . . . . 60.520000000000003 113.515 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 20' ' ' ILE . 65.7 mt -119.93 137.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.511 -0.768 . . . . 72.209999999999994 109.88 173.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.88 116.61 28.28 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.249 0.547 . . . . 71.349999999999994 112.269 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -106.28 149.56 26.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.155 -0.475 . . . . 44.119999999999997 110.705 177.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB2' HG22 ' A' ' 68' ' ' THR . 82.9 tttt -123.88 131.8 53.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.905 0.383 . . . . 72.510000000000005 111.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB2' HD23 ' A' ' 63' ' ' LEU . 28.3 t30 -85.94 112.0 20.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.725 0.298 . . . . 72.019999999999996 110.564 172.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -98.63 14.54 28.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.834 0.35 . . . . 65.319999999999993 111.848 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 t -87.74 -177.57 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.012 0.434 . . . . 61.43 111.369 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.1 -19.9 16.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.153 0.501 . . . . 71.239999999999995 111.632 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.56 155.95 17.78 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.187 -0.46 . . . . 61.229999999999997 112.11 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 5.0 m-20 -64.66 91.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.164 -0.471 . . . . 62.049999999999997 110.165 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -76.56 116.77 59.42 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 112.82 0.674 . . . . 73.450000000000003 112.82 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.83 144.09 63.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.171 1.914 . . . . 73.099999999999994 112.143 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.801 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -51.78 -26.79 10.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.005 0.431 . . . . 62.109999999999999 111.671 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.1 -100.35 0.45 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 114.448 0.539 . . . . 73.319999999999993 114.448 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 57' ' ' TYR . . . 172.27 55.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.549 0 N-CA-C 112.098 -0.401 . . . . 64.239999999999995 112.098 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -89.43 152.93 21.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.147 0.499 . . . . 74.319999999999993 112.102 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -97.39 118.75 34.55 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.909 -0.587 . . . . 73.140000000000001 111.372 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.585 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 55.8 ttp -98.99 104.75 16.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.188 -0.46 . . . . 63.130000000000003 110.794 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.8 mt -90.96 116.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.327 -0.397 . . . . 74.219999999999999 111.095 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.583 ' HE ' HG21 ' A' ' 100' ' ' VAL . 59.0 ttt180 -116.98 137.3 52.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.694 0.283 . . . . 73.319999999999993 111.513 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 50' ' ' ASP . 85.1 tttt -133.53 116.98 16.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.138 0.494 . . . . 73.140000000000001 110.811 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -113.09 119.56 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.108 -0.496 . . . . 71.120000000000005 110.937 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.22 -78.78 0.22 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 111.893 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 34.3 t70 -149.75 -15.33 0.27 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 111.801 0.297 . . . . 60.210000000000001 111.801 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -80.33 143.63 33.43 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.983 -0.448 . . . . 74.120000000000005 111.044 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.2 p -123.98 149.49 45.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.514 0.673 . . . . 72.319999999999993 112.68 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.75 145.23 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.49 -0.777 . . . . 64.120000000000005 110.33 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.3 p -128.08 127.68 43.55 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.734 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -119.94 137.2 54.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.397 -0.365 . . . . 74.040000000000006 111.311 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -99.97 131.4 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.029 0.442 . . . . 40.020000000000003 111.668 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 60.6 m-85 -86.05 94.82 9.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.368 -0.378 . . . . 72.010000000000005 111.771 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -71.92 137.8 47.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.157 0.503 . . . . 74.420000000000002 112.247 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.801 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 79.5 p -72.25 91.22 1.29 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.304 0.483 . . . . 72.510000000000005 112.304 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.484 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 14.4 ptm180 -109.08 -16.82 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.692 0.282 . . . . 71.129999999999995 111.666 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.484 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 46.9 p90 -158.15 -177.71 6.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.642 0.258 . . . . 54.210000000000001 111.051 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.13 159.35 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.399 0.619 . . . . 72.430000000000007 112.102 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 31' ' ' ASN . 24.0 tp -124.19 113.87 18.89 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.08 -0.509 . . . . 73.230000000000004 110.047 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 39.0 tttp -75.29 169.15 18.61 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.605 0.594 . . . . 62.310000000000002 112.605 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.71 127.46 20.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.781 0.66 . . . . 64.219999999999999 112.781 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.61 -18.2 9.28 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.173 -0.467 . . . . 32.520000000000003 114.014 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -72.41 138.51 47.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.176 0.512 . . . . 71.129999999999995 111.674 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 30' ' ' LYS . 59.9 p -105.47 132.51 51.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 112.052 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.8 140.93 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.91 0.386 . . . . 61.420000000000002 111.41 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.2 m -109.8 122.39 47.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 63.43 111.473 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 mm -105.61 102.35 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.399 -0.364 . . . . 70.239999999999995 111.255 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -82.94 125.92 31.93 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.821 0.304 . . . . 75.140000000000001 111.821 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.19 81.46 2.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.197 0.443 . . . . 65.409999999999997 112.197 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 64.83 -67.14 0.12 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.844 1.053 . . . . 71.340000000000003 113.844 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -71.39 75.58 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.113 0.412 . . . . 64.230000000000004 112.113 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.84 -48.82 3.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 72.019999999999996 111.697 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.48 -35.69 3.3 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.444 -0.407 . . . . 72.510000000000005 113.19 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.75 -173.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.144 0.424 . . . . 74.299999999999997 112.144 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -52.83 121.97 8.29 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.186 -0.461 . . . . 70.310000000000002 111.836 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.69 91.05 0.29 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.617 0.969 . . . . 65.310000000000002 113.617 -173.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 87' ' ' ILE . 33.8 t 72.84 87.09 0.1 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 114.151 1.167 . . . . 61.439999999999998 114.151 168.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HB2' ' N ' ' A' ' 84' ' ' THR . 81.8 Cg_exo -50.67 -176.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.576 2.582 0 C-N-CA 123.563 2.842 . . . . 64.400000000000006 112.259 163.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 14.82 47.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.44 0 N-CA-C 122.185 3.879 . . . . 72.150000000000006 122.185 44.6 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.667 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 7.3 t 157.67 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.598 1.159 . . . . 70.129999999999995 111.628 160.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.442 ' OD1' HG23 ' A' ' 84' ' ' THR . 1.5 m-20 -105.72 158.33 16.8 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.805 0.336 . . . . 74.310000000000002 111.203 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 HD11 ' SD ' ' A' ' 39' ' ' MET . 76.5 mt -126.25 139.6 53.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.844 0.354 . . . . 72.319999999999993 111.493 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 81' ' ' SER . 1.8 mp -105.39 116.17 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.081 0.467 . . . . 75.510000000000005 111.061 176.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 7.9 t90 -74.69 105.85 5.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 110.421 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.24 -5.15 58.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.805 0.669 . . . . 62.420000000000002 112.805 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.59 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 20.1 m120 -91.35 -42.95 10.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.588 0.588 . . . . 62.439999999999998 112.588 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -120.52 143.54 48.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.82 0.343 . . . . 72.230000000000004 111.398 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -93.52 177.21 6.1 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.057 0.455 . . . . 72.420000000000002 111.395 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.7 p -60.46 113.24 2.31 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.123 0.487 . . . . 71.25 111.153 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -76.24 -32.96 59.17 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.76 0.652 . . . . 71.219999999999999 112.76 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.98 50.54 21.11 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.292 0.477 . . . . 43.32 114.292 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.7 p -97.52 -44.78 6.68 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.724 0.639 . . . . 62.140000000000001 112.724 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 80.17 -33.73 2.21 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.898 -0.668 . . . . 54.210000000000001 112.676 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.75 148.15 47.61 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.799 0.333 . . . . 74.150000000000006 111.109 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 4.6 p-10 -64.43 126.41 27.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.341 0.867 . . . . 71.430000000000007 113.341 -173.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.583 HG21 ' HE ' ' A' ' 46' ' ' ARG . 7.7 p -124.92 141.71 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.794 -0.639 . . . . 73.200000000000003 110.938 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -109.55 134.88 51.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.919 0.39 . . . . 74.219999999999999 111.726 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 144.86 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.15 0.5 . . . . 45.109999999999999 111.768 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.76 141.46 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 116.186 -0.461 . . . . 74.010000000000005 111.347 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 76.5 mt -114.05 120.46 40.64 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.928 0.394 . . . . 74.310000000000002 111.568 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 95.5 mttt -123.05 146.74 47.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.462 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.606 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 16.8 m120 -76.53 153.33 35.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.036 -0.357 . . . . 61.25 110.036 169.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.8 t -67.94 8.37 0.41 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.277 0.843 . . . . 62.109999999999999 113.277 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.14 3.91 52.9 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.101 -0.374 . . . . 74.209999999999994 111.247 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 36.72 17.27 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.06 -0.591 . . . . 44.539999999999999 112.846 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.1 pt-20 -125.39 126.78 45.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.032 0.444 . . . . 75.25 111.501 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 33.8 tt0 -91.47 129.39 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.891 -0.595 . . . . 73.219999999999999 111.433 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.44 -64.16 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.285 0.476 . . . . 73.219999999999999 112.285 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . . . -101.74 145.4 29.19 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.451 0.537 . . . . 71.510000000000005 112.451 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -145.65 139.96 26.98 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.263 -0.426 . . . . 53.420000000000002 110.981 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 17' ' ' ILE . 47.7 ttm-85 -166.13 136.81 3.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.249 0.547 . . . . 72.319999999999993 112.282 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.7 p -111.32 154.54 24.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.066 -0.516 . . . . 74.140000000000001 110.756 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 20' ' ' ILE . 66.5 p -62.45 107.07 0.85 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.025 0.441 . . . . 72.340000000000003 111.648 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.423 0.63 . . . . 63.530000000000001 111.71 178.924 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.145 0.497 . . . . 54.140000000000001 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.74 128.64 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.425 . . . . 43.409999999999997 111.176 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 p -133.71 155.34 49.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.791 0.329 . . . . 44.009999999999998 111.445 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.799 HG13 HD11 ' A' ' 104' ' ' LEU . 73.7 mt -62.68 120.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 112.276 0.473 . . . . 72.439999999999998 112.276 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 40.6 tt0 -68.38 -55.51 11.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 109.981 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 23.6 tt0 178.52 160.46 0.6 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.665 -0.698 . . . . 75.219999999999999 110.502 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.483 HG23 HG12 ' A' ' 27' ' ' ILE . 57.6 mt -95.39 153.6 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.439 -0.346 . . . . 60.409999999999997 111.412 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.64 147.71 36.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.124 0.487 . . . . 63.329999999999998 111.587 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.35 -28.01 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.113 -0.494 . . . . 63.450000000000003 111.993 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.77 -34.54 13.16 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.886 0.374 . . . . 64.0 110.876 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.01 10.86 8.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.192 -0.458 . . . . 71.030000000000001 113.426 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.36 -27.74 64.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.223 0.823 . . . . 71.310000000000002 113.223 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -158.94 159.65 35.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.972 0.73 . . . . 73.219999999999999 112.972 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.483 HG12 HG23 ' A' ' 20' ' ' ILE . 63.8 mt -125.24 117.19 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.695 -0.684 . . . . 63.420000000000002 110.722 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 17.1 ttm180 -98.55 132.85 43.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 73.040000000000006 112.267 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 6.6 mp -109.65 134.68 51.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.355 -0.384 . . . . 62.119999999999997 111.304 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 68' ' ' THR . 24.3 ttmm -103.37 136.08 43.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.882 0.372 . . . . 72.409999999999997 111.494 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.95 107.43 15.55 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.424 -0.353 . . . . 74.140000000000001 110.833 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.6 p -95.9 17.14 15.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.161 0.505 . . . . 71.349999999999994 111.808 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -70.29 159.32 34.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.1 0.476 . . . . 70.200000000000003 111.869 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.23 -26.35 58.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.222 -0.444 . . . . 52.43 111.717 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 44.6 tt0 -138.9 166.74 23.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.761 0.315 . . . . 72.040000000000006 110.936 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 6.1 m-20 -68.14 117.04 9.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.532 -0.304 . . . . 73.209999999999994 111.224 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -133.68 144.16 50.78 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 111.61 0.226 . . . . 72.400000000000006 111.61 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 36.4 Cg_exo -60.95 147.5 95.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.677 2.251 . . . . 75.140000000000001 112.615 174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.1 tpt -54.82 -50.59 68.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.072 0.463 . . . . 44.310000000000002 112.174 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.17 -122.1 5.83 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.02 -0.609 . . . . 65.319999999999993 113.293 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 108.87 1.14 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.377 -0.439 . . . . 65.420000000000002 113.142 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -135.08 164.87 26.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.641 0.376 . . . . 75.409999999999997 110.515 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -150.25 117.02 5.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.125 0.488 . . . . 74.120000000000005 111.374 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.459 ' HE1' HD11 ' A' ' 29' ' ' LEU . 38.1 ttm -91.81 117.4 29.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.245 -0.434 . . . . 73.319999999999993 111.721 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.59 102.65 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.859 0.361 . . . . 73.140000000000001 110.549 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -90.37 120.41 31.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.747 0.308 . . . . 64.010000000000005 111.414 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.27 113.86 27.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.409 -0.359 . . . . 53.130000000000003 111.035 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.54 137.98 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.572 -0.285 . . . . 74.430000000000007 110.86 -176.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' N ' HD13 ' A' ' 48' ' ' ILE . . . 55.35 36.46 63.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.191 -0.528 . . . . 62.409999999999997 113.438 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.18 -4.29 1.59 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.829 0.852 . . . . 74.349999999999994 113.028 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -103.68 173.45 6.3 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.685 -0.634 . . . . 71.230000000000004 111.057 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -139.34 150.46 45.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.34 0.59 . . . . 60.310000000000002 112.105 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.58 130.36 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.636 -0.711 . . . . 74.299999999999997 110.354 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' MET . 94.0 p -105.43 148.72 26.84 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.328 0.585 . . . . 70.439999999999998 112.183 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -128.73 112.08 13.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.945 -0.57 . . . . 75.310000000000002 110.476 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.26 125.75 33.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.99 0.424 . . . . 75.329999999999998 111.651 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.441 ' HE2' HD11 ' A' ' 71' ' ' ILE . 54.0 m-85 -85.9 168.9 13.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.509 0.671 . . . . 60.009999999999998 112.391 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -140.05 157.99 44.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.678 -0.692 . . . . 72.010000000000005 111.797 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.7 p -87.62 23.23 2.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.205 -0.452 . . . . 63.119999999999997 111.923 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -69.53 -2.18 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.624 0.602 . . . . 73.120000000000005 112.624 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -151.29 156.94 41.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.172 0.51 . . . . 72.329999999999998 111.7 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 83.2 t -103.6 124.77 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.16 -0.473 . . . . 65.340000000000003 111.659 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.8 mm? -84.12 109.85 18.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.008 0.432 . . . . 53.229999999999997 111.328 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.75 144.5 32.11 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.372 -0.376 . . . . 64.420000000000002 111.145 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.22 119.53 4.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.909 0.385 . . . . 74.129999999999995 111.798 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.16 -41.49 2.5 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.184 -0.532 . . . . 64.239999999999995 113.218 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -65.54 140.25 58.54 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.314 -0.521 . . . . 51.5 111.187 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 30' ' ' LYS . 70.1 p -111.49 153.72 25.78 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.726 0.639 . . . . 71.040000000000006 112.726 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -114.57 123.24 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.968 -0.56 . . . . 75.400000000000006 110.566 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m -94.13 124.61 38.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.186 0.517 . . . . 72.420000000000002 111.516 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.441 HD11 ' HE2' ' A' ' 57' ' ' TYR . 41.6 mm -86.21 99.67 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 75.420000000000002 110.048 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -84.38 -178.45 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 43.420000000000002 110.971 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.37 170.48 7.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.715 -0.221 . . . . 55.329999999999998 110.95 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.19 32.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.194 0.442 . . . . 73.519999999999996 112.194 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.07 32.48 2.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.455 -0.339 . . . . 62.219999999999999 111.563 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.16 -48.55 44.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.913 0.708 . . . . 74.310000000000002 112.913 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.17 -33.66 6.23 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.13 -0.557 . . . . 64.400000000000006 112.277 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.33 -171.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 122.555 0.342 . . . . 72.140000000000001 110.843 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.3 p -69.97 147.33 50.29 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.98 -0.45 . . . . 65.120000000000005 111.369 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.91 2.65 3.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.642 0.608 . . . . 53.030000000000001 112.642 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -169.68 86.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.073 0.549 . . . . 73.409999999999997 110.345 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HB2' ' N ' ' A' ' 84' ' ' THR . 53.5 Cg_exo -53.0 -46.95 30.3 Favored 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.262 2.641 . . . . 74.530000000000001 115.972 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.7 Cg_endo -101.73 21.86 17.36 Favored 'Cis proline' 0 C--N 1.363 1.322 0 CA-C-N 121.307 1.503 . . . . 72.109999999999999 114.664 2.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.552 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 10.2 t -55.74 -41.44 73.91 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.443 0.535 . . . . 62.219999999999999 112.443 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -97.37 164.35 12.5 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.117 0.484 . . . . 72.540000000000006 111.29 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.04 126.24 51.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.071 0.462 . . . . 72.230000000000004 111.378 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.0 mp -91.84 127.38 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 64.510000000000005 110.938 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -69.6 79.35 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.175 0.512 . . . . 70.439999999999998 110.183 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -58.29 -22.19 51.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.856 0.687 . . . . 73.140000000000001 112.856 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.6 -23.7 58.77 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.706 0.632 . . . . 61.149999999999999 112.706 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -146.2 150.06 35.11 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.129 0.788 . . . . 74.310000000000002 113.129 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -75.3 -172.22 1.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.628 -0.715 . . . . 71.120000000000005 110.616 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -74.98 142.3 43.9 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.864 -0.523 . . . . 61.399999999999999 111.214 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -120.47 101.32 7.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.64 0.733 . . . . 74.140000000000001 111.821 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.22 135.74 12.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.163 -0.472 . . . . 75.219999999999999 112.059 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -170.95 -42.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.863 0.69 . . . . 73.439999999999998 112.863 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.51 -15.72 62.68 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.007 -0.616 . . . . 64.230000000000004 113.024 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -56.89 131.94 51.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.74 0.305 . . . . 71.150000000000006 111.236 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.7 m-20 -60.95 114.5 3.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.295 0.569 . . . . 62.340000000000003 112.033 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 48' ' ' ILE . 3.8 p -106.05 136.81 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.727 -0.67 . . . . 72.120000000000005 111.41 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -115.85 132.44 56.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.232 0.539 . . . . 74.319999999999993 110.524 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.413 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 3.3 p -127.3 141.49 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.309 0.576 . . . . 35.32 112.446 -172.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.1 mm -107.47 140.67 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 60.130000000000003 111.618 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.799 HD11 HG13 ' A' ' 17' ' ' ILE . 76.1 mt -110.26 114.89 28.72 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.756 0.312 . . . . 70.040000000000006 111.694 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -106.16 140.29 39.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.956 0.408 . . . . 73.519999999999996 111.421 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 112' ' ' VAL . 10.6 m120 -87.16 -171.2 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.271 -0.422 . . . . 70.299999999999997 111.086 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.9 t -57.91 -36.75 72.9 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.185 0.439 . . . . 52.509999999999998 112.185 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -81.72 3.02 27.16 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.116 0.413 . . . . 51.130000000000003 112.116 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.61 -1.26 78.46 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.174 -0.536 . . . . 64.099999999999994 113.039 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.49 151.25 47.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.884 0.474 . . . . 70.109999999999999 111.223 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -101.79 119.27 38.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.881 0.372 . . . . 73.409999999999997 111.662 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 106' ' ' ASN . 18.8 m -106.41 -18.71 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.347 0.499 . . . . 52.149999999999999 112.347 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -155.04 142.75 19.85 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.575 0.583 . . . . 73.109999999999999 112.575 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.62 122.03 11.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.466 -0.788 . . . . 65.120000000000005 109.842 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -144.5 156.74 44.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.979 0.419 . . . . 73.019999999999996 112.076 -171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.7 p -133.28 175.36 9.47 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.962 0.411 . . . . 52.030000000000001 111.607 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 45.8 p -79.17 -176.38 5.1 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.991 0.424 . . . . 65.319999999999993 111.391 173.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 120.888 0.375 . . . . 63.299999999999997 111.015 177.624 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 121.13 0.49 . . . . 74.409999999999997 110.515 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.2 145.22 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.996 -0.547 . . . . 53.350000000000001 111.087 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.3 p -132.76 154.66 50.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.989 0.423 . . . . 74.510000000000005 111.634 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.63 111.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.321 -0.399 . . . . 55.25 110.796 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.83 -56.33 4.35 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.439999999999998 111.835 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.58 123.77 6.38 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.231 0.538 . . . . 74.239999999999995 112.39 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.62 HG23 HG12 ' A' ' 27' ' ' ILE . 72.2 mt -89.16 140.33 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.878 -0.601 . . . . 71.129999999999995 110.624 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.5 143.07 40.67 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.104 0.478 . . . . 73.109999999999999 111.472 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -85.82 -25.86 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.562 0.578 . . . . 73.109999999999999 112.562 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.83 -21.13 41.06 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.182 0.515 . . . . 71.0 111.009 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 103.45 20.21 11.3 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.796 -0.638 . . . . 55.009999999999998 113.256 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -79.72 -48.58 13.41 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.396 0.517 . . . . 74.319999999999993 112.396 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -160.81 173.25 15.65 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.489 0.922 . . . . 63.43 113.489 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 20' ' ' ILE . 57.0 mt -133.85 121.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.469 -0.787 . . . . 64.5 109.794 170.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -101.4 123.58 45.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.744 -0.597 . . . . 63.350000000000001 112.19 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -110.72 172.45 6.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.021 -0.536 . . . . 63.229999999999997 110.941 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 68' ' ' THR . 7.1 ttpm? -150.61 138.14 19.68 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.007 0.432 . . . . 72.25 111.998 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -78.73 114.52 17.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.144 -0.48 . . . . 51.210000000000001 110.919 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -102.76 12.81 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.919 0.39 . . . . 74.140000000000001 111.876 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 t -77.57 164.55 25.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.06 0.457 . . . . 53.509999999999998 111.426 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -85.91 5.98 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.2 0.444 . . . . 74.530000000000001 112.2 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 60.3 tt0 -146.43 159.9 42.79 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.686 0.279 . . . . 73.349999999999994 111.354 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 32.1 m-20 -63.85 115.29 4.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.817 0.341 . . . . 71.219999999999999 110.409 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 10.9 mm100 -105.71 146.19 32.34 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.333 0.494 . . . . 73.510000000000005 112.333 -172.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 9.2 Cg_exo -72.8 103.22 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.644 2.23 . . . . 54.200000000000003 112.486 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.608 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 tpt -59.88 -28.46 67.57 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 71.329999999999998 111.501 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.802 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.18 5.04 15.58 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 114.539 0.576 . . . . 73.120000000000005 114.539 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.29 8.78 69.62 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.92 -0.657 . . . . 42.130000000000003 113.127 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 23.6 m95 -119.03 170.89 8.66 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.599 0.592 . . . . 74.530000000000001 112.599 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -152.42 130.38 11.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 72.510000000000005 110.845 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 47.7 ttp -96.82 116.62 29.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 73.150000000000006 111.418 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 60.0 mt -105.4 113.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.809 0.338 . . . . 71.329999999999998 111.011 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HE ' ' HZ3' ' A' ' 88' ' ' TRP . 54.2 ttm-85 -98.88 118.15 34.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.246 0.461 . . . . 70.510000000000005 112.246 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -95.39 106.17 18.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.973 -0.38 . . . . 63.350000000000001 109.973 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG23 ' A' ' 100' ' ' VAL . 10.6 tt -116.62 107.23 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.531 0.681 . . . . 71.239999999999995 112.699 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.6 -93.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.658 -0.701 . . . . 53.039999999999999 114.079 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -107.54 -17.42 14.11 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.287 0.477 . . . . 61.340000000000003 112.287 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.8 t -128.21 -172.67 2.75 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.044 0.45 . . . . 73.209999999999994 112.093 -175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 p -154.15 146.6 24.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.115 0.483 . . . . 74.239999999999995 111.693 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.438 HG13 ' HH2' ' A' ' 88' ' ' TRP . 7.7 p -153.52 145.29 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.06 -0.518 . . . . 64.450000000000003 110.404 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.6 p -120.74 168.36 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.296 0.85 . . . . 50.43 113.296 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 29.7 t80 -139.91 110.81 6.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.246 -0.888 . . . . 74.239999999999995 110.944 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -79.75 124.27 28.45 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.683 0.278 . . . . 64.540000000000006 110.327 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -68.53 105.83 2.36 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.967 0.413 . . . . 73.420000000000002 111.619 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t -71.36 121.98 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.231 0.538 . . . . 62.420000000000002 111.226 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.802 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 32.9 t -83.1 82.49 8.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.132 0.491 . . . . 74.519999999999996 112.247 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.769 ' HD2' ' HG2' ' A' ' 82' ' ' PRO . 11.6 ptp180 -104.6 4.19 32.53 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.829 0.347 . . . . 72.420000000000002 111.233 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HE1' HD21 ' A' ' 86' ' ' LEU . 29.8 p90 -163.4 167.33 21.79 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 74.530000000000001 110.695 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.55 150.14 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.947 0.404 . . . . 74.209999999999994 111.804 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.608 HD22 ' SD ' ' A' ' 39' ' ' MET . 39.3 tp -101.96 102.14 12.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.165 0.507 . . . . 71.150000000000006 110.604 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -62.53 162.62 10.09 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.843 0.682 . . . . 75.450000000000003 112.843 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.58 122.02 15.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.112 -0.494 . . . . 62.340000000000003 111.444 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.92 20.42 76.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.211 -0.518 . . . . 74.010000000000005 113.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.441 HE21 ' N ' ' A' ' 68' ' ' THR . 31.1 tp60 -96.45 132.94 41.49 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.94 0.4 . . . . 75.109999999999999 111.99 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 30' ' ' LYS . 74.4 p -93.63 145.86 24.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.229 -0.441 . . . . 74.510000000000005 111.771 175.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.09 146.14 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.67 0.388 . . . . 62.299999999999997 111.29 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.88 129.8 53.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.958 0.355 . . . . 62.420000000000002 111.958 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.91 103.69 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.649 0.261 . . . . 75.239999999999995 110.944 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.5 m95 -83.45 166.69 18.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.579 -0.282 . . . . 64.129999999999995 111.432 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.05 94.31 4.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.815 0.672 . . . . 70.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 47.47 -82.57 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.232 1.197 . . . . 74.209999999999994 114.232 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -77.46 36.24 0.19 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.544 0.572 . . . . 73.150000000000006 112.544 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.08 -11.77 59.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.771 0.319 . . . . 73.239999999999995 111.552 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.24 -42.4 2.56 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.331 -0.462 . . . . 54.520000000000003 113.52 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.2 m -55.42 158.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.765 0.654 . . . . 50.210000000000001 112.765 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.8 p -68.21 136.45 53.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.083 -0.508 . . . . 63.539999999999999 111.597 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -83.0 39.01 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.144 0.424 . . . . 74.420000000000002 112.144 -176.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.2 m -130.24 102.95 16.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 112.563 0.579 . . . . 72.099999999999994 112.563 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 28.4 Cg_exo -44.5 -164.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.397 0 C-N-CA 124.532 3.488 . . . . 70.230000000000004 114.238 168.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 2.4 Cg_endo -84.51 1.42 61.15 Favored 'Cis proline' 0 C--N 1.371 1.714 0 CA-C-N 120.982 1.386 . . . . 64.349999999999994 114.153 11.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.0 p -67.15 -71.63 0.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.487 0.551 . . . . 54.240000000000002 112.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 5.4 m-20 -121.51 169.38 10.72 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.097 0.475 . . . . 75.129999999999995 112.216 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.451 HD21 ' HE1' ' A' ' 61' ' ' TYR . 81.8 mt -115.82 134.69 54.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.211 -0.45 . . . . 74.099999999999994 111.375 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 80' ' ' ALA . 2.5 mp -109.14 114.32 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.949 0.404 . . . . 72.209999999999994 111.245 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.593 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 15.9 t90 -84.52 110.33 18.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.981 0.42 . . . . 72.140000000000001 110.766 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -84.3 -11.48 56.32 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.645 0.98 . . . . 72.140000000000001 113.645 -171.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.97 -54.52 9.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.313 0.486 . . . . 73.299999999999997 112.313 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.429 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 64.7 tt0 -85.95 123.78 31.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.815 0.341 . . . . 62.200000000000003 111.735 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 19.1 m120 -83.17 52.98 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.852 0.316 . . . . 53.149999999999999 111.852 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.2 t 66.6 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.323 0.582 . . . . 45.100000000000001 112.2 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.547 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 42.3 p90 -106.23 171.78 7.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.484 -0.326 . . . . 72.230000000000004 111.117 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.01 105.72 0.28 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.555 -0.831 . . . . 42.039999999999999 113.234 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 t -151.68 -50.17 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.329 0.492 . . . . 72.239999999999995 112.329 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.55 -29.34 2.38 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.167 -0.54 . . . . 61.439999999999998 112.426 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -71.16 144.87 50.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.628 0.251 . . . . 71.109999999999999 111.037 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 23.1 m-20 -75.72 104.3 6.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.693 0.627 . . . . 74.430000000000007 112.693 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 48' ' ' ILE . 4.3 p -81.53 127.11 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.744 -0.662 . . . . 74.340000000000003 110.896 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 36.8 ttpt -97.79 115.84 28.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.331 0.586 . . . . 73.530000000000001 111.905 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 135.36 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.904 -0.589 . . . . 75.439999999999998 111.462 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 114' ' ' GLN . 27.6 mm -116.52 141.91 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 116.111 -0.495 . . . . 74.109999999999999 111.488 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.6 mt -115.35 118.22 32.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.953 0.406 . . . . 63.439999999999998 111.79 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 111' ' ' GLU . 57.9 mttp -125.32 160.22 29.83 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.313 -0.403 . . . . 73.049999999999997 110.951 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 17.1 m120 -99.18 -178.65 3.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 73.450000000000003 111.826 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -50.63 -43.36 56.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.16 0.8 . . . . 74.120000000000005 113.16 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.47 1.48 13.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.411 0.522 . . . . 73.420000000000002 112.411 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.44 84.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.235 -0.507 . . . . 52.5 113.094 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 7.3 pt-20 -78.76 137.94 37.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.922 0.391 . . . . 64.239999999999995 111.059 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 38.8 tt0 -102.0 137.12 40.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.853 0.316 . . . . 73.310000000000002 111.853 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 113' ' ' ALA . 27.1 m -127.89 -47.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 113.008 0.744 . . . . 71.310000000000002 113.008 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -132.19 156.19 46.88 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.169 0.433 . . . . 73.340000000000003 112.169 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 103' ' ' ILE . 14.1 pt20 -175.4 150.18 1.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.331 -0.395 . . . . 64.310000000000002 111.408 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 116' ' ' SER . 35.7 ttp180 -173.52 159.32 3.61 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.897 0.379 . . . . 55.020000000000003 111.52 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.3 p -86.71 -169.35 2.59 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.135 0.493 . . . . 62.420000000000002 111.029 172.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 31.7 p -87.85 -167.91 2.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.976 0.417 . . . . 60.210000000000001 111.51 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.064 0.459 . . . . 74.310000000000002 111.377 -179.524 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 32' ' ' THR . 17.2 m-80 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.657 0.614 . . . . 73.120000000000005 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.88 130.76 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 75.549999999999997 112.031 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -129.15 177.37 7.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.132 -0.485 . . . . 33.32 110.637 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.88 127.55 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 122.007 -0.433 . . . . 61.43 110.721 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.71 -51.45 3.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.37 0.508 . . . . 61.520000000000003 112.37 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -147.86 138.1 22.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.075 0.464 . . . . 71.209999999999994 112.062 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 27' ' ' ILE . 53.3 mt -132.9 139.93 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.256 -0.429 . . . . 70.099999999999994 111.054 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -85.59 126.22 33.72 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.03 0.443 . . . . 63.329999999999998 110.925 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.36 -26.4 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.241 0.46 . . . . 73.420000000000002 112.241 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.12 -37.1 80.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.872 0.368 . . . . 70.239999999999995 111.688 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 119.58 57.86 0.25 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.262 -0.494 . . . . 71.25 113.472 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -129.81 -57.49 1.11 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.49 0.552 . . . . 74.349999999999994 112.49 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.76 161.8 38.35 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.477 0.917 . . . . 75.120000000000005 113.477 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 20' ' ' ILE . 63.6 mt -128.49 160.92 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 114.873 -1.058 . . . . 72.140000000000001 108.634 173.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 28' ' ' ARG . 38.2 ttp-105 -147.2 122.1 10.0 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.251 -0.906 . . . . 70.450000000000003 112.554 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -97.08 172.68 7.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.742 -0.663 . . . . 74.420000000000002 110.507 175.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HG3' HG22 ' A' ' 68' ' ' THR . 74.4 tttt -142.59 121.06 12.43 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.834 0.349 . . . . 73.209999999999994 111.213 -175.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -82.01 86.27 6.59 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.238 0.542 . . . . 41.310000000000002 111.272 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 14' ' ' ASN . 71.8 p -83.65 87.72 7.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.227 -0.442 . . . . 62.520000000000003 110.293 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.5 t -131.46 164.19 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.108 0.781 . . . . 43.009999999999998 113.108 -168.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -81.14 -26.62 35.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.945 -1.025 . . . . 72.129999999999995 110.647 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -140.35 162.4 35.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.644 -0.707 . . . . 74.5 110.488 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -68.98 109.82 4.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.862 0.363 . . . . 65.230000000000004 110.182 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.02 138.6 19.59 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.682 0.623 . . . . 72.420000000000002 112.682 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 84.3 Cg_endo -75.94 46.51 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.87 2.38 . . . . 75.239999999999995 113.348 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' MET . 6.4 tpt 63.11 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.87 0.468 . . . . 44.520000000000003 112.179 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.48 172.55 23.92 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.491 -0.385 . . . . 74.200000000000003 113.467 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.91 78.88 1.64 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.984 -0.627 . . . . 61.219999999999999 113.386 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -99.38 142.45 30.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.661 -0.317 . . . . 73.25 111.597 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -115.57 115.14 25.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.345 . . . . 73.219999999999999 110.478 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.47 ' HE1' HG21 ' A' ' 71' ' ' ILE . 44.9 ttp -99.44 105.91 17.9 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.89 0.33 . . . . 74.310000000000002 111.89 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.655 HG13 ' HB3' ' A' ' 54' ' ' SER . 3.5 mp -91.08 118.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.56 -0.291 . . . . 63.340000000000003 111.313 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' A' ' 88' ' ' TRP . 55.0 ttp180 -94.35 93.79 7.91 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.06 0.457 . . . . 70.409999999999997 111.209 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.4 84.42 5.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.484 0.659 . . . . 61.340000000000003 111.456 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 96' ' ' THR . 16.5 tt -78.8 -14.57 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.606 -0.724 . . . . 71.299999999999997 110.787 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.03 -152.84 10.2 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.583 -0.735 . . . . 62.32 111.828 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.13 82.35 5.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.381 0.61 . . . . 73.319999999999993 109.963 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -167.18 -179.3 4.5 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.501 -0.772 . . . . 64.040000000000006 110.76 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.3 p -142.13 105.93 4.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.046 0.451 . . . . 74.450000000000003 111.605 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.477 HG21 ' NE2' ' A' ' 91' ' ' GLN . 7.1 p -138.2 137.68 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.221 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' HG13 ' A' ' 45' ' ' ILE . 81.2 p -145.94 161.27 40.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.01 0.744 . . . . 75.109999999999999 113.01 -174.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -126.77 126.64 43.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.181 -0.918 . . . . 74.549999999999997 109.785 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.15 141.21 28.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.055 0.455 . . . . 75.140000000000001 111.577 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -83.81 -178.6 7.05 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.995 -0.548 . . . . 72.439999999999998 111.631 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -144.35 149.76 36.69 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.161 0.43 . . . . 41.530000000000001 112.161 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 t -91.91 16.25 11.39 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.114 -0.494 . . . . 73.209999999999994 111.762 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 12.0 ptm180 -72.8 2.18 7.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.777 0.658 . . . . 72.340000000000003 112.777 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 51.4 p90 -148.6 164.5 34.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 74.549999999999997 111.328 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 61.4 t -112.77 119.16 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.907 0.384 . . . . 72.140000000000001 111.315 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.92 116.79 29.16 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.965 0.412 . . . . 64.430000000000007 110.19 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -58.44 153.58 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.687 0.625 . . . . 74.209999999999994 112.687 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.51 133.16 46.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.415 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.43 18.35 79.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.165 -0.54 . . . . 72.109999999999999 113.074 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -112.88 147.13 37.67 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.668 -0.313 . . . . 54.119999999999997 110.778 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 30' ' ' LYS . 43.1 p -95.8 171.4 8.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.354 0.597 . . . . 71.409999999999997 112.119 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.02 122.76 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.038 -0.528 . . . . 64.129999999999995 110.656 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.5 m -94.85 124.57 38.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.493 0.553 . . . . 73.109999999999999 112.493 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.0 mm -94.88 136.38 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.83 -0.623 . . . . 54.109999999999999 110.492 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 90.4 m95 -117.24 179.36 4.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.907 0.384 . . . . 54.130000000000003 111.936 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -84.36 156.37 21.89 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.654 -0.248 . . . . 64.400000000000006 111.42 176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.67 -46.0 1.77 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.368 0.877 . . . . 70.030000000000001 113.368 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -129.28 74.39 1.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.129 0.49 . . . . 61.409999999999997 110.599 174.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.02 -3.48 54.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 52.299999999999997 112.105 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -41.68 2.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.367 -0.444 . . . . 75.409999999999997 113.086 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.05 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.034 0.445 . . . . 74.030000000000001 112.009 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.3 p -63.35 139.56 58.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 54.219999999999999 112.031 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.47 70.29 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.833 0.679 . . . . 62.229999999999997 112.833 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.1 p -139.57 98.68 7.94 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.999 0.428 . . . . 64.109999999999999 111.703 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.57 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 74.9 Cg_exo -52.79 -43.03 59.23 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.003 2.469 . . . . 72.519999999999996 115.324 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 77.4 Cg_endo -99.27 109.91 0.41 Allowed 'Cis proline' 0 C--N 1.368 1.597 0 CA-C-N 121.301 1.5 . . . . 74.099999999999994 113.738 -2.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.44 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 53.1 p -139.08 -66.0 0.48 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.258 0.623 . . . . 72.329999999999998 109.505 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 3.9 m-20 -73.11 130.82 41.14 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.836 -0.62 . . . . 74.230000000000004 109.739 167.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 71' ' ' ILE . 87.7 mt -100.26 108.38 20.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.15 0.5 . . . . 61.520000000000003 111.918 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.7 mp -77.04 131.1 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.004 0.431 . . . . 62.229999999999997 111.183 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 46' ' ' ARG . 2.0 t90 -70.91 77.06 0.64 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.437 0.636 . . . . 75.549999999999997 110.214 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 7.6 mtpm? -68.57 -2.11 8.21 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.07 0.767 . . . . 75.010000000000005 113.07 -175.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.96 -12.78 20.34 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.487 0.551 . . . . 70.120000000000005 112.487 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.477 ' NE2' HG21 ' A' ' 53' ' ' VAL . 36.1 tt0 -164.54 143.32 7.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.041 0.448 . . . . 73.150000000000006 111.363 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -75.24 -164.22 0.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.724 0.773 . . . . 72.510000000000005 112.971 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -62.37 178.38 0.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.92 -1.037 . . . . 73.219999999999999 112.797 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.57 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.1 p90 -141.8 167.76 21.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.715 -0.675 . . . . 75.140000000000001 110.443 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.15 66.35 0.02 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.552 -0.832 . . . . 54.020000000000003 113.702 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 48' ' ' ILE . 47.0 p -78.78 -65.93 0.93 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.964 0.412 . . . . 53.210000000000001 111.445 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.03 -32.22 1.69 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.169 -0.468 . . . . 74.450000000000003 113.094 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.43 -63.38 1.09 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.477 0.547 . . . . 73.340000000000003 112.477 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -177.43 158.77 1.46 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.715 0.293 . . . . 62.32 110.686 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.31 89.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.846 0.831 . . . . 70.430000000000007 110.351 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.6 tttt -91.31 126.61 36.45 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.641 -0.709 . . . . 74.129999999999995 111.783 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.6 t -118.74 136.56 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.041 0.448 . . . . 72.409999999999997 111.657 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 101' ' ' LYS . 45.7 mm -122.34 138.88 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.054 -0.521 . . . . 52.420000000000002 111.039 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 113' ' ' ALA . 78.4 mt -110.63 113.99 27.03 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.253 0.464 . . . . 74.5 112.253 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -108.16 156.18 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.097 0.475 . . . . 62.219999999999999 110.623 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 77.4 m-20 -99.21 179.07 4.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.051 0.453 . . . . 74.040000000000006 111.68 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.7 t -46.96 -40.68 14.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.42 0.896 . . . . 72.209999999999994 113.42 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.83 14.77 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.666 0.617 . . . . 70.010000000000005 112.666 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.55 -21.56 10.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.334 -0.46 . . . . 64.030000000000001 112.881 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 10.7 pt-20 -52.6 125.38 16.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.259 0.624 . . . . 62.549999999999997 111.937 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.88 136.81 35.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.796 -0.638 . . . . 74.150000000000006 111.436 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 ' H ' ' A' ' 113' ' ' ALA . 12.7 m -125.08 -60.83 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.104 0.779 . . . . 75.340000000000003 113.104 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -105.07 154.45 20.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.38 0.511 . . . . 75.049999999999997 112.38 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.73 154.96 33.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.989 -0.551 . . . . 72.329999999999998 111.287 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.9 ttm180 -166.58 123.86 1.32 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.366 0.876 . . . . 64.420000000000002 113.366 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -105.18 129.85 53.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.688 -0.856 . . . . 73.120000000000005 108.688 164.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.2 p -68.45 -94.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.903 0.705 . . . . 70.129999999999995 112.903 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.296 0.569 . . . . 65.129999999999995 111.301 -178.147 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.587 0.708 . . . . 72.430000000000007 109.896 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.27 90.93 1.46 Allowed Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.866 -0.606 . . . . 64.329999999999998 114.537 -171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -100.41 18.33 19.25 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.96 0.409 . . . . 64.319999999999993 111.252 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.11 148.5 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.268 -0.423 . . . . 72.329999999999998 110.672 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -85.75 157.82 20.18 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.944 0.402 . . . . 74.209999999999994 111.686 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -106.02 163.59 12.65 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.692 0.282 . . . . 73.340000000000003 111.428 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -166.43 116.88 0.96 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.783 0.325 . . . . 63.229999999999997 110.612 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -83.68 111.78 19.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.844 0.354 . . . . 75.299999999999997 111.823 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.3 m -156.05 146.68 21.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.255 -0.429 . . . . 45.009999999999998 110.788 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -82.21 84.63 7.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.604 0.24 . . . . 73.239999999999995 111.358 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -74.75 73.5 2.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.595 0.712 . . . . 73.430000000000007 110.734 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.482 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 8.9 t -162.73 170.98 17.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.497 -0.774 . . . . 70.030000000000001 111.285 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 168.26 41.0 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.596 -0.812 . . . . 72.329999999999998 113.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 30.5 t-20 -83.84 67.27 9.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.264 0.554 . . . . 53.32 110.085 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 9.0 p -98.73 135.28 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.854 -0.612 . . . . 74.200000000000003 111.376 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.47 145.51 51.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.202 -0.454 . . . . 64.319999999999993 110.88 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' A' ' 102' ' ' VAL . 57.2 mt -72.65 99.29 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.595 -0.275 . . . . 73.430000000000007 110.629 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -62.09 -56.97 13.53 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.068 0.461 . . . . 74.319999999999993 111.271 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -164.87 143.66 6.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 73.5 111.565 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.443 HG21 HG11 ' A' ' 100' ' ' VAL . 55.7 mt -102.11 138.89 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.938 -0.393 . . . . 63.140000000000001 109.938 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.57 135.56 56.67 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.306 0.484 . . . . 70.140000000000001 112.306 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.77 -26.0 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.616 0.598 . . . . 74.299999999999997 112.616 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 13.7 t70 -85.01 -25.33 27.76 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.279 0.561 . . . . 62.350000000000001 110.326 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.52 30.78 6.38 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.149 -0.478 . . . . 40.039999999999999 112.943 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -90.37 -45.54 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.405 0.52 . . . . 74.409999999999997 112.405 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.46 161.36 38.24 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.648 0.981 . . . . 74.109999999999999 113.648 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -117.41 123.73 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 71.129999999999995 109.923 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -103.98 109.95 21.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.423 0.63 . . . . 75.400000000000006 112.637 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 mp -89.74 156.16 18.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.482 -0.781 . . . . 75.219999999999999 110.224 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 68' ' ' THR . 81.7 tttt -143.25 110.96 5.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.146 -0.346 . . . . 61.0 111.881 -173.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 9.4 t30 -87.02 106.12 17.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.026 0.441 . . . . 64.019999999999996 111.579 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -109.36 40.84 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.396 0.617 . . . . 72.230000000000004 111.406 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 80.7 p -83.33 176.54 9.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.451 0.643 . . . . 62.299999999999997 112.591 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.68 -7.45 54.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.766 -0.652 . . . . 65.540000000000006 111.933 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -149.4 156.45 42.06 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.841 0.353 . . . . 73.299999999999997 111.316 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.1 110.71 1.92 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.97 0.414 . . . . 63.049999999999997 111.244 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.37 128.93 40.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.544 0.572 . . . . 60.240000000000002 112.544 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.38 119.3 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.415 2.076 . . . . 74.420000000000002 112.716 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.2 tpp -62.39 -53.11 59.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.007 0.432 . . . . 74.439999999999998 112.041 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.78 -82.13 0.85 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.736 -0.745 . . . . 75.230000000000004 112.973 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.97 59.48 0.11 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.732 -0.747 . . . . 52.020000000000003 113.65 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.482 ' HE1' ' HA ' ' A' ' 12' ' ' THR . 11.4 m0 -62.27 170.12 2.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.299 0.571 . . . . 74.420000000000002 112.245 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.56 114.06 15.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.182 0.515 . . . . 75.400000000000006 110.801 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -95.51 113.19 24.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.044 -0.525 . . . . 75.200000000000003 111.184 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 2.1 mp -90.44 109.82 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.749 0.309 . . . . 42.310000000000002 110.642 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.01 104.45 16.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.116 0.484 . . . . 75.230000000000004 111.559 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 100' ' ' VAL . 24.3 mtpp -92.73 166.14 12.6 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.324 -0.398 . . . . 74.329999999999998 110.283 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 49' ' ' GLY . 10.2 tt -164.51 -53.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.384 0.513 . . . . 64.140000000000001 112.384 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 48' ' ' ILE . . . -174.43 128.16 1.41 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.175 -0.536 . . . . 51.530000000000001 112.337 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.07 -69.24 0.16 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.156 0.582 . . . . 74.200000000000003 111.995 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -115.96 -174.04 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.733 0.301 . . . . 62.32 111.294 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.5 p -163.6 157.01 18.93 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.878 0.37 . . . . 70.230000000000004 111.722 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.782 HG11 ' HG3' ' A' ' 91' ' ' GLN . 7.3 p -138.38 147.17 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.402 -0.363 . . . . 54.130000000000003 111.172 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.619 ' HB3' HG13 ' A' ' 45' ' ' ILE . 89.2 p -112.86 161.75 16.6 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.088 0.471 . . . . 71.329999999999998 111.969 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.48 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 68.6 t80 -136.46 130.1 32.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.285 -0.416 . . . . 74.25 111.446 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -96.9 144.67 26.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.151 0.5 . . . . 71.340000000000003 111.509 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -93.55 179.85 5.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.166 0.507 . . . . 71.010000000000005 111.979 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -138.42 155.76 48.19 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.061 -0.518 . . . . 70.140000000000001 111.431 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 m -82.38 87.6 6.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.459 -0.337 . . . . 73.150000000000006 111.538 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 83' ' ' PRO . 8.9 ptm180 -141.75 7.49 1.88 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.322 0.49 . . . . 71.340000000000003 112.322 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -163.9 148.03 10.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.968 0.413 . . . . 62.549999999999997 111.643 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.44 131.17 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.224 -0.444 . . . . 33.009999999999998 110.86 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.3 106.54 10.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.055 0.455 . . . . 70.129999999999995 111.636 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.89 164.74 26.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.173 0.511 . . . . 63.240000000000002 111.531 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.4 113.05 3.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.851 0.358 . . . . 61.030000000000001 111.11 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.82 8.57 61.88 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.424 -0.417 . . . . 62.039999999999999 113.04 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -86.11 122.49 30.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.181 0.515 . . . . 72.439999999999998 111.866 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 30' ' ' LYS . 81.3 p -93.35 150.76 20.23 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.307 -0.406 . . . . 73.340000000000003 111.299 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 29' ' ' LEU . 7.7 p -135.87 124.39 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.283 0.563 . . . . 65.209999999999994 110.945 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 29.4 m -103.82 127.69 51.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.088 -0.505 . . . . 72.400000000000006 111.778 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mm -99.38 99.74 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.776 0.322 . . . . 73.030000000000001 111.098 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 80.1 m95 -83.58 119.77 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.502 -0.317 . . . . 62.530000000000001 111.208 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -74.65 82.23 2.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.587 0.588 . . . . 74.540000000000006 112.587 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 60.66 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.605 0.965 . . . . 74.140000000000001 113.605 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -71.39 90.18 0.95 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.194 0.521 . . . . 42.039999999999999 111.269 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -133.03 -39.94 0.94 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.658 0.614 . . . . 61.109999999999999 112.658 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.7 -29.74 6.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.193 -0.527 . . . . 51.039999999999999 112.589 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 79' ' ' THR . 43.8 t -66.67 159.34 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 122.799 0.44 . . . . 73.129999999999995 111.223 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 78' ' ' VAL . 53.8 m -52.26 129.56 28.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.853 0.359 . . . . 74.439999999999998 111.834 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.55 111.05 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.315 0.487 . . . . 71.340000000000003 112.315 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.514 ' H ' HD13 ' A' ' 87' ' ' ILE . 67.4 m 67.25 71.45 0.43 Allowed Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 113.429 0.9 . . . . 61.299999999999997 113.429 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.823 ' HB3' HG22 ' A' ' 84' ' ' THR . 86.2 Cg_exo -51.1 167.16 0.33 Allowed 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.741 2.961 . . . . 70.400000000000006 111.788 168.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD2' ' NH2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 13.41 60.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 N-CA-C 122.017 3.814 . . . . 52.43 122.017 38.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.823 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.3 t 153.68 -52.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.885 1.674 . . . . 74.349999999999994 109.985 161.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.66 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 17.9 m-20 -136.27 -161.45 1.16 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.474 0.71 . . . . 63.219999999999999 109.353 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.1 mt -142.09 144.16 33.41 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.734 -0.604 . . . . 50.0 112.077 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 81' ' ' SER . 1.8 mp -106.55 123.96 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.066 0.46 . . . . 72.030000000000001 111.029 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 73' ' ' ALA . 3.7 t90 -69.14 91.04 0.49 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 110.425 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -80.56 20.41 0.72 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.792 0.664 . . . . 72.019999999999996 112.792 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 83.5 m-20 -128.91 -0.06 5.33 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.008 -0.433 . . . . 74.209999999999994 112.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.782 ' HG3' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -161.11 127.47 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.74 0.305 . . . . 75.329999999999998 110.492 -172.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.678 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 2.8 m-20 -87.34 172.78 9.59 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.982 0.734 . . . . 64.25 112.982 -173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 t -47.27 125.78 8.46 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.103 -0.498 . . . . 64.049999999999997 111.419 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CD1' HD12 ' A' ' 48' ' ' ILE . 48.6 p90 -92.7 -30.98 15.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.531 0.567 . . . . 75.319999999999993 112.531 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 73.31 102.49 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.768 -0.73 . . . . 72.409999999999997 112.072 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.4 t -79.83 28.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.183 0.808 . . . . 60.210000000000001 113.183 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.84 -39.48 62.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.87 -0.892 . . . . 55.219999999999999 110.87 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -87.63 123.97 33.04 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.487 -0.56 . . . . 73.140000000000001 109.487 166.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -52.63 101.63 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.375 0.607 . . . . 73.439999999999998 112.536 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 20' ' ' ILE . 7.4 p -71.96 140.38 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.475 -0.784 . . . . 62.509999999999998 111.657 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -124.92 117.16 23.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.151 -0.477 . . . . 64.120000000000005 110.925 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 17' ' ' ILE . 60.4 t -99.83 123.69 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.111 0.481 . . . . 74.510000000000005 112.049 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 25.1 mm -105.29 116.89 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.037 -0.529 . . . . 70.349999999999994 110.95 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.79 107.8 19.81 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.877 0.37 . . . . 53.409999999999997 111.847 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.42 139.32 49.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 111.147 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.3 m120 -63.81 174.53 1.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.297 0.57 . . . . 72.510000000000005 112.236 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 m -56.87 -28.02 61.22 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.695 -0.684 . . . . 72.420000000000002 112.382 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.53 21.41 14.35 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.934 0.716 . . . . 73.230000000000004 112.934 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.88 5.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.949 -0.643 . . . . 43.409999999999997 114.552 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.9 pt-20 -53.9 150.47 7.65 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.067 0.433 . . . . 74.349999999999994 111.348 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.51 136.11 48.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.129 0.789 . . . . 75.129999999999995 113.129 -169.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.28 -55.23 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.131 -0.486 . . . . 63.310000000000002 111.722 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.19 170.26 21.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 74.329999999999998 112.162 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -152.83 134.54 14.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.891 -0.595 . . . . 71.400000000000006 111.149 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -144.92 150.58 37.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.796 0.331 . . . . 74.25 111.428 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.6 p -126.49 -178.84 4.5 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 111.576 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.5 p -80.01 -176.41 5.49 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.223 0.535 . . . . 32.310000000000002 111.649 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.67 134.11 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.112 -0.495 . . . . 71.299999999999997 110.954 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -64.19 91.65 0.07 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.025 0.441 . . . . 75.019999999999996 111.728 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -141.08 151.97 44.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.927 0.394 . . . . 72.129999999999995 111.167 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -69.25 170.7 9.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.236 -0.438 . . . . 62.539999999999999 111.512 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.252 1.23 0 CA-C-N 116.398 -0.364 . . . . 72.109999999999999 111.898 -178.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.57 0.224 . . . . 53.310000000000002 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.4 99.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 112.893 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -62.68 -9.35 8.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.893 0.701 . . . . 71.310000000000002 112.893 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -57.63 119.98 7.53 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.934 0.397 . . . . 64.219999999999999 110.887 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -97.44 128.51 44.28 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.511 0.56 . . . . 72.400000000000006 112.511 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -78.67 114.99 18.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.989 -0.551 . . . . 71.019999999999996 111.237 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -98.97 134.14 42.24 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.582 0.23 . . . . 70.239999999999995 111.486 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -57.52 90.68 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.293 0.568 . . . . 51.310000000000002 111.458 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.5 p -126.72 -169.68 2.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.275 -0.421 . . . . 75.25 111.672 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -96.74 123.37 40.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.429 . . . . 61.100000000000001 111.283 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.503 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 26.3 mmt -83.26 112.59 20.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.065 0.46 . . . . 72.120000000000005 110.965 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 p -90.03 10.22 24.99 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.976 0.732 . . . . 72.030000000000001 112.976 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.77 88.55 0.46 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.226 -0.511 . . . . 72.549999999999997 113.545 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -68.16 81.0 0.23 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.972 0.415 . . . . 72.540000000000006 111.466 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 29' ' ' LEU . 39.7 t -98.89 109.57 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.057 0.456 . . . . 64.439999999999998 111.888 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 52.8 t -107.63 173.18 6.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.42 -0.355 . . . . 63.140000000000001 110.663 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 62.4 mt -88.97 119.79 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.951 -0.468 . . . . 63.119999999999997 111.766 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.54 -48.43 22.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.85 0.357 . . . . 75.400000000000006 110.537 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.47 153.36 28.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.119 0.414 . . . . 71.420000000000002 112.119 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.452 HG23 HG12 ' A' ' 27' ' ' ILE . 47.0 mt -119.94 126.15 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.427 -0.351 . . . . 71.409999999999997 110.193 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.86 143.91 54.4 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.739 0.644 . . . . 64.5 112.739 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.57 -19.15 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.778 -0.646 . . . . 61.539999999999999 111.339 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.65 -39.03 92.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.096 0.474 . . . . 70.409999999999997 110.409 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.97 23.82 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.911 -0.586 . . . . 63.109999999999999 113.371 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -112.53 -63.07 1.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.391 0.885 . . . . 72.230000000000004 113.391 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.5 154.02 37.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.725 1.38 . . . . 60.229999999999997 114.725 -166.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 102' ' ' VAL . 65.6 mt -123.51 110.72 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.166 -0.924 . . . . 73.519999999999996 109.381 171.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 36.1 ttm180 -92.06 116.63 29.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.119 0.785 . . . . 75.540000000000006 113.119 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 7.7 mp -96.59 179.94 4.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.011 -0.541 . . . . 74.230000000000004 111.163 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -165.1 123.14 1.63 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.647 0.26 . . . . 75.209999999999994 111.423 -171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . 32.6 t30 -74.07 95.37 2.53 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.013 0.435 . . . . 75.439999999999998 111.402 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 p -82.32 87.74 6.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.226 0.536 . . . . 74.010000000000005 111.317 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.7 p -155.67 175.48 13.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.086 -0.506 . . . . 62.130000000000003 111.249 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.71 3.87 37.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.396 0.517 . . . . 51.439999999999998 112.396 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 52.9 tt0 -149.42 153.58 37.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.651 0.263 . . . . 63.25 111.482 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.81 117.25 4.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.904 0.383 . . . . 72.400000000000006 110.998 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 24.7 mm-40 -115.7 164.07 18.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 122.311 -0.243 . . . . 71.219999999999999 111.477 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.0 144.86 27.54 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.19 1.926 . . . . 74.120000000000005 111.152 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.1 tpt -52.42 -56.82 12.46 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.722 0.296 . . . . 74.430000000000007 111.651 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 11' ' ' MET . . . 105.08 148.51 17.79 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.925 -0.655 . . . . 73.0 114.064 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.69 58.88 4.97 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.397 -0.43 . . . . 72.0 112.915 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.79 169.45 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.708 0.29 . . . . 72.540000000000006 110.761 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.57 124.3 21.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.261 0.553 . . . . 75.129999999999995 111.433 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' SER . 55.6 ttp -93.13 108.25 19.88 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.751 -0.659 . . . . 72.319999999999993 111.387 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.4 mp -97.18 115.54 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.706 0.288 . . . . 73.230000000000004 110.758 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -84.35 97.19 9.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.781 0.324 . . . . 64.430000000000007 111.223 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -94.69 131.82 40.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.236 0.541 . . . . 62.530000000000001 111.677 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 48' ' ' ILE . 15.2 tt -150.22 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.708 0.765 . . . . 73.010000000000005 111.079 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.67 -61.67 0.55 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.036 -0.529 . . . . 64.099999999999994 113.562 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -82.57 -66.43 0.89 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.398 -0.472 . . . . 73.310000000000002 112.232 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -95.86 173.43 7.45 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.132 0.491 . . . . 65.540000000000006 112.185 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -145.37 33.03 1.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.003 -0.544 . . . . 70.340000000000003 111.371 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.93 127.72 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.295 0.569 . . . . 70.230000000000004 111.998 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' MET . 82.8 p -114.54 177.7 4.55 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.489 0.662 . . . . 63.409999999999997 112.772 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.518 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 69.6 t80 -152.99 108.39 3.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.492 -0.776 . . . . 64.310000000000002 111.193 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -78.83 121.17 24.47 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.803 -0.443 . . . . 63.340000000000003 109.803 173.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.09 124.46 23.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.893 0.701 . . . . 73.319999999999993 112.893 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -72.27 85.23 1.07 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.478 0.656 . . . . 53.32 111.454 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.9 t -71.93 72.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.374 0.607 . . . . 52.509999999999998 111.217 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 16.4 ptt180 -102.68 5.19 38.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.799 -0.637 . . . . 71.329999999999998 112.152 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 51.3 p90 -158.37 165.53 34.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.886 0.374 . . . . 74.349999999999994 111.529 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.58 143.35 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.069 0.462 . . . . 53.130000000000003 111.792 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 31' ' ' ASN . 18.9 tp -108.95 124.38 50.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.125 0.488 . . . . 64.230000000000004 111.06 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.93 164.89 16.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.639 0.607 . . . . 73.109999999999999 112.639 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.82 124.46 24.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.188 -0.46 . . . . 64.230000000000004 111.421 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.94 7.34 83.9 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.31 -0.471 . . . . 61.329999999999998 113.152 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -71.47 132.74 45.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.999 0.428 . . . . 75.030000000000001 111.585 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.1 p -92.93 99.56 12.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.087 -0.506 . . . . 52.32 111.919 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.11 113.64 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.353 0.596 . . . . 64.340000000000003 110.639 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 21.0 m -99.86 131.81 45.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.963 0.411 . . . . 53.450000000000003 112.002 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.2 mm -93.2 99.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.111 -0.495 . . . . 71.109999999999999 111.051 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 87' ' ' ILE . 65.1 m95 -90.1 120.43 31.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.466 -0.334 . . . . 71.200000000000003 111.098 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -55.33 153.75 6.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.974 0.361 . . . . 70.0 111.974 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.33 -42.56 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.969 0.729 . . . . 75.319999999999993 112.969 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.445 ' HB2' ' H ' ' A' ' 93' ' ' SER . 6.4 m-20 -93.71 43.18 1.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.101 0.477 . . . . 70.219999999999999 111.952 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.81 -4.38 43.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.793 0.33 . . . . 72.129999999999995 111.694 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.02 -49.94 3.85 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.34 -0.457 . . . . 62.130000000000003 113.541 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.01 146.39 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 122.646 0.378 . . . . 74.219999999999999 111.999 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 81' ' ' SER . 92.3 m -54.63 132.19 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.813 0.339 . . . . 72.439999999999998 111.641 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.16 -25.04 20.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.38 0.881 . . . . 62.100000000000001 113.38 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.555 ' H ' HG22 ' A' ' 79' ' ' THR . 9.3 t -132.72 82.81 55.11 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 120.859 0.361 . . . . 52.32 110.892 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 52.7 Cg_exo -53.36 -47.65 26.25 Favored 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 123.372 2.715 . . . . 73.439999999999998 115.283 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 43.0 Cg_endo -103.31 25.77 12.26 Favored 'Cis proline' 0 C--N 1.364 1.391 0 CA-C-N 120.974 1.384 . . . . 70.230000000000004 114.501 -0.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.498 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 8.8 t -56.74 -34.28 67.37 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.905 0.383 . . . . 73.439999999999998 111.743 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -113.35 173.0 6.62 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.363 -0.381 . . . . 72.010000000000005 110.33 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 98.3 mt -122.4 126.36 47.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.368 . . . . 65.329999999999998 111.236 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 72' ' ' TRP . 1.7 mp -91.95 124.92 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.479 0.657 . . . . 71.129999999999995 112.042 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.518 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 7.9 t90 -74.56 80.44 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.692 -0.685 . . . . 72.400000000000006 110.573 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -67.14 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.24 -0.436 . . . . 72.340000000000003 111.979 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.479 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.9 m120 -74.11 -12.02 60.48 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.879 0.326 . . . . 73.239999999999995 111.879 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -148.52 140.29 23.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.12 0.486 . . . . 64.540000000000006 111.697 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.66 -171.48 3.13 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.578 -0.283 . . . . 74.219999999999999 110.919 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 75' ' ' ASN . 94.9 p -73.48 129.53 38.18 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.002 -0.436 . . . . 72.540000000000006 110.687 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -90.65 142.29 27.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.258 0.551 . . . . 73.109999999999999 112.194 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.03 23.86 24.48 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.095 -0.502 . . . . 62.420000000000002 112.654 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.0 p -79.4 127.98 32.78 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.223 0.453 . . . . 61.119999999999997 112.223 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.3 -10.15 66.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.431 -0.414 . . . . 71.530000000000001 113.33 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.64 156.07 39.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.799 0.333 . . . . 74.530000000000001 111.309 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 7.6 p-10 -67.92 89.18 0.28 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.54 0.686 . . . . 62.119999999999997 111.198 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.17 117.56 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.918 -0.583 . . . . 71.099999999999994 110.812 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 3.2 ttmp? -103.51 99.1 8.91 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.463 0.649 . . . . 72.150000000000006 110.925 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 27' ' ' ILE . 80.0 t -82.09 132.88 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.376 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' A' ' 105' ' ' LYS . 38.0 mm -112.42 133.67 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 111.514 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 HG13 ' A' ' 17' ' ' ILE . 87.5 mt -112.5 110.12 20.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.058 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 103' ' ' ILE . 66.8 mttm -120.36 159.32 25.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 70.219999999999999 112.308 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 1.4 m-20 -95.71 -179.27 4.67 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.546 -0.752 . . . . 65.439999999999998 111.996 -176.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -61.13 -19.54 61.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.869 -0.605 . . . . 63.140000000000001 112.336 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -102.83 17.09 24.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.214 0.45 . . . . 73.409999999999997 112.214 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.03 5.36 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.117 -0.563 . . . . 60.329999999999998 113.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 15.0 pt-20 -58.68 159.43 6.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.575 0.35 . . . . 61.119999999999997 111.162 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 105' ' ' LYS . 35.4 tt0 -121.91 127.43 50.42 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.437 0.532 . . . . 74.140000000000001 112.437 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -33.81 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.297 0.481 . . . . 54.200000000000003 112.297 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.18 149.73 17.79 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.753 0.649 . . . . 44.0 112.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -146.89 141.29 26.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.67 -0.695 . . . . 74.230000000000004 110.19 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 115' ' ' ARG . 31.4 ttt180 -154.67 156.71 36.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.019 -0.426 . . . . 54.32 112.038 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 83.9 p -125.63 170.13 11.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.913 0.387 . . . . 64.540000000000006 111.516 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 39.9 p -72.72 159.22 34.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.222 0.534 . . . . 44.240000000000002 111.896 176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -76.8 89.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.306 0.574 . . . . 73.420000000000002 111.001 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -69.83 -25.25 63.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.959 -0.564 . . . . 75.329999999999998 111.407 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 0.5 OUTLIER -101.9 96.38 7.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 60.119999999999997 111.34 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.0 p -80.61 154.56 27.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 111.485 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.253 1.289 0 CA-C-N 116.302 -0.408 . . . . 63.509999999999998 112.033 -179.435 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.378 0.132 . . . . 72.540000000000006 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.11 77.95 0.06 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.399 -0.905 . . . . 51.43 114.394 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -146.85 101.65 3.46 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.236 -0.567 . . . . 74.439999999999998 110.95 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -97.87 14.16 28.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.86 0.689 . . . . 70.129999999999995 112.86 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.9 t60 62.26 21.18 12.31 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.395 0.517 . . . . 72.430000000000007 112.395 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.26 -174.17 5.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.886 -0.509 . . . . 61.530000000000001 112.029 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.4 t60 74.87 26.46 1.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.488 0.715 . . . . 73.400000000000006 111.847 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -64.2 148.66 49.56 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.99 -0.55 . . . . 72.239999999999995 111.519 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 t -63.44 177.15 0.71 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.51 0.559 . . . . 73.010000000000005 112.51 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -111.56 142.92 43.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.507 . . . . 75.209999999999994 111.787 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.411 ' HB3' ' OE1' ' A' ' 37' ' ' GLN . 25.7 mmt -84.77 108.99 17.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.237 -0.438 . . . . 64.120000000000005 111.963 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 t -76.83 -31.53 56.95 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.501 0.556 . . . . 43.119999999999997 112.501 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.52 -169.53 17.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.98 -0.629 . . . . 62.539999999999999 113.818 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.85 108.73 2.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 64.150000000000006 110.757 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 29' ' ' LEU . 57.4 t -127.99 133.03 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.743 0.306 . . . . 73.230000000000004 111.201 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.07 159.13 40.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.8 0.333 . . . . 51.130000000000003 111.591 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.611 HG13 HD11 ' A' ' 104' ' ' LEU . 71.7 mt -82.29 116.99 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.926 0.393 . . . . 62.32 111.75 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -80.61 -50.23 10.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.019 0.437 . . . . 73.540000000000006 111.305 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -161.92 151.91 16.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.202 0.525 . . . . 52.520000000000003 111.451 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 117' ' ' THR . 59.6 mt -115.47 149.22 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.579 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.86 144.51 44.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.067 0.461 . . . . 70.030000000000001 112.119 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -32.19 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.18 -0.464 . . . . 44.350000000000001 112.027 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.8 -47.3 13.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.98 0.419 . . . . 73.140000000000001 110.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.4 23.24 1.4 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.03 -0.532 . . . . 55.229999999999997 113.487 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -90.31 -27.89 19.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.453 0.909 . . . . 74.439999999999998 113.453 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -151.8 160.31 43.61 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.694 0.998 . . . . 74.450000000000003 113.694 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.685 HG23 HG12 ' A' ' 20' ' ' ILE . 70.0 mt -125.98 120.76 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.469 -0.787 . . . . 72.010000000000005 110.366 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -93.38 114.38 26.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.845 0.683 . . . . 71.030000000000001 112.845 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -100.92 165.21 11.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.268 172.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -151.41 139.59 20.23 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.066 0.46 . . . . 75.319999999999993 112.093 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 29.7 t30 -88.12 145.53 25.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.919 -0.582 . . . . 60.32 110.88 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -119.33 8.24 11.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.462 0.541 . . . . 63.229999999999997 112.462 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.0 p -81.58 155.5 25.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.34 0.59 . . . . 63.340000000000003 112.049 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.9 7.65 17.5 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.992 -0.549 . . . . 71.400000000000006 111.947 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.8 156.21 42.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.659 0.266 . . . . 72.209999999999994 111.498 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.58 106.11 2.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.443 -0.344 . . . . 63.32 111.025 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 11' ' ' MET . 18.1 mm-40 -106.13 144.74 29.56 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.699 -0.228 . . . . 64.099999999999994 111.326 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.37 156.03 18.55 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.353 2.035 . . . . 74.209999999999994 112.948 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.589 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 4.2 tpt -60.23 -29.24 68.62 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.978 0.418 . . . . 34.009999999999998 111.926 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.08 176.86 49.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.373 -0.441 . . . . 73.510000000000005 113.559 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 52.63 0.67 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.354 -0.451 . . . . 62.0 112.709 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -98.72 172.36 7.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.554 0.216 . . . . 64.030000000000001 110.856 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 43.5 tt0 -137.35 137.3 38.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.316 0.579 . . . . 75.109999999999999 111.492 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.2 ttp -105.39 122.75 46.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.87 -0.605 . . . . 64.219999999999999 111.417 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.2 mp -104.79 124.29 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.888 0.375 . . . . 70.310000000000002 111.407 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.667 ' HB2' ' HH2' ' A' ' 88' ' ' TRP . 34.7 ttt180 -90.87 123.16 34.18 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.278 -0.264 . . . . 73.400000000000006 111.671 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -116.58 105.53 12.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 64.409999999999997 110.831 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.16 -23.43 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.284 0.564 . . . . 71.019999999999996 110.789 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -94.8 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.035 -0.529 . . . . 71.319999999999993 112.345 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.86 -41.0 11.43 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.691 0.281 . . . . 72.400000000000006 111.384 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.3 t -92.72 147.97 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.162 0.506 . . . . 72.099999999999994 111.792 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p -140.96 168.88 18.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.082 0.468 . . . . 73.120000000000005 111.6 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -162.17 141.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.245 -0.434 . . . . 45.43 110.537 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -115.58 159.72 20.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.539 0.685 . . . . 61.130000000000003 112.782 -174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 84.0 t80 -144.44 115.27 7.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.642 -0.708 . . . . 71.030000000000001 110.597 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 87.3 tttt -86.85 140.39 29.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.189 0.519 . . . . 75.209999999999994 111.583 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.431 ' HE2' HD11 ' A' ' 71' ' ' ILE . 89.2 m-85 -87.56 145.41 26.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 73.510000000000005 111.489 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.8 t -121.55 130.1 53.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.949 0.404 . . . . 62.439999999999998 111.659 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 67.8 m -73.92 74.68 1.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.162 0.506 . . . . 65.200000000000003 111.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -97.76 -2.24 41.56 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.915 -0.584 . . . . 61.43 111.532 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -168.76 172.83 7.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.112 -0.494 . . . . 75.219999999999999 110.617 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.06 126.32 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.14 0.495 . . . . 72.420000000000002 111.652 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -74.38 119.56 18.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.232 -0.655 . . . . 75.129999999999995 109.232 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 66.0 mttm -62.37 158.75 16.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.825 0.676 . . . . 50.420000000000002 112.825 -172.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.21 113.88 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.658 -0.701 . . . . 74.430000000000007 112.006 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . 67.66 21.4 72.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.463 -0.398 . . . . 45.140000000000001 114.029 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.6 tp60 -86.35 149.24 25.17 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.148 0.499 . . . . 73.25 111.844 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.1 p -92.45 145.2 24.64 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.178 -0.465 . . . . 75.109999999999999 111.557 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' HD21 ' A' ' 63' ' ' LEU . 7.0 p -134.49 122.29 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.91 0.386 . . . . 62.130000000000003 110.391 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -103.1 137.33 41.42 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.253 0.549 . . . . 74.420000000000002 112.102 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 86' ' ' LEU . 43.5 mm -95.4 108.85 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.214 -0.448 . . . . 63.039999999999999 110.782 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -97.35 136.22 38.12 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.544 0.212 . . . . 71.120000000000005 110.659 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.31 158.11 18.11 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.086 0.402 . . . . 64.140000000000001 112.086 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 89' ' ' LYS . . . -47.09 -44.92 21.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.594 0.59 . . . . 73.019999999999996 112.594 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 93' ' ' SER . 2.0 m-20 -95.84 74.5 3.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.161 0.505 . . . . 73.420000000000002 111.511 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.9 3.15 8.77 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.08 -0.509 . . . . 72.329999999999998 111.188 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.62 17.32 64.52 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.309 -0.405 . . . . 74.439999999999998 113.651 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.39 171.5 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.152 0.501 . . . . 73.099999999999994 112.317 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -82.2 164.4 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.999 -0.546 . . . . 62.020000000000003 112.207 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.54 89.89 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.359 -0.382 . . . . 63.420000000000002 111.717 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 t 59.83 81.36 0.25 Allowed Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.508 . . . . 45.119999999999997 111.342 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 89.0 Cg_exo -45.23 -51.45 7.75 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.222 2.615 . . . . 65.129999999999995 115.365 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 48.6 Cg_endo -100.13 149.35 4.15 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 121.011 1.397 . . . . 70.510000000000005 114.008 -1.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 t -171.02 -38.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.259 -0.882 . . . . 31.210000000000001 108.892 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -123.21 156.76 34.49 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.838 -1.074 . . . . 72.439999999999998 109.308 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 71' ' ' ILE . 93.3 mt -104.8 141.65 36.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.026 0.441 . . . . 74.400000000000006 111.961 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.5 mp -95.14 121.85 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.313 0.578 . . . . 75.109999999999999 111.343 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.667 ' HH2' ' HB2' ' A' ' 46' ' ' ARG . 4.9 t90 -89.66 84.0 6.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.939 -0.573 . . . . 73.510000000000005 110.463 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 48.8 mtmt -74.61 -16.41 60.79 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.187 0.44 . . . . 73.439999999999998 112.187 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.567 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 0.9 OUTLIER -65.9 -15.86 63.33 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.79 0.328 . . . . 71.420000000000002 111.523 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -148.69 139.01 22.48 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 72.219999999999999 111.103 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.9 m120 -72.72 -177.17 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.035 0.445 . . . . 73.450000000000003 111.231 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 40.4 t -77.69 142.92 38.51 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.226 -0.297 . . . . 73.150000000000006 111.486 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -125.85 157.71 36.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.953 0.406 . . . . 73.140000000000001 111.234 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.92 141.75 7.27 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.93 -0.652 . . . . 61.329999999999998 112.819 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 t 176.46 -27.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.983 0.364 . . . . 63.240000000000002 111.983 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 30.11 20.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.039 -0.6 . . . . 45.240000000000002 113.564 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.58 144.08 28.28 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.005 0.402 . . . . 71.120000000000005 110.757 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.2 m-20 -64.52 99.32 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.172 0.511 . . . . 74.0 112.15 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.36 127.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.578 . . . . 62.219999999999999 111.072 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 19.2 ttpp -104.26 119.53 39.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.336 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.1 t -108.71 147.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.132 0.491 . . . . 74.019999999999996 112.015 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 mm -116.95 126.49 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.094 -0.503 . . . . 75.420000000000002 111.591 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 HG13 ' A' ' 17' ' ' ILE . 66.3 mt -110.58 106.71 16.08 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.702 0.287 . . . . 74.319999999999993 111.697 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -120.52 140.82 50.91 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.323 0.583 . . . . 74.209999999999994 111.731 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.517 ' OD1' HG13 ' A' ' 112' ' ' VAL . 12.4 m120 -80.77 179.68 7.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.739 -0.664 . . . . 73.120000000000005 112.343 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.5 p -54.48 -49.24 70.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.561 -0.745 . . . . 53.5 112.345 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.56 -4.32 22.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.78 0.659 . . . . 71.150000000000006 112.78 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.35 -16.75 60.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.047 -0.597 . . . . 70.230000000000004 113.468 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.76 143.95 55.62 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.456 -0.438 . . . . 74.310000000000002 110.72 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -103.06 130.47 50.21 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.6 0.592 . . . . 74.239999999999995 112.6 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 106' ' ' ASN . 16.0 m -76.7 -45.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.765 -0.198 . . . . 65.109999999999999 111.194 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -176.67 133.7 0.21 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.516 0.561 . . . . 64.329999999999998 112.516 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.28 141.9 35.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.526 -0.546 . . . . 63.420000000000002 109.526 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -155.61 146.91 22.68 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.407 0.521 . . . . 60.229999999999997 112.407 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 79.1 p -109.56 169.98 8.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.005 0.431 . . . . 24.0 111.306 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.782 HG22 ' HB ' ' A' ' 20' ' ' ILE . 62.3 p -71.91 164.81 25.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.152 0.501 . . . . 71.420000000000002 112.106 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.09 117.12 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.051 -0.522 . . . . 62.43 110.65 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -82.16 114.67 20.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.918 0.39 . . . . 75.400000000000006 111.538 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 mttp -80.45 108.3 13.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.286 -0.415 . . . . 65.239999999999995 110.806 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.5 p -76.74 106.5 8.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.925 0.393 . . . . 61.5 111.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.253 1.268 0 N-CA-C 112.187 0.44 . . . . 65.420000000000002 112.187 -178.597 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.513 0.197 . . . . 61.140000000000001 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.45 146.14 48.29 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.185 -0.531 . . . . 72.430000000000007 113.39 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -127.69 22.34 6.38 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.373 0.508 . . . . 71.420000000000002 112.373 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -130.51 109.6 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.835 0.35 . . . . 72.299999999999997 111.179 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -87.35 -63.3 1.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.92 0.391 . . . . 73.040000000000006 111.662 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -107.14 120.46 42.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.265 0.555 . . . . 75.109999999999999 111.367 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -134.87 111.36 9.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.664 -0.698 . . . . 65.430000000000007 110.497 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -137.73 156.49 47.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.209 -0.45 . . . . 72.150000000000006 110.672 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -47.14 125.39 7.69 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.823 0.344 . . . . 63.100000000000001 111.593 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.79 137.22 56.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.922 1.082 . . . . 75.430000000000007 113.922 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.2 mmt -144.84 157.63 44.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.721 -1.127 . . . . 75.109999999999999 109.613 170.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -67.12 -43.82 81.47 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.193 0.442 . . . . 42.219999999999999 112.193 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.62 81.35 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.163 -0.542 . . . . 73.010000000000005 112.515 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 11.9 m120 -76.84 47.69 0.53 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.243 0.46 . . . . 52.229999999999997 112.243 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.53 97.75 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.209 0.528 . . . . 61.329999999999998 110.878 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 p -112.54 158.67 19.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.365 -0.38 . . . . 65.209999999999994 111.416 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.737 HG13 HD11 ' A' ' 104' ' ' LEU . 72.2 mt -62.11 135.73 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.734 -0.212 . . . . 43.140000000000001 111.037 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 33.0 tt0 -90.56 -69.25 0.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 74.209999999999994 110.26 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.85 138.66 22.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 111.408 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.755 HG23 HG12 ' A' ' 27' ' ' ILE . 56.4 mt -101.53 141.77 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.375 -0.375 . . . . 70.200000000000003 110.907 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.0 150.15 35.85 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.368 0.604 . . . . 74.129999999999995 112.419 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 119' ' ' PHE . 7.4 p -89.37 -31.43 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.302 -0.863 . . . . 62.539999999999999 112.569 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.45 -32.15 66.04 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.134 0.492 . . . . 73.120000000000005 111.238 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 108.96 34.04 2.66 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.133 -0.485 . . . . 63.049999999999997 112.303 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.74 -53.13 3.98 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.416 0.524 . . . . 71.530000000000001 112.416 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.39 165.65 35.12 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.834 1.05 . . . . 64.319999999999993 113.834 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.755 HG12 HG23 ' A' ' 20' ' ' ILE . 64.7 mt -129.05 106.44 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.889 -1.05 . . . . 61.530000000000001 109.612 172.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -91.66 124.66 35.97 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.85 -0.531 . . . . 72.150000000000006 112.343 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 8.0 mp -93.49 -177.28 4.36 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.21 -0.45 . . . . 74.200000000000003 111.12 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 61.6 tttp -162.66 119.9 2.0 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.793 0.294 . . . . 73.010000000000005 111.793 -174.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' HB2' HD12 ' A' ' 63' ' ' LEU . 38.5 t30 -90.24 110.43 21.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.609 0.243 . . . . 70.340000000000003 111.032 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.6 p -96.65 13.53 27.99 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.369 0.507 . . . . 74.209999999999994 112.369 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 29.5 t -79.54 157.6 27.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.288 0.566 . . . . 63.43 112.438 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.61 -13.72 59.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.797 -0.638 . . . . 65.319999999999993 110.741 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -115.64 149.26 38.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.191 0.52 . . . . 62.030000000000001 111.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.17 108.83 5.56 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.101 -0.5 . . . . 72.209999999999994 110.141 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -91.2 119.68 68.68 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.384 0.512 . . . . 53.0 112.384 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.87 136.11 47.45 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.269 1.979 . . . . 65.010000000000005 111.844 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 3.0 tpt -59.39 -41.53 89.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.21 0.448 . . . . 65.209999999999994 112.21 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.27 -67.12 1.21 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.375 -0.441 . . . . 70.340000000000003 113.494 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.78 78.52 0.02 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 62.32 112.855 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -98.9 179.96 4.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.73 0.3 . . . . 74.230000000000004 111.067 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.42 130.44 11.83 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.522 0.677 . . . . 64.329999999999998 111.236 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' SER . 52.2 ttp -99.35 111.39 23.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.808 -0.633 . . . . 55.030000000000001 111.416 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.7 mp -89.68 141.6 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.668 0.27 . . . . 75.540000000000006 110.631 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -138.17 126.25 22.8 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.939 -0.475 . . . . 73.109999999999999 111.621 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -111.97 145.38 39.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 74.340000000000003 111.179 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.99 -41.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.062 0.458 . . . . 73.540000000000006 111.923 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.15 103.62 0.17 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.146 -0.55 . . . . 63.240000000000002 112.369 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 72.47 -36.51 0.36 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.457 0.703 . . . . 64.030000000000001 112.616 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -113.84 148.54 36.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.902 0.382 . . . . 73.209999999999994 111.457 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.1 p -137.02 143.43 42.73 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.338 -0.392 . . . . 75.200000000000003 111.023 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.5 147.38 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 63.240000000000002 111.031 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' MET . 97.9 p -131.77 150.32 52.19 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.067 0.461 . . . . 61.119999999999997 111.971 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 33.1 t80 -122.6 120.5 33.93 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.36 -0.382 . . . . 73.150000000000006 111.297 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.69 129.32 34.85 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.965 0.412 . . . . 73.349999999999994 111.649 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HB3' ' SD ' ' A' ' 39' ' ' MET . 86.4 m-85 -88.67 122.59 32.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.311 -0.404 . . . . 55.210000000000001 111.659 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.9 t -81.91 140.57 33.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.639 0.607 . . . . 71.209999999999994 112.639 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 98.9 p -86.05 18.44 3.06 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.17 0.433 . . . . 72.519999999999996 112.17 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 14.4 ptm180 -68.85 -9.8 53.37 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.757 0.651 . . . . 72.010000000000005 112.757 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.49 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 48.6 p90 -152.63 168.44 25.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.279 0.562 . . . . 75.200000000000003 112.043 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.57 140.71 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.682 -0.69 . . . . 72.120000000000005 111.455 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -92.95 100.61 13.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.33 -0.619 . . . . 64.450000000000003 109.33 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 8.4 mtpm? -69.69 163.24 26.08 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.384 0.883 . . . . 75.409999999999997 113.384 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.57 122.53 17.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.834 -0.621 . . . . 75.200000000000003 111.171 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.34 86.72 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.944 -0.646 . . . . 72.049999999999997 113.473 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.438 ' HB3' HD13 ' A' ' 63' ' ' LEU . 7.6 tp60 -89.37 133.9 34.31 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.462 -0.434 . . . . 63.549999999999997 111.041 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.9 p -116.07 100.68 8.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.316 -0.402 . . . . 63.210000000000001 111.821 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.67 132.17 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.927 0.394 . . . . 63.409999999999997 111.206 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 m -101.2 124.23 46.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.826 0.346 . . . . 65.530000000000001 111.694 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 40.7 mm -89.39 96.2 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.91 0.386 . . . . 54.420000000000002 110.985 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' TRP . 94.3 m95 -83.05 133.9 35.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.684 0.253 . . . . 71.409999999999997 111.684 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 163.3 11.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.038 0.447 . . . . 34.420000000000002 111.964 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.35 -21.08 3.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.07 0.767 . . . . 61.240000000000002 113.07 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.97 16.47 4.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.106 0.41 . . . . 75.519999999999996 112.106 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.94 78.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.051 0.453 . . . . 73.150000000000006 111.501 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.36 -26.85 3.34 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.424 -0.417 . . . . 73.310000000000002 113.686 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.26 163.57 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.981 0.42 . . . . 74.530000000000001 111.98 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -78.13 143.6 37.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.064 0.459 . . . . 75.219999999999999 111.662 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.0 78.12 3.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.024 0.44 . . . . 63.409999999999997 111.199 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -136.47 95.07 13.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.503 -0.317 . . . . 70.349999999999994 111.684 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 13.4 Cg_exo -72.72 178.17 6.67 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.248 2.632 . . . . 75.540000000000006 112.278 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 98.6 Cg_endo -99.9 118.82 1.01 Allowed 'Cis proline' 0 C--N 1.361 1.22 0 N-CA-C 114.544 0.94 . . . . 73.129999999999995 114.544 -0.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.9 t -154.96 -56.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.97 -0.559 . . . . 70.010000000000005 109.855 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 84' ' ' THR . 21.4 m-20 -141.2 176.85 8.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.779 -0.646 . . . . 65.019999999999996 109.703 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 97.0 mt -123.02 124.13 42.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.893 0.378 . . . . 74.239999999999995 110.956 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 87' ' ' ILE . 3.2 mp -93.99 111.56 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.167 0.508 . . . . 75.400000000000006 111.31 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.443 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 4.3 t90 -71.09 77.9 0.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.203 0.525 . . . . 74.430000000000007 110.617 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.89 1.8 16.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.022 0.439 . . . . 72.439999999999998 111.607 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.443 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 15.2 m120 -93.57 -4.32 51.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.272 -0.422 . . . . 64.329999999999998 111.812 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -137.79 148.69 45.75 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.171 0.51 . . . . 75.129999999999995 111.457 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -91.44 -174.82 4.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.04 -0.527 . . . . 71.519999999999996 110.789 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 98.7 p -64.41 120.43 12.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.141 0.496 . . . . 54.329999999999998 111.096 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.3 p90 -77.73 118.21 19.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.239 0.542 . . . . 72.340000000000003 112.062 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.36 102.74 0.16 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.932 -0.576 . . . . 75.329999999999998 112.334 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -157.35 26.25 0.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 65.230000000000004 111.718 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -54.11 4.35 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.151 -0.547 . . . . 42.420000000000002 113.102 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.3 119.19 8.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.479 0.312 . . . . 73.209999999999994 111.194 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.04 146.2 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.676 0.621 . . . . 74.219999999999999 112.676 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG12 ' HE1' ' A' ' 119' ' ' PHE . 7.4 p -126.4 128.47 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.786 -0.643 . . . . 73.519999999999996 111.773 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 116' ' ' SER . 80.7 tttt -114.47 142.49 46.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.991 0.424 . . . . 71.140000000000001 111.751 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.82 136.91 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.996 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.73 122.91 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.024 -0.535 . . . . 74.409999999999997 111.432 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 17' ' ' ILE . 97.9 mt -89.69 131.28 35.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.231 -0.293 . . . . 70.349999999999994 111.095 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.6 mttt -141.09 145.72 36.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.209 0.528 . . . . 53.350000000000001 112.052 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' HG3' ' A' ' 110' ' ' GLU . 10.6 m120 -88.31 -173.43 4.2 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.082 0.467 . . . . 74.140000000000001 111.674 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -51.78 -41.96 62.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.742 0.645 . . . . 61.130000000000003 112.742 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.99 -0.69 40.66 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.894 0.702 . . . . 75.129999999999995 112.894 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.1 0.59 80.51 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.896 -0.669 . . . . 22.219999999999999 112.867 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' OD1' ' A' ' 106' ' ' ASN . 13.8 pt-20 -66.8 138.6 57.47 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.718 0.407 . . . . 71.209999999999994 111.108 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.5 tt0 -83.59 133.15 34.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.174 0.512 . . . . 75.430000000000007 111.954 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.71 -50.53 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.964 -0.562 . . . . 71.140000000000001 111.162 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.6 163.78 16.9 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.966 -0.561 . . . . 65.230000000000004 111.58 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -137.16 136.12 37.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.241 -0.436 . . . . 71.340000000000003 111.116 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -160.63 156.25 25.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.118 0.485 . . . . 75.310000000000002 111.486 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 54.4 p -142.54 -171.94 3.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.788 0.328 . . . . 60.329999999999998 111.221 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 14.8 t -147.23 145.47 29.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.652 0.263 . . . . 62.009999999999998 110.571 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 102.16 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.004 0.43 . . . . 71.420000000000002 111.831 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.619 ' HA ' HG23 ' A' ' 22' ' ' VAL . 22.2 p90 -96.14 102.14 13.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.497 0.665 . . . . 72.239999999999995 110.842 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -134.72 160.85 36.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.418 0.628 . . . . 70.019999999999996 112.52 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.6 p -126.98 121.46 31.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.554 -0.748 . . . . 73.129999999999995 110.525 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.036 -0.983 . . . . 74.530000000000001 112.634 -174.656 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.626 0.25 . . . . 74.349999999999994 111.065 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.42 75.91 0.43 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.539 -0.363 . . . . 62.539999999999999 113.089 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -65.09 -53.33 47.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.916 0.389 . . . . 72.340000000000003 111.495 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -91.95 -25.89 18.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.119 0.485 . . . . 74.209999999999994 110.577 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.14 -20.58 66.53 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.796 -0.638 . . . . 64.109999999999999 110.884 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.8 135.34 52.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.242 0.544 . . . . 72.030000000000001 111.055 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -151.94 95.79 2.13 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.935 -0.575 . . . . 64.120000000000005 110.949 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -146.74 121.83 10.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.757 -0.656 . . . . 74.040000000000006 111.037 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 37.7 p -90.03 -179.69 5.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.555 -0.293 . . . . 54.43 111.52 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 9' ' ' SER . 75.8 m-70 68.9 33.09 3.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.153 0.502 . . . . 74.409999999999997 112.102 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 90.4 mmm -82.45 92.78 7.1 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.021 0.438 . . . . 73.150000000000006 110.468 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -91.38 32.19 1.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.408 0.521 . . . . 75.129999999999995 112.408 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' HA2' ' HG3' ' A' ' 37' ' ' GLN . . . -60.41 91.21 0.05 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.412 0.525 . . . . 62.100000000000001 114.412 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -107.43 96.37 6.36 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.103 0.478 . . . . 72.219999999999999 110.428 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.42 140.6 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.015 0.436 . . . . 52.509999999999998 111.873 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -137.81 164.17 29.59 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.209 -0.45 . . . . 62.020000000000003 110.705 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.1 mp -87.49 119.44 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.22 -0.3 . . . . 72.200000000000003 111.28 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.51 -50.52 44.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.785 0.326 . . . . 70.540000000000006 111.361 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -171.31 152.79 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 60.329999999999998 112.149 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 27' ' ' ILE . 65.3 mt -107.49 134.72 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.792 -0.64 . . . . 64.120000000000005 110.816 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.0 130.25 41.66 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.032 0.444 . . . . 65.209999999999994 111.301 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -70.18 -28.25 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.511 0.56 . . . . 74.310000000000002 112.511 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.53 -44.76 56.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 110.835 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 117.02 37.97 0.91 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 116.23 -0.441 . . . . 73.439999999999998 113.236 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -104.69 -39.59 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.452 0.538 . . . . 63.509999999999998 112.452 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.75 160.46 37.9 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.353 0.871 . . . . 72.140000000000001 113.353 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 20' ' ' ILE . 69.7 mt -131.61 122.47 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.611 -0.722 . . . . 71.0 109.781 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -99.72 122.41 42.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.934 0.716 . . . . 73.439999999999998 112.934 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 104' ' ' LEU . 7.0 mp -97.3 173.72 7.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.592 -0.731 . . . . 74.329999999999998 110.587 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.6 131.6 11.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.936 0.398 . . . . 73.120000000000005 111.981 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HB3' HD12 ' A' ' 63' ' ' LEU . 28.4 t30 -89.87 104.36 16.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.249 -0.432 . . . . 65.450000000000003 110.968 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 t -105.72 84.11 2.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 71.450000000000003 110.887 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.6 p -136.4 -177.8 4.88 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.722 -0.672 . . . . 64.420000000000002 112.164 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.45 -22.53 35.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.909 0.707 . . . . 74.510000000000005 112.909 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -146.89 154.56 41.44 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.516 0.561 . . . . 75.120000000000005 112.516 -170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -50.36 128.15 19.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.866 -0.606 . . . . 72.409999999999997 111.569 175.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HG3' ' HA2' ' A' ' 13' ' ' GLY . 30.1 mm-40 -121.08 119.68 29.61 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.805 0.336 . . . . 53.509999999999998 111.633 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 7.3 Cg_exo -74.8 29.9 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.12 2.547 . . . . 64.319999999999993 113.946 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.3 tpt 64.94 -71.18 0.08 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.4 0.518 . . . . 53.140000000000001 112.4 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . 96.37 -75.69 0.76 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.134 -0.555 . . . . 64.329999999999998 113.247 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.48 83.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.22 -0.514 . . . . 40.310000000000002 112.917 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.685 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 9.0 m0 -100.65 174.71 5.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.767 0.318 . . . . 75.540000000000006 111.605 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.28 111.32 15.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.799 0.333 . . . . 71.239999999999995 111.194 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.7 ttp -103.01 121.2 42.07 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.068 -0.395 . . . . 62.329999999999998 111.279 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.28 149.64 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.355 -0.384 . . . . 64.040000000000006 110.716 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 46' ' ' ARG . 28.4 ttp-105 -135.2 105.54 6.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.944 -0.473 . . . . 43.119999999999997 110.878 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 98.3 mttt -88.44 118.91 28.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.481 -0.327 . . . . 71.140000000000001 110.666 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 tt -155.07 99.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.934 0.397 . . . . 73.109999999999999 111.665 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 58.94 93.66 0.01 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.253 -0.431 . . . . 50.420000000000002 114.117 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.9 t70 76.46 -58.75 0.52 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.068 0.766 . . . . 71.209999999999994 113.068 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -103.99 163.42 12.38 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.849 0.685 . . . . 63.340000000000003 112.849 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.4 p -138.02 105.4 5.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.646 -0.706 . . . . 74.230000000000004 110.683 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.1 p -92.28 146.18 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.699 0.285 . . . . 63.420000000000002 111.429 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -123.0 159.35 28.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.21 0.528 . . . . 74.349999999999994 111.77 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 73.6 t80 -138.93 133.52 31.95 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.114 -0.494 . . . . 64.219999999999999 110.813 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -101.18 129.98 47.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.097 0.475 . . . . 72.439999999999998 111.715 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.685 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 68.7 m-85 -88.84 172.89 8.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.033 -0.53 . . . . 72.340000000000003 111.923 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 t -149.71 153.82 37.56 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.984 0.421 . . . . 75.120000000000005 112.111 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 36.9 t -86.3 64.26 8.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.991 0.424 . . . . 53.530000000000001 111.919 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.683 HH11 ' HG2' ' A' ' 82' ' ' PRO . 9.6 ptp180 -106.58 -1.53 22.82 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.747 0.308 . . . . 74.219999999999999 111.785 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HD23 ' A' ' 63' ' ' LEU . 29.9 p90 -154.98 148.61 25.37 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.681 0.277 . . . . 73.129999999999995 111.011 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 47.8 t -97.02 102.37 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 64.109999999999999 111.024 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 31' ' ' ASN . 1.1 tm? -80.74 108.82 14.72 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.204 0.526 . . . . 72.349999999999994 110.623 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 61.7 mttm -64.36 140.5 58.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.024 -0.534 . . . . 73.310000000000002 112.186 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.24 127.19 30.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.253 -0.43 . . . . 61.039999999999999 111.306 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.96 -15.37 55.4 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.152 -0.547 . . . . 71.439999999999998 112.787 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -95.65 168.08 10.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.885 0.374 . . . . 75.409999999999997 110.831 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.8 p -119.25 174.04 6.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.274 0.559 . . . . 74.200000000000003 112.183 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.72 127.92 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.976 -0.556 . . . . 44.049999999999997 110.448 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.5 m -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.955 0.407 . . . . 72.150000000000006 111.96 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 86' ' ' LEU . 29.5 mm -92.54 97.49 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.151 -0.477 . . . . 72.400000000000006 110.423 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 88.0 m95 -79.12 168.72 19.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.938 0.399 . . . . 74.329999999999998 111.792 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.67 16.63 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.569 -0.287 . . . . 64.209999999999994 110.902 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.1 -30.62 37.47 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.108 0.781 . . . . 73.349999999999994 113.108 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -97.9 19.63 13.51 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.429 0.529 . . . . 55.549999999999997 112.429 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -52.91 -47.83 67.68 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 43.32 112.625 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.93 75.48 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.213 -0.518 . . . . 33.549999999999997 112.816 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.91 -164.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.327 0.251 . . . . 64.010000000000005 111.106 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.4 m -48.67 130.29 17.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.771 0.319 . . . . 74.439999999999998 111.165 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.13 62.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.553 0.945 . . . . 73.120000000000005 113.553 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.4 t -159.28 151.91 17.9 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 113.133 0.79 . . . . 74.299999999999997 113.133 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.685 ' HG3' HD23 ' A' ' 86' ' ' LEU . 7.1 Cg_endo -48.79 170.84 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 123.919 3.079 . . . . 74.120000000000005 111.363 168.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -16.82 -80.51 0.0 OUTLIER 'Cis proline' 0 C--N 1.374 1.896 0 N-CA-C 121.329 3.55 . . . . 74.140000000000001 121.329 11.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.2 p -78.62 -83.63 0.09 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.301 1.223 . . . . 62.200000000000003 114.301 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 6.3 m-20 -73.78 122.6 22.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.248 0.547 . . . . 73.230000000000004 112.458 -171.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.685 HD23 ' HG3' ' A' ' 82' ' ' PRO . 12.1 mt -91.09 113.24 25.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.912 -0.585 . . . . 73.450000000000003 111.369 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.5 mp -86.08 119.11 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.18 0.514 . . . . 60.140000000000001 110.944 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.421 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.1 t90 -69.46 77.9 0.4 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.332 0.587 . . . . 75.439999999999998 110.351 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -75.88 27.82 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.324 0.49 . . . . 42.439999999999998 112.324 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -118.1 -1.86 11.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.901 0.381 . . . . 70.510000000000005 110.969 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.455 ' OE1' HG11 ' A' ' 53' ' ' VAL . 25.3 tt0 -157.82 146.27 19.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.966 0.413 . . . . 44.109999999999999 111.111 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -82.81 -167.62 1.71 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.433 -0.349 . . . . 73.120000000000005 110.775 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 t -69.0 145.35 53.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.941 0.401 . . . . 65.420000000000002 111.611 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.512 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 49.4 p90 -121.86 -174.46 2.88 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.217 -0.447 . . . . 64.200000000000003 110.631 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 137.71 50.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.766 -0.731 . . . . 63.340000000000003 113.609 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 98' ' ' GLU . 7.3 t -76.49 -20.91 56.47 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.451 -0.441 . . . . 74.319999999999993 111.982 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.62 4.87 60.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.091 -0.576 . . . . 74.420000000000002 113.517 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.606 ' H ' HG23 ' A' ' 96' ' ' THR . 9.0 mm-40 -85.69 172.46 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.652 -0.322 . . . . 54.439999999999998 111.257 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.05 143.33 55.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.103 0.478 . . . . 52.149999999999999 111.995 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.35 132.74 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.284 0.564 . . . . 75.010000000000005 111.655 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 114' ' ' GLN . 50.6 tttm -123.35 111.8 16.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.07 -0.514 . . . . 61.310000000000002 110.817 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.81 133.09 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.946 0.403 . . . . 72.129999999999995 111.39 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.463 HG21 ' HE2' ' A' ' 105' ' ' LYS . 16.3 mm -126.64 136.53 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 111.828 0.307 . . . . 63.119999999999997 111.828 -173.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 29' ' ' LEU . 79.4 mt -110.13 107.68 17.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.93 0.395 . . . . 51.25 111.559 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' A' ' 103' ' ' ILE . 67.7 mttm -119.31 167.76 11.57 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.373 0.606 . . . . 71.140000000000001 112.061 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HB2' ' CG ' ' A' ' 110' ' ' GLU . 12.8 m120 -113.96 -176.65 2.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.987 -0.551 . . . . 74.540000000000006 111.681 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 t -58.75 -39.32 80.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.307 0.854 . . . . 62.219999999999999 113.307 -173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -73.46 -8.7 57.0 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.552 0.575 . . . . 73.049999999999997 112.552 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.75 68.68 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.648 -0.787 . . . . 65.230000000000004 112.065 -171.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.513 ' CG ' ' HB2' ' A' ' 106' ' ' ASN . 10.5 pt-20 -68.44 168.59 12.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.658 0.383 . . . . 75.299999999999997 110.39 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.71 136.92 48.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.128 -0.358 . . . . 74.5 111.779 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.648 HG21 ' HZ3' ' A' ' 42' ' ' TRP . 29.2 m -96.7 -41.62 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.438 -0.346 . . . . 53.130000000000003 111.61 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.79 168.95 13.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 40.329999999999998 111.504 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 29.5 pt20 -160.0 163.37 34.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.238 -0.437 . . . . 73.239999999999995 110.71 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -161.89 -179.41 7.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.015 0.912 . . . . 54.5 112.793 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.3 p -147.64 -170.99 3.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.821 -1.081 . . . . 73.329999999999998 109.892 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 p -78.71 142.45 37.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.894 0.378 . . . . 74.400000000000006 110.972 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p -78.57 101.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.383 0.611 . . . . 72.109999999999999 111.193 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -99.14 104.22 16.18 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.540000000000006 112.093 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -84.66 124.11 31.11 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.347 -0.388 . . . . 74.209999999999994 110.665 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.9 m -70.64 85.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 73.329999999999998 111.586 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.254 1.315 0 CA-C-O 118.976 -0.535 . . . . 73.209999999999994 111.65 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.559 0.219 . . . . 63.32 110.429 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.02 -107.72 1.04 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.13 -0.557 . . . . 60.049999999999997 112.75 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -144.66 39.7 1.27 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.326 0.584 . . . . 72.109999999999999 110.584 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -99.6 4.83 45.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.47 0.544 . . . . 70.510000000000005 112.47 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -72.07 97.87 1.99 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.119 0.485 . . . . 71.0 111.195 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -125.88 26.29 6.64 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 112.155 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -66.0 99.43 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.992 0.425 . . . . 71.109999999999999 111.4 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -98.25 114.2 26.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.533 -0.303 . . . . 74.510000000000005 110.792 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 t -113.53 81.98 1.6 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.089 0.471 . . . . 74.540000000000006 111.501 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -132.06 119.6 21.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.493 -0.321 . . . . 74.420000000000002 111.435 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 mmt 61.58 108.88 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.419 0.628 . . . . 64.219999999999999 112.389 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -94.26 36.51 1.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.2 0.445 . . . . 71.409999999999997 112.2 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.0 61.96 2.55 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.172 -0.537 . . . . 75.409999999999997 112.902 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.6 m-80 -94.63 -32.91 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.874 0.368 . . . . 75.230000000000004 111.375 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.11 120.27 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.01 0.433 . . . . 73.239999999999995 111.361 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -133.62 156.66 47.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.447 -0.342 . . . . 74.209999999999994 110.906 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 65.2 mt -71.04 126.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.755 0.312 . . . . 64.219999999999999 111.496 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -89.33 -66.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.001 0.429 . . . . 74.430000000000007 110.783 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -136.23 130.25 32.81 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.126 0.489 . . . . 70.209999999999994 112.085 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG23 ' A' ' 27' ' ' ILE . 62.6 mt -103.91 114.45 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.968 -0.56 . . . . 72.239999999999995 110.351 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 17.2 t70 -74.53 139.61 43.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.473 0.654 . . . . 53.219999999999999 112.256 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.5 -16.41 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.609 -0.723 . . . . 73.530000000000001 110.993 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.07 -14.15 61.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.149 -0.478 . . . . 32.420000000000002 111.198 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 99.44 29.22 7.16 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.771 0.669 . . . . 73.099999999999994 114.771 168.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 11.5 mptt -113.3 -54.48 2.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.214 0.82 . . . . 71.340000000000003 113.214 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 46.1 p90 -148.04 167.24 25.46 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.106 1.151 . . . . 75.329999999999998 114.106 -170.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.466 HG23 HG12 ' A' ' 20' ' ' ILE . 69.8 mt -132.63 105.22 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 72.040000000000006 109.345 170.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.1 ttm180 -90.8 119.94 31.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.207 0.817 . . . . 75.450000000000003 113.207 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.0 mp -93.83 -175.88 3.87 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.712 -0.676 . . . . 75.450000000000003 110.333 171.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 35.0 ttpt -157.37 135.16 10.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.996 0.427 . . . . 64.510000000000005 112.009 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -108.33 115.23 29.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.039 -0.528 . . . . 64.239999999999995 111.403 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -102.19 16.56 25.75 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 64.420000000000002 112.116 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 98.3 p -55.24 152.32 8.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.079 0.466 . . . . 63.109999999999999 111.707 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -85.14 -0.35 54.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.799 0.333 . . . . 53.299999999999997 111.811 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.87 161.04 28.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.395 -0.366 . . . . 72.040000000000006 110.269 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.61 111.54 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.725 0.298 . . . . 73.230000000000004 111.244 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -104.85 132.07 21.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 N-CA-C 111.893 0.331 . . . . 75.109999999999999 111.893 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.69 132.93 54.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.456 2.104 . . . . 43.43 112.19 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 tpt -52.45 -72.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.07 0.396 . . . . 74.400000000000006 112.07 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.64 172.45 45.38 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.711 -0.757 . . . . 62.119999999999997 113.085 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.19 89.11 0.41 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.117 -0.563 . . . . 74.510000000000005 113.707 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . 41.3 m95 -102.41 156.43 17.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.773 0.321 . . . . 71.239999999999995 110.434 171.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.84 115.35 6.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.805 0.336 . . . . 74.310000000000002 111.468 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' SER . 54.7 ttp -93.99 114.06 26.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.569 -0.287 . . . . 75.0 111.67 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.8 mp -102.13 106.91 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.894 0.378 . . . . 72.230000000000004 110.36 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HG3' HG22 ' A' ' 102' ' ' VAL . 50.6 ttt180 -99.11 123.62 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.713 0.292 . . . . 74.420000000000002 111.483 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -121.9 116.86 25.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.954 0.407 . . . . 60.509999999999998 111.584 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 tt -103.35 -27.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.165 0.507 . . . . 70.25 110.703 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.96 -137.31 3.21 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 112.305 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -71.25 -40.54 70.93 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.03 0.443 . . . . 43.43 111.454 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -79.05 156.5 28.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.189 0.518 . . . . 51.140000000000001 112.126 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.3 p -133.69 152.55 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.128 -0.487 . . . . 73.040000000000006 111.343 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.9 p -134.96 139.43 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.506 -0.316 . . . . 62.32 111.318 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' MET . 84.0 p -111.53 171.38 7.52 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.233 0.54 . . . . 73.209999999999994 112.369 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.435 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 74.6 t80 -160.47 114.21 2.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.863 -0.608 . . . . 74.549999999999997 111.252 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.15 127.07 33.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.746 0.307 . . . . 71.319999999999993 111.438 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 3.1 m-85 -73.98 121.99 21.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.823 0.344 . . . . 64.230000000000004 111.123 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.53 HG21 ' HG2' ' A' ' 82' ' ' PRO . 5.2 t -68.84 120.96 15.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.543 0.687 . . . . 71.140000000000001 112.213 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -85.89 33.93 0.6 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.113 -0.494 . . . . 63.399999999999999 111.925 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.662 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 13.4 ptp180 -78.47 -3.72 44.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.148 0.425 . . . . 75.049999999999997 112.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.538 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 24.2 p90 -158.54 171.83 19.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.004 0.431 . . . . 71.049999999999997 111.362 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -92.9 138.74 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.3 -0.409 . . . . 63.340000000000003 111.51 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.31 105.7 13.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.137 0.494 . . . . 72.329999999999998 109.68 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 7.4 mtpm? -69.14 154.23 42.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.269 0.557 . . . . 63.43 112.446 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.6 57.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.753 -0.658 . . . . 73.329999999999998 112.187 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.26 -0.495 . . . . 62.439999999999998 113.793 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.89 132.38 34.71 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.229 -0.571 . . . . 71.420000000000002 111.557 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 56.2 p -100.02 83.59 2.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.309 -0.405 . . . . 61.009999999999998 111.019 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 29' ' ' LEU . 4.5 p -57.96 106.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.573 0.701 . . . . 61.219999999999999 111.372 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 86.4 m -93.06 121.31 34.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 74.049999999999997 111.525 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 47.8 mm -83.12 106.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.433 -0.348 . . . . 62.420000000000002 111.047 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -82.95 144.75 29.79 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.564 0.209 . . . . 73.409999999999997 111.564 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.93 157.64 27.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.835 0.35 . . . . 74.450000000000003 111.877 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.98 -30.48 25.16 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.439 0.533 . . . . 62.109999999999999 112.439 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -81.73 28.66 0.4 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.804 0.335 . . . . 60.439999999999998 111.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.62 87.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.176 0.436 . . . . 73.409999999999997 112.176 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.84 -37.7 2.5 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.178 -0.534 . . . . 43.200000000000003 113.771 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.2 -173.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.152 0.427 . . . . 65.510000000000005 112.152 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -51.1 104.92 0.09 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.099999999999994 111.903 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.82 1.32 35.34 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.671 0.619 . . . . 62.310000000000002 112.671 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.4 t -117.2 117.72 36.48 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 120.533 0.206 . . . . 75.209999999999994 111.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.662 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 54.0 Cg_exo -55.91 178.6 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.527 0 C-N-CA 123.776 2.984 . . . . 63.130000000000003 113.414 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 95.4 Cg_endo -76.73 126.19 12.94 Favored 'Cis proline' 0 C--N 1.366 1.459 0 CA-C-N 120.107 1.074 . . . . 71.140000000000001 114.813 6.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 82' ' ' PRO . 8.9 t 176.71 -170.94 0.08 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.353 -0.84 . . . . 70.030000000000001 109.418 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 87' ' ' ILE . 6.5 m-20 -57.4 108.1 0.51 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.735 -0.469 . . . . 74.019999999999996 109.735 171.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 79.6 mt -51.44 109.22 0.32 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.378 0.881 . . . . 72.120000000000005 113.378 -169.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 85' ' ' ASP . 3.6 mp -76.25 117.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.193 0.521 . . . . 64.200000000000003 110.8 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 6.7 t90 -70.31 134.96 48.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.914 -0.584 . . . . 74.519999999999996 110.527 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -127.35 27.99 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.02 0.438 . . . . 73.129999999999995 111.769 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.426 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 13.5 m-80 -121.45 -26.77 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.361 -0.381 . . . . 74.310000000000002 111.522 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -133.32 147.13 51.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.697 0.284 . . . . 54.43 110.874 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -95.51 -171.67 2.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.994 0.426 . . . . 74.420000000000002 111.951 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -59.89 127.03 29.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.892 0.377 . . . . 72.430000000000007 111.056 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -101.47 118.07 36.2 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.244 0.545 . . . . 75.120000000000005 112.457 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -120.93 85.14 0.38 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 111.893 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 p -130.56 -39.09 1.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.132 0.419 . . . . 74.219999999999999 112.132 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.42 89.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.257 -0.496 . . . . 71.140000000000001 112.857 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -96.66 145.75 25.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.97 0.414 . . . . 51.229999999999997 111.858 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 6.1 m-20 -64.59 131.1 46.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.402 0.62 . . . . 61.149999999999999 112.07 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 46' ' ' ARG . 7.5 p -119.09 126.05 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.883 -0.599 . . . . 74.530000000000001 111.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.875 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.3 tttt -90.95 115.99 28.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.189 -0.46 . . . . 70.299999999999997 110.797 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 46' ' ' ARG . 46.6 t -104.55 123.76 58.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.907 0.384 . . . . 73.340000000000003 111.518 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.875 HD11 ' HE2' ' A' ' 101' ' ' LYS . 50.4 mm -105.92 131.7 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.281 0.474 . . . . 72.209999999999994 112.281 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.4 mt -105.12 112.54 25.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.903 0.382 . . . . 74.25 110.943 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.75 171.59 7.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.931 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.8 -167.4 1.22 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.941 0.401 . . . . 72.340000000000003 111.253 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.2 t -56.98 -26.91 60.78 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.446 0.906 . . . . 73.430000000000007 113.446 -174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.86 -9.41 31.51 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 122.11 -0.369 . . . . 72.019999999999996 111.565 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.42 9.46 55.18 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.294 -0.479 . . . . 75.5 113.672 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.95 124.97 26.05 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.992 0.425 . . . . 74.450000000000003 111.88 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.5 107.27 7.52 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 110.959 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.59 -37.31 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.616 0.599 . . . . 71.209999999999994 112.616 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -141.39 122.53 14.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.193 0.442 . . . . 55.130000000000003 112.193 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -124.79 141.59 52.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.511 -0.313 . . . . 70.409999999999997 111.224 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -161.46 151.76 17.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.716 0.293 . . . . 74.329999999999998 111.039 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -140.53 174.67 10.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.168 0.509 . . . . 51.520000000000003 111.661 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 38.6 p -70.01 175.49 4.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 73.019999999999996 111.209 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 t -126.79 79.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.171 -0.331 . . . . 75.519999999999996 111.816 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 28.56 75.98 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.395 1.078 . . . . 63.130000000000003 113.79 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.99 122.62 45.77 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.026 0.441 . . . . 60.210000000000001 111.473 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -79.04 98.88 6.65 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.434 0.635 . . . . 62.240000000000002 111.854 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.501 -0.761 . . . . 72.140000000000001 111.924 179.234 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.779 0.323 . . . . 43.409999999999997 111.393 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.21 133.64 0.28 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.458 -0.401 . . . . 52.340000000000003 113.422 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -55.8 123.22 13.49 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 111.983 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -153.44 165.97 34.13 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.082 0.468 . . . . 75.420000000000002 111.351 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -106.48 151.43 24.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.025 -0.534 . . . . 71.430000000000007 110.165 172.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -65.27 93.71 0.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.52 0.676 . . . . 74.519999999999996 112.011 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -126.81 117.48 22.71 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.284 -0.871 . . . . 74.430000000000007 110.364 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -144.99 137.76 26.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.011 0.434 . . . . 71.230000000000004 112.063 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 t -165.45 151.09 9.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.909 -0.587 . . . . 55.100000000000001 110.675 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -90.68 93.19 9.15 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.303 0.573 . . . . 73.420000000000002 111.943 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 mmt -97.8 125.65 42.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.849 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.9 t -58.19 -48.02 81.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.95 0.722 . . . . 70.340000000000003 112.95 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.56 89.08 0.15 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.113 -0.565 . . . . 72.040000000000006 113.547 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 17.6 m120 -123.7 22.74 8.96 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.128 -0.631 . . . . 73.430000000000007 112.533 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.87 85.76 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.246 0.546 . . . . 72.010000000000005 110.164 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.34 147.61 24.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.018 -0.537 . . . . 73.150000000000006 111.679 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.814 HG13 ' HG ' ' A' ' 29' ' ' LEU . 3.0 mp -82.24 96.93 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.787 0.327 . . . . 53.509999999999998 110.145 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.28 -38.61 88.19 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.926 0.393 . . . . 73.109999999999999 111.926 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.42 129.5 14.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.699 0.629 . . . . 63.219999999999999 112.699 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.543 HG12 HG23 ' A' ' 27' ' ' ILE . 57.1 mt -116.65 128.82 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.989 -0.551 . . . . 74.400000000000006 109.738 172.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.76 114.89 9.29 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.325 0.583 . . . . 74.209999999999994 111.351 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' HA3' ' A' ' 97' ' ' GLY . 11.4 p -68.39 -31.12 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 116.123 -0.489 . . . . 72.510000000000005 112.041 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 22.8 t70 -57.08 -48.01 79.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.751 0.31 . . . . 75.099999999999994 111.132 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 136.23 24.01 0.52 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.311 -0.471 . . . . 74.340000000000003 113.985 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -95.57 -63.39 1.16 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.091 0.775 . . . . 74.319999999999993 113.091 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -145.29 161.23 40.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.107 1.151 . . . . 74.099999999999994 114.107 -168.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 20' ' ' ILE . 65.6 mt -116.3 113.81 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.102 -0.953 . . . . 62.509999999999998 109.662 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -102.19 112.94 25.81 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.451 0.538 . . . . 74.319999999999993 112.451 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 17' ' ' ILE . 4.8 mp -91.92 154.54 18.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.116 -0.493 . . . . 72.230000000000004 111.254 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -150.87 123.29 8.41 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.925 0.393 . . . . 73.019999999999996 110.96 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.502 ' HB2' HD12 ' A' ' 63' ' ' LEU . 34.1 t30 -83.94 129.49 34.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.784 0.326 . . . . 62.340000000000003 111.382 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -109.87 11.24 24.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.25 0.463 . . . . 73.439999999999998 112.25 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 94.0 p -80.91 163.44 23.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.454 0.645 . . . . 64.540000000000006 112.148 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.06 -18.61 33.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.719 -0.673 . . . . 63.130000000000003 111.531 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.54 149.77 46.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.693 0.282 . . . . 73.219999999999999 111.288 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -56.69 139.91 48.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.159 0.504 . . . . 64.519999999999996 112.209 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -104.02 117.32 59.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.065 -0.516 . . . . 71.109999999999999 111.235 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.11 127.73 13.9 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.421 2.08 . . . . 52.450000000000003 112.725 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.9 tpp -79.12 -71.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.961 0.41 . . . . 72.25 111.623 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.4 -54.2 2.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.886 -0.673 . . . . 60.020000000000003 112.998 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.69 61.77 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.339 -0.458 . . . . 54.219999999999999 113.323 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -63.09 153.54 33.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.894 0.378 . . . . 73.530000000000001 110.662 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -130.01 116.33 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.206 0.527 . . . . 73.200000000000003 111.388 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 102' ' ' VAL . 47.4 ttp -86.8 109.55 19.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.635 -0.711 . . . . 72.299999999999997 111.964 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.8 mp -82.94 89.68 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.102 -0.703 . . . . 71.510000000000005 109.102 171.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 101.24 6.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.083 0.468 . . . . 75.209999999999994 111.396 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 101' ' ' LYS . 68.3 mttm -84.67 -178.86 6.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.317 -0.401 . . . . 72.450000000000003 111.016 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -171.2 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.233 0.54 . . . . 74.540000000000006 110.547 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.47 -89.24 0.09 OUTLIER Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.96 -0.563 . . . . 55.030000000000001 112.702 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.47 -0.09 56.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.025 0.38 . . . . 64.219999999999999 112.025 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 t -155.54 164.54 38.52 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.691 0.626 . . . . 74.530000000000001 112.691 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -153.15 149.09 27.69 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.658 -0.701 . . . . 72.310000000000002 110.739 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.13 134.79 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.874 0.369 . . . . 64.540000000000006 111.373 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 m -94.12 111.7 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.11 0.411 . . . . 74.349999999999994 112.11 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -103.89 122.82 45.96 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.745 0.307 . . . . 74.140000000000001 110.651 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -95.39 116.39 28.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.799 0.333 . . . . 74.319999999999993 110.922 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -61.25 121.66 13.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.117 0.484 . . . . 71.299999999999997 111.609 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 60' ' ' ARG . 3.5 t -67.2 132.31 47.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.385 0.612 . . . . 62.32 112.019 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.1 p -73.41 23.72 0.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.236 0.828 . . . . 73.319999999999993 113.236 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' A' ' 58' ' ' THR . 8.0 ptp180 -73.02 -8.03 53.9 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.12 -0.363 . . . . 72.230000000000004 111.841 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HE2' HD23 ' A' ' 63' ' ' LEU . 24.8 p90 -145.85 145.07 30.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.173 0.435 . . . . 63.219999999999999 112.173 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.45 124.63 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.185 -0.461 . . . . 65.25 109.777 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -74.4 99.39 3.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.192 0.52 . . . . 74.010000000000005 111.298 -173.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -66.8 165.26 15.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.475 0.655 . . . . 52.340000000000003 112.723 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.77 125.75 25.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.908 -0.587 . . . . 74.049999999999997 111.169 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.22 77.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.197 -0.525 . . . . 52.439999999999998 113.527 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.544 ' HB3' HD13 ' A' ' 63' ' ' LEU . 60.0 tp60 -91.7 153.0 19.95 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.107 0.48 . . . . 74.530000000000001 111.572 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.4 p -121.9 145.58 47.95 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.248 -0.433 . . . . 63.25 111.951 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.82 137.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.288 -0.414 . . . . 71.430000000000007 110.363 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.6 m -118.66 122.44 42.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.162 0.43 . . . . 62.409999999999997 112.162 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 86' ' ' LEU . 41.4 mm -95.2 106.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.69 -0.232 . . . . 72.049999999999997 111.208 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.737 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 84.6 m95 -91.95 123.13 35.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.572 0.225 . . . . 71.230000000000004 111.503 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -79.1 80.54 5.44 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.084 0.772 . . . . 44.32 113.084 -174.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 61.3 -69.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.286 1.217 . . . . 74.409999999999997 114.286 173.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -72.86 36.17 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.337 0.866 . . . . 62.229999999999997 113.337 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -75.24 -50.61 15.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.305 0.483 . . . . 70.430000000000007 112.305 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.62 38.54 20.32 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.165 -0.541 . . . . 74.150000000000006 113.054 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.57 173.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.13 0.49 . . . . 61.130000000000003 112.186 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.3 m -67.84 94.02 0.43 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 74.349999999999994 112.678 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.64 -86.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.264 0.838 . . . . 74.430000000000007 113.264 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.4 t -170.46 110.52 0.44 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.211 0.449 . . . . 74.099999999999994 112.211 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 84' ' ' THR . 58.0 Cg_exo -46.21 160.61 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.486 2.79 . . . . 70.409999999999997 111.521 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER 9.03 64.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.903 0 N-CA-C 121.517 3.622 . . . . 74.209999999999994 121.517 36.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.644 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.0 t 147.78 -67.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.988 1.715 . . . . 72.349999999999994 111.209 161.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' H ' HG23 ' A' ' 84' ' ' THR . 8.0 m-20 -87.67 173.98 8.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.114 -0.366 . . . . 63.020000000000003 110.398 172.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.4 mt -139.96 130.61 25.75 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.751 0.31 . . . . 75.109999999999999 111.128 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.9 mp -87.15 106.01 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.438 0.637 . . . . 72.25 111.136 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.614 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 6.3 t90 -74.24 98.53 3.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.622 -0.717 . . . . 61.409999999999997 111.003 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -73.16 -28.54 62.28 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.404 0.52 . . . . 53.310000000000002 112.404 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.614 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 10.8 m120 -71.55 -16.96 62.33 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.905 0.706 . . . . 64.200000000000003 112.905 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 44.1 tt0 -145.77 139.2 26.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.008 -0.433 . . . . 73.129999999999995 111.731 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.704 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 2.6 m-20 -90.21 -174.82 4.32 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.063 0.459 . . . . 70.219999999999999 111.089 173.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.2 p -56.27 120.48 7.66 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.423 -0.353 . . . . 70.340000000000003 111.864 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.496 ' NE1' ' HA2' ' A' ' 24' ' ' GLY . 33.9 p90 -70.92 -38.74 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.504 0.557 . . . . 75.219999999999999 112.504 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 54.3 63.93 4.74 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.314 -0.47 . . . . 62.409999999999997 113.763 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.596 HG23 ' H ' ' A' ' 97' ' ' GLY . 1.6 t -167.52 -63.25 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.658 0.614 . . . . 65.239999999999995 112.658 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.596 ' H ' HG23 ' A' ' 96' ' ' THR . . . 72.76 10.09 76.0 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.982 -0.628 . . . . 75.030000000000001 113.399 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -70.9 78.57 0.63 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.224 0.512 . . . . 72.329999999999998 112.072 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.81 31.58 20.86 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.464 -0.789 . . . . 62.140000000000001 112.534 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 120.18 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.166 0.507 . . . . 74.209999999999994 109.743 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.4 ttmp? -119.15 121.45 39.79 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.928 0.714 . . . . 73.239999999999995 112.928 -165.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 44' ' ' MET . 98.1 t -86.82 116.54 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.723 -0.671 . . . . 75.0 111.569 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.8 mm -105.27 114.99 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.617 -0.265 . . . . 70.430000000000007 110.766 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.59 102.86 15.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.798 0.666 . . . . 65.409999999999997 112.798 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.97 154.89 25.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.376 -0.375 . . . . 64.349999999999994 110.509 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 14.2 m120 -99.0 -164.31 1.12 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.844 0.683 . . . . 51.420000000000002 112.844 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.1 t -52.98 -51.57 61.11 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.116 1.154 . . . . 45.399999999999999 114.116 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -88.28 -61.04 1.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.287 0.565 . . . . 74.319999999999993 111.731 -172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.59 27.71 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.785 -0.643 . . . . 74.439999999999998 112.697 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 1.2 pm0 -102.69 135.43 44.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.018 0.437 . . . . 55.0 110.681 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.21 132.52 46.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.055 0.391 . . . . 70.400000000000006 112.055 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 66.5 t -88.75 -62.08 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 111.352 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.66 179.16 8.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.168 0.509 . . . . 40.350000000000001 111.852 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.68 152.93 49.79 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.937 -0.574 . . . . 75.519999999999996 110.757 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.59 ' HA ' ' HE ' ' A' ' 115' ' ' ARG . 1.3 tpm_? -151.31 152.04 32.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.614 0.245 . . . . 74.230000000000004 110.892 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.7 p -145.33 170.22 16.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.067 -0.395 . . . . 63.43 111.797 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -67.95 113.96 6.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.542 0.571 . . . . 75.150000000000006 112.542 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 132.21 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.127 -0.488 . . . . 53.530000000000001 111.102 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.77 84.81 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.29 0.567 . . . . 61.329999999999998 111.524 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.89 -21.79 37.23 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.949 -0.568 . . . . 64.310000000000002 111.021 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.0 m 66.4 98.37 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.748 -0.66 . . . . 51.530000000000001 111.261 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.25 1.107 0 C-N-CA 123.421 0.688 . . . . 64.150000000000006 112.676 -179.296 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.802 0.334 . . . . 73.340000000000003 111.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.28 -178.29 53.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.161 -0.542 . . . . 55.140000000000001 113.493 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -135.58 161.18 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.519 -0.4 . . . . 75.510000000000005 111.132 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.48 103.91 4.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.365 -0.379 . . . . 55.509999999999998 111.294 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -144.42 130.43 19.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.145 0.497 . . . . 72.109999999999999 111.254 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -92.66 117.74 30.3 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 73.140000000000001 111.849 -175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -148.44 120.51 8.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.093 0.473 . . . . 63.130000000000003 111.331 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -125.4 116.95 22.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.131 -0.486 . . . . 64.519999999999996 111.214 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -130.56 167.98 17.82 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 71.430000000000007 111.79 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.08 -10.42 36.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.033 0.444 . . . . 65.299999999999997 111.036 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 91.2 mmm -76.21 118.08 18.56 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.16 -0.473 . . . . 71.5 111.601 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.4 p -85.03 -64.1 1.21 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 54.149999999999999 111.294 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.05 108.34 2.38 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.263 -0.494 . . . . 74.150000000000006 113.227 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 32' ' ' THR . 45.3 t30 -77.73 103.91 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.278 0.561 . . . . 74.049999999999997 111.178 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.73 125.68 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.054 -0.521 . . . . 75.409999999999997 110.548 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB1' ' A' ' 113' ' ' ALA . 53.7 t -135.49 159.87 40.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.923 0.392 . . . . 74.319999999999993 111.624 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.6 mp -87.06 131.35 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.6 -0.273 . . . . 63.450000000000003 110.341 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -104.3 -34.27 8.38 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.788 0.292 . . . . 74.310000000000002 111.788 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.78 145.01 30.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.102 0.477 . . . . 52.43 111.449 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.36 130.25 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.273 -0.421 . . . . 73.430000000000007 110.796 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.34 147.25 40.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.189 0.519 . . . . 75.140000000000001 110.888 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 97' ' ' GLY . 13.9 p -105.19 -25.07 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 74.219999999999999 111.693 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 21.2 t70 -64.13 -56.66 13.28 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.064 0.459 . . . . 64.109999999999999 111.539 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 144.33 41.89 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.42 -0.419 . . . . 61.039999999999999 112.575 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -113.17 -61.97 1.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.733 0.642 . . . . 74.120000000000005 112.733 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.95 168.19 26.65 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.107 1.151 . . . . 64.319999999999993 114.107 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.3 mt -126.06 131.08 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.906 -1.043 . . . . 72.109999999999999 109.371 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -100.76 101.81 12.75 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.483 0.549 . . . . 71.510000000000005 112.483 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -88.48 156.01 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.329999999999998 110.159 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -146.61 127.72 14.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.952 0.406 . . . . 73.230000000000004 111.762 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -84.37 110.28 18.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.355 -0.384 . . . . 62.439999999999998 110.673 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 14' ' ' ASN . 11.7 t -95.13 9.78 38.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.095 0.474 . . . . 71.239999999999995 111.163 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.1 t -82.39 149.85 27.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.059 -0.518 . . . . 72.450000000000003 111.391 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.73 43.12 1.01 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.27 -0.423 . . . . 74.310000000000002 111.4 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -168.91 154.17 6.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.872 0.368 . . . . 72.239999999999995 111.677 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 11.9 m-20 -68.08 104.11 1.69 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.448 -0.342 . . . . 72.519999999999996 110.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.95 118.9 66.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.85 0.315 . . . . 75.209999999999994 111.85 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.34 117.54 5.03 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.745 2.297 . . . . 70.120000000000005 112.51 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.34 77.32 3.1 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.98 0.419 . . . . 71.530000000000001 111.5 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.66 -68.96 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.028 -0.606 . . . . 71.340000000000003 113.976 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.59 2.89 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.505 -0.379 . . . . 54.340000000000003 113.722 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -129.58 140.1 51.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.542 0.337 . . . . 73.519999999999996 111.135 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 34.3 tt0 -136.12 125.34 24.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.418 . . . . 74.200000000000003 110.733 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -102.83 133.86 47.2 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.0 0.429 . . . . 65.150000000000006 111.811 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 54' ' ' SER . 32.2 mt -127.17 116.77 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.477 -0.329 . . . . 74.299999999999997 110.865 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.588 ' NH2' HG13 ' A' ' 100' ' ' VAL . 67.5 ttt180 -100.84 122.72 43.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.928 0.394 . . . . 73.120000000000005 110.947 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -98.2 137.36 37.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 111.747 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 100' ' ' VAL . 7.3 tt -130.91 91.72 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.53 0.681 . . . . 72.519999999999996 111.485 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.55 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.811 -0.632 . . . . 71.420000000000002 113.602 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.88 -64.85 1.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.605 0.362 . . . . 73.129999999999995 111.78 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -95.06 178.53 5.52 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.895 0.702 . . . . 71.209999999999994 112.895 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -149.27 152.9 36.71 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.176 -0.466 . . . . 63.32 110.968 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.475 HG11 ' NE2' ' A' ' 91' ' ' GLN . 7.9 p -129.57 137.86 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.701 0.286 . . . . 74.400000000000006 111.193 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.464 ' HB3' HG12 ' A' ' 45' ' ' ILE . 85.8 p -120.46 161.97 20.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.991 0.737 . . . . 61.420000000000002 112.991 -175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -163.57 117.99 1.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.624 -0.716 . . . . 73.200000000000003 111.286 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 56.7 tttm -88.1 151.35 22.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.952 0.406 . . . . 73.209999999999994 111.488 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -98.21 168.34 10.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.004 0.431 . . . . 74.349999999999994 111.718 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -130.37 132.38 45.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.997 0.427 . . . . 54.119999999999997 111.752 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.3 t -72.32 86.64 1.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 53.450000000000003 112.334 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 82' ' ' PRO . 14.6 ptm180 -131.29 6.05 4.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.903 0.383 . . . . 73.109999999999999 111.551 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.42 155.15 29.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.336 -0.393 . . . . 64.450000000000003 110.554 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 31.5 m -114.52 130.33 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.251 0.548 . . . . 63.140000000000001 112.049 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.3 mm? -83.45 114.6 21.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.418 -0.355 . . . . 71.239999999999995 110.93 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 35.9 mtmm -66.4 168.61 8.66 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.065 0.46 . . . . 52.020000000000003 111.866 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.22 107.3 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.352 -0.386 . . . . 65.0 111.47 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.88 6.44 67.27 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.401 -0.428 . . . . 30.219999999999999 113.086 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.5 tp60 -79.71 137.13 36.95 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.467 -0.431 . . . . 74.319999999999993 111.511 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.1 p -103.53 139.67 38.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.16 0.505 . . . . 70.420000000000002 111.718 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.35 123.67 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 110.159 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.3 m -95.15 102.22 14.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.176 -0.465 . . . . 62.530000000000001 111.477 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.18 97.53 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.324 -0.398 . . . . 74.099999999999994 111.105 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB2' HG13 ' A' ' 87' ' ' ILE . 93.2 m95 -78.98 160.55 27.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.239999999999995 111.623 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.28 165.93 20.98 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.391 -0.368 . . . . 75.099999999999994 111.209 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.03 -27.58 45.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.521 0.563 . . . . 74.329999999999998 112.521 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.52 25.49 1.68 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.938 0.347 . . . . 74.200000000000003 111.938 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.08 64.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.814 0.672 . . . . 73.219999999999999 112.814 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.52 75.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.165 -0.541 . . . . 52.240000000000002 113.722 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.52 -172.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.556 -0.379 . . . . 72.150000000000006 111.017 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.0 m -61.39 101.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.656 -0.498 . . . . 64.319999999999993 109.656 171.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.87 42.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.113 0.782 . . . . 65.439999999999998 113.113 -168.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.7 m -157.9 139.2 9.69 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 112.275 0.472 . . . . 41.109999999999999 112.275 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 56.0 Cg_exo -44.12 163.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 123.645 2.897 . . . . 62.229999999999997 112.162 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 26.9 Cg_exo -11.02 -80.75 0.0 OUTLIER 'Cis proline' 0 C--N 1.375 1.925 0 N-CA-C 121.297 3.537 . . . . 63.140000000000001 121.297 17.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.7 t -106.37 -79.39 0.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.83 1.418 . . . . 64.310000000000002 114.83 -165.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.659 ' H ' HG23 ' A' ' 84' ' ' THR . 21.8 m-20 -68.59 129.14 39.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.0 0.741 . . . . 63.100000000000001 113.0 -167.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 104.3 16.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.891 -0.595 . . . . 74.129999999999995 111.288 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -74.52 121.82 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.781 0.324 . . . . 74.349999999999994 110.533 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.412 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.6 t90 -64.91 77.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.352 0.596 . . . . 72.200000000000003 111.078 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.74 22.44 0.59 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.179 -0.464 . . . . 63.520000000000003 112.234 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 18.4 m120 -120.53 11.55 11.36 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.054 0.454 . . . . 75.109999999999999 110.939 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.475 ' NE2' HG11 ' A' ' 53' ' ' VAL . 54.0 tt0 -150.48 131.96 14.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.26 -0.427 . . . . 71.209999999999994 111.096 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -80.26 178.8 8.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.922 0.391 . . . . 61.409999999999997 111.209 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -66.84 116.27 7.53 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.338 -0.226 . . . . 75.329999999999998 111.015 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.469 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 43.6 p90 -60.66 -47.15 87.51 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.319 0.488 . . . . 73.049999999999997 112.319 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 58.26 11.76 10.37 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.721 0.648 . . . . 71.239999999999995 114.721 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -71.0 -31.41 67.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.772 0.656 . . . . 63.43 112.772 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 22' ' ' VAL . . . 69.22 14.22 68.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.981 -0.628 . . . . 63.210000000000001 113.037 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -96.58 179.22 5.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.224 0.535 . . . . 54.420000000000002 112.071 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 15.0 p-10 -60.99 -45.32 95.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.769 -0.651 . . . . 70.349999999999994 111.599 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG13 ' NH2' ' A' ' 46' ' ' ARG . 7.4 p 30.73 88.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 72.340000000000003 113.28 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HD2' ' OE1' ' A' ' 114' ' ' GLN . 34.1 ttpt -86.94 138.53 31.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.077 -0.965 . . . . 75.420000000000002 112.846 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 12.4 p -103.63 142.66 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 112.068 0.396 . . . . 74.099999999999994 112.068 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mm -122.41 138.59 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.763 0.425 . . . . 61.119999999999997 111.579 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 17' ' ' ILE . 52.4 mt -107.79 121.01 43.85 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.953 0.406 . . . . 74.230000000000004 111.769 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 67.8 mttm -115.13 149.0 38.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.087 -0.506 . . . . 62.030000000000001 111.167 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.39 -176.92 6.07 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.105 0.479 . . . . 52.43 111.008 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.3 p -55.62 -34.94 65.35 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.144 -0.48 . . . . 64.120000000000005 111.001 170.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -72.89 -12.64 61.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.128 -0.487 . . . . 51.549999999999997 111.99 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.91 1.58 84.81 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.88 0.712 . . . . 53.009999999999998 114.88 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 105' ' ' LYS . 11.9 pt-20 -92.48 178.52 5.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.107 0.953 . . . . 74.129999999999995 112.033 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -92.24 133.59 35.67 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.244 0.831 . . . . 54.030000000000001 113.244 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.7 t -106.2 -50.23 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.019 -0.537 . . . . 75.129999999999995 110.717 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HB1' ' SG ' ' A' ' 16' ' ' CYS . . . -159.39 162.65 35.82 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.869 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 101' ' ' LYS . 8.0 pt20 -153.17 171.32 18.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.099 -0.501 . . . . 71.510000000000005 111.177 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.3 ttm180 -175.6 147.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.859 0.361 . . . . 74.129999999999995 111.565 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.1 p -110.95 179.26 4.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.457 0.303 . . . . 62.520000000000003 111.002 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 80.7 p -75.48 117.69 17.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.128 0.49 . . . . 63.130000000000003 111.601 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -85.95 111.89 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.914 0.388 . . . . 73.239999999999995 110.623 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.77 70.72 2.57 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.498 0.666 . . . . 74.439999999999998 111.949 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -87.17 -38.92 15.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.845 -0.616 . . . . 64.209999999999994 111.013 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.8 m 57.85 102.33 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.542 0.571 . . . . 64.540000000000006 112.542 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.255 1.371 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 111.932 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.643 ' SD ' ' NE2' ' A' ' 3' ' ' HIS . 20.9 ptp . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 111.732 0.271 . . . . 73.219999999999999 111.732 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.23 1.49 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.029 -0.605 . . . . 72.519999999999996 113.796 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.643 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 33.8 m170 -84.46 88.4 7.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.037 0.446 . . . . 73.219999999999999 110.95 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -94.14 125.14 38.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.957 0.408 . . . . 75.030000000000001 111.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -131.13 93.67 3.43 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.174 0.511 . . . . 73.349999999999994 111.97 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -138.74 102.51 4.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.386 -0.37 . . . . 74.510000000000005 110.891 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -99.58 -3.85 32.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.764 0.653 . . . . 73.0 112.764 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -76.29 105.3 7.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.169 0.509 . . . . 63.130000000000003 110.282 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 m -90.13 97.2 11.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.614 0.598 . . . . 43.219999999999999 112.614 -171.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -134.94 89.35 2.52 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.2 0.524 . . . . 72.549999999999997 110.098 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.5 mmt -88.11 155.36 19.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.765 -0.652 . . . . 63.520000000000003 111.924 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 t -141.52 113.98 8.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.092 -0.503 . . . . 71.430000000000007 111.626 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.3 101.32 2.75 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.226 -0.512 . . . . 72.319999999999993 112.653 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -100.32 9.12 43.16 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.276 0.473 . . . . 70.120000000000005 112.276 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.48 124.48 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.889 0.375 . . . . 75.010000000000005 111.216 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -144.95 174.38 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.502 -0.317 . . . . 65.310000000000002 110.979 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.32 124.5 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.238 -0.289 . . . . 73.510000000000005 111.483 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.77 -53.25 6.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.921 0.391 . . . . 72.219999999999999 110.872 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -165.02 137.06 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.23 0.538 . . . . 54.109999999999999 111.798 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 27' ' ' ILE . 61.2 mt -104.22 126.15 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.27 -0.423 . . . . 64.349999999999994 110.238 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.28 122.47 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.134 0.492 . . . . 73.329999999999998 111.87 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.64 -26.12 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.142 -0.481 . . . . 72.150000000000006 111.938 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -33.48 73.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.818 0.342 . . . . 64.019999999999996 110.586 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.64 30.05 3.92 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 114.126 0.41 . . . . 72.120000000000005 114.126 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 6.8 mtpm? -98.98 -39.94 8.3 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.791 0.663 . . . . 75.409999999999997 112.791 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -153.6 158.19 40.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.265 0.839 . . . . 73.329999999999998 113.265 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 102' ' ' VAL . 66.0 mt -118.89 107.44 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.439999999999998 109.648 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 35.6 ttt85 -97.85 117.61 32.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.317 0.58 . . . . 75.010000000000005 112.512 -171.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.553 ' HB2' HG13 ' A' ' 69' ' ' VAL . 6.5 mp -97.8 -172.68 2.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.011 -0.541 . . . . 63.119999999999997 111.501 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 22.9 ttmm -158.05 139.4 13.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.942 0.401 . . . . 72.239999999999995 111.719 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -103.21 100.26 10.16 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.451 -0.34 . . . . 71.540000000000006 110.253 168.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 5.0 t -102.27 98.83 8.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.411 0.624 . . . . 71.109999999999999 111.314 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -166.69 -178.46 4.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 111.633 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -109.67 7.04 24.25 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.936 -0.574 . . . . 74.319999999999993 110.392 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -135.4 135.03 40.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 74.549999999999997 110.816 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.43 134.19 49.8 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.995 0.426 . . . . 61.130000000000003 111.853 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 27.3 mm-40 -89.0 112.77 52.91 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.391 -0.368 . . . . 72.439999999999998 111.213 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 2.7 Cg_exo -76.3 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.777 2.318 . . . . 32.439999999999998 113.122 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.17 -73.27 0.05 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.104 0.562 . . . . 75.540000000000006 111.734 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 -75.48 1.57 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.143 -0.551 . . . . 73.049999999999997 113.001 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.67 93.7 0.11 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 74.319999999999993 113.403 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -116.44 167.71 10.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.661 0.384 . . . . 72.209999999999994 110.712 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -144.42 132.34 21.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.171 0.51 . . . . 74.219999999999999 111.34 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.6 ttp -103.82 107.78 18.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.848 -0.614 . . . . 60.350000000000001 111.428 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.9 mp -95.11 99.94 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.781 0.324 . . . . 71.340000000000003 110.845 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.438 HH12 ' NE2' ' A' ' 91' ' ' GLN . 32.9 ttt180 -85.89 102.84 14.08 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.128 -0.357 . . . . 73.109999999999999 111.101 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -96.88 117.73 31.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.438 -0.346 . . . . 74.319999999999993 111.09 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.16 122.43 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.134 0.493 . . . . 73.129999999999995 112.037 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.7 -110.28 2.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.989 -0.551 . . . . 33.329999999999998 113.907 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.74 27.4 9.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.973 0.36 . . . . 71.349999999999994 111.973 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -153.62 162.35 41.34 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.237 0.541 . . . . 55.25 112.005 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -153.81 114.01 3.93 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.021 -0.536 . . . . 50.439999999999998 110.205 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.39 134.87 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.941 0.401 . . . . 65.129999999999995 111.809 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.2 m -109.16 124.24 50.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.288 -0.415 . . . . 70.349999999999994 111.697 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.459 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 70.0 t80 -114.26 108.77 17.39 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.807 0.337 . . . . 74.099999999999994 111.686 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.35 109.67 11.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.917 0.389 . . . . 73.349999999999994 110.542 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 94.1 m-85 -56.18 135.49 53.19 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.644 0.609 . . . . 54.420000000000002 112.644 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -97.27 123.1 40.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.044 -0.525 . . . . 64.200000000000003 111.248 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 t -73.56 68.72 1.19 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.118 0.414 . . . . 75.430000000000007 112.118 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -87.04 -12.87 46.02 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.987 0.422 . . . . 73.450000000000003 111.375 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.46 167.8 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.509 -0.314 . . . . 73.420000000000002 110.285 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.76 121.36 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.873 0.368 . . . . 73.450000000000003 111.593 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -76.24 87.1 3.07 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.479 0.657 . . . . 62.030000000000001 110.166 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 158.33 30.62 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.955 0.724 . . . . 62.219999999999999 112.955 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.62 117.89 6.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.612 -0.722 . . . . 75.310000000000002 112.841 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.53 -19.75 35.92 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.306 -0.473 . . . . 63.100000000000001 114.028 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.44 141.7 38.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.396 0.617 . . . . 75.120000000000005 111.747 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.4 p -105.31 98.38 8.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.783 -0.644 . . . . 72.540000000000006 111.735 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 29' ' ' LEU . 3.8 p -69.8 117.61 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 64.209999999999994 111.693 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 37.0 m -97.55 123.05 41.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.149 0.5 . . . . 62.119999999999997 111.921 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 57' ' ' TYR . 47.8 mm -84.28 102.76 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.318 -0.401 . . . . 60.509999999999998 110.928 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.75 118.15 24.26 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.51 -0.314 . . . . 74.310000000000002 110.621 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' ASN . . . -71.45 77.46 0.77 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.65 0.611 . . . . 55.340000000000003 112.65 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 56.51 -72.82 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.399 0.889 . . . . 74.200000000000003 113.399 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 73' ' ' ALA . 65.5 m-20 -87.94 100.71 13.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.908 0.385 . . . . 63.340000000000003 111.43 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.47 9.02 0.34 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.546 0.573 . . . . 54.020000000000003 112.546 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.65 -35.84 1.83 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.169 -0.539 . . . . 42.130000000000003 114.31 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.66 149.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.381 0.511 . . . . 74.420000000000002 112.381 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -62.84 175.7 0.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.54 0.57 . . . . 62.420000000000002 112.54 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.44 76.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.092 0.775 . . . . 75.200000000000003 113.092 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.491 ' HA ' HD13 ' A' ' 87' ' ' ILE . 69.8 m 65.17 104.17 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.621 0.971 . . . . 73.200000000000003 113.621 173.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HB3' HG22 ' A' ' 84' ' ' THR . 67.6 Cg_exo -45.96 169.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 123.747 2.965 . . . . 51.229999999999997 112.016 166.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER 10.76 65.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 N-CA-C 121.65 3.673 . . . . 74.0 121.65 38.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 82' ' ' PRO . 15.3 t 144.74 -59.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.3 1.84 . . . . 71.120000000000005 110.812 162.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' H ' ' CB ' ' A' ' 82' ' ' PRO . 21.3 m-20 -110.76 -168.62 1.33 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.195 0.598 . . . . 61.32 110.296 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -141.78 137.15 31.37 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.945 0.402 . . . . 63.509999999999998 111.603 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 81' ' ' SER . 1.6 mp -91.36 123.7 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.699 0.761 . . . . 71.230000000000004 111.016 175.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.496 ' CE2' ' HB2' ' A' ' 90' ' ' ASN . 21.7 t90 -92.12 109.74 21.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.324 -0.853 . . . . 65.099999999999994 110.999 -176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -93.88 2.07 56.24 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.246 0.832 . . . . 74.549999999999997 113.246 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 17.2 m120 -74.01 -40.81 62.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.86 -0.525 . . . . 72.519999999999996 111.755 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' NE2' HH12 ' A' ' 46' ' ' ARG . 39.9 tt0 -148.52 155.88 41.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.605 0.24 . . . . 71.400000000000006 110.607 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.675 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.7 m120 -91.97 175.96 6.69 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 112.447 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -59.57 125.13 22.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 72.209999999999994 111.508 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -104.56 -173.66 2.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.01 0.433 . . . . 73.019999999999996 111.664 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.76 95.86 0.14 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.265 -0.493 . . . . 52.009999999999998 112.759 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -167.51 160.44 13.1 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.668 -0.313 . . . . 63.420000000000002 111.438 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.15 4.1 62.39 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.289 -0.481 . . . . 44.039999999999999 113.122 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.76 156.67 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.175 0.512 . . . . 64.310000000000002 112.248 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.91 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.777 0.658 . . . . 42.329999999999998 112.777 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 117' ' ' THR . 6.5 p -81.04 79.61 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.079 0.942 . . . . 62.509999999999998 109.622 167.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 3.9 ttmp? -88.13 105.63 17.63 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.554 -0.748 . . . . 62.020000000000003 111.391 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 27' ' ' ILE . 61.7 t -91.05 123.39 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.665 -0.698 . . . . 74.530000000000001 111.48 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 21.4 mm -106.57 117.66 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.149 -0.478 . . . . 61.329999999999998 110.934 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -91.96 121.72 33.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.838 0.351 . . . . 54.119999999999997 111.341 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 93.6 mttt -130.58 168.27 17.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.711 0.291 . . . . 65.409999999999997 111.315 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 20.3 m120 -97.08 175.6 6.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.901 0.381 . . . . 74.409999999999997 111.141 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -57.97 -33.2 68.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.775 0.658 . . . . 75.030000000000001 112.775 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.91 0.68 17.44 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 72.109999999999999 112.436 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.42 33.53 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.152 -0.547 . . . . 30.0 113.336 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 10.9 pt-20 -103.08 127.28 50.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.943 0.401 . . . . 61.43 110.918 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.2 tt0 -76.82 138.93 40.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.978 0.418 . . . . 52.0 111.97 -175.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.45 -61.99 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.256 -0.429 . . . . 44.119999999999997 111.326 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.99 162.19 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.7 0.286 . . . . 62.450000000000003 111.57 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.36 157.64 42.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.993 0.425 . . . . 73.329999999999998 111.834 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -164.31 156.19 16.31 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.977 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.7 p -141.17 -162.37 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.6 0.238 . . . . 75.140000000000001 111.3 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.647 HG23 HG12 ' A' ' 100' ' ' VAL . 17.0 p -61.71 94.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.173 0.511 . . . . 63.32 111.89 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.37 86.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.455 0.645 . . . . 74.510000000000005 110.846 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -78.38 26.0 0.23 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.897 -0.592 . . . . 74.400000000000006 112.39 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -140.48 133.28 29.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.147 -0.346 . . . . 61.140000000000001 110.559 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -94.46 128.26 40.92 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.209 0.528 . . . . 63.100000000000001 111.336 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.041 0.385 . . . . 74.25 112.041 -176.051 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.12 0.486 . . . . 63.240000000000002 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.9 158.61 10.16 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.032 -0.531 . . . . 41.200000000000003 112.784 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -136.62 21.83 3.12 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.72 0.637 . . . . 75.239999999999995 112.72 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -104.56 95.89 6.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.767 0.317 . . . . 74.200000000000003 111.405 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -108.94 -14.73 14.51 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.355 0.502 . . . . 71.040000000000006 112.355 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -75.74 82.97 2.71 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.145 0.498 . . . . 41.119999999999997 111.876 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -128.67 112.02 13.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.206 -0.452 . . . . 75.140000000000001 111.28 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.55 ' NE2' ' SD ' ' A' ' 11' ' ' MET . 56.5 p-80 -132.29 112.91 12.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.981 0.419 . . . . 65.439999999999998 110.304 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 p -82.91 58.83 4.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.187 0.518 . . . . 72.510000000000005 112.221 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -151.44 83.17 1.3 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.085 -0.507 . . . . 74.120000000000005 110.129 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.55 ' SD ' ' NE2' ' A' ' 8' ' ' HIS . 94.3 mmm -140.05 152.5 46.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 74.329999999999998 112.32 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 t -128.14 170.21 13.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.758 -0.655 . . . . 73.5 111.167 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 129.07 10.52 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 114.306 0.482 . . . . 44.509999999999998 114.306 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -114.43 -57.7 2.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.85 0.357 . . . . 73.310000000000002 111.435 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.89 143.68 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.324 -0.398 . . . . 55.409999999999997 111.331 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 44.2 t -141.62 173.37 11.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.091 0.472 . . . . 74.049999999999997 111.699 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.537 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 61.0 mt -81.51 127.45 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.344 -0.389 . . . . 73.209999999999994 111.33 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 37.0 tt0 -81.71 -58.33 3.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.659 -0.497 . . . . 71.439999999999998 109.659 171.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 25.2 tt0 173.82 152.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.799 -0.637 . . . . 65.340000000000003 111.097 169.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 102' ' ' VAL . 23.1 mt -71.89 162.57 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 116.164 -0.471 . . . . 74.299999999999997 111.239 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 20' ' ' ILE . 19.0 t70 -61.14 150.36 34.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.229 0.537 . . . . 73.239999999999995 111.835 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.07 -33.45 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.849 -0.614 . . . . 63.420000000000002 112.268 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.52 -30.58 19.24 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.147 0.498 . . . . 73.219999999999999 111.028 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.04 35.75 3.86 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 112.827 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -96.06 -29.04 14.32 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.709 0.29 . . . . 74.409999999999997 111.759 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.09 176.01 12.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.463 0.649 . . . . 74.409999999999997 112.286 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -119.89 138.54 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.805 -0.634 . . . . 75.530000000000001 109.946 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 28' ' ' ARG . 10.3 ttp180 -119.26 110.21 16.74 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 111.9 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.6 mp -106.9 175.51 5.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.981 -0.554 . . . . 75.219999999999999 110.57 175.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.3 ttmt -151.71 138.67 19.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.936 0.398 . . . . 75.299999999999997 111.713 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -75.46 84.57 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.562 . . . . 63.310000000000002 110.821 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.2 p -78.0 89.03 4.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 61.439999999999998 111.094 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.4 p -158.48 -175.77 5.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.305 -0.407 . . . . 71.430000000000007 111.161 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.47 -4.52 31.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.334 0.494 . . . . 62.32 112.334 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -156.39 166.68 32.72 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.786 0.327 . . . . 65.310000000000002 111.306 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -54.97 117.15 3.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.79 0.293 . . . . 73.530000000000001 111.79 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -127.46 112.86 21.11 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 122.618 0.367 . . . . 72.439999999999998 110.889 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 58.2 Cg_endo -70.67 136.9 31.65 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.251 1.968 . . . . 62.450000000000003 112.921 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 tpt -66.28 -85.59 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 116.452 -0.34 . . . . 75.340000000000003 110.706 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.93 -83.09 0.02 OUTLIER Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.362 0.905 . . . . 61.229999999999997 115.362 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.48 46.07 3.19 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.605 0.602 . . . . 64.230000000000004 114.605 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -120.25 147.27 45.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.457 -0.437 . . . . 73.129999999999995 111.124 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -113.77 109.82 19.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.04 -0.527 . . . . 65.340000000000003 110.758 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -91.34 116.25 28.69 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.236 -0.438 . . . . 73.219999999999999 111.717 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.5 mp -106.26 103.62 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 109.811 -0.44 . . . . 73.120000000000005 109.811 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.503 HH12 ' HB ' ' A' ' 48' ' ' ILE . 47.7 ttp85 -89.39 114.1 25.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 73.129999999999995 111.628 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -93.44 168.71 10.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.101 -0.499 . . . . 74.319999999999993 111.304 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 49' ' ' GLY . 10.8 tt -169.74 -60.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.853 -0.612 . . . . 70.230000000000004 111.148 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -159.68 114.87 0.63 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.235 -0.507 . . . . 70.5 112.584 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 67.45 -75.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.213 0.605 . . . . 75.129999999999995 111.999 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -93.88 150.86 20.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.196 0.522 . . . . 63.240000000000002 112.151 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.6 p -142.06 149.73 40.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.053 0.454 . . . . 72.099999999999994 111.444 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.34 146.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.827 0.346 . . . . 74.010000000000005 111.654 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.417 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.5 p -111.91 164.49 13.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.821 0.674 . . . . 61.100000000000001 112.821 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -161.36 135.07 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.006 -0.543 . . . . 75.010000000000005 111.514 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -91.6 135.12 34.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.566 0.222 . . . . 75.0 110.724 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -67.58 147.02 53.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.044 0.449 . . . . 64.530000000000001 111.974 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 t -81.2 126.24 31.27 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.365 0.602 . . . . 63.109999999999999 112.226 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.9 m -85.49 82.85 8.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 110.94 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -135.32 14.04 3.51 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.633 0.605 . . . . 75.340000000000003 112.633 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -165.53 158.64 15.94 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.895 0.379 . . . . 53.32 111.913 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 38' ' ' PRO . 61.4 t -104.57 113.92 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.268 -0.423 . . . . 75.099999999999994 110.308 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.34 118.56 21.36 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.848 0.356 . . . . 75.420000000000002 111.231 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -64.33 152.62 40.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.377 0.608 . . . . 71.549999999999997 112.628 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 127.84 33.15 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.046 -0.525 . . . . 70.129999999999995 111.851 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.01 -2.05 88.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.149 -0.548 . . . . 72.129999999999995 113.41 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -88.44 148.97 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.541 -0.388 . . . . 72.530000000000001 111.389 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 71.3 p -95.75 157.54 15.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.19 0.519 . . . . 72.340000000000003 112.062 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.65 125.21 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.172 0.51 . . . . 73.329999999999998 110.191 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -101.61 108.23 19.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.279 -0.419 . . . . 64.230000000000004 111.948 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 86' ' ' LEU . 44.0 mm -91.77 102.63 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.464 -0.335 . . . . 63.200000000000003 111.23 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m95 -85.0 170.28 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.0 0.429 . . . . 73.510000000000005 111.979 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.82 167.37 11.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.394 -0.366 . . . . 50.240000000000002 111.285 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -51.08 -41.72 60.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.340000000000003 112.677 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -93.49 35.52 1.11 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.844 0.354 . . . . 65.209999999999994 111.849 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -65.19 -45.94 82.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.486 0.55 . . . . 42.299999999999997 112.486 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.1 -38.47 3.17 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.262 -0.494 . . . . 60.240000000000002 113.122 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 87' ' ' ILE . 27.0 m -68.17 170.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.085 0.402 . . . . 72.219999999999999 112.085 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.0 m -60.46 128.93 39.08 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.497 -0.32 . . . . 51.039999999999999 111.413 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.22 -40.17 46.63 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.853 0.686 . . . . 74.540000000000006 112.853 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -146.95 89.38 5.66 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 121.049 0.452 . . . . 64.510000000000005 111.345 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.712 ' HB2' ' H ' ' A' ' 84' ' ' THR . 47.1 Cg_exo -59.34 -32.13 96.18 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.772 2.981 . . . . 71.430000000000007 117.233 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.659 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 28.0 Cg_endo -101.13 37.79 5.59 Favored 'Cis proline' 0 C--N 1.371 1.718 0 CA-C-N 122.437 1.906 . . . . 74.400000000000006 114.532 3.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.712 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 74.9 p -62.83 -48.51 78.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.098 0.475 . . . . 63.439999999999998 111.219 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 4.8 m-20 -93.29 161.13 14.53 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.087 -0.506 . . . . 63.340000000000003 110.943 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.6 mt -130.02 109.54 10.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.87 0.366 . . . . 62.140000000000001 110.631 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 78' ' ' VAL . 1.5 mp -85.47 111.18 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.653 0.74 . . . . 74.420000000000002 111.637 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.572 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 21.2 t90 -79.68 96.86 6.34 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.309 -0.859 . . . . 73.209999999999994 111.19 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 53.4 mtmt -93.35 22.39 5.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.383 0.883 . . . . 71.200000000000003 113.383 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 14.7 m120 -89.92 -8.58 51.48 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.118 0.485 . . . . 75.519999999999996 110.799 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -150.91 134.47 16.37 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.025 -0.534 . . . . 75.040000000000006 111.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.3 m120 -64.67 -56.06 16.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.467 0.543 . . . . 72.420000000000002 112.467 -175.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.9 t -179.09 -178.44 0.52 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.552 0.341 . . . . 65.019999999999996 110.793 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -142.22 -82.64 0.2 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 111.634 0.235 . . . . 73.310000000000002 111.634 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 35.28 49.06 0.87 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 115.912 1.125 . . . . 43.329999999999998 115.912 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -156.37 137.32 13.53 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.862 1.06 . . . . 64.200000000000003 113.862 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.15 -97.97 0.78 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.51 0.964 . . . . 72.519999999999996 115.51 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -84.92 177.23 8.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.078 0.77 . . . . 75.239999999999995 113.078 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 7.4 p-10 -75.27 121.38 22.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.101 -0.954 . . . . 74.129999999999995 112.382 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 HH11 ' A' ' 46' ' ' ARG . 7.3 p -81.07 128.59 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.171 0.51 . . . . 75.030000000000001 110.955 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -140.15 119.49 12.97 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.34 -0.391 . . . . 65.430000000000007 111.443 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 20' ' ' ILE . 85.0 t -93.81 136.97 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.519 0.563 . . . . 72.120000000000005 112.519 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.0 mm -110.74 132.73 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.772 -0.649 . . . . 53.210000000000001 111.012 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.8 mt -113.61 111.3 21.64 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.762 0.653 . . . . 60.149999999999999 112.762 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -109.07 161.15 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.386 -0.37 . . . . 71.040000000000006 110.765 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 112' ' ' VAL . 7.4 m120 -114.98 97.69 6.37 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.903 0.334 . . . . 74.299999999999997 111.903 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t 47.71 -77.52 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 106' ' ' ASN . 64.6 mt-30 -61.6 -35.46 77.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.77 0.655 . . . . 72.430000000000007 112.77 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.59 -24.17 2.32 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.535 -0.84 . . . . 70.510000000000005 113.618 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.98 150.03 25.7 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.276 0.538 . . . . 75.420000000000002 111.301 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.82 137.53 54.5 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.503 -0.317 . . . . 73.219999999999999 111.655 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.545 HG23 ' OD1' ' A' ' 106' ' ' ASN . 94.7 t -98.91 -68.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.179 0.437 . . . . 64.040000000000006 112.179 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.27 162.78 33.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.067 0.766 . . . . 75.25 113.067 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -152.46 143.72 23.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.151 -0.931 . . . . 52.329999999999998 110.097 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -153.29 142.91 21.86 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.505 0.558 . . . . 61.299999999999997 112.505 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 p -111.94 -174.72 2.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.529 -0.76 . . . . 65.140000000000001 110.812 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 p -122.6 -178.2 3.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.263 0.554 . . . . 71.239999999999995 112.319 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.38 148.23 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.004 -0.543 . . . . 73.030000000000001 111.318 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -77.98 126.85 31.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.387 0.514 . . . . 64.310000000000002 112.387 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -108.3 133.61 52.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.406 0.283 . . . . 64.219999999999999 110.888 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.7 m -76.97 83.69 3.5 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.134 0.492 . . . . 74.430000000000007 111.287 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.625 -0.703 . . . . 73.25 112.005 -177.79 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.005 0.431 . . . . 74.209999999999994 111.652 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.28 49.01 0.05 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.429 -0.415 . . . . 72.530000000000001 112.745 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -102.36 96.71 7.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.866 0.365 . . . . 73.450000000000003 111.353 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -144.26 175.01 10.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.188 0.518 . . . . 74.420000000000002 112.278 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.48 116.92 15.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.091 -0.504 . . . . 74.450000000000003 110.755 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -64.54 107.83 1.5 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.856 0.687 . . . . 73.219999999999999 112.856 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -145.28 137.33 25.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.27 -0.423 . . . . 74.040000000000006 109.901 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -140.62 142.53 35.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.668 0.247 . . . . 64.409999999999997 111.668 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.0 p -178.3 112.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.493 -0.321 . . . . 64.540000000000006 111.757 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -75.63 90.66 2.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.093 0.473 . . . . 72.319999999999993 110.644 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.505 ' HG3' ' HD2' ' A' ' 38' ' ' PRO . 25.4 mmt -99.83 147.27 25.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.149 -0.478 . . . . 74.049999999999997 111.628 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 t -71.9 -37.21 70.14 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.092 -0.504 . . . . 51.420000000000002 111.785 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.62 68.9 1.47 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.013 -0.613 . . . . 72.219999999999999 113.081 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.68 7.79 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.253 -0.557 . . . . 62.530000000000001 110.706 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.419 ' HB ' ' CH2' ' A' ' 42' ' ' TRP . 56.6 t -126.7 139.34 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.059 -0.519 . . . . 63.329999999999998 111.402 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -121.26 159.39 26.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.977 0.418 . . . . 61.119999999999997 111.208 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.572 HD11 ' HG ' ' A' ' 104' ' ' LEU . 55.2 mt -93.13 127.99 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.311 -0.243 . . . . 54.109999999999999 111.316 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.54 -77.02 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.691 0.282 . . . . 74.129999999999995 111.095 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -169.29 158.01 7.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.266 -0.424 . . . . 74.439999999999998 110.838 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 27' ' ' ILE . 48.9 mt -91.69 145.4 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.431 . . . . 71.409999999999997 111.495 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.52 143.45 57.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.394 0.516 . . . . 65.519999999999996 112.394 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.49 -28.31 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.842 -0.617 . . . . 61.229999999999997 112.062 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.09 -31.58 30.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.09 0.471 . . . . 62.43 110.789 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.68 16.55 26.15 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 116.171 -0.468 . . . . 54.119999999999997 113.116 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -78.49 -31.25 47.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.347 0.499 . . . . 72.310000000000002 112.347 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -157.27 167.05 31.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.861 1.06 . . . . 74.030000000000001 113.861 -172.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG23 HG12 ' A' ' 20' ' ' ILE . 68.1 mt -127.07 110.93 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.934 -1.03 . . . . 72.439999999999998 109.343 170.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.3 ttp180 -92.58 117.42 29.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.346 0.593 . . . . 70.5 112.378 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.5 mp -99.91 158.55 15.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.863 -0.608 . . . . 71.150000000000006 110.26 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 65.0 tttm -124.03 116.83 23.47 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.024 -0.422 . . . . 63.43 111.505 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.33 108.14 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.097 0.475 . . . . 73.239999999999995 110.411 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -96.52 18.05 14.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.383 0.512 . . . . 73.420000000000002 112.383 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.8 p -71.72 161.79 30.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.418 0.628 . . . . 73.209999999999994 111.72 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -85.73 -19.4 30.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 72.109999999999999 111.168 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -142.03 158.36 43.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.895 -0.593 . . . . 63.219999999999999 110.587 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.12 135.78 12.62 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.501 0.556 . . . . 75.430000000000007 112.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -134.35 132.46 21.01 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.166 -0.47 . . . . 62.299999999999997 111.33 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 11' ' ' MET . 73.3 Cg_endo -73.46 21.31 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.706 2.271 . . . . 71.109999999999999 113.442 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 tpt 63.5 -78.84 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.474 0.71 . . . . 71.400000000000006 112.285 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.41 -170.49 18.49 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.3 -0.476 . . . . 52.119999999999997 113.732 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.63 1.59 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.309 -0.472 . . . . 70.129999999999995 113.384 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.534 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 11.9 m95 -98.46 151.16 20.9 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 122.481 -0.423 . . . . 75.310000000000002 111.228 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.64 114.41 24.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.884 0.373 . . . . 52.340000000000003 110.001 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.454 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 56.2 ttp -98.33 108.45 21.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.442 -0.344 . . . . 51.030000000000001 111.087 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.4 mp -96.8 109.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.584 -0.28 . . . . 75.319999999999993 111.444 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -99.46 101.29 12.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.69 0.281 . . . . 74.230000000000004 110.931 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 7.6 mtpm? -82.04 84.78 6.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.053 0.454 . . . . 72.129999999999995 110.987 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -103.39 118.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.021 -0.536 . . . . 74.310000000000002 111.248 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 69.02 46.09 60.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.888 -0.672 . . . . 34.119999999999997 111.893 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.8 t70 73.68 -56.25 0.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.456 0.702 . . . . 74.540000000000006 111.953 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -61.61 161.61 9.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.133 0.492 . . . . 75.510000000000005 111.795 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 80.5 p -124.0 132.03 53.64 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.26 0.552 . . . . 61.030000000000001 112.128 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.4 134.31 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.881 -0.6 . . . . 75.0 109.669 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.8 p -120.18 144.18 47.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.167 0.803 . . . . 64.329999999999998 113.167 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -113.83 125.35 53.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.671 -0.695 . . . . 75.019999999999996 110.923 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.97 128.59 38.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.024 0.44 . . . . 63.130000000000003 111.001 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.534 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 21.0 m-85 -84.42 165.19 18.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.202 0.525 . . . . 72.420000000000002 111.694 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -142.96 176.05 9.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.009 -0.541 . . . . 74.5 110.806 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -123.36 105.97 10.28 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.168 0.508 . . . . 71.430000000000007 112.008 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 1.9 ptp180 -140.37 17.68 2.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.974 -0.557 . . . . 74.340000000000003 110.292 173.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 47.1 p90 -162.92 172.13 15.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 111.102 -173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.68 114.63 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.483 -0.326 . . . . 63.350000000000001 110.601 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.45 HD23 ' HE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.42 130.03 39.26 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.073 0.463 . . . . 75.019999999999996 110.645 -177.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 85.2 mttt -71.76 149.63 45.19 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.23 0.538 . . . . 71.329999999999998 112.346 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.47 122.77 14.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.495 . . . . 53.020000000000003 112.036 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 0.04 67.49 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.412 -0.423 . . . . 72.200000000000003 114.111 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.1 tp60 -79.19 148.47 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.173 0.487 . . . . 73.310000000000002 111.898 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 65.1 p -92.7 134.56 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.839 0.352 . . . . 75.430000000000007 111.644 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.31 112.87 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.413 0.625 . . . . 62.350000000000001 111.004 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 85.3 m -91.36 123.95 35.18 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 65.120000000000005 112.047 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.5 mm -90.14 99.24 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.261 -0.427 . . . . 74.140000000000001 110.822 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HB2' HG13 ' A' ' 87' ' ' ILE . 85.6 m95 -84.49 161.79 20.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.975 0.417 . . . . 64.129999999999995 111.966 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -87.27 167.84 13.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.906 0.384 . . . . 51.409999999999997 111.96 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.2 -60.78 2.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.543 0.572 . . . . 62.539999999999999 112.543 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -91.08 41.57 1.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.103 0.477 . . . . 71.150000000000006 111.877 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.27 60.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.81 0.338 . . . . 55.009999999999998 111.664 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.17 -44.22 2.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.319 -0.467 . . . . 74.239999999999995 113.627 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.27 171.03 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.459 0.541 . . . . 71.140000000000001 112.459 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 81' ' ' SER . 57.8 m -53.87 130.24 36.5 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.784 0.326 . . . . 75.450000000000003 111.336 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' HD3' ' A' ' 89' ' ' LYS . . . -78.27 10.28 3.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.413 0.894 . . . . 75.140000000000001 113.413 -173.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.449 ' H ' HG22 ' A' ' 79' ' ' THR . 22.9 t -152.73 133.07 7.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 112.407 0.521 . . . . 73.230000000000004 112.407 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 66.8 Cg_exo -54.33 -178.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.906 3.071 . . . . 54.399999999999999 113.0 172.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 89.6 Cg_endo -93.85 101.67 0.22 Allowed 'Cis proline' 0 C--N 1.366 1.49 0 N-CA-C 115.536 1.322 . . . . 74.319999999999993 115.536 5.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.1 p -158.13 -60.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.509 0.724 . . . . 53.329999999999998 109.56 171.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 8.1 m-20 -122.1 -168.87 1.79 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.304 -0.862 . . . . 74.239999999999995 109.75 172.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.553 ' HB2' HD13 ' A' ' 71' ' ' ILE . 78.4 mt -127.08 108.7 11.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.048 0.452 . . . . 70.25 110.885 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -95.96 108.66 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.318 0.58 . . . . 62.009999999999998 111.436 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.466 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 10.9 t90 -74.35 84.06 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.548 0.69 . . . . 63.520000000000003 110.617 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HD3' ' HB1' ' A' ' 80' ' ' ALA . 9.7 mtmp? -73.1 4.07 4.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.695 0.628 . . . . 73.540000000000006 112.695 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.466 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 16.1 m120 -92.43 -13.35 30.14 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.508 0.559 . . . . 72.540000000000006 112.508 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -151.44 159.13 44.35 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.002 0.43 . . . . 54.240000000000002 111.327 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 52.4 m-80 -109.83 -169.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.565 0.579 . . . . 75.450000000000003 112.565 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.5 m -60.03 156.47 14.77 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.372 0.879 . . . . 70.340000000000003 113.372 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -127.46 160.2 32.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.2 -0.909 . . . . 73.030000000000001 111.116 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.42 48.68 0.36 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.985 -0.626 . . . . 62.020000000000003 112.865 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.4 t -65.65 -22.81 66.68 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.722 0.638 . . . . 73.430000000000007 112.722 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.29 3.43 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.074 -0.584 . . . . 71.219999999999999 113.238 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -82.41 170.22 15.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.145 0.498 . . . . 65.230000000000004 111.849 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.11 164.19 26.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.884 -0.598 . . . . 73.420000000000002 111.781 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.5 p -144.66 140.33 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.96 0.41 . . . . 64.010000000000005 111.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.7 ttpt -107.38 128.87 54.86 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.942 0.401 . . . . 63.310000000000002 111.314 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 17' ' ' ILE . 4.0 p -114.01 136.87 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.325 0.583 . . . . 70.049999999999997 111.886 -178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.38 142.49 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.917 -0.583 . . . . 64.219999999999999 111.599 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 17' ' ' ILE . 38.9 mt -122.95 107.76 12.19 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.054 0.39 . . . . 52.229999999999997 112.054 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -114.12 136.56 52.8 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.296 0.57 . . . . 51.020000000000003 111.337 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 9.4 m120 -93.57 108.05 19.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.823 -0.626 . . . . 73.450000000000003 112.489 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.3 t 59.92 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.297 0.851 . . . . 73.129999999999995 113.297 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.93 -71.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.444 0.64 . . . . 75.239999999999995 111.654 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.58 -22.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.455 -0.793 . . . . 73.400000000000006 111.732 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 9.2 pt-20 -44.28 133.25 5.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.344 0.658 . . . . 73.219999999999999 111.349 171.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.7 128.8 53.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.844 -172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.48 HG13 ' OD1' ' A' ' 106' ' ' ASN . 17.9 m -85.57 -35.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 112.066 0.395 . . . . 72.120000000000005 112.066 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.59 154.01 1.94 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.429 0.633 . . . . 72.099999999999994 112.621 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -139.59 130.15 25.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.565 -0.743 . . . . 74.310000000000002 110.102 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 115' ' ' ARG . 4.0 ttt85 -141.5 148.33 39.24 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.481 0.549 . . . . 51.109999999999999 112.481 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.9 p -106.99 169.8 8.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.241 -0.436 . . . . 44.049999999999997 111.407 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.1 p -78.51 134.22 37.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.032 0.382 . . . . 73.340000000000003 112.032 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.21 135.93 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.945 0.403 . . . . 74.129999999999995 111.475 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -70.69 86.58 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.028 0.442 . . . . 73.430000000000007 111.529 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -96.18 107.58 19.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 75.209999999999994 110.423 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -86.91 -15.3 39.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.97 0.414 . . . . 75.140000000000001 112.07 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.777 -0.63 . . . . 72.230000000000004 110.881 177.013 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.603 0.239 . . . . 71.030000000000001 111.453 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.58 116.43 8.69 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.324 -0.465 . . . . 74.439999999999998 113.449 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -137.64 164.98 27.48 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.439 -0.448 . . . . 64.409999999999997 111.508 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -66.75 91.78 0.2 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.23 -0.441 . . . . 43.119999999999997 111.016 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -82.33 128.29 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.009 0.433 . . . . 72.219999999999999 111.106 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -106.09 175.3 5.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.258 -0.428 . . . . 73.430000000000007 111.122 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -108.34 141.73 39.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.444 0.164 . . . . 71.219999999999999 110.951 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.4 m80 68.91 11.69 8.41 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.098 0.559 . . . . 71.109999999999999 111.708 -172.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -80.3 92.85 5.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.935 0.398 . . . . 63.340000000000003 111.583 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -143.12 123.3 13.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.89 0.376 . . . . 63.340000000000003 111.712 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 mmt -129.88 144.36 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.457 -0.338 . . . . 71.439999999999998 110.798 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.4 p -73.9 -74.35 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.28 0.474 . . . . 72.120000000000005 112.28 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.3 101.82 0.2 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.98 -0.629 . . . . 53.25 113.109 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -102.94 -43.17 5.6 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.598 -0.354 . . . . 72.299999999999997 111.908 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.0 t -84.62 102.84 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.899 0.38 . . . . 73.420000000000002 111.528 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.8 t -121.41 149.82 42.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.818 0.342 . . . . 65.099999999999994 111.404 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 104' ' ' LEU . 61.3 mt -62.37 132.19 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 112.301 0.482 . . . . 75.510000000000005 112.301 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -84.47 -62.39 1.57 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.408 0.623 . . . . 74.109999999999999 110.206 173.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -149.45 136.68 19.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.614 . . . . 72.329999999999998 110.748 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 27' ' ' ILE . 40.9 mt -94.5 146.69 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.945 -0.391 . . . . 75.430000000000007 109.945 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.18 129.87 41.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.141 0.496 . . . . 73.150000000000006 112.069 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.52 -23.54 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.902 -0.59 . . . . 71.150000000000006 111.59 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.37 -32.3 54.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.162 0.506 . . . . 74.120000000000005 110.775 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 102.08 41.9 2.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.073 -0.512 . . . . 73.120000000000005 114.32 173.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -129.36 -6.58 4.77 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.975 1.102 . . . . 71.120000000000005 113.975 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.74 163.19 24.17 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.573 0.953 . . . . 72.409999999999997 113.573 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 20' ' ' ILE . 56.0 mt -134.54 115.5 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.366 -0.834 . . . . 71.219999999999999 110.337 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -94.88 110.34 22.23 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.686 -0.634 . . . . 75.530000000000001 112.172 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 5.8 mp -94.09 145.3 24.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.063 -0.517 . . . . 63.439999999999998 110.636 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -125.65 125.5 43.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.839 0.352 . . . . 71.340000000000003 111.11 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.09 127.54 32.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.719 0.295 . . . . 71.430000000000007 110.906 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.7 p -93.24 -15.99 25.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.313 0.486 . . . . 74.349999999999994 112.313 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.0 p -69.92 134.61 48.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.002 0.429 . . . . 72.319999999999993 111.114 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.62 25.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.118 0.485 . . . . 41.25 111.424 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -147.74 143.74 27.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.16 -0.473 . . . . 71.439999999999998 110.872 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.84 104.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.722 0.409 . . . . 74.019999999999996 111.859 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.04 135.08 20.03 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 111.756 0.28 . . . . 64.209999999999994 111.756 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.95 48.07 2.54 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.701 2.267 . . . . 62.43 112.907 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 tpt 67.23 -69.4 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.422 0.689 . . . . 72.310000000000002 112.059 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.1 4.01 61.53 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.136 -0.554 . . . . 63.119999999999997 113.458 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.87 101.11 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.197 -0.525 . . . . 70.329999999999998 113.345 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -121.16 175.88 5.88 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.599 -0.354 . . . . 74.329999999999998 111.419 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -145.36 123.11 11.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.421 . . . . 74.319999999999993 111.387 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -99.96 117.31 33.98 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.119 -0.491 . . . . 73.150000000000006 111.329 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.2 mp -104.45 105.49 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.036 0.446 . . . . 73.200000000000003 111.036 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.666 HH11 ' HZ3' ' A' ' 88' ' ' TRP . 61.0 ttt180 -82.29 109.02 16.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.499 -0.318 . . . . 74.420000000000002 111.398 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -117.03 141.73 47.88 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.876 0.369 . . . . 75.409999999999997 111.108 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 100' ' ' VAL . 13.3 tt -166.1 -46.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 111.785 0.291 . . . . 73.519999999999996 111.785 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.26 21.29 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.174 -0.536 . . . . 42.509999999999998 113.093 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.23 8.56 5.76 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.536 -0.391 . . . . 74.319999999999993 111.922 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -149.32 166.06 30.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.862 0.363 . . . . 52.509999999999998 111.202 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.0 p -128.26 164.39 22.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.961 0.41 . . . . 74.150000000000006 111.252 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.45 132.69 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.543 -0.299 . . . . 44.140000000000001 110.954 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.413 ' OG ' HG13 ' A' ' 45' ' ' ILE . 69.5 m -104.87 162.05 13.66 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.27 0.557 . . . . 65.140000000000001 112.481 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.402 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 72.3 t80 -142.87 118.96 10.71 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.956 -0.566 . . . . 74.219999999999999 110.645 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -91.67 123.38 35.02 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.834 0.35 . . . . 70.230000000000004 110.54 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -74.56 177.07 6.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.539 0.94 . . . . 64.030000000000001 113.539 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.473 HG23 ' CE2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -125.71 165.87 17.82 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.522 -0.763 . . . . 71.329999999999998 112.09 -177.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 t -106.4 10.4 31.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.216 -0.447 . . . . 54.409999999999997 111.855 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.58 -35.43 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.208 0.448 . . . . 74.230000000000004 112.208 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.473 ' CE2' HG23 ' A' ' 58' ' ' THR . 17.5 p90 -101.19 149.15 24.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.109 0.481 . . . . 72.430000000000007 111.566 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.46 126.11 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.084 0.469 . . . . 70.219999999999999 111.496 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.5 mm? -80.56 96.34 6.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 51.32 110.941 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.41 168.61 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.196 0.522 . . . . 63.329999999999998 111.954 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.76 107.24 0.58 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.137 -0.483 . . . . 61.299999999999997 111.602 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 2.67 83.23 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.44 -0.41 . . . . 74.439999999999998 113.592 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -54.49 120.96 7.38 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.845 0.683 . . . . 72.239999999999995 112.845 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -94.39 112.92 24.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.04 -0.527 . . . . 63.329999999999998 110.975 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.38 128.5 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.02 0.438 . . . . 75.239999999999995 110.726 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.7 m -106.97 118.59 37.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.189 0.519 . . . . 52.210000000000001 112.1 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.36 104.8 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 65.140000000000001 110.644 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 63.3 m95 -87.53 159.19 18.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.953 0.406 . . . . 74.340000000000003 111.26 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.07 175.85 8.77 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.913 0.387 . . . . 70.340000000000003 111.374 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -22.6 19.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.315 0.487 . . . . 60.119999999999997 112.315 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -99.44 29.6 3.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.685 0.278 . . . . 74.109999999999999 111.477 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.77 -62.19 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.07 0.767 . . . . 73.200000000000003 113.07 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.63 -37.72 3.48 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.079 -0.51 . . . . 73.540000000000006 112.351 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 HD11 ' A' ' 87' ' ' ILE . 30.4 m -76.55 166.61 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.84 0.353 . . . . 73.129999999999995 111.707 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -67.13 170.12 7.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.553 0.575 . . . . 55.409999999999997 112.553 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.77 92.2 2.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.834 0.679 . . . . 61.229999999999997 112.834 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.579 ' H ' HD13 ' A' ' 87' ' ' ILE . 71.2 m 59.96 94.54 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.33 0.863 . . . . 65.450000000000003 113.33 172.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.602 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 78.5 Cg_exo -52.77 -41.34 70.54 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.542 2.828 . . . . 62.020000000000003 116.228 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.602 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.4 Cg_endo -98.2 135.97 3.24 Favored 'Cis proline' 0 C--N 1.366 1.477 0 CA-C-N 121.394 1.533 . . . . 71.420000000000002 114.639 -1.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 t -163.8 -48.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.933 -0.766 . . . . 75.219999999999999 108.933 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 8.1 m-20 -86.25 115.11 23.59 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.98 -0.748 . . . . 62.119999999999997 108.98 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -92.59 112.11 23.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.921 0.391 . . . . 50.229999999999997 111.659 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 81' ' ' SER . 2.5 mp -81.93 96.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.578 0.704 . . . . 61.229999999999997 110.636 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.666 ' HZ3' HH11 ' A' ' 46' ' ' ARG . 28.8 t90 -71.44 86.28 0.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.68 -0.691 . . . . 73.120000000000005 111.066 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.17 7.26 9.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.888 0.699 . . . . 72.319999999999993 112.888 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 14.6 m120 -70.06 -27.3 64.52 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.841 0.311 . . . . 72.239999999999995 111.841 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -159.44 156.92 29.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.861 0.362 . . . . 75.430000000000007 111.397 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -170.31 0.97 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.136 0.791 . . . . 70.200000000000003 113.136 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.4 m -67.41 -173.01 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.823 -0.626 . . . . 75.519999999999996 112.58 -173.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.473 ' HB3' ' NH2' ' A' ' 46' ' ' ARG . 49.3 p90 -141.69 147.0 36.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.06 0.457 . . . . 75.329999999999998 111.49 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.66 43.5 0.06 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.357 -0.449 . . . . 75.409999999999997 112.594 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.406 HG22 HD11 ' A' ' 48' ' ' ILE . 14.5 t -83.41 18.65 1.75 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.49 0.552 . . . . 74.219999999999999 112.49 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.61 -37.59 3.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.971 -0.633 . . . . 34.520000000000003 113.115 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.41 151.63 23.38 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.357 0.599 . . . . 71.450000000000003 112.015 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.35 130.34 41.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.33 -0.85 . . . . 71.030000000000001 112.226 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 48' ' ' ILE . 7.3 p -75.85 108.83 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.386 0.612 . . . . 55.130000000000003 110.811 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -90.19 103.13 15.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.491 0.662 . . . . 75.310000000000002 110.859 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.524 HG21 HD13 ' A' ' 27' ' ' ILE . 61.1 t -88.87 126.77 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.575 -0.739 . . . . 75.219999999999999 112.019 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 46.7 mm -97.71 132.18 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.536 -0.756 . . . . 74.049999999999997 111.461 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.663 HD11 HG13 ' A' ' 17' ' ' ILE . 80.8 mt -111.63 108.24 17.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.236 0.541 . . . . 72.230000000000004 111.689 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.85 161.2 16.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.971 -0.559 . . . . 60.030000000000001 111.294 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.58 177.32 7.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.003 0.43 . . . . 72.510000000000005 111.364 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.5 t -74.45 28.96 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.004 0.431 . . . . 54.539999999999999 111.82 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.01 -39.48 1.94 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.126 0.489 . . . . 75.400000000000006 111.374 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.43 -32.93 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.914 -0.474 . . . . 64.25 111.914 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.86 161.32 28.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 74.219999999999999 111.73 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -122.46 138.76 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.261 -0.427 . . . . 75.150000000000006 112.057 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.17 -32.39 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 113.667 0.988 . . . . 74.010000000000005 113.667 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.81 41.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.879 0.696 . . . . 63.0 112.879 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.86 135.93 3.47 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.702 -0.681 . . . . 55.340000000000003 110.894 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -164.32 165.25 21.93 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.17 -0.331 . . . . 75.109999999999999 111.23 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.1 p -129.41 -173.15 2.93 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.884 0.698 . . . . 71.349999999999994 112.884 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.2 p -81.14 127.99 33.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.998 -0.546 . . . . 61.399999999999999 112.404 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.66 103.15 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.096 -0.502 . . . . 63.200000000000003 110.399 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -67.63 105.73 1.97 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.002 0.43 . . . . 73.109999999999999 111.435 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -80.36 105.7 11.82 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 74.549999999999997 111.519 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.7 m -73.39 108.65 6.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.019 -0.537 . . . . 54.140000000000001 111.511 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.697 -0.668 . . . . 63.25 111.585 179.725 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.654 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 120.669 0.271 . . . . 64.340000000000003 111.076 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.34 72.97 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.52 0.568 . . . . 64.329999999999998 114.52 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -84.19 87.79 7.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.467 0.633 . . . . 63.109999999999999 111.775 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -172.72 107.32 0.17 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.073 0.463 . . . . 75.420000000000002 111.762 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -136.97 149.5 47.58 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.522 -0.308 . . . . 74.400000000000006 110.889 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -138.0 159.4 42.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.156 0.503 . . . . 71.109999999999999 112.095 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -123.3 108.73 13.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.405 0.521 . . . . 72.109999999999999 112.405 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -70.57 110.83 5.65 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.859 0.361 . . . . 65.150000000000006 110.374 171.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -98.64 163.83 12.49 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.376 0.51 . . . . 51.539999999999999 112.376 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -133.47 86.24 2.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.03 0.443 . . . . 73.109999999999999 111.428 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.8 mmm -138.77 109.64 6.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.072 -0.513 . . . . 74.030000000000001 110.014 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 -40.67 94.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.356 0.502 . . . . 60.030000000000001 112.356 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.22 -176.0 34.95 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.828 -0.701 . . . . 74.530000000000001 112.736 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -140.54 94.41 2.73 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.265 -0.55 . . . . 70.450000000000003 111.242 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -107.23 104.7 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.434 -0.348 . . . . 75.420000000000002 110.731 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.8 p -119.36 156.28 30.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.786 0.327 . . . . 72.510000000000005 111.69 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 104' ' ' LEU . 67.2 mt -76.08 122.86 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.748 0.309 . . . . 73.219999999999999 111.083 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.11 -35.26 23.8 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.993 0.425 . . . . 71.140000000000001 110.882 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -167.66 145.48 4.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.997 0.427 . . . . 70.219999999999999 111.716 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 27' ' ' ILE . 47.9 mt -113.19 131.92 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.588 -0.278 . . . . 61.140000000000001 110.258 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.55 126.64 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.963 0.411 . . . . 61.200000000000003 111.803 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 7.9 p -82.93 23.03 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.574 0.702 . . . . 73.230000000000004 112.013 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -121.28 -53.08 2.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.048 0.451 . . . . 74.019999999999996 110.112 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.44 13.33 0.57 Allowed Glycine 0 CA--C 1.524 0.64 0 CA-C-N 116.026 -0.534 . . . . 60.43 113.834 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -76.07 -52.94 9.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.596 0.591 . . . . 73.209999999999994 112.596 -176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.35 158.99 39.56 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.472 0.915 . . . . 74.540000000000006 113.472 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 20' ' ' ILE . 59.9 mt -114.33 121.85 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 74.439999999999998 110.153 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -94.41 107.76 19.71 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.391 0.515 . . . . 63.310000000000002 112.391 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.1 mp -100.99 169.4 8.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.851 0.357 . . . . 75.099999999999994 111.118 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.68 128.49 7.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.983 0.364 . . . . 62.329999999999998 111.983 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -91.72 112.4 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.348 -0.387 . . . . 71.409999999999997 110.754 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -100.95 19.0 18.16 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.16 0.505 . . . . 65.439999999999998 111.954 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.0 t -78.27 -176.84 4.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.065 -0.397 . . . . 64.030000000000001 111.646 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.58 -39.19 20.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.053 0.76 . . . . 74.450000000000003 113.053 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 57.9 tt0 -130.5 170.63 13.97 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.822 0.344 . . . . 64.540000000000006 111.591 -171.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.4 m-20 -52.16 104.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.827 0.451 . . . . 54.030000000000001 111.623 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 15.7 mm100 -91.14 136.85 26.79 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.106 0.409 . . . . 74.329999999999998 112.106 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 39.7 Cg_exo -62.08 113.24 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.715 2.277 . . . . 72.519999999999996 112.647 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.59 ' HG3' ' HB3' ' A' ' 57' ' ' TYR . 3.4 tpt -69.56 -28.71 66.22 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.989 0.423 . . . . 72.200000000000003 111.674 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.675 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.28 76.55 0.76 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.387 -0.435 . . . . 64.420000000000002 113.576 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.07 12.63 0.03 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.476 -0.393 . . . . 55.409999999999997 113.156 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.41 ' CZ3' HG21 ' A' ' 112' ' ' VAL . 30.2 m95 -124.89 162.07 25.2 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.696 0.398 . . . . 75.409999999999997 110.803 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -145.49 135.37 23.59 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.029 0.442 . . . . 73.150000000000006 111.371 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.0 ttp -101.69 120.51 40.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.988 -0.551 . . . . 74.219999999999999 111.619 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.4 mp -109.05 118.18 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.647 0.26 . . . . 71.540000000000006 110.576 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.546 ' NH1' HE22 ' A' ' 91' ' ' GLN . 43.8 ttt-85 -90.49 129.77 36.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.066 -0.396 . . . . 54.340000000000003 111.938 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 29.0 mtpp -129.29 147.84 51.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.288 0.566 . . . . 74.329999999999998 111.843 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' HG23 ' A' ' 100' ' ' VAL . 9.6 tt -167.78 -40.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.568 -0.742 . . . . 71.519999999999996 110.193 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.66 -153.94 6.31 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.803 -0.635 . . . . 75.120000000000005 111.864 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 71.73 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.284 0.564 . . . . 73.340000000000003 111.724 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -174.99 163.89 3.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.67 . . . . 74.540000000000006 110.985 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.2 p -163.07 101.51 0.98 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.039 0.447 . . . . 70.430000000000007 111.302 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.17 144.13 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.26 -0.427 . . . . 64.040000000000006 111.37 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.7 m -109.04 158.72 17.46 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.253 0.549 . . . . 53.329999999999998 112.329 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -149.0 109.12 4.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.983 -0.553 . . . . 73.109999999999999 111.204 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -75.8 131.85 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.888 0.375 . . . . 72.099999999999994 111.273 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 52.4 m-85 -78.75 121.76 25.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 110.762 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -79.13 158.04 27.82 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.369 0.507 . . . . 63.219999999999999 112.369 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.675 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 20.7 t -104.29 23.68 12.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.238 -0.437 . . . . 61.140000000000001 111.541 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 81' ' ' SER . 13.5 ptm180 -58.01 -29.67 65.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.867 0.365 . . . . 74.319999999999993 111.618 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -143.18 156.29 44.73 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 71.230000000000004 109.997 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.46 139.8 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.457 -0.338 . . . . 73.420000000000002 111.563 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -84.35 104.3 14.26 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.925 0.393 . . . . 70.409999999999997 111.038 -175.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 63.6 mttm -65.92 168.82 7.5 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.527 0.936 . . . . 65.420000000000002 113.527 -174.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 129.37 37.63 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.541 -0.754 . . . . 73.319999999999993 111.123 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.03 9.15 79.81 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.948 -0.644 . . . . 72.109999999999999 112.763 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.06 117.95 22.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.944 0.402 . . . . 62.229999999999997 111.305 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.0 p -86.1 96.31 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.362 -0.381 . . . . 73.230000000000004 111.011 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' A' ' 29' ' ' LEU . 6.6 p -79.62 119.04 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.538 0.685 . . . . 71.420000000000002 110.988 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 20.2 m -100.0 110.07 22.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 71.310000000000002 111.655 -175.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 49.6 mm -74.12 95.58 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 110.629 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 87.4 m95 -79.89 128.27 33.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.41 -0.359 . . . . 75.340000000000003 110.949 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.51 162.5 6.28 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.284 -0.26 . . . . 55.020000000000003 111.559 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -50.29 -26.02 4.36 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.993 0.738 . . . . 72.140000000000001 112.993 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 92' ' ' ASN . 74.8 m-20 -90.8 28.28 1.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.925 0.393 . . . . 74.540000000000006 111.566 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -59.71 -36.03 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.694 0.627 . . . . 52.219999999999999 112.694 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.1 2.3 82.45 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.095 -0.574 . . . . 63.549999999999997 113.243 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.78 -178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.155 0.502 . . . . 55.009999999999998 111.619 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 m -75.26 139.85 42.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.264 -0.426 . . . . 52.219999999999999 111.288 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.25 79.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.212 0.53 . . . . 73.420000000000002 111.574 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.533 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 8.5 t 66.08 89.87 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 115.484 -0.78 . . . . 54.43 111.729 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 84' ' ' THR . 41.0 Cg_exo -60.97 -30.23 89.5 Favored 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 124.112 3.208 . . . . 72.209999999999994 118.084 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.687 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 33.3 Cg_endo -97.97 -179.43 6.05 Favored 'Cis proline' 0 C--N 1.367 1.532 0 CA-C-N 122.249 1.839 . . . . 72.510000000000005 115.284 6.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.716 HG22 ' HD2' ' A' ' 82' ' ' PRO . 2.9 t 177.01 -44.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.682 -1.599 . . . . 72.329999999999998 108.724 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 70' ' ' THR . 18.2 m-20 -140.06 -171.9 3.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.014 -0.994 . . . . 65.409999999999997 110.157 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 88.9 mt -123.02 132.33 54.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.936 0.398 . . . . 72.530000000000001 111.278 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.8 mp -95.68 125.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.25 0.547 . . . . 64.329999999999998 111.396 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.512 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 16.2 t90 -80.33 90.42 5.58 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.754 -0.657 . . . . 73.099999999999994 111.033 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -80.16 -5.2 55.62 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.424 0.527 . . . . 75.310000000000002 112.424 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 15.1 m120 -82.31 -14.45 55.33 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.543 0.572 . . . . 71.010000000000005 112.543 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.546 HE22 ' NH1' ' A' ' 46' ' ' ARG . 46.7 tt0 -154.27 143.05 20.94 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.254 0.55 . . . . 74.209999999999994 111.528 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.6 m120 -75.11 172.28 12.65 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.111 -0.495 . . . . 74.540000000000006 111.021 175.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.8 p -71.79 114.36 9.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.582 0.23 . . . . 74.329999999999998 110.568 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -59.32 -29.84 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.131 0.419 . . . . 64.409999999999997 112.131 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 48.03 39.41 18.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 114.733 0.653 . . . . 62.409999999999997 114.733 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -133.85 12.4 4.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.158 0.504 . . . . 72.219999999999999 110.941 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 67.18 -112.58 4.94 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.982 -0.628 . . . . 52.240000000000002 112.759 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 66.41 163.13 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.914 0.709 . . . . 74.329999999999998 112.914 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 11.1 p-10 -95.9 87.8 4.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.639 0.733 . . . . 64.530000000000001 110.711 176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 48' ' ' ILE . 7.6 p -96.25 135.38 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.059 -0.519 . . . . 71.439999999999998 111.299 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -115.31 124.26 50.85 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.094 0.473 . . . . 65.140000000000001 111.199 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 27' ' ' ILE . 87.6 t -98.9 136.39 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.035 -0.53 . . . . 72.530000000000001 112.075 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 43.9 mm -103.2 121.31 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.821 -0.627 . . . . 62.109999999999999 111.286 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.746 HD11 HG13 ' A' ' 17' ' ' ILE . 80.7 mt -97.5 121.77 39.78 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.352 -0.218 . . . . 72.129999999999995 111.083 175.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.9 mttt -129.36 159.24 36.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.031 0.443 . . . . 72.450000000000003 111.457 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -93.21 163.77 13.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 54.539999999999999 110.938 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -57.3 -29.75 64.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.306 0.484 . . . . 62.549999999999997 112.306 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -74.75 -19.26 60.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.69 0.626 . . . . 75.319999999999993 112.69 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 135.28 -46.89 1.01 Allowed Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.663 1.025 . . . . 64.299999999999997 115.663 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.91 169.48 17.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.596 0.698 . . . . 73.109999999999999 112.746 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 36.5 tt0 -94.7 146.97 23.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.713 -0.676 . . . . 74.209999999999994 112.181 -173.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.41 HG21 ' CZ3' ' A' ' 42' ' ' TRP . 46.6 t -97.9 -59.6 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.949 -0.569 . . . . 62.119999999999997 110.806 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.59 159.73 14.48 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 64.140000000000001 111.563 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.27 152.03 45.17 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.64 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 115' ' ' ARG . 18.6 ttt180 -156.11 144.87 20.26 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.781 -0.19 . . . . 71.319999999999993 111.362 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.2 p -114.64 175.35 5.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 62.130000000000003 112.377 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 33.0 p -77.17 -174.59 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.936 -0.575 . . . . 71.530000000000001 111.18 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.23 113.26 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.546 -0.297 . . . . 74.030000000000001 111.252 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -61.35 98.15 0.08 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.85 0.357 . . . . 74.430000000000007 110.853 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.28 103.67 6.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.282 -0.417 . . . . 74.230000000000004 111.803 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.6 m -117.04 92.45 3.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.09 0.471 . . . . 63.119999999999997 110.467 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.656 -0.688 . . . . 64.219999999999999 111.921 -177.586 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtm . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.605 -0.146 . . . . 71.120000000000005 110.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 47.89 36.46 14.09 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.369 0.508 . . . . 75.329999999999998 114.369 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -60.03 -41.9 93.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.993 0.425 . . . . 74.019999999999996 110.934 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -59.92 124.06 19.0 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.981 -0.554 . . . . 54.0 111.474 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -88.55 164.98 15.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.427 -0.352 . . . . 75.25 111.589 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.64 85.56 0.11 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.133 0.492 . . . . 75.540000000000006 111.29 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -86.99 128.4 35.08 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.108 0.781 . . . . 61.240000000000002 113.108 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -130.22 131.23 45.46 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.644 -0.707 . . . . 72.109999999999999 109.881 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m -99.05 88.06 3.86 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.075 0.398 . . . . 65.310000000000002 112.075 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -144.98 109.18 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.772 0.32 . . . . 61.210000000000001 110.842 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.6 mmt -94.42 106.67 18.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.757 0.313 . . . . 65.140000000000001 111.392 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.4 p -112.57 97.22 6.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.095 0.474 . . . . 62.420000000000002 111.781 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.9 61.76 4.5 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.455 -0.402 . . . . 64.120000000000005 113.212 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 77.5 m-20 -100.03 23.42 9.9 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.514 -0.404 . . . . 73.239999999999995 111.963 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -102.7 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.961 0.41 . . . . 73.219999999999999 110.221 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.25 151.0 25.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.076 0.465 . . . . 73.030000000000001 112.016 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 104' ' ' LEU . 56.4 mt -77.28 115.4 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.264 -0.426 . . . . 71.239999999999995 110.619 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -84.19 -42.34 16.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.722 0.296 . . . . 73.439999999999998 111.522 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.1 148.61 27.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.230000000000004 112.037 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.66 123.35 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.908 -0.587 . . . . 62.340000000000003 110.265 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.17 140.05 40.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.487 0.661 . . . . 51.5 112.462 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -97.1 -20.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.716 -0.674 . . . . 70.140000000000001 111.142 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -68.02 -34.62 76.83 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.15 0.5 . . . . 62.200000000000003 110.381 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 104.03 44.53 1.61 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.345 0.498 . . . . 44.350000000000001 114.345 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -128.3 -26.08 2.86 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.373 0.879 . . . . 75.430000000000007 113.373 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' HB2' ' CG2' ' A' ' 70' ' ' THR . 49.2 p90 -156.08 152.46 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.884 1.068 . . . . 75.150000000000006 113.884 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -127.06 118.55 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.748 . . . . 75.209999999999994 109.537 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 28' ' ' ARG . 37.8 ttp180 -101.61 110.3 22.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.689 0.626 . . . . 71.319999999999993 112.689 -171.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.9 mp -97.92 169.47 9.62 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.89 -0.596 . . . . 74.25 110.439 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -149.99 140.84 22.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.148 0.499 . . . . 65.219999999999999 111.843 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' HB3' HD12 ' A' ' 63' ' ' LEU . 37.5 t30 -100.27 126.9 46.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.259 -0.428 . . . . 71.540000000000006 111.079 177.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.2 t -113.16 10.97 18.7 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.806 0.336 . . . . 64.400000000000006 111.597 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 32.2 m -65.94 146.23 54.97 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.327 -0.233 . . . . 55.32 111.186 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.88 -19.21 62.65 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.415 0.524 . . . . 62.25 112.415 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 42.7 tt0 -123.06 166.06 15.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.81 0.338 . . . . 72.329999999999998 111.167 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.7 m-20 -55.09 130.84 43.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.763 0.425 . . . . 75.439999999999998 111.84 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -116.41 113.32 40.95 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 112.459 0.54 . . . . 71.439999999999998 112.459 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.54 125.44 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.748 2.299 . . . . 74.019999999999996 111.211 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 tpp -58.07 -20.88 42.89 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.777 0.658 . . . . 53.140000000000001 112.777 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.06 -90.19 0.08 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.249 -0.501 . . . . 70.120000000000005 113.518 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.08 59.66 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.047 -0.597 . . . . 65.329999999999998 113.577 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -76.43 168.8 19.42 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.475 -0.426 . . . . 73.549999999999997 110.912 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.33 113.82 26.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.099 0.476 . . . . 72.540000000000006 111.606 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.4 ttp -92.28 125.54 36.99 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.147 -0.479 . . . . 70.530000000000001 111.213 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.7 mt -117.21 109.11 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.783 0.325 . . . . 73.439999999999998 111.371 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -90.21 107.69 19.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.812 0.339 . . . . 72.010000000000005 111.141 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 37.3 mttm -95.83 129.32 43.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.811 0.339 . . . . 74.239999999999995 111.217 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.6 tt -134.67 100.82 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.445 0.641 . . . . 51.32 110.901 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.83 -103.98 1.31 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.1 -0.571 . . . . 74.019999999999996 112.419 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -102.74 -32.12 9.99 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.035 0.383 . . . . 74.150000000000006 112.035 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -92.91 168.69 10.99 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.3 0.572 . . . . 64.219999999999999 112.39 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.51 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 92.5 p -155.1 150.75 27.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.959 -0.564 . . . . 64.120000000000005 111.415 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.5 p -134.61 140.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.443 -0.344 . . . . 72.430000000000007 110.874 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.4 p -108.3 158.01 17.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.409 0.623 . . . . 73.200000000000003 112.584 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -154.56 115.27 3.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.735 -0.666 . . . . 75.510000000000005 111.069 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -86.33 133.82 33.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.921 0.391 . . . . 75.010000000000005 110.867 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.79 -177.86 2.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.195 0.521 . . . . 70.129999999999995 111.851 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -148.36 142.95 26.5 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.084 -0.507 . . . . 72.340000000000003 110.982 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -95.43 82.45 3.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.049 0.452 . . . . 73.530000000000001 111.983 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.36 6.25 10.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 71.209999999999994 111.209 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.01 152.26 31.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 74.340000000000003 110.362 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 36' ' ' ASP . 11.7 t -115.47 116.92 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.825 0.345 . . . . 71.049999999999997 110.733 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -93.0 123.83 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.488 -0.324 . . . . 43.420000000000002 111.07 -173.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -80.97 -169.82 2.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.753 0.649 . . . . 75.120000000000005 112.753 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' SER . . . -81.68 144.3 31.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.67 0.619 . . . . 71.049999999999997 112.67 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.2 12.32 62.94 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.953 -0.567 . . . . 31.300000000000001 114.038 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -109.32 144.41 37.52 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.446 -0.443 . . . . 72.400000000000006 110.938 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -99.73 143.59 29.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.963 0.411 . . . . 63.340000000000003 112.011 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.77 123.96 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.208 -0.451 . . . . 72.25 110.121 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 86.6 m -101.74 126.72 48.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.472 . . . . 74.540000000000006 112.008 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.7 mm -92.01 103.1 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.43 . . . . 74.319999999999993 110.253 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.429 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -85.58 135.12 33.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.3 -0.409 . . . . 65.019999999999996 111.607 -177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 153.23 40.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.657 0.265 . . . . 71.030000000000001 111.533 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -53.88 -34.32 59.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.736 0.643 . . . . 73.310000000000002 112.736 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.419 HD21 ' HB3' ' A' ' 92' ' ' ASN . 77.2 m-20 -82.37 6.73 16.13 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.651 0.612 . . . . 61.130000000000003 112.651 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.68 77.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.974 0.361 . . . . 64.450000000000003 111.974 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.56 2.02 90.57 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.152 -0.547 . . . . 64.040000000000006 114.2 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.0 171.79 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 122.389 -0.477 . . . . 75.030000000000001 111.823 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 ' H ' ' A' ' 81' ' ' SER . 85.6 m -69.26 126.61 30.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 74.120000000000005 111.701 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -64.99 -15.25 62.08 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.177 0.806 . . . . 73.0 113.177 -176.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.659 ' H ' HG22 ' A' ' 79' ' ' THR . 23.2 t -149.25 86.53 5.55 Favored Pre-proline 0 N--CA 1.474 0.745 0 O-C-N 122.154 -0.341 . . . . 65.150000000000006 111.743 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 84' ' ' THR . 53.9 Cg_exo -53.65 -44.8 45.94 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 122.984 2.456 . . . . 73.530000000000001 115.399 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 69.7 Cg_endo -99.97 132.9 2.21 Favored 'Cis proline' 0 C--N 1.369 1.649 0 CA-C-N 121.161 1.45 . . . . 75.209999999999994 114.095 -1.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.569 HG22 ' HB2' ' A' ' 82' ' ' PRO . 5.1 t -174.72 -47.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.96 -0.563 . . . . 74.0 110.241 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' THR . 17.3 m-20 -89.98 164.55 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.513 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 92.1 mt -126.47 133.85 51.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.035 0.445 . . . . 73.439999999999998 111.412 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 80' ' ' ALA . 1.6 mp -94.28 114.9 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.995 0.426 . . . . 61.310000000000002 111.281 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.509 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 4.5 t90 -66.96 93.46 0.27 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.055 -0.52 . . . . 73.439999999999998 110.691 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -78.51 -28.04 46.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.106 0.41 . . . . 74.310000000000002 112.106 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 15.9 m120 -63.32 -20.31 65.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.287 0.477 . . . . 63.329999999999998 112.287 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 47.5 tt0 -132.63 127.18 34.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.864 0.364 . . . . 64.230000000000004 110.817 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.1 m120 -67.19 -51.81 48.95 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.349 . . . . 72.150000000000006 111.205 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 t -175.21 -179.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 61.229999999999997 111.577 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.547 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 38.5 p90 -153.48 -178.81 7.24 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.131 -0.486 . . . . 73.120000000000005 110.116 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.18 55.17 0.02 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.394 -0.908 . . . . 70.329999999999998 113.166 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -79.83 -40.9 27.47 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.145 0.498 . . . . 73.109999999999999 111.513 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.82 -23.25 19.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.063 -0.517 . . . . 52.539999999999999 112.789 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.51 179.35 5.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.257 0.551 . . . . 64.140000000000001 112.073 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.4 124.41 23.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.741 -0.663 . . . . 72.030000000000001 112.22 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.97 135.64 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.134 0.492 . . . . 75.010000000000005 111.072 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 103' ' ' ILE . 7.7 ttpm? -122.96 136.68 54.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.087 -0.506 . . . . 50.229999999999997 111.718 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.18 123.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.198 0.523 . . . . 72.400000000000006 111.246 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 101' ' ' LYS . 48.8 mm -102.95 135.34 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.831 -0.622 . . . . 65.200000000000003 111.93 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 17' ' ' ILE . 68.6 mt -111.45 105.75 14.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 54.229999999999997 110.797 173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 103' ' ' ILE . 68.3 mttm -107.69 130.62 54.91 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.16 0.505 . . . . 65.230000000000004 111.423 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.94 156.11 39.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.609 . . . . 73.540000000000006 111.66 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -57.5 -16.43 9.75 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.173 0.805 . . . . 75.129999999999995 113.173 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -101.08 12.81 36.95 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.449 0.537 . . . . 73.420000000000002 112.449 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.35 -23.81 33.96 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.888 0.715 . . . . 52.32 114.888 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -76.77 174.8 10.06 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.462 0.631 . . . . 72.310000000000002 111.905 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.87 142.4 50.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.519 -0.31 . . . . 70.219999999999999 111.282 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.84 -32.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 113.323 0.86 . . . . 75.329999999999998 113.323 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.98 152.53 47.75 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.636 0.606 . . . . 74.230000000000004 112.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.65 46.88 0.49 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.313 0.577 . . . . 73.140000000000001 111.276 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -75.54 151.1 37.98 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.183 0.516 . . . . 71.400000000000006 111.958 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.2 p -116.55 173.35 6.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.387 -0.369 . . . . 64.030000000000001 110.903 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.5 p -80.56 169.2 17.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.054 0.454 . . . . 75.319999999999993 111.508 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.39 130.46 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.109 -0.496 . . . . 64.219999999999999 110.705 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -125.99 113.46 17.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.399 0.618 . . . . 74.540000000000006 111.822 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -143.9 27.12 1.49 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.564 -0.744 . . . . 51.439999999999998 110.608 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.1 p 47.68 67.71 0.78 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.293 0.568 . . . . 75.420000000000002 111.166 -172.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.485 -0.769 . . . . 72.510000000000005 112.46 -172.51 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.807 0.337 . . . . 74.230000000000004 111.71 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.61 -129.07 2.7 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.216 -0.447 . . . . 64.420000000000002 112.243 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -77.63 122.47 25.36 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.904 0.383 . . . . 73.420000000000002 111.266 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -70.33 -35.78 73.83 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.815 0.302 . . . . 72.340000000000003 111.815 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 t60 60.72 43.71 12.04 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 112.125 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -118.0 116.02 26.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.176 0.512 . . . . 73.25 111.722 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -140.53 102.83 4.41 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.077 -0.511 . . . . 74.409999999999997 109.912 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -85.73 18.24 2.98 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.554 0.946 . . . . 71.420000000000002 113.554 -168.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -62.72 130.71 46.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.149 0.5 . . . . 64.409999999999997 112.157 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -93.84 11.56 28.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.25 -0.432 . . . . 75.019999999999996 111.621 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 96.1 mmm -70.09 110.18 4.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.028 0.442 . . . . 74.239999999999995 111.49 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -67.02 156.63 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 70.150000000000006 112.093 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.97 76.33 1.42 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.004 -0.617 . . . . 63.240000000000002 113.49 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -79.91 54.5 1.89 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 73.120000000000005 111.902 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.93 114.17 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.41 . . . . 71.409999999999997 110.759 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.67 150.71 20.36 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.23 0.538 . . . . 73.140000000000001 112.243 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.39 110.15 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 62.219999999999999 110.163 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -77.22 -68.13 0.64 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.937 0.347 . . . . 64.319999999999993 111.937 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -155.92 150.49 25.97 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.287 0.565 . . . . 62.310000000000002 111.848 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.665 HD13 HH12 ' A' ' 46' ' ' ARG . 63.4 mt -108.86 137.1 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.065 -0.516 . . . . 72.319999999999993 110.864 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 11.0 t70 -70.19 147.22 50.1 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.392 0.615 . . . . 73.140000000000001 111.939 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.95 -16.87 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.643 -0.708 . . . . 70.209999999999994 111.488 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.5 -26.71 60.17 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 52.020000000000003 110.705 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.93 41.15 3.38 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.928 -0.578 . . . . 74.230000000000004 113.128 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 -37.75 2.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.356 0.872 . . . . 72.420000000000002 113.356 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.596 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 51.3 p90 -155.46 171.78 19.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.186 1.18 . . . . 74.019999999999996 114.186 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 20' ' ' ILE . 60.2 mt -136.68 143.9 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.221 -0.9 . . . . 70.340000000000003 109.265 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.65 115.04 22.02 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.576 -0.703 . . . . 74.450000000000003 112.401 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -104.58 170.42 7.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.876 -0.602 . . . . 61.329999999999998 110.521 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.84 127.76 17.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.019 0.377 . . . . 60.119999999999997 112.019 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -90.38 131.52 36.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 64.219999999999999 110.742 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.4 p -117.5 11.23 13.78 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.31 0.485 . . . . 74.549999999999997 112.31 -176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.7 p -72.78 155.86 39.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.181 0.437 . . . . 64.340000000000003 112.181 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.99 -28.24 68.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.116 0.484 . . . . 64.230000000000004 112.209 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -124.58 139.0 54.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.077 -0.51 . . . . 70.099999999999994 110.411 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.27 126.35 22.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.792 0.329 . . . . 73.530000000000001 111.708 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -91.1 120.93 68.45 Favored Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 54.140000000000001 111.934 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.23 107.74 0.34 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.343 2.029 . . . . 73.519999999999996 112.432 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 tpt -78.99 91.49 4.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.777 0.323 . . . . 72.420000000000002 111.147 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.04 -51.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.89 -0.671 . . . . 74.319999999999993 113.802 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.39 50.72 3.53 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.114 -0.565 . . . . 72.310000000000002 113.619 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -140.92 141.15 34.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.014 0.526 . . . . 73.420000000000002 110.592 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 38.0 tt0 -124.32 126.9 46.8 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.171 0.51 . . . . 72.420000000000002 110.836 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.697 ' HE1' HG21 ' A' ' 71' ' ' ILE . 30.9 ttp -102.04 116.06 31.87 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.653 -0.703 . . . . 74.430000000000007 111.384 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.4 mt -100.41 161.46 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.476 -0.329 . . . . 64.310000000000002 110.615 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.665 HH12 HD13 ' A' ' 20' ' ' ILE . 46.7 ttt85 -158.87 137.07 10.63 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.817 -0.552 . . . . 74.439999999999998 111.344 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 100' ' ' VAL . 94.4 mttt -123.88 147.55 47.56 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.515 0.561 . . . . 72.200000000000003 112.515 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 tt -139.91 109.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.519 -0.764 . . . . 53.310000000000002 110.286 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.13 -78.17 0.68 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.008 -0.615 . . . . 34.130000000000003 112.847 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -136.94 -43.78 0.58 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.951 0.405 . . . . 74.140000000000001 111.502 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -68.01 137.78 55.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.182 0.515 . . . . 71.430000000000007 112.343 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.9 p -118.97 153.08 35.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.229 0.538 . . . . 62.140000000000001 112.044 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.11 151.55 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 115.743 -0.662 . . . . 75.420000000000002 110.288 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -134.99 165.97 24.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.1 0.476 . . . . 71.230000000000004 112.046 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -157.03 113.93 3.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 74.209999999999994 111.109 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 22.2 ttpp -84.01 133.85 34.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.858 0.361 . . . . 70.319999999999993 110.8 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -69.37 158.02 35.9 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.909 0.385 . . . . 71.540000000000006 110.973 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -120.33 129.55 54.03 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.158 0.504 . . . . 71.230000000000004 111.487 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.7 t -76.93 85.96 3.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.084 0.469 . . . . 74.209999999999994 112.05 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 9.8 ptp180 -119.54 4.85 11.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.399 . . . . 71.439999999999998 110.902 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 8.3 p90 -170.79 173.96 5.08 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.127 0.489 . . . . 70.349999999999994 110.69 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.48 129.02 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.208 -0.451 . . . . 62.409999999999997 110.75 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.32 105.71 1.51 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.561 -0.533 . . . . 63.229999999999997 109.561 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -54.55 136.05 45.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.71 0.633 . . . . 63.100000000000001 112.71 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.86 128.92 39.13 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.726 -0.67 . . . . 72.099999999999994 111.508 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.35 32.76 72.13 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.091 -0.576 . . . . 53.43 113.392 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -127.71 149.49 50.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.154 0.502 . . . . 72.040000000000006 111.814 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.4 p -96.4 135.53 38.13 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.104 -0.498 . . . . 61.299999999999997 111.754 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.6 134.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.397 -0.365 . . . . 73.109999999999999 110.828 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 m -104.56 118.62 37.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.267 0.556 . . . . 74.120000000000005 111.951 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.697 HG21 ' HE1' ' A' ' 44' ' ' MET . 44.4 mm -89.18 102.1 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.158 -0.474 . . . . 44.100000000000001 110.859 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -84.29 125.8 32.59 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.631 -0.259 . . . . 74.140000000000001 111.467 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -177.49 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.014 0.435 . . . . 62.43 111.751 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 -16.97 16.96 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.138 0.422 . . . . 71.299999999999997 112.138 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -93.11 19.17 8.24 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.538 -0.301 . . . . 52.439999999999998 111.204 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.662 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -46.54 -61.74 1.68 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.504 0.927 . . . . 75.129999999999995 113.504 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.17 21.48 78.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.799 -0.715 . . . . 62.140000000000001 112.792 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.662 HG22 ' HB1' ' A' ' 76' ' ' ALA . 30.2 m -127.54 -173.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.561 0.344 . . . . 73.219999999999999 110.863 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 p -60.69 123.47 17.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.088 0.471 . . . . 70.099999999999994 111.302 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 9.36 3.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.348 0.499 . . . . 64.209999999999994 112.348 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -134.46 119.04 13.95 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.174 0.435 . . . . 72.329999999999998 112.174 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.653 ' HG3' ' O ' ' A' ' 85' ' ' ASP . 36.8 Cg_exo -54.88 138.18 76.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.773 2.316 . . . . 64.109999999999999 110.101 168.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 5.3 Cg_exo 0.29 103.57 0.0 OUTLIER 'Cis proline' 0 C--N 1.363 1.329 0 N-CA-C 121.498 3.615 . . . . 61.299999999999997 121.498 25.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' ASP . 12.6 t 51.28 -67.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 117.062 2.245 . . . . 75.340000000000003 117.062 162.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 50.5 m-20 -68.21 -178.47 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.758 -0.589 . . . . 74.239999999999995 112.132 -171.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 29.3 mt -146.22 142.85 28.8 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.016 -0.427 . . . . 50.200000000000003 111.419 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.8 mp -103.57 116.41 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 112.033 0.383 . . . . 54.439999999999998 112.033 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.529 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.5 t90 -74.22 82.9 1.84 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.53 0.681 . . . . 74.409999999999997 109.792 173.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -77.13 17.48 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.874 -0.603 . . . . 74.040000000000006 112.414 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.529 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 78.6 m-20 -127.39 12.16 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.378 0.511 . . . . 43.240000000000002 112.378 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -148.64 145.64 27.84 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.205 -0.31 . . . . 64.349999999999994 111.533 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -100.64 -137.16 0.32 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 111.686 0.254 . . . . 71.219999999999999 111.686 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 96.8 p -75.93 -2.3 29.67 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.821 1.045 . . . . 72.310000000000002 113.821 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.0 p90 45.39 22.24 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.154 1.168 . . . . 74.209999999999994 114.154 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.98 -156.67 15.84 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.295 -0.478 . . . . 63.32 113.597 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 t -127.05 -31.3 2.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.103 0.478 . . . . 73.340000000000003 111.515 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.81 48.45 0.21 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.808 -0.517 . . . . 75.430000000000007 111.808 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.01 162.84 14.54 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.618 -0.342 . . . . 74.400000000000006 111.191 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -78.39 43.97 0.49 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.54 0.686 . . . . 51.219999999999999 111.215 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.6 p -66.31 136.3 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 115.534 -0.757 . . . . 71.420000000000002 111.487 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -130.1 150.32 51.42 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.003 0.372 . . . . 70.510000000000005 112.003 -171.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.84 155.71 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.859 0.689 . . . . 75.329999999999998 112.859 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 19.7 mm -126.52 134.73 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.819 0.848 . . . . 74.450000000000003 111.068 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.77 112.84 22.61 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.722 0.296 . . . . 73.109999999999999 111.487 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.34 155.92 34.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.74 0.305 . . . . 65.450000000000003 111.169 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.11 177.98 6.0 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.221 0.534 . . . . 75.129999999999995 111.677 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.8 p -57.79 -20.92 38.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.039 -0.528 . . . . 70.230000000000004 112.027 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.01 -4.61 58.86 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.258 0.466 . . . . 55.210000000000001 112.258 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.89 -19.46 45.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.296 -0.478 . . . . 63.32 113.954 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.09 152.68 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.328 -0.513 . . . . 73.340000000000003 111.759 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -99.55 128.91 45.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.098 -0.501 . . . . 62.310000000000002 112.269 -171.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -84.97 -54.7 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.885 0.374 . . . . 74.200000000000003 111.32 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.83 167.36 30.64 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.395 0.617 . . . . 74.450000000000003 112.483 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.06 153.82 30.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.501 -0.772 . . . . 55.130000000000003 110.896 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -160.26 152.52 20.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.74 0.305 . . . . 73.109999999999999 111.502 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -115.02 178.89 4.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.068 0.461 . . . . 74.129999999999995 111.942 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 p -77.76 149.72 34.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.14 0.495 . . . . 75.329999999999998 111.255 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.11 143.33 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 70.219999999999999 111.241 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.97 100.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.865 0.364 . . . . 53.310000000000002 110.907 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 10.3 mmpt? -114.73 145.41 42.11 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.405 0.622 . . . . 71.400000000000006 112.064 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.6 t -140.22 31.82 1.94 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.54 -0.755 . . . . 65.140000000000001 110.179 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.758 -0.655 . . . . 71.439999999999998 112.348 -177.821 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.745 0.307 . . . . 63.530000000000001 111.704 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.68 -175.22 52.02 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.318 -0.467 . . . . 70.430000000000007 113.779 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -88.58 21.76 2.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.908 0.385 . . . . 73.409999999999997 111.391 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -70.34 66.63 0.31 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.353 0.661 . . . . 72.510000000000005 111.5 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -116.77 104.33 11.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 74.400000000000006 112.08 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -146.19 -174.19 4.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.553 0.341 . . . . 75.319999999999993 110.619 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -79.57 123.57 27.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.108 0.48 . . . . 75.219999999999999 111.526 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -85.75 167.17 15.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.18 -0.464 . . . . 64.099999999999994 111.342 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.0 m -124.65 138.59 54.29 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.906 0.384 . . . . 43.219999999999999 111.69 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -90.5 116.27 28.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.027 0.442 . . . . 70.129999999999995 111.92 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mmt -123.43 141.59 51.84 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.246 -0.434 . . . . 42.310000000000002 111.105 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -81.56 -52.14 7.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.144 0.497 . . . . 62.5 110.802 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.06 100.19 2.22 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.883 -0.599 . . . . 65.299999999999997 113.286 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.62 96.93 10.91 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.322 -0.516 . . . . 70.439999999999998 110.69 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.75 149.74 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.063 -0.517 . . . . 71.129999999999995 110.581 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 p -134.96 145.54 48.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.833 0.349 . . . . 73.219999999999999 111.903 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.13 96.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.978 0.418 . . . . 75.420000000000002 110.554 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.57 -53.2 59.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 64.409999999999997 111.563 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -157.97 146.59 19.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.054 0.454 . . . . 61.200000000000003 111.566 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 HG12 ' A' ' 27' ' ' ILE . 30.7 mt -114.58 122.32 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.465 -0.569 . . . . 62.299999999999997 109.465 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.59 133.32 36.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.022 0.749 . . . . 70.549999999999997 113.022 -171.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.61 -21.76 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.655 -0.702 . . . . 73.420000000000002 112.453 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.69 -24.08 23.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 110.939 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.73 26.22 9.27 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.272 -0.422 . . . . 65.209999999999994 113.508 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 8.5 mtpm? -95.02 -28.08 15.3 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.088 0.773 . . . . 72.200000000000003 113.088 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.58 174.45 11.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.93 0.715 . . . . 75.450000000000003 112.93 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.627 HG12 HG23 ' A' ' 20' ' ' ILE . 52.3 mt -127.81 149.65 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.461 -0.79 . . . . 61.140000000000001 109.357 173.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -130.76 116.3 17.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.332 0.587 . . . . 63.420000000000002 112.071 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -109.1 154.24 22.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.795 -0.639 . . . . 74.450000000000003 110.288 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -124.2 124.28 42.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 65.530000000000001 111.523 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -74.83 97.29 3.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.7 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -79.6 -2.15 41.21 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.912 0.387 . . . . 61.310000000000002 111.391 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -75.37 118.08 17.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.43 -0.35 . . . . 55.43 110.536 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.79 61.24 5.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 71.299999999999997 111.227 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -170.11 159.26 7.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.968 -0.56 . . . . 71.519999999999996 110.463 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.38 101.4 0.95 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.759 0.314 . . . . 62.210000000000001 110.655 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.8 mm100 -105.07 123.74 38.83 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 112.402 0.519 . . . . 63.130000000000003 112.402 -174.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 13.3 Cg_exo -71.28 135.29 26.58 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.589 2.193 . . . . 75.329999999999998 111.91 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 3.2 tpt -65.45 -19.04 65.77 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.958 0.408 . . . . 45.109999999999999 111.943 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -109.13 2.68 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.209 -0.519 . . . . 73.209999999999994 113.312 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.82 60.07 0.2 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.264 -0.493 . . . . 45.119999999999997 112.592 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.8 m0 -79.92 -178.12 6.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.952 0.406 . . . . 64.230000000000004 111.321 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.63 119.52 11.92 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.198 0.523 . . . . 74.019999999999996 111.101 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.503 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 50.8 ttp -97.7 118.14 33.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 111.192 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' SER . 59.7 mt -103.17 132.87 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.555 -0.293 . . . . 71.140000000000001 111.177 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD2' HE22 ' A' ' 91' ' ' GLN . 51.4 ttm-85 -113.51 130.88 56.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.859 0.361 . . . . 62.140000000000001 111.909 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -120.52 133.4 55.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.874 0.368 . . . . 74.120000000000005 110.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 100' ' ' VAL . 11.9 tt -159.17 -42.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.004 0.372 . . . . 53.140000000000001 112.004 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.65 93.87 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.955 -0.64 . . . . 64.409999999999997 113.449 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.65 25.44 14.37 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.438 0.533 . . . . 74.129999999999995 112.438 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -146.92 144.51 29.29 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.201 0.524 . . . . 75.510000000000005 112.386 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -121.79 32.7 5.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.999 -0.546 . . . . 71.329999999999998 110.394 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.22 123.54 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.837 -0.62 . . . . 62.509999999999998 112.145 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.505 ' HB3' HG12 ' A' ' 45' ' ' ILE . 60.3 p -118.6 163.88 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.118 0.485 . . . . 30.329999999999998 111.98 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 62.9 t80 -137.51 111.35 8.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.956 -0.566 . . . . 63.140000000000001 111.901 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -72.33 116.8 13.2 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.033 -0.531 . . . . 75.400000000000006 111.077 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HE2' ' HB2' ' A' ' 44' ' ' MET . 55.4 m-85 -72.13 162.62 29.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.242 0.544 . . . . 71.319999999999993 112.32 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -128.7 133.96 48.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.988 -0.551 . . . . 75.109999999999999 111.574 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 14.8 t -86.46 34.62 0.64 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.431 -0.35 . . . . 62.420000000000002 111.338 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.653 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 2.5 ptm180 -59.03 -22.67 61.08 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.242 0.46 . . . . 45.119999999999997 112.242 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.653 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 44.4 p90 -143.09 149.84 38.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.021 0.439 . . . . 72.409999999999997 110.96 175.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.81 114.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.413 -0.358 . . . . 71.219999999999999 110.576 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.61 136.05 52.41 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.114 0.483 . . . . 71.409999999999997 112.273 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -72.85 160.22 32.5 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 74.319999999999993 112.157 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.59 130.36 41.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.038 -0.528 . . . . 55.350000000000001 111.981 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.05 73.81 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.082 -0.58 . . . . 62.340000000000003 113.551 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -83.52 135.55 34.6 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.97 0.414 . . . . 71.450000000000003 111.859 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -96.13 109.35 21.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.007 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.12 133.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.315 0.578 . . . . 73.200000000000003 111.651 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 55.8 m -105.33 111.64 24.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 52.439999999999998 111.441 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.33 100.28 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.086 0.47 . . . . 55.310000000000002 110.415 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 72.7 m95 -77.47 166.64 22.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.16 -0.473 . . . . 64.120000000000005 111.318 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.67 178.12 4.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.572 -0.285 . . . . 60.310000000000002 110.73 174.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.78 16.46 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.023 0.439 . . . . 50.310000000000002 112.023 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -89.34 19.7 4.26 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.866 0.321 . . . . 70.299999999999997 111.866 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -58.04 -34.5 70.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.005 0.743 . . . . 73.150000000000006 113.005 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -41.53 2.76 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.911 -0.662 . . . . 73.219999999999999 112.865 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.24 -179.6 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.244 0.545 . . . . 73.510000000000005 111.959 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.9 p -76.54 161.02 28.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.109 0.481 . . . . 55.109999999999999 111.521 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.89 2.18 9.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.808 0.67 . . . . 75.329999999999998 112.808 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -144.44 87.89 7.47 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 122.2 -0.313 . . . . 54.100000000000001 111.774 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.594 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 50.8 Cg_exo -55.8 -42.46 67.0 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 123.159 2.572 . . . . 73.319999999999993 115.582 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.594 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 41.6 Cg_endo -99.68 19.72 23.35 Favored 'Cis proline' 0 C--N 1.37 1.683 0 CA-C-N 121.509 1.575 . . . . 74.140000000000001 113.905 1.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.534 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 44.5 p -59.28 -48.73 80.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.012 0.434 . . . . 75.420000000000002 112.104 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 70' ' ' THR . 12.9 m-20 -98.58 179.27 4.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.068 -0.514 . . . . 70.209999999999994 111.833 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.94 129.11 45.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 63.229999999999997 110.974 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.2 mp -96.59 109.21 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.749 0.309 . . . . 73.200000000000003 111.162 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 7.6 t90 -74.55 86.62 2.09 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.256 0.55 . . . . 63.039999999999999 110.422 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -71.59 -20.21 62.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.419 0.526 . . . . 71.030000000000001 112.419 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 10.0 m120 -68.01 -13.57 62.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.365 0.505 . . . . 72.219999999999999 112.365 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.419 HE22 ' HD2' ' A' ' 46' ' ' ARG . 63.6 tt0 -143.29 142.88 31.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.158 0.504 . . . . 75.310000000000002 112.172 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.82 -172.65 3.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 112.003 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.1 p -60.32 127.48 32.0 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 72.310000000000002 111.013 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -102.81 2.1 35.03 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.58 0.956 . . . . 64.010000000000005 113.58 -169.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 96' ' ' THR . . . 84.06 -44.55 3.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.875 -0.679 . . . . 71.129999999999995 114.171 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 95' ' ' GLY . 2.6 m 76.73 -32.86 0.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.705 1.002 . . . . 72.439999999999998 113.705 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.15 -23.33 24.48 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.261 0.864 . . . . 62.5 115.261 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.37 17.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.055 0.761 . . . . 73.519999999999996 113.055 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 t70 59.12 73.29 0.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.502 0.668 . . . . 74.219999999999999 110.308 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 48' ' ' ILE . 6.1 p -81.2 120.62 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.557 -175.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.97 122.18 38.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.113 0.482 . . . . 74.230000000000004 111.768 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.12 131.73 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.891 -0.595 . . . . 72.530000000000001 111.304 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.9 mm -111.99 120.39 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.368 -0.378 . . . . 75.319999999999993 111.395 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -102.95 109.76 21.42 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.382 -0.199 . . . . 71.420000000000002 111.412 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.64 141.16 52.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.375 0.607 . . . . 74.239999999999995 112.162 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -77.27 172.93 12.51 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.653 -0.703 . . . . 70.349999999999994 111.237 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.4 m -57.75 -21.76 43.01 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 111.985 0.365 . . . . 54.119999999999997 111.985 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.72 -7.54 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.574 0.583 . . . . 70.219999999999999 112.574 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 -17.22 57.81 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.957 -0.639 . . . . 52.109999999999999 113.334 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.78 164.15 22.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 60.030000000000001 111.306 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -104.35 142.29 34.83 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.086 0.772 . . . . 75.310000000000002 113.086 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.74 -51.91 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.708 -0.678 . . . . 75.120000000000005 110.14 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -172.6 163.92 5.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.498 -0.773 . . . . 32.119999999999997 111.137 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.1 145.2 31.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.857 0.36 . . . . 70.340000000000003 110.922 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -150.97 143.57 24.37 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.783 0.325 . . . . 72.420000000000002 111.811 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.6 p -108.0 178.66 4.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.501 -0.318 . . . . 73.430000000000007 110.935 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.53 HG22 ' HB ' ' A' ' 20' ' ' ILE . 30.0 p -99.86 120.87 40.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.344 0.868 . . . . 75.409999999999997 113.344 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.76 95.51 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.684 -0.487 . . . . 63.130000000000003 109.684 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -57.72 112.61 1.51 Allowed 'General case' 0 CA--C 1.543 0.712 0 CA-C-O 121.454 0.645 . . . . 63.219999999999999 112.223 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.15 158.73 20.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.785 -0.643 . . . . 75.010000000000005 111.846 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.5 m -137.56 94.8 2.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.69 -0.686 . . . . 71.549999999999997 110.02 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.252 1.213 0 N-CA-C 112.366 0.506 . . . . 64.230000000000004 112.366 -175.788 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.86 0.362 . . . . 61.420000000000002 111.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.19 146.94 21.52 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.125 -0.559 . . . . 64.299999999999997 112.842 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -95.62 143.89 26.52 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.079 0.466 . . . . 60.240000000000002 111.537 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -130.64 124.79 32.44 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.198 -0.456 . . . . 70.439999999999998 110.932 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -68.68 122.99 19.69 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.87 0.367 . . . . 70.319999999999993 111.72 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 7' ' ' HIS . 12.6 t60 -132.28 164.77 25.69 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 110.126 -0.324 . . . . 71.450000000000003 110.126 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 9.6 m170 68.99 31.39 4.17 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.11 0.481 . . . . 71.040000000000006 111.133 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -79.19 73.02 5.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.076 0.465 . . . . 74.420000000000002 110.891 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -96.66 178.86 5.18 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.23 0.456 . . . . 64.120000000000005 112.23 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -141.66 122.2 14.17 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 111.285 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.4 mmt -133.21 120.41 21.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.997 0.427 . . . . 73.25 111.718 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -96.45 -157.88 0.62 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.231 -0.44 . . . . 72.219999999999999 111.018 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.72 78.1 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 C-N-CA 121.329 -0.462 . . . . 53.030000000000001 113.46 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -97.13 3.55 51.59 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.159 0.429 . . . . 75.200000000000003 112.159 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -90.28 94.87 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.166 0.508 . . . . 71.439999999999998 110.384 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.62 153.09 18.01 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.908 0.385 . . . . 71.340000000000003 112.032 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.437 HG22 ' HD2' ' A' ' 115' ' ' ARG . 59.2 mt -65.22 125.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.496 -0.32 . . . . 53.039999999999999 110.854 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.07 -52.62 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.186 0.517 . . . . 71.340000000000003 111.046 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.1 158.34 36.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.319999999999993 111.309 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 27' ' ' ILE . 59.7 mt -126.66 143.92 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.752 -0.462 . . . . 71.340000000000003 109.752 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.74 137.73 56.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.912 0.387 . . . . 70.409999999999997 111.345 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.3 p -65.19 -36.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.258 0.466 . . . . 75.239999999999995 112.258 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -81.54 -70.37 0.54 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.016 0.436 . . . . 75.030000000000001 110.461 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.42 38.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.385 -0.912 . . . . 74.400000000000006 114.784 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -89.09 -50.52 6.11 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.48 0.64 . . . . 65.140000000000001 112.457 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.0 162.86 35.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.515 0.932 . . . . 60.520000000000003 113.515 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 20' ' ' ILE . 65.7 mt -119.93 137.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.511 -0.768 . . . . 72.209999999999994 109.88 173.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.88 116.61 28.28 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.249 0.547 . . . . 71.349999999999994 112.269 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -106.28 149.56 26.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.155 -0.475 . . . . 44.119999999999997 110.705 177.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB2' HG22 ' A' ' 68' ' ' THR . 82.9 tttt -123.88 131.8 53.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.905 0.383 . . . . 72.510000000000005 111.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB2' HD23 ' A' ' 63' ' ' LEU . 28.3 t30 -85.94 112.0 20.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.725 0.298 . . . . 72.019999999999996 110.564 172.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -98.63 14.54 28.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.834 0.35 . . . . 65.319999999999993 111.848 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 t -87.74 -177.57 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.012 0.434 . . . . 61.43 111.369 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.1 -19.9 16.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.153 0.501 . . . . 71.239999999999995 111.632 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.56 155.95 17.78 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.187 -0.46 . . . . 61.229999999999997 112.11 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 5.0 m-20 -64.66 91.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.164 -0.471 . . . . 62.049999999999997 110.165 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -76.56 116.77 59.42 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 112.82 0.674 . . . . 73.450000000000003 112.82 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.83 144.09 63.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.171 1.914 . . . . 73.099999999999994 112.143 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.801 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -51.78 -26.79 10.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.005 0.431 . . . . 62.109999999999999 111.671 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.1 -100.35 0.45 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 114.448 0.539 . . . . 73.319999999999993 114.448 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 57' ' ' TYR . . . 172.27 55.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.549 0 N-CA-C 112.098 -0.401 . . . . 64.239999999999995 112.098 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -89.43 152.93 21.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.147 0.499 . . . . 74.319999999999993 112.102 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -97.39 118.75 34.55 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.909 -0.587 . . . . 73.140000000000001 111.372 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.585 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 55.8 ttp -98.99 104.75 16.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.188 -0.46 . . . . 63.130000000000003 110.794 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.8 mt -90.96 116.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.327 -0.397 . . . . 74.219999999999999 111.095 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.583 ' HE ' HG21 ' A' ' 100' ' ' VAL . 59.0 ttt180 -116.98 137.3 52.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.694 0.283 . . . . 73.319999999999993 111.513 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 50' ' ' ASP . 85.1 tttt -133.53 116.98 16.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.138 0.494 . . . . 73.140000000000001 110.811 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -113.09 119.56 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.108 -0.496 . . . . 71.120000000000005 110.937 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.22 -78.78 0.22 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 111.893 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 34.3 t70 -149.75 -15.33 0.27 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 111.801 0.297 . . . . 60.210000000000001 111.801 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -80.33 143.63 33.43 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.983 -0.448 . . . . 74.120000000000005 111.044 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.2 p -123.98 149.49 45.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.514 0.673 . . . . 72.319999999999993 112.68 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.75 145.23 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.49 -0.777 . . . . 64.120000000000005 110.33 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.3 p -128.08 127.68 43.55 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.734 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -119.94 137.2 54.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.397 -0.365 . . . . 74.040000000000006 111.311 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -99.97 131.4 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.029 0.442 . . . . 40.020000000000003 111.668 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 60.6 m-85 -86.05 94.82 9.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.368 -0.378 . . . . 72.010000000000005 111.771 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -71.92 137.8 47.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.157 0.503 . . . . 74.420000000000002 112.247 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.801 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 79.5 p -72.25 91.22 1.29 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.304 0.483 . . . . 72.510000000000005 112.304 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.484 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 14.4 ptm180 -109.08 -16.82 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.692 0.282 . . . . 71.129999999999995 111.666 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.484 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 46.9 p90 -158.15 -177.71 6.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.642 0.258 . . . . 54.210000000000001 111.051 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.13 159.35 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.399 0.619 . . . . 72.430000000000007 112.102 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 31' ' ' ASN . 24.0 tp -124.19 113.87 18.89 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.08 -0.509 . . . . 73.230000000000004 110.047 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 39.0 tttp -75.29 169.15 18.61 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.605 0.594 . . . . 62.310000000000002 112.605 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.71 127.46 20.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.781 0.66 . . . . 64.219999999999999 112.781 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.61 -18.2 9.28 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.173 -0.467 . . . . 32.520000000000003 114.014 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -72.41 138.51 47.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.176 0.512 . . . . 71.129999999999995 111.674 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 30' ' ' LYS . 59.9 p -105.47 132.51 51.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 112.052 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.8 140.93 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.91 0.386 . . . . 61.420000000000002 111.41 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.2 m -109.8 122.39 47.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 63.43 111.473 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 mm -105.61 102.35 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.399 -0.364 . . . . 70.239999999999995 111.255 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -82.94 125.92 31.93 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.821 0.304 . . . . 75.140000000000001 111.821 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.19 81.46 2.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.197 0.443 . . . . 65.409999999999997 112.197 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 64.83 -67.14 0.12 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.844 1.053 . . . . 71.340000000000003 113.844 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -71.39 75.58 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.113 0.412 . . . . 64.230000000000004 112.113 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.84 -48.82 3.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 72.019999999999996 111.697 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.48 -35.69 3.3 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.444 -0.407 . . . . 72.510000000000005 113.19 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.75 -173.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.144 0.424 . . . . 74.299999999999997 112.144 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -52.83 121.97 8.29 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.186 -0.461 . . . . 70.310000000000002 111.836 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.69 91.05 0.29 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.617 0.969 . . . . 65.310000000000002 113.617 -173.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 87' ' ' ILE . 33.8 t 72.84 87.09 0.1 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 114.151 1.167 . . . . 61.439999999999998 114.151 168.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HB2' ' N ' ' A' ' 84' ' ' THR . 81.8 Cg_exo -50.67 -176.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.576 2.582 0 C-N-CA 123.563 2.842 . . . . 64.400000000000006 112.259 163.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 14.82 47.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.44 0 N-CA-C 122.185 3.879 . . . . 72.150000000000006 122.185 44.6 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.667 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 7.3 t 157.67 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.598 1.159 . . . . 70.129999999999995 111.628 160.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.442 ' OD1' HG23 ' A' ' 84' ' ' THR . 1.5 m-20 -105.72 158.33 16.8 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.805 0.336 . . . . 74.310000000000002 111.203 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 HD11 ' SD ' ' A' ' 39' ' ' MET . 76.5 mt -126.25 139.6 53.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.844 0.354 . . . . 72.319999999999993 111.493 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 81' ' ' SER . 1.8 mp -105.39 116.17 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.081 0.467 . . . . 75.510000000000005 111.061 176.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 7.9 t90 -74.69 105.85 5.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 110.421 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.24 -5.15 58.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.805 0.669 . . . . 62.420000000000002 112.805 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.59 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 20.1 m120 -91.35 -42.95 10.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.588 0.588 . . . . 62.439999999999998 112.588 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -120.52 143.54 48.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.82 0.343 . . . . 72.230000000000004 111.398 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -93.52 177.21 6.1 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.057 0.455 . . . . 72.420000000000002 111.395 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.7 p -60.46 113.24 2.31 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.123 0.487 . . . . 71.25 111.153 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -76.24 -32.96 59.17 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.76 0.652 . . . . 71.219999999999999 112.76 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.98 50.54 21.11 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.292 0.477 . . . . 43.32 114.292 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.7 p -97.52 -44.78 6.68 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.724 0.639 . . . . 62.140000000000001 112.724 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 80.17 -33.73 2.21 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.898 -0.668 . . . . 54.210000000000001 112.676 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.75 148.15 47.61 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.799 0.333 . . . . 74.150000000000006 111.109 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 4.6 p-10 -64.43 126.41 27.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.341 0.867 . . . . 71.430000000000007 113.341 -173.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.583 HG21 ' HE ' ' A' ' 46' ' ' ARG . 7.7 p -124.92 141.71 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.794 -0.639 . . . . 73.200000000000003 110.938 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -109.55 134.88 51.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.919 0.39 . . . . 74.219999999999999 111.726 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 144.86 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.15 0.5 . . . . 45.109999999999999 111.768 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.76 141.46 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 116.186 -0.461 . . . . 74.010000000000005 111.347 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 76.5 mt -114.05 120.46 40.64 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.928 0.394 . . . . 74.310000000000002 111.568 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 95.5 mttt -123.05 146.74 47.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.462 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.606 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 34.1 m-80 -76.53 153.33 35.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.036 -0.357 . . . . 61.25 110.036 169.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.8 t -67.94 8.37 0.41 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.277 0.843 . . . . 62.109999999999999 113.277 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.14 3.91 52.9 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.101 -0.374 . . . . 74.209999999999994 111.247 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 36.72 17.27 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.06 -0.591 . . . . 44.539999999999999 112.846 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.1 pt-20 -125.39 126.78 45.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.032 0.444 . . . . 75.25 111.501 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 33.8 tt0 -91.47 129.39 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.891 -0.595 . . . . 73.219999999999999 111.433 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.44 -64.16 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.285 0.476 . . . . 73.219999999999999 112.285 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . . . -101.74 145.4 29.19 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.451 0.537 . . . . 71.510000000000005 112.451 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -145.65 139.96 26.98 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.263 -0.426 . . . . 53.420000000000002 110.981 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 17' ' ' ILE . 47.7 ttm-85 -166.13 136.81 3.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.249 0.547 . . . . 72.319999999999993 112.282 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.7 p -111.32 154.54 24.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.066 -0.516 . . . . 74.140000000000001 110.756 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 20' ' ' ILE . 66.5 p -62.45 107.07 0.85 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.025 0.441 . . . . 72.340000000000003 111.648 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.29 96.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.423 0.63 . . . . 63.530000000000001 111.71 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -67.96 135.43 52.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.154 0.502 . . . . 70.329999999999998 111.01 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -121.5 136.04 54.98 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.447 0.536 . . . . 70.430000000000007 112.447 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 95.52 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.077 -0.51 . . . . 72.319999999999993 110.499 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.998 -0.525 . . . . 74.5 111.533 -178.185 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.836 0.351 . . . . 61.130000000000003 111.335 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.86 45.98 0.1 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.062 -0.589 . . . . 72.329999999999998 113.366 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -96.86 95.38 7.82 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.373 -0.486 . . . . 75.120000000000005 110.569 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -77.47 134.25 38.4 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.282 0.563 . . . . 61.130000000000003 111.846 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -124.61 133.89 53.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.885 -0.598 . . . . 63.329999999999998 110.391 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -101.86 -78.78 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.184 -0.323 . . . . 75.109999999999999 111.218 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -170.69 164.67 8.15 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.81 0.338 . . . . 51.149999999999999 111.193 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -105.01 149.53 25.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.525 -0.307 . . . . 64.040000000000006 110.614 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 t -149.58 168.68 22.88 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.878 0.37 . . . . 64.129999999999995 111.427 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -106.13 134.2 49.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 65.109999999999999 111.658 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.5 mmt -87.27 108.3 18.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.477 -0.329 . . . . 73.409999999999997 111.235 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.1 p -91.07 3.23 55.3 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.784 0.326 . . . . 74.150000000000006 111.655 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.16 82.35 0.89 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.319 -0.401 . . . . 65.109999999999999 113.325 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.48 94.41 9.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.145 0.497 . . . . 54.140000000000001 111.237 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.74 128.64 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.425 . . . . 43.409999999999997 111.176 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 p -133.71 155.34 49.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.791 0.329 . . . . 44.009999999999998 111.445 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.799 HG13 HD11 ' A' ' 104' ' ' LEU . 73.7 mt -62.68 120.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 112.276 0.473 . . . . 72.439999999999998 112.276 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 40.6 tt0 -68.38 -55.51 11.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 109.981 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 23.6 tt0 178.52 160.46 0.6 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.665 -0.698 . . . . 75.219999999999999 110.502 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.483 HG23 HG12 ' A' ' 27' ' ' ILE . 57.6 mt -95.39 153.6 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.439 -0.346 . . . . 60.409999999999997 111.412 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.64 147.71 36.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.124 0.487 . . . . 63.329999999999998 111.587 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.35 -28.01 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.113 -0.494 . . . . 63.450000000000003 111.993 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.77 -34.54 13.16 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.886 0.374 . . . . 64.0 110.876 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.01 10.86 8.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.192 -0.458 . . . . 71.030000000000001 113.426 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.36 -27.74 64.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.223 0.823 . . . . 71.310000000000002 113.223 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -158.94 159.65 35.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.972 0.73 . . . . 73.219999999999999 112.972 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.483 HG12 HG23 ' A' ' 20' ' ' ILE . 63.8 mt -125.24 117.19 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.695 -0.684 . . . . 63.420000000000002 110.722 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 17.1 ttm180 -98.55 132.85 43.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 73.040000000000006 112.267 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 6.6 mp -109.65 134.68 51.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.355 -0.384 . . . . 62.119999999999997 111.304 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 68' ' ' THR . 24.3 ttmm -103.37 136.08 43.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.882 0.372 . . . . 72.409999999999997 111.494 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.95 107.43 15.55 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.424 -0.353 . . . . 74.140000000000001 110.833 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.6 p -95.9 17.14 15.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.161 0.505 . . . . 71.349999999999994 111.808 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -70.29 159.32 34.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.1 0.476 . . . . 70.200000000000003 111.869 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.23 -26.35 58.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.222 -0.444 . . . . 52.43 111.717 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 44.6 tt0 -138.9 166.74 23.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.761 0.315 . . . . 72.040000000000006 110.936 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 6.1 m-20 -68.14 117.04 9.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.532 -0.304 . . . . 73.209999999999994 111.224 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -133.68 144.16 50.78 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 111.61 0.226 . . . . 72.400000000000006 111.61 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 36.4 Cg_exo -60.95 147.5 95.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.677 2.251 . . . . 75.140000000000001 112.615 174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.1 tpt -54.82 -50.59 68.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.072 0.463 . . . . 44.310000000000002 112.174 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.17 -122.1 5.83 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.02 -0.609 . . . . 65.319999999999993 113.293 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 108.87 1.14 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.377 -0.439 . . . . 65.420000000000002 113.142 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -135.08 164.87 26.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.641 0.376 . . . . 75.409999999999997 110.515 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -150.25 117.02 5.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.125 0.488 . . . . 74.120000000000005 111.374 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.459 ' HE1' HD11 ' A' ' 29' ' ' LEU . 38.1 ttm -91.81 117.4 29.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.245 -0.434 . . . . 73.319999999999993 111.721 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.59 102.65 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.859 0.361 . . . . 73.140000000000001 110.549 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -90.37 120.41 31.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.747 0.308 . . . . 64.010000000000005 111.414 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.27 113.86 27.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.409 -0.359 . . . . 53.130000000000003 111.035 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.54 137.98 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.572 -0.285 . . . . 74.430000000000007 110.86 -176.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' N ' HD13 ' A' ' 48' ' ' ILE . . . 55.35 36.46 63.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.191 -0.528 . . . . 62.409999999999997 113.438 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.18 -4.29 1.59 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.829 0.852 . . . . 74.349999999999994 113.028 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -103.68 173.45 6.3 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.685 -0.634 . . . . 71.230000000000004 111.057 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -139.34 150.46 45.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.34 0.59 . . . . 60.310000000000002 112.105 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.58 130.36 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.636 -0.711 . . . . 74.299999999999997 110.354 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' MET . 94.0 p -105.43 148.72 26.84 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.328 0.585 . . . . 70.439999999999998 112.183 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -128.73 112.08 13.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.945 -0.57 . . . . 75.310000000000002 110.476 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.26 125.75 33.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.99 0.424 . . . . 75.329999999999998 111.651 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.441 ' HE2' HD11 ' A' ' 71' ' ' ILE . 54.0 m-85 -85.9 168.9 13.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.509 0.671 . . . . 60.009999999999998 112.391 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -140.05 157.99 44.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.678 -0.692 . . . . 72.010000000000005 111.797 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.7 p -87.62 23.23 2.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.205 -0.452 . . . . 63.119999999999997 111.923 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -69.53 -2.18 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.624 0.602 . . . . 73.120000000000005 112.624 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -151.29 156.94 41.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.172 0.51 . . . . 72.329999999999998 111.7 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 83.2 t -103.6 124.77 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.16 -0.473 . . . . 65.340000000000003 111.659 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.8 mm? -84.12 109.85 18.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.008 0.432 . . . . 53.229999999999997 111.328 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.75 144.5 32.11 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.372 -0.376 . . . . 64.420000000000002 111.145 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.22 119.53 4.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.909 0.385 . . . . 74.129999999999995 111.798 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.16 -41.49 2.5 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.184 -0.532 . . . . 64.239999999999995 113.218 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -65.54 140.25 58.54 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.314 -0.521 . . . . 51.5 111.187 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 30' ' ' LYS . 70.1 p -111.49 153.72 25.78 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.726 0.639 . . . . 71.040000000000006 112.726 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -114.57 123.24 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.968 -0.56 . . . . 75.400000000000006 110.566 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m -94.13 124.61 38.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.186 0.517 . . . . 72.420000000000002 111.516 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.441 HD11 ' HE2' ' A' ' 57' ' ' TYR . 41.6 mm -86.21 99.67 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 75.420000000000002 110.048 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -84.38 -178.45 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 43.420000000000002 110.971 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.37 170.48 7.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.715 -0.221 . . . . 55.329999999999998 110.95 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.19 32.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.194 0.442 . . . . 73.519999999999996 112.194 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.07 32.48 2.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.455 -0.339 . . . . 62.219999999999999 111.563 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.16 -48.55 44.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.913 0.708 . . . . 74.310000000000002 112.913 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.17 -33.66 6.23 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.13 -0.557 . . . . 64.400000000000006 112.277 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.33 -171.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 122.555 0.342 . . . . 72.140000000000001 110.843 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.3 p -69.97 147.33 50.29 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.98 -0.45 . . . . 65.120000000000005 111.369 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.91 2.65 3.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.642 0.608 . . . . 53.030000000000001 112.642 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -169.68 86.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.073 0.549 . . . . 73.409999999999997 110.345 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HB2' ' N ' ' A' ' 84' ' ' THR . 53.5 Cg_exo -53.0 -46.95 30.3 Favored 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.262 2.641 . . . . 74.530000000000001 115.972 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.7 Cg_endo -101.73 21.86 17.36 Favored 'Cis proline' 0 C--N 1.363 1.322 0 CA-C-N 121.307 1.503 . . . . 72.109999999999999 114.664 2.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.552 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 10.2 t -55.74 -41.44 73.91 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.443 0.535 . . . . 62.219999999999999 112.443 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -97.37 164.35 12.5 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.117 0.484 . . . . 72.540000000000006 111.29 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.04 126.24 51.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.071 0.462 . . . . 72.230000000000004 111.378 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 87' ' ' ILE . 2.0 mp -91.84 127.38 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 64.510000000000005 110.938 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -69.6 79.35 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.175 0.512 . . . . 70.439999999999998 110.183 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -58.29 -22.19 51.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.856 0.687 . . . . 73.140000000000001 112.856 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.6 -23.7 58.77 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.706 0.632 . . . . 61.149999999999999 112.706 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -146.2 150.06 35.11 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.129 0.788 . . . . 74.310000000000002 113.129 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -75.3 -172.22 1.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.628 -0.715 . . . . 71.120000000000005 110.616 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -74.98 142.3 43.9 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.864 -0.523 . . . . 61.399999999999999 111.214 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -120.47 101.32 7.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.64 0.733 . . . . 74.140000000000001 111.821 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.22 135.74 12.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.163 -0.472 . . . . 75.219999999999999 112.059 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -170.95 -42.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.863 0.69 . . . . 73.439999999999998 112.863 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.51 -15.72 62.68 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.007 -0.616 . . . . 64.230000000000004 113.024 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -56.89 131.94 51.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.74 0.305 . . . . 71.150000000000006 111.236 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.7 m-20 -60.95 114.5 3.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.295 0.569 . . . . 62.340000000000003 112.033 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 48' ' ' ILE . 3.8 p -106.05 136.81 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.727 -0.67 . . . . 72.120000000000005 111.41 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -115.85 132.44 56.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.232 0.539 . . . . 74.319999999999993 110.524 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.413 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 3.3 p -127.3 141.49 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.309 0.576 . . . . 35.32 112.446 -172.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.1 mm -107.47 140.67 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 60.130000000000003 111.618 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.799 HD11 HG13 ' A' ' 17' ' ' ILE . 76.1 mt -110.26 114.89 28.72 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.756 0.312 . . . . 70.040000000000006 111.694 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -106.16 140.29 39.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.956 0.408 . . . . 73.519999999999996 111.421 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 112' ' ' VAL . 10.6 m120 -87.16 -171.2 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.271 -0.422 . . . . 70.299999999999997 111.086 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.9 t -57.91 -36.75 72.9 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.185 0.439 . . . . 52.509999999999998 112.185 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -81.72 3.02 27.16 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.116 0.413 . . . . 51.130000000000003 112.116 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.61 -1.26 78.46 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.174 -0.536 . . . . 64.099999999999994 113.039 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.49 151.25 47.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.884 0.474 . . . . 70.109999999999999 111.223 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -101.79 119.27 38.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.881 0.372 . . . . 73.409999999999997 111.662 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 106' ' ' ASN . 18.8 m -106.41 -18.71 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.347 0.499 . . . . 52.149999999999999 112.347 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -155.04 142.75 19.85 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.575 0.583 . . . . 73.109999999999999 112.575 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.62 122.03 11.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.466 -0.788 . . . . 65.120000000000005 109.842 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -144.5 156.74 44.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.979 0.419 . . . . 73.019999999999996 112.076 -171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.7 p -133.28 175.36 9.47 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.962 0.411 . . . . 52.030000000000001 111.607 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 45.8 p -79.17 -176.38 5.1 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.991 0.424 . . . . 65.319999999999993 111.391 173.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.36 129.88 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.888 0.375 . . . . 63.299999999999997 111.015 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -59.71 95.59 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 72.530000000000001 112.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -126.67 150.63 48.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.051 -0.522 . . . . 61.420000000000002 111.176 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 86.5 m -121.5 92.62 3.79 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 63.439999999999998 110.703 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.843 -0.598 . . . . 73.109999999999999 111.801 -178.151 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.718 0.294 . . . . 61.340000000000003 111.383 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.71 -64.58 2.22 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.202 -0.523 . . . . 73.310000000000002 113.219 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.58 132.41 38.3 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.794 0.331 . . . . 73.120000000000005 111.224 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -149.73 -178.07 6.25 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.061 0.458 . . . . 44.5 111.893 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -115.09 177.26 4.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.956 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -155.32 157.91 37.92 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.689 -0.232 . . . . 72.120000000000005 110.429 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -71.05 161.71 30.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.657 0.614 . . . . 74.299999999999997 112.657 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -147.86 109.19 4.32 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.82 -0.627 . . . . 74.140000000000001 110.989 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 m -117.3 156.88 27.04 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.95 0.405 . . . . 70.430000000000007 111.51 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -125.56 178.61 5.55 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.132 0.491 . . . . 74.010000000000005 111.538 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -125.17 129.45 50.16 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.298 -0.41 . . . . 71.420000000000002 110.866 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -71.63 -23.65 61.73 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.332 0.493 . . . . 72.140000000000001 112.332 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.97 142.52 13.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.141 -0.552 . . . . 61.109999999999999 112.843 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -131.98 91.78 3.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.13 0.49 . . . . 74.409999999999997 110.515 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.2 145.22 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.996 -0.547 . . . . 53.350000000000001 111.087 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.3 p -132.76 154.66 50.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.989 0.423 . . . . 74.510000000000005 111.634 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.63 111.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.321 -0.399 . . . . 55.25 110.796 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.83 -56.33 4.35 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.439999999999998 111.835 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.58 123.77 6.38 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.231 0.538 . . . . 74.239999999999995 112.39 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.62 HG23 HG12 ' A' ' 27' ' ' ILE . 72.2 mt -89.16 140.33 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.878 -0.601 . . . . 71.129999999999995 110.624 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.5 143.07 40.67 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.104 0.478 . . . . 73.109999999999999 111.472 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -85.82 -25.86 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.562 0.578 . . . . 73.109999999999999 112.562 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.83 -21.13 41.06 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.182 0.515 . . . . 71.0 111.009 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 103.45 20.21 11.3 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.796 -0.638 . . . . 55.009999999999998 113.256 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -79.72 -48.58 13.41 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.396 0.517 . . . . 74.319999999999993 112.396 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -160.81 173.25 15.65 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.489 0.922 . . . . 63.43 113.489 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 20' ' ' ILE . 57.0 mt -133.85 121.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.469 -0.787 . . . . 64.5 109.794 170.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -101.4 123.58 45.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.744 -0.597 . . . . 63.350000000000001 112.19 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -110.72 172.45 6.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.021 -0.536 . . . . 63.229999999999997 110.941 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 68' ' ' THR . 7.1 ttpm? -150.61 138.14 19.68 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.007 0.432 . . . . 72.25 111.998 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -78.73 114.52 17.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.144 -0.48 . . . . 51.210000000000001 110.919 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -102.76 12.81 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.919 0.39 . . . . 74.140000000000001 111.876 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 t -77.57 164.55 25.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.06 0.457 . . . . 53.509999999999998 111.426 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -85.91 5.98 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.2 0.444 . . . . 74.530000000000001 112.2 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 60.3 tt0 -146.43 159.9 42.79 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.686 0.279 . . . . 73.349999999999994 111.354 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 32.1 m-20 -63.85 115.29 4.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.817 0.341 . . . . 71.219999999999999 110.409 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.2 mm-40 -105.71 146.19 32.34 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.333 0.494 . . . . 73.510000000000005 112.333 -172.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 9.2 Cg_exo -72.8 103.22 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.644 2.23 . . . . 54.200000000000003 112.486 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.608 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 tpt -59.88 -28.46 67.57 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 71.329999999999998 111.501 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.802 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.18 5.04 15.58 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 114.539 0.576 . . . . 73.120000000000005 114.539 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.29 8.78 69.62 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.92 -0.657 . . . . 42.130000000000003 113.127 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 23.6 m95 -119.03 170.89 8.66 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.599 0.592 . . . . 74.530000000000001 112.599 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -152.42 130.38 11.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 72.510000000000005 110.845 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 47.7 ttp -96.82 116.62 29.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 73.150000000000006 111.418 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 60.0 mt -105.4 113.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.809 0.338 . . . . 71.329999999999998 111.011 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HE ' ' HZ3' ' A' ' 88' ' ' TRP . 54.2 ttm-85 -98.88 118.15 34.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.246 0.461 . . . . 70.510000000000005 112.246 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -95.39 106.17 18.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.973 -0.38 . . . . 63.350000000000001 109.973 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG23 ' A' ' 100' ' ' VAL . 10.6 tt -116.62 107.23 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.531 0.681 . . . . 71.239999999999995 112.699 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.6 -93.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.658 -0.701 . . . . 53.039999999999999 114.079 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -107.54 -17.42 14.11 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.287 0.477 . . . . 61.340000000000003 112.287 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.8 t -128.21 -172.67 2.75 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.044 0.45 . . . . 73.209999999999994 112.093 -175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 p -154.15 146.6 24.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.115 0.483 . . . . 74.239999999999995 111.693 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.438 HG13 ' HH2' ' A' ' 88' ' ' TRP . 7.7 p -153.52 145.29 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.06 -0.518 . . . . 64.450000000000003 110.404 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.6 p -120.74 168.36 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.296 0.85 . . . . 50.43 113.296 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 29.7 t80 -139.91 110.81 6.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.246 -0.888 . . . . 74.239999999999995 110.944 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -79.75 124.27 28.45 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.683 0.278 . . . . 64.540000000000006 110.327 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -68.53 105.83 2.36 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.967 0.413 . . . . 73.420000000000002 111.619 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t -71.36 121.98 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.231 0.538 . . . . 62.420000000000002 111.226 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.802 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 32.9 t -83.1 82.49 8.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.132 0.491 . . . . 74.519999999999996 112.247 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.769 ' HD2' ' HG2' ' A' ' 82' ' ' PRO . 11.6 ptp180 -104.6 4.19 32.53 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.829 0.347 . . . . 72.420000000000002 111.233 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HE1' HD21 ' A' ' 86' ' ' LEU . 29.8 p90 -163.4 167.33 21.79 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 74.530000000000001 110.695 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.55 150.14 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.947 0.404 . . . . 74.209999999999994 111.804 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.608 HD22 ' SD ' ' A' ' 39' ' ' MET . 39.3 tp -101.96 102.14 12.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.165 0.507 . . . . 71.150000000000006 110.604 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -62.53 162.62 10.09 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.843 0.682 . . . . 75.450000000000003 112.843 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.58 122.02 15.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.112 -0.494 . . . . 62.340000000000003 111.444 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.92 20.42 76.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.211 -0.518 . . . . 74.010000000000005 113.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.441 HE21 ' N ' ' A' ' 68' ' ' THR . 31.1 tp60 -96.45 132.94 41.49 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.94 0.4 . . . . 75.109999999999999 111.99 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 30' ' ' LYS . 74.4 p -93.63 145.86 24.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.229 -0.441 . . . . 74.510000000000005 111.771 175.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.09 146.14 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.67 0.388 . . . . 62.299999999999997 111.29 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.88 129.8 53.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.958 0.355 . . . . 62.420000000000002 111.958 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.91 103.69 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.649 0.261 . . . . 75.239999999999995 110.944 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.5 m95 -83.45 166.69 18.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.579 -0.282 . . . . 64.129999999999995 111.432 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.05 94.31 4.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.815 0.672 . . . . 70.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 47.47 -82.57 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.232 1.197 . . . . 74.209999999999994 114.232 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -77.46 36.24 0.19 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.544 0.572 . . . . 73.150000000000006 112.544 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.08 -11.77 59.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.771 0.319 . . . . 73.239999999999995 111.552 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.24 -42.4 2.56 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.331 -0.462 . . . . 54.520000000000003 113.52 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.2 m -55.42 158.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.765 0.654 . . . . 50.210000000000001 112.765 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.8 p -68.21 136.45 53.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.083 -0.508 . . . . 63.539999999999999 111.597 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -83.0 39.01 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.144 0.424 . . . . 74.420000000000002 112.144 -176.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.2 m -130.24 102.95 16.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 112.563 0.579 . . . . 72.099999999999994 112.563 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 28.4 Cg_exo -44.5 -164.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.397 0 C-N-CA 124.532 3.488 . . . . 70.230000000000004 114.238 168.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 2.4 Cg_endo -84.51 1.42 61.15 Favored 'Cis proline' 0 C--N 1.371 1.714 0 CA-C-N 120.982 1.386 . . . . 64.349999999999994 114.153 11.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.0 p -67.15 -71.63 0.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.487 0.551 . . . . 54.240000000000002 112.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 5.4 m-20 -121.51 169.38 10.72 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.097 0.475 . . . . 75.129999999999995 112.216 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.451 HD21 ' HE1' ' A' ' 61' ' ' TYR . 81.8 mt -115.82 134.69 54.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.211 -0.45 . . . . 74.099999999999994 111.375 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 80' ' ' ALA . 2.5 mp -109.14 114.32 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.949 0.404 . . . . 72.209999999999994 111.245 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.593 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 15.9 t90 -84.52 110.33 18.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.981 0.42 . . . . 72.140000000000001 110.766 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -84.3 -11.48 56.32 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.645 0.98 . . . . 72.140000000000001 113.645 -171.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.97 -54.52 9.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.313 0.486 . . . . 73.299999999999997 112.313 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.429 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 64.7 tt0 -85.95 123.78 31.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.815 0.341 . . . . 62.200000000000003 111.735 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 19.1 m120 -83.17 52.98 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.852 0.316 . . . . 53.149999999999999 111.852 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.2 t 66.6 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.323 0.582 . . . . 45.100000000000001 112.2 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.547 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 42.3 p90 -106.23 171.78 7.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.484 -0.326 . . . . 72.230000000000004 111.117 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.01 105.72 0.28 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.555 -0.831 . . . . 42.039999999999999 113.234 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 t -151.68 -50.17 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.329 0.492 . . . . 72.239999999999995 112.329 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.55 -29.34 2.38 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.167 -0.54 . . . . 61.439999999999998 112.426 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -71.16 144.87 50.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.628 0.251 . . . . 71.109999999999999 111.037 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 23.1 m-20 -75.72 104.3 6.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.693 0.627 . . . . 74.430000000000007 112.693 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 48' ' ' ILE . 4.3 p -81.53 127.11 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.744 -0.662 . . . . 74.340000000000003 110.896 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 36.8 ttpt -97.79 115.84 28.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.331 0.586 . . . . 73.530000000000001 111.905 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 135.36 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.904 -0.589 . . . . 75.439999999999998 111.462 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 114' ' ' GLN . 27.6 mm -116.52 141.91 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 116.111 -0.495 . . . . 74.109999999999999 111.488 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.6 mt -115.35 118.22 32.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.953 0.406 . . . . 63.439999999999998 111.79 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 111' ' ' GLU . 57.9 mttp -125.32 160.22 29.83 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.313 -0.403 . . . . 73.049999999999997 110.951 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 17.1 m120 -99.18 -178.65 3.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 73.450000000000003 111.826 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -50.63 -43.36 56.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.16 0.8 . . . . 74.120000000000005 113.16 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.47 1.48 13.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.411 0.522 . . . . 73.420000000000002 112.411 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.44 84.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.235 -0.507 . . . . 52.5 113.094 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 7.3 pt-20 -78.76 137.94 37.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.922 0.391 . . . . 64.239999999999995 111.059 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 38.8 tt0 -102.0 137.12 40.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.853 0.316 . . . . 73.310000000000002 111.853 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 113' ' ' ALA . 27.1 m -127.89 -47.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 113.008 0.744 . . . . 71.310000000000002 113.008 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -132.19 156.19 46.88 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.169 0.433 . . . . 73.340000000000003 112.169 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 103' ' ' ILE . 14.1 pt20 -175.4 150.18 1.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.331 -0.395 . . . . 64.310000000000002 111.408 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 116' ' ' SER . 35.7 ttp180 -173.52 159.32 3.61 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.897 0.379 . . . . 55.020000000000003 111.52 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.3 p -86.71 -169.35 2.59 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.135 0.493 . . . . 62.420000000000002 111.029 172.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 31.7 p -87.85 -167.91 2.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.976 0.417 . . . . 60.210000000000001 111.51 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 120' ' ' LYS . 40.6 t -90.29 109.13 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.064 0.459 . . . . 74.310000000000002 111.377 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -79.17 21.78 0.44 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.515 0.561 . . . . 62.409999999999997 112.515 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' H ' HG12 ' A' ' 118' ' ' VAL . 62.5 tttm -58.02 98.74 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.142 0.496 . . . . 51.310000000000002 112.123 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 32.9 m -90.5 142.45 27.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 110.093 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.201 -0.904 . . . . 64.450000000000003 112.418 -176.615 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptt? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.106 0.479 . . . . 71.120000000000005 111.181 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.03 114.57 2.56 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-N 116.143 -0.48 . . . . 63.310000000000002 112.134 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -92.41 -57.43 2.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.0 0.429 . . . . 75.140000000000001 112.057 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -102.66 110.94 23.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.714 0.292 . . . . 72.230000000000004 111.154 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -148.33 87.11 1.57 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.268 0.556 . . . . 71.25 111.833 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -147.24 144.87 29.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.227 -0.442 . . . . 73.25 110.968 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -80.67 97.12 7.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.35 0.595 . . . . 74.299999999999997 110.212 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -87.03 9.62 19.07 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.26 0.837 . . . . 71.109999999999999 113.26 -171.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -63.07 125.98 25.83 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.84 0.352 . . . . 63.240000000000002 111.0 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -101.73 133.51 46.34 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.949 0.404 . . . . 73.439999999999998 111.702 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.624 ' SD ' ' NE2' ' A' ' 37' ' ' GLN . 21.9 mmt -70.54 114.6 8.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.852 0.358 . . . . 64.239999999999995 110.741 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -65.06 -17.53 64.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.095 0.776 . . . . 71.430000000000007 113.095 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.72 94.49 1.24 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.087 -0.577 . . . . 55.020000000000003 112.273 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 32' ' ' THR . 17.2 m-80 -115.8 8.17 14.77 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.657 0.614 . . . . 73.120000000000005 112.657 -172.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.88 130.76 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 75.549999999999997 112.031 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -129.15 177.37 7.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.132 -0.485 . . . . 33.32 110.637 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.88 127.55 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 122.007 -0.433 . . . . 61.43 110.721 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.71 -51.45 3.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.37 0.508 . . . . 61.520000000000003 112.37 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -147.86 138.1 22.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.075 0.464 . . . . 71.209999999999994 112.062 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 27' ' ' ILE . 53.3 mt -132.9 139.93 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.256 -0.429 . . . . 70.099999999999994 111.054 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -85.59 126.22 33.72 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.03 0.443 . . . . 63.329999999999998 110.925 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.36 -26.4 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.241 0.46 . . . . 73.420000000000002 112.241 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.12 -37.1 80.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.872 0.368 . . . . 70.239999999999995 111.688 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 119.58 57.86 0.25 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.262 -0.494 . . . . 71.25 113.472 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -129.81 -57.49 1.11 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.49 0.552 . . . . 74.349999999999994 112.49 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.76 161.8 38.35 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.477 0.917 . . . . 75.120000000000005 113.477 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 20' ' ' ILE . 63.6 mt -128.49 160.92 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 114.873 -1.058 . . . . 72.140000000000001 108.634 173.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 28' ' ' ARG . 38.2 ttp-105 -147.2 122.1 10.0 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.251 -0.906 . . . . 70.450000000000003 112.554 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -97.08 172.68 7.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.742 -0.663 . . . . 74.420000000000002 110.507 175.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HG3' HG22 ' A' ' 68' ' ' THR . 74.4 tttt -142.59 121.06 12.43 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.834 0.349 . . . . 73.209999999999994 111.213 -175.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -82.01 86.27 6.59 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.238 0.542 . . . . 41.310000000000002 111.272 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 14' ' ' ASN . 71.8 p -83.65 87.72 7.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.227 -0.442 . . . . 62.520000000000003 110.293 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.5 t -131.46 164.19 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.108 0.781 . . . . 43.009999999999998 113.108 -168.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -81.14 -26.62 35.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.945 -1.025 . . . . 72.129999999999995 110.647 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -140.35 162.4 35.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.644 -0.707 . . . . 74.5 110.488 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -68.98 109.82 4.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.862 0.363 . . . . 65.230000000000004 110.182 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.624 ' NE2' ' SD ' ' A' ' 11' ' ' MET . 14.2 mm100 -103.02 138.6 19.59 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.682 0.623 . . . . 72.420000000000002 112.682 -170.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 84.3 Cg_endo -75.94 46.51 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.87 2.38 . . . . 75.239999999999995 113.348 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' MET . 6.4 tpt 63.11 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.87 0.468 . . . . 44.520000000000003 112.179 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.48 172.55 23.92 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.491 -0.385 . . . . 74.200000000000003 113.467 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.91 78.88 1.64 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.984 -0.627 . . . . 61.219999999999999 113.386 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -99.38 142.45 30.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.661 -0.317 . . . . 73.25 111.597 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -115.57 115.14 25.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.345 . . . . 73.219999999999999 110.478 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.47 ' HE1' HG21 ' A' ' 71' ' ' ILE . 44.9 ttp -99.44 105.91 17.9 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.89 0.33 . . . . 74.310000000000002 111.89 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.655 HG13 ' HB3' ' A' ' 54' ' ' SER . 3.5 mp -91.08 118.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.56 -0.291 . . . . 63.340000000000003 111.313 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' A' ' 88' ' ' TRP . 55.0 ttp180 -94.35 93.79 7.91 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.06 0.457 . . . . 70.409999999999997 111.209 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.4 84.42 5.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.484 0.659 . . . . 61.340000000000003 111.456 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 96' ' ' THR . 16.5 tt -78.8 -14.57 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.606 -0.724 . . . . 71.299999999999997 110.787 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.03 -152.84 10.2 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.583 -0.735 . . . . 62.32 111.828 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.13 82.35 5.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.381 0.61 . . . . 73.319999999999993 109.963 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -167.18 -179.3 4.5 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.501 -0.772 . . . . 64.040000000000006 110.76 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.3 p -142.13 105.93 4.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.046 0.451 . . . . 74.450000000000003 111.605 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.477 HG21 ' NE2' ' A' ' 91' ' ' GLN . 7.1 p -138.2 137.68 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.221 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' HG13 ' A' ' 45' ' ' ILE . 81.2 p -145.94 161.27 40.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.01 0.744 . . . . 75.109999999999999 113.01 -174.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -126.77 126.64 43.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.181 -0.918 . . . . 74.549999999999997 109.785 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.15 141.21 28.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.055 0.455 . . . . 75.140000000000001 111.577 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -83.81 -178.6 7.05 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.995 -0.548 . . . . 72.439999999999998 111.631 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -144.35 149.76 36.69 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.161 0.43 . . . . 41.530000000000001 112.161 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 t -91.91 16.25 11.39 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.114 -0.494 . . . . 73.209999999999994 111.762 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 12.0 ptm180 -72.8 2.18 7.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.777 0.658 . . . . 72.340000000000003 112.777 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 51.4 p90 -148.6 164.5 34.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 74.549999999999997 111.328 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 61.4 t -112.77 119.16 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.907 0.384 . . . . 72.140000000000001 111.315 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.92 116.79 29.16 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.965 0.412 . . . . 64.430000000000007 110.19 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -58.44 153.58 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.687 0.625 . . . . 74.209999999999994 112.687 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.51 133.16 46.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.415 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.43 18.35 79.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.165 -0.54 . . . . 72.109999999999999 113.074 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -112.88 147.13 37.67 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.668 -0.313 . . . . 54.119999999999997 110.778 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 30' ' ' LYS . 43.1 p -95.8 171.4 8.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.354 0.597 . . . . 71.409999999999997 112.119 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.02 122.76 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.038 -0.528 . . . . 64.129999999999995 110.656 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.5 m -94.85 124.57 38.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.493 0.553 . . . . 73.109999999999999 112.493 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.0 mm -94.88 136.38 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.83 -0.623 . . . . 54.109999999999999 110.492 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 90.4 m95 -117.24 179.36 4.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.907 0.384 . . . . 54.130000000000003 111.936 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -84.36 156.37 21.89 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.654 -0.248 . . . . 64.400000000000006 111.42 176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.67 -46.0 1.77 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.368 0.877 . . . . 70.030000000000001 113.368 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -129.28 74.39 1.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.129 0.49 . . . . 61.409999999999997 110.599 174.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.02 -3.48 54.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 52.299999999999997 112.105 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -41.68 2.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.367 -0.444 . . . . 75.409999999999997 113.086 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.05 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.034 0.445 . . . . 74.030000000000001 112.009 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.3 p -63.35 139.56 58.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 54.219999999999999 112.031 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.47 70.29 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.833 0.679 . . . . 62.229999999999997 112.833 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.1 p -139.57 98.68 7.94 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.999 0.428 . . . . 64.109999999999999 111.703 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.57 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 74.9 Cg_exo -52.79 -43.03 59.23 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.003 2.469 . . . . 72.519999999999996 115.324 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 77.4 Cg_endo -99.27 109.91 0.41 Allowed 'Cis proline' 0 C--N 1.368 1.597 0 CA-C-N 121.301 1.5 . . . . 74.099999999999994 113.738 -2.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.44 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 53.1 p -139.08 -66.0 0.48 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.258 0.623 . . . . 72.329999999999998 109.505 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 3.9 m-20 -73.11 130.82 41.14 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.836 -0.62 . . . . 74.230000000000004 109.739 167.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 71' ' ' ILE . 87.7 mt -100.26 108.38 20.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.15 0.5 . . . . 61.520000000000003 111.918 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.7 mp -77.04 131.1 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.004 0.431 . . . . 62.229999999999997 111.183 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 46' ' ' ARG . 2.0 t90 -70.91 77.06 0.64 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.437 0.636 . . . . 75.549999999999997 110.214 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 7.6 mtpm? -68.57 -2.11 8.21 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.07 0.767 . . . . 75.010000000000005 113.07 -175.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.96 -12.78 20.34 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.487 0.551 . . . . 70.120000000000005 112.487 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.477 ' NE2' HG21 ' A' ' 53' ' ' VAL . 36.1 tt0 -164.54 143.32 7.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.041 0.448 . . . . 73.150000000000006 111.363 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -75.24 -164.22 0.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.724 0.773 . . . . 72.510000000000005 112.971 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -62.37 178.38 0.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.92 -1.037 . . . . 73.219999999999999 112.797 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.57 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.1 p90 -141.8 167.76 21.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.715 -0.675 . . . . 75.140000000000001 110.443 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.15 66.35 0.02 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.552 -0.832 . . . . 54.020000000000003 113.702 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 48' ' ' ILE . 47.0 p -78.78 -65.93 0.93 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.964 0.412 . . . . 53.210000000000001 111.445 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.03 -32.22 1.69 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.169 -0.468 . . . . 74.450000000000003 113.094 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.43 -63.38 1.09 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.477 0.547 . . . . 73.340000000000003 112.477 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -177.43 158.77 1.46 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.715 0.293 . . . . 62.32 110.686 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.31 89.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.846 0.831 . . . . 70.430000000000007 110.351 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.6 tttt -91.31 126.61 36.45 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.641 -0.709 . . . . 74.129999999999995 111.783 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.6 t -118.74 136.56 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.041 0.448 . . . . 72.409999999999997 111.657 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 101' ' ' LYS . 45.7 mm -122.34 138.88 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.054 -0.521 . . . . 52.420000000000002 111.039 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 113' ' ' ALA . 78.4 mt -110.63 113.99 27.03 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.253 0.464 . . . . 74.5 112.253 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -108.16 156.18 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.097 0.475 . . . . 62.219999999999999 110.623 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 77.4 m-20 -99.21 179.07 4.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.051 0.453 . . . . 74.040000000000006 111.68 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.7 t -46.96 -40.68 14.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.42 0.896 . . . . 72.209999999999994 113.42 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.83 14.77 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.666 0.617 . . . . 70.010000000000005 112.666 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.55 -21.56 10.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.334 -0.46 . . . . 64.030000000000001 112.881 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 10.7 pt-20 -52.6 125.38 16.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.259 0.624 . . . . 62.549999999999997 111.937 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.88 136.81 35.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.796 -0.638 . . . . 74.150000000000006 111.436 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 ' H ' ' A' ' 113' ' ' ALA . 12.7 m -125.08 -60.83 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.104 0.779 . . . . 75.340000000000003 113.104 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -105.07 154.45 20.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.38 0.511 . . . . 75.049999999999997 112.38 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.73 154.96 33.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.989 -0.551 . . . . 72.329999999999998 111.287 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.9 ttm180 -166.58 123.86 1.32 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.366 0.876 . . . . 64.420000000000002 113.366 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -105.18 129.85 53.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.688 -0.856 . . . . 73.120000000000005 108.688 164.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.2 p -68.45 -94.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.903 0.705 . . . . 70.129999999999995 112.903 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.47 130.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.296 0.569 . . . . 65.129999999999995 111.301 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -87.38 29.62 0.85 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.179 -0.464 . . . . 70.120000000000005 111.85 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -74.87 -5.23 42.51 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.029 0.442 . . . . 70.510000000000005 111.907 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.0 t -63.46 0.09 0.79 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.929 0.714 . . . . 73.049999999999997 112.929 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.3 p . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.632 -0.699 . . . . 61.310000000000002 112.064 177.458 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 121.264 0.554 . . . . 53.32 110.085 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 9.0 p -98.73 135.28 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.376 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.47 145.51 51.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.202 -0.454 . . . . 64.32 110.88 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' A' ' 102' ' ' VAL . 57.2 mt -72.65 99.29 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.595 -0.275 . . . . 73.43 110.629 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -62.09 -56.97 13.53 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.068 0.461 . . . . 74.32 111.271 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -164.87 143.66 6.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 73.5 111.565 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.443 HG21 HG11 ' A' ' 100' ' ' VAL . 55.7 mt -102.11 138.89 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.938 -0.393 . . . . 63.14 109.938 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.57 135.56 56.67 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.306 0.484 . . . . 70.14 112.306 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.77 -26.0 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.616 0.598 . . . . 74.3 112.616 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 13.7 t70 -85.01 -25.33 27.76 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.279 0.561 . . . . 62.35 110.326 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.52 30.78 6.38 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.149 -0.478 . . . . 40.04 112.943 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -90.37 -45.54 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.405 0.52 . . . . 74.41 112.405 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.46 161.36 38.24 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.648 0.981 . . . . 74.11 113.648 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -117.41 123.73 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 71.13 109.923 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -103.98 109.95 21.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.423 0.63 . . . . 75.4 112.637 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 mp -89.74 156.16 18.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.482 -0.781 . . . . 75.22 110.224 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 68' ' ' THR . 81.7 tttt -143.25 110.96 5.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.146 -0.346 . . . . 61.0 111.881 -173.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 9.4 t30 -87.02 106.12 17.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.026 0.441 . . . . 64.02 111.579 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -109.36 40.84 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.396 0.617 . . . . 72.23 111.406 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 80.7 p -83.33 176.54 9.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.451 0.643 . . . . 62.3 112.591 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.68 -7.45 54.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.766 -0.652 . . . . 65.54 111.933 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -149.4 156.45 42.06 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.841 0.353 . . . . 73.3 111.316 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.1 110.71 1.92 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.97 0.414 . . . . 63.05 111.244 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.37 128.93 40.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.544 0.572 . . . . 60.24 112.544 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.38 119.3 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.415 2.076 . . . . 74.42 112.716 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.2 tpp -62.39 -53.11 59.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.007 0.432 . . . . 74.44 112.041 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.78 -82.13 0.85 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.736 -0.745 . . . . 75.23 112.973 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.97 59.48 0.11 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.732 -0.747 . . . . 52.02 113.65 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -62.27 170.12 2.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.299 0.571 . . . . 74.42 112.245 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.56 114.06 15.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.182 0.515 . . . . 75.4 110.801 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -95.51 113.19 24.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.044 -0.525 . . . . 75.2 111.184 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 2.1 mp -90.44 109.82 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.749 0.309 . . . . 42.31 110.642 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.01 104.45 16.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.116 0.484 . . . . 75.23 111.559 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 100' ' ' VAL . 24.3 mtpp -92.73 166.14 12.6 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.283 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 49' ' ' GLY . 10.2 tt -164.51 -53.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.384 0.513 . . . . 64.14 112.384 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 48' ' ' ILE . . . -174.43 128.16 1.41 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.175 -0.536 . . . . 51.53 112.337 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.07 -69.24 0.16 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.156 0.582 . . . . 74.2 111.995 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -115.96 -174.04 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.733 0.301 . . . . 62.32 111.294 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.5 p -163.6 157.01 18.93 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.878 0.37 . . . . 70.23 111.722 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.782 HG11 ' HG3' ' A' ' 91' ' ' GLN . 7.3 p -138.38 147.17 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.172 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.619 ' HB3' HG13 ' A' ' 45' ' ' ILE . 89.2 p -112.86 161.75 16.6 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.088 0.471 . . . . 71.33 111.969 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.48 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 68.6 t80 -136.46 130.1 32.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.285 -0.416 . . . . 74.25 111.446 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -96.9 144.67 26.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.151 0.5 . . . . 71.34 111.509 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -93.55 179.85 5.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.166 0.507 . . . . 71.01 111.979 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -138.42 155.76 48.19 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.061 -0.518 . . . . 70.14 111.431 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 m -82.38 87.6 6.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.459 -0.337 . . . . 73.15 111.538 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 83' ' ' PRO . 8.9 ptm180 -141.75 7.49 1.88 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.322 0.49 . . . . 71.34 112.322 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -163.9 148.03 10.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.968 0.413 . . . . 62.55 111.643 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.44 131.17 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.224 -0.444 . . . . 33.01 110.86 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.3 106.54 10.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.055 0.455 . . . . 70.13 111.636 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.89 164.74 26.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.173 0.511 . . . . 63.24 111.531 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.4 113.05 3.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.851 0.358 . . . . 61.03 111.11 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.82 8.57 61.88 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.424 -0.417 . . . . 62.04 113.04 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -86.11 122.49 30.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.181 0.515 . . . . 72.44 111.866 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 30' ' ' LYS . 81.3 p -93.35 150.76 20.23 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.307 -0.406 . . . . 73.34 111.299 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 29' ' ' LEU . 7.7 p -135.87 124.39 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.283 0.563 . . . . 65.21 110.945 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 29.4 m -103.82 127.69 51.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.088 -0.505 . . . . 72.4 111.778 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mm -99.38 99.74 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.776 0.322 . . . . 73.03 111.098 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 80.1 m95 -83.58 119.77 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.502 -0.317 . . . . 62.53 111.208 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -74.65 82.23 2.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.587 0.588 . . . . 74.54 112.587 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 60.66 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.605 0.965 . . . . 74.14 113.605 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -71.39 90.18 0.95 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.194 0.521 . . . . 42.04 111.269 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -133.03 -39.94 0.94 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.658 0.614 . . . . 61.11 112.658 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.7 -29.74 6.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.193 -0.527 . . . . 51.04 112.589 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 79' ' ' THR . 43.8 t -66.67 159.34 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 122.799 0.44 . . . . 73.13 111.223 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 78' ' ' VAL . 53.8 m -52.26 129.56 28.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.853 0.359 . . . . 74.44 111.834 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.55 111.05 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.315 0.487 . . . . 71.34 112.315 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.514 ' H ' HD13 ' A' ' 87' ' ' ILE . 67.4 m 67.25 71.45 0.43 Allowed Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 113.429 0.9 . . . . 61.3 113.429 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.823 ' HB3' HG22 ' A' ' 84' ' ' THR . 86.2 Cg_exo -51.1 167.16 0.33 Allowed 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.741 2.961 . . . . 70.4 111.788 168.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD2' ' NH2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 13.41 60.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 N-CA-C 122.017 3.814 . . . . 52.43 122.017 38.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.823 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.3 t 153.68 -52.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.885 1.674 . . . . 74.35 109.985 161.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.66 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 17.9 m-20 -136.27 -161.45 1.16 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.474 0.71 . . . . 63.22 109.353 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.1 mt -142.09 144.16 33.41 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.734 -0.604 . . . . 50.0 112.077 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 81' ' ' SER . 1.8 mp -106.55 123.96 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.066 0.46 . . . . 72.03 111.029 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 73' ' ' ALA . 3.7 t90 -69.14 91.04 0.49 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.425 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -80.56 20.41 0.72 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.792 0.664 . . . . 72.02 112.792 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.8 m120 -128.91 -0.06 5.33 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.008 -0.433 . . . . 74.21 112.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.782 ' HG3' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -161.11 127.47 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.74 0.305 . . . . 75.33 110.492 -172.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.678 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 2.8 m-20 -87.34 172.78 9.59 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.982 0.734 . . . . 64.25 112.982 -173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 t -47.27 125.78 8.46 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.103 -0.498 . . . . 64.05 111.419 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CD1' HD12 ' A' ' 48' ' ' ILE . 48.6 p90 -92.7 -30.98 15.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.531 0.567 . . . . 75.32 112.531 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 73.31 102.49 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.768 -0.73 . . . . 72.41 112.072 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.4 t -79.83 28.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.183 0.808 . . . . 60.21 113.183 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.84 -39.48 62.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.87 -0.892 . . . . 55.22 110.87 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -87.63 123.97 33.04 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.487 -0.56 . . . . 73.14 109.487 166.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -52.63 101.63 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.375 0.607 . . . . 73.44 112.536 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 20' ' ' ILE . 7.4 p -71.96 140.38 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.475 -0.784 . . . . 62.51 111.657 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -124.92 117.16 23.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.925 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 17' ' ' ILE . 60.4 t -99.83 123.69 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.111 0.481 . . . . 74.51 112.049 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 25.1 mm -105.29 116.89 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.037 -0.529 . . . . 70.35 110.95 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.79 107.8 19.81 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.877 0.37 . . . . 53.41 111.847 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.42 139.32 49.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.904 0.383 . . . . 73.34 111.147 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.3 m120 -63.81 174.53 1.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.297 0.57 . . . . 72.51 112.236 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 m -56.87 -28.02 61.22 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.695 -0.684 . . . . 72.42 112.382 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.53 21.41 14.35 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.934 0.716 . . . . 73.23 112.934 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.88 5.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.949 -0.643 . . . . 43.41 114.552 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.9 pt-20 -53.9 150.47 7.65 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.067 0.433 . . . . 74.35 111.348 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.51 136.11 48.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.129 0.789 . . . . 75.13 113.129 -169.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.28 -55.23 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.131 -0.486 . . . . 63.31 111.722 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.19 170.26 21.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 74.33 112.162 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -152.83 134.54 14.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.891 -0.595 . . . . 71.4 111.149 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -144.92 150.58 37.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.796 0.331 . . . . 74.25 111.428 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.6 p -126.49 -178.84 4.5 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 73.44 111.576 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.5 p -80.01 -176.41 5.49 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.223 0.535 . . . . 32.31 111.649 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.47 0.555 0 CA-C-N 116.112 -0.495 . . . . 71.3 110.954 178.122 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.972 0.415 . . . . 72.54 111.466 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 29' ' ' LEU . 39.7 t -98.89 109.57 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.057 0.456 . . . . 64.44 111.888 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 52.8 t -107.63 173.18 6.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.42 -0.355 . . . . 63.14 110.663 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 62.4 mt -88.97 119.79 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.951 -0.468 . . . . 63.12 111.766 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.54 -48.43 22.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.85 0.357 . . . . 75.4 110.537 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.47 153.36 28.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.119 0.414 . . . . 71.42 112.119 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.452 HG23 HG12 ' A' ' 27' ' ' ILE . 47.0 mt -119.94 126.15 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.427 -0.351 . . . . 71.41 110.193 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.86 143.91 54.4 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.739 0.644 . . . . 64.5 112.739 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.57 -19.15 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.778 -0.646 . . . . 61.54 111.339 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.65 -39.03 92.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.096 0.474 . . . . 70.41 110.409 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.97 23.82 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.911 -0.586 . . . . 63.11 113.371 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -112.53 -63.07 1.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.391 0.885 . . . . 72.23 113.391 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.5 154.02 37.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.725 1.38 . . . . 60.23 114.725 -166.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 102' ' ' VAL . 65.6 mt -123.51 110.72 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.166 -0.924 . . . . 73.52 109.381 171.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 36.1 ttm180 -92.06 116.63 29.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.119 0.785 . . . . 75.54 113.119 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 7.7 mp -96.59 179.94 4.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.011 -0.541 . . . . 74.23 111.163 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -165.1 123.14 1.63 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.647 0.26 . . . . 75.21 111.423 -171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . 32.6 t30 -74.07 95.37 2.53 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.013 0.435 . . . . 75.44 111.402 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 p -82.32 87.74 6.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.226 0.536 . . . . 74.01 111.317 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.7 p -155.67 175.48 13.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.086 -0.506 . . . . 62.13 111.249 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.71 3.87 37.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.396 0.517 . . . . 51.44 112.396 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 52.9 tt0 -149.42 153.58 37.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.651 0.263 . . . . 63.25 111.482 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.81 117.25 4.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.904 0.383 . . . . 72.4 110.998 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 24.7 mm-40 -115.7 164.07 18.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 122.311 -0.243 . . . . 71.22 111.477 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.0 144.86 27.54 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.19 1.926 . . . . 74.12 111.152 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.1 tpt -52.42 -56.82 12.46 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.722 0.296 . . . . 74.43 111.651 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.08 148.51 17.79 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.925 -0.655 . . . . 73.0 114.064 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.69 58.88 4.97 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.397 -0.43 . . . . 72.0 112.915 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.79 169.45 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.708 0.29 . . . . 72.54 110.761 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.57 124.3 21.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.261 0.553 . . . . 75.13 111.433 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' SER . 55.6 ttp -93.13 108.25 19.88 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.751 -0.659 . . . . 72.32 111.387 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -97.18 115.54 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.706 0.288 . . . . 73.23 110.758 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -84.35 97.19 9.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.781 0.324 . . . . 64.43 111.223 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -94.69 131.82 40.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.236 0.541 . . . . 62.53 111.677 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 48' ' ' ILE . 15.2 tt -150.22 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.708 0.765 . . . . 73.01 111.079 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.67 -61.67 0.55 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.036 -0.529 . . . . 64.1 113.562 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -82.57 -66.43 0.89 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.398 -0.472 . . . . 73.31 112.232 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -95.86 173.43 7.45 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.132 0.491 . . . . 65.54 112.185 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -145.37 33.03 1.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.003 -0.544 . . . . 70.34 111.371 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.93 127.72 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.295 0.569 . . . . 70.23 111.998 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' MET . 82.8 p -114.54 177.7 4.55 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.489 0.662 . . . . 63.41 112.772 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.518 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 69.6 t80 -152.99 108.39 3.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.492 -0.776 . . . . 64.31 111.193 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -78.83 121.17 24.47 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.803 -0.443 . . . . 63.34 109.803 173.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.09 124.46 23.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.893 0.701 . . . . 73.32 112.893 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -72.27 85.23 1.07 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.478 0.656 . . . . 53.32 111.454 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.9 t -71.93 72.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.374 0.607 . . . . 52.51 111.217 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 16.4 ptt180 -102.68 5.19 38.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.799 -0.637 . . . . 71.33 112.152 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 51.3 p90 -158.37 165.53 34.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.886 0.374 . . . . 74.35 111.529 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.58 143.35 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.069 0.462 . . . . 53.13 111.792 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 31' ' ' ASN . 18.9 tp -108.95 124.38 50.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.125 0.488 . . . . 64.23 111.06 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.93 164.89 16.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.639 0.607 . . . . 73.11 112.639 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.82 124.46 24.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.188 -0.46 . . . . 64.23 111.421 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.94 7.34 83.9 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.31 -0.471 . . . . 61.33 113.152 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.47 132.74 45.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.999 0.428 . . . . 75.03 111.585 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.1 p -92.93 99.56 12.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.087 -0.506 . . . . 52.32 111.919 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.11 113.64 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.353 0.596 . . . . 64.34 110.639 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 21.0 m -99.86 131.81 45.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.963 0.411 . . . . 53.45 112.002 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.2 mm -93.2 99.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.111 -0.495 . . . . 71.11 111.051 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 87' ' ' ILE . 65.1 m95 -90.1 120.43 31.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.466 -0.334 . . . . 71.2 111.098 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -55.33 153.75 6.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.974 0.361 . . . . 70.0 111.974 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.33 -42.56 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.969 0.729 . . . . 75.32 112.969 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -93.71 43.18 1.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.101 0.477 . . . . 70.22 111.952 -178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.81 -4.38 43.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.793 0.33 . . . . 72.13 111.694 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.02 -49.94 3.85 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.34 -0.457 . . . . 62.13 113.541 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.01 146.39 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 122.646 0.378 . . . . 74.22 111.999 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 81' ' ' SER . 92.3 m -54.63 132.19 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.813 0.339 . . . . 72.44 111.641 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.16 -25.04 20.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.38 0.881 . . . . 62.1 113.38 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.555 ' H ' HG22 ' A' ' 79' ' ' THR . 9.3 t -132.72 82.81 55.11 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 120.859 0.361 . . . . 52.32 110.892 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 52.7 Cg_exo -53.36 -47.65 26.25 Favored 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 123.372 2.715 . . . . 73.44 115.283 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 43.0 Cg_endo -103.31 25.77 12.26 Favored 'Cis proline' 0 C--N 1.364 1.391 0 CA-C-N 120.974 1.384 . . . . 70.23 114.501 -0.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.498 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 8.8 t -56.74 -34.28 67.37 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.905 0.383 . . . . 73.44 111.743 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -113.35 173.0 6.62 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.363 -0.381 . . . . 72.01 110.33 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 98.3 mt -122.4 126.36 47.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.368 . . . . 65.33 111.236 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 72' ' ' TRP . 1.7 mp -91.95 124.92 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.479 0.657 . . . . 71.13 112.042 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.518 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 7.9 t90 -74.56 80.44 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.692 -0.685 . . . . 72.4 110.573 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -67.14 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.979 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.479 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.9 m120 -74.11 -12.02 60.48 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -148.52 140.29 23.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.12 0.486 . . . . 64.54 111.697 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.554 HD22 ' N ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -80.66 -171.48 3.13 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.578 -0.283 . . . . 74.22 110.919 174.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 75' ' ' ASN . 94.9 p -73.48 129.53 38.18 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.002 -0.436 . . . . 72.54 110.687 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -90.65 142.29 27.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.258 0.551 . . . . 73.11 112.194 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.03 23.86 24.48 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.095 -0.502 . . . . 62.42 112.654 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.0 p -79.4 127.98 32.78 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.223 0.453 . . . . 61.12 112.223 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.3 -10.15 66.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.431 -0.414 . . . . 71.53 113.33 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.64 156.07 39.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.799 0.333 . . . . 74.53 111.309 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 7.6 p-10 -67.92 89.18 0.28 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.54 0.686 . . . . 62.12 111.198 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.17 117.56 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.918 -0.583 . . . . 71.1 110.812 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.553 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 3.2 ttmp? -103.51 99.1 8.91 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.463 0.649 . . . . 72.15 110.925 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 27' ' ' ILE . 80.0 t -82.09 132.88 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.376 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' A' ' 105' ' ' LYS . 38.0 mm -112.42 133.67 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.123 -0.489 . . . . 74.43 111.514 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 HG13 ' A' ' 17' ' ' ILE . 87.5 mt -112.5 110.12 20.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.692 0.282 . . . . 74.32 111.058 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 103' ' ' ILE . 66.8 mttm -120.36 159.32 25.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 70.22 112.308 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 1.4 m-20 -95.71 -179.27 4.67 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.546 -0.752 . . . . 65.44 111.996 -176.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -61.13 -19.54 61.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.869 -0.605 . . . . 63.14 112.336 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -102.83 17.09 24.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.214 0.45 . . . . 73.41 112.214 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.03 5.36 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.117 -0.563 . . . . 60.33 113.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 15.0 pt-20 -58.68 159.43 6.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.575 0.35 . . . . 61.12 111.162 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 105' ' ' LYS . 35.4 tt0 -121.91 127.43 50.42 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.437 0.532 . . . . 74.14 112.437 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -33.81 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.297 0.481 . . . . 54.2 112.297 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.18 149.73 17.79 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.753 0.649 . . . . 44.0 112.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -146.89 141.29 26.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.67 -0.695 . . . . 74.23 110.19 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 115' ' ' ARG . 31.4 ttt180 -154.67 156.71 36.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.019 -0.426 . . . . 54.32 112.038 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 83.9 p -125.63 170.13 11.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.913 0.387 . . . . 64.54 111.516 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 39.9 p -72.72 159.22 34.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.222 0.534 . . . . 44.24 111.896 176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.306 0.574 . . . . 73.42 111.001 177.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 64.15 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 29' ' ' LEU . 57.4 t -127.99 133.03 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.743 0.306 . . . . 73.23 111.201 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.07 159.13 40.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.8 0.333 . . . . 51.13 111.591 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.611 HG13 HD11 ' A' ' 104' ' ' LEU . 71.7 mt -82.29 116.99 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.926 0.393 . . . . 62.32 111.75 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -80.61 -50.23 10.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.019 0.437 . . . . 73.54 111.305 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -161.92 151.91 16.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.202 0.525 . . . . 52.52 111.451 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 117' ' ' THR . 59.6 mt -115.47 149.22 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.579 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.86 144.51 44.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.067 0.461 . . . . 70.03 112.119 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -32.19 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.18 -0.464 . . . . 44.35 112.027 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.8 -47.3 13.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.98 0.419 . . . . 73.14 110.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.4 23.24 1.4 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.03 -0.532 . . . . 55.23 113.487 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -90.31 -27.89 19.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.453 0.909 . . . . 74.44 113.453 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -151.8 160.31 43.61 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.694 0.998 . . . . 74.45 113.694 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.685 HG23 HG12 ' A' ' 20' ' ' ILE . 70.0 mt -125.98 120.76 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.469 -0.787 . . . . 72.01 110.366 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -93.38 114.38 26.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.845 0.683 . . . . 71.03 112.845 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -100.92 165.21 11.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.268 172.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -151.41 139.59 20.23 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.066 0.46 . . . . 75.32 112.093 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 29.7 t30 -88.12 145.53 25.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.919 -0.582 . . . . 60.32 110.88 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -119.33 8.24 11.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.462 0.541 . . . . 63.23 112.462 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.0 p -81.58 155.5 25.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.34 0.59 . . . . 63.34 112.049 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.9 7.65 17.5 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.992 -0.549 . . . . 71.4 111.947 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.8 156.21 42.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.659 0.266 . . . . 72.21 111.498 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.58 106.11 2.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.443 -0.344 . . . . 63.32 111.025 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -106.13 144.74 29.56 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.699 -0.228 . . . . 64.1 111.326 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.37 156.03 18.55 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.353 2.035 . . . . 74.21 112.948 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.589 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 4.2 tpt -60.23 -29.24 68.62 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.978 0.418 . . . . 34.01 111.926 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.08 176.86 49.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.373 -0.441 . . . . 73.51 113.559 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 52.63 0.67 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.354 -0.451 . . . . 62.0 112.709 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -98.72 172.36 7.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.554 0.216 . . . . 64.03 110.856 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 43.5 tt0 -137.35 137.3 38.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.316 0.579 . . . . 75.11 111.492 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.2 ttp -105.39 122.75 46.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.87 -0.605 . . . . 64.22 111.417 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.502 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.2 mp -104.79 124.29 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.888 0.375 . . . . 70.31 111.407 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.667 ' HB2' ' HH2' ' A' ' 88' ' ' TRP . 34.7 ttt180 -90.87 123.16 34.18 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.278 -0.264 . . . . 73.4 111.671 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -116.58 105.53 12.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 64.41 110.831 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.16 -23.43 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.284 0.564 . . . . 71.02 110.789 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -94.8 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.035 -0.529 . . . . 71.32 112.345 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.86 -41.0 11.43 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.691 0.281 . . . . 72.4 111.384 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.3 t -92.72 147.97 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.162 0.506 . . . . 72.1 111.792 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p -140.96 168.88 18.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.082 0.468 . . . . 73.12 111.6 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -162.17 141.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.245 -0.434 . . . . 45.43 110.537 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -115.58 159.72 20.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.539 0.685 . . . . 61.13 112.782 -174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 84.0 t80 -144.44 115.27 7.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.642 -0.708 . . . . 71.03 110.597 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 87.3 tttt -86.85 140.39 29.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.189 0.519 . . . . 75.21 111.583 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.431 ' HE2' HD11 ' A' ' 71' ' ' ILE . 89.2 m-85 -87.56 145.41 26.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 73.51 111.489 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.8 t -121.55 130.1 53.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.949 0.404 . . . . 62.44 111.659 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 67.8 m -73.92 74.68 1.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.162 0.506 . . . . 65.2 111.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -97.76 -2.24 41.56 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.915 -0.584 . . . . 61.43 111.532 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -168.76 172.83 7.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.617 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.06 126.32 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.14 0.495 . . . . 72.42 111.652 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -74.38 119.56 18.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.232 -0.655 . . . . 75.13 109.232 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 66.0 mttm -62.37 158.75 16.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.825 0.676 . . . . 50.42 112.825 -172.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.21 113.88 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.658 -0.701 . . . . 74.43 112.006 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . 67.66 21.4 72.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.463 -0.398 . . . . 45.14 114.029 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.489 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -86.35 149.24 25.17 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.148 0.499 . . . . 73.25 111.844 -178.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.1 p -92.45 145.2 24.64 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.178 -0.465 . . . . 75.11 111.557 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' HD21 ' A' ' 63' ' ' LEU . 7.0 p -134.49 122.29 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.91 0.386 . . . . 62.13 110.391 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -103.1 137.33 41.42 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.253 0.549 . . . . 74.42 112.102 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 86' ' ' LEU . 43.5 mm -95.4 108.85 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.214 -0.448 . . . . 63.04 110.782 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -97.35 136.22 38.12 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.544 0.212 . . . . 71.12 110.659 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.31 158.11 18.11 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.086 0.402 . . . . 64.14 112.086 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 89' ' ' LYS . . . -47.09 -44.92 21.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.594 0.59 . . . . 73.02 112.594 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 93' ' ' SER . 2.0 m-20 -95.84 74.5 3.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.161 0.505 . . . . 73.42 111.511 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.9 3.15 8.77 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.08 -0.509 . . . . 72.33 111.188 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.62 17.32 64.52 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.309 -0.405 . . . . 74.44 113.651 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.39 171.5 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.152 0.501 . . . . 73.1 112.317 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -82.2 164.4 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.999 -0.546 . . . . 62.02 112.207 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.54 89.89 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.359 -0.382 . . . . 63.42 111.717 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 t 59.83 81.36 0.25 Allowed Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.508 . . . . 45.12 111.342 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 89.0 Cg_exo -45.23 -51.45 7.75 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.222 2.615 . . . . 65.13 115.365 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 48.6 Cg_endo -100.13 149.35 4.15 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 121.011 1.397 . . . . 70.51 114.008 -1.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 t -171.02 -38.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.259 -0.882 . . . . 31.21 108.892 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -123.21 156.76 34.49 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.838 -1.074 . . . . 72.44 109.308 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 71' ' ' ILE . 93.3 mt -104.8 141.65 36.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.026 0.441 . . . . 74.4 111.961 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.5 mp -95.14 121.85 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.313 0.578 . . . . 75.11 111.343 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.667 ' HH2' ' HB2' ' A' ' 46' ' ' ARG . 4.9 t90 -89.66 84.0 6.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.939 -0.573 . . . . 73.51 110.463 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 48.8 mtmt -74.61 -16.41 60.79 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.187 0.44 . . . . 73.44 112.187 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.567 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 0.9 OUTLIER -65.9 -15.86 63.33 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.79 0.328 . . . . 71.42 111.523 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -148.69 139.01 22.48 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 72.22 111.103 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.9 m120 -72.72 -177.17 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.035 0.445 . . . . 73.45 111.231 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 40.4 t -77.69 142.92 38.51 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.226 -0.297 . . . . 73.15 111.486 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -125.85 157.71 36.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.953 0.406 . . . . 73.14 111.234 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.92 141.75 7.27 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.93 -0.652 . . . . 61.33 112.819 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 t 176.46 -27.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.983 0.364 . . . . 63.24 111.983 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 30.11 20.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.039 -0.6 . . . . 45.24 113.564 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.58 144.08 28.28 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.005 0.402 . . . . 71.12 110.757 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.2 m-20 -64.52 99.32 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.172 0.511 . . . . 74.0 112.15 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.36 127.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.578 . . . . 62.22 111.072 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 19.2 ttpp -104.26 119.53 39.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.188 0.518 . . . . 74.23 111.336 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.1 t -108.71 147.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.132 0.491 . . . . 74.02 112.015 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 mm -116.95 126.49 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.094 -0.503 . . . . 75.42 111.591 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 HG13 ' A' ' 17' ' ' ILE . 66.3 mt -110.58 106.71 16.08 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.702 0.287 . . . . 74.32 111.697 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -120.52 140.82 50.91 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.323 0.583 . . . . 74.21 111.731 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.517 ' OD1' HG13 ' A' ' 112' ' ' VAL . 12.4 m120 -80.77 179.68 7.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.739 -0.664 . . . . 73.12 112.343 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.5 p -54.48 -49.24 70.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.561 -0.745 . . . . 53.5 112.345 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.56 -4.32 22.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.78 0.659 . . . . 71.15 112.78 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.35 -16.75 60.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.047 -0.597 . . . . 70.23 113.468 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.76 143.95 55.62 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.456 -0.438 . . . . 74.31 110.72 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -103.06 130.47 50.21 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.6 0.592 . . . . 74.24 112.6 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 106' ' ' ASN . 16.0 m -76.7 -45.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.765 -0.198 . . . . 65.11 111.194 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -176.67 133.7 0.21 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.516 0.561 . . . . 64.33 112.516 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.28 141.9 35.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.526 -0.546 . . . . 63.42 109.526 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -155.61 146.91 22.68 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.407 0.521 . . . . 60.23 112.407 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 79.1 p -109.56 169.98 8.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.005 0.431 . . . . 24.0 111.306 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.782 HG22 ' HB ' ' A' ' 20' ' ' ILE . 62.3 p -71.91 164.81 25.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.152 0.501 . . . . 71.42 112.106 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 CA--C 1.536 0.406 0 CA-C-N 116.051 -0.522 . . . . 62.43 110.65 174.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 11.9 m120 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 112.243 0.46 . . . . 52.23 112.243 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.53 97.75 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.209 0.528 . . . . 61.33 110.878 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 p -112.54 158.67 19.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.365 -0.38 . . . . 65.21 111.416 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.737 HG13 HD11 ' A' ' 104' ' ' LEU . 72.2 mt -62.11 135.73 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.734 -0.212 . . . . 43.14 111.037 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 33.0 tt0 -90.56 -69.25 0.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 74.21 110.26 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.85 138.66 22.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.408 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.755 HG23 HG12 ' A' ' 27' ' ' ILE . 56.4 mt -101.53 141.77 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.375 -0.375 . . . . 70.2 110.907 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.0 150.15 35.85 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.368 0.604 . . . . 74.13 112.419 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.37 -31.43 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.302 -0.863 . . . . 62.54 112.569 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.45 -32.15 66.04 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.134 0.492 . . . . 73.12 111.238 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 108.96 34.04 2.66 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.133 -0.485 . . . . 63.05 112.303 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.74 -53.13 3.98 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.416 0.524 . . . . 71.53 112.416 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.39 165.65 35.12 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.834 1.05 . . . . 64.32 113.834 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.755 HG12 HG23 ' A' ' 20' ' ' ILE . 64.7 mt -129.05 106.44 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.889 -1.05 . . . . 61.53 109.612 172.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -91.66 124.66 35.97 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.85 -0.531 . . . . 72.15 112.343 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 8.0 mp -93.49 -177.28 4.36 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.12 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 61.6 tttp -162.66 119.9 2.0 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.793 0.294 . . . . 73.01 111.793 -174.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.571 ' HB2' HD12 ' A' ' 63' ' ' LEU . 38.5 t30 -90.24 110.43 21.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.609 0.243 . . . . 70.34 111.032 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.6 p -96.65 13.53 27.99 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.369 0.507 . . . . 74.21 112.369 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 29.5 t -79.54 157.6 27.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.288 0.566 . . . . 63.43 112.438 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.61 -13.72 59.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.797 -0.638 . . . . 65.32 110.741 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -115.64 149.26 38.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.191 0.52 . . . . 62.03 111.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.17 108.83 5.56 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.101 -0.5 . . . . 72.21 110.141 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -91.2 119.68 68.68 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.384 0.512 . . . . 53.0 112.384 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.87 136.11 47.45 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.269 1.979 . . . . 65.01 111.844 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 3.0 tpt -59.39 -41.53 89.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.21 0.448 . . . . 65.21 112.21 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.27 -67.12 1.21 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.375 -0.441 . . . . 70.34 113.494 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.78 78.52 0.02 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 62.32 112.855 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -98.9 179.96 4.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.73 0.3 . . . . 74.23 111.067 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.42 130.44 11.83 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.522 0.677 . . . . 64.33 111.236 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' SER . 52.2 ttp -99.35 111.39 23.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.808 -0.633 . . . . 55.03 111.416 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.7 mp -89.68 141.6 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.668 0.27 . . . . 75.54 110.631 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -138.17 126.25 22.8 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.939 -0.475 . . . . 73.11 111.621 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -111.97 145.38 39.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 74.34 111.179 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.99 -41.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.062 0.458 . . . . 73.54 111.923 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.15 103.62 0.17 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.146 -0.55 . . . . 63.24 112.369 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 72.47 -36.51 0.36 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.457 0.703 . . . . 64.03 112.616 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -113.84 148.54 36.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.902 0.382 . . . . 73.21 111.457 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.1 p -137.02 143.43 42.73 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.338 -0.392 . . . . 75.2 111.023 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.5 147.38 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 63.24 111.031 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' MET . 97.9 p -131.77 150.32 52.19 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.067 0.461 . . . . 61.12 111.971 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 33.1 t80 -122.6 120.5 33.93 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.36 -0.382 . . . . 73.15 111.297 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.69 129.32 34.85 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.965 0.412 . . . . 73.35 111.649 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HB3' ' SD ' ' A' ' 39' ' ' MET . 86.4 m-85 -88.67 122.59 32.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.311 -0.404 . . . . 55.21 111.659 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.9 t -81.91 140.57 33.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.639 0.607 . . . . 71.21 112.639 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 98.9 p -86.05 18.44 3.06 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.17 0.433 . . . . 72.52 112.17 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 14.4 ptm180 -68.85 -9.8 53.37 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.757 0.651 . . . . 72.01 112.757 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.49 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 48.6 p90 -152.63 168.44 25.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.279 0.562 . . . . 75.2 112.043 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.57 140.71 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.682 -0.69 . . . . 72.12 111.455 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -92.95 100.61 13.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.33 -0.619 . . . . 64.45 109.33 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 8.4 mtpm? -69.69 163.24 26.08 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.384 0.883 . . . . 75.41 113.384 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.57 122.53 17.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.834 -0.621 . . . . 75.2 111.171 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.34 86.72 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.944 -0.646 . . . . 72.05 113.473 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.633 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -89.37 133.9 34.31 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.462 -0.434 . . . . 63.55 111.041 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.9 p -116.07 100.68 8.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.316 -0.402 . . . . 63.21 111.821 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.67 132.17 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.927 0.394 . . . . 63.41 111.206 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 m -101.2 124.23 46.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.826 0.346 . . . . 65.53 111.694 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 40.7 mm -89.39 96.2 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.91 0.386 . . . . 54.42 110.985 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' TRP . 94.3 m95 -83.05 133.9 35.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.684 0.253 . . . . 71.41 111.684 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 163.3 11.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.038 0.447 . . . . 34.42 111.964 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.35 -21.08 3.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.07 0.767 . . . . 61.24 113.07 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -86.97 16.47 4.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.106 0.41 . . . . 75.52 112.106 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.94 78.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.051 0.453 . . . . 73.15 111.501 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.36 -26.85 3.34 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.424 -0.417 . . . . 73.31 113.686 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.26 163.57 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.981 0.42 . . . . 74.53 111.98 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -78.13 143.6 37.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.064 0.459 . . . . 75.22 111.662 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.0 78.12 3.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.024 0.44 . . . . 63.41 111.199 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -136.47 95.07 13.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.503 -0.317 . . . . 70.35 111.684 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 13.4 Cg_exo -72.72 178.17 6.67 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.248 2.632 . . . . 75.54 112.278 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 98.6 Cg_endo -99.9 118.82 1.01 Allowed 'Cis proline' 0 C--N 1.361 1.22 0 N-CA-C 114.544 0.94 . . . . 73.13 114.544 -0.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.9 t -154.96 -56.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.97 -0.559 . . . . 70.01 109.855 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 84' ' ' THR . 21.4 m-20 -141.2 176.85 8.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.779 -0.646 . . . . 65.02 109.703 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 97.0 mt -123.02 124.13 42.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.893 0.378 . . . . 74.24 110.956 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 87' ' ' ILE . 3.2 mp -93.99 111.56 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.167 0.508 . . . . 75.4 111.31 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.443 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 4.3 t90 -71.09 77.9 0.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.203 0.525 . . . . 74.43 110.617 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.89 1.8 16.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.022 0.439 . . . . 72.44 111.607 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.443 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 15.2 m120 -93.57 -4.32 51.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.272 -0.422 . . . . 64.33 111.812 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -137.79 148.69 45.75 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.171 0.51 . . . . 75.13 111.457 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -91.44 -174.82 4.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.04 -0.527 . . . . 71.52 110.789 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 98.7 p -64.41 120.43 12.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.141 0.496 . . . . 54.33 111.096 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.3 p90 -77.73 118.21 19.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.239 0.542 . . . . 72.34 112.062 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.36 102.74 0.16 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.932 -0.576 . . . . 75.33 112.334 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -157.35 26.25 0.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 65.23 111.718 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -54.11 4.35 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.151 -0.547 . . . . 42.42 113.102 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.3 119.19 8.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.479 0.312 . . . . 73.21 111.194 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.04 146.2 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.676 0.621 . . . . 74.22 112.676 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.4 128.47 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.773 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 116' ' ' SER . 80.7 tttt -114.47 142.49 46.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.991 0.424 . . . . 71.14 111.751 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.82 136.91 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 116.192 -0.458 . . . . 71.11 111.996 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.73 122.91 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.024 -0.535 . . . . 74.41 111.432 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 17' ' ' ILE . 97.9 mt -89.69 131.28 35.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.231 -0.293 . . . . 70.35 111.095 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.6 mttt -141.09 145.72 36.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.209 0.528 . . . . 53.35 112.052 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' HG3' ' A' ' 110' ' ' GLU . 10.6 m120 -88.31 -173.43 4.2 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.082 0.467 . . . . 74.14 111.674 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -51.78 -41.96 62.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.742 0.645 . . . . 61.13 112.742 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.99 -0.69 40.66 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.894 0.702 . . . . 75.13 112.894 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.1 0.59 80.51 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.896 -0.669 . . . . 22.22 112.867 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' OD1' ' A' ' 106' ' ' ASN . 13.8 pt-20 -66.8 138.6 57.47 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.718 0.407 . . . . 71.21 111.108 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.5 tt0 -83.59 133.15 34.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.174 0.512 . . . . 75.43 111.954 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.71 -50.53 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.964 -0.562 . . . . 71.14 111.162 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.6 163.78 16.9 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.966 -0.561 . . . . 65.23 111.58 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -137.16 136.12 37.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.241 -0.436 . . . . 71.34 111.116 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -160.63 156.25 25.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.118 0.485 . . . . 75.31 111.486 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 54.4 p -142.54 -171.94 3.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.788 0.328 . . . . 60.33 111.221 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 14.8 t -147.23 145.47 29.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.652 0.263 . . . . 62.01 110.571 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.004 0.43 . . . . 71.42 111.831 -176.381 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 . . . . . 0 CA--C 1.542 0.644 0 CA-C-O 121.103 0.478 . . . . 72.22 110.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.42 140.6 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.015 0.436 . . . . 52.51 111.873 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -137.81 164.17 29.59 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.209 -0.45 . . . . 62.02 110.705 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.1 mp -87.49 119.44 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.22 -0.3 . . . . 72.2 111.28 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.51 -50.52 44.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.785 0.326 . . . . 70.54 111.361 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -171.31 152.79 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 60.33 112.149 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 27' ' ' ILE . 65.3 mt -107.49 134.72 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.792 -0.64 . . . . 64.12 110.816 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.0 130.25 41.66 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.032 0.444 . . . . 65.21 111.301 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -70.18 -28.25 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.511 0.56 . . . . 74.31 112.511 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.53 -44.76 56.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.77 0.319 . . . . 74.33 110.835 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 117.02 37.97 0.91 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 116.23 -0.441 . . . . 73.44 113.236 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -104.69 -39.59 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.452 0.538 . . . . 63.51 112.452 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.75 160.46 37.9 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.353 0.871 . . . . 72.14 113.353 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 20' ' ' ILE . 69.7 mt -131.61 122.47 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.611 -0.722 . . . . 71.0 109.781 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -99.72 122.41 42.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.934 0.716 . . . . 73.44 112.934 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 104' ' ' LEU . 7.0 mp -97.3 173.72 7.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.592 -0.731 . . . . 74.33 110.587 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.6 131.6 11.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.936 0.398 . . . . 73.12 111.981 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HB3' HD12 ' A' ' 63' ' ' LEU . 28.4 t30 -89.87 104.36 16.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.249 -0.432 . . . . 65.45 110.968 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 t -105.72 84.11 2.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 71.45 110.887 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.6 p -136.4 -177.8 4.88 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.722 -0.672 . . . . 64.42 112.164 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.45 -22.53 35.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.909 0.707 . . . . 74.51 112.909 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -146.89 154.56 41.44 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.516 0.561 . . . . 75.12 112.516 -170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -50.36 128.15 19.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.866 -0.606 . . . . 72.41 111.569 175.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.1 mm-40 -121.08 119.68 29.61 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.805 0.336 . . . . 53.51 111.633 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 7.3 Cg_exo -74.8 29.9 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.12 2.547 . . . . 64.32 113.946 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.3 tpt 64.94 -71.18 0.08 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.4 0.518 . . . . 53.14 112.4 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . 96.37 -75.69 0.76 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.134 -0.555 . . . . 64.33 113.247 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.48 83.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.22 -0.514 . . . . 40.31 112.917 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.685 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 9.0 m0 -100.65 174.71 5.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.767 0.318 . . . . 75.54 111.605 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.28 111.32 15.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.799 0.333 . . . . 71.24 111.194 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.7 ttp -103.01 121.2 42.07 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.068 -0.395 . . . . 62.33 111.279 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.28 149.64 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.355 -0.384 . . . . 64.04 110.716 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HD3' HH11 ' A' ' 46' ' ' ARG . 28.4 ttp-105 -135.2 105.54 6.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.944 -0.473 . . . . 43.12 110.878 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 98.3 mttt -88.44 118.91 28.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.481 -0.327 . . . . 71.14 110.666 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 tt -155.07 99.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.934 0.397 . . . . 73.11 111.665 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 58.94 93.66 0.01 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.253 -0.431 . . . . 50.42 114.117 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.9 t70 76.46 -58.75 0.52 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.068 0.766 . . . . 71.21 113.068 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -103.99 163.42 12.38 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.849 0.685 . . . . 63.34 112.849 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.4 p -138.02 105.4 5.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.646 -0.706 . . . . 74.23 110.683 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.1 p -92.28 146.18 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.699 0.285 . . . . 63.42 111.429 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -123.0 159.35 28.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.21 0.528 . . . . 74.35 111.77 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 73.6 t80 -138.93 133.52 31.95 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.114 -0.494 . . . . 64.22 110.813 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -101.18 129.98 47.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.097 0.475 . . . . 72.44 111.715 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.685 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 68.7 m-85 -88.84 172.89 8.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.033 -0.53 . . . . 72.34 111.923 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 t -149.71 153.82 37.56 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.984 0.421 . . . . 75.12 112.111 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 36.9 t -86.3 64.26 8.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.991 0.424 . . . . 53.53 111.919 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.683 HH11 ' HG2' ' A' ' 82' ' ' PRO . 9.6 ptp180 -106.58 -1.53 22.82 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.747 0.308 . . . . 74.22 111.785 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HD23 ' A' ' 63' ' ' LEU . 29.9 p90 -154.98 148.61 25.37 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.681 0.277 . . . . 73.13 111.011 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 47.8 t -97.02 102.37 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 64.11 111.024 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 31' ' ' ASN . 1.1 tm? -80.74 108.82 14.72 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.204 0.526 . . . . 72.35 110.623 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 61.7 mttm -64.36 140.5 58.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.024 -0.534 . . . . 73.31 112.186 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.24 127.19 30.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.253 -0.43 . . . . 61.04 111.306 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.96 -15.37 55.4 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.152 -0.547 . . . . 71.44 112.787 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 1.7 mp0 -95.65 168.08 10.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.885 0.374 . . . . 75.41 110.831 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.8 p -119.25 174.04 6.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.274 0.559 . . . . 74.2 112.183 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.72 127.92 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.976 -0.556 . . . . 44.05 110.448 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.5 m -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.955 0.407 . . . . 72.15 111.96 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 86' ' ' LEU . 29.5 mm -92.54 97.49 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.151 -0.477 . . . . 72.4 110.423 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 88.0 m95 -79.12 168.72 19.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.938 0.399 . . . . 74.33 111.792 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.67 16.63 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.569 -0.287 . . . . 64.21 110.902 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.1 -30.62 37.47 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.108 0.781 . . . . 73.35 113.108 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -97.9 19.63 13.51 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.429 0.529 . . . . 55.55 112.429 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -52.91 -47.83 67.68 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 43.32 112.625 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.93 75.48 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.213 -0.518 . . . . 33.55 112.816 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.91 -164.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.327 0.251 . . . . 64.01 111.106 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.4 m -48.67 130.29 17.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.771 0.319 . . . . 74.44 111.165 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.13 62.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.553 0.945 . . . . 73.12 113.553 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.4 t -159.28 151.91 17.9 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 113.133 0.79 . . . . 74.3 113.133 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.685 ' HG3' HD23 ' A' ' 86' ' ' LEU . 7.1 Cg_endo -48.79 170.84 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 123.919 3.079 . . . . 74.12 111.363 168.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -16.82 -80.51 0.0 OUTLIER 'Cis proline' 0 C--N 1.374 1.896 0 N-CA-C 121.329 3.55 . . . . 74.14 121.329 11.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.2 p -78.62 -83.63 0.09 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.301 1.223 . . . . 62.2 114.301 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 6.3 m-20 -73.78 122.6 22.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.248 0.547 . . . . 73.23 112.458 -171.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.685 HD23 ' HG3' ' A' ' 82' ' ' PRO . 12.1 mt -91.09 113.24 25.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.912 -0.585 . . . . 73.45 111.369 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.5 mp -86.08 119.11 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.18 0.514 . . . . 60.14 110.944 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.421 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.1 t90 -69.46 77.9 0.4 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.332 0.587 . . . . 75.44 110.351 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -75.88 27.82 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.324 0.49 . . . . 42.44 112.324 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.1 -1.86 11.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.901 0.381 . . . . 70.51 110.969 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.455 ' OE1' HG11 ' A' ' 53' ' ' VAL . 25.3 tt0 -157.82 146.27 19.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.966 0.413 . . . . 44.11 111.111 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -82.81 -167.62 1.71 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.433 -0.349 . . . . 73.12 110.775 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 t -69.0 145.35 53.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.941 0.401 . . . . 65.42 111.611 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.512 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 49.4 p90 -121.86 -174.46 2.88 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.217 -0.447 . . . . 64.2 110.631 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 137.71 50.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.766 -0.731 . . . . 63.34 113.609 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 98' ' ' GLU . 7.3 t -76.49 -20.91 56.47 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.451 -0.441 . . . . 74.32 111.982 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.62 4.87 60.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.091 -0.576 . . . . 74.42 113.517 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.606 ' H ' HG23 ' A' ' 96' ' ' THR . 9.0 mm-40 -85.69 172.46 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.652 -0.322 . . . . 54.44 111.257 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.05 143.33 55.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.103 0.478 . . . . 52.15 111.995 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.35 132.74 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.284 0.564 . . . . 75.01 111.655 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 114' ' ' GLN . 50.6 tttm -123.35 111.8 16.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.07 -0.514 . . . . 61.31 110.817 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.81 133.09 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.946 0.403 . . . . 72.13 111.39 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.463 HG21 ' HE2' ' A' ' 105' ' ' LYS . 16.3 mm -126.64 136.53 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 111.828 0.307 . . . . 63.12 111.828 -173.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 29' ' ' LEU . 79.4 mt -110.13 107.68 17.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.93 0.395 . . . . 51.25 111.559 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' A' ' 103' ' ' ILE . 67.7 mttm -119.31 167.76 11.57 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.373 0.606 . . . . 71.14 112.061 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HB2' ' CG ' ' A' ' 110' ' ' GLU . 12.8 m120 -113.96 -176.65 2.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.987 -0.551 . . . . 74.54 111.681 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 t -58.75 -39.32 80.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.307 0.854 . . . . 62.22 113.307 -173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -73.46 -8.7 57.0 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.552 0.575 . . . . 73.05 112.552 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.75 68.68 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.648 -0.787 . . . . 65.23 112.065 -171.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.513 ' CG ' ' HB2' ' A' ' 106' ' ' ASN . 10.5 pt-20 -68.44 168.59 12.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.658 0.383 . . . . 75.3 110.39 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.71 136.92 48.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.128 -0.358 . . . . 74.5 111.779 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.648 HG21 ' HZ3' ' A' ' 42' ' ' TRP . 29.2 m -96.7 -41.62 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.438 -0.346 . . . . 53.13 111.61 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.79 168.95 13.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 40.33 111.504 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 29.5 pt20 -160.0 163.37 34.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.71 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -161.89 -179.41 7.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.015 0.912 . . . . 54.5 112.793 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.3 p -147.64 -170.99 3.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.821 -1.081 . . . . 73.33 109.892 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 p -78.71 142.45 37.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.894 0.378 . . . . 74.4 110.972 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.383 0.611 . . . . 72.11 111.193 178.051 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.6 m-80 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 120.874 0.368 . . . . 75.23 111.375 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.11 120.27 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.01 0.433 . . . . 73.24 111.361 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -133.62 156.66 47.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.447 -0.342 . . . . 74.21 110.906 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 65.2 mt -71.04 126.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.755 0.312 . . . . 64.22 111.496 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -89.33 -66.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.001 0.429 . . . . 74.43 110.783 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -136.23 130.25 32.81 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.126 0.489 . . . . 70.21 112.085 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG23 ' A' ' 27' ' ' ILE . 62.6 mt -103.91 114.45 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.968 -0.56 . . . . 72.24 110.351 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 17.2 t70 -74.53 139.61 43.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.473 0.654 . . . . 53.22 112.256 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.5 -16.41 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.609 -0.723 . . . . 73.53 110.993 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.07 -14.15 61.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.149 -0.478 . . . . 32.42 111.198 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 99.44 29.22 7.16 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.771 0.669 . . . . 73.1 114.771 168.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.5 mptt -113.3 -54.48 2.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.214 0.82 . . . . 71.34 113.214 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 46.1 p90 -148.04 167.24 25.46 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.106 1.151 . . . . 75.33 114.106 -170.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.466 HG23 HG12 ' A' ' 20' ' ' ILE . 69.8 mt -132.63 105.22 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 72.04 109.345 170.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.1 ttm180 -90.8 119.94 31.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.207 0.817 . . . . 75.45 113.207 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.0 mp -93.83 -175.88 3.87 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.712 -0.676 . . . . 75.45 110.333 171.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 35.0 ttpt -157.37 135.16 10.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.996 0.427 . . . . 64.51 112.009 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -108.33 115.23 29.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.039 -0.528 . . . . 64.24 111.403 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -102.19 16.56 25.75 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 64.42 112.116 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 98.3 p -55.24 152.32 8.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.079 0.466 . . . . 63.11 111.707 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -85.14 -0.35 54.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.799 0.333 . . . . 53.3 111.811 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.87 161.04 28.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.395 -0.366 . . . . 72.04 110.269 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.61 111.54 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.725 0.298 . . . . 73.23 111.244 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -104.85 132.07 21.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 N-CA-C 111.893 0.331 . . . . 75.11 111.893 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.69 132.93 54.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.456 2.104 . . . . 43.43 112.19 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 tpt -52.45 -72.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.07 0.396 . . . . 74.4 112.07 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.64 172.45 45.38 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.711 -0.757 . . . . 62.12 113.085 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.19 89.11 0.41 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.117 -0.563 . . . . 74.51 113.707 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . 41.3 m95 -102.41 156.43 17.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.773 0.321 . . . . 71.24 110.434 171.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.84 115.35 6.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.805 0.336 . . . . 74.31 111.468 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' SER . 54.7 ttp -93.99 114.06 26.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.569 -0.287 . . . . 75.0 111.67 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.8 mp -102.13 106.91 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.894 0.378 . . . . 72.23 110.36 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HG3' HG22 ' A' ' 102' ' ' VAL . 50.6 ttt180 -99.11 123.62 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.713 0.292 . . . . 74.42 111.483 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -121.9 116.86 25.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.954 0.407 . . . . 60.51 111.584 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 tt -103.35 -27.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.165 0.507 . . . . 70.25 110.703 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.96 -137.31 3.21 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.858 -0.61 . . . . 74.31 112.305 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -71.25 -40.54 70.93 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.03 0.443 . . . . 43.43 111.454 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -79.05 156.5 28.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.189 0.518 . . . . 51.14 112.126 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.3 p -133.69 152.55 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.343 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.9 p -134.96 139.43 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.506 -0.316 . . . . 62.32 111.318 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' MET . 84.0 p -111.53 171.38 7.52 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.233 0.54 . . . . 73.21 112.369 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.435 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 74.6 t80 -160.47 114.21 2.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.863 -0.608 . . . . 74.55 111.252 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.15 127.07 33.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.746 0.307 . . . . 71.32 111.438 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 3.1 m-85 -73.98 121.99 21.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.823 0.344 . . . . 64.23 111.123 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.53 HG21 ' HG2' ' A' ' 82' ' ' PRO . 5.2 t -68.84 120.96 15.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.543 0.687 . . . . 71.14 112.213 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -85.89 33.93 0.6 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.113 -0.494 . . . . 63.4 111.925 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.662 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 13.4 ptp180 -78.47 -3.72 44.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.148 0.425 . . . . 75.05 112.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.538 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 24.2 p90 -158.54 171.83 19.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.004 0.431 . . . . 71.05 111.362 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -92.9 138.74 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.3 -0.409 . . . . 63.34 111.51 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.31 105.7 13.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.137 0.494 . . . . 72.33 109.68 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 7.4 mtpm? -69.14 154.23 42.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.269 0.557 . . . . 63.43 112.446 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.6 57.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.753 -0.658 . . . . 73.33 112.187 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.26 -0.495 . . . . 62.44 113.793 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.671 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.89 132.38 34.71 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.229 -0.571 . . . . 71.42 111.557 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 56.2 p -100.02 83.59 2.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.309 -0.405 . . . . 61.01 111.019 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 29' ' ' LEU . 4.5 p -57.96 106.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.573 0.701 . . . . 61.22 111.372 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 86.4 m -93.06 121.31 34.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 74.05 111.525 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 47.8 mm -83.12 106.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.433 -0.348 . . . . 62.42 111.047 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -82.95 144.75 29.79 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.564 0.209 . . . . 73.41 111.564 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.93 157.64 27.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.835 0.35 . . . . 74.45 111.877 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.98 -30.48 25.16 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.439 0.533 . . . . 62.11 112.439 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -81.73 28.66 0.4 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.804 0.335 . . . . 60.44 111.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.62 87.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.176 0.436 . . . . 73.41 112.176 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.84 -37.7 2.5 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.178 -0.534 . . . . 43.2 113.771 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.2 -173.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.152 0.427 . . . . 65.51 112.152 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -51.1 104.92 0.09 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.1 111.903 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.82 1.32 35.34 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.671 0.619 . . . . 62.31 112.671 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.4 t -117.2 117.72 36.48 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 120.533 0.206 . . . . 75.21 111.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.662 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 54.0 Cg_exo -55.91 178.6 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.527 0 C-N-CA 123.776 2.984 . . . . 63.13 113.414 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 95.4 Cg_endo -76.73 126.19 12.94 Favored 'Cis proline' 0 C--N 1.366 1.459 0 CA-C-N 120.107 1.074 . . . . 71.14 114.813 6.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 82' ' ' PRO . 8.9 t 176.71 -170.94 0.08 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.353 -0.84 . . . . 70.03 109.418 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 87' ' ' ILE . 6.5 m-20 -57.4 108.1 0.51 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.735 -0.469 . . . . 74.02 109.735 171.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 79.6 mt -51.44 109.22 0.32 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.378 0.881 . . . . 72.12 113.378 -169.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 85' ' ' ASP . 3.6 mp -76.25 117.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.193 0.521 . . . . 64.2 110.8 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 6.7 t90 -70.31 134.96 48.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.914 -0.584 . . . . 74.52 110.527 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -127.35 27.99 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.02 0.438 . . . . 73.13 111.769 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.426 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.1 m120 -121.45 -26.77 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.361 -0.381 . . . . 74.31 111.522 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -133.32 147.13 51.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.697 0.284 . . . . 54.43 110.874 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -95.51 -171.67 2.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.994 0.426 . . . . 74.42 111.951 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -59.89 127.03 29.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.892 0.377 . . . . 72.43 111.056 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -101.47 118.07 36.2 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.244 0.545 . . . . 75.12 112.457 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -120.93 85.14 0.38 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 72.23 111.893 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 p -130.56 -39.09 1.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.132 0.419 . . . . 74.22 112.132 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.42 89.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.257 -0.496 . . . . 71.14 112.857 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -96.66 145.75 25.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.97 0.414 . . . . 51.23 111.858 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 6.1 m-20 -64.59 131.1 46.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.402 0.62 . . . . 61.15 112.07 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 46' ' ' ARG . 7.5 p -119.09 126.05 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.883 -0.599 . . . . 74.53 111.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.875 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.3 tttt -90.95 115.99 28.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.797 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 46' ' ' ARG . 46.6 t -104.55 123.76 58.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.907 0.384 . . . . 73.34 111.518 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.875 HD11 ' HE2' ' A' ' 101' ' ' LYS . 50.4 mm -105.92 131.7 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.281 0.474 . . . . 72.21 112.281 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.4 mt -105.12 112.54 25.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.903 0.382 . . . . 74.25 110.943 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.75 171.59 7.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.17 -0.468 . . . . 73.1 110.931 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.8 -167.4 1.22 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.941 0.401 . . . . 72.34 111.253 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.2 t -56.98 -26.91 60.78 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.446 0.906 . . . . 73.43 113.446 -174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.86 -9.41 31.51 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 122.11 -0.369 . . . . 72.02 111.565 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.42 9.46 55.18 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.294 -0.479 . . . . 75.5 113.672 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.95 124.97 26.05 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.992 0.425 . . . . 74.45 111.88 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.5 107.27 7.52 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.303 -0.408 . . . . 75.21 110.959 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.59 -37.31 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.616 0.599 . . . . 71.21 112.616 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -141.39 122.53 14.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.193 0.442 . . . . 55.13 112.193 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -124.79 141.59 52.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.511 -0.313 . . . . 70.41 111.224 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -161.46 151.76 17.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.716 0.293 . . . . 74.33 111.039 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -140.53 174.67 10.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.168 0.509 . . . . 51.52 111.661 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 38.6 p -70.01 175.49 4.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 73.02 111.209 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.471 0.623 0 O-C-N 122.171 -0.331 . . . . 75.52 111.816 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 m-80 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 112.533 0.568 . . . . 73.43 112.533 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.87 85.76 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.246 0.546 . . . . 72.01 110.164 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.34 147.61 24.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.018 -0.537 . . . . 73.15 111.679 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.814 HG13 ' HG ' ' A' ' 29' ' ' LEU . 3.0 mp -82.24 96.93 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.787 0.327 . . . . 53.51 110.145 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.28 -38.61 88.19 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.926 0.393 . . . . 73.11 111.926 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.42 129.5 14.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.699 0.629 . . . . 63.22 112.699 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.543 HG12 HG23 ' A' ' 27' ' ' ILE . 57.1 mt -116.65 128.82 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.989 -0.551 . . . . 74.4 109.738 172.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.76 114.89 9.29 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.325 0.583 . . . . 74.21 111.351 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' HA3' ' A' ' 97' ' ' GLY . 11.4 p -68.39 -31.12 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 116.123 -0.489 . . . . 72.51 112.041 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 22.8 t70 -57.08 -48.01 79.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.751 0.31 . . . . 75.1 111.132 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 136.23 24.01 0.52 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.311 -0.471 . . . . 74.34 113.985 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -95.57 -63.39 1.16 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.091 0.775 . . . . 74.32 113.091 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -145.29 161.23 40.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.107 1.151 . . . . 74.1 114.107 -168.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 20' ' ' ILE . 65.6 mt -116.3 113.81 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.102 -0.953 . . . . 62.51 109.662 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -102.19 112.94 25.81 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.451 0.538 . . . . 74.32 112.451 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 17' ' ' ILE . 4.8 mp -91.92 154.54 18.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.116 -0.493 . . . . 72.23 111.254 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -150.87 123.29 8.41 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.925 0.393 . . . . 73.02 110.96 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.502 ' HB2' HD12 ' A' ' 63' ' ' LEU . 34.1 t30 -83.94 129.49 34.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.784 0.326 . . . . 62.34 111.382 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -109.87 11.24 24.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.25 0.463 . . . . 73.44 112.25 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 94.0 p -80.91 163.44 23.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.454 0.645 . . . . 64.54 112.148 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.06 -18.61 33.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.719 -0.673 . . . . 63.13 111.531 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.54 149.77 46.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.693 0.282 . . . . 73.22 111.288 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -56.69 139.91 48.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.159 0.504 . . . . 64.52 112.209 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -104.02 117.32 59.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.235 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.11 127.73 13.9 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.421 2.08 . . . . 52.45 112.725 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.9 tpp -79.12 -71.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.961 0.41 . . . . 72.25 111.623 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.4 -54.2 2.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.886 -0.673 . . . . 60.02 112.998 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.69 61.77 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.339 -0.458 . . . . 54.22 113.323 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -63.09 153.54 33.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.894 0.378 . . . . 73.53 110.662 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -130.01 116.33 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.206 0.527 . . . . 73.2 111.388 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 102' ' ' VAL . 47.4 ttp -86.8 109.55 19.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.635 -0.711 . . . . 72.3 111.964 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.8 mp -82.94 89.68 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.102 -0.703 . . . . 71.51 109.102 171.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 101.24 6.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.083 0.468 . . . . 75.21 111.396 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 101' ' ' LYS . 68.3 mttm -84.67 -178.86 6.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.317 -0.401 . . . . 72.45 111.016 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -171.2 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.233 0.54 . . . . 74.54 110.547 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.47 -89.24 0.09 OUTLIER Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.96 -0.563 . . . . 55.03 112.702 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.47 -0.09 56.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.025 0.38 . . . . 64.22 112.025 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 t -155.54 164.54 38.52 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.691 0.626 . . . . 74.53 112.691 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -153.15 149.09 27.69 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.658 -0.701 . . . . 72.31 110.739 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.13 134.79 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.874 0.369 . . . . 64.54 111.373 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 m -94.12 111.7 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.11 0.411 . . . . 74.35 112.11 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -103.89 122.82 45.96 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.745 0.307 . . . . 74.14 110.651 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -95.39 116.39 28.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.799 0.333 . . . . 74.32 110.922 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -61.25 121.66 13.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.117 0.484 . . . . 71.3 111.609 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 60' ' ' ARG . 3.5 t -67.2 132.31 47.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.385 0.612 . . . . 62.32 112.019 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.1 p -73.41 23.72 0.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.236 0.828 . . . . 73.32 113.236 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' A' ' 58' ' ' THR . 8.0 ptp180 -73.02 -8.03 53.9 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.12 -0.363 . . . . 72.23 111.841 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HE2' HD23 ' A' ' 63' ' ' LEU . 24.8 p90 -145.85 145.07 30.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.173 0.435 . . . . 63.22 112.173 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.45 124.63 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.185 -0.461 . . . . 65.25 109.777 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -74.4 99.39 3.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.192 0.52 . . . . 74.01 111.298 -173.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -66.8 165.26 15.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.475 0.655 . . . . 52.34 112.723 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.77 125.75 25.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.908 -0.587 . . . . 74.05 111.169 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.22 77.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.197 -0.525 . . . . 52.44 113.527 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.544 ' HB3' HD13 ' A' ' 63' ' ' LEU . 8.6 tp-100 -91.7 153.0 19.95 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.107 0.48 . . . . 74.53 111.572 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.4 p -121.9 145.58 47.95 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.248 -0.433 . . . . 63.25 111.951 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.82 137.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.288 -0.414 . . . . 71.43 110.363 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.6 m -118.66 122.44 42.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.162 0.43 . . . . 62.41 112.162 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 86' ' ' LEU . 41.4 mm -95.2 106.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.69 -0.232 . . . . 72.05 111.208 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.737 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 84.6 m95 -91.95 123.13 35.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.572 0.225 . . . . 71.23 111.503 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -79.1 80.54 5.44 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.084 0.772 . . . . 44.32 113.084 -174.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 61.3 -69.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.286 1.217 . . . . 74.41 114.286 173.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -72.86 36.17 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.337 0.866 . . . . 62.23 113.337 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -75.24 -50.61 15.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.305 0.483 . . . . 70.43 112.305 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.62 38.54 20.32 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.165 -0.541 . . . . 74.15 113.054 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.57 173.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.13 0.49 . . . . 61.13 112.186 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.3 m -67.84 94.02 0.43 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 74.35 112.678 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.64 -86.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.264 0.838 . . . . 74.43 113.264 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.4 t -170.46 110.52 0.44 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.211 0.449 . . . . 74.1 112.211 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 84' ' ' THR . 58.0 Cg_exo -46.21 160.61 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.486 2.79 . . . . 70.41 111.521 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER 9.03 64.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.903 0 N-CA-C 121.517 3.622 . . . . 74.21 121.517 36.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.644 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.0 t 147.78 -67.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.988 1.715 . . . . 72.35 111.209 161.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' H ' HG23 ' A' ' 84' ' ' THR . 8.0 m-20 -87.67 173.98 8.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.114 -0.366 . . . . 63.02 110.398 172.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.4 mt -139.96 130.61 25.75 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.751 0.31 . . . . 75.11 111.128 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.9 mp -87.15 106.01 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.438 0.637 . . . . 72.25 111.136 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.614 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 6.3 t90 -74.24 98.53 3.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.622 -0.717 . . . . 61.41 111.003 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -73.16 -28.54 62.28 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.404 0.52 . . . . 53.31 112.404 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.614 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 10.8 m120 -71.55 -16.96 62.33 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.905 0.706 . . . . 64.2 112.905 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 44.1 tt0 -145.77 139.2 26.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.008 -0.433 . . . . 73.13 111.731 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.704 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -90.21 -174.82 4.32 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.063 0.459 . . . . 70.22 111.089 173.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.2 p -56.27 120.48 7.66 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.423 -0.353 . . . . 70.34 111.864 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.496 ' NE1' ' HA2' ' A' ' 24' ' ' GLY . 33.9 p90 -70.92 -38.74 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.504 0.557 . . . . 75.22 112.504 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 54.3 63.93 4.74 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.314 -0.47 . . . . 62.41 113.763 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.596 HG23 ' H ' ' A' ' 97' ' ' GLY . 1.6 t -167.52 -63.25 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.658 0.614 . . . . 65.24 112.658 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.596 ' H ' HG23 ' A' ' 96' ' ' THR . . . 72.76 10.09 76.0 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.982 -0.628 . . . . 75.03 113.399 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -70.9 78.57 0.63 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.224 0.512 . . . . 72.33 112.072 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.81 31.58 20.86 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.464 -0.789 . . . . 62.14 112.534 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 120.18 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.166 0.507 . . . . 74.21 109.743 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 4.4 ttmp? -119.15 121.45 39.79 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.928 0.714 . . . . 73.24 112.928 -165.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 44' ' ' MET . 98.1 t -86.82 116.54 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.723 -0.671 . . . . 75.0 111.569 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.8 mm -105.27 114.99 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.617 -0.265 . . . . 70.43 110.766 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.59 102.86 15.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.798 0.666 . . . . 65.41 112.798 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.97 154.89 25.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.376 -0.375 . . . . 64.35 110.509 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 14.2 m120 -99.0 -164.31 1.12 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.844 0.683 . . . . 51.42 112.844 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.1 t -52.98 -51.57 61.11 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.116 1.154 . . . . 45.4 114.116 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -88.28 -61.04 1.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.287 0.565 . . . . 74.32 111.731 -172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.59 27.71 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.785 -0.643 . . . . 74.44 112.697 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 1.2 pm0 -102.69 135.43 44.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.018 0.437 . . . . 55.0 110.681 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.21 132.52 46.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.055 0.391 . . . . 70.4 112.055 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 66.5 t -88.75 -62.08 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.267 -0.424 . . . . 72.41 111.352 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.66 179.16 8.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.168 0.509 . . . . 40.35 111.852 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.68 152.93 49.79 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.937 -0.574 . . . . 75.52 110.757 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.59 ' HE ' ' HA ' ' A' ' 115' ' ' ARG . 1.3 tpm_? -151.31 152.04 32.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.614 0.245 . . . . 74.23 110.892 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.7 p -145.33 170.22 16.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.067 -0.395 . . . . 63.43 111.797 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -67.95 113.96 6.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.542 0.571 . . . . 75.15 112.542 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.127 -0.488 . . . . 53.53 111.102 175.707 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 32' ' ' THR . 45.3 t30 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.278 0.561 . . . . 74.05 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.73 125.68 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.548 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB1' ' A' ' 113' ' ' ALA . 53.7 t -135.49 159.87 40.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.923 0.392 . . . . 74.32 111.624 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.6 mp -87.06 131.35 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.6 -0.273 . . . . 63.45 110.341 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -104.3 -34.27 8.38 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.788 0.292 . . . . 74.31 111.788 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.78 145.01 30.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.102 0.477 . . . . 52.43 111.449 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.36 130.25 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.273 -0.421 . . . . 73.43 110.796 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.34 147.25 40.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.189 0.519 . . . . 75.14 110.888 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 97' ' ' GLY . 13.9 p -105.19 -25.07 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 74.22 111.693 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 21.2 t70 -64.13 -56.66 13.28 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.064 0.459 . . . . 64.11 111.539 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 144.33 41.89 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.42 -0.419 . . . . 61.04 112.575 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -113.17 -61.97 1.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.733 0.642 . . . . 74.12 112.733 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.95 168.19 26.65 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.107 1.151 . . . . 64.32 114.107 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.3 mt -126.06 131.08 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.906 -1.043 . . . . 72.11 109.371 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -100.76 101.81 12.75 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.483 0.549 . . . . 71.51 112.483 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -88.48 156.01 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.33 110.159 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -146.61 127.72 14.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.952 0.406 . . . . 73.23 111.762 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -84.37 110.28 18.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.355 -0.384 . . . . 62.44 110.673 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 14' ' ' ASN . 11.7 t -95.13 9.78 38.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.095 0.474 . . . . 71.24 111.163 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.1 t -82.39 149.85 27.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.059 -0.518 . . . . 72.45 111.391 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.73 43.12 1.01 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.27 -0.423 . . . . 74.31 111.4 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -168.91 154.17 6.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.872 0.368 . . . . 72.24 111.677 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 11.9 m-20 -68.08 104.11 1.69 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.448 -0.342 . . . . 72.52 110.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.95 118.9 66.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.85 0.315 . . . . 75.21 111.85 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.34 117.54 5.03 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.745 2.297 . . . . 70.12 112.51 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.34 77.32 3.1 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.98 0.419 . . . . 71.53 111.5 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.66 -68.96 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.028 -0.606 . . . . 71.34 113.976 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.59 2.89 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.505 -0.379 . . . . 54.34 113.722 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -129.58 140.1 51.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.542 0.337 . . . . 73.52 111.135 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 34.3 tt0 -136.12 125.34 24.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.418 . . . . 74.2 110.733 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -102.83 133.86 47.2 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.0 0.429 . . . . 65.15 111.811 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 54' ' ' SER . 32.2 mt -127.17 116.77 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.477 -0.329 . . . . 74.3 110.865 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.588 ' NH2' HG13 ' A' ' 100' ' ' VAL . 67.5 ttt180 -100.84 122.72 43.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.928 0.394 . . . . 73.12 110.947 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -98.2 137.36 37.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.747 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 100' ' ' VAL . 7.3 tt -130.91 91.72 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.53 0.681 . . . . 72.52 111.485 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.55 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.811 -0.632 . . . . 71.42 113.602 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.88 -64.85 1.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.605 0.362 . . . . 73.13 111.78 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -95.06 178.53 5.52 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.895 0.702 . . . . 71.21 112.895 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -149.27 152.9 36.71 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.176 -0.466 . . . . 63.32 110.968 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -129.57 137.86 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.701 0.286 . . . . 74.4 111.193 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.464 ' HB3' HG12 ' A' ' 45' ' ' ILE . 85.8 p -120.46 161.97 20.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.991 0.737 . . . . 61.42 112.991 -175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -163.57 117.99 1.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.624 -0.716 . . . . 73.2 111.286 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 56.7 tttm -88.1 151.35 22.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.952 0.406 . . . . 73.21 111.488 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -98.21 168.34 10.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.004 0.431 . . . . 74.35 111.718 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -130.37 132.38 45.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.997 0.427 . . . . 54.12 111.752 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.3 t -72.32 86.64 1.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 53.45 112.334 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 82' ' ' PRO . 14.6 ptm180 -131.29 6.05 4.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.903 0.383 . . . . 73.11 111.551 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.42 155.15 29.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.336 -0.393 . . . . 64.45 110.554 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 31.5 m -114.52 130.33 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.251 0.548 . . . . 63.14 112.049 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.3 mm? -83.45 114.6 21.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.418 -0.355 . . . . 71.24 110.93 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 35.9 mtmm -66.4 168.61 8.66 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.065 0.46 . . . . 52.02 111.866 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.22 107.3 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.352 -0.386 . . . . 65.0 111.47 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.88 6.44 67.27 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.401 -0.428 . . . . 30.22 113.086 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.547 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -79.71 137.13 36.95 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.467 -0.431 . . . . 74.32 111.511 -178.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.1 p -103.53 139.67 38.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.16 0.505 . . . . 70.42 111.718 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.35 123.67 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.188 0.518 . . . . 74.34 110.159 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.3 m -95.15 102.22 14.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.176 -0.465 . . . . 62.53 111.477 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.18 97.53 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.324 -0.398 . . . . 74.1 111.105 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB2' HG13 ' A' ' 87' ' ' ILE . 93.2 m95 -78.98 160.55 27.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.24 111.623 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.28 165.93 20.98 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.391 -0.368 . . . . 75.1 111.209 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.03 -27.58 45.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.52 25.49 1.68 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.938 0.347 . . . . 74.2 111.938 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.08 64.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.814 0.672 . . . . 73.22 112.814 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.52 75.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.165 -0.541 . . . . 52.24 113.722 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.52 -172.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.556 -0.379 . . . . 72.15 111.017 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.0 m -61.39 101.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.656 -0.498 . . . . 64.32 109.656 171.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.87 42.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.113 0.782 . . . . 65.44 113.113 -168.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.7 m -157.9 139.2 9.69 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 112.275 0.472 . . . . 41.11 112.275 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 56.0 Cg_exo -44.12 163.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 123.645 2.897 . . . . 62.23 112.162 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 26.9 Cg_exo -11.02 -80.75 0.0 OUTLIER 'Cis proline' 0 C--N 1.375 1.925 0 N-CA-C 121.297 3.537 . . . . 63.14 121.297 17.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.7 t -106.37 -79.39 0.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.83 1.418 . . . . 64.31 114.83 -165.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.659 ' H ' HG23 ' A' ' 84' ' ' THR . 21.8 m-20 -68.59 129.14 39.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.0 0.741 . . . . 63.1 113.0 -167.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 104.3 16.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.891 -0.595 . . . . 74.13 111.288 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -74.52 121.82 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.781 0.324 . . . . 74.35 110.533 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.412 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.6 t90 -64.91 77.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.352 0.596 . . . . 72.2 111.078 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.74 22.44 0.59 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.179 -0.464 . . . . 63.52 112.234 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 18.4 m120 -120.53 11.55 11.36 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.054 0.454 . . . . 75.11 110.939 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -150.48 131.96 14.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.26 -0.427 . . . . 71.21 111.096 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -80.26 178.8 8.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.922 0.391 . . . . 61.41 111.209 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -66.84 116.27 7.53 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.338 -0.226 . . . . 75.33 111.015 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.469 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 43.6 p90 -60.66 -47.15 87.51 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.319 0.488 . . . . 73.05 112.319 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 58.26 11.76 10.37 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.721 0.648 . . . . 71.24 114.721 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -71.0 -31.41 67.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.772 0.656 . . . . 63.43 112.772 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 22' ' ' VAL . . . 69.22 14.22 68.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.981 -0.628 . . . . 63.21 113.037 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -96.58 179.22 5.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.224 0.535 . . . . 54.42 112.071 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 15.0 p-10 -60.99 -45.32 95.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.769 -0.651 . . . . 70.35 111.599 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG13 ' NH2' ' A' ' 46' ' ' ARG . 7.4 p 30.73 88.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 72.34 113.28 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HD2' ' NE2' ' A' ' 114' ' ' GLN . 34.1 ttpt -86.94 138.53 31.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.077 -0.965 . . . . 75.42 112.846 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 12.4 p -103.63 142.66 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 112.068 0.396 . . . . 74.1 112.068 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mm -122.41 138.59 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.763 0.425 . . . . 61.12 111.579 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 17' ' ' ILE . 52.4 mt -107.79 121.01 43.85 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.953 0.406 . . . . 74.23 111.769 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 67.8 mttm -115.13 149.0 38.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.087 -0.506 . . . . 62.03 111.167 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.39 -176.92 6.07 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.105 0.479 . . . . 52.43 111.008 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.3 p -55.62 -34.94 65.35 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.144 -0.48 . . . . 64.12 111.001 170.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -72.89 -12.64 61.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.128 -0.487 . . . . 51.55 111.99 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.91 1.58 84.81 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.88 0.712 . . . . 53.01 114.88 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 105' ' ' LYS . 11.9 pt-20 -92.48 178.52 5.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.107 0.953 . . . . 74.13 112.033 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -92.24 133.59 35.67 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.244 0.831 . . . . 54.03 113.244 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.7 t -106.2 -50.23 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.019 -0.537 . . . . 75.13 110.717 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HB1' ' SG ' ' A' ' 16' ' ' CYS . . . -159.39 162.65 35.82 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.869 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.598 ' NE2' ' HD2' ' A' ' 101' ' ' LYS . 12.6 pt20 -153.17 171.32 18.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.099 -0.501 . . . . 71.51 111.177 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.3 ttm180 -175.6 147.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.859 0.361 . . . . 74.13 111.565 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.1 p -110.95 179.26 4.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.457 0.303 . . . . 62.52 111.002 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 80.7 p -75.48 117.69 17.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.128 0.49 . . . . 63.13 111.601 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.914 0.388 . . . . 73.24 110.623 177.15 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.276 0.473 . . . . 70.12 112.276 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.48 124.48 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.889 0.375 . . . . 75.01 111.216 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -144.95 174.38 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.502 -0.317 . . . . 65.31 110.979 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.32 124.5 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.238 -0.289 . . . . 73.51 111.483 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.77 -53.25 6.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.921 0.391 . . . . 72.22 110.872 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -165.02 137.06 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.23 0.538 . . . . 54.11 111.798 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 27' ' ' ILE . 61.2 mt -104.22 126.15 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.27 -0.423 . . . . 64.35 110.238 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.28 122.47 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.134 0.492 . . . . 73.33 111.87 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.64 -26.12 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.142 -0.481 . . . . 72.15 111.938 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -33.48 73.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.818 0.342 . . . . 64.02 110.586 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.64 30.05 3.92 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 114.126 0.41 . . . . 72.12 114.126 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 6.8 mtpm? -98.98 -39.94 8.3 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.791 0.663 . . . . 75.41 112.791 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -153.6 158.19 40.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.265 0.839 . . . . 73.33 113.265 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 102' ' ' VAL . 66.0 mt -118.89 107.44 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.44 109.648 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 35.6 ttt85 -97.85 117.61 32.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.317 0.58 . . . . 75.01 112.512 -171.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.553 ' HB2' HG13 ' A' ' 69' ' ' VAL . 6.5 mp -97.8 -172.68 2.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.011 -0.541 . . . . 63.12 111.501 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 22.9 ttmm -158.05 139.4 13.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.942 0.401 . . . . 72.24 111.719 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -103.21 100.26 10.16 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.451 -0.34 . . . . 71.54 110.253 168.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 5.0 t -102.27 98.83 8.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.411 0.624 . . . . 71.11 111.314 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -166.69 -178.46 4.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.312 0.577 . . . . 73.32 111.633 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -109.67 7.04 24.25 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.936 -0.574 . . . . 74.32 110.392 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -135.4 135.03 40.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 74.55 110.816 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.43 134.19 49.8 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.995 0.426 . . . . 61.13 111.853 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 27.3 mm-40 -89.0 112.77 52.91 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.391 -0.368 . . . . 72.44 111.213 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 2.7 Cg_exo -76.3 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.777 2.318 . . . . 32.44 113.122 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.17 -73.27 0.05 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.104 0.562 . . . . 75.54 111.734 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 -75.48 1.57 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.143 -0.551 . . . . 73.05 113.001 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.67 93.7 0.11 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 74.32 113.403 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -116.44 167.71 10.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.661 0.384 . . . . 72.21 110.712 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -144.42 132.34 21.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.171 0.51 . . . . 74.22 111.34 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.6 ttp -103.82 107.78 18.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.848 -0.614 . . . . 60.35 111.428 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.9 mp -95.11 99.94 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.781 0.324 . . . . 71.34 110.845 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.438 HH12 ' NE2' ' A' ' 91' ' ' GLN . 32.9 ttt180 -85.89 102.84 14.08 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.128 -0.357 . . . . 73.11 111.101 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -96.88 117.73 31.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.438 -0.346 . . . . 74.32 111.09 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.16 122.43 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.134 0.493 . . . . 73.13 112.037 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.7 -110.28 2.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.989 -0.551 . . . . 33.33 113.907 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.74 27.4 9.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.973 0.36 . . . . 71.35 111.973 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -153.62 162.35 41.34 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.237 0.541 . . . . 55.25 112.005 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -153.81 114.01 3.93 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.021 -0.536 . . . . 50.44 110.205 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.39 134.87 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.941 0.401 . . . . 65.13 111.809 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.2 m -109.16 124.24 50.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.288 -0.415 . . . . 70.35 111.697 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.459 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 70.0 t80 -114.26 108.77 17.39 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.807 0.337 . . . . 74.1 111.686 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.35 109.67 11.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.917 0.389 . . . . 73.35 110.542 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 94.1 m-85 -56.18 135.49 53.19 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.644 0.609 . . . . 54.42 112.644 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -97.27 123.1 40.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.044 -0.525 . . . . 64.2 111.248 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 t -73.56 68.72 1.19 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.118 0.414 . . . . 75.43 112.118 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -87.04 -12.87 46.02 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.987 0.422 . . . . 73.45 111.375 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.46 167.8 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.285 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.76 121.36 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.873 0.368 . . . . 73.45 111.593 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -76.24 87.1 3.07 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.479 0.657 . . . . 62.03 110.166 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 158.33 30.62 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.955 0.724 . . . . 62.22 112.955 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.62 117.89 6.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.612 -0.722 . . . . 75.31 112.841 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.53 -19.75 35.92 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.306 -0.473 . . . . 63.1 114.028 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.44 141.7 38.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.396 0.617 . . . . 75.12 111.747 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.4 p -105.31 98.38 8.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.783 -0.644 . . . . 72.54 111.735 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 29' ' ' LEU . 3.8 p -69.8 117.61 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 64.21 111.693 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 37.0 m -97.55 123.05 41.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.149 0.5 . . . . 62.12 111.921 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 57' ' ' TYR . 47.8 mm -84.28 102.76 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.318 -0.401 . . . . 60.51 110.928 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.75 118.15 24.26 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.51 -0.314 . . . . 74.31 110.621 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' ASN . . . -71.45 77.46 0.77 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.65 0.611 . . . . 55.34 112.65 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 56.51 -72.82 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.399 0.889 . . . . 74.2 113.399 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 73' ' ' ALA . 65.5 m-20 -87.94 100.71 13.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.908 0.385 . . . . 63.34 111.43 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.47 9.02 0.34 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.546 0.573 . . . . 54.02 112.546 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.65 -35.84 1.83 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.169 -0.539 . . . . 42.13 114.31 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.66 149.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.381 0.511 . . . . 74.42 112.381 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -62.84 175.7 0.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.54 0.57 . . . . 62.42 112.54 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.44 76.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.092 0.775 . . . . 75.2 113.092 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.491 ' HA ' HD13 ' A' ' 87' ' ' ILE . 69.8 m 65.17 104.17 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.621 0.971 . . . . 73.2 113.621 173.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HB3' HG22 ' A' ' 84' ' ' THR . 67.6 Cg_exo -45.96 169.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 123.747 2.965 . . . . 51.23 112.016 166.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER 10.76 65.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 N-CA-C 121.65 3.673 . . . . 74.0 121.65 38.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 82' ' ' PRO . 15.3 t 144.74 -59.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.3 1.84 . . . . 71.12 110.812 162.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' H ' ' CB ' ' A' ' 82' ' ' PRO . 21.3 m-20 -110.76 -168.62 1.33 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.195 0.598 . . . . 61.32 110.296 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -141.78 137.15 31.37 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.945 0.402 . . . . 63.51 111.603 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 81' ' ' SER . 1.6 mp -91.36 123.7 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.699 0.761 . . . . 71.23 111.016 175.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.496 ' CE2' ' HB2' ' A' ' 90' ' ' ASN . 21.7 t90 -92.12 109.74 21.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.324 -0.853 . . . . 65.1 110.999 -176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -93.88 2.07 56.24 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.246 0.832 . . . . 74.55 113.246 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 17.2 m120 -74.01 -40.81 62.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.86 -0.525 . . . . 72.52 111.755 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' NE2' HH12 ' A' ' 46' ' ' ARG . 39.9 tt0 -148.52 155.88 41.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.605 0.24 . . . . 71.4 110.607 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.675 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.7 m120 -91.97 175.96 6.69 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.284 0.564 . . . . 73.44 112.447 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -59.57 125.13 22.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 72.21 111.508 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -104.56 -173.66 2.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.01 0.433 . . . . 73.02 111.664 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.76 95.86 0.14 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.265 -0.493 . . . . 52.01 112.759 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -167.51 160.44 13.1 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.668 -0.313 . . . . 63.42 111.438 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.15 4.1 62.39 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.289 -0.481 . . . . 44.04 113.122 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.76 156.67 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.175 0.512 . . . . 64.31 112.248 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.91 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.777 0.658 . . . . 42.33 112.777 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 117' ' ' THR . 6.5 p -81.04 79.61 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.079 0.942 . . . . 62.51 109.622 167.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 3.9 ttmp? -88.13 105.63 17.63 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.554 -0.748 . . . . 62.02 111.391 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 27' ' ' ILE . 61.7 t -91.05 123.39 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.665 -0.698 . . . . 74.53 111.48 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 21.4 mm -106.57 117.66 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.149 -0.478 . . . . 61.33 110.934 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -91.96 121.72 33.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.838 0.351 . . . . 54.12 111.341 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 93.6 mttt -130.58 168.27 17.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.711 0.291 . . . . 65.41 111.315 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 20.3 m120 -97.08 175.6 6.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.901 0.381 . . . . 74.41 111.141 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -57.97 -33.2 68.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.775 0.658 . . . . 75.03 112.775 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.91 0.68 17.44 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 72.11 112.436 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.42 33.53 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.152 -0.547 . . . . 30.0 113.336 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 10.9 pt-20 -103.08 127.28 50.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.943 0.401 . . . . 61.43 110.918 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.2 tt0 -76.82 138.93 40.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.978 0.418 . . . . 52.0 111.97 -175.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.45 -61.99 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.256 -0.429 . . . . 44.12 111.326 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.99 162.19 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.7 0.286 . . . . 62.45 111.57 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.36 157.64 42.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.993 0.425 . . . . 73.33 111.834 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -164.31 156.19 16.31 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.201 -0.454 . . . . 75.43 110.977 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.7 p -141.17 -162.37 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.6 0.238 . . . . 75.14 111.3 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.647 HG23 HG12 ' A' ' 100' ' ' VAL . 17.0 p -61.71 94.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.173 0.511 . . . . 63.32 111.89 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.455 0.645 . . . . 74.51 110.846 176.777 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.85 0.357 . . . . 73.31 111.435 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.89 143.68 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.324 -0.398 . . . . 55.41 111.331 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 44.2 t -141.62 173.37 11.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.091 0.472 . . . . 74.05 111.699 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.537 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 61.0 mt -81.51 127.45 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.344 -0.389 . . . . 73.21 111.33 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 37.0 tt0 -81.71 -58.33 3.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.659 -0.497 . . . . 71.44 109.659 171.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 25.2 tt0 173.82 152.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.799 -0.637 . . . . 65.34 111.097 169.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 102' ' ' VAL . 23.1 mt -71.89 162.57 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 116.164 -0.471 . . . . 74.3 111.239 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 20' ' ' ILE . 19.0 t70 -61.14 150.36 34.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.229 0.537 . . . . 73.24 111.835 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.07 -33.45 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.849 -0.614 . . . . 63.42 112.268 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.52 -30.58 19.24 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.147 0.498 . . . . 73.22 111.028 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.04 35.75 3.86 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.104 -0.498 . . . . 73.32 112.827 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -96.06 -29.04 14.32 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.709 0.29 . . . . 74.41 111.759 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.09 176.01 12.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.463 0.649 . . . . 74.41 112.286 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -119.89 138.54 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.805 -0.634 . . . . 75.53 109.946 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 28' ' ' ARG . 10.3 ttp180 -119.26 110.21 16.74 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.213 0.53 . . . . 75.43 111.9 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.6 mp -106.9 175.51 5.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.981 -0.554 . . . . 75.22 110.57 175.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.3 ttmt -151.71 138.67 19.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.936 0.398 . . . . 75.3 111.713 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -75.46 84.57 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.562 . . . . 63.31 110.821 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.2 p -78.0 89.03 4.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 61.44 111.094 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.4 p -158.48 -175.77 5.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.305 -0.407 . . . . 71.43 111.161 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.47 -4.52 31.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.334 0.494 . . . . 62.32 112.334 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -156.39 166.68 32.72 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.786 0.327 . . . . 65.31 111.306 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -54.97 117.15 3.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.79 0.293 . . . . 73.53 111.79 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -127.46 112.86 21.11 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 122.618 0.367 . . . . 72.44 110.889 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 58.2 Cg_endo -70.67 136.9 31.65 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.251 1.968 . . . . 62.45 112.921 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 tpt -66.28 -85.59 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 116.452 -0.34 . . . . 75.34 110.706 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.93 -83.09 0.02 OUTLIER Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.362 0.905 . . . . 61.23 115.362 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.48 46.07 3.19 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.605 0.602 . . . . 64.23 114.605 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -120.25 147.27 45.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.457 -0.437 . . . . 73.13 111.124 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -113.77 109.82 19.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.04 -0.527 . . . . 65.34 110.758 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -91.34 116.25 28.69 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.236 -0.438 . . . . 73.22 111.717 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.5 mp -106.26 103.62 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 109.811 -0.44 . . . . 73.12 109.811 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.503 HH12 ' HB ' ' A' ' 48' ' ' ILE . 47.7 ttp85 -89.39 114.1 25.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 73.13 111.628 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -93.44 168.71 10.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.101 -0.499 . . . . 74.32 111.304 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 49' ' ' GLY . 10.8 tt -169.74 -60.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.853 -0.612 . . . . 70.23 111.148 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -159.68 114.87 0.63 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.235 -0.507 . . . . 70.5 112.584 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 67.45 -75.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.213 0.605 . . . . 75.13 111.999 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -93.88 150.86 20.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.196 0.522 . . . . 63.24 112.151 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.6 p -142.06 149.73 40.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.053 0.454 . . . . 72.1 111.444 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.34 146.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.827 0.346 . . . . 74.01 111.654 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.417 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.5 p -111.91 164.49 13.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.821 0.674 . . . . 61.1 112.821 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -161.36 135.07 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.006 -0.543 . . . . 75.01 111.514 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -91.6 135.12 34.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.566 0.222 . . . . 75.0 110.724 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -67.58 147.02 53.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.044 0.449 . . . . 64.53 111.974 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 t -81.2 126.24 31.27 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.365 0.602 . . . . 63.11 112.226 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.9 m -85.49 82.85 8.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 63.33 110.94 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -135.32 14.04 3.51 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.633 0.605 . . . . 75.34 112.633 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -165.53 158.64 15.94 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.895 0.379 . . . . 53.32 111.913 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 38' ' ' PRO . 61.4 t -104.57 113.92 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.268 -0.423 . . . . 75.1 110.308 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.34 118.56 21.36 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.848 0.356 . . . . 75.42 111.231 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -64.33 152.62 40.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.377 0.608 . . . . 71.55 112.628 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 127.84 33.15 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.046 -0.525 . . . . 70.13 111.851 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.01 -2.05 88.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.149 -0.548 . . . . 72.13 113.41 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.693 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.44 148.97 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.541 -0.388 . . . . 72.53 111.389 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 71.3 p -95.75 157.54 15.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.19 0.519 . . . . 72.34 112.062 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.65 125.21 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.172 0.51 . . . . 73.33 110.191 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -101.61 108.23 19.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.279 -0.419 . . . . 64.23 111.948 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 86' ' ' LEU . 44.0 mm -91.77 102.63 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.464 -0.335 . . . . 63.2 111.23 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m95 -85.0 170.28 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.0 0.429 . . . . 73.51 111.979 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.82 167.37 11.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.394 -0.366 . . . . 50.24 111.285 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -51.08 -41.72 60.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -93.49 35.52 1.11 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.844 0.354 . . . . 65.21 111.849 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -65.19 -45.94 82.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.486 0.55 . . . . 42.3 112.486 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.1 -38.47 3.17 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.262 -0.494 . . . . 60.24 113.122 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 87' ' ' ILE . 27.0 m -68.17 170.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.085 0.402 . . . . 72.22 112.085 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.0 m -60.46 128.93 39.08 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.497 -0.32 . . . . 51.04 111.413 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.22 -40.17 46.63 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.853 0.686 . . . . 74.54 112.853 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -146.95 89.38 5.66 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 121.049 0.452 . . . . 64.51 111.345 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.712 ' HB2' ' H ' ' A' ' 84' ' ' THR . 47.1 Cg_exo -59.34 -32.13 96.18 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.772 2.981 . . . . 71.43 117.233 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.659 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 28.0 Cg_endo -101.13 37.79 5.59 Favored 'Cis proline' 0 C--N 1.371 1.718 0 CA-C-N 122.437 1.906 . . . . 74.4 114.532 3.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.712 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 74.9 p -62.83 -48.51 78.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.098 0.475 . . . . 63.44 111.219 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 4.8 m-20 -93.29 161.13 14.53 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.087 -0.506 . . . . 63.34 110.943 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.6 mt -130.02 109.54 10.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.87 0.366 . . . . 62.14 110.631 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 78' ' ' VAL . 1.5 mp -85.47 111.18 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.653 0.74 . . . . 74.42 111.637 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.572 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 21.2 t90 -79.68 96.86 6.34 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.309 -0.859 . . . . 73.21 111.19 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 53.4 mtmt -93.35 22.39 5.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.383 0.883 . . . . 71.2 113.383 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 14.7 m120 -89.92 -8.58 51.48 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.118 0.485 . . . . 75.52 110.799 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -150.91 134.47 16.37 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.025 -0.534 . . . . 75.04 111.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.3 m120 -64.67 -56.06 16.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.467 0.543 . . . . 72.42 112.467 -175.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.9 t -179.09 -178.44 0.52 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.552 0.341 . . . . 65.02 110.793 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -142.22 -82.64 0.2 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 111.634 0.235 . . . . 73.31 111.634 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 35.28 49.06 0.87 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 115.912 1.125 . . . . 43.33 115.912 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -156.37 137.32 13.53 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.862 1.06 . . . . 64.2 113.862 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.15 -97.97 0.78 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.51 0.964 . . . . 72.52 115.51 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -84.92 177.23 8.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.078 0.77 . . . . 75.24 113.078 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 7.4 p-10 -75.27 121.38 22.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.101 -0.954 . . . . 74.13 112.382 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 HH11 ' A' ' 46' ' ' ARG . 7.3 p -81.07 128.59 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.171 0.51 . . . . 75.03 110.955 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -140.15 119.49 12.97 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.34 -0.391 . . . . 65.43 111.443 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 20' ' ' ILE . 85.0 t -93.81 136.97 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.519 0.563 . . . . 72.12 112.519 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.0 mm -110.74 132.73 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.772 -0.649 . . . . 53.21 111.012 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.8 mt -113.61 111.3 21.64 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.762 0.653 . . . . 60.15 112.762 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -109.07 161.15 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.386 -0.37 . . . . 71.04 110.765 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 112' ' ' VAL . 7.4 m120 -114.98 97.69 6.37 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.903 0.334 . . . . 74.3 111.903 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t 47.71 -77.52 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.987 1.106 . . . . 73.34 113.987 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 106' ' ' ASN . 64.6 mt-30 -61.6 -35.46 77.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.77 0.655 . . . . 72.43 112.77 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.59 -24.17 2.32 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.535 -0.84 . . . . 70.51 113.618 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.98 150.03 25.7 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.276 0.538 . . . . 75.42 111.301 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.82 137.53 54.5 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.503 -0.317 . . . . 73.22 111.655 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.545 HG23 ' OD1' ' A' ' 106' ' ' ASN . 94.7 t -98.91 -68.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.179 0.437 . . . . 64.04 112.179 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.27 162.78 33.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.067 0.766 . . . . 75.25 113.067 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -152.46 143.72 23.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.151 -0.931 . . . . 52.33 110.097 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -153.29 142.91 21.86 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.505 0.558 . . . . 61.3 112.505 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 p -111.94 -174.72 2.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.529 -0.76 . . . . 65.14 110.812 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 p -122.6 -178.2 3.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.263 0.554 . . . . 71.24 112.319 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 116.004 -0.543 . . . . 73.03 111.318 179.362 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 121.253 0.549 . . . . 62.53 110.706 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.419 ' HB ' ' CH2' ' A' ' 42' ' ' TRP . 56.6 t -126.7 139.34 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.059 -0.519 . . . . 63.33 111.402 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -121.26 159.39 26.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.977 0.418 . . . . 61.12 111.208 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.572 HD11 ' HG ' ' A' ' 104' ' ' LEU . 55.2 mt -93.13 127.99 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.311 -0.243 . . . . 54.11 111.316 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.54 -77.02 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.691 0.282 . . . . 74.13 111.095 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -169.29 158.01 7.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.266 -0.424 . . . . 74.44 110.838 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 27' ' ' ILE . 48.9 mt -91.69 145.4 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.431 . . . . 71.41 111.495 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.52 143.45 57.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.394 0.516 . . . . 65.52 112.394 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.49 -28.31 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.842 -0.617 . . . . 61.23 112.062 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.09 -31.58 30.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.09 0.471 . . . . 62.43 110.789 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.68 16.55 26.15 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 116.171 -0.468 . . . . 54.12 113.116 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -78.49 -31.25 47.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.347 0.499 . . . . 72.31 112.347 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -157.27 167.05 31.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.861 1.06 . . . . 74.03 113.861 -172.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG23 HG12 ' A' ' 20' ' ' ILE . 68.1 mt -127.07 110.93 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.934 -1.03 . . . . 72.44 109.343 170.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.3 ttp180 -92.58 117.42 29.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.346 0.593 . . . . 70.5 112.378 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.5 mp -99.91 158.55 15.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.863 -0.608 . . . . 71.15 110.26 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 65.0 tttm -124.03 116.83 23.47 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.024 -0.422 . . . . 63.43 111.505 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.33 108.14 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.097 0.475 . . . . 73.24 110.411 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -96.52 18.05 14.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.383 0.512 . . . . 73.42 112.383 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.8 p -71.72 161.79 30.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.418 0.628 . . . . 73.21 111.72 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -85.73 -19.4 30.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 72.11 111.168 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -142.03 158.36 43.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.587 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.12 135.78 12.62 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.501 0.556 . . . . 75.43 112.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -134.35 132.46 21.01 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.166 -0.47 . . . . 62.3 111.33 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.46 21.31 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.706 2.271 . . . . 71.11 113.442 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 tpt 63.5 -78.84 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.474 0.71 . . . . 71.4 112.285 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.41 -170.49 18.49 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.3 -0.476 . . . . 52.12 113.732 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.63 1.59 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.309 -0.472 . . . . 70.13 113.384 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.534 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 11.9 m95 -98.46 151.16 20.9 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 122.481 -0.423 . . . . 75.31 111.228 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.64 114.41 24.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.884 0.373 . . . . 52.34 110.001 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.454 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 56.2 ttp -98.33 108.45 21.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.442 -0.344 . . . . 51.03 111.087 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -96.8 109.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.584 -0.28 . . . . 75.32 111.444 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -99.46 101.29 12.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.69 0.281 . . . . 74.23 110.931 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 47' ' ' LYS . 7.6 mtpm? -82.04 84.78 6.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.053 0.454 . . . . 72.13 110.987 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -103.39 118.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.021 -0.536 . . . . 74.31 111.248 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 69.02 46.09 60.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.888 -0.672 . . . . 34.12 111.893 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.8 t70 73.68 -56.25 0.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.456 0.702 . . . . 74.54 111.953 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -61.61 161.61 9.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.133 0.492 . . . . 75.51 111.795 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 80.5 p -124.0 132.03 53.64 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.26 0.552 . . . . 61.03 112.128 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.4 134.31 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.881 -0.6 . . . . 75.0 109.669 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.8 p -120.18 144.18 47.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.167 0.803 . . . . 64.33 113.167 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -113.83 125.35 53.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.671 -0.695 . . . . 75.02 110.923 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.97 128.59 38.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.024 0.44 . . . . 63.13 111.001 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.534 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 21.0 m-85 -84.42 165.19 18.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.202 0.525 . . . . 72.42 111.694 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -142.96 176.05 9.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.009 -0.541 . . . . 74.5 110.806 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -123.36 105.97 10.28 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.168 0.508 . . . . 71.43 112.008 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 1.9 ptp180 -140.37 17.68 2.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.974 -0.557 . . . . 74.34 110.292 173.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 47.1 p90 -162.92 172.13 15.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.031 -0.532 . . . . 73.43 111.102 -173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.68 114.63 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.483 -0.326 . . . . 63.35 110.601 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.45 HD23 ' HE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.42 130.03 39.26 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.073 0.463 . . . . 75.02 110.645 -177.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 85.2 mttt -71.76 149.63 45.19 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.23 0.538 . . . . 71.33 112.346 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.47 122.77 14.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.495 . . . . 53.02 112.036 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 0.04 67.49 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.412 -0.423 . . . . 72.2 114.111 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -79.19 148.47 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.173 0.487 . . . . 73.31 111.898 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 65.1 p -92.7 134.56 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.839 0.352 . . . . 75.43 111.644 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.31 112.87 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.413 0.625 . . . . 62.35 111.004 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 85.3 m -91.36 123.95 35.18 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 65.12 112.047 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.5 mm -90.14 99.24 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.822 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HB2' HG13 ' A' ' 87' ' ' ILE . 85.6 m95 -84.49 161.79 20.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.975 0.417 . . . . 64.13 111.966 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -87.27 167.84 13.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.906 0.384 . . . . 51.41 111.96 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.2 -60.78 2.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.543 0.572 . . . . 62.54 112.543 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -91.08 41.57 1.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.103 0.477 . . . . 71.15 111.877 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.27 60.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.81 0.338 . . . . 55.01 111.664 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.17 -44.22 2.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.319 -0.467 . . . . 74.24 113.627 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.27 171.03 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.459 0.541 . . . . 71.14 112.459 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 81' ' ' SER . 57.8 m -53.87 130.24 36.5 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.784 0.326 . . . . 75.45 111.336 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' HD3' ' A' ' 89' ' ' LYS . . . -78.27 10.28 3.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.413 0.894 . . . . 75.14 113.413 -173.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.449 ' H ' HG22 ' A' ' 79' ' ' THR . 22.9 t -152.73 133.07 7.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 112.407 0.521 . . . . 73.23 112.407 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 66.8 Cg_exo -54.33 -178.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.906 3.071 . . . . 54.4 113.0 172.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 89.6 Cg_endo -93.85 101.67 0.22 Allowed 'Cis proline' 0 C--N 1.366 1.49 0 N-CA-C 115.536 1.322 . . . . 74.32 115.536 5.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.1 p -158.13 -60.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.509 0.724 . . . . 53.33 109.56 171.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 8.1 m-20 -122.1 -168.87 1.79 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.304 -0.862 . . . . 74.24 109.75 172.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.553 ' HB2' HD13 ' A' ' 71' ' ' ILE . 78.4 mt -127.08 108.7 11.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.048 0.452 . . . . 70.25 110.885 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -95.96 108.66 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.318 0.58 . . . . 62.01 111.436 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.466 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 10.9 t90 -74.35 84.06 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.548 0.69 . . . . 63.52 110.617 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HD3' ' HB1' ' A' ' 80' ' ' ALA . 9.7 mtmp? -73.1 4.07 4.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.695 0.628 . . . . 73.54 112.695 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.466 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 16.1 m120 -92.43 -13.35 30.14 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.508 0.559 . . . . 72.54 112.508 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -151.44 159.13 44.35 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.002 0.43 . . . . 54.24 111.327 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 52.4 m-80 -109.83 -169.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.565 0.579 . . . . 75.45 112.565 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.5 m -60.03 156.47 14.77 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.372 0.879 . . . . 70.34 113.372 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -127.46 160.2 32.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.2 -0.909 . . . . 73.03 111.116 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.42 48.68 0.36 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.985 -0.626 . . . . 62.02 112.865 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.4 t -65.65 -22.81 66.68 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.722 0.638 . . . . 73.43 112.722 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.29 3.43 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.074 -0.584 . . . . 71.22 113.238 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -82.41 170.22 15.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.145 0.498 . . . . 65.23 111.849 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.11 164.19 26.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.884 -0.598 . . . . 73.42 111.781 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.5 p -144.66 140.33 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.96 0.41 . . . . 64.01 111.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.7 ttpt -107.38 128.87 54.86 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.942 0.401 . . . . 63.31 111.314 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 17' ' ' ILE . 4.0 p -114.01 136.87 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.325 0.583 . . . . 70.05 111.886 -178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.38 142.49 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.917 -0.583 . . . . 64.22 111.599 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 17' ' ' ILE . 38.9 mt -122.95 107.76 12.19 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.054 0.39 . . . . 52.23 112.054 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -114.12 136.56 52.8 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.296 0.57 . . . . 51.02 111.337 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 9.4 m120 -93.57 108.05 19.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.823 -0.626 . . . . 73.45 112.489 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.3 t 59.92 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.297 0.851 . . . . 73.13 113.297 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.93 -71.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.444 0.64 . . . . 75.24 111.654 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.58 -22.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.455 -0.793 . . . . 73.4 111.732 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 9.2 pt-20 -44.28 133.25 5.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.344 0.658 . . . . 73.22 111.349 171.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.7 128.8 53.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.898 0.38 . . . . 75.21 111.844 -172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.48 HG13 ' OD1' ' A' ' 106' ' ' ASN . 17.9 m -85.57 -35.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 112.066 0.395 . . . . 72.12 112.066 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.59 154.01 1.94 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.429 0.633 . . . . 72.1 112.621 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -139.59 130.15 25.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.565 -0.743 . . . . 74.31 110.102 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 115' ' ' ARG . 4.0 ttt85 -141.5 148.33 39.24 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.481 0.549 . . . . 51.11 112.481 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.9 p -106.99 169.8 8.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.241 -0.436 . . . . 44.05 111.407 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.1 p -78.51 134.22 37.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.032 0.382 . . . . 73.34 112.032 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.945 0.403 . . . . 74.13 111.475 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.908 0.336 . . . . 72.3 111.908 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.0 t -84.62 102.84 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.899 0.38 . . . . 73.42 111.528 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.8 t -121.41 149.82 42.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.818 0.342 . . . . 65.1 111.404 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 104' ' ' LEU . 61.3 mt -62.37 132.19 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 112.301 0.482 . . . . 75.51 112.301 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -84.47 -62.39 1.57 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.408 0.623 . . . . 74.11 110.206 173.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -149.45 136.68 19.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.614 . . . . 72.33 110.748 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 27' ' ' ILE . 40.9 mt -94.5 146.69 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.945 -0.391 . . . . 75.43 109.945 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.18 129.87 41.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.141 0.496 . . . . 73.15 112.069 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.52 -23.54 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.902 -0.59 . . . . 71.15 111.59 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.37 -32.3 54.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.162 0.506 . . . . 74.12 110.775 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 102.08 41.9 2.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.073 -0.512 . . . . 73.12 114.32 173.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -129.36 -6.58 4.77 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.975 1.102 . . . . 71.12 113.975 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.74 163.19 24.17 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.573 0.953 . . . . 72.41 113.573 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 20' ' ' ILE . 56.0 mt -134.54 115.5 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.366 -0.834 . . . . 71.22 110.337 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -94.88 110.34 22.23 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.686 -0.634 . . . . 75.53 112.172 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 5.8 mp -94.09 145.3 24.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.063 -0.517 . . . . 63.44 110.636 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -125.65 125.5 43.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.839 0.352 . . . . 71.34 111.11 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.09 127.54 32.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.719 0.295 . . . . 71.43 110.906 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.7 p -93.24 -15.99 25.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.313 0.486 . . . . 74.35 112.313 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.0 p -69.92 134.61 48.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.002 0.429 . . . . 72.32 111.114 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.62 25.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.118 0.485 . . . . 41.25 111.424 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.74 143.74 27.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.16 -0.473 . . . . 71.44 110.872 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.84 104.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.722 0.409 . . . . 74.02 111.859 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.04 135.08 20.03 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 111.756 0.28 . . . . 64.21 111.756 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.95 48.07 2.54 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.701 2.267 . . . . 62.43 112.907 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 tpt 67.23 -69.4 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.422 0.689 . . . . 72.31 112.059 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.1 4.01 61.53 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.136 -0.554 . . . . 63.12 113.458 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.87 101.11 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.197 -0.525 . . . . 70.33 113.345 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -121.16 175.88 5.88 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.599 -0.354 . . . . 74.33 111.419 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -145.36 123.11 11.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.421 . . . . 74.32 111.387 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -99.96 117.31 33.98 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.119 -0.491 . . . . 73.15 111.329 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.2 mp -104.45 105.49 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.036 0.446 . . . . 73.2 111.036 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.666 HH11 ' HZ3' ' A' ' 88' ' ' TRP . 61.0 ttt180 -82.29 109.02 16.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.499 -0.318 . . . . 74.42 111.398 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -117.03 141.73 47.88 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.876 0.369 . . . . 75.41 111.108 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 100' ' ' VAL . 13.3 tt -166.1 -46.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 111.785 0.291 . . . . 73.52 111.785 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.26 21.29 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.174 -0.536 . . . . 42.51 113.093 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.23 8.56 5.76 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.536 -0.391 . . . . 74.32 111.922 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -149.32 166.06 30.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.862 0.363 . . . . 52.51 111.202 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.0 p -128.26 164.39 22.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.961 0.41 . . . . 74.15 111.252 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.45 132.69 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.543 -0.299 . . . . 44.14 110.954 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.413 ' OG ' HG13 ' A' ' 45' ' ' ILE . 69.5 m -104.87 162.05 13.66 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.27 0.557 . . . . 65.14 112.481 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.402 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 72.3 t80 -142.87 118.96 10.71 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.956 -0.566 . . . . 74.22 110.645 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -91.67 123.38 35.02 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.834 0.35 . . . . 70.23 110.54 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -74.56 177.07 6.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.539 0.94 . . . . 64.03 113.539 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.473 HG23 ' CE2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -125.71 165.87 17.82 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.522 -0.763 . . . . 71.33 112.09 -177.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 t -106.4 10.4 31.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.216 -0.447 . . . . 54.41 111.855 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.58 -35.43 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.208 0.448 . . . . 74.23 112.208 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.473 ' CE2' HG23 ' A' ' 58' ' ' THR . 17.5 p90 -101.19 149.15 24.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.109 0.481 . . . . 72.43 111.566 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.46 126.11 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.084 0.469 . . . . 70.22 111.496 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.5 mm? -80.56 96.34 6.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 51.32 110.941 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.41 168.61 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.196 0.522 . . . . 63.33 111.954 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.76 107.24 0.58 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.137 -0.483 . . . . 61.3 111.602 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 2.67 83.23 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.44 -0.41 . . . . 74.44 113.592 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -54.49 120.96 7.38 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.845 0.683 . . . . 72.24 112.845 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -94.39 112.92 24.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.04 -0.527 . . . . 63.33 110.975 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.38 128.5 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.02 0.438 . . . . 75.24 110.726 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.7 m -106.97 118.59 37.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.189 0.519 . . . . 52.21 112.1 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.36 104.8 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 65.14 110.644 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 63.3 m95 -87.53 159.19 18.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.953 0.406 . . . . 74.34 111.26 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.07 175.85 8.77 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.913 0.387 . . . . 70.34 111.374 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -22.6 19.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.315 0.487 . . . . 60.12 112.315 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.44 29.6 3.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.685 0.278 . . . . 74.11 111.477 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.77 -62.19 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.07 0.767 . . . . 73.2 113.07 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.63 -37.72 3.48 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.079 -0.51 . . . . 73.54 112.351 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 HD11 ' A' ' 87' ' ' ILE . 30.4 m -76.55 166.61 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.84 0.353 . . . . 73.13 111.707 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -67.13 170.12 7.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.553 0.575 . . . . 55.41 112.553 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.77 92.2 2.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.834 0.679 . . . . 61.23 112.834 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.579 ' H ' HD13 ' A' ' 87' ' ' ILE . 71.2 m 59.96 94.54 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.33 0.863 . . . . 65.45 113.33 172.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.602 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 78.5 Cg_exo -52.77 -41.34 70.54 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.542 2.828 . . . . 62.02 116.228 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.602 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.4 Cg_endo -98.2 135.97 3.24 Favored 'Cis proline' 0 C--N 1.366 1.477 0 CA-C-N 121.394 1.533 . . . . 71.42 114.639 -1.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 t -163.8 -48.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.933 -0.766 . . . . 75.22 108.933 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 8.1 m-20 -86.25 115.11 23.59 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.98 -0.748 . . . . 62.12 108.98 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -92.59 112.11 23.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.921 0.391 . . . . 50.23 111.659 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 81' ' ' SER . 2.5 mp -81.93 96.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.578 0.704 . . . . 61.23 110.636 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.666 ' HZ3' HH11 ' A' ' 46' ' ' ARG . 28.8 t90 -71.44 86.28 0.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.68 -0.691 . . . . 73.12 111.066 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.17 7.26 9.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.888 0.699 . . . . 72.32 112.888 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 14.6 m120 -70.06 -27.3 64.52 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.841 0.311 . . . . 72.24 111.841 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -159.44 156.92 29.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.861 0.362 . . . . 75.43 111.397 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -170.31 0.97 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.136 0.791 . . . . 70.2 113.136 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.4 m -67.41 -173.01 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.823 -0.626 . . . . 75.52 112.58 -173.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.473 ' HB3' ' NH2' ' A' ' 46' ' ' ARG . 49.3 p90 -141.69 147.0 36.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.06 0.457 . . . . 75.33 111.49 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.66 43.5 0.06 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.357 -0.449 . . . . 75.41 112.594 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.406 HG22 HD11 ' A' ' 48' ' ' ILE . 14.5 t -83.41 18.65 1.75 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.49 0.552 . . . . 74.22 112.49 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.61 -37.59 3.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.971 -0.633 . . . . 34.52 113.115 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.41 151.63 23.38 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.357 0.599 . . . . 71.45 112.015 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.35 130.34 41.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.33 -0.85 . . . . 71.03 112.226 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 48' ' ' ILE . 7.3 p -75.85 108.83 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.386 0.612 . . . . 55.13 110.811 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -90.19 103.13 15.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.491 0.662 . . . . 75.31 110.859 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.524 HG21 HD13 ' A' ' 27' ' ' ILE . 61.1 t -88.87 126.77 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.575 -0.739 . . . . 75.22 112.019 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 46.7 mm -97.71 132.18 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.536 -0.756 . . . . 74.05 111.461 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.663 HD11 HG13 ' A' ' 17' ' ' ILE . 80.8 mt -111.63 108.24 17.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.236 0.541 . . . . 72.23 111.689 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.85 161.2 16.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.971 -0.559 . . . . 60.03 111.294 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.58 177.32 7.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.003 0.43 . . . . 72.51 111.364 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.5 t -74.45 28.96 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.004 0.431 . . . . 54.54 111.82 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.01 -39.48 1.94 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.126 0.489 . . . . 75.4 111.374 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.43 -32.93 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.914 -0.474 . . . . 64.25 111.914 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.86 161.32 28.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 74.22 111.73 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -122.46 138.76 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.261 -0.427 . . . . 75.15 112.057 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.17 -32.39 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 113.667 0.988 . . . . 74.01 113.667 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.81 41.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.879 0.696 . . . . 63.0 112.879 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.86 135.93 3.47 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.702 -0.681 . . . . 55.34 110.894 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -164.32 165.25 21.93 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.17 -0.331 . . . . 75.11 111.23 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.1 p -129.41 -173.15 2.93 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.884 0.698 . . . . 71.35 112.884 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.2 p -81.14 127.99 33.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.998 -0.546 . . . . 61.4 112.404 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 116.096 -0.502 . . . . 63.2 110.399 174.072 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.866 0.365 . . . . 70.45 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -107.23 104.7 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.434 -0.348 . . . . 75.42 110.731 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.8 p -119.36 156.28 30.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.786 0.327 . . . . 72.51 111.69 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 104' ' ' LEU . 67.2 mt -76.08 122.86 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.748 0.309 . . . . 73.22 111.083 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.11 -35.26 23.8 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.993 0.425 . . . . 71.14 110.882 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -167.66 145.48 4.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.997 0.427 . . . . 70.22 111.716 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 27' ' ' ILE . 47.9 mt -113.19 131.92 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.588 -0.278 . . . . 61.14 110.258 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.55 126.64 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.963 0.411 . . . . 61.2 111.803 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 7.9 p -82.93 23.03 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.574 0.702 . . . . 73.23 112.013 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -121.28 -53.08 2.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.048 0.451 . . . . 74.02 110.112 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.44 13.33 0.57 Allowed Glycine 0 CA--C 1.524 0.64 0 CA-C-N 116.026 -0.534 . . . . 60.43 113.834 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -76.07 -52.94 9.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.596 0.591 . . . . 73.21 112.596 -176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.35 158.99 39.56 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.472 0.915 . . . . 74.54 113.472 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 20' ' ' ILE . 59.9 mt -114.33 121.85 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.153 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -94.41 107.76 19.71 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.391 0.515 . . . . 63.31 112.391 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.1 mp -100.99 169.4 8.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.851 0.357 . . . . 75.1 111.118 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.68 128.49 7.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.983 0.364 . . . . 62.33 111.983 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -91.72 112.4 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.348 -0.387 . . . . 71.41 110.754 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -100.95 19.0 18.16 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.16 0.505 . . . . 65.44 111.954 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.0 t -78.27 -176.84 4.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.065 -0.397 . . . . 64.03 111.646 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.58 -39.19 20.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.053 0.76 . . . . 74.45 113.053 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 57.9 tt0 -130.5 170.63 13.97 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.822 0.344 . . . . 64.54 111.591 -171.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.4 m-20 -52.16 104.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.827 0.451 . . . . 54.03 111.623 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 15.7 mm100 -91.14 136.85 26.79 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.106 0.409 . . . . 74.33 112.106 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 39.7 Cg_exo -62.08 113.24 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.715 2.277 . . . . 72.52 112.647 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.59 ' HG3' ' HB3' ' A' ' 57' ' ' TYR . 3.4 tpt -69.56 -28.71 66.22 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.989 0.423 . . . . 72.2 111.674 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.675 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.28 76.55 0.76 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.387 -0.435 . . . . 64.42 113.576 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.07 12.63 0.03 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.476 -0.393 . . . . 55.41 113.156 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.41 ' CZ3' HG21 ' A' ' 112' ' ' VAL . 30.2 m95 -124.89 162.07 25.2 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.696 0.398 . . . . 75.41 110.803 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -145.49 135.37 23.59 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.029 0.442 . . . . 73.15 111.371 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.0 ttp -101.69 120.51 40.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.988 -0.551 . . . . 74.22 111.619 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -109.05 118.18 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.647 0.26 . . . . 71.54 110.576 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.546 ' NH1' HE22 ' A' ' 91' ' ' GLN . 43.8 ttt-85 -90.49 129.77 36.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.066 -0.396 . . . . 54.34 111.938 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 29.0 mtpp -129.29 147.84 51.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.288 0.566 . . . . 74.33 111.843 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' HG23 ' A' ' 100' ' ' VAL . 9.6 tt -167.78 -40.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.568 -0.742 . . . . 71.52 110.193 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.66 -153.94 6.31 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.803 -0.635 . . . . 75.12 111.864 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 71.73 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.284 0.564 . . . . 73.34 111.724 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -174.99 163.89 3.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.67 . . . . 74.54 110.985 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.2 p -163.07 101.51 0.98 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.039 0.447 . . . . 70.43 111.302 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.17 144.13 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.37 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.7 m -109.04 158.72 17.46 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.253 0.549 . . . . 53.33 112.329 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -149.0 109.12 4.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.983 -0.553 . . . . 73.11 111.204 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -75.8 131.85 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.888 0.375 . . . . 72.1 111.273 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 52.4 m-85 -78.75 121.76 25.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.878 0.37 . . . . 70.33 110.762 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -79.13 158.04 27.82 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.369 0.507 . . . . 63.22 112.369 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.675 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 20.7 t -104.29 23.68 12.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.238 -0.437 . . . . 61.14 111.541 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 81' ' ' SER . 13.5 ptm180 -58.01 -29.67 65.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.867 0.365 . . . . 74.32 111.618 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -143.18 156.29 44.73 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 71.23 109.997 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.46 139.8 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.457 -0.338 . . . . 73.42 111.563 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -84.35 104.3 14.26 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.925 0.393 . . . . 70.41 111.038 -175.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 63.6 mttm -65.92 168.82 7.5 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.527 0.936 . . . . 65.42 113.527 -174.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 129.37 37.63 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.541 -0.754 . . . . 73.32 111.123 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.03 9.15 79.81 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.948 -0.644 . . . . 72.11 112.763 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -81.06 117.95 22.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.944 0.402 . . . . 62.23 111.305 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.0 p -86.1 96.31 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.011 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' A' ' 29' ' ' LEU . 6.6 p -79.62 119.04 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.538 0.685 . . . . 71.42 110.988 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 20.2 m -100.0 110.07 22.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 71.31 111.655 -175.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 49.6 mm -74.12 95.58 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.878 0.371 . . . . 72.33 110.629 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 87.4 m95 -79.89 128.27 33.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.41 -0.359 . . . . 75.34 110.949 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.51 162.5 6.28 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.284 -0.26 . . . . 55.02 111.559 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -50.29 -26.02 4.36 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.993 0.738 . . . . 72.14 112.993 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 92' ' ' ASN . 74.8 m-20 -90.8 28.28 1.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.925 0.393 . . . . 74.54 111.566 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -59.71 -36.03 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.694 0.627 . . . . 52.22 112.694 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.1 2.3 82.45 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.095 -0.574 . . . . 63.55 113.243 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.78 -178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.155 0.502 . . . . 55.01 111.619 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 m -75.26 139.85 42.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.264 -0.426 . . . . 52.22 111.288 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.25 79.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.212 0.53 . . . . 73.42 111.574 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.533 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 8.5 t 66.08 89.87 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 115.484 -0.78 . . . . 54.43 111.729 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 84' ' ' THR . 41.0 Cg_exo -60.97 -30.23 89.5 Favored 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 124.112 3.208 . . . . 72.21 118.084 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.687 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 33.3 Cg_endo -97.97 -179.43 6.05 Favored 'Cis proline' 0 C--N 1.367 1.532 0 CA-C-N 122.249 1.839 . . . . 72.51 115.284 6.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.716 HG22 ' HD2' ' A' ' 82' ' ' PRO . 2.9 t 177.01 -44.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.682 -1.599 . . . . 72.33 108.724 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 70' ' ' THR . 18.2 m-20 -140.06 -171.9 3.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.014 -0.994 . . . . 65.41 110.157 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 88.9 mt -123.02 132.33 54.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.936 0.398 . . . . 72.53 111.278 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.8 mp -95.68 125.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.25 0.547 . . . . 64.33 111.396 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.512 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 16.2 t90 -80.33 90.42 5.58 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.754 -0.657 . . . . 73.1 111.033 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -80.16 -5.2 55.62 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 15.1 m120 -82.31 -14.45 55.33 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.543 0.572 . . . . 71.01 112.543 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.546 HE22 ' NH1' ' A' ' 46' ' ' ARG . 46.7 tt0 -154.27 143.05 20.94 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.254 0.55 . . . . 74.21 111.528 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.6 m120 -75.11 172.28 12.65 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.021 175.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.8 p -71.79 114.36 9.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.582 0.23 . . . . 74.33 110.568 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -59.32 -29.84 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.131 0.419 . . . . 64.41 112.131 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 48.03 39.41 18.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 114.733 0.653 . . . . 62.41 114.733 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -133.85 12.4 4.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.158 0.504 . . . . 72.22 110.941 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 67.18 -112.58 4.94 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.982 -0.628 . . . . 52.24 112.759 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 66.41 163.13 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.914 0.709 . . . . 74.33 112.914 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 11.1 p-10 -95.9 87.8 4.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.639 0.733 . . . . 64.53 110.711 176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 48' ' ' ILE . 7.6 p -96.25 135.38 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.059 -0.519 . . . . 71.44 111.299 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -115.31 124.26 50.85 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.094 0.473 . . . . 65.14 111.199 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 27' ' ' ILE . 87.6 t -98.9 136.39 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.035 -0.53 . . . . 72.53 112.075 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 43.9 mm -103.2 121.31 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.821 -0.627 . . . . 62.11 111.286 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.746 HD11 HG13 ' A' ' 17' ' ' ILE . 80.7 mt -97.5 121.77 39.78 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.352 -0.218 . . . . 72.13 111.083 175.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.9 mttt -129.36 159.24 36.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.031 0.443 . . . . 72.45 111.457 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -93.21 163.77 13.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 54.54 110.938 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -57.3 -29.75 64.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.306 0.484 . . . . 62.55 112.306 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -74.75 -19.26 60.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.69 0.626 . . . . 75.32 112.69 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 135.28 -46.89 1.01 Allowed Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.663 1.025 . . . . 64.3 115.663 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.91 169.48 17.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.596 0.698 . . . . 73.11 112.746 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 36.5 tt0 -94.7 146.97 23.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.713 -0.676 . . . . 74.21 112.181 -173.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.41 HG21 ' CZ3' ' A' ' 42' ' ' TRP . 46.6 t -97.9 -59.6 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.949 -0.569 . . . . 62.12 110.806 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.59 159.73 14.48 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 64.14 111.563 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.27 152.03 45.17 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.64 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 115' ' ' ARG . 18.6 ttt180 -156.11 144.87 20.26 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.781 -0.19 . . . . 71.32 111.362 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.2 p -114.64 175.35 5.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 62.13 112.377 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 33.0 p -77.17 -174.59 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.936 -0.575 . . . . 71.53 111.18 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 116.546 -0.297 . . . . 74.03 111.252 178.557 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 13.8 m120 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 111.963 0.357 . . . . 73.24 111.963 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -102.7 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.961 0.41 . . . . 73.22 110.221 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.25 151.0 25.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.076 0.465 . . . . 73.03 112.016 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 104' ' ' LEU . 56.4 mt -77.28 115.4 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.264 -0.426 . . . . 71.24 110.619 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -84.19 -42.34 16.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.722 0.296 . . . . 73.44 111.522 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.1 148.61 27.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.23 112.037 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.66 123.35 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.908 -0.587 . . . . 62.34 110.265 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.17 140.05 40.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.487 0.661 . . . . 51.5 112.462 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -97.1 -20.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.716 -0.674 . . . . 70.14 111.142 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -68.02 -34.62 76.83 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.15 0.5 . . . . 62.2 110.381 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 104.03 44.53 1.61 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.345 0.498 . . . . 44.35 114.345 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -128.3 -26.08 2.86 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.373 0.879 . . . . 75.43 113.373 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' HB2' ' CG2' ' A' ' 70' ' ' THR . 49.2 p90 -156.08 152.46 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.884 1.068 . . . . 75.15 113.884 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -127.06 118.55 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.748 . . . . 75.21 109.537 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 28' ' ' ARG . 37.8 ttp180 -101.61 110.3 22.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.689 0.626 . . . . 71.32 112.689 -171.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.9 mp -97.92 169.47 9.62 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.89 -0.596 . . . . 74.25 110.439 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -149.99 140.84 22.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.148 0.499 . . . . 65.22 111.843 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' HB3' HD12 ' A' ' 63' ' ' LEU . 37.5 t30 -100.27 126.9 46.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.259 -0.428 . . . . 71.54 111.079 177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.2 t -113.16 10.97 18.7 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.806 0.336 . . . . 64.4 111.597 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 32.2 m -65.94 146.23 54.97 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.327 -0.233 . . . . 55.32 111.186 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.88 -19.21 62.65 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.415 0.524 . . . . 62.25 112.415 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 42.7 tt0 -123.06 166.06 15.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.81 0.338 . . . . 72.33 111.167 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.7 m-20 -55.09 130.84 43.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.763 0.425 . . . . 75.44 111.84 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.41 113.32 40.95 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 112.459 0.54 . . . . 71.44 112.459 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.54 125.44 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.748 2.299 . . . . 74.02 111.211 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 tpp -58.07 -20.88 42.89 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.777 0.658 . . . . 53.14 112.777 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.06 -90.19 0.08 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.249 -0.501 . . . . 70.12 113.518 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.08 59.66 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.047 -0.597 . . . . 65.33 113.577 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -76.43 168.8 19.42 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.475 -0.426 . . . . 73.55 110.912 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.33 113.82 26.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.099 0.476 . . . . 72.54 111.606 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.4 ttp -92.28 125.54 36.99 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.147 -0.479 . . . . 70.53 111.213 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.7 mt -117.21 109.11 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.783 0.325 . . . . 73.44 111.371 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -90.21 107.69 19.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.812 0.339 . . . . 72.01 111.141 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 37.3 mttm -95.83 129.32 43.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.811 0.339 . . . . 74.24 111.217 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.6 tt -134.67 100.82 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.445 0.641 . . . . 51.32 110.901 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.83 -103.98 1.31 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.1 -0.571 . . . . 74.02 112.419 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -102.74 -32.12 9.99 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.035 0.383 . . . . 74.15 112.035 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -92.91 168.69 10.99 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.3 0.572 . . . . 64.22 112.39 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.51 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 92.5 p -155.1 150.75 27.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.959 -0.564 . . . . 64.12 111.415 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.5 p -134.61 140.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.443 -0.344 . . . . 72.43 110.874 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.4 p -108.3 158.01 17.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.409 0.623 . . . . 73.2 112.584 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -154.56 115.27 3.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.735 -0.666 . . . . 75.51 111.069 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -86.33 133.82 33.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.921 0.391 . . . . 75.01 110.867 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.79 -177.86 2.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.195 0.521 . . . . 70.13 111.851 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -148.36 142.95 26.5 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.084 -0.507 . . . . 72.34 110.982 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -95.43 82.45 3.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.049 0.452 . . . . 73.53 111.983 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.36 6.25 10.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 71.21 111.209 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.01 152.26 31.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 74.34 110.362 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 36' ' ' ASP . 11.7 t -115.47 116.92 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.825 0.345 . . . . 71.05 110.733 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -93.0 123.83 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.488 -0.324 . . . . 43.42 111.07 -173.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -80.97 -169.82 2.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.753 0.649 . . . . 75.12 112.753 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' SER . . . -81.68 144.3 31.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.67 0.619 . . . . 71.05 112.67 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.2 12.32 62.94 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.953 -0.567 . . . . 31.3 114.038 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.32 144.41 37.52 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.446 -0.443 . . . . 72.4 110.938 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -99.73 143.59 29.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.963 0.411 . . . . 63.34 112.011 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.77 123.96 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.208 -0.451 . . . . 72.25 110.121 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 86.6 m -101.74 126.72 48.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.472 . . . . 74.54 112.008 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.7 mm -92.01 103.1 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.43 . . . . 74.32 110.253 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.429 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -85.58 135.12 33.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.3 -0.409 . . . . 65.02 111.607 -177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 153.23 40.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.657 0.265 . . . . 71.03 111.533 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -53.88 -34.32 59.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.736 0.643 . . . . 73.31 112.736 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.419 HD21 ' HB3' ' A' ' 92' ' ' ASN . 77.2 m-20 -82.37 6.73 16.13 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.651 0.612 . . . . 61.13 112.651 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.68 77.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.974 0.361 . . . . 64.45 111.974 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.56 2.02 90.57 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.152 -0.547 . . . . 64.04 114.2 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.0 171.79 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 122.389 -0.477 . . . . 75.03 111.823 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 ' H ' ' A' ' 81' ' ' SER . 85.6 m -69.26 126.61 30.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 74.12 111.701 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -64.99 -15.25 62.08 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.177 0.806 . . . . 73.0 113.177 -176.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.659 ' H ' HG22 ' A' ' 79' ' ' THR . 23.2 t -149.25 86.53 5.55 Favored Pre-proline 0 N--CA 1.474 0.745 0 O-C-N 122.154 -0.341 . . . . 65.15 111.743 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 84' ' ' THR . 53.9 Cg_exo -53.65 -44.8 45.94 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 122.984 2.456 . . . . 73.53 115.399 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 69.7 Cg_endo -99.97 132.9 2.21 Favored 'Cis proline' 0 C--N 1.369 1.649 0 CA-C-N 121.161 1.45 . . . . 75.21 114.095 -1.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.569 HG22 ' HB2' ' A' ' 82' ' ' PRO . 5.1 t -174.72 -47.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.96 -0.563 . . . . 74.0 110.241 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' THR . 17.3 m-20 -89.98 164.55 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.513 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 92.1 mt -126.47 133.85 51.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.035 0.445 . . . . 73.44 111.412 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 80' ' ' ALA . 1.6 mp -94.28 114.9 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.995 0.426 . . . . 61.31 111.281 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.509 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 4.5 t90 -66.96 93.46 0.27 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.055 -0.52 . . . . 73.44 110.691 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -78.51 -28.04 46.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.106 0.41 . . . . 74.31 112.106 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 15.9 m120 -63.32 -20.31 65.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.287 0.477 . . . . 63.33 112.287 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 47.5 tt0 -132.63 127.18 34.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.864 0.364 . . . . 64.23 110.817 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.1 m120 -67.19 -51.81 48.95 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.349 . . . . 72.15 111.205 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 t -175.21 -179.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 61.23 111.577 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.547 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 38.5 p90 -153.48 -178.81 7.24 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.116 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.18 55.17 0.02 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.394 -0.908 . . . . 70.33 113.166 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -79.83 -40.9 27.47 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.145 0.498 . . . . 73.11 111.513 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.82 -23.25 19.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.063 -0.517 . . . . 52.54 112.789 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.51 179.35 5.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.257 0.551 . . . . 64.14 112.073 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.4 124.41 23.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.741 -0.663 . . . . 72.03 112.22 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.97 135.64 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.134 0.492 . . . . 75.01 111.072 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 103' ' ' ILE . 7.7 ttpm? -122.96 136.68 54.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.087 -0.506 . . . . 50.23 111.718 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.18 123.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.198 0.523 . . . . 72.4 111.246 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 101' ' ' LYS . 48.8 mm -102.95 135.34 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.831 -0.622 . . . . 65.2 111.93 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 17' ' ' ILE . 68.6 mt -111.45 105.75 14.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 54.23 110.797 173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 103' ' ' ILE . 68.3 mttm -107.69 130.62 54.91 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.16 0.505 . . . . 65.23 111.423 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.94 156.11 39.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.609 . . . . 73.54 111.66 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -57.5 -16.43 9.75 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.173 0.805 . . . . 75.13 113.173 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -101.08 12.81 36.95 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.449 0.537 . . . . 73.42 112.449 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.35 -23.81 33.96 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.888 0.715 . . . . 52.32 114.888 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -76.77 174.8 10.06 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.462 0.631 . . . . 72.31 111.905 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.87 142.4 50.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.519 -0.31 . . . . 70.22 111.282 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.84 -32.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 113.323 0.86 . . . . 75.33 113.323 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.98 152.53 47.75 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.636 0.606 . . . . 74.23 112.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.65 46.88 0.49 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.313 0.577 . . . . 73.14 111.276 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -75.54 151.1 37.98 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.183 0.516 . . . . 71.4 111.958 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.2 p -116.55 173.35 6.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.387 -0.369 . . . . 64.03 110.903 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.5 p -80.56 169.2 17.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.054 0.454 . . . . 75.32 111.508 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 116.109 -0.496 . . . . 64.22 110.705 177.6 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 73.12 111.902 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.93 114.17 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.41 . . . . 71.41 110.759 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.67 150.71 20.36 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.23 0.538 . . . . 73.14 112.243 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.39 110.15 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 62.22 110.163 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -77.22 -68.13 0.64 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.937 0.347 . . . . 64.32 111.937 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -155.92 150.49 25.97 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.287 0.565 . . . . 62.31 111.848 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.665 HD13 HH12 ' A' ' 46' ' ' ARG . 63.4 mt -108.86 137.1 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.065 -0.516 . . . . 72.32 110.864 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 11.0 t70 -70.19 147.22 50.1 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.392 0.615 . . . . 73.14 111.939 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.95 -16.87 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.643 -0.708 . . . . 70.21 111.488 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.5 -26.71 60.17 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 52.02 110.705 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.93 41.15 3.38 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.928 -0.578 . . . . 74.23 113.128 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 -37.75 2.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.356 0.872 . . . . 72.42 113.356 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.596 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 51.3 p90 -155.46 171.78 19.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.186 1.18 . . . . 74.02 114.186 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 20' ' ' ILE . 60.2 mt -136.68 143.9 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.221 -0.9 . . . . 70.34 109.265 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.65 115.04 22.02 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.576 -0.703 . . . . 74.45 112.401 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -104.58 170.42 7.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.876 -0.602 . . . . 61.33 110.521 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.84 127.76 17.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.019 0.377 . . . . 60.12 112.019 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -90.38 131.52 36.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 64.22 110.742 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.4 p -117.5 11.23 13.78 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.31 0.485 . . . . 74.55 112.31 -176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.7 p -72.78 155.86 39.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.181 0.437 . . . . 64.34 112.181 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.99 -28.24 68.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.116 0.484 . . . . 64.23 112.209 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -124.58 139.0 54.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.077 -0.51 . . . . 70.1 110.411 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.27 126.35 22.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.792 0.329 . . . . 73.53 111.708 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -91.1 120.93 68.45 Favored Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 54.14 111.934 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.23 107.74 0.34 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.343 2.029 . . . . 73.52 112.432 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 tpt -78.99 91.49 4.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.777 0.323 . . . . 72.42 111.147 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.04 -51.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.89 -0.671 . . . . 74.32 113.802 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.39 50.72 3.53 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.114 -0.565 . . . . 72.31 113.619 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -140.92 141.15 34.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.014 0.526 . . . . 73.42 110.592 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 38.0 tt0 -124.32 126.9 46.8 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.171 0.51 . . . . 72.42 110.836 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HE1' HG21 ' A' ' 71' ' ' ILE . 30.9 ttp -102.04 116.06 31.87 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.653 -0.703 . . . . 74.43 111.384 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.4 mt -100.41 161.46 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.476 -0.329 . . . . 64.31 110.615 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.665 HH12 HD13 ' A' ' 20' ' ' ILE . 46.7 ttt85 -158.87 137.07 10.63 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.817 -0.552 . . . . 74.44 111.344 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 100' ' ' VAL . 94.4 mttt -123.88 147.55 47.56 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.515 0.561 . . . . 72.2 112.515 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 tt -139.91 109.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.519 -0.764 . . . . 53.31 110.286 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.13 -78.17 0.68 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.008 -0.615 . . . . 34.13 112.847 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -136.94 -43.78 0.58 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.951 0.405 . . . . 74.14 111.502 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -68.01 137.78 55.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.182 0.515 . . . . 71.43 112.343 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.9 p -118.97 153.08 35.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.229 0.538 . . . . 62.14 112.044 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.11 151.55 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 115.743 -0.662 . . . . 75.42 110.288 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -134.99 165.97 24.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.1 0.476 . . . . 71.23 112.046 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -157.03 113.93 3.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 74.21 111.109 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 22.2 ttpp -84.01 133.85 34.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.858 0.361 . . . . 70.32 110.8 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -69.37 158.02 35.9 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.909 0.385 . . . . 71.54 110.973 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -120.33 129.55 54.03 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.158 0.504 . . . . 71.23 111.487 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.7 t -76.93 85.96 3.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.084 0.469 . . . . 74.21 112.05 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 9.8 ptp180 -119.54 4.85 11.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.399 . . . . 71.44 110.902 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 8.3 p90 -170.79 173.96 5.08 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.127 0.489 . . . . 70.35 110.69 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.48 129.02 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.75 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.32 105.71 1.51 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.561 -0.533 . . . . 63.23 109.561 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -54.55 136.05 45.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.71 0.633 . . . . 63.1 112.71 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.86 128.92 39.13 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.726 -0.67 . . . . 72.1 111.508 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.35 32.76 72.13 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.091 -0.576 . . . . 53.43 113.392 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.618 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -127.71 149.49 50.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.154 0.502 . . . . 72.04 111.814 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.4 p -96.4 135.53 38.13 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.104 -0.498 . . . . 61.3 111.754 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.6 134.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.397 -0.365 . . . . 73.11 110.828 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 m -104.56 118.62 37.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.267 0.556 . . . . 74.12 111.951 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.706 HG21 ' HE1' ' A' ' 44' ' ' MET . 44.4 mm -89.18 102.1 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.158 -0.474 . . . . 44.1 110.859 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -84.29 125.8 32.59 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.631 -0.259 . . . . 74.14 111.467 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -177.49 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.014 0.435 . . . . 62.43 111.751 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 -16.97 16.96 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.138 0.422 . . . . 71.3 112.138 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -93.11 19.17 8.24 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.538 -0.301 . . . . 52.44 111.204 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.662 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -46.54 -61.74 1.68 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.504 0.927 . . . . 75.13 113.504 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.17 21.48 78.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.799 -0.715 . . . . 62.14 112.792 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.662 HG22 ' HB1' ' A' ' 76' ' ' ALA . 30.2 m -127.54 -173.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.561 0.344 . . . . 73.22 110.863 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 p -60.69 123.47 17.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.088 0.471 . . . . 70.1 111.302 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 9.36 3.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.348 0.499 . . . . 64.21 112.348 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -134.46 119.04 13.95 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.174 0.435 . . . . 72.33 112.174 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.653 ' HG3' ' O ' ' A' ' 85' ' ' ASP . 36.8 Cg_exo -54.88 138.18 76.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.773 2.316 . . . . 64.11 110.101 168.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 5.3 Cg_exo 0.29 103.57 0.0 OUTLIER 'Cis proline' 0 C--N 1.363 1.329 0 N-CA-C 121.498 3.615 . . . . 61.3 121.498 25.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' ASP . 12.6 t 51.28 -67.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 117.062 2.245 . . . . 75.34 117.062 162.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 50.5 m-20 -68.21 -178.47 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.758 -0.589 . . . . 74.24 112.132 -171.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 29.3 mt -146.22 142.85 28.8 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.016 -0.427 . . . . 50.2 111.419 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.8 mp -103.57 116.41 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 112.033 0.383 . . . . 54.44 112.033 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.529 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.5 t90 -74.22 82.9 1.84 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.53 0.681 . . . . 74.41 109.792 173.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -77.13 17.48 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.874 -0.603 . . . . 74.04 112.414 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.529 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.1 m120 -127.39 12.16 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.378 0.511 . . . . 43.24 112.378 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -148.64 145.64 27.84 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.205 -0.31 . . . . 64.35 111.533 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -100.64 -137.16 0.32 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 111.686 0.254 . . . . 71.22 111.686 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 96.8 p -75.93 -2.3 29.67 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.821 1.045 . . . . 72.31 113.821 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.0 p90 45.39 22.24 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.154 1.168 . . . . 74.21 114.154 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.98 -156.67 15.84 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.295 -0.478 . . . . 63.32 113.597 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 t -127.05 -31.3 2.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.103 0.478 . . . . 73.34 111.515 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.81 48.45 0.21 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.808 -0.517 . . . . 75.43 111.808 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.01 162.84 14.54 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.618 -0.342 . . . . 74.4 111.191 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -78.39 43.97 0.49 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.54 0.686 . . . . 51.22 111.215 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.6 p -66.31 136.3 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 115.534 -0.757 . . . . 71.42 111.487 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -130.1 150.32 51.42 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.003 0.372 . . . . 70.51 112.003 -171.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.84 155.71 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.859 0.689 . . . . 75.33 112.859 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 19.7 mm -126.52 134.73 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.819 0.848 . . . . 74.45 111.068 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.77 112.84 22.61 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.722 0.296 . . . . 73.11 111.487 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.34 155.92 34.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.74 0.305 . . . . 65.45 111.169 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.11 177.98 6.0 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.221 0.534 . . . . 75.13 111.677 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.8 p -57.79 -20.92 38.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.039 -0.528 . . . . 70.23 112.027 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.01 -4.61 58.86 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.258 0.466 . . . . 55.21 112.258 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.89 -19.46 45.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.296 -0.478 . . . . 63.32 113.954 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.09 152.68 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.328 -0.513 . . . . 73.34 111.759 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -99.55 128.91 45.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.098 -0.501 . . . . 62.31 112.269 -171.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -84.97 -54.7 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.885 0.374 . . . . 74.2 111.32 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.83 167.36 30.64 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.395 0.617 . . . . 74.45 112.483 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.06 153.82 30.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.501 -0.772 . . . . 55.13 110.896 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -160.26 152.52 20.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.74 0.305 . . . . 73.11 111.502 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -115.02 178.89 4.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.068 0.461 . . . . 74.13 111.942 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 p -77.76 149.72 34.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.14 0.495 . . . . 75.33 111.255 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 70.22 111.241 -178.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 121.115 0.483 . . . . 70.44 110.69 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.75 149.74 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.063 -0.517 . . . . 71.13 110.581 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 p -134.96 145.54 48.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.833 0.349 . . . . 73.22 111.903 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.13 96.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.978 0.418 . . . . 75.42 110.554 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.57 -53.2 59.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 64.41 111.563 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -157.97 146.59 19.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.054 0.454 . . . . 61.2 111.566 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 HG12 ' A' ' 27' ' ' ILE . 30.7 mt -114.58 122.32 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.465 -0.569 . . . . 62.3 109.465 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.59 133.32 36.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.022 0.749 . . . . 70.55 113.022 -171.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.61 -21.76 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.655 -0.702 . . . . 73.42 112.453 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.69 -24.08 23.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.898 0.38 . . . . 73.33 110.939 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.73 26.22 9.27 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.272 -0.422 . . . . 65.21 113.508 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' NZ ' ' HB3' ' A' ' 25' ' ' LYS . 8.5 mtpm? -95.02 -28.08 15.3 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.088 0.773 . . . . 72.2 113.088 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.58 174.45 11.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.93 0.715 . . . . 75.45 112.93 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.627 HG12 HG23 ' A' ' 20' ' ' ILE . 52.3 mt -127.81 149.65 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.461 -0.79 . . . . 61.14 109.357 173.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -130.76 116.3 17.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.332 0.587 . . . . 63.42 112.071 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -109.1 154.24 22.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.795 -0.639 . . . . 74.45 110.288 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -124.2 124.28 42.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 65.53 111.523 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -74.83 97.29 3.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.7 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -79.6 -2.15 41.21 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.912 0.387 . . . . 61.31 111.391 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -75.37 118.08 17.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.43 -0.35 . . . . 55.43 110.536 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.79 61.24 5.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 71.3 111.227 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -170.11 159.26 7.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.968 -0.56 . . . . 71.52 110.463 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.38 101.4 0.95 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.759 0.314 . . . . 62.21 110.655 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.8 mm100 -105.07 123.74 38.83 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 112.402 0.519 . . . . 63.13 112.402 -174.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 13.3 Cg_exo -71.28 135.29 26.58 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.589 2.193 . . . . 75.33 111.91 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 3.2 tpt -65.45 -19.04 65.77 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.958 0.408 . . . . 45.11 111.943 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -109.13 2.68 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.209 -0.519 . . . . 73.21 113.312 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.82 60.07 0.2 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.264 -0.493 . . . . 45.12 112.592 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.8 m0 -79.92 -178.12 6.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.952 0.406 . . . . 64.23 111.321 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.63 119.52 11.92 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.198 0.523 . . . . 74.02 111.101 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.503 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 50.8 ttp -97.7 118.14 33.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.192 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' SER . 59.7 mt -103.17 132.87 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.555 -0.293 . . . . 71.14 111.177 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD2' HE22 ' A' ' 91' ' ' GLN . 51.4 ttm-85 -113.51 130.88 56.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.859 0.361 . . . . 62.14 111.909 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -120.52 133.4 55.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.874 0.368 . . . . 74.12 110.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 100' ' ' VAL . 11.9 tt -159.17 -42.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.004 0.372 . . . . 53.14 112.004 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.65 93.87 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.955 -0.64 . . . . 64.41 113.449 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.65 25.44 14.37 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.438 0.533 . . . . 74.13 112.438 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -146.92 144.51 29.29 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.201 0.524 . . . . 75.51 112.386 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -121.79 32.7 5.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.999 -0.546 . . . . 71.33 110.394 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.22 123.54 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.837 -0.62 . . . . 62.51 112.145 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.505 ' HB3' HG12 ' A' ' 45' ' ' ILE . 60.3 p -118.6 163.88 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.118 0.485 . . . . 30.33 111.98 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 62.9 t80 -137.51 111.35 8.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.956 -0.566 . . . . 63.14 111.901 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -72.33 116.8 13.2 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.033 -0.531 . . . . 75.4 111.077 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HE2' ' HB2' ' A' ' 44' ' ' MET . 55.4 m-85 -72.13 162.62 29.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.242 0.544 . . . . 71.32 112.32 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -128.7 133.96 48.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.988 -0.551 . . . . 75.11 111.574 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 14.8 t -86.46 34.62 0.64 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.431 -0.35 . . . . 62.42 111.338 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.653 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 2.5 ptm180 -59.03 -22.67 61.08 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.242 0.46 . . . . 45.12 112.242 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.653 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 44.4 p90 -143.09 149.84 38.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.021 0.439 . . . . 72.41 110.96 175.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.81 114.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.413 -0.358 . . . . 71.22 110.576 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.61 136.05 52.41 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.114 0.483 . . . . 71.41 112.273 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -72.85 160.22 32.5 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 74.32 112.157 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.59 130.36 41.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.038 -0.528 . . . . 55.35 111.981 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.05 73.81 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.082 -0.58 . . . . 62.34 113.551 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -83.52 135.55 34.6 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.97 0.414 . . . . 71.45 111.859 -177.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -96.13 109.35 21.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.007 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.12 133.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.315 0.578 . . . . 73.2 111.651 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 55.8 m -105.33 111.64 24.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 52.44 111.441 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.33 100.28 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.086 0.47 . . . . 55.31 110.415 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 72.7 m95 -77.47 166.64 22.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.16 -0.473 . . . . 64.12 111.318 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.67 178.12 4.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.572 -0.285 . . . . 60.31 110.73 174.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.78 16.46 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.023 0.439 . . . . 50.31 112.023 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -89.34 19.7 4.26 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.866 0.321 . . . . 70.3 111.866 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -58.04 -34.5 70.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.005 0.743 . . . . 73.15 113.005 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -41.53 2.76 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.911 -0.662 . . . . 73.22 112.865 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.24 -179.6 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.244 0.545 . . . . 73.51 111.959 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.9 p -76.54 161.02 28.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.109 0.481 . . . . 55.11 111.521 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.89 2.18 9.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.808 0.67 . . . . 75.33 112.808 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -144.44 87.89 7.47 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 122.2 -0.313 . . . . 54.1 111.774 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.594 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 50.8 Cg_exo -55.8 -42.46 67.0 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 123.159 2.572 . . . . 73.32 115.582 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.594 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 41.6 Cg_endo -99.68 19.72 23.35 Favored 'Cis proline' 0 C--N 1.37 1.683 0 CA-C-N 121.509 1.575 . . . . 74.14 113.905 1.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.534 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 44.5 p -59.28 -48.73 80.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.012 0.434 . . . . 75.42 112.104 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 70' ' ' THR . 12.9 m-20 -98.58 179.27 4.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.068 -0.514 . . . . 70.21 111.833 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.94 129.11 45.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 63.23 110.974 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.2 mp -96.59 109.21 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.749 0.309 . . . . 73.2 111.162 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 7.6 t90 -74.55 86.62 2.09 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.256 0.55 . . . . 63.04 110.422 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -71.59 -20.21 62.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.419 0.526 . . . . 71.03 112.419 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 10.0 m120 -68.01 -13.57 62.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.365 0.505 . . . . 72.22 112.365 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.419 HE22 ' HD2' ' A' ' 46' ' ' ARG . 63.6 tt0 -143.29 142.88 31.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.158 0.504 . . . . 75.31 112.172 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.82 -172.65 3.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.211 -0.45 . . . . 64.23 112.003 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.1 p -60.32 127.48 32.0 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 72.31 111.013 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -102.81 2.1 35.03 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.58 0.956 . . . . 64.01 113.58 -169.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 96' ' ' THR . . . 84.06 -44.55 3.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.875 -0.679 . . . . 71.13 114.171 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 95' ' ' GLY . 2.6 m 76.73 -32.86 0.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.705 1.002 . . . . 72.44 113.705 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.15 -23.33 24.48 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.261 0.864 . . . . 62.5 115.261 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.37 17.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.055 0.761 . . . . 73.52 113.055 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 t70 59.12 73.29 0.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.502 0.668 . . . . 74.22 110.308 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 48' ' ' ILE . 6.1 p -81.2 120.62 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.557 -175.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.97 122.18 38.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.113 0.482 . . . . 74.23 111.768 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.12 131.73 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.891 -0.595 . . . . 72.53 111.304 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.9 mm -111.99 120.39 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.368 -0.378 . . . . 75.32 111.395 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -102.95 109.76 21.42 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.382 -0.199 . . . . 71.42 111.412 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.64 141.16 52.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.375 0.607 . . . . 74.24 112.162 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -77.27 172.93 12.51 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.653 -0.703 . . . . 70.35 111.237 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.4 m -57.75 -21.76 43.01 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 111.985 0.365 . . . . 54.12 111.985 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.72 -7.54 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.574 0.583 . . . . 70.22 112.574 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 -17.22 57.81 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.957 -0.639 . . . . 52.11 113.334 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.78 164.15 22.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 60.03 111.306 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -104.35 142.29 34.83 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.086 0.772 . . . . 75.31 113.086 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.74 -51.91 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.708 -0.678 . . . . 75.12 110.14 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -172.6 163.92 5.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.498 -0.773 . . . . 32.12 111.137 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -144.1 145.2 31.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.857 0.36 . . . . 70.34 110.922 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -150.97 143.57 24.37 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.783 0.325 . . . . 72.42 111.811 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.6 p -108.0 178.66 4.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.501 -0.318 . . . . 73.43 110.935 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.53 HG22 ' HB ' ' A' ' 20' ' ' ILE . 30.0 p -99.86 120.87 40.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.684 -0.487 . . . . 63.13 109.684 171.278 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.449 HD21 ' NE2' ' A' ' 37' ' ' GLN . 8.3 p30 . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.159 0.429 . . . . 75.2 112.159 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -90.28 94.87 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.166 0.508 . . . . 71.44 110.384 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.62 153.09 18.01 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.908 0.385 . . . . 71.34 112.032 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.437 HG22 ' HD2' ' A' ' 115' ' ' ARG . 59.2 mt -65.22 125.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.496 -0.32 . . . . 53.04 110.854 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.07 -52.62 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.186 0.517 . . . . 71.34 111.046 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.1 158.34 36.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.32 111.309 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 27' ' ' ILE . 59.7 mt -126.66 143.92 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.752 -0.462 . . . . 71.34 109.752 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.74 137.73 56.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.912 0.387 . . . . 70.41 111.345 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.3 p -65.19 -36.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.258 0.466 . . . . 75.24 112.258 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -81.54 -70.37 0.54 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.016 0.436 . . . . 75.03 110.461 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.42 38.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.385 -0.912 . . . . 74.4 114.784 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -89.09 -50.52 6.11 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.48 0.64 . . . . 65.14 112.457 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.0 162.86 35.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.515 0.932 . . . . 60.52 113.515 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 20' ' ' ILE . 65.7 mt -119.93 137.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.511 -0.768 . . . . 72.21 109.88 173.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.88 116.61 28.28 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.249 0.547 . . . . 71.35 112.269 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -106.28 149.56 26.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.155 -0.475 . . . . 44.12 110.705 177.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB2' HG22 ' A' ' 68' ' ' THR . 82.9 tttt -123.88 131.8 53.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.905 0.383 . . . . 72.51 111.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB2' HD23 ' A' ' 63' ' ' LEU . 28.3 t30 -85.94 112.0 20.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.725 0.298 . . . . 72.02 110.564 172.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -98.63 14.54 28.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.834 0.35 . . . . 65.32 111.848 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 t -87.74 -177.57 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.012 0.434 . . . . 61.43 111.369 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.1 -19.9 16.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.153 0.501 . . . . 71.24 111.632 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -101.56 155.95 17.78 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.187 -0.46 . . . . 61.23 112.11 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 5.0 m-20 -64.66 91.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.164 -0.471 . . . . 62.05 110.165 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' NE2' HD21 ' A' ' 14' ' ' ASN . 16.0 mm100 -76.56 116.77 59.42 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 112.82 0.674 . . . . 73.45 112.82 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.83 144.09 63.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.171 1.914 . . . . 73.1 112.143 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.801 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -51.78 -26.79 10.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.005 0.431 . . . . 62.11 111.671 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.1 -100.35 0.45 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 114.448 0.539 . . . . 73.32 114.448 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 57' ' ' TYR . . . 172.27 55.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.549 0 N-CA-C 112.098 -0.401 . . . . 64.24 112.098 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -89.43 152.93 21.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.147 0.499 . . . . 74.32 112.102 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -97.39 118.75 34.55 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.909 -0.587 . . . . 73.14 111.372 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.585 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 55.8 ttp -98.99 104.75 16.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.188 -0.46 . . . . 63.13 110.794 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.8 mt -90.96 116.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.327 -0.397 . . . . 74.22 111.095 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.583 ' HE ' HG21 ' A' ' 100' ' ' VAL . 59.0 ttt180 -116.98 137.3 52.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.694 0.283 . . . . 73.32 111.513 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 50' ' ' ASP . 85.1 tttt -133.53 116.98 16.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.138 0.494 . . . . 73.14 110.811 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -113.09 119.56 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.108 -0.496 . . . . 71.12 110.937 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.22 -78.78 0.22 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.926 -0.654 . . . . 51.13 111.893 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 34.3 t70 -149.75 -15.33 0.27 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 111.801 0.297 . . . . 60.21 111.801 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -80.33 143.63 33.43 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.983 -0.448 . . . . 74.12 111.044 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.2 p -123.98 149.49 45.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.514 0.673 . . . . 72.32 112.68 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.75 145.23 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.49 -0.777 . . . . 64.12 110.33 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.3 p -128.08 127.68 43.55 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.089 0.471 . . . . 74.22 111.734 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -119.94 137.2 54.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.397 -0.365 . . . . 74.04 111.311 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -99.97 131.4 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.029 0.442 . . . . 40.02 111.668 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 60.6 m-85 -86.05 94.82 9.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.368 -0.378 . . . . 72.01 111.771 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -71.92 137.8 47.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.157 0.503 . . . . 74.42 112.247 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.801 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 79.5 p -72.25 91.22 1.29 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.304 0.483 . . . . 72.51 112.304 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.484 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 14.4 ptm180 -109.08 -16.82 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.692 0.282 . . . . 71.13 111.666 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.484 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 46.9 p90 -158.15 -177.71 6.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.642 0.258 . . . . 54.21 111.051 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.13 159.35 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.399 0.619 . . . . 72.43 112.102 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 31' ' ' ASN . 24.0 tp -124.19 113.87 18.89 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.08 -0.509 . . . . 73.23 110.047 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 39.0 tttp -75.29 169.15 18.61 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.605 0.594 . . . . 62.31 112.605 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.71 127.46 20.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.781 0.66 . . . . 64.22 112.781 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.61 -18.2 9.28 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.173 -0.467 . . . . 32.52 114.014 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.529 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -72.41 138.51 47.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.176 0.512 . . . . 71.13 111.674 -176.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 30' ' ' LYS . 59.9 p -105.47 132.51 51.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.197 -0.456 . . . . 74.32 112.052 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.8 140.93 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.91 0.386 . . . . 61.42 111.41 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.2 m -109.8 122.39 47.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 63.43 111.473 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 mm -105.61 102.35 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.399 -0.364 . . . . 70.24 111.255 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -82.94 125.92 31.93 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.821 0.304 . . . . 75.14 111.821 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.19 81.46 2.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.197 0.443 . . . . 65.41 112.197 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 64.83 -67.14 0.12 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.844 1.053 . . . . 71.34 113.844 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -71.39 75.58 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.113 0.412 . . . . 64.23 112.113 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.84 -48.82 3.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 72.02 111.697 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.48 -35.69 3.3 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.444 -0.407 . . . . 72.51 113.19 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.75 -173.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.144 0.424 . . . . 74.3 112.144 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -52.83 121.97 8.29 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.186 -0.461 . . . . 70.31 111.836 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.69 91.05 0.29 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.617 0.969 . . . . 65.31 113.617 -173.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 87' ' ' ILE . 33.8 t 72.84 87.09 0.1 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 114.151 1.167 . . . . 61.44 114.151 168.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HB2' ' N ' ' A' ' 84' ' ' THR . 81.8 Cg_exo -50.67 -176.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.576 2.582 0 C-N-CA 123.563 2.842 . . . . 64.4 112.259 163.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 14.82 47.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.44 0 N-CA-C 122.185 3.879 . . . . 72.15 122.185 44.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.667 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 7.3 t 157.67 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.598 1.159 . . . . 70.13 111.628 160.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.442 ' OD1' HG23 ' A' ' 84' ' ' THR . 1.5 m-20 -105.72 158.33 16.8 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.805 0.336 . . . . 74.31 111.203 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 HD11 ' SD ' ' A' ' 39' ' ' MET . 76.5 mt -126.25 139.6 53.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.844 0.354 . . . . 72.32 111.493 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 81' ' ' SER . 1.8 mp -105.39 116.17 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.081 0.467 . . . . 75.51 111.061 176.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 7.9 t90 -74.69 105.85 5.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.146 -0.479 . . . . 73.43 110.421 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.24 -5.15 58.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.805 0.669 . . . . 62.42 112.805 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.59 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 20.1 m120 -91.35 -42.95 10.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.588 0.588 . . . . 62.44 112.588 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -120.52 143.54 48.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.82 0.343 . . . . 72.23 111.398 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -93.52 177.21 6.1 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.057 0.455 . . . . 72.42 111.395 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.7 p -60.46 113.24 2.31 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.123 0.487 . . . . 71.25 111.153 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -76.24 -32.96 59.17 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.76 0.652 . . . . 71.22 112.76 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.98 50.54 21.11 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.292 0.477 . . . . 43.32 114.292 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.7 p -97.52 -44.78 6.68 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.724 0.639 . . . . 62.14 112.724 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 80.17 -33.73 2.21 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.898 -0.668 . . . . 54.21 112.676 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.75 148.15 47.61 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.799 0.333 . . . . 74.15 111.109 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 4.6 p-10 -64.43 126.41 27.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.341 0.867 . . . . 71.43 113.341 -173.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.583 HG21 ' HE ' ' A' ' 46' ' ' ARG . 7.7 p -124.92 141.71 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.794 -0.639 . . . . 73.2 110.938 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -109.55 134.88 51.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.919 0.39 . . . . 74.22 111.726 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 144.86 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.15 0.5 . . . . 45.11 111.768 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.76 141.46 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 116.186 -0.461 . . . . 74.01 111.347 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 76.5 mt -114.05 120.46 40.64 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.928 0.394 . . . . 74.31 111.568 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 95.5 mttt -123.05 146.74 47.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.462 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.606 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 16.8 m120 -76.53 153.33 35.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.036 -0.357 . . . . 61.25 110.036 169.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.8 t -67.94 8.37 0.41 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.277 0.843 . . . . 62.11 113.277 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.14 3.91 52.9 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.101 -0.374 . . . . 74.21 111.247 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 36.72 17.27 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.06 -0.591 . . . . 44.54 112.846 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.1 pt-20 -125.39 126.78 45.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.032 0.444 . . . . 75.25 111.501 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 33.8 tt0 -91.47 129.39 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.891 -0.595 . . . . 73.22 111.433 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.44 -64.16 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.285 0.476 . . . . 73.22 112.285 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . . . -101.74 145.4 29.19 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.451 0.537 . . . . 71.51 112.451 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.65 139.96 26.98 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.263 -0.426 . . . . 53.42 110.981 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 17' ' ' ILE . 47.7 ttm-85 -166.13 136.81 3.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.249 0.547 . . . . 72.32 112.282 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.7 p -111.32 154.54 24.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.756 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 20' ' ' ILE . 66.5 p -62.45 107.07 0.85 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.025 0.441 . . . . 72.34 111.648 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.423 0.63 . . . . 63.53 111.71 178.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.145 0.497 . . . . 54.14 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.74 128.64 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.425 . . . . 43.41 111.176 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 p -133.71 155.34 49.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.791 0.329 . . . . 44.01 111.445 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.799 HG13 HD11 ' A' ' 104' ' ' LEU . 73.7 mt -62.68 120.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 112.276 0.473 . . . . 72.44 112.276 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 40.6 tt0 -68.38 -55.51 11.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.252 -0.431 . . . . 71.24 109.981 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 23.6 tt0 178.52 160.46 0.6 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.665 -0.698 . . . . 75.22 110.502 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.483 HG23 HG12 ' A' ' 27' ' ' ILE . 57.6 mt -95.39 153.6 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.439 -0.346 . . . . 60.41 111.412 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.64 147.71 36.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.124 0.487 . . . . 63.33 111.587 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.35 -28.01 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.113 -0.494 . . . . 63.45 111.993 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.77 -34.54 13.16 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.886 0.374 . . . . 64.0 110.876 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.01 10.86 8.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.192 -0.458 . . . . 71.03 113.426 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.36 -27.74 64.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.223 0.823 . . . . 71.31 113.223 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -158.94 159.65 35.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.972 0.73 . . . . 73.22 112.972 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.483 HG12 HG23 ' A' ' 20' ' ' ILE . 63.8 mt -125.24 117.19 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.695 -0.684 . . . . 63.42 110.722 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 17.1 ttm180 -98.55 132.85 43.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 73.04 112.267 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 6.6 mp -109.65 134.68 51.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.355 -0.384 . . . . 62.12 111.304 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 68' ' ' THR . 24.3 ttmm -103.37 136.08 43.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.882 0.372 . . . . 72.41 111.494 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.95 107.43 15.55 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.424 -0.353 . . . . 74.14 110.833 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.6 p -95.9 17.14 15.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.161 0.505 . . . . 71.35 111.808 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -70.29 159.32 34.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.1 0.476 . . . . 70.2 111.869 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.23 -26.35 58.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.222 -0.444 . . . . 52.43 111.717 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 44.6 tt0 -138.9 166.74 23.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.761 0.315 . . . . 72.04 110.936 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 6.1 m-20 -68.14 117.04 9.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.532 -0.304 . . . . 73.21 111.224 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -133.68 144.16 50.78 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 111.61 0.226 . . . . 72.4 111.61 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 36.4 Cg_exo -60.95 147.5 95.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.677 2.251 . . . . 75.14 112.615 174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.1 tpt -54.82 -50.59 68.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.072 0.463 . . . . 44.31 112.174 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.17 -122.1 5.83 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.02 -0.609 . . . . 65.32 113.293 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 108.87 1.14 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.377 -0.439 . . . . 65.42 113.142 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -135.08 164.87 26.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.641 0.376 . . . . 75.41 110.515 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -150.25 117.02 5.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.125 0.488 . . . . 74.12 111.374 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.459 ' HE1' HD11 ' A' ' 29' ' ' LEU . 38.1 ttm -91.81 117.4 29.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.245 -0.434 . . . . 73.32 111.721 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.59 102.65 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.859 0.361 . . . . 73.14 110.549 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -90.37 120.41 31.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.747 0.308 . . . . 64.01 111.414 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.27 113.86 27.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.409 -0.359 . . . . 53.13 111.035 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.54 137.98 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.572 -0.285 . . . . 74.43 110.86 -176.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' N ' HD13 ' A' ' 48' ' ' ILE . . . 55.35 36.46 63.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.191 -0.528 . . . . 62.41 113.438 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.18 -4.29 1.59 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.829 0.852 . . . . 74.35 113.028 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -103.68 173.45 6.3 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.685 -0.634 . . . . 71.23 111.057 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -139.34 150.46 45.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.34 0.59 . . . . 60.31 112.105 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.58 130.36 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.636 -0.711 . . . . 74.3 110.354 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' MET . 94.0 p -105.43 148.72 26.84 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.328 0.585 . . . . 70.44 112.183 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -128.73 112.08 13.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.945 -0.57 . . . . 75.31 110.476 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.26 125.75 33.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.99 0.424 . . . . 75.33 111.651 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.441 ' HE2' HD11 ' A' ' 71' ' ' ILE . 54.0 m-85 -85.9 168.9 13.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.509 0.671 . . . . 60.01 112.391 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -140.05 157.99 44.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.678 -0.692 . . . . 72.01 111.797 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.7 p -87.62 23.23 2.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.205 -0.452 . . . . 63.12 111.923 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -69.53 -2.18 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.624 0.602 . . . . 73.12 112.624 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -151.29 156.94 41.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.172 0.51 . . . . 72.33 111.7 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 83.2 t -103.6 124.77 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.16 -0.473 . . . . 65.34 111.659 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.8 mm? -84.12 109.85 18.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.008 0.432 . . . . 53.23 111.328 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.75 144.5 32.11 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.372 -0.376 . . . . 64.42 111.145 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.22 119.53 4.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.909 0.385 . . . . 74.13 111.798 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.16 -41.49 2.5 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.184 -0.532 . . . . 64.24 113.218 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.54 140.25 58.54 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.314 -0.521 . . . . 51.5 111.187 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 30' ' ' LYS . 70.1 p -111.49 153.72 25.78 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.726 0.639 . . . . 71.04 112.726 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -114.57 123.24 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.968 -0.56 . . . . 75.4 110.566 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m -94.13 124.61 38.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.186 0.517 . . . . 72.42 111.516 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.441 HD11 ' HE2' ' A' ' 57' ' ' TYR . 41.6 mm -86.21 99.67 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.048 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -84.38 -178.45 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 43.42 110.971 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.37 170.48 7.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.715 -0.221 . . . . 55.33 110.95 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB3' HD22 ' A' ' 92' ' ' ASN . . . -51.62 -33.19 32.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.194 0.442 . . . . 73.52 112.194 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.07 32.48 2.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.455 -0.339 . . . . 62.22 111.563 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.16 -48.55 44.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.913 0.708 . . . . 74.31 112.913 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.17 -33.66 6.23 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.13 -0.557 . . . . 64.4 112.277 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.33 -171.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 122.555 0.342 . . . . 72.14 110.843 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.3 p -69.97 147.33 50.29 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.98 -0.45 . . . . 65.12 111.369 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.91 2.65 3.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.642 0.608 . . . . 53.03 112.642 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -169.68 86.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.073 0.549 . . . . 73.41 110.345 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HB2' ' N ' ' A' ' 84' ' ' THR . 53.5 Cg_exo -53.0 -46.95 30.3 Favored 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.262 2.641 . . . . 74.53 115.972 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.7 Cg_endo -101.73 21.86 17.36 Favored 'Cis proline' 0 C--N 1.363 1.322 0 CA-C-N 121.307 1.503 . . . . 72.11 114.664 2.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.552 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 10.2 t -55.74 -41.44 73.91 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.443 0.535 . . . . 62.22 112.443 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -97.37 164.35 12.5 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.117 0.484 . . . . 72.54 111.29 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.04 126.24 51.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.071 0.462 . . . . 72.23 111.378 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.0 mp -91.84 127.38 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 64.51 110.938 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -69.6 79.35 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.175 0.512 . . . . 70.44 110.183 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -58.29 -22.19 51.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.856 0.687 . . . . 73.14 112.856 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.6 -23.7 58.77 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.706 0.632 . . . . 61.15 112.706 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -146.2 150.06 35.11 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.129 0.788 . . . . 74.31 113.129 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.566 HD22 ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -75.3 -172.22 1.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.628 -0.715 . . . . 71.12 110.616 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -74.98 142.3 43.9 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.864 -0.523 . . . . 61.4 111.214 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -120.47 101.32 7.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.64 0.733 . . . . 74.14 111.821 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.22 135.74 12.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.163 -0.472 . . . . 75.22 112.059 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -170.95 -42.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.863 0.69 . . . . 73.44 112.863 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.51 -15.72 62.68 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.007 -0.616 . . . . 64.23 113.024 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -56.89 131.94 51.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.74 0.305 . . . . 71.15 111.236 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.7 m-20 -60.95 114.5 3.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.295 0.569 . . . . 62.34 112.033 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 48' ' ' ILE . 3.8 p -106.05 136.81 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.727 -0.67 . . . . 72.12 111.41 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -115.85 132.44 56.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.232 0.539 . . . . 74.32 110.524 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.413 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 3.3 p -127.3 141.49 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.309 0.576 . . . . 35.32 112.446 -172.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.1 mm -107.47 140.67 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 60.13 111.618 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.799 HD11 HG13 ' A' ' 17' ' ' ILE . 76.1 mt -110.26 114.89 28.72 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.756 0.312 . . . . 70.04 111.694 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -106.16 140.29 39.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.956 0.408 . . . . 73.52 111.421 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 112' ' ' VAL . 10.6 m120 -87.16 -171.2 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.271 -0.422 . . . . 70.3 111.086 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.9 t -57.91 -36.75 72.9 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.185 0.439 . . . . 52.51 112.185 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -81.72 3.02 27.16 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.116 0.413 . . . . 51.13 112.116 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.61 -1.26 78.46 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.174 -0.536 . . . . 64.1 113.039 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.49 151.25 47.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.884 0.474 . . . . 70.11 111.223 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -101.79 119.27 38.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.881 0.372 . . . . 73.41 111.662 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 106' ' ' ASN . 18.8 m -106.41 -18.71 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.347 0.499 . . . . 52.15 112.347 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -155.04 142.75 19.85 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.575 0.583 . . . . 73.11 112.575 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.62 122.03 11.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.466 -0.788 . . . . 65.12 109.842 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -144.5 156.74 44.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.979 0.419 . . . . 73.02 112.076 -171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.7 p -133.28 175.36 9.47 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.962 0.411 . . . . 52.03 111.607 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 45.8 p -79.17 -176.38 5.1 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.991 0.424 . . . . 65.32 111.391 173.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 120.888 0.375 . . . . 63.3 111.015 177.624 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 121.13 0.49 . . . . 74.41 110.515 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.2 145.22 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.996 -0.547 . . . . 53.35 111.087 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.3 p -132.76 154.66 50.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.989 0.423 . . . . 74.51 111.634 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.63 111.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.321 -0.399 . . . . 55.25 110.796 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.83 -56.33 4.35 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.44 111.835 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.58 123.77 6.38 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.231 0.538 . . . . 74.24 112.39 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.62 HG23 HG12 ' A' ' 27' ' ' ILE . 72.2 mt -89.16 140.33 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.878 -0.601 . . . . 71.13 110.624 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.5 143.07 40.67 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.104 0.478 . . . . 73.11 111.472 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -85.82 -25.86 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.562 0.578 . . . . 73.11 112.562 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.83 -21.13 41.06 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.182 0.515 . . . . 71.0 111.009 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 103.45 20.21 11.3 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.796 -0.638 . . . . 55.01 113.256 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -79.72 -48.58 13.41 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.396 0.517 . . . . 74.32 112.396 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -160.81 173.25 15.65 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.489 0.922 . . . . 63.43 113.489 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 20' ' ' ILE . 57.0 mt -133.85 121.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.469 -0.787 . . . . 64.5 109.794 170.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -101.4 123.58 45.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.744 -0.597 . . . . 63.35 112.19 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -110.72 172.45 6.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.021 -0.536 . . . . 63.23 110.941 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 68' ' ' THR . 7.1 ttpm? -150.61 138.14 19.68 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.007 0.432 . . . . 72.25 111.998 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -78.73 114.52 17.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.144 -0.48 . . . . 51.21 110.919 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -102.76 12.81 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.919 0.39 . . . . 74.14 111.876 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 t -77.57 164.55 25.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.06 0.457 . . . . 53.51 111.426 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -85.91 5.98 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.2 0.444 . . . . 74.53 112.2 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 60.3 tt0 -146.43 159.9 42.79 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.686 0.279 . . . . 73.35 111.354 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 32.1 m-20 -63.85 115.29 4.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.817 0.341 . . . . 71.22 110.409 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.2 mm-40 -105.71 146.19 32.34 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.333 0.494 . . . . 73.51 112.333 -172.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 9.2 Cg_exo -72.8 103.22 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.644 2.23 . . . . 54.2 112.486 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.608 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 tpt -59.88 -28.46 67.57 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 71.33 111.501 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.802 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.18 5.04 15.58 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 114.539 0.576 . . . . 73.12 114.539 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.29 8.78 69.62 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.92 -0.657 . . . . 42.13 113.127 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 23.6 m95 -119.03 170.89 8.66 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.599 0.592 . . . . 74.53 112.599 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -152.42 130.38 11.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 72.51 110.845 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 47.7 ttp -96.82 116.62 29.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 73.15 111.418 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 60.0 mt -105.4 113.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.809 0.338 . . . . 71.33 111.011 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HE ' ' HZ3' ' A' ' 88' ' ' TRP . 54.2 ttm-85 -98.88 118.15 34.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.246 0.461 . . . . 70.51 112.246 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -95.39 106.17 18.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.973 -0.38 . . . . 63.35 109.973 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG23 ' A' ' 100' ' ' VAL . 10.6 tt -116.62 107.23 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.531 0.681 . . . . 71.24 112.699 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.6 -93.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.658 -0.701 . . . . 53.04 114.079 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -107.54 -17.42 14.11 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.287 0.477 . . . . 61.34 112.287 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.8 t -128.21 -172.67 2.75 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.044 0.45 . . . . 73.21 112.093 -175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 p -154.15 146.6 24.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.115 0.483 . . . . 74.24 111.693 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.438 HG13 ' HH2' ' A' ' 88' ' ' TRP . 7.7 p -153.52 145.29 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.06 -0.518 . . . . 64.45 110.404 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.6 p -120.74 168.36 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.296 0.85 . . . . 50.43 113.296 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 29.7 t80 -139.91 110.81 6.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.246 -0.888 . . . . 74.24 110.944 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -79.75 124.27 28.45 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.683 0.278 . . . . 64.54 110.327 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -68.53 105.83 2.36 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.967 0.413 . . . . 73.42 111.619 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t -71.36 121.98 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.231 0.538 . . . . 62.42 111.226 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.802 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 32.9 t -83.1 82.49 8.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.132 0.491 . . . . 74.52 112.247 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.769 ' HD2' ' HG2' ' A' ' 82' ' ' PRO . 11.6 ptp180 -104.6 4.19 32.53 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.829 0.347 . . . . 72.42 111.233 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HE1' HD21 ' A' ' 86' ' ' LEU . 29.8 p90 -163.4 167.33 21.79 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.695 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.55 150.14 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.947 0.404 . . . . 74.21 111.804 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.608 HD22 ' SD ' ' A' ' 39' ' ' MET . 39.3 tp -101.96 102.14 12.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.165 0.507 . . . . 71.15 110.604 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -62.53 162.62 10.09 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.843 0.682 . . . . 75.45 112.843 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.58 122.02 15.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.112 -0.494 . . . . 62.34 111.444 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.92 20.42 76.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.211 -0.518 . . . . 74.01 113.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.441 HE21 ' N ' ' A' ' 68' ' ' THR . 31.1 tp60 -96.45 132.94 41.49 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.94 0.4 . . . . 75.11 111.99 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 30' ' ' LYS . 74.4 p -93.63 145.86 24.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.771 175.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.09 146.14 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.67 0.388 . . . . 62.3 111.29 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.88 129.8 53.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.958 0.355 . . . . 62.42 111.958 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.91 103.69 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.649 0.261 . . . . 75.24 110.944 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.5 m95 -83.45 166.69 18.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.579 -0.282 . . . . 64.13 111.432 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.05 94.31 4.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.815 0.672 . . . . 70.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 47.47 -82.57 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.232 1.197 . . . . 74.21 114.232 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -77.46 36.24 0.19 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.544 0.572 . . . . 73.15 112.544 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.08 -11.77 59.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.771 0.319 . . . . 73.24 111.552 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.24 -42.4 2.56 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.331 -0.462 . . . . 54.52 113.52 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.2 m -55.42 158.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.765 0.654 . . . . 50.21 112.765 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.8 p -68.21 136.45 53.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.083 -0.508 . . . . 63.54 111.597 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -83.0 39.01 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.144 0.424 . . . . 74.42 112.144 -176.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.2 m -130.24 102.95 16.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 112.563 0.579 . . . . 72.1 112.563 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 28.4 Cg_exo -44.5 -164.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.397 0 C-N-CA 124.532 3.488 . . . . 70.23 114.238 168.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 2.4 Cg_endo -84.51 1.42 61.15 Favored 'Cis proline' 0 C--N 1.371 1.714 0 CA-C-N 120.982 1.386 . . . . 64.35 114.153 11.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.0 p -67.15 -71.63 0.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.487 0.551 . . . . 54.24 112.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 5.4 m-20 -121.51 169.38 10.72 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.097 0.475 . . . . 75.13 112.216 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.451 HD21 ' HE1' ' A' ' 61' ' ' TYR . 81.8 mt -115.82 134.69 54.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.375 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 80' ' ' ALA . 2.5 mp -109.14 114.32 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.949 0.404 . . . . 72.21 111.245 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.593 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 15.9 t90 -84.52 110.33 18.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.981 0.42 . . . . 72.14 110.766 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -84.3 -11.48 56.32 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.645 0.98 . . . . 72.14 113.645 -171.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.97 -54.52 9.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.313 0.486 . . . . 73.3 112.313 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.429 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 64.7 tt0 -85.95 123.78 31.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.815 0.341 . . . . 62.2 111.735 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 19.1 m120 -83.17 52.98 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.852 0.316 . . . . 53.15 111.852 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.2 t 66.6 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.323 0.582 . . . . 45.1 112.2 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.547 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 42.3 p90 -106.23 171.78 7.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.484 -0.326 . . . . 72.23 111.117 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.01 105.72 0.28 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.555 -0.831 . . . . 42.04 113.234 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 t -151.68 -50.17 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.329 0.492 . . . . 72.24 112.329 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.55 -29.34 2.38 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.167 -0.54 . . . . 61.44 112.426 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -71.16 144.87 50.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.628 0.251 . . . . 71.11 111.037 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 23.1 m-20 -75.72 104.3 6.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.693 0.627 . . . . 74.43 112.693 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 48' ' ' ILE . 4.3 p -81.53 127.11 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.744 -0.662 . . . . 74.34 110.896 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 36.8 ttpt -97.79 115.84 28.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.331 0.586 . . . . 73.53 111.905 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 135.36 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.904 -0.589 . . . . 75.44 111.462 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 114' ' ' GLN . 27.6 mm -116.52 141.91 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 116.111 -0.495 . . . . 74.11 111.488 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.6 mt -115.35 118.22 32.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.953 0.406 . . . . 63.44 111.79 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 111' ' ' GLU . 57.9 mttp -125.32 160.22 29.83 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.313 -0.403 . . . . 73.05 110.951 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 17.1 m120 -99.18 -178.65 3.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 73.45 111.826 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -50.63 -43.36 56.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.16 0.8 . . . . 74.12 113.16 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.47 1.48 13.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.411 0.522 . . . . 73.42 112.411 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.44 84.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.235 -0.507 . . . . 52.5 113.094 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 7.3 pt-20 -78.76 137.94 37.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.922 0.391 . . . . 64.24 111.059 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 38.8 tt0 -102.0 137.12 40.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.853 0.316 . . . . 73.31 111.853 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 113' ' ' ALA . 27.1 m -127.89 -47.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 113.008 0.744 . . . . 71.31 113.008 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -132.19 156.19 46.88 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.169 0.433 . . . . 73.34 112.169 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 103' ' ' ILE . 3.3 pt20 -175.4 150.18 1.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.331 -0.395 . . . . 64.31 111.408 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 116' ' ' SER . 35.7 ttp180 -173.52 159.32 3.61 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.897 0.379 . . . . 55.02 111.52 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.3 p -86.71 -169.35 2.59 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.135 0.493 . . . . 62.42 111.029 172.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 31.7 p -87.85 -167.91 2.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.976 0.417 . . . . 60.21 111.51 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.064 0.459 . . . . 74.31 111.377 -179.524 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 32' ' ' THR . 17.2 m-80 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.657 0.614 . . . . 73.12 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.88 130.76 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 75.55 112.031 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -129.15 177.37 7.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.132 -0.485 . . . . 33.32 110.637 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.88 127.55 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 122.007 -0.433 . . . . 61.43 110.721 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.71 -51.45 3.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.37 0.508 . . . . 61.52 112.37 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -147.86 138.1 22.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.075 0.464 . . . . 71.21 112.062 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 27' ' ' ILE . 53.3 mt -132.9 139.93 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.256 -0.429 . . . . 70.1 111.054 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -85.59 126.22 33.72 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.03 0.443 . . . . 63.33 110.925 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.36 -26.4 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.241 0.46 . . . . 73.42 112.241 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.12 -37.1 80.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.872 0.368 . . . . 70.24 111.688 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 119.58 57.86 0.25 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.262 -0.494 . . . . 71.25 113.472 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -129.81 -57.49 1.11 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.49 0.552 . . . . 74.35 112.49 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.76 161.8 38.35 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.477 0.917 . . . . 75.12 113.477 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 20' ' ' ILE . 63.6 mt -128.49 160.92 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 114.873 -1.058 . . . . 72.14 108.634 173.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 28' ' ' ARG . 38.2 ttp-105 -147.2 122.1 10.0 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.251 -0.906 . . . . 70.45 112.554 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -97.08 172.68 7.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.742 -0.663 . . . . 74.42 110.507 175.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HG3' HG22 ' A' ' 68' ' ' THR . 74.4 tttt -142.59 121.06 12.43 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.834 0.349 . . . . 73.21 111.213 -175.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -82.01 86.27 6.59 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.238 0.542 . . . . 41.31 111.272 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 14' ' ' ASN . 71.8 p -83.65 87.72 7.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.227 -0.442 . . . . 62.52 110.293 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.5 t -131.46 164.19 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.108 0.781 . . . . 43.01 113.108 -168.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -81.14 -26.62 35.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.945 -1.025 . . . . 72.13 110.647 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -140.35 162.4 35.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.644 -0.707 . . . . 74.5 110.488 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -68.98 109.82 4.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.862 0.363 . . . . 65.23 110.182 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.02 138.6 19.59 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.682 0.623 . . . . 72.42 112.682 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 84.3 Cg_endo -75.94 46.51 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.87 2.38 . . . . 75.24 113.348 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' MET . 6.4 tpt 63.11 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.87 0.468 . . . . 44.52 112.179 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.48 172.55 23.92 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.491 -0.385 . . . . 74.2 113.467 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.91 78.88 1.64 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.984 -0.627 . . . . 61.22 113.386 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -99.38 142.45 30.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.661 -0.317 . . . . 73.25 111.597 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -115.57 115.14 25.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.345 . . . . 73.22 110.478 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.47 ' HE1' HG21 ' A' ' 71' ' ' ILE . 44.9 ttp -99.44 105.91 17.9 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.89 0.33 . . . . 74.31 111.89 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.655 HG13 ' HB3' ' A' ' 54' ' ' SER . 3.5 mp -91.08 118.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.56 -0.291 . . . . 63.34 111.313 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' A' ' 88' ' ' TRP . 55.0 ttp180 -94.35 93.79 7.91 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.06 0.457 . . . . 70.41 111.209 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.4 84.42 5.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.484 0.659 . . . . 61.34 111.456 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 96' ' ' THR . 16.5 tt -78.8 -14.57 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.606 -0.724 . . . . 71.3 110.787 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.03 -152.84 10.2 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.583 -0.735 . . . . 62.32 111.828 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.13 82.35 5.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.381 0.61 . . . . 73.32 109.963 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -167.18 -179.3 4.5 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.501 -0.772 . . . . 64.04 110.76 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.3 p -142.13 105.93 4.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.046 0.451 . . . . 74.45 111.605 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.477 HG21 ' NE2' ' A' ' 91' ' ' GLN . 7.1 p -138.2 137.68 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.221 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' HG13 ' A' ' 45' ' ' ILE . 81.2 p -145.94 161.27 40.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.01 0.744 . . . . 75.11 113.01 -174.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -126.77 126.64 43.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.181 -0.918 . . . . 74.55 109.785 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.15 141.21 28.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.055 0.455 . . . . 75.14 111.577 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -83.81 -178.6 7.05 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.995 -0.548 . . . . 72.44 111.631 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -144.35 149.76 36.69 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.161 0.43 . . . . 41.53 112.161 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 t -91.91 16.25 11.39 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.114 -0.494 . . . . 73.21 111.762 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 12.0 ptm180 -72.8 2.18 7.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.777 0.658 . . . . 72.34 112.777 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 51.4 p90 -148.6 164.5 34.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 74.55 111.328 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 61.4 t -112.77 119.16 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.907 0.384 . . . . 72.14 111.315 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.92 116.79 29.16 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.965 0.412 . . . . 64.43 110.19 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -58.44 153.58 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.687 0.625 . . . . 74.21 112.687 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.51 133.16 46.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.415 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.43 18.35 79.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.165 -0.54 . . . . 72.11 113.074 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.88 147.13 37.67 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.668 -0.313 . . . . 54.12 110.778 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 30' ' ' LYS . 43.1 p -95.8 171.4 8.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.354 0.597 . . . . 71.41 112.119 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.02 122.76 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.038 -0.528 . . . . 64.13 110.656 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.5 m -94.85 124.57 38.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.493 0.553 . . . . 73.11 112.493 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.0 mm -94.88 136.38 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.83 -0.623 . . . . 54.11 110.492 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 90.4 m95 -117.24 179.36 4.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.907 0.384 . . . . 54.13 111.936 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -84.36 156.37 21.89 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.654 -0.248 . . . . 64.4 111.42 176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.67 -46.0 1.77 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.368 0.877 . . . . 70.03 113.368 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -129.28 74.39 1.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.129 0.49 . . . . 61.41 110.599 174.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.02 -3.48 54.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 52.3 112.105 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -41.68 2.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.367 -0.444 . . . . 75.41 113.086 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.05 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.034 0.445 . . . . 74.03 112.009 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.3 p -63.35 139.56 58.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 54.22 112.031 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.47 70.29 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.833 0.679 . . . . 62.23 112.833 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.1 p -139.57 98.68 7.94 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.999 0.428 . . . . 64.11 111.703 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.57 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 74.9 Cg_exo -52.79 -43.03 59.23 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.003 2.469 . . . . 72.52 115.324 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 77.4 Cg_endo -99.27 109.91 0.41 Allowed 'Cis proline' 0 C--N 1.368 1.597 0 CA-C-N 121.301 1.5 . . . . 74.1 113.738 -2.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.44 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 53.1 p -139.08 -66.0 0.48 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.258 0.623 . . . . 72.33 109.505 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 3.9 m-20 -73.11 130.82 41.14 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.836 -0.62 . . . . 74.23 109.739 167.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 71' ' ' ILE . 87.7 mt -100.26 108.38 20.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.15 0.5 . . . . 61.52 111.918 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.7 mp -77.04 131.1 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.004 0.431 . . . . 62.23 111.183 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 46' ' ' ARG . 2.0 t90 -70.91 77.06 0.64 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.437 0.636 . . . . 75.55 110.214 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 7.6 mtpm? -68.57 -2.11 8.21 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.07 0.767 . . . . 75.01 113.07 -175.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.96 -12.78 20.34 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.487 0.551 . . . . 70.12 112.487 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.477 ' NE2' HG21 ' A' ' 53' ' ' VAL . 36.1 tt0 -164.54 143.32 7.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.041 0.448 . . . . 73.15 111.363 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -75.24 -164.22 0.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.724 0.773 . . . . 72.51 112.971 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -62.37 178.38 0.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.92 -1.037 . . . . 73.22 112.797 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.57 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.1 p90 -141.8 167.76 21.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.715 -0.675 . . . . 75.14 110.443 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.15 66.35 0.02 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.552 -0.832 . . . . 54.02 113.702 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 48' ' ' ILE . 47.0 p -78.78 -65.93 0.93 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.964 0.412 . . . . 53.21 111.445 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.03 -32.22 1.69 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.169 -0.468 . . . . 74.45 113.094 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.43 -63.38 1.09 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.477 0.547 . . . . 73.34 112.477 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -177.43 158.77 1.46 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.715 0.293 . . . . 62.32 110.686 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.31 89.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.846 0.831 . . . . 70.43 110.351 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.6 tttt -91.31 126.61 36.45 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.641 -0.709 . . . . 74.13 111.783 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.6 t -118.74 136.56 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.041 0.448 . . . . 72.41 111.657 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 101' ' ' LYS . 45.7 mm -122.34 138.88 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.054 -0.521 . . . . 52.42 111.039 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 113' ' ' ALA . 78.4 mt -110.63 113.99 27.03 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.253 0.464 . . . . 74.5 112.253 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -108.16 156.18 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.097 0.475 . . . . 62.22 110.623 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.7 m120 -99.21 179.07 4.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.051 0.453 . . . . 74.04 111.68 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.7 t -46.96 -40.68 14.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.42 0.896 . . . . 72.21 113.42 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.83 14.77 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.666 0.617 . . . . 70.01 112.666 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.55 -21.56 10.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.334 -0.46 . . . . 64.03 112.881 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 10.7 pt-20 -52.6 125.38 16.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.259 0.624 . . . . 62.55 111.937 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.88 136.81 35.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.796 -0.638 . . . . 74.15 111.436 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 ' H ' ' A' ' 113' ' ' ALA . 12.7 m -125.08 -60.83 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.104 0.779 . . . . 75.34 113.104 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -105.07 154.45 20.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.38 0.511 . . . . 75.05 112.38 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.73 154.96 33.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.989 -0.551 . . . . 72.33 111.287 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.9 ttm180 -166.58 123.86 1.32 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.366 0.876 . . . . 64.42 113.366 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -105.18 129.85 53.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.688 -0.856 . . . . 73.12 108.688 164.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.2 p -68.45 -94.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.903 0.705 . . . . 70.13 112.903 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.296 0.569 . . . . 65.13 111.301 -178.147 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.587 0.708 . . . . 72.43 109.896 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.27 90.93 1.46 Allowed Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.866 -0.606 . . . . 64.33 114.537 -171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -100.41 18.33 19.25 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.96 0.409 . . . . 64.32 111.252 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.11 148.5 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.268 -0.423 . . . . 72.33 110.672 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -85.75 157.82 20.18 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.944 0.402 . . . . 74.21 111.686 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -106.02 163.59 12.65 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.692 0.282 . . . . 73.34 111.428 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -166.43 116.88 0.96 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.783 0.325 . . . . 63.23 110.612 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -83.68 111.78 19.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.844 0.354 . . . . 75.3 111.823 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.3 m -156.05 146.68 21.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.255 -0.429 . . . . 45.01 110.788 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -82.21 84.63 7.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.604 0.24 . . . . 73.24 111.358 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mmt -74.75 73.5 2.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.595 0.712 . . . . 73.43 110.734 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.482 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 8.9 t -162.73 170.98 17.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.497 -0.774 . . . . 70.03 111.285 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 168.26 41.0 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.596 -0.812 . . . . 72.33 113.699 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 0.2 OUTLIER -83.84 67.27 9.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.264 0.554 . . . . 53.32 110.085 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 9.0 p -98.73 135.28 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.376 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.47 145.51 51.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.202 -0.454 . . . . 64.32 110.88 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' A' ' 102' ' ' VAL . 57.2 mt -72.65 99.29 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.595 -0.275 . . . . 73.43 110.629 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -62.09 -56.97 13.53 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.068 0.461 . . . . 74.32 111.271 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -164.87 143.66 6.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 73.5 111.565 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.443 HG21 HG11 ' A' ' 100' ' ' VAL . 55.7 mt -102.11 138.89 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.938 -0.393 . . . . 63.14 109.938 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.57 135.56 56.67 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.306 0.484 . . . . 70.14 112.306 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.77 -26.0 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.616 0.598 . . . . 74.3 112.616 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 13.7 t70 -85.01 -25.33 27.76 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.279 0.561 . . . . 62.35 110.326 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.52 30.78 6.38 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.149 -0.478 . . . . 40.04 112.943 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -90.37 -45.54 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.405 0.52 . . . . 74.41 112.405 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.46 161.36 38.24 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.648 0.981 . . . . 74.11 113.648 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -117.41 123.73 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 71.13 109.923 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -103.98 109.95 21.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.423 0.63 . . . . 75.4 112.637 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 mp -89.74 156.16 18.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.482 -0.781 . . . . 75.22 110.224 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 68' ' ' THR . 81.7 tttt -143.25 110.96 5.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.146 -0.346 . . . . 61.0 111.881 -173.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 9.4 t30 -87.02 106.12 17.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.026 0.441 . . . . 64.02 111.579 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -109.36 40.84 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.396 0.617 . . . . 72.23 111.406 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 80.7 p -83.33 176.54 9.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.451 0.643 . . . . 62.3 112.591 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.68 -7.45 54.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.766 -0.652 . . . . 65.54 111.933 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -149.4 156.45 42.06 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.841 0.353 . . . . 73.3 111.316 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.1 110.71 1.92 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.97 0.414 . . . . 63.05 111.244 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.37 128.93 40.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.544 0.572 . . . . 60.24 112.544 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.38 119.3 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.415 2.076 . . . . 74.42 112.716 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.2 tpp -62.39 -53.11 59.75 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.007 0.432 . . . . 74.44 112.041 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.78 -82.13 0.85 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.736 -0.745 . . . . 75.23 112.973 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.97 59.48 0.11 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.732 -0.747 . . . . 52.02 113.65 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.482 ' HE1' ' HA ' ' A' ' 12' ' ' THR . 11.4 m0 -62.27 170.12 2.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.299 0.571 . . . . 74.42 112.245 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.56 114.06 15.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.182 0.515 . . . . 75.4 110.801 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -95.51 113.19 24.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.044 -0.525 . . . . 75.2 111.184 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 2.1 mp -90.44 109.82 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.749 0.309 . . . . 42.31 110.642 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.01 104.45 16.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.116 0.484 . . . . 75.23 111.559 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 100' ' ' VAL . 24.3 mtpp -92.73 166.14 12.6 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.283 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 49' ' ' GLY . 10.2 tt -164.51 -53.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.384 0.513 . . . . 64.14 112.384 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 48' ' ' ILE . . . -174.43 128.16 1.41 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.175 -0.536 . . . . 51.53 112.337 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 69.07 -69.24 0.16 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.156 0.582 . . . . 74.2 111.995 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -115.96 -174.04 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.733 0.301 . . . . 62.32 111.294 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.5 p -163.6 157.01 18.93 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.878 0.37 . . . . 70.23 111.722 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.782 HG11 ' HG3' ' A' ' 91' ' ' GLN . 7.3 p -138.38 147.17 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.172 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.619 ' HB3' HG13 ' A' ' 45' ' ' ILE . 89.2 p -112.86 161.75 16.6 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.088 0.471 . . . . 71.33 111.969 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.48 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 68.6 t80 -136.46 130.1 32.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.285 -0.416 . . . . 74.25 111.446 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -96.9 144.67 26.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.151 0.5 . . . . 71.34 111.509 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -93.55 179.85 5.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.166 0.507 . . . . 71.01 111.979 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -138.42 155.76 48.19 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.061 -0.518 . . . . 70.14 111.431 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 m -82.38 87.6 6.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.459 -0.337 . . . . 73.15 111.538 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 83' ' ' PRO . 8.9 ptm180 -141.75 7.49 1.88 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.322 0.49 . . . . 71.34 112.322 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -163.9 148.03 10.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.968 0.413 . . . . 62.55 111.643 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.44 131.17 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.224 -0.444 . . . . 33.01 110.86 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.3 106.54 10.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.055 0.455 . . . . 70.13 111.636 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.89 164.74 26.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.173 0.511 . . . . 63.24 111.531 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.4 113.05 3.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.851 0.358 . . . . 61.03 111.11 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.82 8.57 61.88 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.424 -0.417 . . . . 62.04 113.04 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -86.11 122.49 30.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.181 0.515 . . . . 72.44 111.866 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 30' ' ' LYS . 81.3 p -93.35 150.76 20.23 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.307 -0.406 . . . . 73.34 111.299 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 29' ' ' LEU . 7.7 p -135.87 124.39 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.283 0.563 . . . . 65.21 110.945 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 29.4 m -103.82 127.69 51.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.088 -0.505 . . . . 72.4 111.778 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mm -99.38 99.74 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.776 0.322 . . . . 73.03 111.098 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 80.1 m95 -83.58 119.77 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.502 -0.317 . . . . 62.53 111.208 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -74.65 82.23 2.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.587 0.588 . . . . 74.54 112.587 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 60.66 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.605 0.965 . . . . 74.14 113.605 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -71.39 90.18 0.95 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.194 0.521 . . . . 42.04 111.269 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -133.03 -39.94 0.94 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.658 0.614 . . . . 61.11 112.658 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.7 -29.74 6.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.193 -0.527 . . . . 51.04 112.589 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 79' ' ' THR . 43.8 t -66.67 159.34 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 122.799 0.44 . . . . 73.13 111.223 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 78' ' ' VAL . 53.8 m -52.26 129.56 28.37 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.853 0.359 . . . . 74.44 111.834 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.55 111.05 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.315 0.487 . . . . 71.34 112.315 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.514 ' H ' HD13 ' A' ' 87' ' ' ILE . 67.4 m 67.25 71.45 0.43 Allowed Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 113.429 0.9 . . . . 61.3 113.429 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.823 ' HB3' HG22 ' A' ' 84' ' ' THR . 86.2 Cg_exo -51.1 167.16 0.33 Allowed 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.741 2.961 . . . . 70.4 111.788 168.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD2' ' NH2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 13.41 60.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 N-CA-C 122.017 3.814 . . . . 52.43 122.017 38.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.823 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.3 t 153.68 -52.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.885 1.674 . . . . 74.35 109.985 161.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.66 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 17.9 m-20 -136.27 -161.45 1.16 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.474 0.71 . . . . 63.22 109.353 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.1 mt -142.09 144.16 33.41 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.734 -0.604 . . . . 50.0 112.077 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 81' ' ' SER . 1.8 mp -106.55 123.96 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.066 0.46 . . . . 72.03 111.029 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 73' ' ' ALA . 3.7 t90 -69.14 91.04 0.49 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.425 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -80.56 20.41 0.72 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.792 0.664 . . . . 72.02 112.792 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.8 m120 -128.91 -0.06 5.33 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.008 -0.433 . . . . 74.21 112.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.782 ' HG3' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -161.11 127.47 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.74 0.305 . . . . 75.33 110.492 -172.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.678 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 2.8 m-20 -87.34 172.78 9.59 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.982 0.734 . . . . 64.25 112.982 -173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 t -47.27 125.78 8.46 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.103 -0.498 . . . . 64.05 111.419 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CD1' HD12 ' A' ' 48' ' ' ILE . 48.6 p90 -92.7 -30.98 15.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.531 0.567 . . . . 75.32 112.531 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 73.31 102.49 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.768 -0.73 . . . . 72.41 112.072 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.4 t -79.83 28.34 0.28 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.183 0.808 . . . . 60.21 113.183 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.84 -39.48 62.15 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.87 -0.892 . . . . 55.22 110.87 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -87.63 123.97 33.04 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.487 -0.56 . . . . 73.14 109.487 166.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -52.63 101.63 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.375 0.607 . . . . 73.44 112.536 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 20' ' ' ILE . 7.4 p -71.96 140.38 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.475 -0.784 . . . . 62.51 111.657 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -124.92 117.16 23.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.925 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 17' ' ' ILE . 60.4 t -99.83 123.69 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.111 0.481 . . . . 74.51 112.049 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.693 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 25.1 mm -105.29 116.89 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.037 -0.529 . . . . 70.35 110.95 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.79 107.8 19.81 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.877 0.37 . . . . 53.41 111.847 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.42 139.32 49.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.904 0.383 . . . . 73.34 111.147 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.3 m120 -63.81 174.53 1.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.297 0.57 . . . . 72.51 112.236 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 m -56.87 -28.02 61.22 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.695 -0.684 . . . . 72.42 112.382 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.53 21.41 14.35 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.934 0.716 . . . . 73.23 112.934 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.88 5.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.949 -0.643 . . . . 43.41 114.552 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.9 pt-20 -53.9 150.47 7.65 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.067 0.433 . . . . 74.35 111.348 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.51 136.11 48.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.129 0.789 . . . . 75.13 113.129 -169.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.28 -55.23 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.131 -0.486 . . . . 63.31 111.722 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.19 170.26 21.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 74.33 112.162 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -152.83 134.54 14.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.891 -0.595 . . . . 71.4 111.149 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -144.92 150.58 37.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.796 0.331 . . . . 74.25 111.428 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.6 p -126.49 -178.84 4.5 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 73.44 111.576 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.5 p -80.01 -176.41 5.49 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.223 0.535 . . . . 32.31 111.649 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.67 134.11 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.112 -0.495 . . . . 71.3 110.954 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -64.19 91.65 0.07 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.025 0.441 . . . . 75.02 111.728 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -141.08 151.97 44.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.927 0.394 . . . . 72.13 111.167 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -69.25 170.7 9.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.236 -0.438 . . . . 62.54 111.512 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.252 1.23 0 CA-C-N 116.398 -0.364 . . . . 72.11 111.898 -178.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.57 0.224 . . . . 53.31 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.4 99.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.105 -0.569 . . . . 41.22 112.893 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -62.68 -9.35 8.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.893 0.701 . . . . 71.31 112.893 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -57.63 119.98 7.53 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.934 0.397 . . . . 64.22 110.887 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -97.44 128.51 44.28 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.511 0.56 . . . . 72.4 112.511 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -78.67 114.99 18.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.989 -0.551 . . . . 71.02 111.237 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -98.97 134.14 42.24 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.582 0.23 . . . . 70.24 111.486 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -57.52 90.68 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.293 0.568 . . . . 51.31 111.458 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.5 p -126.72 -169.68 2.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.275 -0.421 . . . . 75.25 111.672 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -96.74 123.37 40.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.429 . . . . 61.1 111.283 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.503 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 26.3 mmt -83.26 112.59 20.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.065 0.46 . . . . 72.12 110.965 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 p -90.03 10.22 24.99 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.976 0.732 . . . . 72.03 112.976 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.77 88.55 0.46 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.226 -0.511 . . . . 72.55 113.545 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -68.16 81.0 0.23 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.972 0.415 . . . . 72.54 111.466 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 29' ' ' LEU . 39.7 t -98.89 109.57 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.057 0.456 . . . . 64.44 111.888 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 52.8 t -107.63 173.18 6.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.42 -0.355 . . . . 63.14 110.663 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 62.4 mt -88.97 119.79 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.951 -0.468 . . . . 63.12 111.766 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.54 -48.43 22.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.85 0.357 . . . . 75.4 110.537 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.47 153.36 28.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.119 0.414 . . . . 71.42 112.119 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.452 HG23 HG12 ' A' ' 27' ' ' ILE . 47.0 mt -119.94 126.15 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.427 -0.351 . . . . 71.41 110.193 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.86 143.91 54.4 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.739 0.644 . . . . 64.5 112.739 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.57 -19.15 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.778 -0.646 . . . . 61.54 111.339 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.65 -39.03 92.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.096 0.474 . . . . 70.41 110.409 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.97 23.82 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.911 -0.586 . . . . 63.11 113.371 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -112.53 -63.07 1.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.391 0.885 . . . . 72.23 113.391 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.5 154.02 37.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.725 1.38 . . . . 60.23 114.725 -166.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 102' ' ' VAL . 65.6 mt -123.51 110.72 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.166 -0.924 . . . . 73.52 109.381 171.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 36.1 ttm180 -92.06 116.63 29.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.119 0.785 . . . . 75.54 113.119 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 7.7 mp -96.59 179.94 4.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.011 -0.541 . . . . 74.23 111.163 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -165.1 123.14 1.63 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.647 0.26 . . . . 75.21 111.423 -171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . 32.6 t30 -74.07 95.37 2.53 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.013 0.435 . . . . 75.44 111.402 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 p -82.32 87.74 6.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.226 0.536 . . . . 74.01 111.317 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.7 p -155.67 175.48 13.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.086 -0.506 . . . . 62.13 111.249 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.71 3.87 37.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.396 0.517 . . . . 51.44 112.396 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 52.9 tt0 -149.42 153.58 37.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.651 0.263 . . . . 63.25 111.482 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.81 117.25 4.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.904 0.383 . . . . 72.4 110.998 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 35' ' ' GLN . 24.7 mm-40 -115.7 164.07 18.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 122.311 -0.243 . . . . 71.22 111.477 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.0 144.86 27.54 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.19 1.926 . . . . 74.12 111.152 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.1 tpt -52.42 -56.82 12.46 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.722 0.296 . . . . 74.43 111.651 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 11' ' ' MET . . . 105.08 148.51 17.79 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.925 -0.655 . . . . 73.0 114.064 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.69 58.88 4.97 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.397 -0.43 . . . . 72.0 112.915 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.79 169.45 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.708 0.29 . . . . 72.54 110.761 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.57 124.3 21.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.261 0.553 . . . . 75.13 111.433 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' SER . 55.6 ttp -93.13 108.25 19.88 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.751 -0.659 . . . . 72.32 111.387 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -97.18 115.54 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.706 0.288 . . . . 73.23 110.758 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -84.35 97.19 9.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.781 0.324 . . . . 64.43 111.223 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -94.69 131.82 40.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.236 0.541 . . . . 62.53 111.677 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 48' ' ' ILE . 15.2 tt -150.22 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.708 0.765 . . . . 73.01 111.079 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.67 -61.67 0.55 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.036 -0.529 . . . . 64.1 113.562 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -82.57 -66.43 0.89 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.398 -0.472 . . . . 73.31 112.232 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 t -95.86 173.43 7.45 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.132 0.491 . . . . 65.54 112.185 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -145.37 33.03 1.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.003 -0.544 . . . . 70.34 111.371 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.93 127.72 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.295 0.569 . . . . 70.23 111.998 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' MET . 82.8 p -114.54 177.7 4.55 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.489 0.662 . . . . 63.41 112.772 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.518 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 69.6 t80 -152.99 108.39 3.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.492 -0.776 . . . . 64.31 111.193 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -78.83 121.17 24.47 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.803 -0.443 . . . . 63.34 109.803 173.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.09 124.46 23.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.893 0.701 . . . . 73.32 112.893 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -72.27 85.23 1.07 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.478 0.656 . . . . 53.32 111.454 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.9 t -71.93 72.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.374 0.607 . . . . 52.51 111.217 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 16.4 ptt180 -102.68 5.19 38.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.799 -0.637 . . . . 71.33 112.152 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 51.3 p90 -158.37 165.53 34.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.886 0.374 . . . . 74.35 111.529 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.58 143.35 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.069 0.462 . . . . 53.13 111.792 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 31' ' ' ASN . 18.9 tp -108.95 124.38 50.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.125 0.488 . . . . 64.23 111.06 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.93 164.89 16.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.639 0.607 . . . . 73.11 112.639 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.82 124.46 24.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.188 -0.46 . . . . 64.23 111.421 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.94 7.34 83.9 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.31 -0.471 . . . . 61.33 113.152 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.47 132.74 45.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.999 0.428 . . . . 75.03 111.585 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.1 p -92.93 99.56 12.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.087 -0.506 . . . . 52.32 111.919 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.11 113.64 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.353 0.596 . . . . 64.34 110.639 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 21.0 m -99.86 131.81 45.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.963 0.411 . . . . 53.45 112.002 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.2 mm -93.2 99.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.111 -0.495 . . . . 71.11 111.051 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.482 ' HB2' HG13 ' A' ' 87' ' ' ILE . 65.1 m95 -90.1 120.43 31.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.466 -0.334 . . . . 71.2 111.098 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -55.33 153.75 6.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.974 0.361 . . . . 70.0 111.974 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.33 -42.56 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.969 0.729 . . . . 75.32 112.969 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -93.71 43.18 1.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.101 0.477 . . . . 70.22 111.952 -178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.81 -4.38 43.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.793 0.33 . . . . 72.13 111.694 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.02 -49.94 3.85 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.34 -0.457 . . . . 62.13 113.541 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.01 146.39 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 122.646 0.378 . . . . 74.22 111.999 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 81' ' ' SER . 92.3 m -54.63 132.19 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.813 0.339 . . . . 72.44 111.641 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.16 -25.04 20.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.38 0.881 . . . . 62.1 113.38 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.555 ' H ' HG22 ' A' ' 79' ' ' THR . 9.3 t -132.72 82.81 55.11 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 120.859 0.361 . . . . 52.32 110.892 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 52.7 Cg_exo -53.36 -47.65 26.25 Favored 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 123.372 2.715 . . . . 73.44 115.283 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 43.0 Cg_endo -103.31 25.77 12.26 Favored 'Cis proline' 0 C--N 1.364 1.391 0 CA-C-N 120.974 1.384 . . . . 70.23 114.501 -0.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.498 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 8.8 t -56.74 -34.28 67.37 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.905 0.383 . . . . 73.44 111.743 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -113.35 173.0 6.62 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.363 -0.381 . . . . 72.01 110.33 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 98.3 mt -122.4 126.36 47.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.368 . . . . 65.33 111.236 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 72' ' ' TRP . 1.7 mp -91.95 124.92 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.479 0.657 . . . . 71.13 112.042 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.518 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 7.9 t90 -74.56 80.44 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.692 -0.685 . . . . 72.4 110.573 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -67.14 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.979 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.479 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.9 m120 -74.11 -12.02 60.48 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -148.52 140.29 23.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.12 0.486 . . . . 64.54 111.697 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.554 HD22 ' N ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -80.66 -171.48 3.13 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.578 -0.283 . . . . 74.22 110.919 174.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 75' ' ' ASN . 94.9 p -73.48 129.53 38.18 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.002 -0.436 . . . . 72.54 110.687 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -90.65 142.29 27.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.258 0.551 . . . . 73.11 112.194 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.03 23.86 24.48 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.095 -0.502 . . . . 62.42 112.654 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.0 p -79.4 127.98 32.78 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.223 0.453 . . . . 61.12 112.223 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.3 -10.15 66.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.431 -0.414 . . . . 71.53 113.33 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.64 156.07 39.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.799 0.333 . . . . 74.53 111.309 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 7.6 p-10 -67.92 89.18 0.28 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.54 0.686 . . . . 62.12 111.198 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.17 117.56 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.918 -0.583 . . . . 71.1 110.812 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.553 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 3.2 ttmp? -103.51 99.1 8.91 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.463 0.649 . . . . 72.15 110.925 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 27' ' ' ILE . 80.0 t -82.09 132.88 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.376 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' A' ' 105' ' ' LYS . 38.0 mm -112.42 133.67 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.123 -0.489 . . . . 74.43 111.514 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 HG13 ' A' ' 17' ' ' ILE . 87.5 mt -112.5 110.12 20.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.692 0.282 . . . . 74.32 111.058 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 103' ' ' ILE . 66.8 mttm -120.36 159.32 25.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 70.22 112.308 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 1.4 m-20 -95.71 -179.27 4.67 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.546 -0.752 . . . . 65.44 111.996 -176.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -61.13 -19.54 61.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.869 -0.605 . . . . 63.14 112.336 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -102.83 17.09 24.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.214 0.45 . . . . 73.41 112.214 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.79 -19.03 5.36 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.117 -0.563 . . . . 60.33 113.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 15.0 pt-20 -58.68 159.43 6.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.575 0.35 . . . . 61.12 111.162 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 105' ' ' LYS . 35.4 tt0 -121.91 127.43 50.42 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.437 0.532 . . . . 74.14 112.437 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -33.81 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.297 0.481 . . . . 54.2 112.297 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -160.18 149.73 17.79 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.753 0.649 . . . . 44.0 112.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -146.89 141.29 26.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.67 -0.695 . . . . 74.23 110.19 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 115' ' ' ARG . 31.4 ttt180 -154.67 156.71 36.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.019 -0.426 . . . . 54.32 112.038 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 83.9 p -125.63 170.13 11.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.913 0.387 . . . . 64.54 111.516 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 39.9 p -72.72 159.22 34.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.222 0.534 . . . . 44.24 111.896 176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -76.8 89.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.306 0.574 . . . . 73.42 111.001 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -69.83 -25.25 63.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.959 -0.564 . . . . 75.33 111.407 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.699 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 0.5 OUTLIER -101.9 96.38 7.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 60.12 111.34 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.0 p -80.61 154.56 27.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.193 -0.458 . . . . 70.52 111.485 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.253 1.289 0 CA-C-N 116.302 -0.408 . . . . 63.51 112.033 -179.435 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.378 0.132 . . . . 72.54 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.11 77.95 0.06 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.399 -0.905 . . . . 51.43 114.394 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -146.85 101.65 3.46 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.236 -0.567 . . . . 74.44 110.95 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -97.87 14.16 28.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.86 0.689 . . . . 70.13 112.86 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.9 t60 62.26 21.18 12.31 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.395 0.517 . . . . 72.43 112.395 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.26 -174.17 5.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.886 -0.509 . . . . 61.53 112.029 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.4 t60 74.87 26.46 1.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.488 0.715 . . . . 73.4 111.847 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -64.2 148.66 49.56 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.99 -0.55 . . . . 72.24 111.519 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 t -63.44 177.15 0.71 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.51 0.559 . . . . 73.01 112.51 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -111.56 142.92 43.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.507 . . . . 75.21 111.787 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.559 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 25.7 mmt -84.77 108.99 17.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.237 -0.438 . . . . 64.12 111.963 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 t -76.83 -31.53 56.95 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.501 0.556 . . . . 43.12 112.501 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.52 -169.53 17.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.98 -0.629 . . . . 62.54 113.818 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.85 108.73 2.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 64.15 110.757 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 29' ' ' LEU . 57.4 t -127.99 133.03 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.743 0.306 . . . . 73.23 111.201 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.07 159.13 40.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.8 0.333 . . . . 51.13 111.591 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.611 HG13 HD11 ' A' ' 104' ' ' LEU . 71.7 mt -82.29 116.99 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.926 0.393 . . . . 62.32 111.75 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -80.61 -50.23 10.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.019 0.437 . . . . 73.54 111.305 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -161.92 151.91 16.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.202 0.525 . . . . 52.52 111.451 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 117' ' ' THR . 59.6 mt -115.47 149.22 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.579 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.86 144.51 44.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.067 0.461 . . . . 70.03 112.119 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -32.19 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.18 -0.464 . . . . 44.35 112.027 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.8 -47.3 13.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.98 0.419 . . . . 73.14 110.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.4 23.24 1.4 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.03 -0.532 . . . . 55.23 113.487 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -90.31 -27.89 19.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.453 0.909 . . . . 74.44 113.453 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -151.8 160.31 43.61 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.694 0.998 . . . . 74.45 113.694 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.685 HG23 HG12 ' A' ' 20' ' ' ILE . 70.0 mt -125.98 120.76 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.469 -0.787 . . . . 72.01 110.366 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -93.38 114.38 26.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.845 0.683 . . . . 71.03 112.845 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -100.92 165.21 11.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.268 172.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -151.41 139.59 20.23 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.066 0.46 . . . . 75.32 112.093 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 29.7 t30 -88.12 145.53 25.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.919 -0.582 . . . . 60.32 110.88 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -119.33 8.24 11.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.462 0.541 . . . . 63.23 112.462 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.0 p -81.58 155.5 25.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.34 0.59 . . . . 63.34 112.049 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.9 7.65 17.5 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.992 -0.549 . . . . 71.4 111.947 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.8 156.21 42.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.659 0.266 . . . . 72.21 111.498 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.58 106.11 2.47 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.443 -0.344 . . . . 63.32 111.025 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.559 ' NE2' ' HB3' ' A' ' 11' ' ' MET . 10.2 mm100 -106.13 144.74 29.56 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.699 -0.228 . . . . 64.1 111.326 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.37 156.03 18.55 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.353 2.035 . . . . 74.21 112.948 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.589 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 4.2 tpt -60.23 -29.24 68.62 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.978 0.418 . . . . 34.01 111.926 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.08 176.86 49.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.373 -0.441 . . . . 73.51 113.559 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 52.63 0.67 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.354 -0.451 . . . . 62.0 112.709 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -98.72 172.36 7.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.554 0.216 . . . . 64.03 110.856 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 43.5 tt0 -137.35 137.3 38.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.316 0.579 . . . . 75.11 111.492 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.2 ttp -105.39 122.75 46.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.87 -0.605 . . . . 64.22 111.417 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.502 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.2 mp -104.79 124.29 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.888 0.375 . . . . 70.31 111.407 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.667 ' HB2' ' HH2' ' A' ' 88' ' ' TRP . 34.7 ttt180 -90.87 123.16 34.18 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.278 -0.264 . . . . 73.4 111.671 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -116.58 105.53 12.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 64.41 110.831 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.16 -23.43 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.284 0.564 . . . . 71.02 110.789 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -94.8 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.035 -0.529 . . . . 71.32 112.345 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.86 -41.0 11.43 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.691 0.281 . . . . 72.4 111.384 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.3 t -92.72 147.97 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.162 0.506 . . . . 72.1 111.792 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p -140.96 168.88 18.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.082 0.468 . . . . 73.12 111.6 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -162.17 141.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.245 -0.434 . . . . 45.43 110.537 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -115.58 159.72 20.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.539 0.685 . . . . 61.13 112.782 -174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 84.0 t80 -144.44 115.27 7.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.642 -0.708 . . . . 71.03 110.597 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 87.3 tttt -86.85 140.39 29.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.189 0.519 . . . . 75.21 111.583 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.431 ' HE2' HD11 ' A' ' 71' ' ' ILE . 89.2 m-85 -87.56 145.41 26.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 73.51 111.489 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.8 t -121.55 130.1 53.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.949 0.404 . . . . 62.44 111.659 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 67.8 m -73.92 74.68 1.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.162 0.506 . . . . 65.2 111.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -97.76 -2.24 41.56 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.915 -0.584 . . . . 61.43 111.532 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -168.76 172.83 7.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.617 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.06 126.32 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.14 0.495 . . . . 72.42 111.652 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -74.38 119.56 18.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.232 -0.655 . . . . 75.13 109.232 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 66.0 mttm -62.37 158.75 16.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.825 0.676 . . . . 50.42 112.825 -172.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.21 113.88 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.658 -0.701 . . . . 74.43 112.006 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . 67.66 21.4 72.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.463 -0.398 . . . . 45.14 114.029 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.489 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -86.35 149.24 25.17 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.148 0.499 . . . . 73.25 111.844 -178.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.1 p -92.45 145.2 24.64 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.178 -0.465 . . . . 75.11 111.557 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.527 ' HB ' HD21 ' A' ' 63' ' ' LEU . 7.0 p -134.49 122.29 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.91 0.386 . . . . 62.13 110.391 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -103.1 137.33 41.42 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.253 0.549 . . . . 74.42 112.102 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 86' ' ' LEU . 43.5 mm -95.4 108.85 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.214 -0.448 . . . . 63.04 110.782 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -97.35 136.22 38.12 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.544 0.212 . . . . 71.12 110.659 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.31 158.11 18.11 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.086 0.402 . . . . 64.14 112.086 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 89' ' ' LYS . . . -47.09 -44.92 21.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.594 0.59 . . . . 73.02 112.594 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 93' ' ' SER . 2.0 m-20 -95.84 74.5 3.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.161 0.505 . . . . 73.42 111.511 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.9 3.15 8.77 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.08 -0.509 . . . . 72.33 111.188 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.62 17.32 64.52 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.309 -0.405 . . . . 74.44 113.651 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.39 171.5 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.152 0.501 . . . . 73.1 112.317 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -82.2 164.4 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.999 -0.546 . . . . 62.02 112.207 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.54 89.89 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.359 -0.382 . . . . 63.42 111.717 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 t 59.83 81.36 0.25 Allowed Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.508 . . . . 45.12 111.342 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 89.0 Cg_exo -45.23 -51.45 7.75 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.222 2.615 . . . . 65.13 115.365 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 48.6 Cg_endo -100.13 149.35 4.15 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 121.011 1.397 . . . . 70.51 114.008 -1.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 t -171.02 -38.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.259 -0.882 . . . . 31.21 108.892 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -123.21 156.76 34.49 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.838 -1.074 . . . . 72.44 109.308 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 71' ' ' ILE . 93.3 mt -104.8 141.65 36.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.026 0.441 . . . . 74.4 111.961 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.5 mp -95.14 121.85 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.313 0.578 . . . . 75.11 111.343 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.667 ' HH2' ' HB2' ' A' ' 46' ' ' ARG . 4.9 t90 -89.66 84.0 6.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.939 -0.573 . . . . 73.51 110.463 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 48.8 mtmt -74.61 -16.41 60.79 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.187 0.44 . . . . 73.44 112.187 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.567 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 0.9 OUTLIER -65.9 -15.86 63.33 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.79 0.328 . . . . 71.42 111.523 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -148.69 139.01 22.48 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 72.22 111.103 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.9 m120 -72.72 -177.17 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.035 0.445 . . . . 73.45 111.231 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 40.4 t -77.69 142.92 38.51 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.226 -0.297 . . . . 73.15 111.486 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -125.85 157.71 36.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.953 0.406 . . . . 73.14 111.234 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.92 141.75 7.27 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.93 -0.652 . . . . 61.33 112.819 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 t 176.46 -27.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.983 0.364 . . . . 63.24 111.983 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 30.11 20.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.039 -0.6 . . . . 45.24 113.564 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.58 144.08 28.28 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.005 0.402 . . . . 71.12 110.757 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.2 m-20 -64.52 99.32 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.172 0.511 . . . . 74.0 112.15 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.36 127.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.578 . . . . 62.22 111.072 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 19.2 ttpp -104.26 119.53 39.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.188 0.518 . . . . 74.23 111.336 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.1 t -108.71 147.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.132 0.491 . . . . 74.02 112.015 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 mm -116.95 126.49 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.094 -0.503 . . . . 75.42 111.591 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 HG13 ' A' ' 17' ' ' ILE . 66.3 mt -110.58 106.71 16.08 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.702 0.287 . . . . 74.32 111.697 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -120.52 140.82 50.91 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.323 0.583 . . . . 74.21 111.731 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.517 ' OD1' HG13 ' A' ' 112' ' ' VAL . 12.4 m120 -80.77 179.68 7.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.739 -0.664 . . . . 73.12 112.343 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.5 p -54.48 -49.24 70.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.561 -0.745 . . . . 53.5 112.345 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.56 -4.32 22.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.78 0.659 . . . . 71.15 112.78 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.35 -16.75 60.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.047 -0.597 . . . . 70.23 113.468 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.76 143.95 55.62 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.456 -0.438 . . . . 74.31 110.72 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -103.06 130.47 50.21 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.6 0.592 . . . . 74.24 112.6 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 106' ' ' ASN . 16.0 m -76.7 -45.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.765 -0.198 . . . . 65.11 111.194 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -176.67 133.7 0.21 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.516 0.561 . . . . 64.33 112.516 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.28 141.9 35.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.526 -0.546 . . . . 63.42 109.526 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -155.61 146.91 22.68 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.407 0.521 . . . . 60.23 112.407 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 79.1 p -109.56 169.98 8.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.005 0.431 . . . . 24.0 111.306 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.782 HG22 ' HB ' ' A' ' 20' ' ' ILE . 62.3 p -71.91 164.81 25.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.152 0.501 . . . . 71.42 112.106 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.09 117.12 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.051 -0.522 . . . . 62.43 110.65 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -82.16 114.67 20.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.918 0.39 . . . . 75.4 111.538 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 mttp -80.45 108.3 13.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.286 -0.415 . . . . 65.24 110.806 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.5 p -76.74 106.5 8.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.925 0.393 . . . . 61.5 111.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.253 1.268 0 N-CA-C 112.187 0.44 . . . . 65.42 112.187 -178.597 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.513 0.197 . . . . 61.14 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.45 146.14 48.29 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.185 -0.531 . . . . 72.43 113.39 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -127.69 22.34 6.38 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.373 0.508 . . . . 71.42 112.373 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -130.51 109.6 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.835 0.35 . . . . 72.3 111.179 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -87.35 -63.3 1.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.92 0.391 . . . . 73.04 111.662 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -107.14 120.46 42.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.265 0.555 . . . . 75.11 111.367 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -134.87 111.36 9.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.664 -0.698 . . . . 65.43 110.497 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -137.73 156.49 47.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.209 -0.45 . . . . 72.15 110.672 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -47.14 125.39 7.69 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.823 0.344 . . . . 63.1 111.593 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.79 137.22 56.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.922 1.082 . . . . 75.43 113.922 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.2 mmt -144.84 157.63 44.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.721 -1.127 . . . . 75.11 109.613 170.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -67.12 -43.82 81.47 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.193 0.442 . . . . 42.22 112.193 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.62 81.35 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.163 -0.542 . . . . 73.01 112.515 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 11.9 m120 -76.84 47.69 0.53 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.243 0.46 . . . . 52.23 112.243 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.53 97.75 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.209 0.528 . . . . 61.33 110.878 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 p -112.54 158.67 19.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.365 -0.38 . . . . 65.21 111.416 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.737 HG13 HD11 ' A' ' 104' ' ' LEU . 72.2 mt -62.11 135.73 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.734 -0.212 . . . . 43.14 111.037 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 33.0 tt0 -90.56 -69.25 0.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 74.21 110.26 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.85 138.66 22.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.408 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.755 HG23 HG12 ' A' ' 27' ' ' ILE . 56.4 mt -101.53 141.77 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.375 -0.375 . . . . 70.2 110.907 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.0 150.15 35.85 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.368 0.604 . . . . 74.13 112.419 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 119' ' ' PHE . 7.4 p -89.37 -31.43 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.302 -0.863 . . . . 62.54 112.569 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.45 -32.15 66.04 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.134 0.492 . . . . 73.12 111.238 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 108.96 34.04 2.66 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.133 -0.485 . . . . 63.05 112.303 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.74 -53.13 3.98 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.416 0.524 . . . . 71.53 112.416 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.39 165.65 35.12 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.834 1.05 . . . . 64.32 113.834 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.755 HG12 HG23 ' A' ' 20' ' ' ILE . 64.7 mt -129.05 106.44 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.889 -1.05 . . . . 61.53 109.612 172.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -91.66 124.66 35.97 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.85 -0.531 . . . . 72.15 112.343 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 8.0 mp -93.49 -177.28 4.36 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.12 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 61.6 tttp -162.66 119.9 2.0 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.793 0.294 . . . . 73.01 111.793 -174.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.571 ' HB2' HD12 ' A' ' 63' ' ' LEU . 38.5 t30 -90.24 110.43 21.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.609 0.243 . . . . 70.34 111.032 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.6 p -96.65 13.53 27.99 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.369 0.507 . . . . 74.21 112.369 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 29.5 t -79.54 157.6 27.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.288 0.566 . . . . 63.43 112.438 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.61 -13.72 59.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.797 -0.638 . . . . 65.32 110.741 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -115.64 149.26 38.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.191 0.52 . . . . 62.03 111.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.17 108.83 5.56 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.101 -0.5 . . . . 72.21 110.141 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -91.2 119.68 68.68 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.384 0.512 . . . . 53.0 112.384 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.87 136.11 47.45 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.269 1.979 . . . . 65.01 111.844 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 3.0 tpt -59.39 -41.53 89.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.21 0.448 . . . . 65.21 112.21 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.27 -67.12 1.21 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.375 -0.441 . . . . 70.34 113.494 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.78 78.52 0.02 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 62.32 112.855 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -98.9 179.96 4.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.73 0.3 . . . . 74.23 111.067 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.42 130.44 11.83 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.522 0.677 . . . . 64.33 111.236 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' SER . 52.2 ttp -99.35 111.39 23.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.808 -0.633 . . . . 55.03 111.416 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.7 mp -89.68 141.6 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.668 0.27 . . . . 75.54 110.631 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -138.17 126.25 22.8 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.939 -0.475 . . . . 73.11 111.621 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -111.97 145.38 39.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 74.34 111.179 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.99 -41.43 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.062 0.458 . . . . 73.54 111.923 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.15 103.62 0.17 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.146 -0.55 . . . . 63.24 112.369 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 72.47 -36.51 0.36 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.457 0.703 . . . . 64.03 112.616 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -113.84 148.54 36.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.902 0.382 . . . . 73.21 111.457 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.1 p -137.02 143.43 42.73 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.338 -0.392 . . . . 75.2 111.023 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.5 147.38 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 63.24 111.031 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' MET . 97.9 p -131.77 150.32 52.19 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.067 0.461 . . . . 61.12 111.971 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 33.1 t80 -122.6 120.5 33.93 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.36 -0.382 . . . . 73.15 111.297 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.69 129.32 34.85 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.965 0.412 . . . . 73.35 111.649 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HB3' ' SD ' ' A' ' 39' ' ' MET . 86.4 m-85 -88.67 122.59 32.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.311 -0.404 . . . . 55.21 111.659 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.9 t -81.91 140.57 33.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.639 0.607 . . . . 71.21 112.639 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 98.9 p -86.05 18.44 3.06 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.17 0.433 . . . . 72.52 112.17 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 14.4 ptm180 -68.85 -9.8 53.37 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.757 0.651 . . . . 72.01 112.757 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.49 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 48.6 p90 -152.63 168.44 25.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.279 0.562 . . . . 75.2 112.043 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.57 140.71 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.682 -0.69 . . . . 72.12 111.455 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -92.95 100.61 13.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.33 -0.619 . . . . 64.45 109.33 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 8.4 mtpm? -69.69 163.24 26.08 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.384 0.883 . . . . 75.41 113.384 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.57 122.53 17.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.834 -0.621 . . . . 75.2 111.171 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.34 86.72 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.944 -0.646 . . . . 72.05 113.473 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.633 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -89.37 133.9 34.31 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.462 -0.434 . . . . 63.55 111.041 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.9 p -116.07 100.68 8.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.316 -0.402 . . . . 63.21 111.821 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.67 132.17 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.927 0.394 . . . . 63.41 111.206 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 m -101.2 124.23 46.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.826 0.346 . . . . 65.53 111.694 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 40.7 mm -89.39 96.2 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.91 0.386 . . . . 54.42 110.985 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' TRP . 94.3 m95 -83.05 133.9 35.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.684 0.253 . . . . 71.41 111.684 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 163.3 11.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.038 0.447 . . . . 34.42 111.964 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.35 -21.08 3.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.07 0.767 . . . . 61.24 113.07 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -86.97 16.47 4.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.106 0.41 . . . . 75.52 112.106 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.94 78.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.051 0.453 . . . . 73.15 111.501 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.36 -26.85 3.34 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.424 -0.417 . . . . 73.31 113.686 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.26 163.57 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.981 0.42 . . . . 74.53 111.98 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -78.13 143.6 37.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.064 0.459 . . . . 75.22 111.662 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.0 78.12 3.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.024 0.44 . . . . 63.41 111.199 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -136.47 95.07 13.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.503 -0.317 . . . . 70.35 111.684 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 13.4 Cg_exo -72.72 178.17 6.67 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.248 2.632 . . . . 75.54 112.278 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 82' ' ' PRO . 98.6 Cg_endo -99.9 118.82 1.01 Allowed 'Cis proline' 0 C--N 1.361 1.22 0 N-CA-C 114.544 0.94 . . . . 73.13 114.544 -0.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.9 t -154.96 -56.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.97 -0.559 . . . . 70.01 109.855 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 84' ' ' THR . 21.4 m-20 -141.2 176.85 8.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.779 -0.646 . . . . 65.02 109.703 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 97.0 mt -123.02 124.13 42.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.893 0.378 . . . . 74.24 110.956 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 87' ' ' ILE . 3.2 mp -93.99 111.56 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.167 0.508 . . . . 75.4 111.31 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.443 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 4.3 t90 -71.09 77.9 0.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.203 0.525 . . . . 74.43 110.617 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.89 1.8 16.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.022 0.439 . . . . 72.44 111.607 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.443 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 15.2 m120 -93.57 -4.32 51.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.272 -0.422 . . . . 64.33 111.812 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -137.79 148.69 45.75 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.171 0.51 . . . . 75.13 111.457 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -91.44 -174.82 4.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.04 -0.527 . . . . 71.52 110.789 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 98.7 p -64.41 120.43 12.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.141 0.496 . . . . 54.33 111.096 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.3 p90 -77.73 118.21 19.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.239 0.542 . . . . 72.34 112.062 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.36 102.74 0.16 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.932 -0.576 . . . . 75.33 112.334 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -157.35 26.25 0.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 65.23 111.718 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -54.11 4.35 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.151 -0.547 . . . . 42.42 113.102 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.3 119.19 8.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.479 0.312 . . . . 73.21 111.194 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.04 146.2 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.676 0.621 . . . . 74.22 112.676 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG12 ' HE1' ' A' ' 119' ' ' PHE . 7.4 p -126.4 128.47 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.773 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 116' ' ' SER . 80.7 tttt -114.47 142.49 46.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.991 0.424 . . . . 71.14 111.751 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.82 136.91 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 116.192 -0.458 . . . . 71.11 111.996 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.73 122.91 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.024 -0.535 . . . . 74.41 111.432 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 17' ' ' ILE . 97.9 mt -89.69 131.28 35.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.231 -0.293 . . . . 70.35 111.095 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.6 mttt -141.09 145.72 36.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.209 0.528 . . . . 53.35 112.052 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' HG3' ' A' ' 110' ' ' GLU . 10.6 m120 -88.31 -173.43 4.2 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.082 0.467 . . . . 74.14 111.674 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -51.78 -41.96 62.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.742 0.645 . . . . 61.13 112.742 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -80.99 -0.69 40.66 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.894 0.702 . . . . 75.13 112.894 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.1 0.59 80.51 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.896 -0.669 . . . . 22.22 112.867 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HG3' ' OD1' ' A' ' 106' ' ' ASN . 13.8 pt-20 -66.8 138.6 57.47 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.718 0.407 . . . . 71.21 111.108 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.5 tt0 -83.59 133.15 34.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.174 0.512 . . . . 75.43 111.954 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.71 -50.53 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.964 -0.562 . . . . 71.14 111.162 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.6 163.78 16.9 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.966 -0.561 . . . . 65.23 111.58 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -137.16 136.12 37.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.241 -0.436 . . . . 71.34 111.116 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -160.63 156.25 25.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.118 0.485 . . . . 75.31 111.486 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 54.4 p -142.54 -171.94 3.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.788 0.328 . . . . 60.33 111.221 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 14.8 t -147.23 145.47 29.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.652 0.263 . . . . 62.01 110.571 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 102.16 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.004 0.43 . . . . 71.42 111.831 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.619 ' HA ' HG23 ' A' ' 22' ' ' VAL . 22.2 p90 -96.14 102.14 13.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.497 0.665 . . . . 72.24 110.842 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -134.72 160.85 36.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.418 0.628 . . . . 70.02 112.52 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.6 p -126.98 121.46 31.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.554 -0.748 . . . . 73.13 110.525 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.036 -0.983 . . . . 74.53 112.634 -174.656 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.626 0.25 . . . . 74.35 111.065 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.42 75.91 0.43 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.539 -0.363 . . . . 62.54 113.089 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -65.09 -53.33 47.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.916 0.389 . . . . 72.34 111.495 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -91.95 -25.89 18.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.119 0.485 . . . . 74.21 110.577 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.14 -20.58 66.53 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.796 -0.638 . . . . 64.11 110.884 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.8 135.34 52.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.242 0.544 . . . . 72.03 111.055 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -151.94 95.79 2.13 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.935 -0.575 . . . . 64.12 110.949 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -146.74 121.83 10.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.757 -0.656 . . . . 74.04 111.037 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 37.7 p -90.03 -179.69 5.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.555 -0.293 . . . . 54.43 111.52 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 9' ' ' SER . 75.8 m-70 68.9 33.09 3.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.153 0.502 . . . . 74.41 112.102 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 90.4 mmm -82.45 92.78 7.1 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.021 0.438 . . . . 73.15 110.468 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -91.38 32.19 1.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.408 0.521 . . . . 75.13 112.408 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' HA2' ' HG3' ' A' ' 37' ' ' GLN . . . -60.41 91.21 0.05 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.412 0.525 . . . . 62.1 114.412 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -107.43 96.37 6.36 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.103 0.478 . . . . 72.22 110.428 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.42 140.6 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.015 0.436 . . . . 52.51 111.873 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -137.81 164.17 29.59 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.209 -0.45 . . . . 62.02 110.705 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.1 mp -87.49 119.44 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.22 -0.3 . . . . 72.2 111.28 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.51 -50.52 44.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.785 0.326 . . . . 70.54 111.361 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -171.31 152.79 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 60.33 112.149 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 27' ' ' ILE . 65.3 mt -107.49 134.72 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.792 -0.64 . . . . 64.12 110.816 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.0 130.25 41.66 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.032 0.444 . . . . 65.21 111.301 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -70.18 -28.25 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.511 0.56 . . . . 74.31 112.511 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.53 -44.76 56.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.77 0.319 . . . . 74.33 110.835 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 117.02 37.97 0.91 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 116.23 -0.441 . . . . 73.44 113.236 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -104.69 -39.59 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.452 0.538 . . . . 63.51 112.452 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.75 160.46 37.9 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.353 0.871 . . . . 72.14 113.353 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG12 HG23 ' A' ' 20' ' ' ILE . 69.7 mt -131.61 122.47 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.611 -0.722 . . . . 71.0 109.781 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -99.72 122.41 42.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.934 0.716 . . . . 73.44 112.934 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 104' ' ' LEU . 7.0 mp -97.3 173.72 7.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.592 -0.731 . . . . 74.33 110.587 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.6 131.6 11.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.936 0.398 . . . . 73.12 111.981 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HB3' HD12 ' A' ' 63' ' ' LEU . 28.4 t30 -89.87 104.36 16.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.249 -0.432 . . . . 65.45 110.968 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 t -105.72 84.11 2.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 71.45 110.887 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.6 p -136.4 -177.8 4.88 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.722 -0.672 . . . . 64.42 112.164 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.45 -22.53 35.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.909 0.707 . . . . 74.51 112.909 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -146.89 154.56 41.44 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.516 0.561 . . . . 75.12 112.516 -170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -50.36 128.15 19.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.866 -0.606 . . . . 72.41 111.569 175.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HG3' ' HA2' ' A' ' 13' ' ' GLY . 30.1 mm-40 -121.08 119.68 29.61 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.805 0.336 . . . . 53.51 111.633 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 7.3 Cg_exo -74.8 29.9 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.12 2.547 . . . . 64.32 113.946 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.3 tpt 64.94 -71.18 0.08 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.4 0.518 . . . . 53.14 112.4 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . 96.37 -75.69 0.76 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.134 -0.555 . . . . 64.33 113.247 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.48 83.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.22 -0.514 . . . . 40.31 112.917 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.685 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 9.0 m0 -100.65 174.71 5.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.767 0.318 . . . . 75.54 111.605 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.28 111.32 15.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.799 0.333 . . . . 71.24 111.194 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.7 ttp -103.01 121.2 42.07 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.068 -0.395 . . . . 62.33 111.279 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.28 149.64 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.355 -0.384 . . . . 64.04 110.716 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HD3' HH11 ' A' ' 46' ' ' ARG . 28.4 ttp-105 -135.2 105.54 6.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.944 -0.473 . . . . 43.12 110.878 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 98.3 mttt -88.44 118.91 28.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.481 -0.327 . . . . 71.14 110.666 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 tt -155.07 99.93 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.934 0.397 . . . . 73.11 111.665 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 58.94 93.66 0.01 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.253 -0.431 . . . . 50.42 114.117 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.9 t70 76.46 -58.75 0.52 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.068 0.766 . . . . 71.21 113.068 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -103.99 163.42 12.38 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.849 0.685 . . . . 63.34 112.849 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.4 p -138.02 105.4 5.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.646 -0.706 . . . . 74.23 110.683 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.1 p -92.28 146.18 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.699 0.285 . . . . 63.42 111.429 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -123.0 159.35 28.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.21 0.528 . . . . 74.35 111.77 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 73.6 t80 -138.93 133.52 31.95 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.114 -0.494 . . . . 64.22 110.813 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -101.18 129.98 47.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.097 0.475 . . . . 72.44 111.715 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.685 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 68.7 m-85 -88.84 172.89 8.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.033 -0.53 . . . . 72.34 111.923 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 t -149.71 153.82 37.56 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.984 0.421 . . . . 75.12 112.111 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 36.9 t -86.3 64.26 8.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.991 0.424 . . . . 53.53 111.919 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.683 HH11 ' HG2' ' A' ' 82' ' ' PRO . 9.6 ptp180 -106.58 -1.53 22.82 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.747 0.308 . . . . 74.22 111.785 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HD23 ' A' ' 63' ' ' LEU . 29.9 p90 -154.98 148.61 25.37 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.681 0.277 . . . . 73.13 111.011 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 47.8 t -97.02 102.37 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 64.11 111.024 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 31' ' ' ASN . 1.1 tm? -80.74 108.82 14.72 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.204 0.526 . . . . 72.35 110.623 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 61.7 mttm -64.36 140.5 58.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.024 -0.534 . . . . 73.31 112.186 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.24 127.19 30.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.253 -0.43 . . . . 61.04 111.306 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.96 -15.37 55.4 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.152 -0.547 . . . . 71.44 112.787 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 1.7 mp0 -95.65 168.08 10.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.885 0.374 . . . . 75.41 110.831 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.8 p -119.25 174.04 6.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.274 0.559 . . . . 74.2 112.183 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.72 127.92 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.976 -0.556 . . . . 44.05 110.448 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.5 m -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.955 0.407 . . . . 72.15 111.96 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 86' ' ' LEU . 29.5 mm -92.54 97.49 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.151 -0.477 . . . . 72.4 110.423 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 88.0 m95 -79.12 168.72 19.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.938 0.399 . . . . 74.33 111.792 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.67 16.63 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.569 -0.287 . . . . 64.21 110.902 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.1 -30.62 37.47 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.108 0.781 . . . . 73.35 113.108 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -97.9 19.63 13.51 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.429 0.529 . . . . 55.55 112.429 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -52.91 -47.83 67.68 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 43.32 112.625 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.93 75.48 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.213 -0.518 . . . . 33.55 112.816 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.91 -164.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.327 0.251 . . . . 64.01 111.106 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.4 m -48.67 130.29 17.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.771 0.319 . . . . 74.44 111.165 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.13 62.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.553 0.945 . . . . 73.12 113.553 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.4 t -159.28 151.91 17.9 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 113.133 0.79 . . . . 74.3 113.133 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.685 ' HG3' HD23 ' A' ' 86' ' ' LEU . 7.1 Cg_endo -48.79 170.84 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 123.919 3.079 . . . . 74.12 111.363 168.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -16.82 -80.51 0.0 OUTLIER 'Cis proline' 0 C--N 1.374 1.896 0 N-CA-C 121.329 3.55 . . . . 74.14 121.329 11.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.2 p -78.62 -83.63 0.09 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.301 1.223 . . . . 62.2 114.301 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 6.3 m-20 -73.78 122.6 22.68 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.248 0.547 . . . . 73.23 112.458 -171.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.685 HD23 ' HG3' ' A' ' 82' ' ' PRO . 12.1 mt -91.09 113.24 25.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.912 -0.585 . . . . 73.45 111.369 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.5 mp -86.08 119.11 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.18 0.514 . . . . 60.14 110.944 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.421 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 3.1 t90 -69.46 77.9 0.4 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.332 0.587 . . . . 75.44 110.351 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -75.88 27.82 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.324 0.49 . . . . 42.44 112.324 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.1 -1.86 11.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.901 0.381 . . . . 70.51 110.969 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.455 ' OE1' HG11 ' A' ' 53' ' ' VAL . 25.3 tt0 -157.82 146.27 19.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.966 0.413 . . . . 44.11 111.111 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -82.81 -167.62 1.71 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.433 -0.349 . . . . 73.12 110.775 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 t -69.0 145.35 53.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.941 0.401 . . . . 65.42 111.611 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.512 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 49.4 p90 -121.86 -174.46 2.88 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.217 -0.447 . . . . 64.2 110.631 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 137.71 50.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.766 -0.731 . . . . 63.34 113.609 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 98' ' ' GLU . 7.3 t -76.49 -20.91 56.47 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.451 -0.441 . . . . 74.32 111.982 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.62 4.87 60.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.091 -0.576 . . . . 74.42 113.517 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.606 ' H ' HG23 ' A' ' 96' ' ' THR . 9.0 mm-40 -85.69 172.46 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.652 -0.322 . . . . 54.44 111.257 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.05 143.33 55.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.103 0.478 . . . . 52.15 111.995 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.35 132.74 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.284 0.564 . . . . 75.01 111.655 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 114' ' ' GLN . 50.6 tttm -123.35 111.8 16.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.07 -0.514 . . . . 61.31 110.817 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.81 133.09 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.946 0.403 . . . . 72.13 111.39 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.463 HG21 ' HE2' ' A' ' 105' ' ' LYS . 16.3 mm -126.64 136.53 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 111.828 0.307 . . . . 63.12 111.828 -173.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 29' ' ' LEU . 79.4 mt -110.13 107.68 17.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.93 0.395 . . . . 51.25 111.559 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' A' ' 103' ' ' ILE . 67.7 mttm -119.31 167.76 11.57 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.373 0.606 . . . . 71.14 112.061 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HB2' ' CG ' ' A' ' 110' ' ' GLU . 12.8 m120 -113.96 -176.65 2.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.987 -0.551 . . . . 74.54 111.681 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 t -58.75 -39.32 80.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.307 0.854 . . . . 62.22 113.307 -173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -73.46 -8.7 57.0 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.552 0.575 . . . . 73.05 112.552 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.75 68.68 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.648 -0.787 . . . . 65.23 112.065 -171.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.513 ' CG ' ' HB2' ' A' ' 106' ' ' ASN . 10.5 pt-20 -68.44 168.59 12.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.658 0.383 . . . . 75.3 110.39 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.71 136.92 48.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.128 -0.358 . . . . 74.5 111.779 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.648 HG21 ' HZ3' ' A' ' 42' ' ' TRP . 29.2 m -96.7 -41.62 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.438 -0.346 . . . . 53.13 111.61 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.79 168.95 13.77 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 40.33 111.504 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 29.5 pt20 -160.0 163.37 34.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.71 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -161.89 -179.41 7.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.015 0.912 . . . . 54.5 112.793 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.3 p -147.64 -170.99 3.7 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.821 -1.081 . . . . 73.33 109.892 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 p -78.71 142.45 37.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.894 0.378 . . . . 74.4 110.972 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p -78.57 101.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.383 0.611 . . . . 72.11 111.193 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -99.14 104.22 16.18 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.54 112.093 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -84.66 124.11 31.11 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.347 -0.388 . . . . 74.21 110.665 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.9 m -70.64 85.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 73.33 111.586 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.254 1.315 0 CA-C-O 118.976 -0.535 . . . . 73.21 111.65 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.559 0.219 . . . . 63.32 110.429 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.02 -107.72 1.04 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.13 -0.557 . . . . 60.05 112.75 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -144.66 39.7 1.27 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.326 0.584 . . . . 72.11 110.584 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -99.6 4.83 45.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.47 0.544 . . . . 70.51 112.47 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -72.07 97.87 1.99 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.119 0.485 . . . . 71.0 111.195 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -125.88 26.29 6.64 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 71.23 112.155 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -66.0 99.43 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.992 0.425 . . . . 71.11 111.4 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -98.25 114.2 26.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.533 -0.303 . . . . 74.51 110.792 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 t -113.53 81.98 1.6 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.089 0.471 . . . . 74.54 111.501 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -132.06 119.6 21.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.493 -0.321 . . . . 74.42 111.435 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 mmt 61.58 108.88 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.419 0.628 . . . . 64.22 112.389 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -94.26 36.51 1.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.2 0.445 . . . . 71.41 112.2 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.0 61.96 2.55 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.172 -0.537 . . . . 75.41 112.902 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.6 m-80 -94.63 -32.91 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.874 0.368 . . . . 75.23 111.375 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.11 120.27 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.01 0.433 . . . . 73.24 111.361 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -133.62 156.66 47.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.447 -0.342 . . . . 74.21 110.906 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . 65.2 mt -71.04 126.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.755 0.312 . . . . 64.22 111.496 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -89.33 -66.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.001 0.429 . . . . 74.43 110.783 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -136.23 130.25 32.81 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.126 0.489 . . . . 70.21 112.085 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG23 ' A' ' 27' ' ' ILE . 62.6 mt -103.91 114.45 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.968 -0.56 . . . . 72.24 110.351 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 17.2 t70 -74.53 139.61 43.92 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.473 0.654 . . . . 53.22 112.256 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.5 -16.41 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.609 -0.723 . . . . 73.53 110.993 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.07 -14.15 61.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.149 -0.478 . . . . 32.42 111.198 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 99.44 29.22 7.16 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.771 0.669 . . . . 73.1 114.771 168.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.5 mptt -113.3 -54.48 2.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.214 0.82 . . . . 71.34 113.214 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 46.1 p90 -148.04 167.24 25.46 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.106 1.151 . . . . 75.33 114.106 -170.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.466 HG23 HG12 ' A' ' 20' ' ' ILE . 69.8 mt -132.63 105.22 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 72.04 109.345 170.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.1 ttm180 -90.8 119.94 31.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.207 0.817 . . . . 75.45 113.207 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.0 mp -93.83 -175.88 3.87 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.712 -0.676 . . . . 75.45 110.333 171.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 35.0 ttpt -157.37 135.16 10.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.996 0.427 . . . . 64.51 112.009 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -108.33 115.23 29.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.039 -0.528 . . . . 64.24 111.403 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -102.19 16.56 25.75 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 64.42 112.116 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' ASN . 98.3 p -55.24 152.32 8.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.079 0.466 . . . . 63.11 111.707 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -85.14 -0.35 54.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.799 0.333 . . . . 53.3 111.811 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.87 161.04 28.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.395 -0.366 . . . . 72.04 110.269 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.61 111.54 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.725 0.298 . . . . 73.23 111.244 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -104.85 132.07 21.23 Favored Pre-proline 0 N--CA 1.47 0.564 0 N-CA-C 111.893 0.331 . . . . 75.11 111.893 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.69 132.93 54.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.456 2.104 . . . . 43.43 112.19 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 tpt -52.45 -72.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.07 0.396 . . . . 74.4 112.07 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.64 172.45 45.38 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.711 -0.757 . . . . 62.12 113.085 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.19 89.11 0.41 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.117 -0.563 . . . . 74.51 113.707 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . 41.3 m95 -102.41 156.43 17.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.773 0.321 . . . . 71.24 110.434 171.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.84 115.35 6.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.805 0.336 . . . . 74.31 111.468 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' SER . 54.7 ttp -93.99 114.06 26.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.569 -0.287 . . . . 75.0 111.67 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.8 mp -102.13 106.91 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.894 0.378 . . . . 72.23 110.36 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HG3' HG22 ' A' ' 102' ' ' VAL . 50.6 ttt180 -99.11 123.62 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.713 0.292 . . . . 74.42 111.483 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -121.9 116.86 25.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.954 0.407 . . . . 60.51 111.584 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 tt -103.35 -27.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.165 0.507 . . . . 70.25 110.703 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.96 -137.31 3.21 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.858 -0.61 . . . . 74.31 112.305 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -71.25 -40.54 70.93 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.03 0.443 . . . . 43.43 111.454 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -79.05 156.5 28.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.189 0.518 . . . . 51.14 112.126 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.3 p -133.69 152.55 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.343 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.9 p -134.96 139.43 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.506 -0.316 . . . . 62.32 111.318 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' MET . 84.0 p -111.53 171.38 7.52 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.233 0.54 . . . . 73.21 112.369 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.435 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 74.6 t80 -160.47 114.21 2.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.863 -0.608 . . . . 74.55 111.252 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.15 127.07 33.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.746 0.307 . . . . 71.32 111.438 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 3.1 m-85 -73.98 121.99 21.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.823 0.344 . . . . 64.23 111.123 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.53 HG21 ' HG2' ' A' ' 82' ' ' PRO . 5.2 t -68.84 120.96 15.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.543 0.687 . . . . 71.14 112.213 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -85.89 33.93 0.6 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.113 -0.494 . . . . 63.4 111.925 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.662 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 13.4 ptp180 -78.47 -3.72 44.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.148 0.425 . . . . 75.05 112.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.538 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 24.2 p90 -158.54 171.83 19.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.004 0.431 . . . . 71.05 111.362 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -92.9 138.74 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.3 -0.409 . . . . 63.34 111.51 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.31 105.7 13.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.137 0.494 . . . . 72.33 109.68 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 7.4 mtpm? -69.14 154.23 42.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.269 0.557 . . . . 63.43 112.446 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.6 57.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.753 -0.658 . . . . 73.33 112.187 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.26 -0.495 . . . . 62.44 113.793 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.671 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.89 132.38 34.71 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.229 -0.571 . . . . 71.42 111.557 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 56.2 p -100.02 83.59 2.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.309 -0.405 . . . . 61.01 111.019 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 29' ' ' LEU . 4.5 p -57.96 106.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.573 0.701 . . . . 61.22 111.372 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 86.4 m -93.06 121.31 34.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 74.05 111.525 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 47.8 mm -83.12 106.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.433 -0.348 . . . . 62.42 111.047 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -82.95 144.75 29.79 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.564 0.209 . . . . 73.41 111.564 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.93 157.64 27.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.835 0.35 . . . . 74.45 111.877 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.98 -30.48 25.16 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.439 0.533 . . . . 62.11 112.439 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -81.73 28.66 0.4 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.804 0.335 . . . . 60.44 111.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.62 87.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.176 0.436 . . . . 73.41 112.176 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.84 -37.7 2.5 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.178 -0.534 . . . . 43.2 113.771 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.2 -173.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.152 0.427 . . . . 65.51 112.152 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -51.1 104.92 0.09 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.1 111.903 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.82 1.32 35.34 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.671 0.619 . . . . 62.31 112.671 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.4 t -117.2 117.72 36.48 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 120.533 0.206 . . . . 75.21 111.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.662 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 54.0 Cg_exo -55.91 178.6 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.527 0 C-N-CA 123.776 2.984 . . . . 63.13 113.414 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 95.4 Cg_endo -76.73 126.19 12.94 Favored 'Cis proline' 0 C--N 1.366 1.459 0 CA-C-N 120.107 1.074 . . . . 71.14 114.813 6.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 82' ' ' PRO . 8.9 t 176.71 -170.94 0.08 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.353 -0.84 . . . . 70.03 109.418 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 87' ' ' ILE . 6.5 m-20 -57.4 108.1 0.51 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.735 -0.469 . . . . 74.02 109.735 171.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 79.6 mt -51.44 109.22 0.32 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.378 0.881 . . . . 72.12 113.378 -169.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 85' ' ' ASP . 3.6 mp -76.25 117.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.193 0.521 . . . . 64.2 110.8 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 55' ' ' TYR . 6.7 t90 -70.31 134.96 48.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.914 -0.584 . . . . 74.52 110.527 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -127.35 27.99 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.02 0.438 . . . . 73.13 111.769 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.426 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 9.1 m120 -121.45 -26.77 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.361 -0.381 . . . . 74.31 111.522 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -133.32 147.13 51.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.697 0.284 . . . . 54.43 110.874 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -95.51 -171.67 2.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.994 0.426 . . . . 74.42 111.951 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -59.89 127.03 29.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.892 0.377 . . . . 72.43 111.056 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -101.47 118.07 36.2 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.244 0.545 . . . . 75.12 112.457 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -120.93 85.14 0.38 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 72.23 111.893 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 p -130.56 -39.09 1.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.132 0.419 . . . . 74.22 112.132 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.42 89.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.257 -0.496 . . . . 71.14 112.857 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -96.66 145.75 25.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.97 0.414 . . . . 51.23 111.858 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 6.1 m-20 -64.59 131.1 46.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.402 0.62 . . . . 61.15 112.07 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 46' ' ' ARG . 7.5 p -119.09 126.05 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.883 -0.599 . . . . 74.53 111.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.875 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.3 tttt -90.95 115.99 28.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.797 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 46' ' ' ARG . 46.6 t -104.55 123.76 58.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.907 0.384 . . . . 73.34 111.518 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.875 HD11 ' HE2' ' A' ' 101' ' ' LYS . 50.4 mm -105.92 131.7 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.281 0.474 . . . . 72.21 112.281 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.4 mt -105.12 112.54 25.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.903 0.382 . . . . 74.25 110.943 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.75 171.59 7.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.17 -0.468 . . . . 73.1 110.931 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.8 -167.4 1.22 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.941 0.401 . . . . 72.34 111.253 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.2 t -56.98 -26.91 60.78 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.446 0.906 . . . . 73.43 113.446 -174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.86 -9.41 31.51 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 122.11 -0.369 . . . . 72.02 111.565 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.42 9.46 55.18 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.294 -0.479 . . . . 75.5 113.672 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.95 124.97 26.05 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.992 0.425 . . . . 74.45 111.88 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.5 107.27 7.52 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.303 -0.408 . . . . 75.21 110.959 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.59 -37.31 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.616 0.599 . . . . 71.21 112.616 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -141.39 122.53 14.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.193 0.442 . . . . 55.13 112.193 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -124.79 141.59 52.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.511 -0.313 . . . . 70.41 111.224 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -161.46 151.76 17.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.716 0.293 . . . . 74.33 111.039 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -140.53 174.67 10.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.168 0.509 . . . . 51.52 111.661 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 38.6 p -70.01 175.49 4.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 73.02 111.209 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 t -126.79 79.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.171 -0.331 . . . . 75.52 111.816 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 28.56 75.98 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.395 1.078 . . . . 63.13 113.79 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.99 122.62 45.77 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.026 0.441 . . . . 60.21 111.473 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -79.04 98.88 6.65 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.434 0.635 . . . . 62.24 111.854 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.501 -0.761 . . . . 72.14 111.924 179.234 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.779 0.323 . . . . 43.41 111.393 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.21 133.64 0.28 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.458 -0.401 . . . . 52.34 113.422 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -55.8 123.22 13.49 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.881 0.372 . . . . 71.41 111.983 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -153.44 165.97 34.13 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.082 0.468 . . . . 75.42 111.351 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -106.48 151.43 24.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.165 172.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -65.27 93.71 0.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.52 0.676 . . . . 74.52 112.011 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -126.81 117.48 22.71 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.284 -0.871 . . . . 74.43 110.364 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -144.99 137.76 26.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.011 0.434 . . . . 71.23 112.063 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 t -165.45 151.09 9.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.909 -0.587 . . . . 55.1 110.675 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -90.68 93.19 9.15 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.303 0.573 . . . . 73.42 111.943 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.4 mmt -97.8 125.65 42.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.849 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.9 t -58.19 -48.02 81.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.95 0.722 . . . . 70.34 112.95 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.56 89.08 0.15 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.113 -0.565 . . . . 72.04 113.547 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 m-80 -123.7 22.74 8.96 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.128 -0.631 . . . . 73.43 112.533 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.87 85.76 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.246 0.546 . . . . 72.01 110.164 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.34 147.61 24.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.018 -0.537 . . . . 73.15 111.679 -175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.814 HG13 ' HG ' ' A' ' 29' ' ' LEU . 3.0 mp -82.24 96.93 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.787 0.327 . . . . 53.51 110.145 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.28 -38.61 88.19 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.926 0.393 . . . . 73.11 111.926 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.42 129.5 14.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.699 0.629 . . . . 63.22 112.699 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.543 HG12 HG23 ' A' ' 27' ' ' ILE . 57.1 mt -116.65 128.82 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.989 -0.551 . . . . 74.4 109.738 172.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.76 114.89 9.29 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.325 0.583 . . . . 74.21 111.351 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' HA3' ' A' ' 97' ' ' GLY . 11.4 p -68.39 -31.12 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 116.123 -0.489 . . . . 72.51 112.041 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 22.8 t70 -57.08 -48.01 79.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.751 0.31 . . . . 75.1 111.132 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 136.23 24.01 0.52 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.311 -0.471 . . . . 74.34 113.985 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -95.57 -63.39 1.16 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.091 0.775 . . . . 74.32 113.091 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -145.29 161.23 40.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.107 1.151 . . . . 74.1 114.107 -168.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 20' ' ' ILE . 65.6 mt -116.3 113.81 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.102 -0.953 . . . . 62.51 109.662 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -102.19 112.94 25.81 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.451 0.538 . . . . 74.32 112.451 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 17' ' ' ILE . 4.8 mp -91.92 154.54 18.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.116 -0.493 . . . . 72.23 111.254 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -150.87 123.29 8.41 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.925 0.393 . . . . 73.02 110.96 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.502 ' HB2' HD12 ' A' ' 63' ' ' LEU . 34.1 t30 -83.94 129.49 34.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.784 0.326 . . . . 62.34 111.382 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -109.87 11.24 24.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.25 0.463 . . . . 73.44 112.25 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 94.0 p -80.91 163.44 23.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.454 0.645 . . . . 64.54 112.148 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.06 -18.61 33.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.719 -0.673 . . . . 63.13 111.531 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.54 149.77 46.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.693 0.282 . . . . 73.22 111.288 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -56.69 139.91 48.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.159 0.504 . . . . 64.52 112.209 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -104.02 117.32 59.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.235 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.11 127.73 13.9 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.421 2.08 . . . . 52.45 112.725 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.9 tpp -79.12 -71.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.961 0.41 . . . . 72.25 111.623 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.4 -54.2 2.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.886 -0.673 . . . . 60.02 112.998 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.69 61.77 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.339 -0.458 . . . . 54.22 113.323 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -63.09 153.54 33.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.894 0.378 . . . . 73.53 110.662 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -130.01 116.33 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.206 0.527 . . . . 73.2 111.388 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 102' ' ' VAL . 47.4 ttp -86.8 109.55 19.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.635 -0.711 . . . . 72.3 111.964 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.8 mp -82.94 89.68 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.102 -0.703 . . . . 71.51 109.102 171.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 101.24 6.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.083 0.468 . . . . 75.21 111.396 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 101' ' ' LYS . 68.3 mttm -84.67 -178.86 6.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.317 -0.401 . . . . 72.45 111.016 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -171.2 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.233 0.54 . . . . 74.54 110.547 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.47 -89.24 0.09 OUTLIER Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.96 -0.563 . . . . 55.03 112.702 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.47 -0.09 56.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.025 0.38 . . . . 64.22 112.025 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 t -155.54 164.54 38.52 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.691 0.626 . . . . 74.53 112.691 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -153.15 149.09 27.69 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.658 -0.701 . . . . 72.31 110.739 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.13 134.79 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.874 0.369 . . . . 64.54 111.373 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 m -94.12 111.7 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.11 0.411 . . . . 74.35 112.11 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -103.89 122.82 45.96 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.745 0.307 . . . . 74.14 110.651 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -95.39 116.39 28.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.799 0.333 . . . . 74.32 110.922 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -61.25 121.66 13.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.117 0.484 . . . . 71.3 111.609 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 60' ' ' ARG . 3.5 t -67.2 132.31 47.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.385 0.612 . . . . 62.32 112.019 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.1 p -73.41 23.72 0.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.236 0.828 . . . . 73.32 113.236 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' A' ' 58' ' ' THR . 8.0 ptp180 -73.02 -8.03 53.9 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.12 -0.363 . . . . 72.23 111.841 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HE2' HD23 ' A' ' 63' ' ' LEU . 24.8 p90 -145.85 145.07 30.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.173 0.435 . . . . 63.22 112.173 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.45 124.63 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.185 -0.461 . . . . 65.25 109.777 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -74.4 99.39 3.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.192 0.52 . . . . 74.01 111.298 -173.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -66.8 165.26 15.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.475 0.655 . . . . 52.34 112.723 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.77 125.75 25.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.908 -0.587 . . . . 74.05 111.169 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.22 77.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.197 -0.525 . . . . 52.44 113.527 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.544 ' HB3' HD13 ' A' ' 63' ' ' LEU . 8.6 tp-100 -91.7 153.0 19.95 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.107 0.48 . . . . 74.53 111.572 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.4 p -121.9 145.58 47.95 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.248 -0.433 . . . . 63.25 111.951 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.82 137.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.288 -0.414 . . . . 71.43 110.363 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.6 m -118.66 122.44 42.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.162 0.43 . . . . 62.41 112.162 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 86' ' ' LEU . 41.4 mm -95.2 106.37 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.69 -0.232 . . . . 72.05 111.208 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.737 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 84.6 m95 -91.95 123.13 35.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.572 0.225 . . . . 71.23 111.503 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 88' ' ' TRP . . . -79.1 80.54 5.44 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.084 0.772 . . . . 44.32 113.084 -174.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 61.3 -69.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.286 1.217 . . . . 74.41 114.286 173.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -72.86 36.17 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.337 0.866 . . . . 62.23 113.337 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -75.24 -50.61 15.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.305 0.483 . . . . 70.43 112.305 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.62 38.54 20.32 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.165 -0.541 . . . . 74.15 113.054 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.57 173.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.13 0.49 . . . . 61.13 112.186 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.3 m -67.84 94.02 0.43 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 74.35 112.678 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.64 -86.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.264 0.838 . . . . 74.43 113.264 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.4 t -170.46 110.52 0.44 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.211 0.449 . . . . 74.1 112.211 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 84' ' ' THR . 58.0 Cg_exo -46.21 160.61 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.486 2.79 . . . . 70.41 111.521 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER 9.03 64.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.903 0 N-CA-C 121.517 3.622 . . . . 74.21 121.517 36.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.644 HG22 ' HB3' ' A' ' 82' ' ' PRO . 9.0 t 147.78 -67.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.988 1.715 . . . . 72.35 111.209 161.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' H ' HG23 ' A' ' 84' ' ' THR . 8.0 m-20 -87.67 173.98 8.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.114 -0.366 . . . . 63.02 110.398 172.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.4 mt -139.96 130.61 25.75 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.751 0.31 . . . . 75.11 111.128 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.9 mp -87.15 106.01 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.438 0.637 . . . . 72.25 111.136 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.614 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 6.3 t90 -74.24 98.53 3.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.622 -0.717 . . . . 61.41 111.003 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -73.16 -28.54 62.28 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.404 0.52 . . . . 53.31 112.404 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.614 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 10.8 m120 -71.55 -16.96 62.33 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.905 0.706 . . . . 64.2 112.905 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 44.1 tt0 -145.77 139.2 26.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.008 -0.433 . . . . 73.13 111.731 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.704 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -90.21 -174.82 4.32 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.063 0.459 . . . . 70.22 111.089 173.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.2 p -56.27 120.48 7.66 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.423 -0.353 . . . . 70.34 111.864 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.496 ' NE1' ' HA2' ' A' ' 24' ' ' GLY . 33.9 p90 -70.92 -38.74 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.504 0.557 . . . . 75.22 112.504 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 54.3 63.93 4.74 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.314 -0.47 . . . . 62.41 113.763 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.596 HG23 ' H ' ' A' ' 97' ' ' GLY . 1.6 t -167.52 -63.25 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.658 0.614 . . . . 65.24 112.658 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.596 ' H ' HG23 ' A' ' 96' ' ' THR . . . 72.76 10.09 76.0 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.982 -0.628 . . . . 75.03 113.399 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -70.9 78.57 0.63 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.224 0.512 . . . . 72.33 112.072 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.81 31.58 20.86 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.464 -0.789 . . . . 62.14 112.534 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 120.18 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.166 0.507 . . . . 74.21 109.743 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 4.4 ttmp? -119.15 121.45 39.79 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.928 0.714 . . . . 73.24 112.928 -165.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 44' ' ' MET . 98.1 t -86.82 116.54 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.723 -0.671 . . . . 75.0 111.569 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.8 mm -105.27 114.99 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.617 -0.265 . . . . 70.43 110.766 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.59 102.86 15.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.798 0.666 . . . . 65.41 112.798 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.97 154.89 25.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.376 -0.375 . . . . 64.35 110.509 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 14.2 m120 -99.0 -164.31 1.12 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.844 0.683 . . . . 51.42 112.844 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.1 t -52.98 -51.57 61.11 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.116 1.154 . . . . 45.4 114.116 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -88.28 -61.04 1.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.287 0.565 . . . . 74.32 111.731 -172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.59 27.71 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.785 -0.643 . . . . 74.44 112.697 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 1.2 pm0 -102.69 135.43 44.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.018 0.437 . . . . 55.0 110.681 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.21 132.52 46.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.055 0.391 . . . . 70.4 112.055 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 66.5 t -88.75 -62.08 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.267 -0.424 . . . . 72.41 111.352 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.66 179.16 8.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.168 0.509 . . . . 40.35 111.852 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.68 152.93 49.79 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.937 -0.574 . . . . 75.52 110.757 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.59 ' HE ' ' HA ' ' A' ' 115' ' ' ARG . 1.3 tpm_? -151.31 152.04 32.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.614 0.245 . . . . 74.23 110.892 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.7 p -145.33 170.22 16.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.067 -0.395 . . . . 63.43 111.797 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -67.95 113.96 6.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.542 0.571 . . . . 75.15 112.542 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 132.21 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.127 -0.488 . . . . 53.53 111.102 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.77 84.81 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.29 0.567 . . . . 61.33 111.524 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.89 -21.79 37.23 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.949 -0.568 . . . . 64.31 111.021 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.0 m 66.4 98.37 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.748 -0.66 . . . . 51.53 111.261 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.25 1.107 0 C-N-CA 123.421 0.688 . . . . 64.15 112.676 -179.296 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.802 0.334 . . . . 73.34 111.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.28 -178.29 53.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.161 -0.542 . . . . 55.14 113.493 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -135.58 161.18 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.519 -0.4 . . . . 75.51 111.132 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.48 103.91 4.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.365 -0.379 . . . . 55.51 111.294 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -144.42 130.43 19.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.145 0.497 . . . . 72.11 111.254 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -92.66 117.74 30.3 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 73.14 111.849 -175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -148.44 120.51 8.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.093 0.473 . . . . 63.13 111.331 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -125.4 116.95 22.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.131 -0.486 . . . . 64.52 111.214 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -130.56 167.98 17.82 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 71.43 111.79 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.08 -10.42 36.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.033 0.444 . . . . 65.3 111.036 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 91.2 mmm -76.21 118.08 18.56 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.16 -0.473 . . . . 71.5 111.601 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.4 p -85.03 -64.1 1.21 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 54.15 111.294 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.05 108.34 2.38 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.263 -0.494 . . . . 74.15 113.227 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 32' ' ' THR . 45.3 t30 -77.73 103.91 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.278 0.561 . . . . 74.05 111.178 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.73 125.68 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.548 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB1' ' A' ' 113' ' ' ALA . 53.7 t -135.49 159.87 40.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.923 0.392 . . . . 74.32 111.624 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.6 mp -87.06 131.35 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.6 -0.273 . . . . 63.45 110.341 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -104.3 -34.27 8.38 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.788 0.292 . . . . 74.31 111.788 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.78 145.01 30.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.102 0.477 . . . . 52.43 111.449 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.36 130.25 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.273 -0.421 . . . . 73.43 110.796 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.34 147.25 40.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.189 0.519 . . . . 75.14 110.888 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 97' ' ' GLY . 13.9 p -105.19 -25.07 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 74.22 111.693 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 21.2 t70 -64.13 -56.66 13.28 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.064 0.459 . . . . 64.11 111.539 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 144.33 41.89 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.42 -0.419 . . . . 61.04 112.575 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -113.17 -61.97 1.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.733 0.642 . . . . 74.12 112.733 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.95 168.19 26.65 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.107 1.151 . . . . 64.32 114.107 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.3 mt -126.06 131.08 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.906 -1.043 . . . . 72.11 109.371 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -100.76 101.81 12.75 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.483 0.549 . . . . 71.51 112.483 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -88.48 156.01 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.33 110.159 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -146.61 127.72 14.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.952 0.406 . . . . 73.23 111.762 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -84.37 110.28 18.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.355 -0.384 . . . . 62.44 110.673 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 14' ' ' ASN . 11.7 t -95.13 9.78 38.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.095 0.474 . . . . 71.24 111.163 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.1 t -82.39 149.85 27.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.059 -0.518 . . . . 72.45 111.391 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.73 43.12 1.01 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.27 -0.423 . . . . 74.31 111.4 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -168.91 154.17 6.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.872 0.368 . . . . 72.24 111.677 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 11.9 m-20 -68.08 104.11 1.69 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.448 -0.342 . . . . 72.52 110.928 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.95 118.9 66.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.85 0.315 . . . . 75.21 111.85 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.34 117.54 5.03 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.745 2.297 . . . . 70.12 112.51 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.34 77.32 3.1 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.98 0.419 . . . . 71.53 111.5 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.66 -68.96 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.028 -0.606 . . . . 71.34 113.976 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.59 2.89 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.505 -0.379 . . . . 54.34 113.722 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -129.58 140.1 51.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.542 0.337 . . . . 73.52 111.135 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 34.3 tt0 -136.12 125.34 24.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.418 . . . . 74.2 110.733 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.5 ttp -102.83 133.86 47.2 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.0 0.429 . . . . 65.15 111.811 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 54' ' ' SER . 32.2 mt -127.17 116.77 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.477 -0.329 . . . . 74.3 110.865 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.588 ' NH2' HG13 ' A' ' 100' ' ' VAL . 67.5 ttt180 -100.84 122.72 43.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.928 0.394 . . . . 73.12 110.947 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -98.2 137.36 37.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.747 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 100' ' ' VAL . 7.3 tt -130.91 91.72 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.53 0.681 . . . . 72.52 111.485 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.55 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.811 -0.632 . . . . 71.42 113.602 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.88 -64.85 1.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.605 0.362 . . . . 73.13 111.78 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -95.06 178.53 5.52 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.895 0.702 . . . . 71.21 112.895 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -149.27 152.9 36.71 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.176 -0.466 . . . . 63.32 110.968 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -129.57 137.86 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.701 0.286 . . . . 74.4 111.193 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.464 ' HB3' HG12 ' A' ' 45' ' ' ILE . 85.8 p -120.46 161.97 20.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.991 0.737 . . . . 61.42 112.991 -175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -163.57 117.99 1.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.624 -0.716 . . . . 73.2 111.286 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 56.7 tttm -88.1 151.35 22.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.952 0.406 . . . . 73.21 111.488 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -98.21 168.34 10.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.004 0.431 . . . . 74.35 111.718 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -130.37 132.38 45.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.997 0.427 . . . . 54.12 111.752 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.3 t -72.32 86.64 1.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 53.45 112.334 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 82' ' ' PRO . 14.6 ptm180 -131.29 6.05 4.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.903 0.383 . . . . 73.11 111.551 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.42 155.15 29.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.336 -0.393 . . . . 64.45 110.554 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 31.5 m -114.52 130.33 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.251 0.548 . . . . 63.14 112.049 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.3 mm? -83.45 114.6 21.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.418 -0.355 . . . . 71.24 110.93 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 35.9 mtmm -66.4 168.61 8.66 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.065 0.46 . . . . 52.02 111.866 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.22 107.3 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.352 -0.386 . . . . 65.0 111.47 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.88 6.44 67.27 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.401 -0.428 . . . . 30.22 113.086 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.547 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -79.71 137.13 36.95 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.467 -0.431 . . . . 74.32 111.511 -178.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.1 p -103.53 139.67 38.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.16 0.505 . . . . 70.42 111.718 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.35 123.67 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.188 0.518 . . . . 74.34 110.159 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.3 m -95.15 102.22 14.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.176 -0.465 . . . . 62.53 111.477 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.18 97.53 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.324 -0.398 . . . . 74.1 111.105 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' HB2' HG13 ' A' ' 87' ' ' ILE . 93.2 m95 -78.98 160.55 27.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.24 111.623 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.28 165.93 20.98 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.391 -0.368 . . . . 75.1 111.209 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.03 -27.58 45.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.52 25.49 1.68 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.938 0.347 . . . . 74.2 111.938 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.08 64.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.814 0.672 . . . . 73.22 112.814 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.52 75.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.165 -0.541 . . . . 52.24 113.722 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.52 -172.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.556 -0.379 . . . . 72.15 111.017 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.0 m -61.39 101.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.656 -0.498 . . . . 64.32 109.656 171.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.87 42.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.113 0.782 . . . . 65.44 113.113 -168.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.7 m -157.9 139.2 9.69 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 112.275 0.472 . . . . 41.11 112.275 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 56.0 Cg_exo -44.12 163.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 123.645 2.897 . . . . 62.23 112.162 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 26.9 Cg_exo -11.02 -80.75 0.0 OUTLIER 'Cis proline' 0 C--N 1.375 1.925 0 N-CA-C 121.297 3.537 . . . . 63.14 121.297 17.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 85' ' ' ASP . 1.7 t -106.37 -79.39 0.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.83 1.418 . . . . 64.31 114.83 -165.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.659 ' H ' HG23 ' A' ' 84' ' ' THR . 21.8 m-20 -68.59 129.14 39.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.0 0.741 . . . . 63.1 113.0 -167.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 104.3 16.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.891 -0.595 . . . . 74.13 111.288 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -74.52 121.82 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.781 0.324 . . . . 74.35 110.533 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.412 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.6 t90 -64.91 77.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.352 0.596 . . . . 72.2 111.078 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.74 22.44 0.59 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.179 -0.464 . . . . 63.52 112.234 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 18.4 m120 -120.53 11.55 11.36 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.054 0.454 . . . . 75.11 110.939 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -150.48 131.96 14.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.26 -0.427 . . . . 71.21 111.096 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -80.26 178.8 8.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.922 0.391 . . . . 61.41 111.209 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -66.84 116.27 7.53 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.338 -0.226 . . . . 75.33 111.015 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.469 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 43.6 p90 -60.66 -47.15 87.51 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.319 0.488 . . . . 73.05 112.319 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' ASP . . . 58.26 11.76 10.37 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.721 0.648 . . . . 71.24 114.721 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -71.0 -31.41 67.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.772 0.656 . . . . 63.43 112.772 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 22' ' ' VAL . . . 69.22 14.22 68.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.981 -0.628 . . . . 63.21 113.037 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -96.58 179.22 5.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.224 0.535 . . . . 54.42 112.071 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 15.0 p-10 -60.99 -45.32 95.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.769 -0.651 . . . . 70.35 111.599 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG13 ' NH2' ' A' ' 46' ' ' ARG . 7.4 p 30.73 88.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 72.34 113.28 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HD2' ' NE2' ' A' ' 114' ' ' GLN . 34.1 ttpt -86.94 138.53 31.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.077 -0.965 . . . . 75.42 112.846 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 12.4 p -103.63 142.66 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 112.068 0.396 . . . . 74.1 112.068 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mm -122.41 138.59 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.763 0.425 . . . . 61.12 111.579 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 17' ' ' ILE . 52.4 mt -107.79 121.01 43.85 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.953 0.406 . . . . 74.23 111.769 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' GLU . 67.8 mttm -115.13 149.0 38.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.087 -0.506 . . . . 62.03 111.167 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.39 -176.92 6.07 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.105 0.479 . . . . 52.43 111.008 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.3 p -55.62 -34.94 65.35 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.144 -0.48 . . . . 64.12 111.001 170.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -72.89 -12.64 61.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.128 -0.487 . . . . 51.55 111.99 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.91 1.58 84.81 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.88 0.712 . . . . 53.01 114.88 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 105' ' ' LYS . 11.9 pt-20 -92.48 178.52 5.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.107 0.953 . . . . 74.13 112.033 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -92.24 133.59 35.67 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.244 0.831 . . . . 54.03 113.244 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.7 t -106.2 -50.23 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.019 -0.537 . . . . 75.13 110.717 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HB1' ' SG ' ' A' ' 16' ' ' CYS . . . -159.39 162.65 35.82 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.869 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.598 ' NE2' ' HD2' ' A' ' 101' ' ' LYS . 12.6 pt20 -153.17 171.32 18.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.099 -0.501 . . . . 71.51 111.177 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.3 ttm180 -175.6 147.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.859 0.361 . . . . 74.13 111.565 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.1 p -110.95 179.26 4.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.457 0.303 . . . . 62.52 111.002 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 80.7 p -75.48 117.69 17.55 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.128 0.49 . . . . 63.13 111.601 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -85.95 111.89 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.914 0.388 . . . . 73.24 110.623 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.77 70.72 2.57 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.498 0.666 . . . . 74.44 111.949 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -87.17 -38.92 15.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.845 -0.616 . . . . 64.21 111.013 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.8 m 57.85 102.33 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.542 0.571 . . . . 64.54 112.542 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.255 1.371 0 CA-C-N 116.15 -0.477 . . . . 74.4 111.932 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.643 ' SD ' ' NE2' ' A' ' 3' ' ' HIS . 20.9 ptp . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 111.732 0.271 . . . . 73.22 111.732 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.23 1.49 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.029 -0.605 . . . . 72.52 113.796 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.643 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 33.8 m170 -84.46 88.4 7.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.037 0.446 . . . . 73.22 110.95 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -94.14 125.14 38.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.957 0.408 . . . . 75.03 111.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -131.13 93.67 3.43 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.174 0.511 . . . . 73.35 111.97 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -138.74 102.51 4.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.386 -0.37 . . . . 74.51 110.891 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -99.58 -3.85 32.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.764 0.653 . . . . 73.0 112.764 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -76.29 105.3 7.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.169 0.509 . . . . 63.13 110.282 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 m -90.13 97.2 11.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.614 0.598 . . . . 43.22 112.614 -171.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -134.94 89.35 2.52 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.2 0.524 . . . . 72.55 110.098 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.5 mmt -88.11 155.36 19.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.765 -0.652 . . . . 63.52 111.924 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 t -141.52 113.98 8.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.092 -0.503 . . . . 71.43 111.626 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.3 101.32 2.75 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.226 -0.512 . . . . 72.32 112.653 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -100.32 9.12 43.16 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.276 0.473 . . . . 70.12 112.276 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.48 124.48 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.889 0.375 . . . . 75.01 111.216 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -144.95 174.38 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.502 -0.317 . . . . 65.31 110.979 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.32 124.5 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.238 -0.289 . . . . 73.51 111.483 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.77 -53.25 6.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.921 0.391 . . . . 72.22 110.872 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -165.02 137.06 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.23 0.538 . . . . 54.11 111.798 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 27' ' ' ILE . 61.2 mt -104.22 126.15 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.27 -0.423 . . . . 64.35 110.238 176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.28 122.47 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.134 0.492 . . . . 73.33 111.87 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.64 -26.12 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.142 -0.481 . . . . 72.15 111.938 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -33.48 73.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.818 0.342 . . . . 64.02 110.586 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.64 30.05 3.92 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 114.126 0.41 . . . . 72.12 114.126 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 6.8 mtpm? -98.98 -39.94 8.3 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.791 0.663 . . . . 75.41 112.791 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -153.6 158.19 40.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.265 0.839 . . . . 73.33 113.265 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 102' ' ' VAL . 66.0 mt -118.89 107.44 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.44 109.648 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 35.6 ttt85 -97.85 117.61 32.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.317 0.58 . . . . 75.01 112.512 -171.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.553 ' HB2' HG13 ' A' ' 69' ' ' VAL . 6.5 mp -97.8 -172.68 2.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.011 -0.541 . . . . 63.12 111.501 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 22.9 ttmm -158.05 139.4 13.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.942 0.401 . . . . 72.24 111.719 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -103.21 100.26 10.16 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.451 -0.34 . . . . 71.54 110.253 168.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 5.0 t -102.27 98.83 8.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.411 0.624 . . . . 71.11 111.314 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -166.69 -178.46 4.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.312 0.577 . . . . 73.32 111.633 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -109.67 7.04 24.25 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.936 -0.574 . . . . 74.32 110.392 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -135.4 135.03 40.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 74.55 110.816 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.43 134.19 49.8 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.995 0.426 . . . . 61.13 111.853 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 27.3 mm-40 -89.0 112.77 52.91 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.391 -0.368 . . . . 72.44 111.213 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 2.7 Cg_exo -76.3 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.777 2.318 . . . . 32.44 113.122 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.17 -73.27 0.05 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.104 0.562 . . . . 75.54 111.734 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 -75.48 1.57 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.143 -0.551 . . . . 73.05 113.001 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.67 93.7 0.11 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 74.32 113.403 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -116.44 167.71 10.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.661 0.384 . . . . 72.21 110.712 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -144.42 132.34 21.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.171 0.51 . . . . 74.22 111.34 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.6 ttp -103.82 107.78 18.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.848 -0.614 . . . . 60.35 111.428 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.9 mp -95.11 99.94 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.781 0.324 . . . . 71.34 110.845 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.438 HH12 ' NE2' ' A' ' 91' ' ' GLN . 32.9 ttt180 -85.89 102.84 14.08 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.128 -0.357 . . . . 73.11 111.101 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -96.88 117.73 31.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.438 -0.346 . . . . 74.32 111.09 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.16 122.43 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.134 0.493 . . . . 73.13 112.037 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.7 -110.28 2.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.989 -0.551 . . . . 33.33 113.907 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.74 27.4 9.7 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.973 0.36 . . . . 71.35 111.973 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -153.62 162.35 41.34 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.237 0.541 . . . . 55.25 112.005 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -153.81 114.01 3.93 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.021 -0.536 . . . . 50.44 110.205 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.39 134.87 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 120.941 0.401 . . . . 65.13 111.809 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.2 m -109.16 124.24 50.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.288 -0.415 . . . . 70.35 111.697 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.459 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 70.0 t80 -114.26 108.77 17.39 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.807 0.337 . . . . 74.1 111.686 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.35 109.67 11.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.917 0.389 . . . . 73.35 110.542 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 94.1 m-85 -56.18 135.49 53.19 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.644 0.609 . . . . 54.42 112.644 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -97.27 123.1 40.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.044 -0.525 . . . . 64.2 111.248 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 t -73.56 68.72 1.19 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.118 0.414 . . . . 75.43 112.118 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -87.04 -12.87 46.02 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.987 0.422 . . . . 73.45 111.375 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.46 167.8 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.285 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.76 121.36 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.873 0.368 . . . . 73.45 111.593 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -76.24 87.1 3.07 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.479 0.657 . . . . 62.03 110.166 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 158.33 30.62 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.955 0.724 . . . . 62.22 112.955 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.62 117.89 6.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.612 -0.722 . . . . 75.31 112.841 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.53 -19.75 35.92 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.306 -0.473 . . . . 63.1 114.028 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.44 141.7 38.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.396 0.617 . . . . 75.12 111.747 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.4 p -105.31 98.38 8.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.783 -0.644 . . . . 72.54 111.735 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 29' ' ' LEU . 3.8 p -69.8 117.61 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 64.21 111.693 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 37.0 m -97.55 123.05 41.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.149 0.5 . . . . 62.12 111.921 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 57' ' ' TYR . 47.8 mm -84.28 102.76 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.318 -0.401 . . . . 60.51 110.928 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.75 118.15 24.26 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.51 -0.314 . . . . 74.31 110.621 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' ASN . . . -71.45 77.46 0.77 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.65 0.611 . . . . 55.34 112.65 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 56.51 -72.82 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.399 0.889 . . . . 74.2 113.399 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 73' ' ' ALA . 65.5 m-20 -87.94 100.71 13.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.908 0.385 . . . . 63.34 111.43 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.47 9.02 0.34 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.546 0.573 . . . . 54.02 112.546 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.65 -35.84 1.83 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.169 -0.539 . . . . 42.13 114.31 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.66 149.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.381 0.511 . . . . 74.42 112.381 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -62.84 175.7 0.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.54 0.57 . . . . 62.42 112.54 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.44 76.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.092 0.775 . . . . 75.2 113.092 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.491 ' HA ' HD13 ' A' ' 87' ' ' ILE . 69.8 m 65.17 104.17 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.621 0.971 . . . . 73.2 113.621 173.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HB3' HG22 ' A' ' 84' ' ' THR . 67.6 Cg_exo -45.96 169.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 123.747 2.965 . . . . 51.23 112.016 166.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' C ' ' HB3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER 10.76 65.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 N-CA-C 121.65 3.673 . . . . 74.0 121.65 38.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 82' ' ' PRO . 15.3 t 144.74 -59.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.3 1.84 . . . . 71.12 110.812 162.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' H ' ' CB ' ' A' ' 82' ' ' PRO . 21.3 m-20 -110.76 -168.62 1.33 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.195 0.598 . . . . 61.32 110.296 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -141.78 137.15 31.37 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.945 0.402 . . . . 63.51 111.603 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 81' ' ' SER . 1.6 mp -91.36 123.7 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.699 0.761 . . . . 71.23 111.016 175.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.496 ' CE2' ' HB2' ' A' ' 90' ' ' ASN . 21.7 t90 -92.12 109.74 21.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.324 -0.853 . . . . 65.1 110.999 -176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -93.88 2.07 56.24 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.246 0.832 . . . . 74.55 113.246 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 17.2 m120 -74.01 -40.81 62.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.86 -0.525 . . . . 72.52 111.755 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' NE2' HH12 ' A' ' 46' ' ' ARG . 39.9 tt0 -148.52 155.88 41.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.605 0.24 . . . . 71.4 110.607 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.675 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.7 m120 -91.97 175.96 6.69 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.284 0.564 . . . . 73.44 112.447 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -59.57 125.13 22.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 72.21 111.508 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -104.56 -173.66 2.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.01 0.433 . . . . 73.02 111.664 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.76 95.86 0.14 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.265 -0.493 . . . . 52.01 112.759 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -167.51 160.44 13.1 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.668 -0.313 . . . . 63.42 111.438 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.15 4.1 62.39 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.289 -0.481 . . . . 44.04 113.122 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.76 156.67 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.175 0.512 . . . . 64.31 112.248 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.91 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.777 0.658 . . . . 42.33 112.777 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 117' ' ' THR . 6.5 p -81.04 79.61 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.079 0.942 . . . . 62.51 109.622 167.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 3.9 ttmp? -88.13 105.63 17.63 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.554 -0.748 . . . . 62.02 111.391 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 27' ' ' ILE . 61.7 t -91.05 123.39 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.665 -0.698 . . . . 74.53 111.48 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 21.4 mm -106.57 117.66 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.149 -0.478 . . . . 61.33 110.934 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -91.96 121.72 33.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.838 0.351 . . . . 54.12 111.341 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 93.6 mttt -130.58 168.27 17.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.711 0.291 . . . . 65.41 111.315 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 20.3 m120 -97.08 175.6 6.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.901 0.381 . . . . 74.41 111.141 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -57.97 -33.2 68.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.775 0.658 . . . . 75.03 112.775 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.91 0.68 17.44 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 72.11 112.436 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.42 33.53 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.152 -0.547 . . . . 30.0 113.336 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 10.9 pt-20 -103.08 127.28 50.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.943 0.401 . . . . 61.43 110.918 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 34.2 tt0 -76.82 138.93 40.14 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.978 0.418 . . . . 52.0 111.97 -175.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.45 -61.99 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.256 -0.429 . . . . 44.12 111.326 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.99 162.19 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.7 0.286 . . . . 62.45 111.57 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.36 157.64 42.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.993 0.425 . . . . 73.33 111.834 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -164.31 156.19 16.31 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.201 -0.454 . . . . 75.43 110.977 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.7 p -141.17 -162.37 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.6 0.238 . . . . 75.14 111.3 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.647 HG23 HG12 ' A' ' 100' ' ' VAL . 17.0 p -61.71 94.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.173 0.511 . . . . 63.32 111.89 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.37 86.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.455 0.645 . . . . 74.51 110.846 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -78.38 26.0 0.23 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.897 -0.592 . . . . 74.4 112.39 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -140.48 133.28 29.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.147 -0.346 . . . . 61.14 110.559 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -94.46 128.26 40.92 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.209 0.528 . . . . 63.1 111.336 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.041 0.385 . . . . 74.25 112.041 -176.051 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.12 0.486 . . . . 63.24 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.9 158.61 10.16 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.032 -0.531 . . . . 41.2 112.784 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -136.62 21.83 3.12 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.72 0.637 . . . . 75.24 112.72 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -104.56 95.89 6.22 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.767 0.317 . . . . 74.2 111.405 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -108.94 -14.73 14.51 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.355 0.502 . . . . 71.04 112.355 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -75.74 82.97 2.71 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.145 0.498 . . . . 41.12 111.876 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -128.67 112.02 13.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.206 -0.452 . . . . 75.14 111.28 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.55 ' NE2' ' SD ' ' A' ' 11' ' ' MET . 56.5 p-80 -132.29 112.91 12.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.981 0.419 . . . . 65.44 110.304 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 p -82.91 58.83 4.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.187 0.518 . . . . 72.51 112.221 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -151.44 83.17 1.3 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.085 -0.507 . . . . 74.12 110.129 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.55 ' SD ' ' NE2' ' A' ' 8' ' ' HIS . 94.3 mmm -140.05 152.5 46.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 74.33 112.32 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 t -128.14 170.21 13.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.758 -0.655 . . . . 73.5 111.167 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 129.07 10.52 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 114.306 0.482 . . . . 44.51 114.306 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -114.43 -57.7 2.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.85 0.357 . . . . 73.31 111.435 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.89 143.68 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.324 -0.398 . . . . 55.41 111.331 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 17' ' ' ILE . 44.2 t -141.62 173.37 11.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.091 0.472 . . . . 74.05 111.699 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.537 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 61.0 mt -81.51 127.45 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.344 -0.389 . . . . 73.21 111.33 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 37.0 tt0 -81.71 -58.33 3.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.659 -0.497 . . . . 71.44 109.659 171.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 25.2 tt0 173.82 152.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.799 -0.637 . . . . 65.34 111.097 169.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 102' ' ' VAL . 23.1 mt -71.89 162.57 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 116.164 -0.471 . . . . 74.3 111.239 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 20' ' ' ILE . 19.0 t70 -61.14 150.36 34.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.229 0.537 . . . . 73.24 111.835 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.07 -33.45 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.849 -0.614 . . . . 63.42 112.268 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.52 -30.58 19.24 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.147 0.498 . . . . 73.22 111.028 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.04 35.75 3.86 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.104 -0.498 . . . . 73.32 112.827 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -96.06 -29.04 14.32 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.709 0.29 . . . . 74.41 111.759 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.09 176.01 12.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.463 0.649 . . . . 74.41 112.286 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -119.89 138.54 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.805 -0.634 . . . . 75.53 109.946 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 28' ' ' ARG . 10.3 ttp180 -119.26 110.21 16.74 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.213 0.53 . . . . 75.43 111.9 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.6 mp -106.9 175.51 5.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.981 -0.554 . . . . 75.22 110.57 175.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 39.3 ttmt -151.71 138.67 19.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.936 0.398 . . . . 75.3 111.713 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -75.46 84.57 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.562 . . . . 63.31 110.821 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.2 p -78.0 89.03 4.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 61.44 111.094 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.4 p -158.48 -175.77 5.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.305 -0.407 . . . . 71.43 111.161 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.47 -4.52 31.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.334 0.494 . . . . 62.32 112.334 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -156.39 166.68 32.72 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.786 0.327 . . . . 65.31 111.306 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -54.97 117.15 3.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.79 0.293 . . . . 73.53 111.79 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -127.46 112.86 21.11 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 122.618 0.367 . . . . 72.44 110.889 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 58.2 Cg_endo -70.67 136.9 31.65 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.251 1.968 . . . . 62.45 112.921 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 tpt -66.28 -85.59 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 116.452 -0.34 . . . . 75.34 110.706 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.93 -83.09 0.02 OUTLIER Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.362 0.905 . . . . 61.23 115.362 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.48 46.07 3.19 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.605 0.602 . . . . 64.23 114.605 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -120.25 147.27 45.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.457 -0.437 . . . . 73.13 111.124 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -113.77 109.82 19.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.04 -0.527 . . . . 65.34 110.758 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -91.34 116.25 28.69 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.236 -0.438 . . . . 73.22 111.717 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.5 mp -106.26 103.62 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 109.811 -0.44 . . . . 73.12 109.811 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.503 HH12 ' HB ' ' A' ' 48' ' ' ILE . 47.7 ttp85 -89.39 114.1 25.5 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 73.13 111.628 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -93.44 168.71 10.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.101 -0.499 . . . . 74.32 111.304 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 49' ' ' GLY . 10.8 tt -169.74 -60.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.853 -0.612 . . . . 70.23 111.148 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -159.68 114.87 0.63 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.235 -0.507 . . . . 70.5 112.584 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 67.45 -75.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.213 0.605 . . . . 75.13 111.999 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -93.88 150.86 20.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.196 0.522 . . . . 63.24 112.151 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.6 p -142.06 149.73 40.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.053 0.454 . . . . 72.1 111.444 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.34 146.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.827 0.346 . . . . 74.01 111.654 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.417 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.5 p -111.91 164.49 13.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.821 0.674 . . . . 61.1 112.821 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -161.36 135.07 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.006 -0.543 . . . . 75.01 111.514 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -91.6 135.12 34.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.566 0.222 . . . . 75.0 110.724 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -67.58 147.02 53.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.044 0.449 . . . . 64.53 111.974 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 t -81.2 126.24 31.27 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.365 0.602 . . . . 63.11 112.226 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.9 m -85.49 82.85 8.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 63.33 110.94 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -135.32 14.04 3.51 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.633 0.605 . . . . 75.34 112.633 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -165.53 158.64 15.94 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.895 0.379 . . . . 53.32 111.913 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 38' ' ' PRO . 61.4 t -104.57 113.92 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.268 -0.423 . . . . 75.1 110.308 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.34 118.56 21.36 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.848 0.356 . . . . 75.42 111.231 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -64.33 152.62 40.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.377 0.608 . . . . 71.55 112.628 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 127.84 33.15 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.046 -0.525 . . . . 70.13 111.851 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.01 -2.05 88.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.149 -0.548 . . . . 72.13 113.41 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.693 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -88.44 148.97 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.541 -0.388 . . . . 72.53 111.389 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 71.3 p -95.75 157.54 15.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.19 0.519 . . . . 72.34 112.062 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.65 125.21 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.172 0.51 . . . . 73.33 110.191 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -101.61 108.23 19.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.279 -0.419 . . . . 64.23 111.948 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 86' ' ' LEU . 44.0 mm -91.77 102.63 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.464 -0.335 . . . . 63.2 111.23 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m95 -85.0 170.28 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.0 0.429 . . . . 73.51 111.979 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.82 167.37 11.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.394 -0.366 . . . . 50.24 111.285 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -51.08 -41.72 60.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -93.49 35.52 1.11 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.844 0.354 . . . . 65.21 111.849 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -65.19 -45.94 82.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.486 0.55 . . . . 42.3 112.486 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.1 -38.47 3.17 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.262 -0.494 . . . . 60.24 113.122 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 87' ' ' ILE . 27.0 m -68.17 170.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.085 0.402 . . . . 72.22 112.085 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.0 m -60.46 128.93 39.08 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.497 -0.32 . . . . 51.04 111.413 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.22 -40.17 46.63 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.853 0.686 . . . . 74.54 112.853 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -146.95 89.38 5.66 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 121.049 0.452 . . . . 64.51 111.345 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.712 ' HB2' ' H ' ' A' ' 84' ' ' THR . 47.1 Cg_exo -59.34 -32.13 96.18 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.772 2.981 . . . . 71.43 117.233 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.659 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 28.0 Cg_endo -101.13 37.79 5.59 Favored 'Cis proline' 0 C--N 1.371 1.718 0 CA-C-N 122.437 1.906 . . . . 74.4 114.532 3.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.712 ' H ' ' HB2' ' A' ' 82' ' ' PRO . 74.9 p -62.83 -48.51 78.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.098 0.475 . . . . 63.44 111.219 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 4.8 m-20 -93.29 161.13 14.53 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.087 -0.506 . . . . 63.34 110.943 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 71' ' ' ILE . 90.6 mt -130.02 109.54 10.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.87 0.366 . . . . 62.14 110.631 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 78' ' ' VAL . 1.5 mp -85.47 111.18 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.653 0.74 . . . . 74.42 111.637 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.572 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 21.2 t90 -79.68 96.86 6.34 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.309 -0.859 . . . . 73.21 111.19 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 74' ' ' ALA . 53.4 mtmt -93.35 22.39 5.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.383 0.883 . . . . 71.2 113.383 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 14.7 m120 -89.92 -8.58 51.48 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.118 0.485 . . . . 75.52 110.799 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -150.91 134.47 16.37 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.025 -0.534 . . . . 75.04 111.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.3 m120 -64.67 -56.06 16.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.467 0.543 . . . . 72.42 112.467 -175.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.9 t -179.09 -178.44 0.52 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.552 0.341 . . . . 65.02 110.793 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -142.22 -82.64 0.2 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 111.634 0.235 . . . . 73.31 111.634 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 35.28 49.06 0.87 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 115.912 1.125 . . . . 43.33 115.912 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -156.37 137.32 13.53 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.862 1.06 . . . . 64.2 113.862 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.15 -97.97 0.78 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.51 0.964 . . . . 72.52 115.51 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -84.92 177.23 8.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.078 0.77 . . . . 75.24 113.078 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 7.4 p-10 -75.27 121.38 22.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.101 -0.954 . . . . 74.13 112.382 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 HH11 ' A' ' 46' ' ' ARG . 7.3 p -81.07 128.59 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.171 0.51 . . . . 75.03 110.955 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -140.15 119.49 12.97 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.34 -0.391 . . . . 65.43 111.443 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 20' ' ' ILE . 85.0 t -93.81 136.97 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.519 0.563 . . . . 72.12 112.519 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.0 mm -110.74 132.73 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.772 -0.649 . . . . 53.21 111.012 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.8 mt -113.61 111.3 21.64 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.762 0.653 . . . . 60.15 112.762 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -109.07 161.15 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.386 -0.37 . . . . 71.04 110.765 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 112' ' ' VAL . 7.4 m120 -114.98 97.69 6.37 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.903 0.334 . . . . 74.3 111.903 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t 47.71 -77.52 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.987 1.106 . . . . 73.34 113.987 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 106' ' ' ASN . 64.6 mt-30 -61.6 -35.46 77.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.77 0.655 . . . . 72.43 112.77 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.59 -24.17 2.32 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.535 -0.84 . . . . 70.51 113.618 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.98 150.03 25.7 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.276 0.538 . . . . 75.42 111.301 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.82 137.53 54.5 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.503 -0.317 . . . . 73.22 111.655 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.545 HG23 ' OD1' ' A' ' 106' ' ' ASN . 94.7 t -98.91 -68.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.179 0.437 . . . . 64.04 112.179 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.27 162.78 33.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.067 0.766 . . . . 75.25 113.067 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -152.46 143.72 23.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.151 -0.931 . . . . 52.33 110.097 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -153.29 142.91 21.86 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.505 0.558 . . . . 61.3 112.505 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 p -111.94 -174.72 2.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.529 -0.76 . . . . 65.14 110.812 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 p -122.6 -178.2 3.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.263 0.554 . . . . 71.24 112.319 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.38 148.23 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.004 -0.543 . . . . 73.03 111.318 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -77.98 126.85 31.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.387 0.514 . . . . 64.31 112.387 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -108.3 133.61 52.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.406 0.283 . . . . 64.22 110.888 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.7 m -76.97 83.69 3.5 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.134 0.492 . . . . 74.43 111.287 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.625 -0.703 . . . . 73.25 112.005 -177.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.005 0.431 . . . . 74.21 111.652 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.28 49.01 0.05 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.429 -0.415 . . . . 72.53 112.745 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -102.36 96.71 7.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.866 0.365 . . . . 73.45 111.353 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -144.26 175.01 10.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.188 0.518 . . . . 74.42 112.278 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.48 116.92 15.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.091 -0.504 . . . . 74.45 110.755 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -64.54 107.83 1.5 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.856 0.687 . . . . 73.22 112.856 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -145.28 137.33 25.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.27 -0.423 . . . . 74.04 109.901 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -140.62 142.53 35.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.668 0.247 . . . . 64.41 111.668 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.0 p -178.3 112.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.493 -0.321 . . . . 64.54 111.757 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -75.63 90.66 2.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.093 0.473 . . . . 72.32 110.644 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.505 ' HG3' ' HD2' ' A' ' 38' ' ' PRO . 25.4 mmt -99.83 147.27 25.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.149 -0.478 . . . . 74.05 111.628 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 t -71.9 -37.21 70.14 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.092 -0.504 . . . . 51.42 111.785 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.62 68.9 1.47 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.013 -0.613 . . . . 72.22 113.081 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.68 7.79 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.253 -0.557 . . . . 62.53 110.706 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.419 ' HB ' ' CH2' ' A' ' 42' ' ' TRP . 56.6 t -126.7 139.34 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.059 -0.519 . . . . 63.33 111.402 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -121.26 159.39 26.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.977 0.418 . . . . 61.12 111.208 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.572 HD11 ' HG ' ' A' ' 104' ' ' LEU . 55.2 mt -93.13 127.99 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.311 -0.243 . . . . 54.11 111.316 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.54 -77.02 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.691 0.282 . . . . 74.13 111.095 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -169.29 158.01 7.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.266 -0.424 . . . . 74.44 110.838 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 27' ' ' ILE . 48.9 mt -91.69 145.4 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.431 . . . . 71.41 111.495 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.52 143.45 57.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.394 0.516 . . . . 65.52 112.394 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.49 -28.31 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.842 -0.617 . . . . 61.23 112.062 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.09 -31.58 30.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.09 0.471 . . . . 62.43 110.789 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.68 16.55 26.15 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 116.171 -0.468 . . . . 54.12 113.116 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -78.49 -31.25 47.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.347 0.499 . . . . 72.31 112.347 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -157.27 167.05 31.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.861 1.06 . . . . 74.03 113.861 -172.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG23 HG12 ' A' ' 20' ' ' ILE . 68.1 mt -127.07 110.93 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.934 -1.03 . . . . 72.44 109.343 170.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.3 ttp180 -92.58 117.42 29.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.346 0.593 . . . . 70.5 112.378 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.5 mp -99.91 158.55 15.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.863 -0.608 . . . . 71.15 110.26 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 65.0 tttm -124.03 116.83 23.47 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.024 -0.422 . . . . 63.43 111.505 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.33 108.14 3.58 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.097 0.475 . . . . 73.24 110.411 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -96.52 18.05 14.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.383 0.512 . . . . 73.42 112.383 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.8 p -71.72 161.79 30.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.418 0.628 . . . . 73.21 111.72 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -85.73 -19.4 30.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 72.11 111.168 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -142.03 158.36 43.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.587 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.12 135.78 12.62 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.501 0.556 . . . . 75.43 112.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -134.35 132.46 21.01 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.166 -0.47 . . . . 62.3 111.33 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 11' ' ' MET . 73.3 Cg_endo -73.46 21.31 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.706 2.271 . . . . 71.11 113.442 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 tpt 63.5 -78.84 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.474 0.71 . . . . 71.4 112.285 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.41 -170.49 18.49 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.3 -0.476 . . . . 52.12 113.732 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.63 1.59 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.309 -0.472 . . . . 70.13 113.384 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.534 ' H ' ' HB2' ' A' ' 57' ' ' TYR . 11.9 m95 -98.46 151.16 20.9 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 122.481 -0.423 . . . . 75.31 111.228 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.64 114.41 24.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.884 0.373 . . . . 52.34 110.001 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.454 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 56.2 ttp -98.33 108.45 21.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.442 -0.344 . . . . 51.03 111.087 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -96.8 109.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.584 -0.28 . . . . 75.32 111.444 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -99.46 101.29 12.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.69 0.281 . . . . 74.23 110.931 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 47' ' ' LYS . 7.6 mtpm? -82.04 84.78 6.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.053 0.454 . . . . 72.13 110.987 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -103.39 118.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.021 -0.536 . . . . 74.31 111.248 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . 69.02 46.09 60.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.888 -0.672 . . . . 34.12 111.893 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 23.8 t70 73.68 -56.25 0.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.456 0.702 . . . . 74.54 111.953 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -61.61 161.61 9.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.133 0.492 . . . . 75.51 111.795 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 80.5 p -124.0 132.03 53.64 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.26 0.552 . . . . 61.03 112.128 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.4 134.31 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.881 -0.6 . . . . 75.0 109.669 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.8 p -120.18 144.18 47.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.167 0.803 . . . . 64.33 113.167 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -113.83 125.35 53.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.671 -0.695 . . . . 75.02 110.923 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -92.97 128.59 38.89 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.024 0.44 . . . . 63.13 111.001 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.534 ' HB2' ' H ' ' A' ' 42' ' ' TRP . 21.0 m-85 -84.42 165.19 18.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.202 0.525 . . . . 72.42 111.694 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -142.96 176.05 9.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.009 -0.541 . . . . 74.5 110.806 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -123.36 105.97 10.28 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.168 0.508 . . . . 71.43 112.008 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 1.9 ptp180 -140.37 17.68 2.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.974 -0.557 . . . . 74.34 110.292 173.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 47.1 p90 -162.92 172.13 15.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.031 -0.532 . . . . 73.43 111.102 -173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.68 114.63 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.483 -0.326 . . . . 63.35 110.601 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.45 HD23 ' HE2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.42 130.03 39.26 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.073 0.463 . . . . 75.02 110.645 -177.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 85.2 mttt -71.76 149.63 45.19 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.23 0.538 . . . . 71.33 112.346 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.47 122.77 14.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.495 . . . . 53.02 112.036 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 0.04 67.49 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.412 -0.423 . . . . 72.2 114.111 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -79.19 148.47 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.173 0.487 . . . . 73.31 111.898 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 65.1 p -92.7 134.56 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.839 0.352 . . . . 75.43 111.644 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.31 112.87 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.413 0.625 . . . . 62.35 111.004 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 85.3 m -91.36 123.95 35.18 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 65.12 112.047 -176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.5 mm -90.14 99.24 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.822 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HB2' HG13 ' A' ' 87' ' ' ILE . 85.6 m95 -84.49 161.79 20.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.975 0.417 . . . . 64.13 111.966 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 92' ' ' ASN . . . -87.27 167.84 13.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.906 0.384 . . . . 51.41 111.96 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.2 -60.78 2.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.543 0.572 . . . . 62.54 112.543 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -91.08 41.57 1.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.103 0.477 . . . . 71.15 111.877 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.27 60.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.81 0.338 . . . . 55.01 111.664 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.17 -44.22 2.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.319 -0.467 . . . . 74.24 113.627 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.27 171.03 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.459 0.541 . . . . 71.14 112.459 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 81' ' ' SER . 57.8 m -53.87 130.24 36.5 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.784 0.326 . . . . 75.45 111.336 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' HD3' ' A' ' 89' ' ' LYS . . . -78.27 10.28 3.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.413 0.894 . . . . 75.14 113.413 -173.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.449 ' H ' HG22 ' A' ' 79' ' ' THR . 22.9 t -152.73 133.07 7.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 112.407 0.521 . . . . 73.23 112.407 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 66.8 Cg_exo -54.33 -178.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.906 3.071 . . . . 54.4 113.0 172.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 89.6 Cg_endo -93.85 101.67 0.22 Allowed 'Cis proline' 0 C--N 1.366 1.49 0 N-CA-C 115.536 1.322 . . . . 74.32 115.536 5.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.1 p -158.13 -60.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.509 0.724 . . . . 53.33 109.56 171.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 8.1 m-20 -122.1 -168.87 1.79 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.304 -0.862 . . . . 74.24 109.75 172.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.553 ' HB2' HD13 ' A' ' 71' ' ' ILE . 78.4 mt -127.08 108.7 11.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.048 0.452 . . . . 70.25 110.885 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 72' ' ' TRP . 2.2 mp -95.96 108.66 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.318 0.58 . . . . 62.01 111.436 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.466 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 10.9 t90 -74.35 84.06 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.548 0.69 . . . . 63.52 110.617 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HD3' ' HB1' ' A' ' 80' ' ' ALA . 9.7 mtmp? -73.1 4.07 4.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.695 0.628 . . . . 73.54 112.695 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.466 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 16.1 m120 -92.43 -13.35 30.14 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.508 0.559 . . . . 72.54 112.508 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -151.44 159.13 44.35 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.002 0.43 . . . . 54.24 111.327 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 52.4 m-80 -109.83 -169.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.565 0.579 . . . . 75.45 112.565 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.5 m -60.03 156.47 14.77 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.372 0.879 . . . . 70.34 113.372 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -127.46 160.2 32.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.2 -0.909 . . . . 73.03 111.116 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.42 48.68 0.36 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.985 -0.626 . . . . 62.02 112.865 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.4 t -65.65 -22.81 66.68 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.722 0.638 . . . . 73.43 112.722 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.29 3.43 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.074 -0.584 . . . . 71.22 113.238 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -82.41 170.22 15.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.145 0.498 . . . . 65.23 111.849 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.11 164.19 26.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.884 -0.598 . . . . 73.42 111.781 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.5 p -144.66 140.33 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.96 0.41 . . . . 64.01 111.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 39.7 ttpt -107.38 128.87 54.86 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.942 0.401 . . . . 63.31 111.314 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 17' ' ' ILE . 4.0 p -114.01 136.87 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.325 0.583 . . . . 70.05 111.886 -178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.38 142.49 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.917 -0.583 . . . . 64.22 111.599 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 17' ' ' ILE . 38.9 mt -122.95 107.76 12.19 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.054 0.39 . . . . 52.23 112.054 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -114.12 136.56 52.8 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.296 0.57 . . . . 51.02 111.337 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 9.4 m120 -93.57 108.05 19.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.823 -0.626 . . . . 73.45 112.489 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.3 t 59.92 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.297 0.851 . . . . 73.13 113.297 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -80.93 -71.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.444 0.64 . . . . 75.24 111.654 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.58 -22.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.455 -0.793 . . . . 73.4 111.732 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 9.2 pt-20 -44.28 133.25 5.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.344 0.658 . . . . 73.22 111.349 171.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.7 128.8 53.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.898 0.38 . . . . 75.21 111.844 -172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.48 HG13 ' OD1' ' A' ' 106' ' ' ASN . 17.9 m -85.57 -35.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 112.066 0.395 . . . . 72.12 112.066 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.59 154.01 1.94 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.429 0.633 . . . . 72.1 112.621 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -139.59 130.15 25.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.565 -0.743 . . . . 74.31 110.102 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 115' ' ' ARG . 4.0 ttt85 -141.5 148.33 39.24 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.481 0.549 . . . . 51.11 112.481 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.9 p -106.99 169.8 8.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.241 -0.436 . . . . 44.05 111.407 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.1 p -78.51 134.22 37.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.032 0.382 . . . . 73.34 112.032 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.21 135.93 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.945 0.403 . . . . 74.13 111.475 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -70.69 86.58 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.028 0.442 . . . . 73.43 111.529 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -96.18 107.58 19.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 75.21 110.423 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -86.91 -15.3 39.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.97 0.414 . . . . 75.14 112.07 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.777 -0.63 . . . . 72.23 110.881 177.013 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.603 0.239 . . . . 71.03 111.453 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.58 116.43 8.69 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.324 -0.465 . . . . 74.44 113.449 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -137.64 164.98 27.48 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.439 -0.448 . . . . 64.41 111.508 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -66.75 91.78 0.2 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.23 -0.441 . . . . 43.12 111.016 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -82.33 128.29 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.009 0.433 . . . . 72.22 111.106 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -106.09 175.3 5.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.258 -0.428 . . . . 73.43 111.122 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -108.34 141.73 39.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.444 0.164 . . . . 71.22 110.951 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.4 m80 68.91 11.69 8.41 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.098 0.559 . . . . 71.11 111.708 -172.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -80.3 92.85 5.82 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.935 0.398 . . . . 63.34 111.583 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -143.12 123.3 13.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.89 0.376 . . . . 63.34 111.712 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 mmt -129.88 144.36 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.457 -0.338 . . . . 71.44 110.798 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.4 p -73.9 -74.35 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.28 0.474 . . . . 72.12 112.28 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.3 101.82 0.2 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.98 -0.629 . . . . 53.25 113.109 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -102.94 -43.17 5.6 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.598 -0.354 . . . . 72.3 111.908 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.0 t -84.62 102.84 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.899 0.38 . . . . 73.42 111.528 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.8 t -121.41 149.82 42.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.818 0.342 . . . . 65.1 111.404 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 104' ' ' LEU . 61.3 mt -62.37 132.19 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 112.301 0.482 . . . . 75.51 112.301 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -84.47 -62.39 1.57 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.408 0.623 . . . . 74.11 110.206 173.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -149.45 136.68 19.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.614 . . . . 72.33 110.748 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 27' ' ' ILE . 40.9 mt -94.5 146.69 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.945 -0.391 . . . . 75.43 109.945 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.18 129.87 41.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.141 0.496 . . . . 73.15 112.069 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.52 -23.54 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.902 -0.59 . . . . 71.15 111.59 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.37 -32.3 54.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.162 0.506 . . . . 74.12 110.775 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA2' ' NE1' ' A' ' 94' ' ' TRP . . . 102.08 41.9 2.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.073 -0.512 . . . . 73.12 114.32 173.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -129.36 -6.58 4.77 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.975 1.102 . . . . 71.12 113.975 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.74 163.19 24.17 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.573 0.953 . . . . 72.41 113.573 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 20' ' ' ILE . 56.0 mt -134.54 115.5 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.366 -0.834 . . . . 71.22 110.337 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -94.88 110.34 22.23 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.686 -0.634 . . . . 75.53 112.172 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 5.8 mp -94.09 145.3 24.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.063 -0.517 . . . . 63.44 110.636 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -125.65 125.5 43.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.839 0.352 . . . . 71.34 111.11 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.09 127.54 32.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.719 0.295 . . . . 71.43 110.906 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.7 p -93.24 -15.99 25.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.313 0.486 . . . . 74.35 112.313 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.0 p -69.92 134.61 48.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.002 0.429 . . . . 72.32 111.114 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -80.62 25.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.118 0.485 . . . . 41.25 111.424 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.74 143.74 27.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.16 -0.473 . . . . 71.44 110.872 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.84 104.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.722 0.409 . . . . 74.02 111.859 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.04 135.08 20.03 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 111.756 0.28 . . . . 64.21 111.756 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.95 48.07 2.54 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.701 2.267 . . . . 62.43 112.907 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 tpt 67.23 -69.4 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.422 0.689 . . . . 72.31 112.059 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.1 4.01 61.53 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.136 -0.554 . . . . 63.12 113.458 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.87 101.11 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.197 -0.525 . . . . 70.33 113.345 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -121.16 175.88 5.88 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.599 -0.354 . . . . 74.33 111.419 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -145.36 123.11 11.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.421 . . . . 74.32 111.387 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.6 ttp -99.96 117.31 33.98 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.119 -0.491 . . . . 73.15 111.329 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.2 mp -104.45 105.49 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.036 0.446 . . . . 73.2 111.036 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.666 HH11 ' HZ3' ' A' ' 88' ' ' TRP . 61.0 ttt180 -82.29 109.02 16.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.499 -0.318 . . . . 74.42 111.398 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -117.03 141.73 47.88 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.876 0.369 . . . . 75.41 111.108 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 100' ' ' VAL . 13.3 tt -166.1 -46.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 111.785 0.291 . . . . 73.52 111.785 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.26 21.29 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.174 -0.536 . . . . 42.51 113.093 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.23 8.56 5.76 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.536 -0.391 . . . . 74.32 111.922 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -149.32 166.06 30.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.862 0.363 . . . . 52.51 111.202 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.0 p -128.26 164.39 22.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.961 0.41 . . . . 74.15 111.252 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.45 132.69 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.543 -0.299 . . . . 44.14 110.954 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.413 ' OG ' HG13 ' A' ' 45' ' ' ILE . 69.5 m -104.87 162.05 13.66 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.27 0.557 . . . . 65.14 112.481 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.402 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 72.3 t80 -142.87 118.96 10.71 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.956 -0.566 . . . . 74.22 110.645 172.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -91.67 123.38 35.02 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.834 0.35 . . . . 70.23 110.54 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -74.56 177.07 6.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.539 0.94 . . . . 64.03 113.539 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.473 HG23 ' CE2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -125.71 165.87 17.82 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.522 -0.763 . . . . 71.33 112.09 -177.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 t -106.4 10.4 31.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.216 -0.447 . . . . 54.41 111.855 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.58 -35.43 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.208 0.448 . . . . 74.23 112.208 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.473 ' CE2' HG23 ' A' ' 58' ' ' THR . 17.5 p90 -101.19 149.15 24.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.109 0.481 . . . . 72.43 111.566 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.46 126.11 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.084 0.469 . . . . 70.22 111.496 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.5 mm? -80.56 96.34 6.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 51.32 110.941 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.41 168.61 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.196 0.522 . . . . 63.33 111.954 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.76 107.24 0.58 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.137 -0.483 . . . . 61.3 111.602 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 2.67 83.23 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.44 -0.41 . . . . 74.44 113.592 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -54.49 120.96 7.38 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.845 0.683 . . . . 72.24 112.845 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -94.39 112.92 24.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.04 -0.527 . . . . 63.33 110.975 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.38 128.5 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.02 0.438 . . . . 75.24 110.726 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.7 m -106.97 118.59 37.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.189 0.519 . . . . 52.21 112.1 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.36 104.8 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 65.14 110.644 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 63.3 m95 -87.53 159.19 18.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.953 0.406 . . . . 74.34 111.26 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.07 175.85 8.77 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.913 0.387 . . . . 70.34 111.374 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -22.6 19.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.315 0.487 . . . . 60.12 112.315 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -99.44 29.6 3.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.685 0.278 . . . . 74.11 111.477 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.77 -62.19 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.07 0.767 . . . . 73.2 113.07 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.63 -37.72 3.48 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.079 -0.51 . . . . 73.54 112.351 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 HD11 ' A' ' 87' ' ' ILE . 30.4 m -76.55 166.61 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.84 0.353 . . . . 73.13 111.707 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -67.13 170.12 7.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.553 0.575 . . . . 55.41 112.553 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.77 92.2 2.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.834 0.679 . . . . 61.23 112.834 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.579 ' H ' HD13 ' A' ' 87' ' ' ILE . 71.2 m 59.96 94.54 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.33 0.863 . . . . 65.45 113.33 172.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.602 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 78.5 Cg_exo -52.77 -41.34 70.54 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.542 2.828 . . . . 62.02 116.228 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.602 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.4 Cg_endo -98.2 135.97 3.24 Favored 'Cis proline' 0 C--N 1.366 1.477 0 CA-C-N 121.394 1.533 . . . . 71.42 114.639 -1.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 t -163.8 -48.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.933 -0.766 . . . . 75.22 108.933 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 8.1 m-20 -86.25 115.11 23.59 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.98 -0.748 . . . . 62.12 108.98 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -92.59 112.11 23.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.921 0.391 . . . . 50.23 111.659 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 81' ' ' SER . 2.5 mp -81.93 96.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.578 0.704 . . . . 61.23 110.636 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.666 ' HZ3' HH11 ' A' ' 46' ' ' ARG . 28.8 t90 -71.44 86.28 0.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.68 -0.691 . . . . 73.12 111.066 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.17 7.26 9.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.888 0.699 . . . . 72.32 112.888 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 14.6 m120 -70.06 -27.3 64.52 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.841 0.311 . . . . 72.24 111.841 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -159.44 156.92 29.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.861 0.362 . . . . 75.43 111.397 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -170.31 0.97 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.136 0.791 . . . . 70.2 113.136 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.4 m -67.41 -173.01 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.823 -0.626 . . . . 75.52 112.58 -173.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.473 ' HB3' ' NH2' ' A' ' 46' ' ' ARG . 49.3 p90 -141.69 147.0 36.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.06 0.457 . . . . 75.33 111.49 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.66 43.5 0.06 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.357 -0.449 . . . . 75.41 112.594 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.406 HG22 HD11 ' A' ' 48' ' ' ILE . 14.5 t -83.41 18.65 1.75 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.49 0.552 . . . . 74.22 112.49 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.61 -37.59 3.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.971 -0.633 . . . . 34.52 113.115 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.41 151.63 23.38 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.357 0.599 . . . . 71.45 112.015 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.35 130.34 41.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.33 -0.85 . . . . 71.03 112.226 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 48' ' ' ILE . 7.3 p -75.85 108.83 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.386 0.612 . . . . 55.13 110.811 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -90.19 103.13 15.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.491 0.662 . . . . 75.31 110.859 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.524 HG21 HD13 ' A' ' 27' ' ' ILE . 61.1 t -88.87 126.77 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.575 -0.739 . . . . 75.22 112.019 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.785 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 46.7 mm -97.71 132.18 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.536 -0.756 . . . . 74.05 111.461 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.663 HD11 HG13 ' A' ' 17' ' ' ILE . 80.8 mt -111.63 108.24 17.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.236 0.541 . . . . 72.23 111.689 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.85 161.2 16.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.971 -0.559 . . . . 60.03 111.294 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.58 177.32 7.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.003 0.43 . . . . 72.51 111.364 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.5 t -74.45 28.96 0.08 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.004 0.431 . . . . 54.54 111.82 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.01 -39.48 1.94 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.126 0.489 . . . . 75.4 111.374 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.43 -32.93 2.65 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.914 -0.474 . . . . 64.25 111.914 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.86 161.32 28.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 74.22 111.73 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -122.46 138.76 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.261 -0.427 . . . . 75.15 112.057 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.17 -32.39 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 113.667 0.988 . . . . 74.01 113.667 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.81 41.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.879 0.696 . . . . 63.0 112.879 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.86 135.93 3.47 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.702 -0.681 . . . . 55.34 110.894 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -164.32 165.25 21.93 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.17 -0.331 . . . . 75.11 111.23 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.1 p -129.41 -173.15 2.93 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.884 0.698 . . . . 71.35 112.884 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.2 p -81.14 127.99 33.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.998 -0.546 . . . . 61.4 112.404 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.66 103.15 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.096 -0.502 . . . . 63.2 110.399 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -67.63 105.73 1.97 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.002 0.43 . . . . 73.11 111.435 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -80.36 105.7 11.82 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 74.55 111.519 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.7 m -73.39 108.65 6.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.019 -0.537 . . . . 54.14 111.511 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.697 -0.668 . . . . 63.25 111.585 179.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.654 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 120.669 0.271 . . . . 64.34 111.076 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.34 72.97 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.52 0.568 . . . . 64.33 114.52 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -84.19 87.79 7.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.467 0.633 . . . . 63.11 111.775 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -172.72 107.32 0.17 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.073 0.463 . . . . 75.42 111.762 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -136.97 149.5 47.58 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.522 -0.308 . . . . 74.4 110.889 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -138.0 159.4 42.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.156 0.503 . . . . 71.11 112.095 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -123.3 108.73 13.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.405 0.521 . . . . 72.11 112.405 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -70.57 110.83 5.65 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.859 0.361 . . . . 65.15 110.374 171.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -98.64 163.83 12.49 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.376 0.51 . . . . 51.54 112.376 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -133.47 86.24 2.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.03 0.443 . . . . 73.11 111.428 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.8 mmm -138.77 109.64 6.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.072 -0.513 . . . . 74.03 110.014 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 -40.67 94.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.356 0.502 . . . . 60.03 112.356 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.22 -176.0 34.95 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.828 -0.701 . . . . 74.53 112.736 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -140.54 94.41 2.73 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.265 -0.55 . . . . 70.45 111.242 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -107.23 104.7 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.434 -0.348 . . . . 75.42 110.731 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.8 p -119.36 156.28 30.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.786 0.327 . . . . 72.51 111.69 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 104' ' ' LEU . 67.2 mt -76.08 122.86 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.748 0.309 . . . . 73.22 111.083 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.11 -35.26 23.8 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.993 0.425 . . . . 71.14 110.882 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -167.66 145.48 4.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.997 0.427 . . . . 70.22 111.716 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 27' ' ' ILE . 47.9 mt -113.19 131.92 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.588 -0.278 . . . . 61.14 110.258 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.55 126.64 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.963 0.411 . . . . 61.2 111.803 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 7.9 p -82.93 23.03 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.574 0.702 . . . . 73.23 112.013 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -121.28 -53.08 2.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.048 0.451 . . . . 74.02 110.112 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.44 13.33 0.57 Allowed Glycine 0 CA--C 1.524 0.64 0 CA-C-N 116.026 -0.534 . . . . 60.43 113.834 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -76.07 -52.94 9.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.596 0.591 . . . . 73.21 112.596 -176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.35 158.99 39.56 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.472 0.915 . . . . 74.54 113.472 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 20' ' ' ILE . 59.9 mt -114.33 121.85 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.153 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -94.41 107.76 19.71 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.391 0.515 . . . . 63.31 112.391 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB2' HG13 ' A' ' 69' ' ' VAL . 7.1 mp -100.99 169.4 8.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.851 0.357 . . . . 75.1 111.118 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.68 128.49 7.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.983 0.364 . . . . 62.33 111.983 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -91.72 112.4 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.348 -0.387 . . . . 71.41 110.754 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -100.95 19.0 18.16 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.16 0.505 . . . . 65.44 111.954 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.0 t -78.27 -176.84 4.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.065 -0.397 . . . . 64.03 111.646 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.58 -39.19 20.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.053 0.76 . . . . 74.45 113.053 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 57.9 tt0 -130.5 170.63 13.97 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.822 0.344 . . . . 64.54 111.591 -171.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.4 m-20 -52.16 104.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.827 0.451 . . . . 54.03 111.623 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 15.7 mm100 -91.14 136.85 26.79 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.106 0.409 . . . . 74.33 112.106 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 39.7 Cg_exo -62.08 113.24 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.715 2.277 . . . . 72.52 112.647 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.59 ' HG3' ' HB3' ' A' ' 57' ' ' TYR . 3.4 tpt -69.56 -28.71 66.22 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.989 0.423 . . . . 72.2 111.674 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.675 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.28 76.55 0.76 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.387 -0.435 . . . . 64.42 113.576 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.07 12.63 0.03 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.476 -0.393 . . . . 55.41 113.156 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.41 ' CZ3' HG21 ' A' ' 112' ' ' VAL . 30.2 m95 -124.89 162.07 25.2 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.696 0.398 . . . . 75.41 110.803 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -145.49 135.37 23.59 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.029 0.442 . . . . 73.15 111.371 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.0 ttp -101.69 120.51 40.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.988 -0.551 . . . . 74.22 111.619 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.4 mp -109.05 118.18 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.647 0.26 . . . . 71.54 110.576 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.546 ' NH1' HE22 ' A' ' 91' ' ' GLN . 43.8 ttt-85 -90.49 129.77 36.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.066 -0.396 . . . . 54.34 111.938 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 29.0 mtpp -129.29 147.84 51.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.288 0.566 . . . . 74.33 111.843 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' HG23 ' A' ' 100' ' ' VAL . 9.6 tt -167.78 -40.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.568 -0.742 . . . . 71.52 110.193 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.66 -153.94 6.31 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.803 -0.635 . . . . 75.12 111.864 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 71.73 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.284 0.564 . . . . 73.34 111.724 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -174.99 163.89 3.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.67 . . . . 74.54 110.985 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.2 p -163.07 101.51 0.98 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.039 0.447 . . . . 70.43 111.302 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.17 144.13 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.37 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.7 m -109.04 158.72 17.46 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.253 0.549 . . . . 53.33 112.329 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -149.0 109.12 4.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.983 -0.553 . . . . 73.11 111.204 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -75.8 131.85 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.888 0.375 . . . . 72.1 111.273 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 52.4 m-85 -78.75 121.76 25.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.878 0.37 . . . . 70.33 110.762 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 t -79.13 158.04 27.82 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.369 0.507 . . . . 63.22 112.369 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.675 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 20.7 t -104.29 23.68 12.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.238 -0.437 . . . . 61.14 111.541 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 81' ' ' SER . 13.5 ptm180 -58.01 -29.67 65.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.867 0.365 . . . . 74.32 111.618 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -143.18 156.29 44.73 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 71.23 109.997 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.46 139.8 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.457 -0.338 . . . . 73.42 111.563 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD21 ' HB ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -84.35 104.3 14.26 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.925 0.393 . . . . 70.41 111.038 -175.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 63.6 mttm -65.92 168.82 7.5 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.527 0.936 . . . . 65.42 113.527 -174.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 129.37 37.63 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.541 -0.754 . . . . 73.32 111.123 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.03 9.15 79.81 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.948 -0.644 . . . . 72.11 112.763 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -81.06 117.95 22.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.944 0.402 . . . . 62.23 111.305 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.0 p -86.1 96.31 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.011 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' A' ' 29' ' ' LEU . 6.6 p -79.62 119.04 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.538 0.685 . . . . 71.42 110.988 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 20.2 m -100.0 110.07 22.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 71.31 111.655 -175.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 49.6 mm -74.12 95.58 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.878 0.371 . . . . 72.33 110.629 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 87.4 m95 -79.89 128.27 33.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.41 -0.359 . . . . 75.34 110.949 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.51 162.5 6.28 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.284 -0.26 . . . . 55.02 111.559 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -50.29 -26.02 4.36 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.993 0.738 . . . . 72.14 112.993 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 92' ' ' ASN . 74.8 m-20 -90.8 28.28 1.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.925 0.393 . . . . 74.54 111.566 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -59.71 -36.03 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.694 0.627 . . . . 52.22 112.694 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.1 2.3 82.45 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.095 -0.574 . . . . 63.55 113.243 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.78 -178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.155 0.502 . . . . 55.01 111.619 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 m -75.26 139.85 42.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.264 -0.426 . . . . 52.22 111.288 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.25 79.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.212 0.53 . . . . 73.42 111.574 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.533 ' C ' ' HA ' ' A' ' 83' ' ' PRO . 8.5 t 66.08 89.87 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 115.484 -0.78 . . . . 54.43 111.729 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 84' ' ' THR . 41.0 Cg_exo -60.97 -30.23 89.5 Favored 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 124.112 3.208 . . . . 72.21 118.084 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.687 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 33.3 Cg_endo -97.97 -179.43 6.05 Favored 'Cis proline' 0 C--N 1.367 1.532 0 CA-C-N 122.249 1.839 . . . . 72.51 115.284 6.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.716 HG22 ' HD2' ' A' ' 82' ' ' PRO . 2.9 t 177.01 -44.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.682 -1.599 . . . . 72.33 108.724 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 70' ' ' THR . 18.2 m-20 -140.06 -171.9 3.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.014 -0.994 . . . . 65.41 110.157 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 88.9 mt -123.02 132.33 54.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.936 0.398 . . . . 72.53 111.278 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.8 mp -95.68 125.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.25 0.547 . . . . 64.33 111.396 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.512 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 16.2 t90 -80.33 90.42 5.58 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.754 -0.657 . . . . 73.1 111.033 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -80.16 -5.2 55.62 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 15.1 m120 -82.31 -14.45 55.33 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.543 0.572 . . . . 71.01 112.543 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.546 HE22 ' NH1' ' A' ' 46' ' ' ARG . 46.7 tt0 -154.27 143.05 20.94 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.254 0.55 . . . . 74.21 111.528 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 15.6 m120 -75.11 172.28 12.65 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.021 175.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.8 p -71.79 114.36 9.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.582 0.23 . . . . 74.33 110.568 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -59.32 -29.84 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.131 0.419 . . . . 64.41 112.131 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 48.03 39.41 18.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 114.733 0.653 . . . . 62.41 114.733 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -133.85 12.4 4.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.158 0.504 . . . . 72.22 110.941 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 67.18 -112.58 4.94 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.982 -0.628 . . . . 52.24 112.759 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 66.41 163.13 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.914 0.709 . . . . 74.33 112.914 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 11.1 p-10 -95.9 87.8 4.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.639 0.733 . . . . 64.53 110.711 176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 48' ' ' ILE . 7.6 p -96.25 135.38 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.059 -0.519 . . . . 71.44 111.299 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -115.31 124.26 50.85 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.094 0.473 . . . . 65.14 111.199 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 27' ' ' ILE . 87.6 t -98.9 136.39 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.035 -0.53 . . . . 72.53 112.075 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 43.9 mm -103.2 121.31 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.821 -0.627 . . . . 62.11 111.286 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.746 HD11 HG13 ' A' ' 17' ' ' ILE . 80.7 mt -97.5 121.77 39.78 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.352 -0.218 . . . . 72.13 111.083 175.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 97.9 mttt -129.36 159.24 36.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.031 0.443 . . . . 72.45 111.457 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -93.21 163.77 13.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 54.54 110.938 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -57.3 -29.75 64.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.306 0.484 . . . . 62.55 112.306 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -74.75 -19.26 60.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.69 0.626 . . . . 75.32 112.69 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 135.28 -46.89 1.01 Allowed Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.663 1.025 . . . . 64.3 115.663 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.91 169.48 17.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.596 0.698 . . . . 73.11 112.746 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 36.5 tt0 -94.7 146.97 23.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.713 -0.676 . . . . 74.21 112.181 -173.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.41 HG21 ' CZ3' ' A' ' 42' ' ' TRP . 46.6 t -97.9 -59.6 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.949 -0.569 . . . . 62.12 110.806 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -166.59 159.73 14.48 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 64.14 111.563 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.27 152.03 45.17 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.64 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 115' ' ' ARG . 18.6 ttt180 -156.11 144.87 20.26 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.781 -0.19 . . . . 71.32 111.362 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.2 p -114.64 175.35 5.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 62.13 112.377 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 33.0 p -77.17 -174.59 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.936 -0.575 . . . . 71.53 111.18 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.23 113.26 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.546 -0.297 . . . . 74.03 111.252 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -61.35 98.15 0.08 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.85 0.357 . . . . 74.43 110.853 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.28 103.67 6.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.282 -0.417 . . . . 74.23 111.803 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.6 m -117.04 92.45 3.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.09 0.471 . . . . 63.12 110.467 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.656 -0.688 . . . . 64.22 111.921 -177.586 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtm . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.605 -0.146 . . . . 71.12 110.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 47.89 36.46 14.09 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.369 0.508 . . . . 75.33 114.369 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -60.03 -41.9 93.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.993 0.425 . . . . 74.02 110.934 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.428 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.9 p80 -59.92 124.06 19.0 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.981 -0.554 . . . . 54.0 111.474 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -88.55 164.98 15.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.427 -0.352 . . . . 75.25 111.589 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.64 85.56 0.11 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.133 0.492 . . . . 75.54 111.29 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -86.99 128.4 35.08 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.108 0.781 . . . . 61.24 113.108 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -130.22 131.23 45.46 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.644 -0.707 . . . . 72.11 109.881 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m -99.05 88.06 3.86 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.075 0.398 . . . . 65.31 112.075 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -144.98 109.18 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.772 0.32 . . . . 61.21 110.842 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.6 mmt -94.42 106.67 18.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.757 0.313 . . . . 65.14 111.392 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.4 p -112.57 97.22 6.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.095 0.474 . . . . 62.42 111.781 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.9 61.76 4.5 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.455 -0.402 . . . . 64.12 113.212 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 13.8 m120 -100.03 23.42 9.9 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.514 -0.404 . . . . 73.24 111.963 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -102.7 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.961 0.41 . . . . 73.22 110.221 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.25 151.0 25.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.076 0.465 . . . . 73.03 112.016 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 104' ' ' LEU . 56.4 mt -77.28 115.4 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.264 -0.426 . . . . 71.24 110.619 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -84.19 -42.34 16.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.722 0.296 . . . . 73.44 111.522 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.1 148.61 27.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.23 112.037 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.66 123.35 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.908 -0.587 . . . . 62.34 110.265 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.17 140.05 40.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.487 0.661 . . . . 51.5 112.462 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -97.1 -20.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.716 -0.674 . . . . 70.14 111.142 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -68.02 -34.62 76.83 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.15 0.5 . . . . 62.2 110.381 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 104.03 44.53 1.61 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.345 0.498 . . . . 44.35 114.345 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -128.3 -26.08 2.86 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.373 0.879 . . . . 75.43 113.373 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' HB2' ' CG2' ' A' ' 70' ' ' THR . 49.2 p90 -156.08 152.46 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.884 1.068 . . . . 75.15 113.884 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -127.06 118.55 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.748 . . . . 75.21 109.537 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 28' ' ' ARG . 37.8 ttp180 -101.61 110.3 22.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.689 0.626 . . . . 71.32 112.689 -171.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.9 mp -97.92 169.47 9.62 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.89 -0.596 . . . . 74.25 110.439 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -149.99 140.84 22.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.148 0.499 . . . . 65.22 111.843 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' HB3' HD12 ' A' ' 63' ' ' LEU . 37.5 t30 -100.27 126.9 46.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.259 -0.428 . . . . 71.54 111.079 177.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.2 t -113.16 10.97 18.7 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.806 0.336 . . . . 64.4 111.597 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 32.2 m -65.94 146.23 54.97 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.327 -0.233 . . . . 55.32 111.186 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.88 -19.21 62.65 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.415 0.524 . . . . 62.25 112.415 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 42.7 tt0 -123.06 166.06 15.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.81 0.338 . . . . 72.33 111.167 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.7 m-20 -55.09 130.84 43.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.763 0.425 . . . . 75.44 111.84 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.41 113.32 40.95 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 112.459 0.54 . . . . 71.44 112.459 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.54 125.44 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.748 2.299 . . . . 74.02 111.211 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.9 tpp -58.07 -20.88 42.89 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.777 0.658 . . . . 53.14 112.777 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.06 -90.19 0.08 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.249 -0.501 . . . . 70.12 113.518 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.08 59.66 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.047 -0.597 . . . . 65.33 113.577 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -76.43 168.8 19.42 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.475 -0.426 . . . . 73.55 110.912 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.33 113.82 26.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.099 0.476 . . . . 72.54 111.606 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.4 ttp -92.28 125.54 36.99 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.147 -0.479 . . . . 70.53 111.213 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.7 mt -117.21 109.11 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.783 0.325 . . . . 73.44 111.371 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -90.21 107.69 19.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.812 0.339 . . . . 72.01 111.141 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 37.3 mttm -95.83 129.32 43.1 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.811 0.339 . . . . 74.24 111.217 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.6 tt -134.67 100.82 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.445 0.641 . . . . 51.32 110.901 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.83 -103.98 1.31 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.1 -0.571 . . . . 74.02 112.419 -176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -102.74 -32.12 9.99 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.035 0.383 . . . . 74.15 112.035 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -92.91 168.69 10.99 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.3 0.572 . . . . 64.22 112.39 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.51 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 92.5 p -155.1 150.75 27.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.959 -0.564 . . . . 64.12 111.415 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG11 ' OE1' ' A' ' 91' ' ' GLN . 7.5 p -134.61 140.79 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.443 -0.344 . . . . 72.43 110.874 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.4 p -108.3 158.01 17.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.409 0.623 . . . . 73.2 112.584 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -154.56 115.27 3.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.735 -0.666 . . . . 75.51 111.069 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -86.33 133.82 33.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.921 0.391 . . . . 75.01 110.867 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.79 -177.86 2.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.195 0.521 . . . . 70.13 111.851 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -148.36 142.95 26.5 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.084 -0.507 . . . . 72.34 110.982 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -95.43 82.45 3.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.049 0.452 . . . . 73.53 111.983 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.36 6.25 10.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 71.21 111.209 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.01 152.26 31.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 74.34 110.362 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 36' ' ' ASP . 11.7 t -115.47 116.92 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.825 0.345 . . . . 71.05 110.733 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -93.0 123.83 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.488 -0.324 . . . . 43.42 111.07 -173.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -80.97 -169.82 2.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.753 0.649 . . . . 75.12 112.753 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' SER . . . -81.68 144.3 31.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.67 0.619 . . . . 71.05 112.67 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.2 12.32 62.94 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.953 -0.567 . . . . 31.3 114.038 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.32 144.41 37.52 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.446 -0.443 . . . . 72.4 110.938 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.6 p -99.73 143.59 29.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.963 0.411 . . . . 63.34 112.011 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.77 123.96 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.208 -0.451 . . . . 72.25 110.121 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 86.6 m -101.74 126.72 48.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.472 . . . . 74.54 112.008 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.7 mm -92.01 103.1 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.43 . . . . 74.32 110.253 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.429 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.1 m95 -85.58 135.12 33.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.3 -0.409 . . . . 65.02 111.607 -177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 153.23 40.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.657 0.265 . . . . 71.03 111.533 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . -53.88 -34.32 59.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.736 0.643 . . . . 73.31 112.736 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.419 HD21 ' HB3' ' A' ' 92' ' ' ASN . 77.2 m-20 -82.37 6.73 16.13 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.651 0.612 . . . . 61.13 112.651 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.68 77.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.974 0.361 . . . . 64.45 111.974 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.56 2.02 90.57 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.152 -0.547 . . . . 64.04 114.2 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.0 171.79 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 122.389 -0.477 . . . . 75.03 111.823 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 ' H ' ' A' ' 81' ' ' SER . 85.6 m -69.26 126.61 30.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 74.12 111.701 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -64.99 -15.25 62.08 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.177 0.806 . . . . 73.0 113.177 -176.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.659 ' H ' HG22 ' A' ' 79' ' ' THR . 23.2 t -149.25 86.53 5.55 Favored Pre-proline 0 N--CA 1.474 0.745 0 O-C-N 122.154 -0.341 . . . . 65.15 111.743 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 84' ' ' THR . 53.9 Cg_exo -53.65 -44.8 45.94 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 122.984 2.456 . . . . 73.53 115.399 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 69.7 Cg_endo -99.97 132.9 2.21 Favored 'Cis proline' 0 C--N 1.369 1.649 0 CA-C-N 121.161 1.45 . . . . 75.21 114.095 -1.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.569 HG22 ' HB2' ' A' ' 82' ' ' PRO . 5.1 t -174.72 -47.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.96 -0.563 . . . . 74.0 110.241 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' THR . 17.3 m-20 -89.98 164.55 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.513 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 92.1 mt -126.47 133.85 51.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.035 0.445 . . . . 73.44 111.412 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 80' ' ' ALA . 1.6 mp -94.28 114.9 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.995 0.426 . . . . 61.31 111.281 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.509 ' HE1' ' HB2' ' A' ' 90' ' ' ASN . 4.5 t90 -66.96 93.46 0.27 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.055 -0.52 . . . . 73.44 110.691 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 89' ' ' LYS . 10.7 mtmp? -78.51 -28.04 46.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.106 0.41 . . . . 74.31 112.106 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' HB2' ' HE1' ' A' ' 88' ' ' TRP . 15.9 m120 -63.32 -20.31 65.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.287 0.477 . . . . 63.33 112.287 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 47.5 tt0 -132.63 127.18 34.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.864 0.364 . . . . 64.23 110.817 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.1 m120 -67.19 -51.81 48.95 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.349 . . . . 72.15 111.205 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 t -175.21 -179.09 1.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 61.23 111.577 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.547 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 38.5 p90 -153.48 -178.81 7.24 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.116 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.18 55.17 0.02 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.394 -0.908 . . . . 70.33 113.166 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -79.83 -40.9 27.47 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.145 0.498 . . . . 73.11 111.513 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.82 -23.25 19.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.063 -0.517 . . . . 52.54 112.789 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.51 179.35 5.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.257 0.551 . . . . 64.14 112.073 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.4 124.41 23.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.741 -0.663 . . . . 72.03 112.22 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.97 135.64 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.134 0.492 . . . . 75.01 111.072 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 103' ' ' ILE . 7.7 ttpm? -122.96 136.68 54.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.087 -0.506 . . . . 50.23 111.718 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.18 123.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.198 0.523 . . . . 72.4 111.246 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 101' ' ' LYS . 48.8 mm -102.95 135.34 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.831 -0.622 . . . . 65.2 111.93 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 17' ' ' ILE . 68.6 mt -111.45 105.75 14.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 54.23 110.797 173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 103' ' ' ILE . 68.3 mttm -107.69 130.62 54.91 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.16 0.505 . . . . 65.23 111.423 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.94 156.11 39.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.859 -0.609 . . . . 73.54 111.66 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -57.5 -16.43 9.75 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.173 0.805 . . . . 75.13 113.173 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -101.08 12.81 36.95 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.449 0.537 . . . . 73.42 112.449 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.35 -23.81 33.96 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.888 0.715 . . . . 52.32 114.888 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -76.77 174.8 10.06 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 117.462 0.631 . . . . 72.31 111.905 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.87 142.4 50.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.519 -0.31 . . . . 70.22 111.282 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.84 -32.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 113.323 0.86 . . . . 75.33 113.323 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.98 152.53 47.75 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.636 0.606 . . . . 74.23 112.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.65 46.88 0.49 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.313 0.577 . . . . 73.14 111.276 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -75.54 151.1 37.98 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.183 0.516 . . . . 71.4 111.958 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.2 p -116.55 173.35 6.66 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.387 -0.369 . . . . 64.03 110.903 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.5 p -80.56 169.2 17.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.054 0.454 . . . . 75.32 111.508 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.39 130.46 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.109 -0.496 . . . . 64.22 110.705 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -125.99 113.46 17.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.399 0.618 . . . . 74.54 111.822 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -143.9 27.12 1.49 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.564 -0.744 . . . . 51.44 110.608 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 50.1 p 47.68 67.71 0.78 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.293 0.568 . . . . 75.42 111.166 -172.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.485 -0.769 . . . . 72.51 112.46 -172.51 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.807 0.337 . . . . 74.23 111.71 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.61 -129.07 2.7 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.216 -0.447 . . . . 64.42 112.243 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -77.63 122.47 25.36 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.904 0.383 . . . . 73.42 111.266 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -70.33 -35.78 73.83 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.815 0.302 . . . . 72.34 111.815 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 t60 60.72 43.71 12.04 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.196 0.522 . . . . 74.31 112.125 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -118.0 116.02 26.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.176 0.512 . . . . 73.25 111.722 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -140.53 102.83 4.41 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.077 -0.511 . . . . 74.41 109.912 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -85.73 18.24 2.98 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.554 0.946 . . . . 71.42 113.554 -168.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -62.72 130.71 46.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.149 0.5 . . . . 64.41 112.157 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -93.84 11.56 28.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.25 -0.432 . . . . 75.02 111.621 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 96.1 mmm -70.09 110.18 4.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.028 0.442 . . . . 74.24 111.49 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -67.02 156.63 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 70.15 112.093 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.97 76.33 1.42 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.004 -0.617 . . . . 63.24 113.49 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -79.91 54.5 1.89 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 73.12 111.902 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.93 114.17 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.41 . . . . 71.41 110.759 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.67 150.71 20.36 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.23 0.538 . . . . 73.14 112.243 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.39 110.15 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 62.22 110.163 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -77.22 -68.13 0.64 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.937 0.347 . . . . 64.32 111.937 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -155.92 150.49 25.97 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.287 0.565 . . . . 62.31 111.848 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.665 HD13 HH12 ' A' ' 46' ' ' ARG . 63.4 mt -108.86 137.1 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.065 -0.516 . . . . 72.32 110.864 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 26' ' ' PHE . 11.0 t70 -70.19 147.22 50.1 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.392 0.615 . . . . 73.14 111.939 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.95 -16.87 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.643 -0.708 . . . . 70.21 111.488 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.5 -26.71 60.17 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 52.02 110.705 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.93 41.15 3.38 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.928 -0.578 . . . . 74.23 113.128 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 -37.75 2.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.356 0.872 . . . . 72.42 113.356 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.596 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 51.3 p90 -155.46 171.78 19.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.186 1.18 . . . . 74.02 114.186 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 20' ' ' ILE . 60.2 mt -136.68 143.9 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.221 -0.9 . . . . 70.34 109.265 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.65 115.04 22.02 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.576 -0.703 . . . . 74.45 112.401 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -104.58 170.42 7.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.876 -0.602 . . . . 61.33 110.521 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.84 127.76 17.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.019 0.377 . . . . 60.12 112.019 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -90.38 131.52 36.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 64.22 110.742 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.4 p -117.5 11.23 13.78 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.31 0.485 . . . . 74.55 112.31 -176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.7 p -72.78 155.86 39.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.181 0.437 . . . . 64.34 112.181 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.99 -28.24 68.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.116 0.484 . . . . 64.23 112.209 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -124.58 139.0 54.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.077 -0.51 . . . . 70.1 110.411 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -54.27 126.35 22.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.792 0.329 . . . . 73.53 111.708 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -91.1 120.93 68.45 Favored Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 54.14 111.934 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.23 107.74 0.34 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.343 2.029 . . . . 73.52 112.432 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 tpt -78.99 91.49 4.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.777 0.323 . . . . 72.42 111.147 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.04 -51.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.89 -0.671 . . . . 74.32 113.802 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.39 50.72 3.53 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.114 -0.565 . . . . 72.31 113.619 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -140.92 141.15 34.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.014 0.526 . . . . 73.42 110.592 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 38.0 tt0 -124.32 126.9 46.8 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.171 0.51 . . . . 72.42 110.836 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.697 ' HE1' HG21 ' A' ' 71' ' ' ILE . 30.9 ttp -102.04 116.06 31.87 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.653 -0.703 . . . . 74.43 111.384 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.4 mt -100.41 161.46 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.476 -0.329 . . . . 64.31 110.615 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.665 HH12 HD13 ' A' ' 20' ' ' ILE . 46.7 ttt85 -158.87 137.07 10.63 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.817 -0.552 . . . . 74.44 111.344 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 100' ' ' VAL . 94.4 mttt -123.88 147.55 47.56 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.515 0.561 . . . . 72.2 112.515 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 tt -139.91 109.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.519 -0.764 . . . . 53.31 110.286 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.13 -78.17 0.68 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.008 -0.615 . . . . 34.13 112.847 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -136.94 -43.78 0.58 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.951 0.405 . . . . 74.14 111.502 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -68.01 137.78 55.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.182 0.515 . . . . 71.43 112.343 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 78.9 p -118.97 153.08 35.22 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.229 0.538 . . . . 62.14 112.044 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.11 151.55 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 115.743 -0.662 . . . . 75.42 110.288 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -134.99 165.97 24.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.1 0.476 . . . . 71.23 112.046 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -157.03 113.93 3.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 74.21 111.109 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 22.2 ttpp -84.01 133.85 34.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.858 0.361 . . . . 70.32 110.8 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -69.37 158.02 35.9 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.909 0.385 . . . . 71.54 110.973 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -120.33 129.55 54.03 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.158 0.504 . . . . 71.23 111.487 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.7 t -76.93 85.96 3.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.084 0.469 . . . . 74.21 112.05 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 9.8 ptp180 -119.54 4.85 11.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.399 . . . . 71.44 110.902 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 8.3 p90 -170.79 173.96 5.08 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.127 0.489 . . . . 70.35 110.69 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.48 129.02 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.75 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.32 105.71 1.51 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.561 -0.533 . . . . 63.23 109.561 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -54.55 136.05 45.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.71 0.633 . . . . 63.1 112.71 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.86 128.92 39.13 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.726 -0.67 . . . . 72.1 111.508 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.35 32.76 72.13 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.091 -0.576 . . . . 53.43 113.392 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.618 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -127.71 149.49 50.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.154 0.502 . . . . 72.04 111.814 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.4 p -96.4 135.53 38.13 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.104 -0.498 . . . . 61.3 111.754 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.6 134.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.397 -0.365 . . . . 73.11 110.828 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 m -104.56 118.62 37.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.267 0.556 . . . . 74.12 111.951 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.697 HG21 ' HE1' ' A' ' 44' ' ' MET . 44.4 mm -89.18 102.1 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.158 -0.474 . . . . 44.1 110.859 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -84.29 125.8 32.59 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.631 -0.259 . . . . 74.14 111.467 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -177.49 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.014 0.435 . . . . 62.43 111.751 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 -16.97 16.96 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.138 0.422 . . . . 71.3 112.138 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -93.11 19.17 8.24 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.538 -0.301 . . . . 52.44 111.204 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.662 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -46.54 -61.74 1.68 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.504 0.927 . . . . 75.13 113.504 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.17 21.48 78.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.799 -0.715 . . . . 62.14 112.792 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.662 HG22 ' HB1' ' A' ' 76' ' ' ALA . 30.2 m -127.54 -173.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.561 0.344 . . . . 73.22 110.863 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 p -60.69 123.47 17.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.088 0.471 . . . . 70.1 111.302 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 9.36 3.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.348 0.499 . . . . 64.21 112.348 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -134.46 119.04 13.95 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.174 0.435 . . . . 72.33 112.174 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.653 ' HG3' ' O ' ' A' ' 85' ' ' ASP . 36.8 Cg_exo -54.88 138.18 76.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.773 2.316 . . . . 64.11 110.101 168.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 5.3 Cg_exo 0.29 103.57 0.0 OUTLIER 'Cis proline' 0 C--N 1.363 1.329 0 N-CA-C 121.498 3.615 . . . . 61.3 121.498 25.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' ASP . 12.6 t 51.28 -67.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 117.062 2.245 . . . . 75.34 117.062 162.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 50.5 m-20 -68.21 -178.47 1.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.758 -0.589 . . . . 74.24 112.132 -171.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 29.3 mt -146.22 142.85 28.8 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.016 -0.427 . . . . 50.2 111.419 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.8 mp -103.57 116.41 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 112.033 0.383 . . . . 54.44 112.033 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.529 ' HD1' ' H ' ' A' ' 90' ' ' ASN . 3.5 t90 -74.22 82.9 1.84 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.53 0.681 . . . . 74.41 109.792 173.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -77.13 17.48 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.874 -0.603 . . . . 74.04 112.414 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.529 ' H ' ' HD1' ' A' ' 88' ' ' TRP . 13.1 m120 -127.39 12.16 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.378 0.511 . . . . 43.24 112.378 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -148.64 145.64 27.84 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.205 -0.31 . . . . 64.35 111.533 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -100.64 -137.16 0.32 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 111.686 0.254 . . . . 71.22 111.686 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 96.8 p -75.93 -2.3 29.67 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.821 1.045 . . . . 72.31 113.821 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.0 p90 45.39 22.24 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.154 1.168 . . . . 74.21 114.154 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.98 -156.67 15.84 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.295 -0.478 . . . . 63.32 113.597 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 t -127.05 -31.3 2.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.103 0.478 . . . . 73.34 111.515 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.81 48.45 0.21 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.808 -0.517 . . . . 75.43 111.808 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.01 162.84 14.54 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.618 -0.342 . . . . 74.4 111.191 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -78.39 43.97 0.49 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.54 0.686 . . . . 51.22 111.215 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.6 p -66.31 136.3 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 115.534 -0.757 . . . . 71.42 111.487 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -130.1 150.32 51.42 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.003 0.372 . . . . 70.51 112.003 -171.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.84 155.71 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.859 0.689 . . . . 75.33 112.859 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.727 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 19.7 mm -126.52 134.73 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.819 0.848 . . . . 74.45 111.068 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.77 112.84 22.61 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.722 0.296 . . . . 73.11 111.487 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.34 155.92 34.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.74 0.305 . . . . 65.45 111.169 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.11 177.98 6.0 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.221 0.534 . . . . 75.13 111.677 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.8 p -57.79 -20.92 38.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.039 -0.528 . . . . 70.23 112.027 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.01 -4.61 58.86 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.258 0.466 . . . . 55.21 112.258 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.89 -19.46 45.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.296 -0.478 . . . . 63.32 113.954 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.09 152.68 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.328 -0.513 . . . . 73.34 111.759 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -99.55 128.91 45.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.098 -0.501 . . . . 62.31 112.269 -171.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -84.97 -54.7 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.885 0.374 . . . . 74.2 111.32 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.83 167.36 30.64 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.395 0.617 . . . . 74.45 112.483 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.06 153.82 30.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.501 -0.772 . . . . 55.13 110.896 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -160.26 152.52 20.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.74 0.305 . . . . 73.11 111.502 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 90.0 p -115.02 178.89 4.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.068 0.461 . . . . 74.13 111.942 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 p -77.76 149.72 34.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.14 0.495 . . . . 75.33 111.255 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.11 143.33 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 70.22 111.241 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.97 100.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.865 0.364 . . . . 53.31 110.907 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.701 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 10.3 mmpt? -114.73 145.41 42.11 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.405 0.622 . . . . 71.4 112.064 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.6 t -140.22 31.82 1.94 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.54 -0.755 . . . . 65.14 110.179 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.758 -0.655 . . . . 71.44 112.348 -177.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.745 0.307 . . . . 63.53 111.704 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.68 -175.22 52.02 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.318 -0.467 . . . . 70.43 113.779 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -88.58 21.76 2.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.908 0.385 . . . . 73.41 111.391 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -70.34 66.63 0.31 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.353 0.661 . . . . 72.51 111.5 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -116.77 104.33 11.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 74.4 112.08 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -146.19 -174.19 4.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.553 0.341 . . . . 75.32 110.619 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -79.57 123.57 27.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.108 0.48 . . . . 75.22 111.526 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -85.75 167.17 15.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.18 -0.464 . . . . 64.1 111.342 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.0 m -124.65 138.59 54.29 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.906 0.384 . . . . 43.22 111.69 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -90.5 116.27 28.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.027 0.442 . . . . 70.13 111.92 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mmt -123.43 141.59 51.84 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.246 -0.434 . . . . 42.31 111.105 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -81.56 -52.14 7.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.144 0.497 . . . . 62.5 110.802 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.06 100.19 2.22 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.883 -0.599 . . . . 65.3 113.286 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.62 96.93 10.91 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.322 -0.516 . . . . 70.44 110.69 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.75 149.74 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.063 -0.517 . . . . 71.13 110.581 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 p -134.96 145.54 48.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.833 0.349 . . . . 73.22 111.903 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.13 96.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.978 0.418 . . . . 75.42 110.554 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.57 -53.2 59.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 64.41 111.563 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -157.97 146.59 19.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.054 0.454 . . . . 61.2 111.566 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 HG12 ' A' ' 27' ' ' ILE . 30.7 mt -114.58 122.32 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.465 -0.569 . . . . 62.3 109.465 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.59 133.32 36.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.022 0.749 . . . . 70.55 113.022 -171.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.61 -21.76 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.655 -0.702 . . . . 73.42 112.453 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.69 -24.08 23.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.898 0.38 . . . . 73.33 110.939 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.73 26.22 9.27 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.272 -0.422 . . . . 65.21 113.508 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' NZ ' ' HB3' ' A' ' 25' ' ' LYS . 8.5 mtpm? -95.02 -28.08 15.3 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.088 0.773 . . . . 72.2 113.088 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.58 174.45 11.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.93 0.715 . . . . 75.45 112.93 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.627 HG12 HG23 ' A' ' 20' ' ' ILE . 52.3 mt -127.81 149.65 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.461 -0.79 . . . . 61.14 109.357 173.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -130.76 116.3 17.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.332 0.587 . . . . 63.42 112.071 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -109.1 154.24 22.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.795 -0.639 . . . . 74.45 110.288 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -124.2 124.28 42.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 65.53 111.523 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -74.83 97.29 3.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.7 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -79.6 -2.15 41.21 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.912 0.387 . . . . 61.31 111.391 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -75.37 118.08 17.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.43 -0.35 . . . . 55.43 110.536 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.79 61.24 5.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 71.3 111.227 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -170.11 159.26 7.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.968 -0.56 . . . . 71.52 110.463 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.38 101.4 0.95 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.759 0.314 . . . . 62.21 110.655 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.8 mm100 -105.07 123.74 38.83 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 112.402 0.519 . . . . 63.13 112.402 -174.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 13.3 Cg_exo -71.28 135.29 26.58 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.589 2.193 . . . . 75.33 111.91 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 3.2 tpt -65.45 -19.04 65.77 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.958 0.408 . . . . 45.11 111.943 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -109.13 2.68 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.209 -0.519 . . . . 73.21 113.312 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.82 60.07 0.2 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.264 -0.493 . . . . 45.12 112.592 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.8 m0 -79.92 -178.12 6.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.952 0.406 . . . . 64.23 111.321 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.63 119.52 11.92 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.198 0.523 . . . . 74.02 111.101 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.503 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 50.8 ttp -97.7 118.14 33.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.192 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' SER . 59.7 mt -103.17 132.87 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.555 -0.293 . . . . 71.14 111.177 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD2' HE22 ' A' ' 91' ' ' GLN . 51.4 ttm-85 -113.51 130.88 56.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.859 0.361 . . . . 62.14 111.909 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -120.52 133.4 55.4 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.874 0.368 . . . . 74.12 110.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 100' ' ' VAL . 11.9 tt -159.17 -42.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.004 0.372 . . . . 53.14 112.004 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.65 93.87 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.955 -0.64 . . . . 64.41 113.449 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.65 25.44 14.37 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.438 0.533 . . . . 74.13 112.438 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -146.92 144.51 29.29 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.201 0.524 . . . . 75.51 112.386 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -121.79 32.7 5.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.999 -0.546 . . . . 71.33 110.394 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.22 123.54 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.837 -0.62 . . . . 62.51 112.145 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.505 ' HB3' HG12 ' A' ' 45' ' ' ILE . 60.3 p -118.6 163.88 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.118 0.485 . . . . 30.33 111.98 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 62.9 t80 -137.51 111.35 8.23 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.956 -0.566 . . . . 63.14 111.901 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -72.33 116.8 13.2 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.033 -0.531 . . . . 75.4 111.077 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HE2' ' HB2' ' A' ' 44' ' ' MET . 55.4 m-85 -72.13 162.62 29.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.242 0.544 . . . . 71.32 112.32 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -128.7 133.96 48.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.988 -0.551 . . . . 75.11 111.574 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 14.8 t -86.46 34.62 0.64 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.431 -0.35 . . . . 62.42 111.338 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.653 ' HG3' ' HD1' ' A' ' 61' ' ' TYR . 2.5 ptm180 -59.03 -22.67 61.08 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.242 0.46 . . . . 45.12 112.242 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.653 ' HD1' ' HG3' ' A' ' 60' ' ' ARG . 44.4 p90 -143.09 149.84 38.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.021 0.439 . . . . 72.41 110.96 175.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.81 114.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.413 -0.358 . . . . 71.22 110.576 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.61 136.05 52.41 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.114 0.483 . . . . 71.41 112.273 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -72.85 160.22 32.5 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 74.32 112.157 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.59 130.36 41.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.038 -0.528 . . . . 55.35 111.981 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.05 73.81 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.082 -0.58 . . . . 62.34 113.551 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -83.52 135.55 34.6 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.97 0.414 . . . . 71.45 111.859 -177.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -96.13 109.35 21.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.007 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.12 133.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.315 0.578 . . . . 73.2 111.651 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 55.8 m -105.33 111.64 24.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 52.44 111.441 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.33 100.28 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.086 0.47 . . . . 55.31 110.415 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 72.7 m95 -77.47 166.64 22.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.16 -0.473 . . . . 64.12 111.318 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.67 178.12 4.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.572 -0.285 . . . . 60.31 110.73 174.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.78 16.46 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.023 0.439 . . . . 50.31 112.023 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -89.34 19.7 4.26 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.866 0.321 . . . . 70.3 111.866 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 72' ' ' TRP . . . -58.04 -34.5 70.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.005 0.743 . . . . 73.15 113.005 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -41.53 2.76 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.911 -0.662 . . . . 73.22 112.865 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.24 -179.6 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.244 0.545 . . . . 73.51 111.959 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.9 p -76.54 161.02 28.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.109 0.481 . . . . 55.11 111.521 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.89 2.18 9.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.808 0.67 . . . . 75.33 112.808 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -144.44 87.89 7.47 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 122.2 -0.313 . . . . 54.1 111.774 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.594 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 50.8 Cg_exo -55.8 -42.46 67.0 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 123.159 2.572 . . . . 73.32 115.582 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.594 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 41.6 Cg_endo -99.68 19.72 23.35 Favored 'Cis proline' 0 C--N 1.37 1.683 0 CA-C-N 121.509 1.575 . . . . 74.14 113.905 1.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.534 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 44.5 p -59.28 -48.73 80.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.012 0.434 . . . . 75.42 112.104 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 70' ' ' THR . 12.9 m-20 -98.58 179.27 4.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.068 -0.514 . . . . 70.21 111.833 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.94 129.11 45.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 63.23 110.974 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.2 mp -96.59 109.21 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.749 0.309 . . . . 73.2 111.162 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 7.6 t90 -74.55 86.62 2.09 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.256 0.55 . . . . 63.04 110.422 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -71.59 -20.21 62.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.419 0.526 . . . . 71.03 112.419 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 10.0 m120 -68.01 -13.57 62.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.365 0.505 . . . . 72.22 112.365 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.419 HE22 ' HD2' ' A' ' 46' ' ' ARG . 63.6 tt0 -143.29 142.88 31.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.158 0.504 . . . . 75.31 112.172 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.82 -172.65 3.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.211 -0.45 . . . . 64.23 112.003 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.1 p -60.32 127.48 32.0 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 72.31 111.013 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -102.81 2.1 35.03 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.58 0.956 . . . . 64.01 113.58 -169.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 96' ' ' THR . . . 84.06 -44.55 3.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.875 -0.679 . . . . 71.13 114.171 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 95' ' ' GLY . 2.6 m 76.73 -32.86 0.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.705 1.002 . . . . 72.44 113.705 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.15 -23.33 24.48 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.261 0.864 . . . . 62.5 115.261 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.37 17.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.055 0.761 . . . . 73.52 113.055 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 t70 59.12 73.29 0.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.502 0.668 . . . . 74.22 110.308 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 48' ' ' ILE . 6.1 p -81.2 120.62 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.557 -175.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.97 122.18 38.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.113 0.482 . . . . 74.23 111.768 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.12 131.73 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.891 -0.595 . . . . 72.53 111.304 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.9 mm -111.99 120.39 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.368 -0.378 . . . . 75.32 111.395 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -102.95 109.76 21.42 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.382 -0.199 . . . . 71.42 111.412 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.64 141.16 52.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.375 0.607 . . . . 74.24 112.162 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -77.27 172.93 12.51 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.653 -0.703 . . . . 70.35 111.237 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.4 m -57.75 -21.76 43.01 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 111.985 0.365 . . . . 54.12 111.985 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.72 -7.54 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.574 0.583 . . . . 70.22 112.574 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 -17.22 57.81 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.957 -0.639 . . . . 52.11 113.334 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.78 164.15 22.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 60.03 111.306 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -104.35 142.29 34.83 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.086 0.772 . . . . 75.31 113.086 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.74 -51.91 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.708 -0.678 . . . . 75.12 110.14 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -172.6 163.92 5.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.498 -0.773 . . . . 32.12 111.137 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -144.1 145.2 31.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.857 0.36 . . . . 70.34 110.922 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -150.97 143.57 24.37 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.783 0.325 . . . . 72.42 111.811 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.6 p -108.0 178.66 4.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.501 -0.318 . . . . 73.43 110.935 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.53 HG22 ' HB ' ' A' ' 20' ' ' ILE . 30.0 p -99.86 120.87 40.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.76 95.51 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.684 -0.487 . . . . 63.13 109.684 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -57.72 112.61 1.51 Allowed 'General case' 0 CA--C 1.543 0.712 0 CA-C-O 121.454 0.645 . . . . 63.22 112.223 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.15 158.73 20.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.785 -0.643 . . . . 75.01 111.846 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.5 m -137.56 94.8 2.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.69 -0.686 . . . . 71.55 110.02 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.252 1.213 0 N-CA-C 112.366 0.506 . . . . 64.23 112.366 -175.788 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.86 0.362 . . . . 61.42 111.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.19 146.94 21.52 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.125 -0.559 . . . . 64.3 112.842 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -95.62 143.89 26.52 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.079 0.466 . . . . 60.24 111.537 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -130.64 124.79 32.44 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.198 -0.456 . . . . 70.44 110.932 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -68.68 122.99 19.69 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.87 0.367 . . . . 70.32 111.72 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 7' ' ' HIS . 12.6 t60 -132.28 164.77 25.69 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 110.126 -0.324 . . . . 71.45 110.126 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 9.6 m170 68.99 31.39 4.17 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.11 0.481 . . . . 71.04 111.133 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -79.19 73.02 5.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.076 0.465 . . . . 74.42 110.891 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -96.66 178.86 5.18 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.23 0.456 . . . . 64.12 112.23 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -141.66 122.2 14.17 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.243 -0.435 . . . . 72.42 111.285 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.474 ' HB3' HE22 ' A' ' 37' ' ' GLN . 19.4 mmt -133.21 120.41 21.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.997 0.427 . . . . 73.25 111.718 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -96.45 -157.88 0.62 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.231 -0.44 . . . . 72.22 111.018 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.72 78.1 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 C-N-CA 121.329 -0.462 . . . . 53.03 113.46 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 HD21 ' NE2' ' A' ' 37' ' ' GLN . 8.3 p30 -97.13 3.55 51.59 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.159 0.429 . . . . 75.2 112.159 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -90.28 94.87 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.166 0.508 . . . . 71.44 110.384 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.62 153.09 18.01 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.908 0.385 . . . . 71.34 112.032 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.437 HG22 ' HD2' ' A' ' 115' ' ' ARG . 59.2 mt -65.22 125.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.496 -0.32 . . . . 53.04 110.854 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.07 -52.62 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.186 0.517 . . . . 71.34 111.046 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.1 158.34 36.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.32 111.309 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 27' ' ' ILE . 59.7 mt -126.66 143.92 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.752 -0.462 . . . . 71.34 109.752 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.74 137.73 56.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.912 0.387 . . . . 70.41 111.345 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.3 p -65.19 -36.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.258 0.466 . . . . 75.24 112.258 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -81.54 -70.37 0.54 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.016 0.436 . . . . 75.03 110.461 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.42 38.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.385 -0.912 . . . . 74.4 114.784 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -89.09 -50.52 6.11 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.48 0.64 . . . . 65.14 112.457 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.0 162.86 35.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.515 0.932 . . . . 60.52 113.515 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 20' ' ' ILE . 65.7 mt -119.93 137.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.511 -0.768 . . . . 72.21 109.88 173.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.88 116.61 28.28 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.249 0.547 . . . . 71.35 112.269 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -106.28 149.56 26.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.155 -0.475 . . . . 44.12 110.705 177.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB2' HG22 ' A' ' 68' ' ' THR . 82.9 tttt -123.88 131.8 53.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.905 0.383 . . . . 72.51 111.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB2' HD23 ' A' ' 63' ' ' LEU . 28.3 t30 -85.94 112.0 20.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.725 0.298 . . . . 72.02 110.564 172.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -98.63 14.54 28.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.834 0.35 . . . . 65.32 111.848 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 t -87.74 -177.57 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.012 0.434 . . . . 61.43 111.369 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.1 -19.9 16.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.153 0.501 . . . . 71.24 111.632 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -101.56 155.95 17.78 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.187 -0.46 . . . . 61.23 112.11 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 5.0 m-20 -64.66 91.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.164 -0.471 . . . . 62.05 110.165 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.474 HE22 ' HB3' ' A' ' 11' ' ' MET . 16.0 mm100 -76.56 116.77 59.42 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 112.82 0.674 . . . . 73.45 112.82 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.83 144.09 63.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.171 1.914 . . . . 73.1 112.143 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.801 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -51.78 -26.79 10.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.005 0.431 . . . . 62.11 111.671 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.1 -100.35 0.45 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 114.448 0.539 . . . . 73.32 114.448 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 57' ' ' TYR . . . 172.27 55.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.549 0 N-CA-C 112.098 -0.401 . . . . 64.24 112.098 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -89.43 152.93 21.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.147 0.499 . . . . 74.32 112.102 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -97.39 118.75 34.55 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.909 -0.587 . . . . 73.14 111.372 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.585 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 55.8 ttp -98.99 104.75 16.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.188 -0.46 . . . . 63.13 110.794 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.8 mt -90.96 116.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.327 -0.397 . . . . 74.22 111.095 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.583 ' HE ' HG21 ' A' ' 100' ' ' VAL . 59.0 ttt180 -116.98 137.3 52.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.694 0.283 . . . . 73.32 111.513 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 50' ' ' ASP . 85.1 tttt -133.53 116.98 16.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.138 0.494 . . . . 73.14 110.811 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.6 tt -113.09 119.56 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.108 -0.496 . . . . 71.12 110.937 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.22 -78.78 0.22 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.926 -0.654 . . . . 51.13 111.893 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 34.3 t70 -149.75 -15.33 0.27 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 111.801 0.297 . . . . 60.21 111.801 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -80.33 143.63 33.43 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.983 -0.448 . . . . 74.12 111.044 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.2 p -123.98 149.49 45.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.514 0.673 . . . . 72.32 112.68 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.75 145.23 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.49 -0.777 . . . . 64.12 110.33 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.3 p -128.08 127.68 43.55 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.089 0.471 . . . . 74.22 111.734 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -119.94 137.2 54.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.397 -0.365 . . . . 74.04 111.311 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -99.97 131.4 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.029 0.442 . . . . 40.02 111.668 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 60.6 m-85 -86.05 94.82 9.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.368 -0.378 . . . . 72.01 111.771 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -71.92 137.8 47.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.157 0.503 . . . . 74.42 112.247 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.801 ' HA ' ' HB3' ' A' ' 39' ' ' MET . 79.5 p -72.25 91.22 1.29 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.304 0.483 . . . . 72.51 112.304 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.484 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 14.4 ptm180 -109.08 -16.82 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.692 0.282 . . . . 71.13 111.666 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.484 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 46.9 p90 -158.15 -177.71 6.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.642 0.258 . . . . 54.21 111.051 173.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.13 159.35 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.399 0.619 . . . . 72.43 112.102 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 31' ' ' ASN . 24.0 tp -124.19 113.87 18.89 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.08 -0.509 . . . . 73.23 110.047 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 39.0 tttp -75.29 169.15 18.61 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.605 0.594 . . . . 62.31 112.605 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.71 127.46 20.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.781 0.66 . . . . 64.22 112.781 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.61 -18.2 9.28 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.173 -0.467 . . . . 32.52 114.014 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.529 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -72.41 138.51 47.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.176 0.512 . . . . 71.13 111.674 -176.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 30' ' ' LYS . 59.9 p -105.47 132.51 51.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.197 -0.456 . . . . 74.32 112.052 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.8 140.93 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.91 0.386 . . . . 61.42 111.41 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.2 m -109.8 122.39 47.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 63.43 111.473 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 mm -105.61 102.35 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.399 -0.364 . . . . 70.24 111.255 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -82.94 125.92 31.93 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.821 0.304 . . . . 75.14 111.821 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.19 81.46 2.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.197 0.443 . . . . 65.41 112.197 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 64.83 -67.14 0.12 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.844 1.053 . . . . 71.34 113.844 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -71.39 75.58 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.113 0.412 . . . . 64.23 112.113 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.84 -48.82 3.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 72.02 111.697 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.48 -35.69 3.3 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.444 -0.407 . . . . 72.51 113.19 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.75 -173.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.144 0.424 . . . . 74.3 112.144 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -52.83 121.97 8.29 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.186 -0.461 . . . . 70.31 111.836 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.69 91.05 0.29 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.617 0.969 . . . . 65.31 113.617 -173.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 87' ' ' ILE . 33.8 t 72.84 87.09 0.1 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 114.151 1.167 . . . . 61.44 114.151 168.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HB2' ' N ' ' A' ' 84' ' ' THR . 81.8 Cg_exo -50.67 -176.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.576 2.582 0 C-N-CA 123.563 2.842 . . . . 64.4 112.259 163.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 14.82 47.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.44 0 N-CA-C 122.185 3.879 . . . . 72.15 122.185 44.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.667 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 7.3 t 157.67 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.598 1.159 . . . . 70.13 111.628 160.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.442 ' OD1' HG23 ' A' ' 84' ' ' THR . 1.5 m-20 -105.72 158.33 16.8 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.805 0.336 . . . . 74.31 111.203 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 HD11 ' SD ' ' A' ' 39' ' ' MET . 76.5 mt -126.25 139.6 53.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.844 0.354 . . . . 72.32 111.493 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 81' ' ' SER . 1.8 mp -105.39 116.17 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.081 0.467 . . . . 75.51 111.061 176.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 90' ' ' ASN . 7.9 t90 -74.69 105.85 5.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.146 -0.479 . . . . 73.43 110.421 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.24 -5.15 58.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.805 0.669 . . . . 62.42 112.805 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.59 ' HB2' ' NE1' ' A' ' 88' ' ' TRP . 20.1 m120 -91.35 -42.95 10.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.588 0.588 . . . . 62.44 112.588 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -120.52 143.54 48.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.82 0.343 . . . . 72.23 111.398 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -93.52 177.21 6.1 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.057 0.455 . . . . 72.42 111.395 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.7 p -60.46 113.24 2.31 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.123 0.487 . . . . 71.25 111.153 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -76.24 -32.96 59.17 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.76 0.652 . . . . 71.22 112.76 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.98 50.54 21.11 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.292 0.477 . . . . 43.32 114.292 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.7 p -97.52 -44.78 6.68 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.724 0.639 . . . . 62.14 112.724 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . 80.17 -33.73 2.21 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.898 -0.668 . . . . 54.21 112.676 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.75 148.15 47.61 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.799 0.333 . . . . 74.15 111.109 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 4.6 p-10 -64.43 126.41 27.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.341 0.867 . . . . 71.43 113.341 -173.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.583 HG21 ' HE ' ' A' ' 46' ' ' ARG . 7.7 p -124.92 141.71 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.794 -0.639 . . . . 73.2 110.938 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -109.55 134.88 51.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.919 0.39 . . . . 74.22 111.726 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 144.86 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 121.15 0.5 . . . . 45.11 111.768 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.76 141.46 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 116.186 -0.461 . . . . 74.01 111.347 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 76.5 mt -114.05 120.46 40.64 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.928 0.394 . . . . 74.31 111.568 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 95.5 mttt -123.05 146.74 47.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.462 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.606 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 16.8 m120 -76.53 153.33 35.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.036 -0.357 . . . . 61.25 110.036 169.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.8 t -67.94 8.37 0.41 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.277 0.843 . . . . 62.11 113.277 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.14 3.91 52.9 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.101 -0.374 . . . . 74.21 111.247 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 36.72 17.27 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.06 -0.591 . . . . 44.54 112.846 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 6.1 pt-20 -125.39 126.78 45.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.032 0.444 . . . . 75.25 111.501 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' LYS . 33.8 tt0 -91.47 129.39 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.891 -0.595 . . . . 73.22 111.433 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.44 -64.16 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.285 0.476 . . . . 73.22 112.285 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . . . -101.74 145.4 29.19 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.451 0.537 . . . . 71.51 112.451 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.65 139.96 26.98 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.263 -0.426 . . . . 53.42 110.981 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 17' ' ' ILE . 47.7 ttm-85 -166.13 136.81 3.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.249 0.547 . . . . 72.32 112.282 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.7 p -111.32 154.54 24.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.066 -0.516 . . . . 74.14 110.756 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 20' ' ' ILE . 66.5 p -62.45 107.07 0.85 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.025 0.441 . . . . 72.34 111.648 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.29 96.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.423 0.63 . . . . 63.53 111.71 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -67.96 135.43 52.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.154 0.502 . . . . 70.33 111.01 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -121.5 136.04 54.98 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.447 0.536 . . . . 70.43 112.447 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 95.52 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.077 -0.51 . . . . 72.32 110.499 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.998 -0.525 . . . . 74.5 111.533 -178.185 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.836 0.351 . . . . 61.13 111.335 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.86 45.98 0.1 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.062 -0.589 . . . . 72.33 113.366 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -96.86 95.38 7.82 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.373 -0.486 . . . . 75.12 110.569 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -77.47 134.25 38.4 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.282 0.563 . . . . 61.13 111.846 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -124.61 133.89 53.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.885 -0.598 . . . . 63.33 110.391 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -101.86 -78.78 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.184 -0.323 . . . . 75.11 111.218 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -170.69 164.67 8.15 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.81 0.338 . . . . 51.15 111.193 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -105.01 149.53 25.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.525 -0.307 . . . . 64.04 110.614 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 t -149.58 168.68 22.88 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.878 0.37 . . . . 64.13 111.427 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -106.13 134.2 49.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 65.11 111.658 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.5 mmt -87.27 108.3 18.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.235 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.1 p -91.07 3.23 55.3 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.784 0.326 . . . . 74.15 111.655 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.16 82.35 0.89 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.319 -0.401 . . . . 65.11 113.325 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.48 94.41 9.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.145 0.497 . . . . 54.14 111.237 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.74 128.64 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.425 . . . . 43.41 111.176 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 p -133.71 155.34 49.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.791 0.329 . . . . 44.01 111.445 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.799 HG13 HD11 ' A' ' 104' ' ' LEU . 73.7 mt -62.68 120.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 112.276 0.473 . . . . 72.44 112.276 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 40.6 tt0 -68.38 -55.51 11.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.252 -0.431 . . . . 71.24 109.981 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 23.6 tt0 178.52 160.46 0.6 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.665 -0.698 . . . . 75.22 110.502 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.483 HG23 HG12 ' A' ' 27' ' ' ILE . 57.6 mt -95.39 153.6 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.439 -0.346 . . . . 60.41 111.412 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.64 147.71 36.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.124 0.487 . . . . 63.33 111.587 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.35 -28.01 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.113 -0.494 . . . . 63.45 111.993 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.77 -34.54 13.16 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.886 0.374 . . . . 64.0 110.876 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.01 10.86 8.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.192 -0.458 . . . . 71.03 113.426 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.36 -27.74 64.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.223 0.823 . . . . 71.31 113.223 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -158.94 159.65 35.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.972 0.73 . . . . 73.22 112.972 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.483 HG12 HG23 ' A' ' 20' ' ' ILE . 63.8 mt -125.24 117.19 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.695 -0.684 . . . . 63.42 110.722 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 17.1 ttm180 -98.55 132.85 43.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 73.04 112.267 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 6.6 mp -109.65 134.68 51.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.355 -0.384 . . . . 62.12 111.304 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 68' ' ' THR . 24.3 ttmm -103.37 136.08 43.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.882 0.372 . . . . 72.41 111.494 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.95 107.43 15.55 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.424 -0.353 . . . . 74.14 110.833 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.6 p -95.9 17.14 15.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.161 0.505 . . . . 71.35 111.808 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -70.29 159.32 34.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.1 0.476 . . . . 70.2 111.869 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.23 -26.35 58.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.222 -0.444 . . . . 52.43 111.717 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 36' ' ' ASP . 44.6 tt0 -138.9 166.74 23.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.761 0.315 . . . . 72.04 110.936 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 6.1 m-20 -68.14 117.04 9.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.532 -0.304 . . . . 73.21 111.224 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -133.68 144.16 50.78 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 111.61 0.226 . . . . 72.4 111.61 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 36.4 Cg_exo -60.95 147.5 95.4 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.677 2.251 . . . . 75.14 112.615 174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.1 tpt -54.82 -50.59 68.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.072 0.463 . . . . 44.31 112.174 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.17 -122.1 5.83 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.02 -0.609 . . . . 65.32 113.293 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 108.87 1.14 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.377 -0.439 . . . . 65.42 113.142 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -135.08 164.87 26.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.641 0.376 . . . . 75.41 110.515 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -150.25 117.02 5.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.125 0.488 . . . . 74.12 111.374 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.459 ' HE1' HD11 ' A' ' 29' ' ' LEU . 38.1 ttm -91.81 117.4 29.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.245 -0.434 . . . . 73.32 111.721 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.59 102.65 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.859 0.361 . . . . 73.14 110.549 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -90.37 120.41 31.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.747 0.308 . . . . 64.01 111.414 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.27 113.86 27.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.409 -0.359 . . . . 53.13 111.035 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.54 137.98 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.572 -0.285 . . . . 74.43 110.86 -176.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' N ' HD13 ' A' ' 48' ' ' ILE . . . 55.35 36.46 63.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.191 -0.528 . . . . 62.41 113.438 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.18 -4.29 1.59 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.829 0.852 . . . . 74.35 113.028 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.4 t -103.68 173.45 6.3 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.685 -0.634 . . . . 71.23 111.057 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -139.34 150.46 45.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.34 0.59 . . . . 60.31 112.105 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.58 130.36 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.636 -0.711 . . . . 74.3 110.354 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' MET . 94.0 p -105.43 148.72 26.84 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.328 0.585 . . . . 70.44 112.183 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -128.73 112.08 13.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.945 -0.57 . . . . 75.31 110.476 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.26 125.75 33.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.99 0.424 . . . . 75.33 111.651 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.441 ' HE2' HD11 ' A' ' 71' ' ' ILE . 54.0 m-85 -85.9 168.9 13.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.509 0.671 . . . . 60.01 112.391 -177.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -140.05 157.99 44.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.678 -0.692 . . . . 72.01 111.797 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.7 p -87.62 23.23 2.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.205 -0.452 . . . . 63.12 111.923 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -69.53 -2.18 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.624 0.602 . . . . 73.12 112.624 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -151.29 156.94 41.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.172 0.51 . . . . 72.33 111.7 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 83.2 t -103.6 124.77 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.16 -0.473 . . . . 65.34 111.659 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.8 mm? -84.12 109.85 18.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.008 0.432 . . . . 53.23 111.328 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.75 144.5 32.11 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.372 -0.376 . . . . 64.42 111.145 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.22 119.53 4.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.909 0.385 . . . . 74.13 111.798 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.16 -41.49 2.5 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.184 -0.532 . . . . 64.24 113.218 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.54 140.25 58.54 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.314 -0.521 . . . . 51.5 111.187 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 30' ' ' LYS . 70.1 p -111.49 153.72 25.78 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.726 0.639 . . . . 71.04 112.726 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -114.57 123.24 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.968 -0.56 . . . . 75.4 110.566 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m -94.13 124.61 38.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.186 0.517 . . . . 72.42 111.516 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.441 HD11 ' HE2' ' A' ' 57' ' ' TYR . 41.6 mm -86.21 99.67 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.048 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -84.38 -178.45 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 43.42 110.971 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.37 170.48 7.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.715 -0.221 . . . . 55.33 110.95 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB3' HD22 ' A' ' 92' ' ' ASN . . . -51.62 -33.19 32.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.194 0.442 . . . . 73.52 112.194 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.07 32.48 2.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.455 -0.339 . . . . 62.22 111.563 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.16 -48.55 44.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.913 0.708 . . . . 74.31 112.913 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.17 -33.66 6.23 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.13 -0.557 . . . . 64.4 112.277 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.33 -171.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 122.555 0.342 . . . . 72.14 110.843 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.3 p -69.97 147.33 50.29 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.98 -0.45 . . . . 65.12 111.369 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.91 2.65 3.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.642 0.608 . . . . 53.03 112.642 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -169.68 86.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.073 0.549 . . . . 73.41 110.345 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HB2' ' N ' ' A' ' 84' ' ' THR . 53.5 Cg_exo -53.0 -46.95 30.3 Favored 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.262 2.641 . . . . 74.53 115.972 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 44.7 Cg_endo -101.73 21.86 17.36 Favored 'Cis proline' 0 C--N 1.363 1.322 0 CA-C-N 121.307 1.503 . . . . 72.11 114.664 2.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.552 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 10.2 t -55.74 -41.44 73.91 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.443 0.535 . . . . 62.22 112.443 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -97.37 164.35 12.5 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.117 0.484 . . . . 72.54 111.29 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.04 126.24 51.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.071 0.462 . . . . 72.23 111.378 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.0 mp -91.84 127.38 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 64.51 110.938 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -69.6 79.35 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.175 0.512 . . . . 70.44 110.183 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -58.29 -22.19 51.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.856 0.687 . . . . 73.14 112.856 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.6 -23.7 58.77 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.706 0.632 . . . . 61.15 112.706 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -146.2 150.06 35.11 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.129 0.788 . . . . 74.31 113.129 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.566 HD22 ' HB3' ' A' ' 74' ' ' ALA . 16.5 m120 -75.3 -172.22 1.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.628 -0.715 . . . . 71.12 110.616 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.0 t -74.98 142.3 43.9 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.864 -0.523 . . . . 61.4 111.214 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -120.47 101.32 7.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.64 0.733 . . . . 74.14 111.821 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.22 135.74 12.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.163 -0.472 . . . . 75.22 112.059 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -170.95 -42.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.863 0.69 . . . . 73.44 112.863 -176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.51 -15.72 62.68 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.007 -0.616 . . . . 64.23 113.024 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -56.89 131.94 51.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.74 0.305 . . . . 71.15 111.236 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 117' ' ' THR . 25.7 m-20 -60.95 114.5 3.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.295 0.569 . . . . 62.34 112.033 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 48' ' ' ILE . 3.8 p -106.05 136.81 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.727 -0.67 . . . . 72.12 111.41 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -115.85 132.44 56.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.232 0.539 . . . . 74.32 110.524 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.413 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 3.3 p -127.3 141.49 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.309 0.576 . . . . 35.32 112.446 -172.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.1 mm -107.47 140.67 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 60.13 111.618 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.799 HD11 HG13 ' A' ' 17' ' ' ILE . 76.1 mt -110.26 114.89 28.72 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.756 0.312 . . . . 70.04 111.694 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -106.16 140.29 39.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.956 0.408 . . . . 73.52 111.421 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 112' ' ' VAL . 10.6 m120 -87.16 -171.2 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.271 -0.422 . . . . 70.3 111.086 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.9 t -57.91 -36.75 72.9 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.185 0.439 . . . . 52.51 112.185 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -81.72 3.02 27.16 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.116 0.413 . . . . 51.13 112.116 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.61 -1.26 78.46 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.174 -0.536 . . . . 64.1 113.039 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.49 151.25 47.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.884 0.474 . . . . 70.11 111.223 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -101.79 119.27 38.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.881 0.372 . . . . 73.41 111.662 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 106' ' ' ASN . 18.8 m -106.41 -18.71 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.347 0.499 . . . . 52.15 112.347 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -155.04 142.75 19.85 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.575 0.583 . . . . 73.11 112.575 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.62 122.03 11.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.466 -0.788 . . . . 65.12 109.842 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -144.5 156.74 44.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.979 0.419 . . . . 73.02 112.076 -171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.7 p -133.28 175.36 9.47 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.962 0.411 . . . . 52.03 111.607 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 45.8 p -79.17 -176.38 5.1 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.991 0.424 . . . . 65.32 111.391 173.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.36 129.88 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.888 0.375 . . . . 63.3 111.015 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -59.71 95.59 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 72.53 112.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -126.67 150.63 48.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.051 -0.522 . . . . 61.42 111.176 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 86.5 m -121.5 92.62 3.79 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 63.44 110.703 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.843 -0.598 . . . . 73.11 111.801 -178.151 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.718 0.294 . . . . 61.34 111.383 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.71 -64.58 2.22 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.202 -0.523 . . . . 73.31 113.219 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.58 132.41 38.3 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.794 0.331 . . . . 73.12 111.224 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -149.73 -178.07 6.25 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.061 0.458 . . . . 44.5 111.893 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -115.09 177.26 4.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.956 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -155.32 157.91 37.92 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.689 -0.232 . . . . 72.12 110.429 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -71.05 161.71 30.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.657 0.614 . . . . 74.3 112.657 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -147.86 109.19 4.32 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.82 -0.627 . . . . 74.14 110.989 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 m -117.3 156.88 27.04 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.95 0.405 . . . . 70.43 111.51 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -125.56 178.61 5.55 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.132 0.491 . . . . 74.01 111.538 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -125.17 129.45 50.16 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.298 -0.41 . . . . 71.42 110.866 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -71.63 -23.65 61.73 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.332 0.493 . . . . 72.14 112.332 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.97 142.52 13.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.141 -0.552 . . . . 61.11 112.843 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -131.98 91.78 3.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.13 0.49 . . . . 74.41 110.515 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.2 145.22 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.996 -0.547 . . . . 53.35 111.087 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.3 p -132.76 154.66 50.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.989 0.423 . . . . 74.51 111.634 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.63 111.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.321 -0.399 . . . . 55.25 110.796 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.83 -56.33 4.35 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.44 111.835 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.58 123.77 6.38 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.231 0.538 . . . . 74.24 112.39 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.62 HG23 HG12 ' A' ' 27' ' ' ILE . 72.2 mt -89.16 140.33 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.878 -0.601 . . . . 71.13 110.624 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.5 143.07 40.67 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.104 0.478 . . . . 73.11 111.472 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -85.82 -25.86 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.562 0.578 . . . . 73.11 112.562 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.83 -21.13 41.06 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.182 0.515 . . . . 71.0 111.009 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 94' ' ' TRP . . . 103.45 20.21 11.3 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.796 -0.638 . . . . 55.01 113.256 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -79.72 -48.58 13.41 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.396 0.517 . . . . 74.32 112.396 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -160.81 173.25 15.65 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.489 0.922 . . . . 63.43 113.489 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 20' ' ' ILE . 57.0 mt -133.85 121.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.469 -0.787 . . . . 64.5 109.794 170.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -101.4 123.58 45.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.744 -0.597 . . . . 63.35 112.19 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -110.72 172.45 6.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.021 -0.536 . . . . 63.23 110.941 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 68' ' ' THR . 7.1 ttpm? -150.61 138.14 19.68 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.007 0.432 . . . . 72.25 111.998 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -78.73 114.52 17.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.144 -0.48 . . . . 51.21 110.919 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -102.76 12.81 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.919 0.39 . . . . 74.14 111.876 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 t -77.57 164.55 25.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.06 0.457 . . . . 53.51 111.426 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -85.91 5.98 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.2 0.444 . . . . 74.53 112.2 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 60.3 tt0 -146.43 159.9 42.79 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.686 0.279 . . . . 73.35 111.354 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 35' ' ' GLN . 32.1 m-20 -63.85 115.29 4.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.817 0.341 . . . . 71.22 110.409 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.2 mm-40 -105.71 146.19 32.34 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.333 0.494 . . . . 73.51 112.333 -172.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' GLN . 9.2 Cg_exo -72.8 103.22 1.54 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.644 2.23 . . . . 54.2 112.486 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.608 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 tpt -59.88 -28.46 67.57 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 71.33 111.501 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.802 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -72.18 5.04 15.58 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 114.539 0.576 . . . . 73.12 114.539 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.29 8.78 69.62 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.92 -0.657 . . . . 42.13 113.127 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 23.6 m95 -119.03 170.89 8.66 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.599 0.592 . . . . 74.53 112.599 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -152.42 130.38 11.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 72.51 110.845 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 47.7 ttp -96.82 116.62 29.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 73.15 111.418 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 60.0 mt -105.4 113.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.809 0.338 . . . . 71.33 111.011 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HE ' ' HZ3' ' A' ' 88' ' ' TRP . 54.2 ttm-85 -98.88 118.15 34.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.246 0.461 . . . . 70.51 112.246 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -95.39 106.17 18.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.973 -0.38 . . . . 63.35 109.973 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG23 ' A' ' 100' ' ' VAL . 10.6 tt -116.62 107.23 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.531 0.681 . . . . 71.24 112.699 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.6 -93.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.658 -0.701 . . . . 53.04 114.079 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -107.54 -17.42 14.11 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.287 0.477 . . . . 61.34 112.287 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.8 t -128.21 -172.67 2.75 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.044 0.45 . . . . 73.21 112.093 -175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 p -154.15 146.6 24.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.115 0.483 . . . . 74.24 111.693 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.438 HG13 ' HH2' ' A' ' 88' ' ' TRP . 7.7 p -153.52 145.29 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.06 -0.518 . . . . 64.45 110.404 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.6 p -120.74 168.36 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.296 0.85 . . . . 50.43 113.296 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . 29.7 t80 -139.91 110.81 6.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.246 -0.888 . . . . 74.24 110.944 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -79.75 124.27 28.45 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.683 0.278 . . . . 64.54 110.327 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -68.53 105.83 2.36 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.967 0.413 . . . . 73.42 111.619 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t -71.36 121.98 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.231 0.538 . . . . 62.42 111.226 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.802 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 32.9 t -83.1 82.49 8.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.132 0.491 . . . . 74.52 112.247 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.769 ' HD2' ' HG2' ' A' ' 82' ' ' PRO . 11.6 ptp180 -104.6 4.19 32.53 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.829 0.347 . . . . 72.42 111.233 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HE1' HD21 ' A' ' 86' ' ' LEU . 29.8 p90 -163.4 167.33 21.79 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.695 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.55 150.14 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.947 0.404 . . . . 74.21 111.804 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.608 HD22 ' SD ' ' A' ' 39' ' ' MET . 39.3 tp -101.96 102.14 12.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.165 0.507 . . . . 71.15 110.604 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -62.53 162.62 10.09 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.843 0.682 . . . . 75.45 112.843 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.58 122.02 15.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.112 -0.494 . . . . 62.34 111.444 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.92 20.42 76.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.211 -0.518 . . . . 74.01 113.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.441 HE21 ' N ' ' A' ' 68' ' ' THR . 31.1 tp60 -96.45 132.94 41.49 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.94 0.4 . . . . 75.11 111.99 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 30' ' ' LYS . 74.4 p -93.63 145.86 24.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.771 175.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.09 146.14 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.67 0.388 . . . . 62.3 111.29 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.88 129.8 53.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.958 0.355 . . . . 62.42 111.958 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.91 103.69 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.649 0.261 . . . . 75.24 110.944 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' HG13 ' A' ' 87' ' ' ILE . 80.5 m95 -83.45 166.69 18.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.579 -0.282 . . . . 64.13 111.432 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.05 94.31 4.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.815 0.672 . . . . 70.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 92' ' ' ASN . . . 47.47 -82.57 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.232 1.197 . . . . 74.21 114.232 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -77.46 36.24 0.19 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.544 0.572 . . . . 73.15 112.544 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.08 -11.77 59.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.771 0.319 . . . . 73.24 111.552 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.24 -42.4 2.56 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.331 -0.462 . . . . 54.52 113.52 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.2 m -55.42 158.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.765 0.654 . . . . 50.21 112.765 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.8 p -68.21 136.45 53.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.083 -0.508 . . . . 63.54 111.597 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -83.0 39.01 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.144 0.424 . . . . 74.42 112.144 -176.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.2 m -130.24 102.95 16.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 112.563 0.579 . . . . 72.1 112.563 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 28.4 Cg_exo -44.5 -164.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.397 0 C-N-CA 124.532 3.488 . . . . 70.23 114.238 168.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . 2.4 Cg_endo -84.51 1.42 61.15 Favored 'Cis proline' 0 C--N 1.371 1.714 0 CA-C-N 120.982 1.386 . . . . 64.35 114.153 11.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.0 p -67.15 -71.63 0.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.487 0.551 . . . . 54.24 112.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 82' ' ' PRO . 5.4 m-20 -121.51 169.38 10.72 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.097 0.475 . . . . 75.13 112.216 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.451 HD21 ' HE1' ' A' ' 61' ' ' TYR . 81.8 mt -115.82 134.69 54.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.375 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 80' ' ' ALA . 2.5 mp -109.14 114.32 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.949 0.404 . . . . 72.21 111.245 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.593 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 15.9 t90 -84.52 110.33 18.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.981 0.42 . . . . 72.14 110.766 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -84.3 -11.48 56.32 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.645 0.98 . . . . 72.14 113.645 -171.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.97 -54.52 9.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.313 0.486 . . . . 73.3 112.313 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.429 ' NE2' ' HB3' ' A' ' 94' ' ' TRP . 64.7 tt0 -85.95 123.78 31.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.815 0.341 . . . . 62.2 111.735 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 19.1 m120 -83.17 52.98 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.852 0.316 . . . . 53.15 111.852 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.2 t 66.6 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.323 0.582 . . . . 45.1 112.2 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.547 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 42.3 p90 -106.23 171.78 7.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.484 -0.326 . . . . 72.23 111.117 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.01 105.72 0.28 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.555 -0.831 . . . . 42.04 113.234 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 t -151.68 -50.17 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.329 0.492 . . . . 72.24 112.329 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.55 -29.34 2.38 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.167 -0.54 . . . . 61.44 112.426 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -71.16 144.87 50.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.628 0.251 . . . . 71.11 111.037 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 23.1 m-20 -75.72 104.3 6.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.693 0.627 . . . . 74.43 112.693 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 48' ' ' ILE . 4.3 p -81.53 127.11 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.744 -0.662 . . . . 74.34 110.896 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 36.8 ttpt -97.79 115.84 28.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.331 0.586 . . . . 73.53 111.905 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 135.36 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.904 -0.589 . . . . 75.44 111.462 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 114' ' ' GLN . 27.6 mm -116.52 141.91 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 116.111 -0.495 . . . . 74.11 111.488 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 113' ' ' ALA . 76.6 mt -115.35 118.22 32.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.953 0.406 . . . . 63.44 111.79 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 111' ' ' GLU . 57.9 mttp -125.32 160.22 29.83 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.313 -0.403 . . . . 73.05 110.951 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 17.1 m120 -99.18 -178.65 3.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 73.45 111.826 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -50.63 -43.36 56.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.16 0.8 . . . . 74.12 113.16 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.47 1.48 13.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.411 0.522 . . . . 73.42 112.411 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.44 84.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.235 -0.507 . . . . 52.5 113.094 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 7.3 pt-20 -78.76 137.94 37.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.922 0.391 . . . . 64.24 111.059 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 38.8 tt0 -102.0 137.12 40.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 111.853 0.316 . . . . 73.31 111.853 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 113' ' ' ALA . 27.1 m -127.89 -47.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 113.008 0.744 . . . . 71.31 113.008 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -132.19 156.19 46.88 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.169 0.433 . . . . 73.34 112.169 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 103' ' ' ILE . 3.3 pt20 -175.4 150.18 1.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.331 -0.395 . . . . 64.31 111.408 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 116' ' ' SER . 35.7 ttp180 -173.52 159.32 3.61 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.897 0.379 . . . . 55.02 111.52 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' LYS . 92.3 p -86.71 -169.35 2.59 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.135 0.493 . . . . 62.42 111.029 172.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 99' ' ' ASP . 31.7 p -87.85 -167.91 2.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.976 0.417 . . . . 60.21 111.51 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 120' ' ' LYS . 40.6 t -90.29 109.13 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.064 0.459 . . . . 74.31 111.377 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -79.17 21.78 0.44 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.515 0.561 . . . . 62.41 112.515 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' H ' HG12 ' A' ' 118' ' ' VAL . 62.5 tttm -58.02 98.74 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.142 0.496 . . . . 51.31 112.123 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 32.9 m -90.5 142.45 27.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.093 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.201 -0.904 . . . . 64.45 112.418 -176.615 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptt? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.106 0.479 . . . . 71.12 111.181 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.03 114.57 2.56 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-N 116.143 -0.48 . . . . 63.31 112.134 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -92.41 -57.43 2.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.0 0.429 . . . . 75.14 112.057 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -102.66 110.94 23.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.714 0.292 . . . . 72.23 111.154 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -148.33 87.11 1.57 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.268 0.556 . . . . 71.25 111.833 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -147.24 144.87 29.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.227 -0.442 . . . . 73.25 110.968 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -80.67 97.12 7.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.35 0.595 . . . . 74.3 110.212 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -87.03 9.62 19.07 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.26 0.837 . . . . 71.11 113.26 -171.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -63.07 125.98 25.83 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.84 0.352 . . . . 63.24 111.0 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -101.73 133.51 46.34 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.949 0.404 . . . . 73.44 111.702 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.624 ' SD ' ' NE2' ' A' ' 37' ' ' GLN . 21.9 mmt -70.54 114.6 8.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.852 0.358 . . . . 64.24 110.741 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -65.06 -17.53 64.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.095 0.776 . . . . 71.43 113.095 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.72 94.49 1.24 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.087 -0.577 . . . . 55.02 112.273 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 32' ' ' THR . 17.2 m-80 -115.8 8.17 14.77 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.657 0.614 . . . . 73.12 112.657 -172.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.88 130.76 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 75.55 112.031 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.7 p -129.15 177.37 7.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.132 -0.485 . . . . 33.32 110.637 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.88 127.55 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 122.007 -0.433 . . . . 61.43 110.721 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.71 -51.45 3.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.37 0.508 . . . . 61.52 112.37 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -147.86 138.1 22.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.075 0.464 . . . . 71.21 112.062 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 27' ' ' ILE . 53.3 mt -132.9 139.93 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.256 -0.429 . . . . 70.1 111.054 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -85.59 126.22 33.72 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.03 0.443 . . . . 63.33 110.925 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.36 -26.4 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.241 0.46 . . . . 73.42 112.241 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.12 -37.1 80.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.872 0.368 . . . . 70.24 111.688 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 94' ' ' TRP . . . 119.58 57.86 0.25 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.262 -0.494 . . . . 71.25 113.472 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -129.81 -57.49 1.11 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.49 0.552 . . . . 74.35 112.49 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.76 161.8 38.35 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.477 0.917 . . . . 75.12 113.477 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 20' ' ' ILE . 63.6 mt -128.49 160.92 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 114.873 -1.058 . . . . 72.14 108.634 173.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 28' ' ' ARG . 38.2 ttp-105 -147.2 122.1 10.0 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.251 -0.906 . . . . 70.45 112.554 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.8 mp -97.08 172.68 7.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.742 -0.663 . . . . 74.42 110.507 175.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HG3' HG22 ' A' ' 68' ' ' THR . 74.4 tttt -142.59 121.06 12.43 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.834 0.349 . . . . 73.21 111.213 -175.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -82.01 86.27 6.59 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.238 0.542 . . . . 41.31 111.272 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 14' ' ' ASN . 71.8 p -83.65 87.72 7.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.227 -0.442 . . . . 62.52 110.293 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.5 t -131.46 164.19 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.108 0.781 . . . . 43.01 113.108 -168.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -81.14 -26.62 35.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.945 -1.025 . . . . 72.13 110.647 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -140.35 162.4 35.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.644 -0.707 . . . . 74.5 110.488 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -68.98 109.82 4.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.862 0.363 . . . . 65.23 110.182 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.624 ' NE2' ' SD ' ' A' ' 11' ' ' MET . 14.2 mm100 -103.02 138.6 19.59 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.682 0.623 . . . . 72.42 112.682 -170.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 84.3 Cg_endo -75.94 46.51 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.87 2.38 . . . . 75.24 113.348 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' MET . 6.4 tpt 63.11 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.87 0.468 . . . . 44.52 112.179 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.48 172.55 23.92 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.491 -0.385 . . . . 74.2 113.467 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.91 78.88 1.64 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.984 -0.627 . . . . 61.22 113.386 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -99.38 142.45 30.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.661 -0.317 . . . . 73.25 111.597 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -115.57 115.14 25.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.345 . . . . 73.22 110.478 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.47 ' HE1' HG21 ' A' ' 71' ' ' ILE . 44.9 ttp -99.44 105.91 17.9 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.89 0.33 . . . . 74.31 111.89 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.655 HG13 ' HB3' ' A' ' 54' ' ' SER . 3.5 mp -91.08 118.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.56 -0.291 . . . . 63.34 111.313 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' A' ' 88' ' ' TRP . 55.0 ttp180 -94.35 93.79 7.91 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.06 0.457 . . . . 70.41 111.209 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.4 84.42 5.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.484 0.659 . . . . 61.34 111.456 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 96' ' ' THR . 16.5 tt -78.8 -14.57 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.606 -0.724 . . . . 71.3 110.787 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.03 -152.84 10.2 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.583 -0.735 . . . . 62.32 111.828 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.13 82.35 5.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.381 0.61 . . . . 73.32 109.963 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -167.18 -179.3 4.5 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.501 -0.772 . . . . 64.04 110.76 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.3 p -142.13 105.93 4.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.046 0.451 . . . . 74.45 111.605 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.477 HG21 ' NE2' ' A' ' 91' ' ' GLN . 7.1 p -138.2 137.68 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.221 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' HG13 ' A' ' 45' ' ' ILE . 81.2 p -145.94 161.27 40.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.01 0.744 . . . . 75.11 113.01 -174.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -126.77 126.64 43.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.181 -0.918 . . . . 74.55 109.785 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.15 141.21 28.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.055 0.455 . . . . 75.14 111.577 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -83.81 -178.6 7.05 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.995 -0.548 . . . . 72.44 111.631 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -144.35 149.76 36.69 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.161 0.43 . . . . 41.53 112.161 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 t -91.91 16.25 11.39 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.114 -0.494 . . . . 73.21 111.762 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HG3' ' HD2' ' A' ' 61' ' ' TYR . 12.0 ptm180 -72.8 2.18 7.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.777 0.658 . . . . 72.34 112.777 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HD2' ' HG3' ' A' ' 60' ' ' ARG . 51.4 p90 -148.6 164.5 34.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 74.55 111.328 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 61.4 t -112.77 119.16 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.907 0.384 . . . . 72.14 111.315 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.92 116.79 29.16 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.965 0.412 . . . . 64.43 110.19 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -58.44 153.58 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.687 0.625 . . . . 74.21 112.687 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.51 133.16 46.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.415 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.43 18.35 79.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.165 -0.54 . . . . 72.11 113.074 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.88 147.13 37.67 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.668 -0.313 . . . . 54.12 110.778 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 30' ' ' LYS . 43.1 p -95.8 171.4 8.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.354 0.597 . . . . 71.41 112.119 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.02 122.76 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.038 -0.528 . . . . 64.13 110.656 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.5 m -94.85 124.57 38.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.493 0.553 . . . . 73.11 112.493 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 86' ' ' LEU . 31.0 mm -94.88 136.38 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.83 -0.623 . . . . 54.11 110.492 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 85' ' ' ASP . 90.4 m95 -117.24 179.36 4.06 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.907 0.384 . . . . 54.13 111.936 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -84.36 156.37 21.89 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.654 -0.248 . . . . 64.4 111.42 176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.67 -46.0 1.77 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.368 0.877 . . . . 70.03 113.368 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -129.28 74.39 1.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.129 0.49 . . . . 61.41 110.599 174.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.02 -3.48 54.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 52.3 112.105 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -41.68 2.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.367 -0.444 . . . . 75.41 113.086 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.05 172.94 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.034 0.445 . . . . 74.03 112.009 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.3 p -63.35 139.56 58.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 54.22 112.031 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.47 70.29 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.833 0.679 . . . . 62.23 112.833 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.1 p -139.57 98.68 7.94 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.999 0.428 . . . . 64.11 111.703 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.57 ' N ' ' HA ' ' A' ' 83' ' ' PRO . 74.9 Cg_exo -52.79 -43.03 59.23 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.003 2.469 . . . . 72.52 115.324 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 82' ' ' PRO . 77.4 Cg_endo -99.27 109.91 0.41 Allowed 'Cis proline' 0 C--N 1.368 1.597 0 CA-C-N 121.301 1.5 . . . . 74.1 113.738 -2.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.44 ' N ' ' HB2' ' A' ' 82' ' ' PRO . 53.1 p -139.08 -66.0 0.48 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.258 0.623 . . . . 72.33 109.505 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 3.9 m-20 -73.11 130.82 41.14 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.836 -0.62 . . . . 74.23 109.739 167.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 71' ' ' ILE . 87.7 mt -100.26 108.38 20.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.15 0.5 . . . . 61.52 111.918 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.7 mp -77.04 131.1 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.004 0.431 . . . . 62.23 111.183 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 46' ' ' ARG . 2.0 t90 -70.91 77.06 0.64 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.437 0.636 . . . . 75.55 110.214 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 7.6 mtpm? -68.57 -2.11 8.21 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.07 0.767 . . . . 75.01 113.07 -175.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.96 -12.78 20.34 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.487 0.551 . . . . 70.12 112.487 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.477 ' NE2' HG21 ' A' ' 53' ' ' VAL . 36.1 tt0 -164.54 143.32 7.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.041 0.448 . . . . 73.15 111.363 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -75.24 -164.22 0.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.724 0.773 . . . . 72.51 112.971 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -62.37 178.38 0.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.92 -1.037 . . . . 73.22 112.797 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.57 ' CE2' ' HA2' ' A' ' 24' ' ' GLY . 37.1 p90 -141.8 167.76 21.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.715 -0.675 . . . . 75.14 110.443 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.15 66.35 0.02 OUTLIER Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.552 -0.832 . . . . 54.02 113.702 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 48' ' ' ILE . 47.0 p -78.78 -65.93 0.93 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.964 0.412 . . . . 53.21 111.445 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.03 -32.22 1.69 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.169 -0.468 . . . . 74.45 113.094 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.43 -63.38 1.09 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.477 0.547 . . . . 73.34 112.477 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -177.43 158.77 1.46 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.715 0.293 . . . . 62.32 110.686 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.31 89.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.846 0.831 . . . . 70.43 110.351 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 103' ' ' ILE . 87.6 tttt -91.31 126.61 36.45 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.641 -0.709 . . . . 74.13 111.783 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.6 t -118.74 136.56 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.041 0.448 . . . . 72.41 111.657 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 101' ' ' LYS . 45.7 mm -122.34 138.88 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.054 -0.521 . . . . 52.42 111.039 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 113' ' ' ALA . 78.4 mt -110.63 113.99 27.03 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.253 0.464 . . . . 74.5 112.253 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -108.16 156.18 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.097 0.475 . . . . 62.22 110.623 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . 12.7 m120 -99.21 179.07 4.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.051 0.453 . . . . 74.04 111.68 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.7 t -46.96 -40.68 14.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.42 0.896 . . . . 72.21 113.42 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.83 14.77 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.666 0.617 . . . . 70.01 112.666 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.55 -21.56 10.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.334 -0.46 . . . . 64.03 112.881 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 10.7 pt-20 -52.6 125.38 16.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.259 0.624 . . . . 62.55 111.937 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.88 136.81 35.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.796 -0.638 . . . . 74.15 111.436 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 ' H ' ' A' ' 113' ' ' ALA . 12.7 m -125.08 -60.83 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.104 0.779 . . . . 75.34 113.104 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -105.07 154.45 20.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.38 0.511 . . . . 75.05 112.38 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.73 154.96 33.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.989 -0.551 . . . . 72.33 111.287 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 115' ' ' ARG . 15.9 ttm180 -166.58 123.86 1.32 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.366 0.876 . . . . 64.42 113.366 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -105.18 129.85 53.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.688 -0.856 . . . . 73.12 108.688 164.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.2 p -68.45 -94.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.903 0.705 . . . . 70.13 112.903 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.47 130.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.296 0.569 . . . . 65.13 111.301 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -87.38 29.62 0.85 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.179 -0.464 . . . . 70.12 111.85 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -74.87 -5.23 42.51 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.029 0.442 . . . . 70.51 111.907 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.0 t -63.46 0.09 0.79 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.929 0.714 . . . . 73.05 112.929 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.3 p . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.632 -0.699 . . . . 61.31 112.064 177.458 . . . . . . . . 0 0 . 1 stop_ save_